Upload 180 files
Browse filesThis view is limited to 50 files because it contains too many changes. See raw diff
- Dockerfile +46 -0
- README.md +63 -12
- UPLOAD.md +138 -0
- config/.env.example +21 -0
- config/batch07_rows.json +542 -0
- config/batch08_rows.json +542 -0
- config/batch09_rows.json +542 -0
- config/batch10_rows.json +542 -0
- config/catalog_300_run_summary.json +0 -0
- config/catalog_batch_run_summary.json +123 -0
- config/catalog_batch_run_summary_100-129.json +484 -0
- config/catalog_batch_run_summary_130-139.json +165 -0
- config/catalog_batch_run_summary_140-149.json +169 -0
- config/catalog_batch_run_summary_150-159.json +171 -0
- config/catalog_batch_run_summary_160-169.json +168 -0
- config/catalog_batch_run_summary_170-179.json +168 -0
- config/catalog_batch_run_summary_180-189.json +169 -0
- config/catalog_batch_run_summary_190-199.json +168 -0
- config/catalog_batch_run_summary_200-209.json +170 -0
- config/catalog_batch_run_summary_210-219.json +169 -0
- config/catalog_batch_run_summary_220-229.json +168 -0
- config/catalog_batch_run_summary_230-239.json +170 -0
- config/catalog_batch_run_summary_240-249.json +168 -0
- config/catalog_batch_run_summary_25-29_90-99.json +251 -0
- config/catalog_batch_run_summary_250-259.json +170 -0
- config/catalog_batch_run_summary_260-269.json +168 -0
- config/catalog_batch_run_summary_270-279.json +169 -0
- config/catalog_batch_run_summary_280-289.json +169 -0
- config/catalog_batch_run_summary_290-300.json +187 -0
- config/catalog_batch_run_summary_30-39.json +171 -0
- config/catalog_batch_run_summary_40-49.json +171 -0
- config/catalog_batch_run_summary_50-59.json +171 -0
- config/catalog_batch_run_summary_60-69.json +170 -0
- config/catalog_batch_run_summary_70-79.json +169 -0
- config/catalog_batch_run_summary_80-89.json +169 -0
- config/catalog_batch_run_summary_batch03.json +148 -0
- config/catalog_batch_run_summary_batch03_rerun.json +74 -0
- config/catalog_batch_run_summary_batch04.json +150 -0
- config/catalog_failure_review.json +159 -0
- config/catalog_het_audit.json +0 -0
- config/catalog_review_1-120.json +2035 -0
- config/catalog_review_1-129.json +2187 -0
- config/catalog_review_1-300.json +0 -0
- config/catalog_review_130-300.json +2942 -0
- config/drug_catalog_300_plan.csv +301 -0
- config/drug_catalog_300_summary.json +33 -0
- config/drug_catalog_batch01_30.csv +31 -0
- config/drug_catalog_batch02_30.csv +31 -0
- config/drug_catalog_batch03_30.csv +31 -0
- config/drug_catalog_batch04_30.csv +31 -0
Dockerfile
ADDED
|
@@ -0,0 +1,46 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
# DrugOps — Hugging Face Docker Space
|
| 2 |
+
FROM python:3.11-slim-bookworm
|
| 3 |
+
|
| 4 |
+
LABEL org.opencontainers.image.title="DrugOps"
|
| 5 |
+
LABEL org.opencontainers.image.description="Modular single-drug docking pipeline UI"
|
| 6 |
+
|
| 7 |
+
RUN apt-get update && apt-get install -y --no-install-recommends \
|
| 8 |
+
autodock-vina \
|
| 9 |
+
openbabel \
|
| 10 |
+
libxrender1 \
|
| 11 |
+
libxext6 \
|
| 12 |
+
libgomp1 \
|
| 13 |
+
libxml2 \
|
| 14 |
+
libxslt1.1 \
|
| 15 |
+
ca-certificates \
|
| 16 |
+
&& rm -rf /var/lib/apt/lists/*
|
| 17 |
+
|
| 18 |
+
WORKDIR /app
|
| 19 |
+
|
| 20 |
+
# Install Python deps inline (do not rely on requirements.txt upload alone)
|
| 21 |
+
RUN pip install --no-cache-dir --upgrade pip && \
|
| 22 |
+
pip install --no-cache-dir \
|
| 23 |
+
"flask>=2.3" \
|
| 24 |
+
"gunicorn>=21.0" \
|
| 25 |
+
"rdkit>=2022.09.1" \
|
| 26 |
+
"numpy>=1.24" \
|
| 27 |
+
"scipy>=1.10" \
|
| 28 |
+
"biopython>=1.81" \
|
| 29 |
+
meeko \
|
| 30 |
+
gemmi && \
|
| 31 |
+
python -c "from Bio.PDB import PDBParser; import rdkit, meeko, numpy, scipy; print('deps ok')"
|
| 32 |
+
|
| 33 |
+
COPY . /app
|
| 34 |
+
|
| 35 |
+
RUN chmod +x /app/huggingface/entrypoint.sh \
|
| 36 |
+
&& mkdir -p /app/data/sessions /app/data/pdb /app/data/examples
|
| 37 |
+
|
| 38 |
+
ENV MOLGATE_UI_HOME=/app \
|
| 39 |
+
MOLGATE_HOST=0.0.0.0 \
|
| 40 |
+
MOLGATE_HF_SPACE=1 \
|
| 41 |
+
MOLGATE_VINA_BIN=/usr/bin/vina \
|
| 42 |
+
PORT=7860
|
| 43 |
+
|
| 44 |
+
EXPOSE 7860
|
| 45 |
+
|
| 46 |
+
CMD ["/app/huggingface/entrypoint.sh"]
|
README.md
CHANGED
|
@@ -1,12 +1,63 @@
|
|
| 1 |
-
---
|
| 2 |
-
title: DrugOps
|
| 3 |
-
emoji:
|
| 4 |
-
colorFrom:
|
| 5 |
-
colorTo:
|
| 6 |
-
sdk: docker
|
| 7 |
-
|
| 8 |
-
|
| 9 |
-
|
| 10 |
-
-
|
| 11 |
-
|
| 12 |
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
---
|
| 2 |
+
title: DrugOps
|
| 3 |
+
emoji: ⚡
|
| 4 |
+
colorFrom: indigo
|
| 5 |
+
colorTo: blue
|
| 6 |
+
sdk: docker
|
| 7 |
+
app_port: 7860
|
| 8 |
+
pinned: false
|
| 9 |
+
license: mit
|
| 10 |
+
short_description: A modular single-drug docking pipeline
|
| 11 |
+
---
|
| 12 |
+
|
| 13 |
+
# DrugOps
|
| 14 |
+
|
| 15 |
+
**CreaDrug** 平台 · **DrugOps** — 27 Stage 品質管控分子對接 pipeline(Module 1→5)。
|
| 16 |
+
|
| 17 |
+
## 功能
|
| 18 |
+
|
| 19 |
+
| 模組 | 說明 |
|
| 20 |
+
|------|------|
|
| 21 |
+
| Module 1 | SMILES / PDB / Catalog 300 比對 |
|
| 22 |
+
| Module 2 | 配體質子化、tautomer、PDBQT |
|
| 23 |
+
| Module 3 | 蛋白清理、receptor 準備 |
|
| 24 |
+
| Module 4 | 口袋定義、HET 選擇 |
|
| 25 |
+
| Module 5 | AutoDock Vina docking + QC |
|
| 26 |
+
|
| 27 |
+
## Catalog 300
|
| 28 |
+
|
| 29 |
+
- `GET /api/catalog/lookup/smiles` — SMILES → catalog 條目
|
| 30 |
+
- `GET /api/catalog/batch-summary` — 300 例 batch 結果 browse
|
| 31 |
+
|
| 32 |
+
## 注意(Space 限制)
|
| 33 |
+
|
| 34 |
+
- **CPU only**:單次 docking 可能需數分鐘
|
| 35 |
+
- **無本地 PDB 快取**:請在 Module 1 勾選 allow network 下載 PDB
|
| 36 |
+
- **Session 不持久**:Space 重啟後 session 目錄清空
|
| 37 |
+
- **AI 助手**:需在 Space Settings → Secrets 設定 `DEEPSEEK_API_KEY`(選填)
|
| 38 |
+
|
| 39 |
+
## 本機開發
|
| 40 |
+
|
| 41 |
+
```bash
|
| 42 |
+
pip install -r huggingface/requirements.txt
|
| 43 |
+
export MOLGATE_GATEWAY_PORT=8780
|
| 44 |
+
python servers/gateway.py
|
| 45 |
+
```
|
| 46 |
+
|
| 47 |
+
Docker 建置:
|
| 48 |
+
|
| 49 |
+
```bash
|
| 50 |
+
docker build -f huggingface/Dockerfile -t creadrug-drugops .
|
| 51 |
+
docker run -p 7860:7860 creadrug-drugops
|
| 52 |
+
```
|
| 53 |
+
|
| 54 |
+
## 品牌
|
| 55 |
+
|
| 56 |
+
- 對外:**CreaDrug**
|
| 57 |
+
- Pipeline UI logo:**Drug** `#4a9eff` + **Ops** `#2dd4bf`
|
| 58 |
+
- 3D 展示:匯出 case 至 [CreaDrug Showboard](https://stromapath.com/creadrug24/creadrug_showboard_24)
|
| 59 |
+
|
| 60 |
+
## 論文 / CMD
|
| 61 |
+
|
| 62 |
+
Batch 結果與 CMD 版見 GitHub:
|
| 63 |
+
https://github.com/jackman993/MolGate-A-modular-single-drug-docking-pipeline
|
UPLOAD.md
ADDED
|
@@ -0,0 +1,138 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
# DrugOps → Hugging Face 網頁上傳指南
|
| 2 |
+
|
| 3 |
+
目標 Space:**https://huggingface.co/spaces/chihsing/DrugOps**
|
| 4 |
+
|
| 5 |
+
## 根目錄結構(上傳後 Space 根目錄應長這樣)
|
| 6 |
+
|
| 7 |
+
```text
|
| 8 |
+
DrugOps/ ← Space 根目錄
|
| 9 |
+
├── README.md ← HF 首頁卡片設定(yaml frontmatter)
|
| 10 |
+
├── index.html ← App 首頁(DrugOps UI 入口)
|
| 11 |
+
├── Dockerfile ← Docker 建置
|
| 12 |
+
├── requirements.txt
|
| 13 |
+
├── config/
|
| 14 |
+
├── engines/
|
| 15 |
+
├── huggingface/
|
| 16 |
+
├── molgate_ui/
|
| 17 |
+
├── servers/
|
| 18 |
+
├── ui/ ← 模組 panel、assets(index 備份在 ui/ 也可)
|
| 19 |
+
└── data/
|
| 20 |
+
```
|
| 21 |
+
|
| 22 |
+
| 根目錄檔案 | 用途 |
|
| 23 |
+
|------------|------|
|
| 24 |
+
| `README.md` | HF Space **About** 卡片(title、sdk、app_port) |
|
| 25 |
+
| `index.html` | 訪客開 App 時的 **DrugOps 首頁**(`/`) |
|
| 26 |
+
| `Dockerfile` | HF 建置容器 |
|
| 27 |
+
|
| 28 |
+
## 這包裡有什麼
|
| 29 |
+
|
| 30 |
+
| 內容 | 說明 |
|
| 31 |
+
|------|------|
|
| 32 |
+
| `Dockerfile` + `README.md` | HF Docker Space 建置入口 |
|
| 33 |
+
| `config/` | Catalog 300、master_index(**無** `.env` / API 金鑰) |
|
| 34 |
+
| `engines/` | Pipeline 引擎(**無** session 快取) |
|
| 35 |
+
| `molgate_ui/`、`servers/`、`ui/` | 完整 DrugOps UI |
|
| 36 |
+
| `huggingface/` | entrypoint、requirements |
|
| 37 |
+
| `data/examples/` | Ibuprofen 示範案例(可選) |
|
| 38 |
+
|
| 39 |
+
**已排除**:sessions(~1GB)、PDB 離線包(~194MB)、Windows vina.exe、論文、bat、金鑰。
|
| 40 |
+
|
| 41 |
+
**總大小**:約 9 MB,175 個檔案。
|
| 42 |
+
|
| 43 |
+
---
|
| 44 |
+
|
| 45 |
+
## 整包重推(你現在的做法 — 正確)
|
| 46 |
+
|
| 47 |
+
HF 無法單刪檔案時:**刪光 Space → 整包重上傳**,這是對的。
|
| 48 |
+
重點只有一個:**上傳的是 `DrugOps-HF-upload`「裡面」的內容,維持資料夾層級,不要拆散丟根目錄。**
|
| 49 |
+
|
| 50 |
+
### 上傳後 Space 根目錄應直接看到
|
| 51 |
+
|
| 52 |
+
```text
|
| 53 |
+
README.md
|
| 54 |
+
index.html ← 首頁(訪客開 / 用這個)
|
| 55 |
+
Dockerfile
|
| 56 |
+
requirements.txt
|
| 57 |
+
config/
|
| 58 |
+
engines/ ← 在根目錄是對的,不是放錯
|
| 59 |
+
molgate_ui/
|
| 60 |
+
servers/
|
| 61 |
+
ui/
|
| 62 |
+
huggingface/
|
| 63 |
+
data/
|
| 64 |
+
```
|
| 65 |
+
|
| 66 |
+
### 根目錄「不應」出現這些(以前放錯會失效)
|
| 67 |
+
|
| 68 |
+
```text
|
| 69 |
+
module3_panel.html ✗ 應在 ui/modules/m3/
|
| 70 |
+
module5_panel.html ✗ 應在 ui/modules/m5/
|
| 71 |
+
molgate.js ✗ 應在 ui/assets/
|
| 72 |
+
gateway.py ✗ 應在 servers/
|
| 73 |
+
paths.py ✗ 應在 molgate_ui/
|
| 74 |
+
```
|
| 75 |
+
|
| 76 |
+
### `ui/index.html` 是什麼?
|
| 77 |
+
|
| 78 |
+
- **根目錄 `index.html`**:程式優先讀這個,**首頁就是它**。
|
| 79 |
+
- **`ui/index.html`**:同內容的**備份**;只有根目錄沒有 `index.html` 時才會用到。
|
| 80 |
+
- **你整包重推時兩個一起上傳即可**,不必單獨管 `ui/index.html`;改首頁只改根目錄 `index.html`(本包兩份已同步)。
|
| 81 |
+
|
| 82 |
+
### 這次 UI 修正實際在包內的路徑
|
| 83 |
+
|
| 84 |
+
| 改什麼 | 包內路徑 |
|
| 85 |
+
|--------|----------|
|
| 86 |
+
| 首頁去掉 HF demo 橫幅 | `index.html`(根目錄) |
|
| 87 |
+
| Module 3 · 4~8 分鐘 | `ui/modules/m3/module3_panel.html` |
|
| 88 |
+
| Module 5 · 3D 固定按鈕 | `ui/modules/m5/module5_panel.html` |
|
| 89 |
+
| 3D session 串接 | `ui/assets/molgate.js`、`servers/gateway.py`、`molgate_ui/paths.py` |
|
| 90 |
+
|
| 91 |
+
### 整包重推步驟
|
| 92 |
+
|
| 93 |
+
1. 本機確認資料夾:`C:\Users\User\Downloads\DrugOps-HF-upload\`
|
| 94 |
+
2. HF Space 刪光舊檔(你平常做法)
|
| 95 |
+
3. **Add file → Upload**:把該資料夾**裡面全部**拖進去(含 `engines/`、`ui/` 等子資料夾)
|
| 96 |
+
4. Commit,等 Building 完成
|
| 97 |
+
5. 強刷 `https://huggingface.co/spaces/chihsing/DrugOps`(Ctrl+F5)
|
| 98 |
+
6. 檢查:首頁無 `CPU demo` 字樣;Module 3 的 Engine C 標題旁有 `預估 4~8 分鐘`
|
| 99 |
+
|
| 100 |
+
---
|
| 101 |
+
|
| 102 |
+
## 上傳步驟
|
| 103 |
+
|
| 104 |
+
1. 開啟 https://huggingface.co/spaces/chihsing/DrugOps
|
| 105 |
+
2. 點 **Files and versions**
|
| 106 |
+
3. 若 Space 裡已有預設檔案(如 `.gitattributes`),可保留
|
| 107 |
+
4. 點 **Add file** → **Upload files**
|
| 108 |
+
5. 把本資料夾 `DrugOps-HF-upload` **裡面的所有檔案與資料夾**拖進去
|
| 109 |
+
- ⚠️ 不要上傳整個 zip;要的是解壓後的內容
|
| 110 |
+
- ⚠️ **根目錄**必須直接看到:`README.md`、`index.html`、`Dockerfile`
|
| 111 |
+
6. Commit message:`CreaDrug DrugOps initial deploy`
|
| 112 |
+
7. 等 **Building** 完成(約 5–15 分鐘)
|
| 113 |
+
|
| 114 |
+
---
|
| 115 |
+
|
| 116 |
+
## 建置完成後驗證
|
| 117 |
+
|
| 118 |
+
- App 首頁能開
|
| 119 |
+
- `GET /api/health`
|
| 120 |
+
- `GET /api/catalog/batch-summary`
|
| 121 |
+
- Module 1 貼 SMILES → catalog 提示
|
| 122 |
+
|
| 123 |
+
---
|
| 124 |
+
|
| 125 |
+
## 選填 Secrets(Space Settings)
|
| 126 |
+
|
| 127 |
+
| Secret | 用途 |
|
| 128 |
+
|--------|------|
|
| 129 |
+
| `DEEPSEEK_API_KEY` | AI 助手 |
|
| 130 |
+
| `CREADRUG_URL` | 3D 連到 CreaDrug showboard |
|
| 131 |
+
|
| 132 |
+
---
|
| 133 |
+
|
| 134 |
+
## 注意
|
| 135 |
+
|
| 136 |
+
- Space 上 **無本地 PDB 快取**:Module 1 請勾選 allow network 下載 PDB
|
| 137 |
+
- **CPU only**:單次 docking 可能需數分鐘
|
| 138 |
+
- Session 不持久:Space 重啟後清空
|
config/.env.example
ADDED
|
@@ -0,0 +1,21 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
# Copy to config/.env or package root .env
|
| 2 |
+
|
| 3 |
+
# HTTP entry port (default 8780 — see config/ui_ports.json)
|
| 4 |
+
# MOLGATE_GATEWAY_PORT=8780
|
| 5 |
+
|
| 6 |
+
# CreaDrug24(DrugOps 匯出 case 目標;預設 ../CreaDrug24)
|
| 7 |
+
CREADRUG_ROOT=C:\Users\User\Downloads\CreaDrug24
|
| 8 |
+
# 本機 gateway 代理:/creadrug24/creadrug_showboard_24.html
|
| 9 |
+
# 線上 stromapath:CREADRUG_URL=https://stromapath.com/creadrug24/creadrug_showboard_24
|
| 10 |
+
# CREADRUG_URL=/creadrug24/creadrug_showboard_24.html
|
| 11 |
+
|
| 12 |
+
# AutoDock Vina(預設:<套件根>/tools/vina/vina.exe)
|
| 13 |
+
# MOLGATE_VINA_BIN=C:\Users\User\Downloads\moltgate_UI\tools\vina\vina.exe
|
| 14 |
+
|
| 15 |
+
LLM_PROVIDER=deepseek
|
| 16 |
+
DEEPSEEK_API_KEY=sk-your-key-here
|
| 17 |
+
DEEPSEEK_MODEL=deepseek-chat
|
| 18 |
+
|
| 19 |
+
# ReasonMind(網頁 /reasonmind 與 deepseek_tg.py 共用)
|
| 20 |
+
REASONMIND_MODEL=deepseek-reasoner
|
| 21 |
+
# TG_TOKEN=123456789:ABCdefGHI... # 選填:gateway 啟動時自動跑 Telegram bot
|
config/batch07_rows.json
ADDED
|
@@ -0,0 +1,542 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
[
|
| 2 |
+
{
|
| 3 |
+
"drug_id": 181,
|
| 4 |
+
"symptom_group": "METABOLIC",
|
| 5 |
+
"group_slot": 59,
|
| 6 |
+
"index_key": "CAPTOPRIL_ACE",
|
| 7 |
+
"canonical_name": "Captopril",
|
| 8 |
+
"smiles": "CSCCC(=O)N1CCC[C@H]1C(=O)O",
|
| 9 |
+
"target_label": "ACE",
|
| 10 |
+
"family": "metalloprotease",
|
| 11 |
+
"pdb_id": "1UZF",
|
| 12 |
+
"het_id": "CAP",
|
| 13 |
+
"state": "bound",
|
| 14 |
+
"anchor_mode": "direct",
|
| 15 |
+
"pocket_rule": "cocrystal_ligand:CAP",
|
| 16 |
+
"tier": "1",
|
| 17 |
+
"notes": "ACE-captopril co-crystal (1UZF/CAP)",
|
| 18 |
+
"batch": "07"
|
| 19 |
+
},
|
| 20 |
+
{
|
| 21 |
+
"drug_id": 182,
|
| 22 |
+
"symptom_group": "METABOLIC",
|
| 23 |
+
"group_slot": 60,
|
| 24 |
+
"index_key": "BENAZEPRIL_ACE_PROXY",
|
| 25 |
+
"canonical_name": "Benazepril",
|
| 26 |
+
"smiles": "C1CCC(CC1)C2=CC(=C(C=C2)CC(=O)O)C(=O)N[C@@H](CCC3=CC=CC=C3)C(=O)O",
|
| 27 |
+
"target_label": "ACE",
|
| 28 |
+
"family": "metalloprotease",
|
| 29 |
+
"pdb_id": "1O86",
|
| 30 |
+
"het_id": "LIS",
|
| 31 |
+
"state": "bound_proxy",
|
| 32 |
+
"anchor_mode": "proxy",
|
| 33 |
+
"pocket_rule": "surrogate_ace_ligand:LIS",
|
| 34 |
+
"tier": "2",
|
| 35 |
+
"notes": "ACE pocket via lisinopril site (1O86/LIS); benazepril is prodrug",
|
| 36 |
+
"batch": "07"
|
| 37 |
+
},
|
| 38 |
+
{
|
| 39 |
+
"drug_id": 183,
|
| 40 |
+
"symptom_group": "METABOLIC",
|
| 41 |
+
"group_slot": 61,
|
| 42 |
+
"index_key": "CHLORTHALIDONE_CA2_PROXY",
|
| 43 |
+
"canonical_name": "Chlorthalidone",
|
| 44 |
+
"smiles": "NS(=O)(=O)C1=C(Cl)C=CC(=C1)C2=C(C(=O)NC2=O)C3=CC=C(C=C3)Cl",
|
| 45 |
+
"target_label": "CA2",
|
| 46 |
+
"family": "metalloenzyme",
|
| 47 |
+
"pdb_id": "3HS4",
|
| 48 |
+
"het_id": "AZM",
|
| 49 |
+
"state": "bound_proxy",
|
| 50 |
+
"anchor_mode": "proxy",
|
| 51 |
+
"pocket_rule": "surrogate_ca2_ligand:AZM",
|
| 52 |
+
"tier": "2",
|
| 53 |
+
"notes": "CA2 template via acetazolamide (3HS4/AZM); thiazide-like diuretic",
|
| 54 |
+
"batch": "07"
|
| 55 |
+
},
|
| 56 |
+
{
|
| 57 |
+
"drug_id": 184,
|
| 58 |
+
"symptom_group": "METABOLIC",
|
| 59 |
+
"group_slot": 62,
|
| 60 |
+
"index_key": "AMILORIDE_ENAC_PROXY",
|
| 61 |
+
"canonical_name": "Amiloride",
|
| 62 |
+
"smiles": "NC(=N)NC(=O)C1=NC(Cl)=C(N)N=C1N",
|
| 63 |
+
"target_label": "ENaC",
|
| 64 |
+
"family": "ion_channel",
|
| 65 |
+
"pdb_id": "3HS4",
|
| 66 |
+
"het_id": "AZM",
|
| 67 |
+
"state": "bound_proxy",
|
| 68 |
+
"anchor_mode": "proxy",
|
| 69 |
+
"pocket_rule": "surrogate_diuretic_ligand:AZM",
|
| 70 |
+
"tier": "2",
|
| 71 |
+
"notes": "Exploratory ENaC blocker template; mechanism differs from CA2 site",
|
| 72 |
+
"batch": "07"
|
| 73 |
+
},
|
| 74 |
+
{
|
| 75 |
+
"drug_id": 185,
|
| 76 |
+
"symptom_group": "METABOLIC",
|
| 77 |
+
"group_slot": 63,
|
| 78 |
+
"index_key": "RANOLAZINE_SCN5A",
|
| 79 |
+
"canonical_name": "Ranolazine",
|
| 80 |
+
"smiles": "COC1=CC(=CC(=C1OC)OC)CCNCC(O)C2=CC=CC=C2",
|
| 81 |
+
"target_label": "SCN5A",
|
| 82 |
+
"family": "ion_channel",
|
| 83 |
+
"pdb_id": "2FBI",
|
| 84 |
+
"het_id": "RAN",
|
| 85 |
+
"state": "bound",
|
| 86 |
+
"anchor_mode": "direct",
|
| 87 |
+
"pocket_rule": "cocrystal_ligand:RAN",
|
| 88 |
+
"tier": "1",
|
| 89 |
+
"notes": "NaV1.5-ranolazine analog site (2FBI/RAN)",
|
| 90 |
+
"batch": "07"
|
| 91 |
+
},
|
| 92 |
+
{
|
| 93 |
+
"drug_id": 186,
|
| 94 |
+
"symptom_group": "METABOLIC",
|
| 95 |
+
"group_slot": 64,
|
| 96 |
+
"index_key": "BROMOCRIPTINE_DRD2",
|
| 97 |
+
"canonical_name": "Bromocriptine",
|
| 98 |
+
"smiles": "CC(C)CC1C(=O)N2CCCC2C3(N1C(=O)C(O3)(C(C)C)NC(=O)C4CC5=CC=CC=C5N4)C",
|
| 99 |
+
"target_label": "DRD2",
|
| 100 |
+
"family": "gpcr",
|
| 101 |
+
"pdb_id": "3PBL",
|
| 102 |
+
"het_id": "BRM",
|
| 103 |
+
"state": "bound",
|
| 104 |
+
"anchor_mode": "direct",
|
| 105 |
+
"pocket_rule": "cocrystal_ligand:BRM",
|
| 106 |
+
"tier": "1",
|
| 107 |
+
"notes": "D2 receptor-bromocriptine (3PBL/BRM)",
|
| 108 |
+
"batch": "07"
|
| 109 |
+
},
|
| 110 |
+
{
|
| 111 |
+
"drug_id": 187,
|
| 112 |
+
"symptom_group": "METABOLIC",
|
| 113 |
+
"group_slot": 65,
|
| 114 |
+
"index_key": "NIACIN_GPR109A",
|
| 115 |
+
"canonical_name": "Niacin",
|
| 116 |
+
"smiles": "C1=CN=CC=C1C(=O)O",
|
| 117 |
+
"target_label": "GPR109A",
|
| 118 |
+
"family": "gpcr",
|
| 119 |
+
"pdb_id": "3R7A",
|
| 120 |
+
"het_id": "NIA",
|
| 121 |
+
"state": "bound",
|
| 122 |
+
"anchor_mode": "direct",
|
| 123 |
+
"pocket_rule": "cocrystal_ligand:NIA",
|
| 124 |
+
"tier": "1",
|
| 125 |
+
"notes": "GPR109A-niacin co-crystal (3R7A/NIA)",
|
| 126 |
+
"batch": "07"
|
| 127 |
+
},
|
| 128 |
+
{
|
| 129 |
+
"drug_id": 188,
|
| 130 |
+
"symptom_group": "METABOLIC",
|
| 131 |
+
"group_slot": 66,
|
| 132 |
+
"index_key": "DIAZOXIDE_KATP_PROXY",
|
| 133 |
+
"canonical_name": "Diazoxide",
|
| 134 |
+
"smiles": "CC1=NS(=O)(=O)C2=C(N1)C=CC(=C2)Cl",
|
| 135 |
+
"target_label": "KATP",
|
| 136 |
+
"family": "ion_channel",
|
| 137 |
+
"pdb_id": "3SYQ",
|
| 138 |
+
"het_id": "GBL",
|
| 139 |
+
"state": "bound_proxy",
|
| 140 |
+
"anchor_mode": "proxy",
|
| 141 |
+
"pocket_rule": "surrogate_katp_ligand:GBL",
|
| 142 |
+
"tier": "2",
|
| 143 |
+
"notes": "KATP channel template via sulfonylurea site (3SYQ/GBL); diazoxide is channel opener",
|
| 144 |
+
"batch": "07"
|
| 145 |
+
},
|
| 146 |
+
{
|
| 147 |
+
"drug_id": 189,
|
| 148 |
+
"symptom_group": "METABOLIC",
|
| 149 |
+
"group_slot": 67,
|
| 150 |
+
"index_key": "SEMAGLUTIDE_GLP1R",
|
| 151 |
+
"canonical_name": "Semaglutide",
|
| 152 |
+
"smiles": "NCCCCC(N)C(=O)O",
|
| 153 |
+
"target_label": "GLP1R",
|
| 154 |
+
"family": "gpcr",
|
| 155 |
+
"pdb_id": "6X18",
|
| 156 |
+
"het_id": "SEM",
|
| 157 |
+
"state": "bound",
|
| 158 |
+
"anchor_mode": "direct",
|
| 159 |
+
"pocket_rule": "cocrystal_ligand:SEM",
|
| 160 |
+
"tier": "1",
|
| 161 |
+
"notes": "GLP-1R-semaglutide cryo-EM (6X18/SEM); peptide SMILES is placeholder",
|
| 162 |
+
"batch": "07"
|
| 163 |
+
},
|
| 164 |
+
{
|
| 165 |
+
"drug_id": 190,
|
| 166 |
+
"symptom_group": "METABOLIC",
|
| 167 |
+
"group_slot": 68,
|
| 168 |
+
"index_key": "EXENATIDE_GLP1R",
|
| 169 |
+
"canonical_name": "Exenatide",
|
| 170 |
+
"smiles": "NCCCCC(N)C(=O)O",
|
| 171 |
+
"target_label": "GLP1R",
|
| 172 |
+
"family": "gpcr",
|
| 173 |
+
"pdb_id": "5VAI",
|
| 174 |
+
"het_id": "EXN",
|
| 175 |
+
"state": "bound",
|
| 176 |
+
"anchor_mode": "direct",
|
| 177 |
+
"pocket_rule": "cocrystal_ligand:EXN",
|
| 178 |
+
"tier": "1",
|
| 179 |
+
"notes": "GLP-1R-exenatide cryo-EM (5VAI/EXN); peptide SMILES is placeholder",
|
| 180 |
+
"batch": "07"
|
| 181 |
+
},
|
| 182 |
+
{
|
| 183 |
+
"drug_id": 191,
|
| 184 |
+
"symptom_group": "INFLAM",
|
| 185 |
+
"group_slot": 60,
|
| 186 |
+
"index_key": "KETAMINE_NMDA",
|
| 187 |
+
"canonical_name": "Ketamine",
|
| 188 |
+
"smiles": "CNC1(CCCCC1=O)C2=CC=CC=C2Cl",
|
| 189 |
+
"target_label": "GRIN1",
|
| 190 |
+
"family": "ion_channel",
|
| 191 |
+
"pdb_id": "3UO9",
|
| 192 |
+
"het_id": "KET",
|
| 193 |
+
"state": "bound",
|
| 194 |
+
"anchor_mode": "direct",
|
| 195 |
+
"pocket_rule": "cocrystal_ligand:KET",
|
| 196 |
+
"tier": "1",
|
| 197 |
+
"notes": "NMDA receptor-ketamine site (3UO9/KET)",
|
| 198 |
+
"batch": "07"
|
| 199 |
+
},
|
| 200 |
+
{
|
| 201 |
+
"drug_id": 192,
|
| 202 |
+
"symptom_group": "INFLAM",
|
| 203 |
+
"group_slot": 61,
|
| 204 |
+
"index_key": "CODEINE_OPRM1_PROXY",
|
| 205 |
+
"canonical_name": "Codeine",
|
| 206 |
+
"smiles": "COC1=C(C=C2C(=C1)CCN(C)CC2)OC",
|
| 207 |
+
"target_label": "OPRM1",
|
| 208 |
+
"family": "gpcr",
|
| 209 |
+
"pdb_id": "8DZP",
|
| 210 |
+
"het_id": "MOR",
|
| 211 |
+
"state": "bound_proxy",
|
| 212 |
+
"anchor_mode": "proxy",
|
| 213 |
+
"pocket_rule": "surrogate_opioid_ligand:MOR",
|
| 214 |
+
"tier": "2",
|
| 215 |
+
"notes": "Mu-opioid receptor template via morphine site (8DZP/MOR)",
|
| 216 |
+
"batch": "07"
|
| 217 |
+
},
|
| 218 |
+
{
|
| 219 |
+
"drug_id": 193,
|
| 220 |
+
"symptom_group": "INFLAM",
|
| 221 |
+
"group_slot": 62,
|
| 222 |
+
"index_key": "BUPROPION_DAT",
|
| 223 |
+
"canonical_name": "Bupropion",
|
| 224 |
+
"smiles": "CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C",
|
| 225 |
+
"target_label": "DAT",
|
| 226 |
+
"family": "membrane_transporter",
|
| 227 |
+
"pdb_id": "4WNT",
|
| 228 |
+
"het_id": "BUP",
|
| 229 |
+
"state": "bound",
|
| 230 |
+
"anchor_mode": "direct",
|
| 231 |
+
"pocket_rule": "cocrystal_ligand:BUP",
|
| 232 |
+
"tier": "1",
|
| 233 |
+
"notes": "DAT-bupropion analog (4WNT/BUP)",
|
| 234 |
+
"batch": "07"
|
| 235 |
+
},
|
| 236 |
+
{
|
| 237 |
+
"drug_id": 194,
|
| 238 |
+
"symptom_group": "INFLAM",
|
| 239 |
+
"group_slot": 63,
|
| 240 |
+
"index_key": "MIRTAZAPINE_HTR2A_PROXY",
|
| 241 |
+
"canonical_name": "Mirtazapine",
|
| 242 |
+
"smiles": "CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42",
|
| 243 |
+
"target_label": "HTR2A",
|
| 244 |
+
"family": "gpcr",
|
| 245 |
+
"pdb_id": "6A93",
|
| 246 |
+
"het_id": "MIR",
|
| 247 |
+
"state": "bound_proxy",
|
| 248 |
+
"anchor_mode": "proxy",
|
| 249 |
+
"pocket_rule": "surrogate_5ht2a_ligand:MIR",
|
| 250 |
+
"tier": "2",
|
| 251 |
+
"notes": "5-HT2A receptor template (6A93/MIR); also alpha2 antagonist",
|
| 252 |
+
"batch": "07"
|
| 253 |
+
},
|
| 254 |
+
{
|
| 255 |
+
"drug_id": 195,
|
| 256 |
+
"symptom_group": "INFLAM",
|
| 257 |
+
"group_slot": 64,
|
| 258 |
+
"index_key": "TRAZODONE_HTR2A_PROXY",
|
| 259 |
+
"canonical_name": "Trazodone",
|
| 260 |
+
"smiles": "C1CC(=O)NC2=C1C=CC(=C2)OCCN3CCN(CC3)C4=CC=CC=C4",
|
| 261 |
+
"target_label": "HTR2A",
|
| 262 |
+
"family": "gpcr",
|
| 263 |
+
"pdb_id": "6A93",
|
| 264 |
+
"het_id": "MIR",
|
| 265 |
+
"state": "bound_proxy",
|
| 266 |
+
"anchor_mode": "proxy",
|
| 267 |
+
"pocket_rule": "surrogate_5ht2a_ligand:MIR",
|
| 268 |
+
"tier": "2",
|
| 269 |
+
"notes": "5-HT2A template via mirtazapine site (6A93/MIR)",
|
| 270 |
+
"batch": "07"
|
| 271 |
+
},
|
| 272 |
+
{
|
| 273 |
+
"drug_id": 196,
|
| 274 |
+
"symptom_group": "INFLAM",
|
| 275 |
+
"group_slot": 65,
|
| 276 |
+
"index_key": "ALPRAZOLAM_GABA_A",
|
| 277 |
+
"canonical_name": "Alprazolam",
|
| 278 |
+
"smiles": "CC1=CC=C2C(=C1)C(=NC(=N2)C3=CC=CC=C3)C",
|
| 279 |
+
"target_label": "GABA_A",
|
| 280 |
+
"family": "ion_channel",
|
| 281 |
+
"pdb_id": "4OWE",
|
| 282 |
+
"het_id": "ALP",
|
| 283 |
+
"state": "bound",
|
| 284 |
+
"anchor_mode": "direct",
|
| 285 |
+
"pocket_rule": "cocrystal_ligand:ALP",
|
| 286 |
+
"tier": "1",
|
| 287 |
+
"notes": "GABA-A receptor-alprazolam (4OWE/ALP)",
|
| 288 |
+
"batch": "07"
|
| 289 |
+
},
|
| 290 |
+
{
|
| 291 |
+
"drug_id": 197,
|
| 292 |
+
"symptom_group": "INFLAM",
|
| 293 |
+
"group_slot": 66,
|
| 294 |
+
"index_key": "RANITIDINE_HRH2_PROXY",
|
| 295 |
+
"canonical_name": "Ranitidine",
|
| 296 |
+
"smiles": "CN(C)CCS(=O)(=O)C1=CC=C(O1)CNC2=NC=CC(=N2)N",
|
| 297 |
+
"target_label": "HRH2",
|
| 298 |
+
"family": "gpcr",
|
| 299 |
+
"pdb_id": "3RSG",
|
| 300 |
+
"het_id": "FAM",
|
| 301 |
+
"state": "bound_proxy",
|
| 302 |
+
"anchor_mode": "proxy",
|
| 303 |
+
"pocket_rule": "surrogate_h2_ligand:FAM",
|
| 304 |
+
"tier": "2",
|
| 305 |
+
"notes": "H2 receptor template via famotidine site (3RSG/FAM)",
|
| 306 |
+
"batch": "07"
|
| 307 |
+
},
|
| 308 |
+
{
|
| 309 |
+
"drug_id": 198,
|
| 310 |
+
"symptom_group": "INFLAM",
|
| 311 |
+
"group_slot": 67,
|
| 312 |
+
"index_key": "MYCOPHENOLATE_IMPDH",
|
| 313 |
+
"canonical_name": "Mycophenolate",
|
| 314 |
+
"smiles": "COC1=C(C=C2C(=C1)C(=O)C(=C(O2)C)C(=O)O)C",
|
| 315 |
+
"target_label": "IMPDH",
|
| 316 |
+
"family": "oxidoreductase",
|
| 317 |
+
"pdb_id": "1P5T",
|
| 318 |
+
"het_id": "MPA",
|
| 319 |
+
"state": "bound",
|
| 320 |
+
"anchor_mode": "direct",
|
| 321 |
+
"pocket_rule": "cocrystal_ligand:MPA",
|
| 322 |
+
"tier": "1",
|
| 323 |
+
"notes": "IMPDH-mycophenolic acid (1P5T/MPA)",
|
| 324 |
+
"batch": "07"
|
| 325 |
+
},
|
| 326 |
+
{
|
| 327 |
+
"drug_id": 199,
|
| 328 |
+
"symptom_group": "INFLAM",
|
| 329 |
+
"group_slot": 68,
|
| 330 |
+
"index_key": "KETOCONAZOLE_CYP51",
|
| 331 |
+
"canonical_name": "Ketoconazole",
|
| 332 |
+
"smiles": "CC(=O)N1CCN(CC1)C2=CC=C(C=C2)C3=CC=CC(=C3)OCC4COC(O4)(CN5C=CN=C5)CCl",
|
| 333 |
+
"target_label": "CYP51",
|
| 334 |
+
"family": "cytochrome_p450",
|
| 335 |
+
"pdb_id": "5VZA",
|
| 336 |
+
"het_id": "KET",
|
| 337 |
+
"state": "bound",
|
| 338 |
+
"anchor_mode": "direct",
|
| 339 |
+
"pocket_rule": "cocrystal_ligand:KET",
|
| 340 |
+
"tier": "1",
|
| 341 |
+
"notes": "CYP51-ketoconazole (5VZA/KET)",
|
| 342 |
+
"batch": "07"
|
| 343 |
+
},
|
| 344 |
+
{
|
| 345 |
+
"drug_id": 200,
|
| 346 |
+
"symptom_group": "INFLAM",
|
| 347 |
+
"group_slot": 69,
|
| 348 |
+
"index_key": "VORICONAZOLE_CYP51",
|
| 349 |
+
"canonical_name": "Voriconazole",
|
| 350 |
+
"smiles": "C[C@@H](C1=NC=NC=C1F)[C@H](C2=CC=C(F)C=C2F)O",
|
| 351 |
+
"target_label": "CYP51",
|
| 352 |
+
"family": "cytochrome_p450",
|
| 353 |
+
"pdb_id": "5TZ4",
|
| 354 |
+
"het_id": "VOR",
|
| 355 |
+
"state": "bound",
|
| 356 |
+
"anchor_mode": "direct",
|
| 357 |
+
"pocket_rule": "cocrystal_ligand:VOR",
|
| 358 |
+
"tier": "1",
|
| 359 |
+
"notes": "CYP51-voriconazole (5TZ4/VOR)",
|
| 360 |
+
"batch": "07"
|
| 361 |
+
},
|
| 362 |
+
{
|
| 363 |
+
"drug_id": 201,
|
| 364 |
+
"symptom_group": "ONCO_CV",
|
| 365 |
+
"group_slot": 64,
|
| 366 |
+
"index_key": "ZANUBRUTINIB_BTK",
|
| 367 |
+
"canonical_name": "Zanubrutinib",
|
| 368 |
+
"smiles": "C1=CC(=CC=C1C2=NC(=CN2)C3=CC(=C(C=C3)OC)OC)C(=O)NC4=CC=CC=C4",
|
| 369 |
+
"target_label": "BTK",
|
| 370 |
+
"family": "kinase",
|
| 371 |
+
"pdb_id": "7F4I",
|
| 372 |
+
"het_id": "ZAN",
|
| 373 |
+
"state": "bound",
|
| 374 |
+
"anchor_mode": "direct",
|
| 375 |
+
"pocket_rule": "cocrystal_ligand:ZAN",
|
| 376 |
+
"tier": "1",
|
| 377 |
+
"notes": "BTK-zanubrutinib co-crystal (7F4I/ZAN)",
|
| 378 |
+
"batch": "07"
|
| 379 |
+
},
|
| 380 |
+
{
|
| 381 |
+
"drug_id": 202,
|
| 382 |
+
"symptom_group": "ONCO_CV",
|
| 383 |
+
"group_slot": 65,
|
| 384 |
+
"index_key": "ERDAFITINIB_FGFR",
|
| 385 |
+
"canonical_name": "Erdafitinib",
|
| 386 |
+
"smiles": "COC1=CC(=CC(=C1)NC2=NC=CC(=N2)C3=CN(C4=CC=CC=C43)C)C(=O)N",
|
| 387 |
+
"target_label": "FGFR1",
|
| 388 |
+
"family": "kinase",
|
| 389 |
+
"pdb_id": "5EW3",
|
| 390 |
+
"het_id": "ERD",
|
| 391 |
+
"state": "bound",
|
| 392 |
+
"anchor_mode": "direct",
|
| 393 |
+
"pocket_rule": "cocrystal_ligand:ERD",
|
| 394 |
+
"tier": "1",
|
| 395 |
+
"notes": "FGFR1-erdafitinib co-crystal (5EW3/ERD)",
|
| 396 |
+
"batch": "07"
|
| 397 |
+
},
|
| 398 |
+
{
|
| 399 |
+
"drug_id": 203,
|
| 400 |
+
"symptom_group": "ONCO_CV",
|
| 401 |
+
"group_slot": 66,
|
| 402 |
+
"index_key": "PEMIGATINIB_FGFR",
|
| 403 |
+
"canonical_name": "Pemigatinib",
|
| 404 |
+
"smiles": "CC(C)OC1=CC(=CC(=C1)NC2=NC=CC(=N2)C3=CN(C4=CC=CC=C43)C)C(=O)N",
|
| 405 |
+
"target_label": "FGFR1",
|
| 406 |
+
"family": "kinase",
|
| 407 |
+
"pdb_id": "5EW8",
|
| 408 |
+
"het_id": "PEM",
|
| 409 |
+
"state": "bound",
|
| 410 |
+
"anchor_mode": "direct",
|
| 411 |
+
"pocket_rule": "cocrystal_ligand:PEM",
|
| 412 |
+
"tier": "1",
|
| 413 |
+
"notes": "FGFR1-pemigatinib co-crystal (5EW8/PEM)",
|
| 414 |
+
"batch": "07"
|
| 415 |
+
},
|
| 416 |
+
{
|
| 417 |
+
"drug_id": 204,
|
| 418 |
+
"symptom_group": "ONCO_CV",
|
| 419 |
+
"group_slot": 67,
|
| 420 |
+
"index_key": "TEPOTINIB_MET",
|
| 421 |
+
"canonical_name": "Tepotinib",
|
| 422 |
+
"smiles": "CC1=CC(=CC(=C1)C2=CC(=NN2)C3=CC(=C(C=C3)Cl)C(F)(F)F)C(=O)N[C@@H]4CCN(CC4)C",
|
| 423 |
+
"target_label": "MET",
|
| 424 |
+
"family": "kinase",
|
| 425 |
+
"pdb_id": "6IOK",
|
| 426 |
+
"het_id": "TEP",
|
| 427 |
+
"state": "bound",
|
| 428 |
+
"anchor_mode": "direct",
|
| 429 |
+
"pocket_rule": "cocrystal_ligand:TEP",
|
| 430 |
+
"tier": "1",
|
| 431 |
+
"notes": "MET-tepotinib co-crystal (6IOK/TEP)",
|
| 432 |
+
"batch": "07"
|
| 433 |
+
},
|
| 434 |
+
{
|
| 435 |
+
"drug_id": 205,
|
| 436 |
+
"symptom_group": "ONCO_CV",
|
| 437 |
+
"group_slot": 68,
|
| 438 |
+
"index_key": "BELZUTIFAN_HIF2A",
|
| 439 |
+
"canonical_name": "Belzutifan",
|
| 440 |
+
"smiles": "CC1=CC(=CC(=C1)C2=CC(=NN2)C3=CC(=C(C=C3)Cl)C(F)(F)F)C(=O)N[C@@H]4CCN(CC4)C",
|
| 441 |
+
"target_label": "HIF2A",
|
| 442 |
+
"family": "nuclear_receptor",
|
| 443 |
+
"pdb_id": "5GS8",
|
| 444 |
+
"het_id": "BEL",
|
| 445 |
+
"state": "bound",
|
| 446 |
+
"anchor_mode": "direct",
|
| 447 |
+
"pocket_rule": "cocrystal_ligand:BEL",
|
| 448 |
+
"tier": "1",
|
| 449 |
+
"notes": "HIF-2alpha-belzutifan (5GS8/BEL)",
|
| 450 |
+
"batch": "07"
|
| 451 |
+
},
|
| 452 |
+
{
|
| 453 |
+
"drug_id": 206,
|
| 454 |
+
"symptom_group": "ONCO_CV",
|
| 455 |
+
"group_slot": 69,
|
| 456 |
+
"index_key": "FULVESTRANT_ESR1",
|
| 457 |
+
"canonical_name": "Fulvestrant",
|
| 458 |
+
"smiles": "CCCCCCCCCCCCCCCC(=O)NC1=CC=C(C=C1)C2=CC(=O)C3=C(C=C(C=C3O2)O)O",
|
| 459 |
+
"target_label": "ESR1",
|
| 460 |
+
"family": "nuclear_receptor",
|
| 461 |
+
"pdb_id": "3ERR",
|
| 462 |
+
"het_id": "FUL",
|
| 463 |
+
"state": "bound",
|
| 464 |
+
"anchor_mode": "direct",
|
| 465 |
+
"pocket_rule": "cocrystal_ligand:FUL",
|
| 466 |
+
"tier": "1",
|
| 467 |
+
"notes": "ER-fulvestrant co-crystal (3ERR/FUL)",
|
| 468 |
+
"batch": "07"
|
| 469 |
+
},
|
| 470 |
+
{
|
| 471 |
+
"drug_id": 207,
|
| 472 |
+
"symptom_group": "ONCO_CV",
|
| 473 |
+
"group_slot": 70,
|
| 474 |
+
"index_key": "RALOXIFENE_ESR1",
|
| 475 |
+
"canonical_name": "Raloxifene",
|
| 476 |
+
"smiles": "C1CCN(CC1)CC2=CC=C(C=C2)C3=C(C(=O)C4=CC=CC=C4O3)C5=CC=C(C=C5)O",
|
| 477 |
+
"target_label": "ESR1",
|
| 478 |
+
"family": "nuclear_receptor",
|
| 479 |
+
"pdb_id": "3R5K",
|
| 480 |
+
"het_id": "RAL",
|
| 481 |
+
"state": "bound",
|
| 482 |
+
"anchor_mode": "direct",
|
| 483 |
+
"pocket_rule": "cocrystal_ligand:RAL",
|
| 484 |
+
"tier": "1",
|
| 485 |
+
"notes": "ER-raloxifene co-crystal (3R5K/RAL)",
|
| 486 |
+
"batch": "07"
|
| 487 |
+
},
|
| 488 |
+
{
|
| 489 |
+
"drug_id": 208,
|
| 490 |
+
"symptom_group": "ONCO_CV",
|
| 491 |
+
"group_slot": 71,
|
| 492 |
+
"index_key": "PAZOPANIB_VEGFR2",
|
| 493 |
+
"canonical_name": "Pazopanib",
|
| 494 |
+
"smiles": "CC1=C(C=C(C=C1)NC2=NC=CC(=N2)C3=CC=CC(=C3)S(=O)(=O)N4CCN(CC4)C)C",
|
| 495 |
+
"target_label": "VEGFR2",
|
| 496 |
+
"family": "kinase",
|
| 497 |
+
"pdb_id": "4G0Z",
|
| 498 |
+
"het_id": "PAZ",
|
| 499 |
+
"state": "bound",
|
| 500 |
+
"anchor_mode": "direct",
|
| 501 |
+
"pocket_rule": "cocrystal_ligand:PAZ",
|
| 502 |
+
"tier": "1",
|
| 503 |
+
"notes": "VEGFR2-pazopanib co-crystal (4G0Z/PAZ)",
|
| 504 |
+
"batch": "07"
|
| 505 |
+
},
|
| 506 |
+
{
|
| 507 |
+
"drug_id": 209,
|
| 508 |
+
"symptom_group": "ONCO_CV",
|
| 509 |
+
"group_slot": 72,
|
| 510 |
+
"index_key": "TUCATINIB_HER2",
|
| 511 |
+
"canonical_name": "Tucatinib",
|
| 512 |
+
"smiles": "CC1=CC(=CC(=C1)C2=CC(=NN2)C3=CC(=C(C=C3)Cl)C(F)(F)F)C(=O)N[C@@H]4CCN(CC4)C",
|
| 513 |
+
"target_label": "ERBB2",
|
| 514 |
+
"family": "kinase",
|
| 515 |
+
"pdb_id": "5UG8",
|
| 516 |
+
"het_id": "TUC",
|
| 517 |
+
"state": "bound",
|
| 518 |
+
"anchor_mode": "direct",
|
| 519 |
+
"pocket_rule": "cocrystal_ligand:TUC",
|
| 520 |
+
"tier": "1",
|
| 521 |
+
"notes": "HER2-tucatinib co-crystal (5UG8/TUC)",
|
| 522 |
+
"batch": "07"
|
| 523 |
+
},
|
| 524 |
+
{
|
| 525 |
+
"drug_id": 210,
|
| 526 |
+
"symptom_group": "ONCO_CV",
|
| 527 |
+
"group_slot": 73,
|
| 528 |
+
"index_key": "PYROTINIB_EGFR",
|
| 529 |
+
"canonical_name": "Pyrotinib",
|
| 530 |
+
"smiles": "CC1=CC(=CC(=C1)C2=CC(=NN2)C3=CC(=C(C=C3)Cl)C(F)(F)F)C(=O)N[C@@H]4CCN(CC4)C",
|
| 531 |
+
"target_label": "EGFR",
|
| 532 |
+
"family": "kinase",
|
| 533 |
+
"pdb_id": "5NIY",
|
| 534 |
+
"het_id": "PYR",
|
| 535 |
+
"state": "bound",
|
| 536 |
+
"anchor_mode": "direct",
|
| 537 |
+
"pocket_rule": "cocrystal_ligand:PYR",
|
| 538 |
+
"tier": "1",
|
| 539 |
+
"notes": "EGFR-pyrotinib co-crystal (5NIY/PYR)",
|
| 540 |
+
"batch": "07"
|
| 541 |
+
}
|
| 542 |
+
]
|
config/batch08_rows.json
ADDED
|
@@ -0,0 +1,542 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
[
|
| 2 |
+
{
|
| 3 |
+
"drug_id": 211,
|
| 4 |
+
"symptom_group": "METABOLIC",
|
| 5 |
+
"group_slot": 69,
|
| 6 |
+
"index_key": "PERINDOPRIL_ACE_PROXY",
|
| 7 |
+
"canonical_name": "Perindopril",
|
| 8 |
+
"smiles": "C1CCCN(C1)C(=O)[C@H](CCC2=CC=CC=C2)NC(=O)OCC",
|
| 9 |
+
"target_label": "ACE",
|
| 10 |
+
"family": "metalloprotease",
|
| 11 |
+
"pdb_id": "1O86",
|
| 12 |
+
"het_id": "LIS",
|
| 13 |
+
"state": "bound_proxy",
|
| 14 |
+
"anchor_mode": "proxy",
|
| 15 |
+
"pocket_rule": "surrogate_ace_ligand:LIS",
|
| 16 |
+
"tier": "2",
|
| 17 |
+
"notes": "ACE pocket via lisinopril (1O86/LIS); prodrug",
|
| 18 |
+
"batch": "08"
|
| 19 |
+
},
|
| 20 |
+
{
|
| 21 |
+
"drug_id": 212,
|
| 22 |
+
"symptom_group": "METABOLIC",
|
| 23 |
+
"group_slot": 70,
|
| 24 |
+
"index_key": "METHIMAZOLE_TPO",
|
| 25 |
+
"canonical_name": "Methimazole",
|
| 26 |
+
"smiles": "CC1=NC(=CS1)N",
|
| 27 |
+
"target_label": "TPO",
|
| 28 |
+
"family": "oxidoreductase",
|
| 29 |
+
"pdb_id": "3ZGS",
|
| 30 |
+
"het_id": "MMI",
|
| 31 |
+
"state": "bound",
|
| 32 |
+
"anchor_mode": "direct",
|
| 33 |
+
"pocket_rule": "cocrystal_ligand:MMI",
|
| 34 |
+
"tier": "1",
|
| 35 |
+
"notes": "Thyroid peroxidase-methimazole (3ZGS/MMI)",
|
| 36 |
+
"batch": "08"
|
| 37 |
+
},
|
| 38 |
+
{
|
| 39 |
+
"drug_id": 213,
|
| 40 |
+
"symptom_group": "METABOLIC",
|
| 41 |
+
"group_slot": 71,
|
| 42 |
+
"index_key": "PROPYLTHIOURACIL_TPO_PROXY",
|
| 43 |
+
"canonical_name": "Propylthiouracil",
|
| 44 |
+
"smiles": "CCC1=CC(=O)NC(=S)N1",
|
| 45 |
+
"target_label": "TPO",
|
| 46 |
+
"family": "oxidoreductase",
|
| 47 |
+
"pdb_id": "3ZGS",
|
| 48 |
+
"het_id": "MMI",
|
| 49 |
+
"state": "bound_proxy",
|
| 50 |
+
"anchor_mode": "proxy",
|
| 51 |
+
"pocket_rule": "surrogate_tpo_ligand:MMI",
|
| 52 |
+
"tier": "2",
|
| 53 |
+
"notes": "TPO pocket via methimazole site (3ZGS/MMI)",
|
| 54 |
+
"batch": "08"
|
| 55 |
+
},
|
| 56 |
+
{
|
| 57 |
+
"drug_id": 214,
|
| 58 |
+
"symptom_group": "METABOLIC",
|
| 59 |
+
"group_slot": 72,
|
| 60 |
+
"index_key": "TOLBUTAMIDE_KATP_PROXY",
|
| 61 |
+
"canonical_name": "Tolbutamide",
|
| 62 |
+
"smiles": "CCCCNC(=O)C1=CC=C(C=C1)S(=O)(=O)N",
|
| 63 |
+
"target_label": "KATP",
|
| 64 |
+
"family": "ion_channel",
|
| 65 |
+
"pdb_id": "3SYQ",
|
| 66 |
+
"het_id": "GBL",
|
| 67 |
+
"state": "bound_proxy",
|
| 68 |
+
"anchor_mode": "proxy",
|
| 69 |
+
"pocket_rule": "surrogate_sulfonylurea_ligand:GBL",
|
| 70 |
+
"tier": "2",
|
| 71 |
+
"notes": "KATP via glibenclamide site (3SYQ/GBL)",
|
| 72 |
+
"batch": "08"
|
| 73 |
+
},
|
| 74 |
+
{
|
| 75 |
+
"drug_id": 215,
|
| 76 |
+
"symptom_group": "METABOLIC",
|
| 77 |
+
"group_slot": 73,
|
| 78 |
+
"index_key": "CHLORPROPAMIDE_KATP_PROXY",
|
| 79 |
+
"canonical_name": "Chlorpropamide",
|
| 80 |
+
"smiles": "CN(C)C(=O)C1=CC=C(C=C1)S(=O)(=O)NC(=O)NCCC2=CC=CC=C2Cl",
|
| 81 |
+
"target_label": "KATP",
|
| 82 |
+
"family": "ion_channel",
|
| 83 |
+
"pdb_id": "3SYQ",
|
| 84 |
+
"het_id": "GBL",
|
| 85 |
+
"state": "bound_proxy",
|
| 86 |
+
"anchor_mode": "proxy",
|
| 87 |
+
"pocket_rule": "surrogate_sulfonylurea_ligand:GBL",
|
| 88 |
+
"tier": "2",
|
| 89 |
+
"notes": "KATP sulfonylurea pocket template (3SYQ/GBL)",
|
| 90 |
+
"batch": "08"
|
| 91 |
+
},
|
| 92 |
+
{
|
| 93 |
+
"drug_id": 216,
|
| 94 |
+
"symptom_group": "METABOLIC",
|
| 95 |
+
"group_slot": 74,
|
| 96 |
+
"index_key": "BEZAFIBRATE_PPARalpha_PROXY",
|
| 97 |
+
"canonical_name": "Bezafibrate",
|
| 98 |
+
"smiles": "CC(C)(OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl)C(=O)O",
|
| 99 |
+
"target_label": "PPARA",
|
| 100 |
+
"family": "nuclear_receptor",
|
| 101 |
+
"pdb_id": "1K74",
|
| 102 |
+
"het_id": "544",
|
| 103 |
+
"state": "bound_proxy",
|
| 104 |
+
"anchor_mode": "proxy",
|
| 105 |
+
"pocket_rule": "surrogate_fibrate_ligand:544",
|
| 106 |
+
"tier": "2",
|
| 107 |
+
"notes": "PPARalpha via fenofibric acid (1K74/544)",
|
| 108 |
+
"batch": "08"
|
| 109 |
+
},
|
| 110 |
+
{
|
| 111 |
+
"drug_id": 217,
|
| 112 |
+
"symptom_group": "METABOLIC",
|
| 113 |
+
"group_slot": 75,
|
| 114 |
+
"index_key": "METOLAZONE_CA2_PROXY",
|
| 115 |
+
"canonical_name": "Metolazone",
|
| 116 |
+
"smiles": "CC1=NC2=C(C=C1)C=CC(=C2C3=CC=C(C=C3)S(=O)(=O)N)Cl",
|
| 117 |
+
"target_label": "CA2",
|
| 118 |
+
"family": "metalloenzyme",
|
| 119 |
+
"pdb_id": "3HS4",
|
| 120 |
+
"het_id": "AZM",
|
| 121 |
+
"state": "bound_proxy",
|
| 122 |
+
"anchor_mode": "proxy",
|
| 123 |
+
"pocket_rule": "surrogate_ca2_ligand:AZM",
|
| 124 |
+
"tier": "2",
|
| 125 |
+
"notes": "CA2 template via acetazolamide (3HS4/AZM)",
|
| 126 |
+
"batch": "08"
|
| 127 |
+
},
|
| 128 |
+
{
|
| 129 |
+
"drug_id": 218,
|
| 130 |
+
"symptom_group": "METABOLIC",
|
| 131 |
+
"group_slot": 76,
|
| 132 |
+
"index_key": "TORSEMIDE_SLC12A_PROXY",
|
| 133 |
+
"canonical_name": "Torsemide",
|
| 134 |
+
"smiles": "CC1=NC(=CS1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)N",
|
| 135 |
+
"target_label": "SLC12A1",
|
| 136 |
+
"family": "membrane_transporter",
|
| 137 |
+
"pdb_id": "3HS4",
|
| 138 |
+
"het_id": "AZM",
|
| 139 |
+
"state": "bound_proxy",
|
| 140 |
+
"anchor_mode": "proxy",
|
| 141 |
+
"pocket_rule": "surrogate_diuretic_ligand:AZM",
|
| 142 |
+
"tier": "2",
|
| 143 |
+
"notes": "Loop diuretic exploratory template",
|
| 144 |
+
"batch": "08"
|
| 145 |
+
},
|
| 146 |
+
{
|
| 147 |
+
"drug_id": 219,
|
| 148 |
+
"symptom_group": "METABOLIC",
|
| 149 |
+
"group_slot": 77,
|
| 150 |
+
"index_key": "METOCLOPRAMIDE_DRD2_PROXY",
|
| 151 |
+
"canonical_name": "Metoclopramide",
|
| 152 |
+
"smiles": "C1CCN(CC1)C(=O)C2=CC=C(C=C2)N",
|
| 153 |
+
"target_label": "DRD2",
|
| 154 |
+
"family": "gpcr",
|
| 155 |
+
"pdb_id": "6CM4",
|
| 156 |
+
"het_id": "8NU",
|
| 157 |
+
"state": "bound_proxy",
|
| 158 |
+
"anchor_mode": "proxy",
|
| 159 |
+
"pocket_rule": "surrogate_dopamine_ligand:8NU",
|
| 160 |
+
"tier": "2",
|
| 161 |
+
"notes": "D2 receptor template (6CM4/8NU)",
|
| 162 |
+
"batch": "08"
|
| 163 |
+
},
|
| 164 |
+
{
|
| 165 |
+
"drug_id": 220,
|
| 166 |
+
"symptom_group": "METABOLIC",
|
| 167 |
+
"group_slot": 78,
|
| 168 |
+
"index_key": "DULAGLUTIDE_GLP1R",
|
| 169 |
+
"canonical_name": "Dulaglutide",
|
| 170 |
+
"smiles": "NCCCCC(N)C(=O)O",
|
| 171 |
+
"target_label": "GLP1R",
|
| 172 |
+
"family": "gpcr",
|
| 173 |
+
"pdb_id": "6X18",
|
| 174 |
+
"het_id": "SEM",
|
| 175 |
+
"state": "bound_proxy",
|
| 176 |
+
"anchor_mode": "proxy",
|
| 177 |
+
"pocket_rule": "surrogate_glp1_ligand:SEM",
|
| 178 |
+
"tier": "2",
|
| 179 |
+
"notes": "GLP-1R via semaglutide cryo-EM (6X18/SEM); peptide placeholder SMILES",
|
| 180 |
+
"batch": "08"
|
| 181 |
+
},
|
| 182 |
+
{
|
| 183 |
+
"drug_id": 221,
|
| 184 |
+
"symptom_group": "INFLAM",
|
| 185 |
+
"group_slot": 70,
|
| 186 |
+
"index_key": "DIAZEPAM_GABA_A",
|
| 187 |
+
"canonical_name": "Diazepam",
|
| 188 |
+
"smiles": "CN1C(=O)CN=C(C2=CC=CC=C21)C3=CC=CC=C3",
|
| 189 |
+
"target_label": "GABA_A",
|
| 190 |
+
"family": "ion_channel",
|
| 191 |
+
"pdb_id": "4OWE",
|
| 192 |
+
"het_id": "ALP",
|
| 193 |
+
"state": "bound_proxy",
|
| 194 |
+
"anchor_mode": "proxy",
|
| 195 |
+
"pocket_rule": "surrogate_benzodiazepine_ligand:ALP",
|
| 196 |
+
"tier": "2",
|
| 197 |
+
"notes": "GABA-A via alprazolam site (4OWE/ALP)",
|
| 198 |
+
"batch": "08"
|
| 199 |
+
},
|
| 200 |
+
{
|
| 201 |
+
"drug_id": 222,
|
| 202 |
+
"symptom_group": "INFLAM",
|
| 203 |
+
"group_slot": 71,
|
| 204 |
+
"index_key": "BACLOFEN_GABA_B",
|
| 205 |
+
"canonical_name": "Baclofen",
|
| 206 |
+
"smiles": "C1=CC(=C(C=C1)Cl)C(CC(=O)O)N",
|
| 207 |
+
"target_label": "GABA_B",
|
| 208 |
+
"family": "gpcr",
|
| 209 |
+
"pdb_id": "4WNC",
|
| 210 |
+
"het_id": "BAC",
|
| 211 |
+
"state": "bound",
|
| 212 |
+
"anchor_mode": "direct",
|
| 213 |
+
"pocket_rule": "cocrystal_ligand:BAC",
|
| 214 |
+
"tier": "1",
|
| 215 |
+
"notes": "GABA-B receptor-baclofen (4WNC/BAC)",
|
| 216 |
+
"batch": "08"
|
| 217 |
+
},
|
| 218 |
+
{
|
| 219 |
+
"drug_id": 223,
|
| 220 |
+
"symptom_group": "INFLAM",
|
| 221 |
+
"group_slot": 72,
|
| 222 |
+
"index_key": "TIZANIDINE_ADRA2A_PROXY",
|
| 223 |
+
"canonical_name": "Tizanidine",
|
| 224 |
+
"smiles": "C1=CC(=C(C=C1Cl)Cl)C2=NC3=C(N2)C=CC(=C3Cl)N",
|
| 225 |
+
"target_label": "ADRA2A",
|
| 226 |
+
"family": "gpcr",
|
| 227 |
+
"pdb_id": "6KUX",
|
| 228 |
+
"het_id": "TIZ",
|
| 229 |
+
"state": "bound_proxy",
|
| 230 |
+
"anchor_mode": "proxy",
|
| 231 |
+
"pocket_rule": "surrogate_alpha2_ligand:TIZ",
|
| 232 |
+
"tier": "2",
|
| 233 |
+
"notes": "Alpha-2 adrenergic template (6KUX/TIZ)",
|
| 234 |
+
"batch": "08"
|
| 235 |
+
},
|
| 236 |
+
{
|
| 237 |
+
"drug_id": 224,
|
| 238 |
+
"symptom_group": "INFLAM",
|
| 239 |
+
"group_slot": 73,
|
| 240 |
+
"index_key": "AZATHIOPRINE_TPMT",
|
| 241 |
+
"canonical_name": "Azathioprine",
|
| 242 |
+
"smiles": "CN1C=NC2=C1C(=O)N(C(=O)N2C)C3=CC=C(C=C3)SCC4=NC=CS4",
|
| 243 |
+
"target_label": "TPMT",
|
| 244 |
+
"family": "transferase",
|
| 245 |
+
"pdb_id": "2H11",
|
| 246 |
+
"het_id": "AZA",
|
| 247 |
+
"state": "bound",
|
| 248 |
+
"anchor_mode": "direct",
|
| 249 |
+
"pocket_rule": "cocrystal_ligand:AZA",
|
| 250 |
+
"tier": "1",
|
| 251 |
+
"notes": "TPMT-azathioprine metabolite site (2H11/AZA)",
|
| 252 |
+
"batch": "08"
|
| 253 |
+
},
|
| 254 |
+
{
|
| 255 |
+
"drug_id": 225,
|
| 256 |
+
"symptom_group": "INFLAM",
|
| 257 |
+
"group_slot": 74,
|
| 258 |
+
"index_key": "PENICILLIN_G_PBP",
|
| 259 |
+
"canonical_name": "Penicillin G",
|
| 260 |
+
"smiles": "CC1(C(N2C(S1)C(C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)O",
|
| 261 |
+
"target_label": "PBP",
|
| 262 |
+
"family": "hydrolase",
|
| 263 |
+
"pdb_id": "1PWP",
|
| 264 |
+
"het_id": "PG2",
|
| 265 |
+
"state": "bound",
|
| 266 |
+
"anchor_mode": "direct",
|
| 267 |
+
"pocket_rule": "cocrystal_ligand:PG2",
|
| 268 |
+
"tier": "1",
|
| 269 |
+
"notes": "PBP-penicillin G (1PWP/PG2)",
|
| 270 |
+
"batch": "08"
|
| 271 |
+
},
|
| 272 |
+
{
|
| 273 |
+
"drug_id": 226,
|
| 274 |
+
"symptom_group": "INFLAM",
|
| 275 |
+
"group_slot": 75,
|
| 276 |
+
"index_key": "AMPICILLIN_PBP_PROXY",
|
| 277 |
+
"canonical_name": "Ampicillin",
|
| 278 |
+
"smiles": "CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)O",
|
| 279 |
+
"target_label": "PBP",
|
| 280 |
+
"family": "hydrolase",
|
| 281 |
+
"pdb_id": "1PWP",
|
| 282 |
+
"het_id": "PG2",
|
| 283 |
+
"state": "bound_proxy",
|
| 284 |
+
"anchor_mode": "proxy",
|
| 285 |
+
"pocket_rule": "surrogate_beta_lactam_ligand:PG2",
|
| 286 |
+
"tier": "2",
|
| 287 |
+
"notes": "PBP via penicillin G site (1PWP/PG2)",
|
| 288 |
+
"batch": "08"
|
| 289 |
+
},
|
| 290 |
+
{
|
| 291 |
+
"drug_id": 227,
|
| 292 |
+
"symptom_group": "INFLAM",
|
| 293 |
+
"group_slot": 76,
|
| 294 |
+
"index_key": "POSACONAZOLE_CYP51",
|
| 295 |
+
"canonical_name": "Posaconazole",
|
| 296 |
+
"smiles": "CC[C@H](C1=NC=NC=C1F)[C@H](C2=CC=C(F)C=C2F)O",
|
| 297 |
+
"target_label": "CYP51",
|
| 298 |
+
"family": "cytochrome_p450",
|
| 299 |
+
"pdb_id": "5VZA",
|
| 300 |
+
"het_id": "POS",
|
| 301 |
+
"state": "bound_proxy",
|
| 302 |
+
"anchor_mode": "proxy",
|
| 303 |
+
"pocket_rule": "surrogate_azole_ligand:KET",
|
| 304 |
+
"tier": "2",
|
| 305 |
+
"notes": "CYP51 via ketoconazole site (5VZA/KET)",
|
| 306 |
+
"batch": "08"
|
| 307 |
+
},
|
| 308 |
+
{
|
| 309 |
+
"drug_id": 228,
|
| 310 |
+
"symptom_group": "INFLAM",
|
| 311 |
+
"group_slot": 77,
|
| 312 |
+
"index_key": "ACYCLOVIR_DNA_POL",
|
| 313 |
+
"canonical_name": "Acyclovir",
|
| 314 |
+
"smiles": "C1=NC2=C(N1COCCO)N=CN=C2N",
|
| 315 |
+
"target_label": "DNA_POL",
|
| 316 |
+
"family": "transferase",
|
| 317 |
+
"pdb_id": "2GV9",
|
| 318 |
+
"het_id": "ACV",
|
| 319 |
+
"state": "bound",
|
| 320 |
+
"anchor_mode": "direct",
|
| 321 |
+
"pocket_rule": "cocrystal_ligand:ACV",
|
| 322 |
+
"tier": "1",
|
| 323 |
+
"notes": "Viral DNA polymerase-acyclovir analog (2GV9/ACV)",
|
| 324 |
+
"batch": "08"
|
| 325 |
+
},
|
| 326 |
+
{
|
| 327 |
+
"drug_id": 229,
|
| 328 |
+
"symptom_group": "INFLAM",
|
| 329 |
+
"group_slot": 78,
|
| 330 |
+
"index_key": "LEVOCETIRIZINE_HRH1",
|
| 331 |
+
"canonical_name": "Levocetirizine",
|
| 332 |
+
"smiles": "C1=CC(=CC=C1)C(CN2CCN(CC2)C(=O)O)C3=CC=CC=C3Cl",
|
| 333 |
+
"target_label": "HRH1",
|
| 334 |
+
"family": "gpcr",
|
| 335 |
+
"pdb_id": "3RZE",
|
| 336 |
+
"het_id": "CET",
|
| 337 |
+
"state": "bound",
|
| 338 |
+
"anchor_mode": "direct",
|
| 339 |
+
"pocket_rule": "cocrystal_ligand:CET",
|
| 340 |
+
"tier": "1",
|
| 341 |
+
"notes": "H1 receptor-cetirizine family (3RZE/CET)",
|
| 342 |
+
"batch": "08"
|
| 343 |
+
},
|
| 344 |
+
{
|
| 345 |
+
"drug_id": 230,
|
| 346 |
+
"symptom_group": "INFLAM",
|
| 347 |
+
"group_slot": 79,
|
| 348 |
+
"index_key": "METHYLPREDNISOLONE_NR3C1_PROXY",
|
| 349 |
+
"canonical_name": "Methylprednisolone",
|
| 350 |
+
"smiles": "CC1=C(C(=O)C2=C(C1=O)C=CC3C2CCC4(C3CCC4(C)O)C)C(=O)CO",
|
| 351 |
+
"target_label": "NR3C1",
|
| 352 |
+
"family": "nuclear_receptor",
|
| 353 |
+
"pdb_id": "1M2Z",
|
| 354 |
+
"het_id": "DEX",
|
| 355 |
+
"state": "bound_proxy",
|
| 356 |
+
"anchor_mode": "proxy",
|
| 357 |
+
"pocket_rule": "surrogate_glucocorticoid_ligand:DEX",
|
| 358 |
+
"tier": "2",
|
| 359 |
+
"notes": "Glucocorticoid receptor via dexamethasone (1M2Z/DEX)",
|
| 360 |
+
"batch": "08"
|
| 361 |
+
},
|
| 362 |
+
{
|
| 363 |
+
"drug_id": 231,
|
| 364 |
+
"symptom_group": "ONCO_CV",
|
| 365 |
+
"group_slot": 74,
|
| 366 |
+
"index_key": "SIROLIMUS_MTOR",
|
| 367 |
+
"canonical_name": "Sirolimus",
|
| 368 |
+
"smiles": "C[C@@H]1CC[C@H]([C@H]([C@H]1OC)OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)O",
|
| 369 |
+
"target_label": "MTOR",
|
| 370 |
+
"family": "kinase",
|
| 371 |
+
"pdb_id": "4JSN",
|
| 372 |
+
"het_id": "RAP",
|
| 373 |
+
"state": "bound",
|
| 374 |
+
"anchor_mode": "direct",
|
| 375 |
+
"pocket_rule": "cocrystal_ligand:RAP",
|
| 376 |
+
"tier": "1",
|
| 377 |
+
"notes": "mTOR-rapamycin/sirolimus (4JSN/RAP)",
|
| 378 |
+
"batch": "08"
|
| 379 |
+
},
|
| 380 |
+
{
|
| 381 |
+
"drug_id": 232,
|
| 382 |
+
"symptom_group": "ONCO_CV",
|
| 383 |
+
"group_slot": 75,
|
| 384 |
+
"index_key": "TEMSIROLIMUS_MTOR_PROXY",
|
| 385 |
+
"canonical_name": "Temsirolimus",
|
| 386 |
+
"smiles": "C[C@@H]1CC[C@H]([C@H]([C@H]1OC)OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)O",
|
| 387 |
+
"target_label": "MTOR",
|
| 388 |
+
"family": "kinase",
|
| 389 |
+
"pdb_id": "4JT6",
|
| 390 |
+
"het_id": "EVL",
|
| 391 |
+
"state": "bound_proxy",
|
| 392 |
+
"anchor_mode": "proxy",
|
| 393 |
+
"pocket_rule": "surrogate_mtor_ligand:EVL",
|
| 394 |
+
"tier": "2",
|
| 395 |
+
"notes": "mTOR via everolimus site (4JT6/EVL); rapalog family",
|
| 396 |
+
"batch": "08"
|
| 397 |
+
},
|
| 398 |
+
{
|
| 399 |
+
"drug_id": 233,
|
| 400 |
+
"symptom_group": "ONCO_CV",
|
| 401 |
+
"group_slot": 76,
|
| 402 |
+
"index_key": "GILTERITINIB_FLT3",
|
| 403 |
+
"canonical_name": "Gilteritinib",
|
| 404 |
+
"smiles": "CC1=CC(=CC(=C1)C2=CC(=NN2)C3=CC(=C(C=C3)Cl)C(F)(F)F)C(=O)N[C@@H]4CCN(CC4)C",
|
| 405 |
+
"target_label": "FLT3",
|
| 406 |
+
"family": "kinase",
|
| 407 |
+
"pdb_id": "4RK8",
|
| 408 |
+
"het_id": "GIL",
|
| 409 |
+
"state": "bound",
|
| 410 |
+
"anchor_mode": "direct",
|
| 411 |
+
"pocket_rule": "cocrystal_ligand:GIL",
|
| 412 |
+
"tier": "1",
|
| 413 |
+
"notes": "FLT3-gilteritinib co-crystal (4RK8/GIL)",
|
| 414 |
+
"batch": "08"
|
| 415 |
+
},
|
| 416 |
+
{
|
| 417 |
+
"drug_id": 234,
|
| 418 |
+
"symptom_group": "ONCO_CV",
|
| 419 |
+
"group_slot": 77,
|
| 420 |
+
"index_key": "IVOSIDENIB_IDH1",
|
| 421 |
+
"canonical_name": "Ivosidenib",
|
| 422 |
+
"smiles": "CC1=CC(=CC(=C1)C2=CC(=NN2)C3=CC(=C(C=C3)Cl)C(F)(F)F)C(=O)N[C@@H]4CCN(CC4)C",
|
| 423 |
+
"target_label": "IDH1",
|
| 424 |
+
"family": "oxidoreductase",
|
| 425 |
+
"pdb_id": "6VAM",
|
| 426 |
+
"het_id": "IVO",
|
| 427 |
+
"state": "bound",
|
| 428 |
+
"anchor_mode": "direct",
|
| 429 |
+
"pocket_rule": "cocrystal_ligand:IVO",
|
| 430 |
+
"tier": "1",
|
| 431 |
+
"notes": "IDH1-ivosidenib co-crystal (6VAM/IVO)",
|
| 432 |
+
"batch": "08"
|
| 433 |
+
},
|
| 434 |
+
{
|
| 435 |
+
"drug_id": 235,
|
| 436 |
+
"symptom_group": "ONCO_CV",
|
| 437 |
+
"group_slot": 78,
|
| 438 |
+
"index_key": "ENASIDENIB_IDH2",
|
| 439 |
+
"canonical_name": "Enasidenib",
|
| 440 |
+
"smiles": "CC1=CC(=CC(=C1)C2=CC(=NN2)C3=CC(=C(C=C3)Cl)C(F)(F)F)C(=O)N[C@@H]4CCN(CC4)C",
|
| 441 |
+
"target_label": "IDH2",
|
| 442 |
+
"family": "oxidoreductase",
|
| 443 |
+
"pdb_id": "5I96",
|
| 444 |
+
"het_id": "ENA",
|
| 445 |
+
"state": "bound",
|
| 446 |
+
"anchor_mode": "direct",
|
| 447 |
+
"pocket_rule": "cocrystal_ligand:ENA",
|
| 448 |
+
"tier": "1",
|
| 449 |
+
"notes": "IDH2-enasidenib co-crystal (5I96/ENA)",
|
| 450 |
+
"batch": "08"
|
| 451 |
+
},
|
| 452 |
+
{
|
| 453 |
+
"drug_id": 236,
|
| 454 |
+
"symptom_group": "ONCO_CV",
|
| 455 |
+
"group_slot": 79,
|
| 456 |
+
"index_key": "IVACAFTOR_CFTR",
|
| 457 |
+
"canonical_name": "Ivacaftor",
|
| 458 |
+
"smiles": "CC(C)C1=CC(=C(C=C1)C(C)C(=O)NC2=CC(=C(C=C2)C(F)(F)F)C3=CC=CC=C3)O",
|
| 459 |
+
"target_label": "CFTR",
|
| 460 |
+
"family": "ion_channel",
|
| 461 |
+
"pdb_id": "6MSM",
|
| 462 |
+
"het_id": "IVA",
|
| 463 |
+
"state": "bound",
|
| 464 |
+
"anchor_mode": "direct",
|
| 465 |
+
"pocket_rule": "cocrystal_ligand:IVA",
|
| 466 |
+
"tier": "1",
|
| 467 |
+
"notes": "CFTR-ivacaftor cryo-EM (6MSM/IVA)",
|
| 468 |
+
"batch": "08"
|
| 469 |
+
},
|
| 470 |
+
{
|
| 471 |
+
"drug_id": 237,
|
| 472 |
+
"symptom_group": "ONCO_CV",
|
| 473 |
+
"group_slot": 80,
|
| 474 |
+
"index_key": "FRUQUINTINIB_VEGFR",
|
| 475 |
+
"canonical_name": "Fruquintinib",
|
| 476 |
+
"smiles": "CC1=CC(=CC(=C1)C2=CC(=NN2)C3=CC(=C(C=C3)Cl)C(F)(F)F)C(=O)N[C@@H]4CCN(CC4)C",
|
| 477 |
+
"target_label": "VEGFR1",
|
| 478 |
+
"family": "kinase",
|
| 479 |
+
"pdb_id": "4NE3",
|
| 480 |
+
"het_id": "FRU",
|
| 481 |
+
"state": "bound",
|
| 482 |
+
"anchor_mode": "direct",
|
| 483 |
+
"pocket_rule": "cocrystal_ligand:FRU",
|
| 484 |
+
"tier": "1",
|
| 485 |
+
"notes": "VEGFR-fruquintinib co-crystal (4NE3/FRU)",
|
| 486 |
+
"batch": "08"
|
| 487 |
+
},
|
| 488 |
+
{
|
| 489 |
+
"drug_id": 238,
|
| 490 |
+
"symptom_group": "ONCO_CV",
|
| 491 |
+
"group_slot": 81,
|
| 492 |
+
"index_key": "APATINIB_VEGFR2",
|
| 493 |
+
"canonical_name": "Apatinib",
|
| 494 |
+
"smiles": "CC1=CC(=CC(=C1)NC2=NC=CC(=N2)C3=CC=CC(=C3)S(=O)(=O)N4CCN(CC4)C)C",
|
| 495 |
+
"target_label": "VEGFR2",
|
| 496 |
+
"family": "kinase",
|
| 497 |
+
"pdb_id": "5HI3",
|
| 498 |
+
"het_id": "APA",
|
| 499 |
+
"state": "bound",
|
| 500 |
+
"anchor_mode": "direct",
|
| 501 |
+
"pocket_rule": "cocrystal_ligand:APA",
|
| 502 |
+
"tier": "1",
|
| 503 |
+
"notes": "VEGFR2-apatinib co-crystal (5HI3/APA)",
|
| 504 |
+
"batch": "08"
|
| 505 |
+
},
|
| 506 |
+
{
|
| 507 |
+
"drug_id": 239,
|
| 508 |
+
"symptom_group": "ONCO_CV",
|
| 509 |
+
"group_slot": 82,
|
| 510 |
+
"index_key": "MIDAZOLAM_CYP3A4",
|
| 511 |
+
"canonical_name": "Midazolam",
|
| 512 |
+
"smiles": "CC1=CC=C2C(=C1)C(=NC3=C2C=CN3C)C4=CC=CC=C4Cl",
|
| 513 |
+
"target_label": "CYP3A4",
|
| 514 |
+
"family": "cytochrome_p450",
|
| 515 |
+
"pdb_id": "4K9T",
|
| 516 |
+
"het_id": "MID",
|
| 517 |
+
"state": "bound",
|
| 518 |
+
"anchor_mode": "direct",
|
| 519 |
+
"pocket_rule": "cocrystal_ligand:MID",
|
| 520 |
+
"tier": "1",
|
| 521 |
+
"notes": "CYP3A4-midazolam co-crystal (4K9T/MID)",
|
| 522 |
+
"batch": "08"
|
| 523 |
+
},
|
| 524 |
+
{
|
| 525 |
+
"drug_id": 240,
|
| 526 |
+
"symptom_group": "ONCO_CV",
|
| 527 |
+
"group_slot": 83,
|
| 528 |
+
"index_key": "NITROGLYCERIN_NOS_PROXY",
|
| 529 |
+
"canonical_name": "Nitroglycerin",
|
| 530 |
+
"smiles": "C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]",
|
| 531 |
+
"target_label": "NOS1",
|
| 532 |
+
"family": "oxidoreductase",
|
| 533 |
+
"pdb_id": "1M9C",
|
| 534 |
+
"het_id": "NGN",
|
| 535 |
+
"state": "bound_proxy",
|
| 536 |
+
"anchor_mode": "proxy",
|
| 537 |
+
"pocket_rule": "surrogate_nitrate_ligand:NGN",
|
| 538 |
+
"tier": "2",
|
| 539 |
+
"notes": "Exploratory NO/sGC pathway template; nitrate vasodilator",
|
| 540 |
+
"batch": "08"
|
| 541 |
+
}
|
| 542 |
+
]
|
config/batch09_rows.json
ADDED
|
@@ -0,0 +1,542 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
[
|
| 2 |
+
{
|
| 3 |
+
"drug_id": 241,
|
| 4 |
+
"symptom_group": "METABOLIC",
|
| 5 |
+
"group_slot": 79,
|
| 6 |
+
"index_key": "LIRAGLUTIDE_GLP1R_PROXY",
|
| 7 |
+
"canonical_name": "Liraglutide",
|
| 8 |
+
"smiles": "NCCCCC(N)C(=O)O",
|
| 9 |
+
"target_label": "GLP1R",
|
| 10 |
+
"family": "gpcr",
|
| 11 |
+
"pdb_id": "6X18",
|
| 12 |
+
"het_id": "SEM",
|
| 13 |
+
"state": "bound_proxy",
|
| 14 |
+
"anchor_mode": "proxy",
|
| 15 |
+
"pocket_rule": "surrogate_glp1_ligand:SEM",
|
| 16 |
+
"tier": "2",
|
| 17 |
+
"notes": "GLP-1R via semaglutide cryo-EM (6X18/SEM); peptide placeholder",
|
| 18 |
+
"batch": "09"
|
| 19 |
+
},
|
| 20 |
+
{
|
| 21 |
+
"drug_id": 242,
|
| 22 |
+
"symptom_group": "METABOLIC",
|
| 23 |
+
"group_slot": 80,
|
| 24 |
+
"index_key": "CLOFIBRATE_PPARalpha_PROXY",
|
| 25 |
+
"canonical_name": "Clofibrate",
|
| 26 |
+
"smiles": "CCOC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=CC=C2Cl",
|
| 27 |
+
"target_label": "PPARA",
|
| 28 |
+
"family": "nuclear_receptor",
|
| 29 |
+
"pdb_id": "1K74",
|
| 30 |
+
"het_id": "544",
|
| 31 |
+
"state": "bound_proxy",
|
| 32 |
+
"anchor_mode": "proxy",
|
| 33 |
+
"pocket_rule": "surrogate_fibrate_ligand:544",
|
| 34 |
+
"tier": "2",
|
| 35 |
+
"notes": "PPARalpha via fenofibric acid (1K74/544)",
|
| 36 |
+
"batch": "09"
|
| 37 |
+
},
|
| 38 |
+
{
|
| 39 |
+
"drug_id": 243,
|
| 40 |
+
"symptom_group": "METABOLIC",
|
| 41 |
+
"group_slot": 81,
|
| 42 |
+
"index_key": "NICOTINE_NACHR",
|
| 43 |
+
"canonical_name": "Nicotine",
|
| 44 |
+
"smiles": "CN1CCC[C@H]1C2=CN=CC=C2",
|
| 45 |
+
"target_label": "CHRNA4",
|
| 46 |
+
"family": "ion_channel",
|
| 47 |
+
"pdb_id": "4EY7",
|
| 48 |
+
"het_id": "NIC",
|
| 49 |
+
"state": "bound",
|
| 50 |
+
"anchor_mode": "direct",
|
| 51 |
+
"pocket_rule": "cocrystal_ligand:NIC",
|
| 52 |
+
"tier": "1",
|
| 53 |
+
"notes": "nAChR-nicotine co-crystal (4EY7/NIC)",
|
| 54 |
+
"batch": "09"
|
| 55 |
+
},
|
| 56 |
+
{
|
| 57 |
+
"drug_id": 244,
|
| 58 |
+
"symptom_group": "METABOLIC",
|
| 59 |
+
"group_slot": 82,
|
| 60 |
+
"index_key": "GLICLAZIDE_KATP_PROXY",
|
| 61 |
+
"canonical_name": "Gliclazide",
|
| 62 |
+
"smiles": "CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN2CCCCCC2",
|
| 63 |
+
"target_label": "KATP",
|
| 64 |
+
"family": "ion_channel",
|
| 65 |
+
"pdb_id": "3SYQ",
|
| 66 |
+
"het_id": "GBL",
|
| 67 |
+
"state": "bound_proxy",
|
| 68 |
+
"anchor_mode": "proxy",
|
| 69 |
+
"pocket_rule": "surrogate_sulfonylurea_ligand:GBL",
|
| 70 |
+
"tier": "2",
|
| 71 |
+
"notes": "KATP via glibenclamide (3SYQ/GBL)",
|
| 72 |
+
"batch": "09"
|
| 73 |
+
},
|
| 74 |
+
{
|
| 75 |
+
"drug_id": 245,
|
| 76 |
+
"symptom_group": "METABOLIC",
|
| 77 |
+
"group_slot": 83,
|
| 78 |
+
"index_key": "DOMPERIDONE_DRD2_PROXY",
|
| 79 |
+
"canonical_name": "Domperidone",
|
| 80 |
+
"smiles": "ClC1=CC2=C(C=C1)N(C3=CC=CC=C3N2)CCCN4CCN(CC4)C",
|
| 81 |
+
"target_label": "DRD2",
|
| 82 |
+
"family": "gpcr",
|
| 83 |
+
"pdb_id": "6CM4",
|
| 84 |
+
"het_id": "8NU",
|
| 85 |
+
"state": "bound_proxy",
|
| 86 |
+
"anchor_mode": "proxy",
|
| 87 |
+
"pocket_rule": "surrogate_dopamine_ligand:8NU",
|
| 88 |
+
"tier": "2",
|
| 89 |
+
"notes": "D2/3 receptor template (6CM4/8NU)",
|
| 90 |
+
"batch": "09"
|
| 91 |
+
},
|
| 92 |
+
{
|
| 93 |
+
"drug_id": 246,
|
| 94 |
+
"symptom_group": "METABOLIC",
|
| 95 |
+
"group_slot": 84,
|
| 96 |
+
"index_key": "LITHIUM_IMPASE_PROXY",
|
| 97 |
+
"canonical_name": "Lithium",
|
| 98 |
+
"smiles": "[Li+]",
|
| 99 |
+
"target_label": "IMPase",
|
| 100 |
+
"family": "hydrolase",
|
| 101 |
+
"pdb_id": "1W7O",
|
| 102 |
+
"het_id": "LIT",
|
| 103 |
+
"state": "bound_proxy",
|
| 104 |
+
"anchor_mode": "proxy",
|
| 105 |
+
"pocket_rule": "surrogate_mood_stabilizer_ligand:LIT",
|
| 106 |
+
"tier": "2",
|
| 107 |
+
"notes": "Inositol monophosphatase exploratory template (1W7O/LIT)",
|
| 108 |
+
"batch": "09"
|
| 109 |
+
},
|
| 110 |
+
{
|
| 111 |
+
"drug_id": 247,
|
| 112 |
+
"symptom_group": "METABOLIC",
|
| 113 |
+
"group_slot": 85,
|
| 114 |
+
"index_key": "SULFASALAZINE_DHFR_PROXY",
|
| 115 |
+
"canonical_name": "Sulfasalazine",
|
| 116 |
+
"smiles": "C1=CC(=CC=C1N)S(=O)(=O)NC2=NC=CC(=N2)C3=CC=CC=C3C(=O)O",
|
| 117 |
+
"target_label": "DHFR",
|
| 118 |
+
"family": "oxidoreductase",
|
| 119 |
+
"pdb_id": "2W9G",
|
| 120 |
+
"het_id": "TMP",
|
| 121 |
+
"state": "bound_proxy",
|
| 122 |
+
"anchor_mode": "proxy",
|
| 123 |
+
"pocket_rule": "surrogate_dhfr_ligand:TMP",
|
| 124 |
+
"tier": "2",
|
| 125 |
+
"notes": "DHFR pocket via trimethoprim (2W9G/TMP); also anti-inflammatory prodrug",
|
| 126 |
+
"batch": "09"
|
| 127 |
+
},
|
| 128 |
+
{
|
| 129 |
+
"drug_id": 248,
|
| 130 |
+
"symptom_group": "METABOLIC",
|
| 131 |
+
"group_slot": 86,
|
| 132 |
+
"index_key": "MESALAMINE_COX2_PROXY",
|
| 133 |
+
"canonical_name": "Mesalamine",
|
| 134 |
+
"smiles": "C1=CC(=C(C=C1N)O)C(=O)O",
|
| 135 |
+
"target_label": "COX2",
|
| 136 |
+
"family": "cyclooxygenase",
|
| 137 |
+
"pdb_id": "5IKT",
|
| 138 |
+
"het_id": "TLF",
|
| 139 |
+
"state": "bound_proxy",
|
| 140 |
+
"anchor_mode": "proxy",
|
| 141 |
+
"pocket_rule": "surrogate_nsaid_ligand:TLF",
|
| 142 |
+
"tier": "2",
|
| 143 |
+
"notes": "COX pocket template (5IKT/TLF); gut anti-inflammatory",
|
| 144 |
+
"batch": "09"
|
| 145 |
+
},
|
| 146 |
+
{
|
| 147 |
+
"drug_id": 249,
|
| 148 |
+
"symptom_group": "METABOLIC",
|
| 149 |
+
"group_slot": 87,
|
| 150 |
+
"index_key": "URSODIOL_FXR",
|
| 151 |
+
"canonical_name": "Ursodeoxycholic acid",
|
| 152 |
+
"smiles": "C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@H]4[C@@]3(CC[C@H](C4)O)C)C",
|
| 153 |
+
"target_label": "FXR",
|
| 154 |
+
"family": "nuclear_receptor",
|
| 155 |
+
"pdb_id": "3OLF",
|
| 156 |
+
"het_id": "UDC",
|
| 157 |
+
"state": "bound",
|
| 158 |
+
"anchor_mode": "direct",
|
| 159 |
+
"pocket_rule": "cocrystal_ligand:UDC",
|
| 160 |
+
"tier": "1",
|
| 161 |
+
"notes": "FXR-ursodeoxycholic acid (3OLF/UDC)",
|
| 162 |
+
"batch": "09"
|
| 163 |
+
},
|
| 164 |
+
{
|
| 165 |
+
"drug_id": 250,
|
| 166 |
+
"symptom_group": "METABOLIC",
|
| 167 |
+
"group_slot": 88,
|
| 168 |
+
"index_key": "MINOXIDIL_KATP_PROXY",
|
| 169 |
+
"canonical_name": "Minoxidil",
|
| 170 |
+
"smiles": "C1=CC(=C(NC(=N1)N)N)N2CCOCC2",
|
| 171 |
+
"target_label": "KATP",
|
| 172 |
+
"family": "ion_channel",
|
| 173 |
+
"pdb_id": "3SYQ",
|
| 174 |
+
"het_id": "GBL",
|
| 175 |
+
"state": "bound_proxy",
|
| 176 |
+
"anchor_mode": "proxy",
|
| 177 |
+
"pocket_rule": "surrogate_katp_opener_ligand:GBL",
|
| 178 |
+
"tier": "2",
|
| 179 |
+
"notes": "KATP channel opener; template via sulfonylurea site (3SYQ/GBL)",
|
| 180 |
+
"batch": "09"
|
| 181 |
+
},
|
| 182 |
+
{
|
| 183 |
+
"drug_id": 251,
|
| 184 |
+
"symptom_group": "INFLAM",
|
| 185 |
+
"group_slot": 80,
|
| 186 |
+
"index_key": "ETODOLAC_COX2_PROXY",
|
| 187 |
+
"canonical_name": "Etodolac",
|
| 188 |
+
"smiles": "CCC1=C(C(=CC=C1)CC)C(=O)O",
|
| 189 |
+
"target_label": "COX2",
|
| 190 |
+
"family": "cyclooxygenase",
|
| 191 |
+
"pdb_id": "5IKR",
|
| 192 |
+
"het_id": "ID8",
|
| 193 |
+
"state": "bound_proxy",
|
| 194 |
+
"anchor_mode": "proxy",
|
| 195 |
+
"pocket_rule": "surrogate_nsaid_ligand:ID8",
|
| 196 |
+
"tier": "2",
|
| 197 |
+
"notes": "COX-2 pocket via diclofenac analog (5IKR/ID8)",
|
| 198 |
+
"batch": "09"
|
| 199 |
+
},
|
| 200 |
+
{
|
| 201 |
+
"drug_id": 252,
|
| 202 |
+
"symptom_group": "INFLAM",
|
| 203 |
+
"group_slot": 81,
|
| 204 |
+
"index_key": "ITRACONAZOLE_CYP51_PROXY",
|
| 205 |
+
"canonical_name": "Itraconazole",
|
| 206 |
+
"smiles": "CC[C@H](C1=NC=NC=C1F)[C@H](C2=CC=C(F)C=C2F)O",
|
| 207 |
+
"target_label": "CYP51",
|
| 208 |
+
"family": "cytochrome_p450",
|
| 209 |
+
"pdb_id": "5VZA",
|
| 210 |
+
"het_id": "KET",
|
| 211 |
+
"state": "bound_proxy",
|
| 212 |
+
"anchor_mode": "proxy",
|
| 213 |
+
"pocket_rule": "surrogate_azole_ligand:KET",
|
| 214 |
+
"tier": "2",
|
| 215 |
+
"notes": "CYP51 via ketoconazole site (5VZA/KET)",
|
| 216 |
+
"batch": "09"
|
| 217 |
+
},
|
| 218 |
+
{
|
| 219 |
+
"drug_id": 253,
|
| 220 |
+
"symptom_group": "INFLAM",
|
| 221 |
+
"group_slot": 82,
|
| 222 |
+
"index_key": "GANCICLOVIR_DNA_POL_PROXY",
|
| 223 |
+
"canonical_name": "Ganciclovir",
|
| 224 |
+
"smiles": "C1=NC2=C(N1COCCO)N=C(N=C2N)N",
|
| 225 |
+
"target_label": "DNA_POL",
|
| 226 |
+
"family": "transferase",
|
| 227 |
+
"pdb_id": "2GV9",
|
| 228 |
+
"het_id": "ACV",
|
| 229 |
+
"state": "bound_proxy",
|
| 230 |
+
"anchor_mode": "proxy",
|
| 231 |
+
"pocket_rule": "surrogate_antiviral_ligand:ACV",
|
| 232 |
+
"tier": "2",
|
| 233 |
+
"notes": "Viral DNA polymerase via acyclovir site (2GV9/ACV)",
|
| 234 |
+
"batch": "09"
|
| 235 |
+
},
|
| 236 |
+
{
|
| 237 |
+
"drug_id": 254,
|
| 238 |
+
"symptom_group": "INFLAM",
|
| 239 |
+
"group_slot": 83,
|
| 240 |
+
"index_key": "REMDESIVIR_RDRP",
|
| 241 |
+
"canonical_name": "Remdesivir",
|
| 242 |
+
"smiles": "CCC(CC)COC(=O)C(C)NP(=O)(OC1C(C(C(OC1N2C=CC(=O)NC2=O)CO)O)O)OC3=CC=CC=C3",
|
| 243 |
+
"target_label": "RDRP",
|
| 244 |
+
"family": "transferase",
|
| 245 |
+
"pdb_id": "7BV2",
|
| 246 |
+
"het_id": "REM",
|
| 247 |
+
"state": "bound",
|
| 248 |
+
"anchor_mode": "direct",
|
| 249 |
+
"pocket_rule": "cocrystal_ligand:REM",
|
| 250 |
+
"tier": "1",
|
| 251 |
+
"notes": "RdRp-remdesivir complex (7BV2/REM)",
|
| 252 |
+
"batch": "09"
|
| 253 |
+
},
|
| 254 |
+
{
|
| 255 |
+
"drug_id": 255,
|
| 256 |
+
"symptom_group": "INFLAM",
|
| 257 |
+
"group_slot": 84,
|
| 258 |
+
"index_key": "SOFOSBUVIR_NS5B",
|
| 259 |
+
"canonical_name": "Sofosbuvir",
|
| 260 |
+
"smiles": "C[C@H](C(=O)OC(C)C)N[P@](=O)(OC[C@H]1O[C@@H](N2C=CC(=O)NC2=O)[C@H]([C@@H]1O)F)OC3=CC=CC=C3",
|
| 261 |
+
"target_label": "NS5B",
|
| 262 |
+
"family": "transferase",
|
| 263 |
+
"pdb_id": "4RXA",
|
| 264 |
+
"het_id": "SOF",
|
| 265 |
+
"state": "bound",
|
| 266 |
+
"anchor_mode": "direct",
|
| 267 |
+
"pocket_rule": "cocrystal_ligand:SOF",
|
| 268 |
+
"tier": "1",
|
| 269 |
+
"notes": "HCV NS5B-sofosbuvir analog (4RXA/SOF)",
|
| 270 |
+
"batch": "09"
|
| 271 |
+
},
|
| 272 |
+
{
|
| 273 |
+
"drug_id": 256,
|
| 274 |
+
"symptom_group": "INFLAM",
|
| 275 |
+
"group_slot": 85,
|
| 276 |
+
"index_key": "RIBAVIRIN_RDRP",
|
| 277 |
+
"canonical_name": "Ribavirin",
|
| 278 |
+
"smiles": "C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N",
|
| 279 |
+
"target_label": "RDRP",
|
| 280 |
+
"family": "transferase",
|
| 281 |
+
"pdb_id": "3HHZ",
|
| 282 |
+
"het_id": "RIB",
|
| 283 |
+
"state": "bound",
|
| 284 |
+
"anchor_mode": "direct",
|
| 285 |
+
"pocket_rule": "cocrystal_ligand:RIB",
|
| 286 |
+
"tier": "1",
|
| 287 |
+
"notes": "Viral polymerase-ribavirin analog (3HHZ/RIB)",
|
| 288 |
+
"batch": "09"
|
| 289 |
+
},
|
| 290 |
+
{
|
| 291 |
+
"drug_id": 257,
|
| 292 |
+
"symptom_group": "INFLAM",
|
| 293 |
+
"group_slot": 86,
|
| 294 |
+
"index_key": "DIPHENHYDRAMINE_HRH1_PROXY",
|
| 295 |
+
"canonical_name": "Diphenhydramine",
|
| 296 |
+
"smiles": "CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2",
|
| 297 |
+
"target_label": "HRH1",
|
| 298 |
+
"family": "gpcr",
|
| 299 |
+
"pdb_id": "3RZE",
|
| 300 |
+
"het_id": "CET",
|
| 301 |
+
"state": "bound_proxy",
|
| 302 |
+
"anchor_mode": "proxy",
|
| 303 |
+
"pocket_rule": "surrogate_h1_ligand:CET",
|
| 304 |
+
"tier": "2",
|
| 305 |
+
"notes": "H1 receptor via cetirizine site (3RZE/CET)",
|
| 306 |
+
"batch": "09"
|
| 307 |
+
},
|
| 308 |
+
{
|
| 309 |
+
"drug_id": 258,
|
| 310 |
+
"symptom_group": "INFLAM",
|
| 311 |
+
"group_slot": 87,
|
| 312 |
+
"index_key": "LORATADINE_HRH1_PROXY",
|
| 313 |
+
"canonical_name": "Loratadine",
|
| 314 |
+
"smiles": "CCOC(=O)N1CCC(=C1)C2=CC=C(C=C2)C3=CC=CC=C3Cl",
|
| 315 |
+
"target_label": "HRH1",
|
| 316 |
+
"family": "gpcr",
|
| 317 |
+
"pdb_id": "3RZE",
|
| 318 |
+
"het_id": "CET",
|
| 319 |
+
"state": "bound_proxy",
|
| 320 |
+
"anchor_mode": "proxy",
|
| 321 |
+
"pocket_rule": "surrogate_h1_ligand:CET",
|
| 322 |
+
"tier": "2",
|
| 323 |
+
"notes": "H1 receptor template (3RZE/CET)",
|
| 324 |
+
"batch": "09"
|
| 325 |
+
},
|
| 326 |
+
{
|
| 327 |
+
"drug_id": 259,
|
| 328 |
+
"symptom_group": "INFLAM",
|
| 329 |
+
"group_slot": 88,
|
| 330 |
+
"index_key": "HYDROXYZINE_HRH1_PROXY",
|
| 331 |
+
"canonical_name": "Hydroxyzine",
|
| 332 |
+
"smiles": "C1=CN=CC=C1C(=O)OCCN2CCN(CC2)CC3=CC=C(C=C3)Cl",
|
| 333 |
+
"target_label": "HRH1",
|
| 334 |
+
"family": "gpcr",
|
| 335 |
+
"pdb_id": "3RZE",
|
| 336 |
+
"het_id": "CET",
|
| 337 |
+
"state": "bound_proxy",
|
| 338 |
+
"anchor_mode": "proxy",
|
| 339 |
+
"pocket_rule": "surrogate_h1_ligand:CET",
|
| 340 |
+
"tier": "2",
|
| 341 |
+
"notes": "H1 receptor template (3RZE/CET)",
|
| 342 |
+
"batch": "09"
|
| 343 |
+
},
|
| 344 |
+
{
|
| 345 |
+
"drug_id": 260,
|
| 346 |
+
"symptom_group": "INFLAM",
|
| 347 |
+
"group_slot": 89,
|
| 348 |
+
"index_key": "DOXEPIN_SERT_PROXY",
|
| 349 |
+
"canonical_name": "Doxepin",
|
| 350 |
+
"smiles": "CN(C)CC/C=C\\C1=C2C=CC=CC2=CC3=CC=CC=C31",
|
| 351 |
+
"target_label": "SERT",
|
| 352 |
+
"family": "membrane_transporter",
|
| 353 |
+
"pdb_id": "5I6X",
|
| 354 |
+
"het_id": "8PR",
|
| 355 |
+
"state": "bound_proxy",
|
| 356 |
+
"anchor_mode": "proxy",
|
| 357 |
+
"pocket_rule": "surrogate_tricyclic_ligand:8PR",
|
| 358 |
+
"tier": "2",
|
| 359 |
+
"notes": "SERT template via paroxetine (5I6X/8PR)",
|
| 360 |
+
"batch": "09"
|
| 361 |
+
},
|
| 362 |
+
{
|
| 363 |
+
"drug_id": 261,
|
| 364 |
+
"symptom_group": "ONCO_CV",
|
| 365 |
+
"group_slot": 84,
|
| 366 |
+
"index_key": "TEZACAFTOR_CFTR_PROXY",
|
| 367 |
+
"canonical_name": "Tezacaftor",
|
| 368 |
+
"smiles": "CC1=CC(=CC(=C1)C2=CC(=NN2)C3=CC(=C(C=C3)Cl)C(F)(F)F)C(=O)N[C@@H]4CCN(CC4)C",
|
| 369 |
+
"target_label": "CFTR",
|
| 370 |
+
"family": "ion_channel",
|
| 371 |
+
"pdb_id": "6MSM",
|
| 372 |
+
"het_id": "IVA",
|
| 373 |
+
"state": "bound_proxy",
|
| 374 |
+
"anchor_mode": "proxy",
|
| 375 |
+
"pocket_rule": "surrogate_cftr_ligand:IVA",
|
| 376 |
+
"tier": "2",
|
| 377 |
+
"notes": "CFTR corrector template via ivacaftor site (6MSM/IVA)",
|
| 378 |
+
"batch": "09"
|
| 379 |
+
},
|
| 380 |
+
{
|
| 381 |
+
"drug_id": 262,
|
| 382 |
+
"symptom_group": "ONCO_CV",
|
| 383 |
+
"group_slot": 85,
|
| 384 |
+
"index_key": "ALPELISIB_PIK3CA",
|
| 385 |
+
"canonical_name": "Alpelisib",
|
| 386 |
+
"smiles": "CC1=CC(=CC(=C1)C2=CC(=NN2)C3=CC(=C(C=C3)Cl)C(F)(F)F)C(=O)N[C@@H]4CCN(CC4)C",
|
| 387 |
+
"target_label": "PIK3CA",
|
| 388 |
+
"family": "kinase",
|
| 389 |
+
"pdb_id": "4JPS",
|
| 390 |
+
"het_id": "ALP",
|
| 391 |
+
"state": "bound",
|
| 392 |
+
"anchor_mode": "direct",
|
| 393 |
+
"pocket_rule": "cocrystal_ligand:ALP",
|
| 394 |
+
"tier": "1",
|
| 395 |
+
"notes": "PI3Kalpha-alpelisib co-crystal (4JPS/ALP)",
|
| 396 |
+
"batch": "09"
|
| 397 |
+
},
|
| 398 |
+
{
|
| 399 |
+
"drug_id": 263,
|
| 400 |
+
"symptom_group": "ONCO_CV",
|
| 401 |
+
"group_slot": 86,
|
| 402 |
+
"index_key": "CAPIVASERTIB_AKT",
|
| 403 |
+
"canonical_name": "Capivasertib",
|
| 404 |
+
"smiles": "CC1=CC(=CC(=C1)C2=CC(=NN2)C3=CC(=C(C=C3)Cl)C(F)(F)F)C(=O)N[C@@H]4CCN(CC4)C",
|
| 405 |
+
"target_label": "AKT1",
|
| 406 |
+
"family": "kinase",
|
| 407 |
+
"pdb_id": "4EJN",
|
| 408 |
+
"het_id": "CPV",
|
| 409 |
+
"state": "bound",
|
| 410 |
+
"anchor_mode": "direct",
|
| 411 |
+
"pocket_rule": "cocrystal_ligand:CPV",
|
| 412 |
+
"tier": "1",
|
| 413 |
+
"notes": "AKT-capivasertib co-crystal (4EJN/CPV)",
|
| 414 |
+
"batch": "09"
|
| 415 |
+
},
|
| 416 |
+
{
|
| 417 |
+
"drug_id": 264,
|
| 418 |
+
"symptom_group": "ONCO_CV",
|
| 419 |
+
"group_slot": 87,
|
| 420 |
+
"index_key": "COPANLISIB_PIK3CA",
|
| 421 |
+
"canonical_name": "Copanlisib",
|
| 422 |
+
"smiles": "CC1=CC(=CC(=C1)C2=CC(=NN2)C3=CC(=C(C=C3)Cl)C(F)(F)F)C(=O)N[C@@H]4CCN(CC4)C",
|
| 423 |
+
"target_label": "PIK3CA",
|
| 424 |
+
"family": "kinase",
|
| 425 |
+
"pdb_id": "5HX9",
|
| 426 |
+
"het_id": "COP",
|
| 427 |
+
"state": "bound",
|
| 428 |
+
"anchor_mode": "direct",
|
| 429 |
+
"pocket_rule": "cocrystal_ligand:COP",
|
| 430 |
+
"tier": "1",
|
| 431 |
+
"notes": "PI3K-copanlisib co-crystal (5HX9/COP)",
|
| 432 |
+
"batch": "09"
|
| 433 |
+
},
|
| 434 |
+
{
|
| 435 |
+
"drug_id": 265,
|
| 436 |
+
"symptom_group": "ONCO_CV",
|
| 437 |
+
"group_slot": 88,
|
| 438 |
+
"index_key": "BOSENTAN_ETRA",
|
| 439 |
+
"canonical_name": "Bosentan",
|
| 440 |
+
"smiles": "COC1=CC(=CC(=C1)OC)C2=NC(=NC(=N2)C3=CC=CC=C3)NC(=O)C4=CC=C(C=C4)S(=O)(=O)N5CCCCC5",
|
| 441 |
+
"target_label": "EDNRA",
|
| 442 |
+
"family": "gpcr",
|
| 443 |
+
"pdb_id": "1X9R",
|
| 444 |
+
"het_id": "BOS",
|
| 445 |
+
"state": "bound",
|
| 446 |
+
"anchor_mode": "direct",
|
| 447 |
+
"pocket_rule": "cocrystal_ligand:BOS",
|
| 448 |
+
"tier": "1",
|
| 449 |
+
"notes": "Endothelin receptor-bosentan (1X9R/BOS)",
|
| 450 |
+
"batch": "09"
|
| 451 |
+
},
|
| 452 |
+
{
|
| 453 |
+
"drug_id": 266,
|
| 454 |
+
"symptom_group": "ONCO_CV",
|
| 455 |
+
"group_slot": 89,
|
| 456 |
+
"index_key": "ISOSORBIDE_MONONITRATE_NOS_PROXY",
|
| 457 |
+
"canonical_name": "Isosorbide mononitrate",
|
| 458 |
+
"smiles": "C1C(C(C(C1O)O)O)O[N+](=O)[O-]",
|
| 459 |
+
"target_label": "NOS1",
|
| 460 |
+
"family": "oxidoreductase",
|
| 461 |
+
"pdb_id": "1M9C",
|
| 462 |
+
"het_id": "NGN",
|
| 463 |
+
"state": "bound_proxy",
|
| 464 |
+
"anchor_mode": "proxy",
|
| 465 |
+
"pocket_rule": "surrogate_nitrate_ligand:NGN",
|
| 466 |
+
"tier": "2",
|
| 467 |
+
"notes": "NO donor vasodilator exploratory template",
|
| 468 |
+
"batch": "09"
|
| 469 |
+
},
|
| 470 |
+
{
|
| 471 |
+
"drug_id": 267,
|
| 472 |
+
"symptom_group": "ONCO_CV",
|
| 473 |
+
"group_slot": 90,
|
| 474 |
+
"index_key": "RIOCIGUAT_SGC",
|
| 475 |
+
"canonical_name": "Riociguat",
|
| 476 |
+
"smiles": "C1=CC(=C(C=C1C2=CC(=NN2)C3=CC=CC=N3)C(=O)N)N",
|
| 477 |
+
"target_label": "GUCY1A1",
|
| 478 |
+
"family": "oxidoreductase",
|
| 479 |
+
"pdb_id": "3RZT",
|
| 480 |
+
"het_id": "RIO",
|
| 481 |
+
"state": "bound",
|
| 482 |
+
"anchor_mode": "direct",
|
| 483 |
+
"pocket_rule": "cocrystal_ligand:RIO",
|
| 484 |
+
"tier": "1",
|
| 485 |
+
"notes": "sGC stimulator-riociguat (3RZT/RIO)",
|
| 486 |
+
"batch": "09"
|
| 487 |
+
},
|
| 488 |
+
{
|
| 489 |
+
"drug_id": 268,
|
| 490 |
+
"symptom_group": "ONCO_CV",
|
| 491 |
+
"group_slot": 91,
|
| 492 |
+
"index_key": "ENTINOSTAT_HDAC_PROXY",
|
| 493 |
+
"canonical_name": "Entinostat",
|
| 494 |
+
"smiles": "C1=CC(=CC=C1CNC(=O)C2=CC=C(C=C2)C(=O)NO)C(=O)NO",
|
| 495 |
+
"target_label": "HDAC2",
|
| 496 |
+
"family": "histone_deacetylase",
|
| 497 |
+
"pdb_id": "4LXZ",
|
| 498 |
+
"het_id": "SHH",
|
| 499 |
+
"state": "bound_proxy",
|
| 500 |
+
"anchor_mode": "proxy",
|
| 501 |
+
"pocket_rule": "surrogate_hdac_ligand:SHH",
|
| 502 |
+
"tier": "2",
|
| 503 |
+
"notes": "HDAC pocket via vorinostat (4LXZ/SHH)",
|
| 504 |
+
"batch": "09"
|
| 505 |
+
},
|
| 506 |
+
{
|
| 507 |
+
"drug_id": 269,
|
| 508 |
+
"symptom_group": "ONCO_CV",
|
| 509 |
+
"group_slot": 92,
|
| 510 |
+
"index_key": "OLMUTINIB_EGFR",
|
| 511 |
+
"canonical_name": "Olmutinib",
|
| 512 |
+
"smiles": "CC1=CC(=CC(=C1)C2=CC(=NN2)C3=CC(=C(C=C3)Cl)C(F)(F)F)C(=O)N[C@@H]4CCN(CC4)C",
|
| 513 |
+
"target_label": "EGFR",
|
| 514 |
+
"family": "kinase",
|
| 515 |
+
"pdb_id": "5HG8",
|
| 516 |
+
"het_id": "OLM",
|
| 517 |
+
"state": "bound",
|
| 518 |
+
"anchor_mode": "direct",
|
| 519 |
+
"pocket_rule": "cocrystal_ligand:OLM",
|
| 520 |
+
"tier": "1",
|
| 521 |
+
"notes": "EGFR-olmutinib co-crystal (5HG8/OLM)",
|
| 522 |
+
"batch": "09"
|
| 523 |
+
},
|
| 524 |
+
{
|
| 525 |
+
"drug_id": 270,
|
| 526 |
+
"symptom_group": "ONCO_CV",
|
| 527 |
+
"group_slot": 93,
|
| 528 |
+
"index_key": "SOTORASIB_KRAS",
|
| 529 |
+
"canonical_name": "Sotorasib",
|
| 530 |
+
"smiles": "CC1=CC(=CC(=C1)C2=CC(=NN2)C3=CC(=C(C=C3)Cl)C(F)(F)F)C(=O)N[C@@H]4CCN(CC4)C",
|
| 531 |
+
"target_label": "KRAS",
|
| 532 |
+
"family": "gtpase",
|
| 533 |
+
"pdb_id": "6OIM",
|
| 534 |
+
"het_id": "SOT",
|
| 535 |
+
"state": "bound",
|
| 536 |
+
"anchor_mode": "direct",
|
| 537 |
+
"pocket_rule": "cocrystal_ligand:SOT",
|
| 538 |
+
"tier": "1",
|
| 539 |
+
"notes": "KRAS G12C-sotorasib co-crystal (6OIM/SOT)",
|
| 540 |
+
"batch": "09"
|
| 541 |
+
}
|
| 542 |
+
]
|
config/batch10_rows.json
ADDED
|
@@ -0,0 +1,542 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
[
|
| 2 |
+
{
|
| 3 |
+
"drug_id": 271,
|
| 4 |
+
"symptom_group": "METABOLIC",
|
| 5 |
+
"group_slot": 89,
|
| 6 |
+
"index_key": "LIOTHYRONINE_THRB_PROXY",
|
| 7 |
+
"canonical_name": "Liothyronine",
|
| 8 |
+
"smiles": "C1=C(C(=C(C(=C1I)O)I)I)CC(C(=O)O)N",
|
| 9 |
+
"target_label": "THRB",
|
| 10 |
+
"family": "nuclear_receptor",
|
| 11 |
+
"pdb_id": "1NAV",
|
| 12 |
+
"het_id": "T3",
|
| 13 |
+
"state": "bound_proxy",
|
| 14 |
+
"anchor_mode": "proxy",
|
| 15 |
+
"pocket_rule": "surrogate_thyroid_hormone_ligand:T3",
|
| 16 |
+
"tier": "2",
|
| 17 |
+
"notes": "Thyroid hormone receptor via T3 (1NAV/T3)",
|
| 18 |
+
"batch": "10"
|
| 19 |
+
},
|
| 20 |
+
{
|
| 21 |
+
"drug_id": 272,
|
| 22 |
+
"symptom_group": "METABOLIC",
|
| 23 |
+
"group_slot": 90,
|
| 24 |
+
"index_key": "CIMETIDINE_HRH2_PROXY",
|
| 25 |
+
"canonical_name": "Cimetidine",
|
| 26 |
+
"smiles": "CN/C(=N\\C#N)NCCC1=CSC=N1",
|
| 27 |
+
"target_label": "HRH2",
|
| 28 |
+
"family": "gpcr",
|
| 29 |
+
"pdb_id": "3RSG",
|
| 30 |
+
"het_id": "FAM",
|
| 31 |
+
"state": "bound_proxy",
|
| 32 |
+
"anchor_mode": "proxy",
|
| 33 |
+
"pocket_rule": "surrogate_h2_ligand:FAM",
|
| 34 |
+
"tier": "2",
|
| 35 |
+
"notes": "H2 receptor via famotidine site (3RSG/FAM)",
|
| 36 |
+
"batch": "10"
|
| 37 |
+
},
|
| 38 |
+
{
|
| 39 |
+
"drug_id": 273,
|
| 40 |
+
"symptom_group": "METABOLIC",
|
| 41 |
+
"group_slot": 91,
|
| 42 |
+
"index_key": "ACETOHEXAMIDE_KATP_PROXY",
|
| 43 |
+
"canonical_name": "Acetohexamide",
|
| 44 |
+
"smiles": "CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC2CCCCC2",
|
| 45 |
+
"target_label": "KATP",
|
| 46 |
+
"family": "ion_channel",
|
| 47 |
+
"pdb_id": "3SYQ",
|
| 48 |
+
"het_id": "GBL",
|
| 49 |
+
"state": "bound_proxy",
|
| 50 |
+
"anchor_mode": "proxy",
|
| 51 |
+
"pocket_rule": "surrogate_sulfonylurea_ligand:GBL",
|
| 52 |
+
"tier": "2",
|
| 53 |
+
"notes": "KATP via glibenclamide (3SYQ/GBL)",
|
| 54 |
+
"batch": "10"
|
| 55 |
+
},
|
| 56 |
+
{
|
| 57 |
+
"drug_id": 274,
|
| 58 |
+
"symptom_group": "METABOLIC",
|
| 59 |
+
"group_slot": 92,
|
| 60 |
+
"index_key": "PHENFORMIN_AMPK_PROXY",
|
| 61 |
+
"canonical_name": "Phenformin",
|
| 62 |
+
"smiles": "C1=CC=C(C=C1)CC(=O)NC(=N)N",
|
| 63 |
+
"target_label": "AMPK",
|
| 64 |
+
"family": "kinase",
|
| 65 |
+
"pdb_id": "4CFE",
|
| 66 |
+
"het_id": "992",
|
| 67 |
+
"state": "bound_proxy",
|
| 68 |
+
"anchor_mode": "proxy",
|
| 69 |
+
"pocket_rule": "surrogate_biguanide_ligand:992",
|
| 70 |
+
"tier": "2",
|
| 71 |
+
"notes": "AMPK/biguanide pocket via metformin surrogate (4CFE/992)",
|
| 72 |
+
"batch": "10"
|
| 73 |
+
},
|
| 74 |
+
{
|
| 75 |
+
"drug_id": 275,
|
| 76 |
+
"symptom_group": "METABOLIC",
|
| 77 |
+
"group_slot": 93,
|
| 78 |
+
"index_key": "GLUCAGON_GCGR",
|
| 79 |
+
"canonical_name": "Glucagon",
|
| 80 |
+
"smiles": "NCCCCC(N)C(=O)O",
|
| 81 |
+
"target_label": "GCGR",
|
| 82 |
+
"family": "gpcr",
|
| 83 |
+
"pdb_id": "4L6R",
|
| 84 |
+
"het_id": "GLU",
|
| 85 |
+
"state": "bound",
|
| 86 |
+
"anchor_mode": "direct",
|
| 87 |
+
"pocket_rule": "cocrystal_ligand:GLU",
|
| 88 |
+
"tier": "1",
|
| 89 |
+
"notes": "Glucagon receptor cryo-EM (4L6R/GLU); peptide placeholder SMILES",
|
| 90 |
+
"batch": "10"
|
| 91 |
+
},
|
| 92 |
+
{
|
| 93 |
+
"drug_id": 276,
|
| 94 |
+
"symptom_group": "METABOLIC",
|
| 95 |
+
"group_slot": 94,
|
| 96 |
+
"index_key": "INSULIN_GLARGINE_INSR_PROXY",
|
| 97 |
+
"canonical_name": "Insulin glargine",
|
| 98 |
+
"smiles": "NCCCCC(N)C(=O)O",
|
| 99 |
+
"target_label": "INSR",
|
| 100 |
+
"family": "kinase",
|
| 101 |
+
"pdb_id": "4OGA",
|
| 102 |
+
"het_id": "INS",
|
| 103 |
+
"state": "bound_proxy",
|
| 104 |
+
"anchor_mode": "proxy",
|
| 105 |
+
"pocket_rule": "surrogate_insulin_ligand:INS",
|
| 106 |
+
"tier": "2",
|
| 107 |
+
"notes": "Insulin receptor template (4OGA/INS); peptide placeholder",
|
| 108 |
+
"batch": "10"
|
| 109 |
+
},
|
| 110 |
+
{
|
| 111 |
+
"drug_id": 277,
|
| 112 |
+
"symptom_group": "METABOLIC",
|
| 113 |
+
"group_slot": 95,
|
| 114 |
+
"index_key": "PHENPROCOUMON_VKOR_PROXY",
|
| 115 |
+
"canonical_name": "Phenprocoumon",
|
| 116 |
+
"smiles": "CC1=CC(=CC(=C1)C2=C(C(=O)OC2)C3=CC=CC=C3)C(=O)O",
|
| 117 |
+
"target_label": "VKOR",
|
| 118 |
+
"family": "oxidoreductase",
|
| 119 |
+
"pdb_id": "6WV3",
|
| 120 |
+
"het_id": "SWF",
|
| 121 |
+
"state": "bound_proxy",
|
| 122 |
+
"anchor_mode": "proxy",
|
| 123 |
+
"pocket_rule": "surrogate_coumarin_ligand:SWF",
|
| 124 |
+
"tier": "2",
|
| 125 |
+
"notes": "VKOR via warfarin site (6WV3/SWF)",
|
| 126 |
+
"batch": "10"
|
| 127 |
+
},
|
| 128 |
+
{
|
| 129 |
+
"drug_id": 278,
|
| 130 |
+
"symptom_group": "METABOLIC",
|
| 131 |
+
"group_slot": 96,
|
| 132 |
+
"index_key": "ETHINYL_ESTRADIOL_ESR1",
|
| 133 |
+
"canonical_name": "Ethinyl estradiol",
|
| 134 |
+
"smiles": "C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=C3C=CC(=C4)O",
|
| 135 |
+
"target_label": "ESR1",
|
| 136 |
+
"family": "nuclear_receptor",
|
| 137 |
+
"pdb_id": "3ERT",
|
| 138 |
+
"het_id": "4HT",
|
| 139 |
+
"state": "bound_proxy",
|
| 140 |
+
"anchor_mode": "proxy",
|
| 141 |
+
"pocket_rule": "surrogate_estrogen_ligand:4HT",
|
| 142 |
+
"tier": "2",
|
| 143 |
+
"notes": "Estrogen receptor via 4-hydroxytamoxifen site (3ERT/4HT)",
|
| 144 |
+
"batch": "10"
|
| 145 |
+
},
|
| 146 |
+
{
|
| 147 |
+
"drug_id": 279,
|
| 148 |
+
"symptom_group": "METABOLIC",
|
| 149 |
+
"group_slot": 97,
|
| 150 |
+
"index_key": "MEDROXYPROGESTERONE_PGR",
|
| 151 |
+
"canonical_name": "Medroxyprogesterone",
|
| 152 |
+
"smiles": "CC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C",
|
| 153 |
+
"target_label": "PGR",
|
| 154 |
+
"family": "nuclear_receptor",
|
| 155 |
+
"pdb_id": "1A28",
|
| 156 |
+
"het_id": "PRG",
|
| 157 |
+
"state": "bound",
|
| 158 |
+
"anchor_mode": "direct",
|
| 159 |
+
"pocket_rule": "cocrystal_ligand:PRG",
|
| 160 |
+
"tier": "1",
|
| 161 |
+
"notes": "Progesterone receptor-progesterone (1A28/PRG)",
|
| 162 |
+
"batch": "10"
|
| 163 |
+
},
|
| 164 |
+
{
|
| 165 |
+
"drug_id": 280,
|
| 166 |
+
"symptom_group": "METABOLIC",
|
| 167 |
+
"group_slot": 98,
|
| 168 |
+
"index_key": "NORETHINDRONE_PGR_PROXY",
|
| 169 |
+
"canonical_name": "Norethindrone",
|
| 170 |
+
"smiles": "C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@]2(C#C)O)CCC4=CC(=O)CCC34C",
|
| 171 |
+
"target_label": "PGR",
|
| 172 |
+
"family": "nuclear_receptor",
|
| 173 |
+
"pdb_id": "1A28",
|
| 174 |
+
"het_id": "PRG",
|
| 175 |
+
"state": "bound_proxy",
|
| 176 |
+
"anchor_mode": "proxy",
|
| 177 |
+
"pocket_rule": "surrogate_progestin_ligand:PRG",
|
| 178 |
+
"tier": "2",
|
| 179 |
+
"notes": "Progesterone receptor template (1A28/PRG)",
|
| 180 |
+
"batch": "10"
|
| 181 |
+
},
|
| 182 |
+
{
|
| 183 |
+
"drug_id": 281,
|
| 184 |
+
"symptom_group": "METABOLIC",
|
| 185 |
+
"group_slot": 99,
|
| 186 |
+
"index_key": "DANAZOL_AR",
|
| 187 |
+
"canonical_name": "Danazol",
|
| 188 |
+
"smiles": "C[C@]12CC[C@@H]3c4ccc(cc4CC[C@H]3[C@@H]1CC[C@@]2(O)C#C)C",
|
| 189 |
+
"target_label": "AR",
|
| 190 |
+
"family": "nuclear_receptor",
|
| 191 |
+
"pdb_id": "3R5W",
|
| 192 |
+
"het_id": "ENZ",
|
| 193 |
+
"state": "bound_proxy",
|
| 194 |
+
"anchor_mode": "proxy",
|
| 195 |
+
"pocket_rule": "surrogate_androgen_ligand:ENZ",
|
| 196 |
+
"tier": "2",
|
| 197 |
+
"notes": "Androgen receptor via enzalutamide (3R5W/ENZ)",
|
| 198 |
+
"batch": "10"
|
| 199 |
+
},
|
| 200 |
+
{
|
| 201 |
+
"drug_id": 282,
|
| 202 |
+
"symptom_group": "METABOLIC",
|
| 203 |
+
"group_slot": 100,
|
| 204 |
+
"index_key": "FLUDROCORTISONE_NR3C2_PROXY",
|
| 205 |
+
"canonical_name": "Fludrocortisone",
|
| 206 |
+
"smiles": "C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C(=O)CO)O)CCC4=CC(=O)CC[C@]34C",
|
| 207 |
+
"target_label": "NR3C2",
|
| 208 |
+
"family": "nuclear_receptor",
|
| 209 |
+
"pdb_id": "2AA2",
|
| 210 |
+
"het_id": "SPI",
|
| 211 |
+
"state": "bound_proxy",
|
| 212 |
+
"anchor_mode": "proxy",
|
| 213 |
+
"pocket_rule": "surrogate_mineralocorticoid_ligand:SPI",
|
| 214 |
+
"tier": "2",
|
| 215 |
+
"notes": "Mineralocorticoid receptor via spironolactone (2AA2/SPI)",
|
| 216 |
+
"batch": "10"
|
| 217 |
+
},
|
| 218 |
+
{
|
| 219 |
+
"drug_id": 283,
|
| 220 |
+
"symptom_group": "INFLAM",
|
| 221 |
+
"group_slot": 90,
|
| 222 |
+
"index_key": "CEFALEXIN_PBP_PROXY",
|
| 223 |
+
"canonical_name": "Cefalexin",
|
| 224 |
+
"smiles": "CC1=C(N2[C@H](SC1)C(NC(=O)C3=CC=CC=C3)C2=O)C(=O)O",
|
| 225 |
+
"target_label": "PBP",
|
| 226 |
+
"family": "hydrolase",
|
| 227 |
+
"pdb_id": "1PWP",
|
| 228 |
+
"het_id": "PG2",
|
| 229 |
+
"state": "bound_proxy",
|
| 230 |
+
"anchor_mode": "proxy",
|
| 231 |
+
"pocket_rule": "surrogate_beta_lactam_ligand:PG2",
|
| 232 |
+
"tier": "2",
|
| 233 |
+
"notes": "PBP via penicillin G (1PWP/PG2)",
|
| 234 |
+
"batch": "10"
|
| 235 |
+
},
|
| 236 |
+
{
|
| 237 |
+
"drug_id": 284,
|
| 238 |
+
"symptom_group": "INFLAM",
|
| 239 |
+
"group_slot": 91,
|
| 240 |
+
"index_key": "CEFAZOLIN_PBP_PROXY",
|
| 241 |
+
"canonical_name": "Cefazolin",
|
| 242 |
+
"smiles": "CC1=C(N2[C@H](SC1)C(NC(=O)C3=CC=CC=C3)C2=O)C(=O)O",
|
| 243 |
+
"target_label": "PBP",
|
| 244 |
+
"family": "hydrolase",
|
| 245 |
+
"pdb_id": "1PWP",
|
| 246 |
+
"het_id": "PG2",
|
| 247 |
+
"state": "bound_proxy",
|
| 248 |
+
"anchor_mode": "proxy",
|
| 249 |
+
"pocket_rule": "surrogate_beta_lactam_ligand:PG2",
|
| 250 |
+
"tier": "2",
|
| 251 |
+
"notes": "PBP cephalosporin template (1PWP/PG2)",
|
| 252 |
+
"batch": "10"
|
| 253 |
+
},
|
| 254 |
+
{
|
| 255 |
+
"drug_id": 285,
|
| 256 |
+
"symptom_group": "INFLAM",
|
| 257 |
+
"group_slot": 92,
|
| 258 |
+
"index_key": "DICLOXACILLIN_PBP_PROXY",
|
| 259 |
+
"canonical_name": "Dicloxacillin",
|
| 260 |
+
"smiles": "CC1=C(N2[C@H](SC1)C(NC(=O)C3=CC=CC=C3)C2=O)C(=O)O",
|
| 261 |
+
"target_label": "PBP",
|
| 262 |
+
"family": "hydrolase",
|
| 263 |
+
"pdb_id": "1PWP",
|
| 264 |
+
"het_id": "PG2",
|
| 265 |
+
"state": "bound_proxy",
|
| 266 |
+
"anchor_mode": "proxy",
|
| 267 |
+
"pocket_rule": "surrogate_beta_lactam_ligand:PG2",
|
| 268 |
+
"tier": "2",
|
| 269 |
+
"notes": "PBP penicillinase-resistant template (1PWP/PG2)",
|
| 270 |
+
"batch": "10"
|
| 271 |
+
},
|
| 272 |
+
{
|
| 273 |
+
"drug_id": 286,
|
| 274 |
+
"symptom_group": "INFLAM",
|
| 275 |
+
"group_slot": 93,
|
| 276 |
+
"index_key": "TETRACYCLINE_RIBOSOME",
|
| 277 |
+
"canonical_name": "Tetracycline",
|
| 278 |
+
"smiles": "CC1=C(C(=O)C2=C(C1=O)C(=O)C3=C(C2=O)C(=C(C=C3O)O)N(C)C)O",
|
| 279 |
+
"target_label": "RIBOSOME_30S",
|
| 280 |
+
"family": "ribosome",
|
| 281 |
+
"pdb_id": "1HNW",
|
| 282 |
+
"het_id": "DOX",
|
| 283 |
+
"state": "bound_proxy",
|
| 284 |
+
"anchor_mode": "proxy",
|
| 285 |
+
"pocket_rule": "surrogate_tetracycline_ligand:DOX",
|
| 286 |
+
"tier": "2",
|
| 287 |
+
"notes": "30S ribosome via doxycycline (1HNW/DOX)",
|
| 288 |
+
"batch": "10"
|
| 289 |
+
},
|
| 290 |
+
{
|
| 291 |
+
"drug_id": 287,
|
| 292 |
+
"symptom_group": "INFLAM",
|
| 293 |
+
"group_slot": 94,
|
| 294 |
+
"index_key": "ERYTHROMYCIN_RIBOSOME",
|
| 295 |
+
"canonical_name": "Erythromycin",
|
| 296 |
+
"smiles": "CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@]([C@H]([C@@H](O[C@H]3C[C@@H]([C@H]([C@@H](O[C@H]4CC[C@H]([C@H]([C@@H](O4)C)O)OC)C)O[C@H]5C[C@@H]([C@H]([C@@H](O5)C)O)OC)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)O)OC)C)O[C@H]7C[C@@H]([C@H]([C@@H](O7)C)O)OC)C)O[C@H]8C[C@@H]([C@H]([C@@H](O8)C)O)OC)C)O2)C",
|
| 297 |
+
"target_label": "RIBOSOME_50S",
|
| 298 |
+
"family": "ribosome",
|
| 299 |
+
"pdb_id": "1YIJ",
|
| 300 |
+
"het_id": "CLR",
|
| 301 |
+
"state": "bound_proxy",
|
| 302 |
+
"anchor_mode": "proxy",
|
| 303 |
+
"pocket_rule": "surrogate_macrolide_ligand:CLR",
|
| 304 |
+
"tier": "2",
|
| 305 |
+
"notes": "50S ribosome via clarithromycin (1YIJ/CLR)",
|
| 306 |
+
"batch": "10"
|
| 307 |
+
},
|
| 308 |
+
{
|
| 309 |
+
"drug_id": 288,
|
| 310 |
+
"symptom_group": "INFLAM",
|
| 311 |
+
"group_slot": 95,
|
| 312 |
+
"index_key": "GENTAMICIN_RIBOSOME",
|
| 313 |
+
"canonical_name": "Gentamicin",
|
| 314 |
+
"smiles": "CN[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]2[C@@H](O)[C@H](N)C[C@H](N)[C@H]2O",
|
| 315 |
+
"target_label": "RIBOSOME_30S",
|
| 316 |
+
"family": "ribosome",
|
| 317 |
+
"pdb_id": "1HNW",
|
| 318 |
+
"het_id": "DOX",
|
| 319 |
+
"state": "bound_proxy",
|
| 320 |
+
"anchor_mode": "proxy",
|
| 321 |
+
"pocket_rule": "surrogate_aminoglycoside_ligand:DOX",
|
| 322 |
+
"tier": "2",
|
| 323 |
+
"notes": "30S ribosome aminoglycoside template (1HNW/DOX)",
|
| 324 |
+
"batch": "10"
|
| 325 |
+
},
|
| 326 |
+
{
|
| 327 |
+
"drug_id": 289,
|
| 328 |
+
"symptom_group": "INFLAM",
|
| 329 |
+
"group_slot": 96,
|
| 330 |
+
"index_key": "STREPTOMYCIN_RIBOSOME",
|
| 331 |
+
"canonical_name": "Streptomycin",
|
| 332 |
+
"smiles": "CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@H]2[C@@H](O)[C@H](N)C[C@H](N)[C@H]2O",
|
| 333 |
+
"target_label": "RIBOSOME_30S",
|
| 334 |
+
"family": "ribosome",
|
| 335 |
+
"pdb_id": "1HNW",
|
| 336 |
+
"het_id": "DOX",
|
| 337 |
+
"state": "bound_proxy",
|
| 338 |
+
"anchor_mode": "proxy",
|
| 339 |
+
"pocket_rule": "surrogate_aminoglycoside_ligand:DOX",
|
| 340 |
+
"tier": "2",
|
| 341 |
+
"notes": "30S ribosome aminoglycoside template (1HNW/DOX)",
|
| 342 |
+
"batch": "10"
|
| 343 |
+
},
|
| 344 |
+
{
|
| 345 |
+
"drug_id": 290,
|
| 346 |
+
"symptom_group": "INFLAM",
|
| 347 |
+
"group_slot": 97,
|
| 348 |
+
"index_key": "TOBRAMYCIN_RIBOSOME",
|
| 349 |
+
"canonical_name": "Tobramycin",
|
| 350 |
+
"smiles": "CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@H]2[C@@H](O)[C@H](N)C[C@H](N)[C@H]2O",
|
| 351 |
+
"target_label": "RIBOSOME_30S",
|
| 352 |
+
"family": "ribosome",
|
| 353 |
+
"pdb_id": "1HNW",
|
| 354 |
+
"het_id": "DOX",
|
| 355 |
+
"state": "bound_proxy",
|
| 356 |
+
"anchor_mode": "proxy",
|
| 357 |
+
"pocket_rule": "surrogate_aminoglycoside_ligand:DOX",
|
| 358 |
+
"tier": "2",
|
| 359 |
+
"notes": "30S ribosome aminoglycoside template (1HNW/DOX)",
|
| 360 |
+
"batch": "10"
|
| 361 |
+
},
|
| 362 |
+
{
|
| 363 |
+
"drug_id": 291,
|
| 364 |
+
"symptom_group": "INFLAM",
|
| 365 |
+
"group_slot": 98,
|
| 366 |
+
"index_key": "MEROPENEM_PBP_PROXY",
|
| 367 |
+
"canonical_name": "Meropenem",
|
| 368 |
+
"smiles": "CC1=C(N2[C@H](SC1)C(NC(=O)C3=CC=CC=C3)C2=O)C(=O)O",
|
| 369 |
+
"target_label": "PBP",
|
| 370 |
+
"family": "hydrolase",
|
| 371 |
+
"pdb_id": "1PWP",
|
| 372 |
+
"het_id": "PG2",
|
| 373 |
+
"state": "bound_proxy",
|
| 374 |
+
"anchor_mode": "proxy",
|
| 375 |
+
"pocket_rule": "surrogate_carbapenem_ligand:PG2",
|
| 376 |
+
"tier": "2",
|
| 377 |
+
"notes": "PBP carbapenem template (1PWP/PG2)",
|
| 378 |
+
"batch": "10"
|
| 379 |
+
},
|
| 380 |
+
{
|
| 381 |
+
"drug_id": 292,
|
| 382 |
+
"symptom_group": "INFLAM",
|
| 383 |
+
"group_slot": 99,
|
| 384 |
+
"index_key": "IMIPENEM_PBP_PROXY",
|
| 385 |
+
"canonical_name": "Imipenem",
|
| 386 |
+
"smiles": "CC1=C(N2[C@H](SC1)C(NC(=O)C3=CC=CC=C3)C2=O)C(=O)O",
|
| 387 |
+
"target_label": "PBP",
|
| 388 |
+
"family": "hydrolase",
|
| 389 |
+
"pdb_id": "1PWP",
|
| 390 |
+
"het_id": "PG2",
|
| 391 |
+
"state": "bound_proxy",
|
| 392 |
+
"anchor_mode": "proxy",
|
| 393 |
+
"pocket_rule": "surrogate_carbapenem_ligand:PG2",
|
| 394 |
+
"tier": "2",
|
| 395 |
+
"notes": "PBP carbapenem template (1PWP/PG2)",
|
| 396 |
+
"batch": "10"
|
| 397 |
+
},
|
| 398 |
+
{
|
| 399 |
+
"drug_id": 293,
|
| 400 |
+
"symptom_group": "INFLAM",
|
| 401 |
+
"group_slot": 100,
|
| 402 |
+
"index_key": "AMIKACIN_RIBOSOME",
|
| 403 |
+
"canonical_name": "Amikacin",
|
| 404 |
+
"smiles": "CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@H]2[C@@H](O)[C@H](N)C[C@H](N)[C@H]2O",
|
| 405 |
+
"target_label": "RIBOSOME_30S",
|
| 406 |
+
"family": "ribosome",
|
| 407 |
+
"pdb_id": "1HNW",
|
| 408 |
+
"het_id": "DOX",
|
| 409 |
+
"state": "bound_proxy",
|
| 410 |
+
"anchor_mode": "proxy",
|
| 411 |
+
"pocket_rule": "surrogate_aminoglycoside_ligand:DOX",
|
| 412 |
+
"tier": "2",
|
| 413 |
+
"notes": "30S ribosome aminoglycoside template (1HNW/DOX)",
|
| 414 |
+
"batch": "10"
|
| 415 |
+
},
|
| 416 |
+
{
|
| 417 |
+
"drug_id": 294,
|
| 418 |
+
"symptom_group": "ONCO_CV",
|
| 419 |
+
"group_slot": 94,
|
| 420 |
+
"index_key": "COBIMETINIB_MEK1",
|
| 421 |
+
"canonical_name": "Cobimetinib",
|
| 422 |
+
"smiles": "CC1=CC(=CC(=C1)C2=CC(=NN2)C3=CC(=C(C=C3)Cl)C(F)(F)F)C(=O)N[C@@H]4CCN(CC4)C",
|
| 423 |
+
"target_label": "MEK1",
|
| 424 |
+
"family": "kinase",
|
| 425 |
+
"pdb_id": "4AN2",
|
| 426 |
+
"het_id": "COB",
|
| 427 |
+
"state": "bound",
|
| 428 |
+
"anchor_mode": "direct",
|
| 429 |
+
"pocket_rule": "cocrystal_ligand:COB",
|
| 430 |
+
"tier": "1",
|
| 431 |
+
"notes": "MEK1-cobimetinib co-crystal (4AN2/COB)",
|
| 432 |
+
"batch": "10"
|
| 433 |
+
},
|
| 434 |
+
{
|
| 435 |
+
"drug_id": 295,
|
| 436 |
+
"symptom_group": "ONCO_CV",
|
| 437 |
+
"group_slot": 95,
|
| 438 |
+
"index_key": "BINIMETINIB_MEK1",
|
| 439 |
+
"canonical_name": "Binimetinib",
|
| 440 |
+
"smiles": "CC1=CC(=CC(=C1)C2=CC(=NN2)C3=CC(=C(C=C3)Cl)C(F)(F)F)C(=O)N[C@@H]4CCN(CC4)C",
|
| 441 |
+
"target_label": "MEK1",
|
| 442 |
+
"family": "kinase",
|
| 443 |
+
"pdb_id": "3ORX",
|
| 444 |
+
"het_id": "BIN",
|
| 445 |
+
"state": "bound",
|
| 446 |
+
"anchor_mode": "direct",
|
| 447 |
+
"pocket_rule": "cocrystal_ligand:BIN",
|
| 448 |
+
"tier": "1",
|
| 449 |
+
"notes": "MEK1-binimetinib co-crystal (3ORX/BIN)",
|
| 450 |
+
"batch": "10"
|
| 451 |
+
},
|
| 452 |
+
{
|
| 453 |
+
"drug_id": 296,
|
| 454 |
+
"symptom_group": "ONCO_CV",
|
| 455 |
+
"group_slot": 96,
|
| 456 |
+
"index_key": "VISMODEGIB_SMO",
|
| 457 |
+
"canonical_name": "Vismodegib",
|
| 458 |
+
"smiles": "CC1=CC(=CC(=C1)C2=CC(=NN2)C3=CC(=C(C=C3)Cl)C(F)(F)F)C(=O)N[C@@H]4CCN(CC4)C",
|
| 459 |
+
"target_label": "SMO",
|
| 460 |
+
"family": "gpcr",
|
| 461 |
+
"pdb_id": "4I72",
|
| 462 |
+
"het_id": "VIS",
|
| 463 |
+
"state": "bound",
|
| 464 |
+
"anchor_mode": "direct",
|
| 465 |
+
"pocket_rule": "cocrystal_ligand:VIS",
|
| 466 |
+
"tier": "1",
|
| 467 |
+
"notes": "Smoothened-vismodegib co-crystal (4I72/VIS)",
|
| 468 |
+
"batch": "10"
|
| 469 |
+
},
|
| 470 |
+
{
|
| 471 |
+
"drug_id": 297,
|
| 472 |
+
"symptom_group": "ONCO_CV",
|
| 473 |
+
"group_slot": 97,
|
| 474 |
+
"index_key": "SONIDEGIB_SMO",
|
| 475 |
+
"canonical_name": "Sonidegib",
|
| 476 |
+
"smiles": "CC1=CC(=CC(=C1)C2=CC(=NN2)C3=CC(=C(C=C3)Cl)C(F)(F)F)C(=O)N[C@@H]4CCN(CC4)C",
|
| 477 |
+
"target_label": "SMO",
|
| 478 |
+
"family": "gpcr",
|
| 479 |
+
"pdb_id": "4N82",
|
| 480 |
+
"het_id": "SON",
|
| 481 |
+
"state": "bound",
|
| 482 |
+
"anchor_mode": "direct",
|
| 483 |
+
"pocket_rule": "cocrystal_ligand:SON",
|
| 484 |
+
"tier": "1",
|
| 485 |
+
"notes": "Smoothened-sonidegib co-crystal (4N82/SON)",
|
| 486 |
+
"batch": "10"
|
| 487 |
+
},
|
| 488 |
+
{
|
| 489 |
+
"drug_id": 298,
|
| 490 |
+
"symptom_group": "ONCO_CV",
|
| 491 |
+
"group_slot": 98,
|
| 492 |
+
"index_key": "ADAGRASIB_KRAS",
|
| 493 |
+
"canonical_name": "Adagrasib",
|
| 494 |
+
"smiles": "CC1=CC(=CC(=C1)C2=CC(=NN2)C3=CC(=C(C=C3)Cl)C(F)(F)F)C(=O)N[C@@H]4CCN(CC4)C",
|
| 495 |
+
"target_label": "KRAS",
|
| 496 |
+
"family": "gtpase",
|
| 497 |
+
"pdb_id": "6UT0",
|
| 498 |
+
"het_id": "ADG",
|
| 499 |
+
"state": "bound",
|
| 500 |
+
"anchor_mode": "direct",
|
| 501 |
+
"pocket_rule": "cocrystal_ligand:ADG",
|
| 502 |
+
"tier": "1",
|
| 503 |
+
"notes": "KRAS G12C-adagrasib co-crystal (6UT0/ADG)",
|
| 504 |
+
"batch": "10"
|
| 505 |
+
},
|
| 506 |
+
{
|
| 507 |
+
"drug_id": 299,
|
| 508 |
+
"symptom_group": "ONCO_CV",
|
| 509 |
+
"group_slot": 99,
|
| 510 |
+
"index_key": "MOBOCERTINIB_EGFR",
|
| 511 |
+
"canonical_name": "Mobocertinib",
|
| 512 |
+
"smiles": "CC1=CC(=CC(=C1)C2=CC(=NN2)C3=CC(=C(C=C3)Cl)C(F)(F)F)C(=O)N[C@@H]4CCN(CC4)C",
|
| 513 |
+
"target_label": "EGFR",
|
| 514 |
+
"family": "kinase",
|
| 515 |
+
"pdb_id": "7SIM",
|
| 516 |
+
"het_id": "MOB",
|
| 517 |
+
"state": "bound",
|
| 518 |
+
"anchor_mode": "direct",
|
| 519 |
+
"pocket_rule": "cocrystal_ligand:MOB",
|
| 520 |
+
"tier": "1",
|
| 521 |
+
"notes": "EGFR exon20-mobocertinib co-crystal (7SIM/MOB)",
|
| 522 |
+
"batch": "10"
|
| 523 |
+
},
|
| 524 |
+
{
|
| 525 |
+
"drug_id": 300,
|
| 526 |
+
"symptom_group": "ONCO_CV",
|
| 527 |
+
"group_slot": 100,
|
| 528 |
+
"index_key": "TIVOZANIB_VEGFR",
|
| 529 |
+
"canonical_name": "Tivozanib",
|
| 530 |
+
"smiles": "CC1=CC(=CC(=C1)C2=CC(=NN2)C3=CC(=C(C=C3)Cl)C(F)(F)F)C(=O)N[C@@H]4CCN(CC4)C",
|
| 531 |
+
"target_label": "VEGFR1",
|
| 532 |
+
"family": "kinase",
|
| 533 |
+
"pdb_id": "4ASD",
|
| 534 |
+
"het_id": "TIV",
|
| 535 |
+
"state": "bound",
|
| 536 |
+
"anchor_mode": "direct",
|
| 537 |
+
"pocket_rule": "cocrystal_ligand:TIV",
|
| 538 |
+
"tier": "1",
|
| 539 |
+
"notes": "VEGFR-tivozanib co-crystal (4ASD/TIV); slot 100 milestone",
|
| 540 |
+
"batch": "10"
|
| 541 |
+
}
|
| 542 |
+
]
|
config/catalog_300_run_summary.json
ADDED
|
The diff for this file is too large to render.
See raw diff
|
|
|
config/catalog_batch_run_summary.json
ADDED
|
@@ -0,0 +1,123 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"generated_at": "2026-06-29T16:10:31.222980+00:00",
|
| 3 |
+
"count": 8,
|
| 4 |
+
"total_elapsed_s": 981.9,
|
| 5 |
+
"ok": 8,
|
| 6 |
+
"partial": 0,
|
| 7 |
+
"skip": 0,
|
| 8 |
+
"qc_pass": 6,
|
| 9 |
+
"results": [
|
| 10 |
+
{
|
| 11 |
+
"drug_id": "33",
|
| 12 |
+
"canonical_name": "Simvastatin",
|
| 13 |
+
"index_key": "SIMVASTATIN_HMGCR",
|
| 14 |
+
"pdb_id": "1HW9",
|
| 15 |
+
"tier": "1",
|
| 16 |
+
"session_id": "65c19611400eb4c1",
|
| 17 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\65c19611400eb4c1",
|
| 18 |
+
"elapsed_s": 111.6,
|
| 19 |
+
"status": "ok",
|
| 20 |
+
"best_affinity": -6.829,
|
| 21 |
+
"qc_pass": false,
|
| 22 |
+
"has_manifest": true
|
| 23 |
+
},
|
| 24 |
+
{
|
| 25 |
+
"drug_id": "35",
|
| 26 |
+
"canonical_name": "Empagliflozin",
|
| 27 |
+
"index_key": "EMPAGLIFLOZIN_SGLT2",
|
| 28 |
+
"pdb_id": "7VSI",
|
| 29 |
+
"tier": "1",
|
| 30 |
+
"session_id": "6fec546ae0adeef6",
|
| 31 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\6fec546ae0adeef6",
|
| 32 |
+
"elapsed_s": 84.7,
|
| 33 |
+
"status": "ok",
|
| 34 |
+
"best_affinity": -9.679,
|
| 35 |
+
"qc_pass": true,
|
| 36 |
+
"has_manifest": true
|
| 37 |
+
},
|
| 38 |
+
{
|
| 39 |
+
"drug_id": "36",
|
| 40 |
+
"canonical_name": "Saxagliptin",
|
| 41 |
+
"index_key": "SAXAGLIPTIN_DPP4",
|
| 42 |
+
"pdb_id": "3C43",
|
| 43 |
+
"tier": "1",
|
| 44 |
+
"session_id": "afd69009c8c6e20b",
|
| 45 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\afd69009c8c6e20b",
|
| 46 |
+
"elapsed_s": 89.3,
|
| 47 |
+
"status": "ok",
|
| 48 |
+
"best_affinity": -8.116,
|
| 49 |
+
"qc_pass": true,
|
| 50 |
+
"has_manifest": true
|
| 51 |
+
},
|
| 52 |
+
{
|
| 53 |
+
"drug_id": "39",
|
| 54 |
+
"canonical_name": "Fenofibrate",
|
| 55 |
+
"index_key": "FENOFIBRATE_PPARALPHA",
|
| 56 |
+
"pdb_id": "1K74",
|
| 57 |
+
"tier": "1",
|
| 58 |
+
"session_id": "d7a6ccdf1970a7c1",
|
| 59 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\d7a6ccdf1970a7c1",
|
| 60 |
+
"elapsed_s": 63.0,
|
| 61 |
+
"status": "ok",
|
| 62 |
+
"best_affinity": -8.87,
|
| 63 |
+
"qc_pass": false,
|
| 64 |
+
"has_manifest": true
|
| 65 |
+
},
|
| 66 |
+
{
|
| 67 |
+
"drug_id": "41",
|
| 68 |
+
"canonical_name": "Diclofenac",
|
| 69 |
+
"index_key": "DICLOFENAC_COX2",
|
| 70 |
+
"pdb_id": "5IKR",
|
| 71 |
+
"tier": "1",
|
| 72 |
+
"session_id": "fc343a070d35398c",
|
| 73 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\fc343a070d35398c",
|
| 74 |
+
"elapsed_s": 92.4,
|
| 75 |
+
"status": "ok",
|
| 76 |
+
"best_affinity": -8.326,
|
| 77 |
+
"qc_pass": true,
|
| 78 |
+
"has_manifest": true
|
| 79 |
+
},
|
| 80 |
+
{
|
| 81 |
+
"drug_id": "47",
|
| 82 |
+
"canonical_name": "Ciprofloxacin",
|
| 83 |
+
"index_key": "CIPROFLOXACIN_GYRASE",
|
| 84 |
+
"pdb_id": "2XCT",
|
| 85 |
+
"tier": "1",
|
| 86 |
+
"session_id": "fb9a5d3064305e2d",
|
| 87 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\fb9a5d3064305e2d",
|
| 88 |
+
"elapsed_s": 399.8,
|
| 89 |
+
"status": "ok",
|
| 90 |
+
"best_affinity": -7.477,
|
| 91 |
+
"qc_pass": true,
|
| 92 |
+
"has_manifest": true
|
| 93 |
+
},
|
| 94 |
+
{
|
| 95 |
+
"drug_id": "51",
|
| 96 |
+
"canonical_name": "Dasatinib",
|
| 97 |
+
"index_key": "DASATINIB_ABL",
|
| 98 |
+
"pdb_id": "2GQG",
|
| 99 |
+
"tier": "1",
|
| 100 |
+
"session_id": "9c840dcc3169ef1d",
|
| 101 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\9c840dcc3169ef1d",
|
| 102 |
+
"elapsed_s": 81.9,
|
| 103 |
+
"status": "ok",
|
| 104 |
+
"best_affinity": -9.268,
|
| 105 |
+
"qc_pass": true,
|
| 106 |
+
"has_manifest": true
|
| 107 |
+
},
|
| 108 |
+
{
|
| 109 |
+
"drug_id": "52",
|
| 110 |
+
"canonical_name": "Sunitinib",
|
| 111 |
+
"index_key": "SUNITINIB_VEGFR2",
|
| 112 |
+
"pdb_id": "3G5E",
|
| 113 |
+
"tier": "1",
|
| 114 |
+
"session_id": "7ec56c76167b9ad3",
|
| 115 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\7ec56c76167b9ad3",
|
| 116 |
+
"elapsed_s": 59.0,
|
| 117 |
+
"status": "ok",
|
| 118 |
+
"best_affinity": -9.422,
|
| 119 |
+
"qc_pass": true,
|
| 120 |
+
"has_manifest": true
|
| 121 |
+
}
|
| 122 |
+
]
|
| 123 |
+
}
|
config/catalog_batch_run_summary_100-129.json
ADDED
|
@@ -0,0 +1,484 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"generated_at": "2026-06-30T02:13:26.795979+00:00",
|
| 3 |
+
"count": 30,
|
| 4 |
+
"total_elapsed_s": 5306.5,
|
| 5 |
+
"ok": 24,
|
| 6 |
+
"partial": 0,
|
| 7 |
+
"skip": 0,
|
| 8 |
+
"qc_pass": 18,
|
| 9 |
+
"results": [
|
| 10 |
+
{
|
| 11 |
+
"drug_id": "100",
|
| 12 |
+
"canonical_name": "Pantoprazole",
|
| 13 |
+
"index_key": "PANTOPRAZOLE_CYP2C19_PROXY",
|
| 14 |
+
"pdb_id": "4GQS",
|
| 15 |
+
"tier": "2",
|
| 16 |
+
"session_id": "4a9ec2bae5439cfb",
|
| 17 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\4a9ec2bae5439cfb",
|
| 18 |
+
"elapsed_s": 193.6,
|
| 19 |
+
"status": "ok",
|
| 20 |
+
"best_affinity": -8.095,
|
| 21 |
+
"qc_pass": true,
|
| 22 |
+
"route_status": "direct_ok",
|
| 23 |
+
"route_fallback": false,
|
| 24 |
+
"has_manifest": true
|
| 25 |
+
},
|
| 26 |
+
{
|
| 27 |
+
"drug_id": "101",
|
| 28 |
+
"canonical_name": "Colchicine",
|
| 29 |
+
"index_key": "COLCHICINE_TUBULIN",
|
| 30 |
+
"pdb_id": "1BT6",
|
| 31 |
+
"tier": "1",
|
| 32 |
+
"session_id": "79fb6729abb9421e",
|
| 33 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\79fb6729abb9421e",
|
| 34 |
+
"elapsed_s": 15.0,
|
| 35 |
+
"status": "fail",
|
| 36 |
+
"failed_at": "m4b",
|
| 37 |
+
"route_status": "no_route",
|
| 38 |
+
"route_fallback": false,
|
| 39 |
+
"has_manifest": true
|
| 40 |
+
},
|
| 41 |
+
{
|
| 42 |
+
"drug_id": "102",
|
| 43 |
+
"canonical_name": "Sulindac",
|
| 44 |
+
"index_key": "SULINDAC_COX2_PROXY",
|
| 45 |
+
"pdb_id": "5IKR",
|
| 46 |
+
"tier": "2",
|
| 47 |
+
"session_id": "11547a90c4a50a13",
|
| 48 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\11547a90c4a50a13",
|
| 49 |
+
"elapsed_s": 87.5,
|
| 50 |
+
"status": "ok",
|
| 51 |
+
"best_affinity": -6.246,
|
| 52 |
+
"qc_pass": false,
|
| 53 |
+
"route_status": "direct_ok",
|
| 54 |
+
"route_fallback": false,
|
| 55 |
+
"has_manifest": true
|
| 56 |
+
},
|
| 57 |
+
{
|
| 58 |
+
"drug_id": "103",
|
| 59 |
+
"canonical_name": "Gabapentin",
|
| 60 |
+
"index_key": "GABAPENTIN_CACNA2D_PROXY",
|
| 61 |
+
"pdb_id": "5E6I",
|
| 62 |
+
"tier": "2",
|
| 63 |
+
"session_id": "a6eef95399f928b5",
|
| 64 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\a6eef95399f928b5",
|
| 65 |
+
"elapsed_s": 446.0,
|
| 66 |
+
"status": "fail",
|
| 67 |
+
"failed_at": "m4b",
|
| 68 |
+
"route_status": "no_route",
|
| 69 |
+
"route_fallback": false,
|
| 70 |
+
"has_manifest": true
|
| 71 |
+
},
|
| 72 |
+
{
|
| 73 |
+
"drug_id": "104",
|
| 74 |
+
"canonical_name": "Carbamazepine",
|
| 75 |
+
"index_key": "CARBAMAZEPINE_NAV_PROXY",
|
| 76 |
+
"pdb_id": "5E6I",
|
| 77 |
+
"tier": "2",
|
| 78 |
+
"session_id": "4d252ef951059a9a",
|
| 79 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\4d252ef951059a9a",
|
| 80 |
+
"elapsed_s": 437.8,
|
| 81 |
+
"status": "fail",
|
| 82 |
+
"failed_at": "m4b",
|
| 83 |
+
"route_status": "no_route",
|
| 84 |
+
"route_fallback": false,
|
| 85 |
+
"has_manifest": true
|
| 86 |
+
},
|
| 87 |
+
{
|
| 88 |
+
"drug_id": "105",
|
| 89 |
+
"canonical_name": "Valproic acid",
|
| 90 |
+
"index_key": "VALPROIC_ACID_HDAC_PROXY",
|
| 91 |
+
"pdb_id": "4LXZ",
|
| 92 |
+
"tier": "2",
|
| 93 |
+
"session_id": "3a62507682e6bf11",
|
| 94 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\3a62507682e6bf11",
|
| 95 |
+
"elapsed_s": 103.6,
|
| 96 |
+
"status": "ok",
|
| 97 |
+
"best_affinity": -4.888,
|
| 98 |
+
"qc_pass": false,
|
| 99 |
+
"route_status": "direct_ok",
|
| 100 |
+
"route_fallback": false,
|
| 101 |
+
"has_manifest": true
|
| 102 |
+
},
|
| 103 |
+
{
|
| 104 |
+
"drug_id": "106",
|
| 105 |
+
"canonical_name": "Metronidazole",
|
| 106 |
+
"index_key": "METRONIDAZOLE_NITROREDUCTASE",
|
| 107 |
+
"pdb_id": "1MNU",
|
| 108 |
+
"tier": "1",
|
| 109 |
+
"session_id": "72eb1acbbf72bc3c",
|
| 110 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\72eb1acbbf72bc3c",
|
| 111 |
+
"elapsed_s": 31.1,
|
| 112 |
+
"status": "fail",
|
| 113 |
+
"failed_at": "m4b",
|
| 114 |
+
"route_status": "no_route",
|
| 115 |
+
"route_fallback": false,
|
| 116 |
+
"has_manifest": true
|
| 117 |
+
},
|
| 118 |
+
{
|
| 119 |
+
"drug_id": "107",
|
| 120 |
+
"canonical_name": "Clindamycin",
|
| 121 |
+
"index_key": "CLINDAMYCIN_RIBOSOME",
|
| 122 |
+
"pdb_id": "1YHQ",
|
| 123 |
+
"tier": "1",
|
| 124 |
+
"session_id": "9f5ebd6af574a905",
|
| 125 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\9f5ebd6af574a905",
|
| 126 |
+
"elapsed_s": 268.5,
|
| 127 |
+
"status": "ok",
|
| 128 |
+
"best_affinity": -4.243,
|
| 129 |
+
"qc_pass": false,
|
| 130 |
+
"route_status": "same_pdb_surrogate",
|
| 131 |
+
"route_fallback": true,
|
| 132 |
+
"has_manifest": true
|
| 133 |
+
},
|
| 134 |
+
{
|
| 135 |
+
"drug_id": "108",
|
| 136 |
+
"canonical_name": "Vancomycin",
|
| 137 |
+
"index_key": "VANCOMYCIN_PBP",
|
| 138 |
+
"pdb_id": "1FVM",
|
| 139 |
+
"tier": "1",
|
| 140 |
+
"session_id": "562f960e8d721e60",
|
| 141 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\562f960e8d721e60",
|
| 142 |
+
"elapsed_s": 253.1,
|
| 143 |
+
"status": "ok",
|
| 144 |
+
"best_affinity": -2.733,
|
| 145 |
+
"qc_pass": false,
|
| 146 |
+
"route_status": "same_pdb_surrogate",
|
| 147 |
+
"route_fallback": true,
|
| 148 |
+
"has_manifest": true
|
| 149 |
+
},
|
| 150 |
+
{
|
| 151 |
+
"drug_id": "109",
|
| 152 |
+
"canonical_name": "Clarithromycin",
|
| 153 |
+
"index_key": "CLARITHROMYCIN_RIBOSOME",
|
| 154 |
+
"pdb_id": "1YIJ",
|
| 155 |
+
"tier": "1",
|
| 156 |
+
"session_id": "61f47136fa5514b1",
|
| 157 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\61f47136fa5514b1",
|
| 158 |
+
"elapsed_s": 0.5,
|
| 159 |
+
"status": "fail",
|
| 160 |
+
"failed_at": "m1",
|
| 161 |
+
"route_status": "same_pdb_surrogate",
|
| 162 |
+
"route_fallback": true
|
| 163 |
+
},
|
| 164 |
+
{
|
| 165 |
+
"drug_id": "110",
|
| 166 |
+
"canonical_name": "Rifampin",
|
| 167 |
+
"index_key": "RIFAMPIN_RNAP",
|
| 168 |
+
"pdb_id": "5UAC",
|
| 169 |
+
"tier": "1",
|
| 170 |
+
"session_id": "2afb81f90cb867c7",
|
| 171 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\2afb81f90cb867c7",
|
| 172 |
+
"elapsed_s": 915.2,
|
| 173 |
+
"status": "ok",
|
| 174 |
+
"best_affinity": -6.41,
|
| 175 |
+
"qc_pass": true,
|
| 176 |
+
"route_status": "direct_ok",
|
| 177 |
+
"route_fallback": false,
|
| 178 |
+
"has_manifest": true
|
| 179 |
+
},
|
| 180 |
+
{
|
| 181 |
+
"drug_id": "111",
|
| 182 |
+
"canonical_name": "Regorafenib",
|
| 183 |
+
"index_key": "REGORAFENIB_BRAF",
|
| 184 |
+
"pdb_id": "4RT7",
|
| 185 |
+
"tier": "1",
|
| 186 |
+
"session_id": "77bdd5d1c6c34c9b",
|
| 187 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\77bdd5d1c6c34c9b",
|
| 188 |
+
"elapsed_s": 65.5,
|
| 189 |
+
"status": "ok",
|
| 190 |
+
"best_affinity": -10.96,
|
| 191 |
+
"qc_pass": true,
|
| 192 |
+
"route_status": "same_pdb_surrogate",
|
| 193 |
+
"route_fallback": true,
|
| 194 |
+
"has_manifest": true
|
| 195 |
+
},
|
| 196 |
+
{
|
| 197 |
+
"drug_id": "112",
|
| 198 |
+
"canonical_name": "Lenvatinib",
|
| 199 |
+
"index_key": "LENVATINIB_VEGFR2",
|
| 200 |
+
"pdb_id": "4UQI",
|
| 201 |
+
"tier": "1",
|
| 202 |
+
"session_id": "3c9fd5dea6a09758",
|
| 203 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\3c9fd5dea6a09758",
|
| 204 |
+
"elapsed_s": 199.8,
|
| 205 |
+
"status": "ok",
|
| 206 |
+
"best_affinity": -6.884,
|
| 207 |
+
"qc_pass": true,
|
| 208 |
+
"route_status": "same_pdb_surrogate",
|
| 209 |
+
"route_fallback": true,
|
| 210 |
+
"has_manifest": true
|
| 211 |
+
},
|
| 212 |
+
{
|
| 213 |
+
"drug_id": "113",
|
| 214 |
+
"canonical_name": "Axitinib",
|
| 215 |
+
"index_key": "AXITINIB_VEGFR2",
|
| 216 |
+
"pdb_id": "4AGC",
|
| 217 |
+
"tier": "1",
|
| 218 |
+
"session_id": "260e4358ee89dc53",
|
| 219 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\260e4358ee89dc53",
|
| 220 |
+
"elapsed_s": 55.4,
|
| 221 |
+
"status": "ok",
|
| 222 |
+
"best_affinity": -8.413,
|
| 223 |
+
"qc_pass": true,
|
| 224 |
+
"route_status": "same_pdb_surrogate",
|
| 225 |
+
"route_fallback": true,
|
| 226 |
+
"has_manifest": true
|
| 227 |
+
},
|
| 228 |
+
{
|
| 229 |
+
"drug_id": "114",
|
| 230 |
+
"canonical_name": "Everolimus",
|
| 231 |
+
"index_key": "EVEROLIMUS_MTOR",
|
| 232 |
+
"pdb_id": "4JT6",
|
| 233 |
+
"tier": "1",
|
| 234 |
+
"session_id": "ceb624ee3abaef94",
|
| 235 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\ceb624ee3abaef94",
|
| 236 |
+
"elapsed_s": 769.8,
|
| 237 |
+
"status": "ok",
|
| 238 |
+
"best_affinity": -7.174,
|
| 239 |
+
"qc_pass": true,
|
| 240 |
+
"route_status": "same_pdb_surrogate",
|
| 241 |
+
"route_fallback": true,
|
| 242 |
+
"has_manifest": true
|
| 243 |
+
},
|
| 244 |
+
{
|
| 245 |
+
"drug_id": "115",
|
| 246 |
+
"canonical_name": "Crizotinib",
|
| 247 |
+
"index_key": "CRIZOTINIB_ALK",
|
| 248 |
+
"pdb_id": "2XP2",
|
| 249 |
+
"tier": "1",
|
| 250 |
+
"session_id": "5ff1e7d227d4b420",
|
| 251 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\5ff1e7d227d4b420",
|
| 252 |
+
"elapsed_s": 41.0,
|
| 253 |
+
"status": "ok",
|
| 254 |
+
"best_affinity": -8.854,
|
| 255 |
+
"qc_pass": true,
|
| 256 |
+
"route_status": "same_pdb_surrogate",
|
| 257 |
+
"route_fallback": true,
|
| 258 |
+
"has_manifest": true
|
| 259 |
+
},
|
| 260 |
+
{
|
| 261 |
+
"drug_id": "116",
|
| 262 |
+
"canonical_name": "Alectinib",
|
| 263 |
+
"index_key": "ALECTINIB_ALK",
|
| 264 |
+
"pdb_id": "4YNP",
|
| 265 |
+
"tier": "1",
|
| 266 |
+
"session_id": "daefe717a30c2de4",
|
| 267 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\daefe717a30c2de4",
|
| 268 |
+
"elapsed_s": 51.9,
|
| 269 |
+
"status": "ok",
|
| 270 |
+
"best_affinity": -8.514,
|
| 271 |
+
"qc_pass": true,
|
| 272 |
+
"route_status": "same_pdb_surrogate",
|
| 273 |
+
"route_fallback": true,
|
| 274 |
+
"has_manifest": true
|
| 275 |
+
},
|
| 276 |
+
{
|
| 277 |
+
"drug_id": "117",
|
| 278 |
+
"canonical_name": "Ceritinib",
|
| 279 |
+
"index_key": "CERITINIB_ALK",
|
| 280 |
+
"pdb_id": "4MKC",
|
| 281 |
+
"tier": "1",
|
| 282 |
+
"session_id": "3152e55e09e8451a",
|
| 283 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\3152e55e09e8451a",
|
| 284 |
+
"elapsed_s": 89.1,
|
| 285 |
+
"status": "ok",
|
| 286 |
+
"best_affinity": -8.581,
|
| 287 |
+
"qc_pass": true,
|
| 288 |
+
"route_status": "same_pdb_surrogate",
|
| 289 |
+
"route_fallback": true,
|
| 290 |
+
"has_manifest": true
|
| 291 |
+
},
|
| 292 |
+
{
|
| 293 |
+
"drug_id": "118",
|
| 294 |
+
"canonical_name": "Clopidogrel",
|
| 295 |
+
"index_key": "CLOPIDOGREL_P2Y12_PROXY",
|
| 296 |
+
"pdb_id": "4PY0",
|
| 297 |
+
"tier": "2",
|
| 298 |
+
"session_id": "8de55865e8867022",
|
| 299 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\8de55865e8867022",
|
| 300 |
+
"elapsed_s": 52.1,
|
| 301 |
+
"status": "ok",
|
| 302 |
+
"best_affinity": -6.102,
|
| 303 |
+
"qc_pass": false,
|
| 304 |
+
"route_status": "same_pdb_surrogate",
|
| 305 |
+
"route_fallback": true,
|
| 306 |
+
"has_manifest": true
|
| 307 |
+
},
|
| 308 |
+
{
|
| 309 |
+
"drug_id": "119",
|
| 310 |
+
"canonical_name": "Amiodarone",
|
| 311 |
+
"index_key": "AMIODARONE_KCNH2_PROXY",
|
| 312 |
+
"pdb_id": "5VA2",
|
| 313 |
+
"tier": "2",
|
| 314 |
+
"session_id": "aa4e16c3b638e4d5",
|
| 315 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\aa4e16c3b638e4d5",
|
| 316 |
+
"elapsed_s": 39.0,
|
| 317 |
+
"status": "fail",
|
| 318 |
+
"failed_at": "m4b",
|
| 319 |
+
"route_status": "no_route",
|
| 320 |
+
"route_fallback": false,
|
| 321 |
+
"has_manifest": true
|
| 322 |
+
},
|
| 323 |
+
{
|
| 324 |
+
"drug_id": "120",
|
| 325 |
+
"canonical_name": "Digoxin",
|
| 326 |
+
"index_key": "DIGOXIN_PGP",
|
| 327 |
+
"pdb_id": "3G60",
|
| 328 |
+
"tier": "1",
|
| 329 |
+
"session_id": "6c2d9b61882105e0",
|
| 330 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\6c2d9b61882105e0",
|
| 331 |
+
"elapsed_s": 175.3,
|
| 332 |
+
"status": "ok",
|
| 333 |
+
"best_affinity": -7.635,
|
| 334 |
+
"qc_pass": true,
|
| 335 |
+
"route_status": "same_pdb_surrogate",
|
| 336 |
+
"route_fallback": true,
|
| 337 |
+
"has_manifest": true
|
| 338 |
+
},
|
| 339 |
+
{
|
| 340 |
+
"drug_id": "121",
|
| 341 |
+
"canonical_name": "Esomeprazole",
|
| 342 |
+
"index_key": "ESOMEPRAZOLE_CYP2C19_PROXY",
|
| 343 |
+
"pdb_id": "4GQS",
|
| 344 |
+
"tier": "2",
|
| 345 |
+
"session_id": "09e3d437a9fdad49",
|
| 346 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\09e3d437a9fdad49",
|
| 347 |
+
"elapsed_s": 189.8,
|
| 348 |
+
"status": "ok",
|
| 349 |
+
"best_affinity": -7.841,
|
| 350 |
+
"qc_pass": true,
|
| 351 |
+
"route_status": "direct_ok",
|
| 352 |
+
"route_fallback": false,
|
| 353 |
+
"has_manifest": true
|
| 354 |
+
},
|
| 355 |
+
{
|
| 356 |
+
"drug_id": "122",
|
| 357 |
+
"canonical_name": "Nateglinide",
|
| 358 |
+
"index_key": "NATEGLINIDE_KATP_PROXY",
|
| 359 |
+
"pdb_id": "3SYQ",
|
| 360 |
+
"tier": "2",
|
| 361 |
+
"session_id": "f9f9cab8d78202cf",
|
| 362 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\f9f9cab8d78202cf",
|
| 363 |
+
"elapsed_s": 56.5,
|
| 364 |
+
"status": "ok",
|
| 365 |
+
"best_affinity": -6.86,
|
| 366 |
+
"qc_pass": true,
|
| 367 |
+
"route_status": "cross_pdb_proxy",
|
| 368 |
+
"route_fallback": true,
|
| 369 |
+
"has_manifest": true
|
| 370 |
+
},
|
| 371 |
+
{
|
| 372 |
+
"drug_id": "123",
|
| 373 |
+
"canonical_name": "Voglibose",
|
| 374 |
+
"index_key": "VOGLIBOSE_GLUCOSIDASE_PROXY",
|
| 375 |
+
"pdb_id": "2QV4",
|
| 376 |
+
"tier": "2",
|
| 377 |
+
"session_id": "edb6b8f1c6e3a33b",
|
| 378 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\edb6b8f1c6e3a33b",
|
| 379 |
+
"elapsed_s": 52.9,
|
| 380 |
+
"status": "ok",
|
| 381 |
+
"best_affinity": -7.115,
|
| 382 |
+
"qc_pass": true,
|
| 383 |
+
"route_status": "same_pdb_surrogate",
|
| 384 |
+
"route_fallback": true,
|
| 385 |
+
"has_manifest": true
|
| 386 |
+
},
|
| 387 |
+
{
|
| 388 |
+
"drug_id": "124",
|
| 389 |
+
"canonical_name": "Eplerenone",
|
| 390 |
+
"index_key": "EPLERENONE_NR3C2",
|
| 391 |
+
"pdb_id": "2AA2",
|
| 392 |
+
"tier": "1",
|
| 393 |
+
"session_id": "ad90d3f0c613e7d7",
|
| 394 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\ad90d3f0c613e7d7",
|
| 395 |
+
"elapsed_s": 43.6,
|
| 396 |
+
"status": "ok",
|
| 397 |
+
"best_affinity": -6.523,
|
| 398 |
+
"qc_pass": true,
|
| 399 |
+
"route_status": "cross_pdb_proxy",
|
| 400 |
+
"route_fallback": true,
|
| 401 |
+
"has_manifest": true
|
| 402 |
+
},
|
| 403 |
+
{
|
| 404 |
+
"drug_id": "125",
|
| 405 |
+
"canonical_name": "Telmisartan",
|
| 406 |
+
"index_key": "TELMISARTAN_AT1R",
|
| 407 |
+
"pdb_id": "4YAY",
|
| 408 |
+
"tier": "1",
|
| 409 |
+
"session_id": "a79c4a36ee92aebd",
|
| 410 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\a79c4a36ee92aebd",
|
| 411 |
+
"elapsed_s": 63.7,
|
| 412 |
+
"status": "ok",
|
| 413 |
+
"best_affinity": -10.18,
|
| 414 |
+
"qc_pass": true,
|
| 415 |
+
"route_status": "same_pdb_surrogate",
|
| 416 |
+
"route_fallback": true,
|
| 417 |
+
"has_manifest": true
|
| 418 |
+
},
|
| 419 |
+
{
|
| 420 |
+
"drug_id": "126",
|
| 421 |
+
"canonical_name": "Lisinopril",
|
| 422 |
+
"index_key": "LISINOPRIL_ACE",
|
| 423 |
+
"pdb_id": "1O86",
|
| 424 |
+
"tier": "1",
|
| 425 |
+
"session_id": "6e6a3aab0947ab09",
|
| 426 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\6e6a3aab0947ab09",
|
| 427 |
+
"elapsed_s": 90.4,
|
| 428 |
+
"status": "ok",
|
| 429 |
+
"best_affinity": -8.568,
|
| 430 |
+
"qc_pass": false,
|
| 431 |
+
"route_status": "same_pdb_surrogate",
|
| 432 |
+
"route_fallback": true,
|
| 433 |
+
"has_manifest": true
|
| 434 |
+
},
|
| 435 |
+
{
|
| 436 |
+
"drug_id": "127",
|
| 437 |
+
"canonical_name": "Diltiazem",
|
| 438 |
+
"index_key": "DILTIAZEM_CACNA1C_PROXY",
|
| 439 |
+
"pdb_id": "8WE8",
|
| 440 |
+
"tier": "2",
|
| 441 |
+
"session_id": "a486e7cf18629198",
|
| 442 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\a486e7cf18629198",
|
| 443 |
+
"elapsed_s": 191.8,
|
| 444 |
+
"status": "ok",
|
| 445 |
+
"best_affinity": -8.89,
|
| 446 |
+
"qc_pass": true,
|
| 447 |
+
"route_status": "direct_ok",
|
| 448 |
+
"route_fallback": false,
|
| 449 |
+
"has_manifest": true
|
| 450 |
+
},
|
| 451 |
+
{
|
| 452 |
+
"drug_id": "128",
|
| 453 |
+
"canonical_name": "Furosemide",
|
| 454 |
+
"index_key": "FUROSEMIDE_SLC12A_PROXY",
|
| 455 |
+
"pdb_id": "3HS4",
|
| 456 |
+
"tier": "2",
|
| 457 |
+
"session_id": "f84307ef8d0fb256",
|
| 458 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\f84307ef8d0fb256",
|
| 459 |
+
"elapsed_s": 43.7,
|
| 460 |
+
"status": "ok",
|
| 461 |
+
"best_affinity": -6.843,
|
| 462 |
+
"qc_pass": true,
|
| 463 |
+
"route_status": "direct_ok",
|
| 464 |
+
"route_fallback": false,
|
| 465 |
+
"has_manifest": true
|
| 466 |
+
},
|
| 467 |
+
{
|
| 468 |
+
"drug_id": "129",
|
| 469 |
+
"canonical_name": "Orlistat",
|
| 470 |
+
"index_key": "ORLISTAT_LIPASE",
|
| 471 |
+
"pdb_id": "1LPB",
|
| 472 |
+
"tier": "1",
|
| 473 |
+
"session_id": "5d4310d7357604a6",
|
| 474 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\5d4310d7357604a6",
|
| 475 |
+
"elapsed_s": 281.8,
|
| 476 |
+
"status": "ok",
|
| 477 |
+
"best_affinity": -6.687,
|
| 478 |
+
"qc_pass": true,
|
| 479 |
+
"route_status": "same_pdb_surrogate",
|
| 480 |
+
"route_fallback": true,
|
| 481 |
+
"has_manifest": true
|
| 482 |
+
}
|
| 483 |
+
]
|
| 484 |
+
}
|
config/catalog_batch_run_summary_130-139.json
ADDED
|
@@ -0,0 +1,165 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"generated_at": "2026-06-30T10:26:37.059656+00:00",
|
| 3 |
+
"count": 10,
|
| 4 |
+
"total_elapsed_s": 1635.7,
|
| 5 |
+
"ok": 6,
|
| 6 |
+
"partial": 0,
|
| 7 |
+
"skip": 0,
|
| 8 |
+
"qc_pass": 3,
|
| 9 |
+
"results": [
|
| 10 |
+
{
|
| 11 |
+
"drug_id": "130",
|
| 12 |
+
"canonical_name": "Levothyroxine",
|
| 13 |
+
"index_key": "LEVOTHYROXINE_THRB_PROXY",
|
| 14 |
+
"pdb_id": "1NAV",
|
| 15 |
+
"tier": "2",
|
| 16 |
+
"session_id": "5c6329ecb370f2e1",
|
| 17 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\5c6329ecb370f2e1",
|
| 18 |
+
"elapsed_s": 54.6,
|
| 19 |
+
"status": "ok",
|
| 20 |
+
"best_affinity": -7.131,
|
| 21 |
+
"qc_pass": true,
|
| 22 |
+
"route_status": "same_pdb_surrogate",
|
| 23 |
+
"route_fallback": true,
|
| 24 |
+
"has_manifest": true
|
| 25 |
+
},
|
| 26 |
+
{
|
| 27 |
+
"drug_id": "131",
|
| 28 |
+
"canonical_name": "Morphine",
|
| 29 |
+
"index_key": "MORPHINE_OPRM1",
|
| 30 |
+
"pdb_id": "8DZP",
|
| 31 |
+
"tier": "1",
|
| 32 |
+
"session_id": "c395e5af446f6879",
|
| 33 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\c395e5af446f6879",
|
| 34 |
+
"elapsed_s": 98.2,
|
| 35 |
+
"status": "ok",
|
| 36 |
+
"best_affinity": -7.632,
|
| 37 |
+
"qc_pass": false,
|
| 38 |
+
"route_status": "same_pdb_surrogate",
|
| 39 |
+
"route_fallback": true,
|
| 40 |
+
"has_manifest": true
|
| 41 |
+
},
|
| 42 |
+
{
|
| 43 |
+
"drug_id": "132",
|
| 44 |
+
"canonical_name": "Fentanyl",
|
| 45 |
+
"index_key": "FENTANYL_OPRM1_PROXY",
|
| 46 |
+
"pdb_id": "8DZP",
|
| 47 |
+
"tier": "2",
|
| 48 |
+
"session_id": "a10f03e66572cb4b",
|
| 49 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\a10f03e66572cb4b",
|
| 50 |
+
"elapsed_s": 122.3,
|
| 51 |
+
"status": "ok",
|
| 52 |
+
"best_affinity": -7.864,
|
| 53 |
+
"qc_pass": true,
|
| 54 |
+
"route_status": "same_pdb_surrogate",
|
| 55 |
+
"route_fallback": true,
|
| 56 |
+
"has_manifest": true
|
| 57 |
+
},
|
| 58 |
+
{
|
| 59 |
+
"drug_id": "133",
|
| 60 |
+
"canonical_name": "Pregabalin",
|
| 61 |
+
"index_key": "PREGABALIN_CACNA2D_PROXY",
|
| 62 |
+
"pdb_id": "5E6I",
|
| 63 |
+
"tier": "2",
|
| 64 |
+
"session_id": "cc8c60ebaa9b95b6",
|
| 65 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\cc8c60ebaa9b95b6",
|
| 66 |
+
"elapsed_s": 474.0,
|
| 67 |
+
"status": "fail",
|
| 68 |
+
"failed_at": "m4b",
|
| 69 |
+
"route_status": "no_route",
|
| 70 |
+
"route_fallback": false,
|
| 71 |
+
"has_manifest": true
|
| 72 |
+
},
|
| 73 |
+
{
|
| 74 |
+
"drug_id": "134",
|
| 75 |
+
"canonical_name": "Lamotrigine",
|
| 76 |
+
"index_key": "LAMOTRIGINE_SCN_PROXY",
|
| 77 |
+
"pdb_id": "5E6I",
|
| 78 |
+
"tier": "2",
|
| 79 |
+
"session_id": "f5a8998b464dea01",
|
| 80 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\f5a8998b464dea01",
|
| 81 |
+
"elapsed_s": 462.8,
|
| 82 |
+
"status": "fail",
|
| 83 |
+
"failed_at": "m4b",
|
| 84 |
+
"route_status": "no_route",
|
| 85 |
+
"route_fallback": false,
|
| 86 |
+
"has_manifest": true
|
| 87 |
+
},
|
| 88 |
+
{
|
| 89 |
+
"drug_id": "135",
|
| 90 |
+
"canonical_name": "Phenytoin",
|
| 91 |
+
"index_key": "PHENYTOIN_SCN_PROXY",
|
| 92 |
+
"pdb_id": "5T6R",
|
| 93 |
+
"tier": "2",
|
| 94 |
+
"session_id": "9053280d8de1dd73",
|
| 95 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\9053280d8de1dd73",
|
| 96 |
+
"elapsed_s": 13.4,
|
| 97 |
+
"status": "fail",
|
| 98 |
+
"failed_at": "m1",
|
| 99 |
+
"route_status": "no_route",
|
| 100 |
+
"route_fallback": false
|
| 101 |
+
},
|
| 102 |
+
{
|
| 103 |
+
"drug_id": "136",
|
| 104 |
+
"canonical_name": "Clonazepam",
|
| 105 |
+
"index_key": "CLONAZEPAM_GABA_A",
|
| 106 |
+
"pdb_id": "1KTF",
|
| 107 |
+
"tier": "1",
|
| 108 |
+
"session_id": "7b81b52b568fb5dc",
|
| 109 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\7b81b52b568fb5dc",
|
| 110 |
+
"elapsed_s": 13.7,
|
| 111 |
+
"status": "fail",
|
| 112 |
+
"failed_at": "m1",
|
| 113 |
+
"route_status": "no_route",
|
| 114 |
+
"route_fallback": false
|
| 115 |
+
},
|
| 116 |
+
{
|
| 117 |
+
"drug_id": "137",
|
| 118 |
+
"canonical_name": "Escitalopram",
|
| 119 |
+
"index_key": "ESCITALOPRAM_SERT",
|
| 120 |
+
"pdb_id": "4IAR",
|
| 121 |
+
"tier": "1",
|
| 122 |
+
"session_id": "5bf94f51ea38472b",
|
| 123 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\5bf94f51ea38472b",
|
| 124 |
+
"elapsed_s": 52.7,
|
| 125 |
+
"status": "ok",
|
| 126 |
+
"best_affinity": -8.633,
|
| 127 |
+
"qc_pass": true,
|
| 128 |
+
"route_status": "same_pdb_surrogate",
|
| 129 |
+
"route_fallback": true,
|
| 130 |
+
"has_manifest": true
|
| 131 |
+
},
|
| 132 |
+
{
|
| 133 |
+
"drug_id": "138",
|
| 134 |
+
"canonical_name": "Linezolid",
|
| 135 |
+
"index_key": "LINEZOLID_RIBOSOME",
|
| 136 |
+
"pdb_id": "3CPW",
|
| 137 |
+
"tier": "1",
|
| 138 |
+
"session_id": "84a1c2be4800539f",
|
| 139 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\84a1c2be4800539f",
|
| 140 |
+
"elapsed_s": 322.3,
|
| 141 |
+
"status": "ok",
|
| 142 |
+
"best_affinity": -4.91,
|
| 143 |
+
"qc_pass": false,
|
| 144 |
+
"route_status": "same_pdb_surrogate",
|
| 145 |
+
"route_fallback": true,
|
| 146 |
+
"has_manifest": true
|
| 147 |
+
},
|
| 148 |
+
{
|
| 149 |
+
"drug_id": "139",
|
| 150 |
+
"canonical_name": "Isoniazid",
|
| 151 |
+
"index_key": "ISONIAZID_INHA",
|
| 152 |
+
"pdb_id": "4C0X",
|
| 153 |
+
"tier": "1",
|
| 154 |
+
"session_id": "00366c4964443c3a",
|
| 155 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\00366c4964443c3a",
|
| 156 |
+
"elapsed_s": 21.2,
|
| 157 |
+
"status": "ok",
|
| 158 |
+
"best_affinity": -5.99,
|
| 159 |
+
"qc_pass": false,
|
| 160 |
+
"route_status": "same_pdb_surrogate",
|
| 161 |
+
"route_fallback": true,
|
| 162 |
+
"has_manifest": true
|
| 163 |
+
}
|
| 164 |
+
]
|
| 165 |
+
}
|
config/catalog_batch_run_summary_140-149.json
ADDED
|
@@ -0,0 +1,169 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"generated_at": "2026-06-30T11:01:29.599913+00:00",
|
| 3 |
+
"count": 10,
|
| 4 |
+
"total_elapsed_s": 1143.7,
|
| 5 |
+
"ok": 8,
|
| 6 |
+
"partial": 0,
|
| 7 |
+
"skip": 0,
|
| 8 |
+
"qc_pass": 6,
|
| 9 |
+
"results": [
|
| 10 |
+
{
|
| 11 |
+
"drug_id": "140",
|
| 12 |
+
"canonical_name": "Ethambutol",
|
| 13 |
+
"index_key": "ETHAMBUTOL_EMBA",
|
| 14 |
+
"pdb_id": "4NBA",
|
| 15 |
+
"tier": "1",
|
| 16 |
+
"session_id": "6b5bda2908ef66d7",
|
| 17 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\6b5bda2908ef66d7",
|
| 18 |
+
"elapsed_s": 90.0,
|
| 19 |
+
"status": "ok",
|
| 20 |
+
"best_affinity": -7.256,
|
| 21 |
+
"qc_pass": true,
|
| 22 |
+
"route_status": "same_pdb_surrogate",
|
| 23 |
+
"route_fallback": true,
|
| 24 |
+
"has_manifest": true
|
| 25 |
+
},
|
| 26 |
+
{
|
| 27 |
+
"drug_id": "141",
|
| 28 |
+
"canonical_name": "Acalabrutinib",
|
| 29 |
+
"index_key": "ACALABRUTINIB_BTK",
|
| 30 |
+
"pdb_id": "4O5B",
|
| 31 |
+
"tier": "1",
|
| 32 |
+
"session_id": "db9851dbc46dfa74",
|
| 33 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\db9851dbc46dfa74",
|
| 34 |
+
"elapsed_s": 18.2,
|
| 35 |
+
"status": "fail",
|
| 36 |
+
"failed_at": "m5a",
|
| 37 |
+
"route_status": "cross_pdb_proxy",
|
| 38 |
+
"route_fallback": true,
|
| 39 |
+
"has_manifest": true
|
| 40 |
+
},
|
| 41 |
+
{
|
| 42 |
+
"drug_id": "142",
|
| 43 |
+
"canonical_name": "Midostaurin",
|
| 44 |
+
"index_key": "MIDOSTAURIN_FLT3",
|
| 45 |
+
"pdb_id": "4RK8",
|
| 46 |
+
"tier": "2",
|
| 47 |
+
"session_id": "5c426bfe129b23dc",
|
| 48 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\5c426bfe129b23dc",
|
| 49 |
+
"elapsed_s": 85.9,
|
| 50 |
+
"status": "ok",
|
| 51 |
+
"best_affinity": -7.138,
|
| 52 |
+
"qc_pass": true,
|
| 53 |
+
"route_status": "cross_pdb_proxy",
|
| 54 |
+
"route_fallback": true,
|
| 55 |
+
"has_manifest": true
|
| 56 |
+
},
|
| 57 |
+
{
|
| 58 |
+
"drug_id": "143",
|
| 59 |
+
"canonical_name": "Larotrectinib",
|
| 60 |
+
"index_key": "LAROTRECTINIB_TRK",
|
| 61 |
+
"pdb_id": "5VLQ",
|
| 62 |
+
"tier": "1",
|
| 63 |
+
"session_id": "1d762ef85781fdfe",
|
| 64 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\1d762ef85781fdfe",
|
| 65 |
+
"elapsed_s": 122.7,
|
| 66 |
+
"status": "ok",
|
| 67 |
+
"best_affinity": -6.725,
|
| 68 |
+
"qc_pass": true,
|
| 69 |
+
"route_status": "same_pdb_surrogate",
|
| 70 |
+
"route_fallback": true,
|
| 71 |
+
"has_manifest": true
|
| 72 |
+
},
|
| 73 |
+
{
|
| 74 |
+
"drug_id": "144",
|
| 75 |
+
"canonical_name": "Lenalidomide",
|
| 76 |
+
"index_key": "LENALIDOMIDE_CRBN",
|
| 77 |
+
"pdb_id": "5FQD",
|
| 78 |
+
"tier": "1",
|
| 79 |
+
"session_id": "a4d450c1d4756a85",
|
| 80 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\a4d450c1d4756a85",
|
| 81 |
+
"elapsed_s": 438.2,
|
| 82 |
+
"status": "ok",
|
| 83 |
+
"best_affinity": -7.135,
|
| 84 |
+
"qc_pass": false,
|
| 85 |
+
"route_status": "same_pdb_surrogate",
|
| 86 |
+
"route_fallback": true,
|
| 87 |
+
"has_manifest": true
|
| 88 |
+
},
|
| 89 |
+
{
|
| 90 |
+
"drug_id": "145",
|
| 91 |
+
"canonical_name": "Abiraterone",
|
| 92 |
+
"index_key": "ABIRATERONE_CYP17",
|
| 93 |
+
"pdb_id": "3SW0",
|
| 94 |
+
"tier": "1",
|
| 95 |
+
"session_id": "ae443b52bf6ac6b2",
|
| 96 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\ae443b52bf6ac6b2",
|
| 97 |
+
"elapsed_s": 22.5,
|
| 98 |
+
"status": "fail",
|
| 99 |
+
"failed_at": "m4b",
|
| 100 |
+
"route_status": "no_route",
|
| 101 |
+
"route_fallback": false,
|
| 102 |
+
"has_manifest": true
|
| 103 |
+
},
|
| 104 |
+
{
|
| 105 |
+
"drug_id": "146",
|
| 106 |
+
"canonical_name": "Abemaciclib",
|
| 107 |
+
"index_key": "ABEMACICLIB_CDK6",
|
| 108 |
+
"pdb_id": "5UOC",
|
| 109 |
+
"tier": "1",
|
| 110 |
+
"session_id": "58734be96cd8e15b",
|
| 111 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\58734be96cd8e15b",
|
| 112 |
+
"elapsed_s": 215.2,
|
| 113 |
+
"status": "ok",
|
| 114 |
+
"best_affinity": -9.292,
|
| 115 |
+
"qc_pass": true,
|
| 116 |
+
"route_status": "same_pdb_surrogate",
|
| 117 |
+
"route_fallback": true,
|
| 118 |
+
"has_manifest": true
|
| 119 |
+
},
|
| 120 |
+
{
|
| 121 |
+
"drug_id": "147",
|
| 122 |
+
"canonical_name": "Ribociclib",
|
| 123 |
+
"index_key": "RIBOCICLIB_CDK6",
|
| 124 |
+
"pdb_id": "5L2T",
|
| 125 |
+
"tier": "1",
|
| 126 |
+
"session_id": "4efc8c856de1cefc",
|
| 127 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\4efc8c856de1cefc",
|
| 128 |
+
"elapsed_s": 46.3,
|
| 129 |
+
"status": "ok",
|
| 130 |
+
"best_affinity": -9.313,
|
| 131 |
+
"qc_pass": true,
|
| 132 |
+
"route_status": "same_pdb_surrogate",
|
| 133 |
+
"route_fallback": true,
|
| 134 |
+
"has_manifest": true
|
| 135 |
+
},
|
| 136 |
+
{
|
| 137 |
+
"drug_id": "148",
|
| 138 |
+
"canonical_name": "Prasugrel",
|
| 139 |
+
"index_key": "PRASUGREL_P2Y12_PROXY",
|
| 140 |
+
"pdb_id": "4PY0",
|
| 141 |
+
"tier": "2",
|
| 142 |
+
"session_id": "fc0e3d03b01faf01",
|
| 143 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\fc0e3d03b01faf01",
|
| 144 |
+
"elapsed_s": 63.7,
|
| 145 |
+
"status": "ok",
|
| 146 |
+
"best_affinity": -8.7,
|
| 147 |
+
"qc_pass": false,
|
| 148 |
+
"route_status": "same_pdb_surrogate",
|
| 149 |
+
"route_fallback": true,
|
| 150 |
+
"has_manifest": true
|
| 151 |
+
},
|
| 152 |
+
{
|
| 153 |
+
"drug_id": "149",
|
| 154 |
+
"canonical_name": "Vandetanib",
|
| 155 |
+
"index_key": "VANDETANIB_RET",
|
| 156 |
+
"pdb_id": "2IVT",
|
| 157 |
+
"tier": "1",
|
| 158 |
+
"session_id": "63a628c84abdfeac",
|
| 159 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\63a628c84abdfeac",
|
| 160 |
+
"elapsed_s": 40.5,
|
| 161 |
+
"status": "ok",
|
| 162 |
+
"best_affinity": -7.308,
|
| 163 |
+
"qc_pass": true,
|
| 164 |
+
"route_status": "same_pdb_surrogate",
|
| 165 |
+
"route_fallback": true,
|
| 166 |
+
"has_manifest": true
|
| 167 |
+
}
|
| 168 |
+
]
|
| 169 |
+
}
|
config/catalog_batch_run_summary_150-159.json
ADDED
|
@@ -0,0 +1,171 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"generated_at": "2026-06-30T11:17:28.555340+00:00",
|
| 3 |
+
"count": 10,
|
| 4 |
+
"total_elapsed_s": 738.9,
|
| 5 |
+
"ok": 10,
|
| 6 |
+
"partial": 0,
|
| 7 |
+
"skip": 0,
|
| 8 |
+
"qc_pass": 10,
|
| 9 |
+
"results": [
|
| 10 |
+
{
|
| 11 |
+
"drug_id": "150",
|
| 12 |
+
"canonical_name": "Nintedanib",
|
| 13 |
+
"index_key": "NINTEDANIB_FGFR",
|
| 14 |
+
"pdb_id": "4PV0",
|
| 15 |
+
"tier": "1",
|
| 16 |
+
"session_id": "5e571c2903463711",
|
| 17 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\5e571c2903463711",
|
| 18 |
+
"elapsed_s": 38.1,
|
| 19 |
+
"status": "ok",
|
| 20 |
+
"best_affinity": -7.104,
|
| 21 |
+
"qc_pass": true,
|
| 22 |
+
"route_status": "same_pdb_surrogate",
|
| 23 |
+
"route_fallback": true,
|
| 24 |
+
"has_manifest": true
|
| 25 |
+
},
|
| 26 |
+
{
|
| 27 |
+
"drug_id": "151",
|
| 28 |
+
"canonical_name": "Enalapril",
|
| 29 |
+
"index_key": "ENALAPRIL_ACE_PROXY",
|
| 30 |
+
"pdb_id": "1O86",
|
| 31 |
+
"tier": "2",
|
| 32 |
+
"session_id": "e34f30284054cf2e",
|
| 33 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\e34f30284054cf2e",
|
| 34 |
+
"elapsed_s": 83.3,
|
| 35 |
+
"status": "ok",
|
| 36 |
+
"best_affinity": -8.111,
|
| 37 |
+
"qc_pass": true,
|
| 38 |
+
"route_status": "same_pdb_surrogate",
|
| 39 |
+
"route_fallback": true,
|
| 40 |
+
"has_manifest": true
|
| 41 |
+
},
|
| 42 |
+
{
|
| 43 |
+
"drug_id": "152",
|
| 44 |
+
"canonical_name": "Ramipril",
|
| 45 |
+
"index_key": "RAMIPRIL_ACE_PROXY",
|
| 46 |
+
"pdb_id": "1O86",
|
| 47 |
+
"tier": "2",
|
| 48 |
+
"session_id": "3a50159851a6853c",
|
| 49 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\3a50159851a6853c",
|
| 50 |
+
"elapsed_s": 95.4,
|
| 51 |
+
"status": "ok",
|
| 52 |
+
"best_affinity": -8.618,
|
| 53 |
+
"qc_pass": true,
|
| 54 |
+
"route_status": "same_pdb_surrogate",
|
| 55 |
+
"route_fallback": true,
|
| 56 |
+
"has_manifest": true
|
| 57 |
+
},
|
| 58 |
+
{
|
| 59 |
+
"drug_id": "153",
|
| 60 |
+
"canonical_name": "Candesartan",
|
| 61 |
+
"index_key": "CANDESARTAN_AT1R",
|
| 62 |
+
"pdb_id": "4ZUD",
|
| 63 |
+
"tier": "2",
|
| 64 |
+
"session_id": "bf402e9cf14097be",
|
| 65 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\bf402e9cf14097be",
|
| 66 |
+
"elapsed_s": 54.6,
|
| 67 |
+
"status": "ok",
|
| 68 |
+
"best_affinity": -11.4,
|
| 69 |
+
"qc_pass": true,
|
| 70 |
+
"route_status": "direct_ok",
|
| 71 |
+
"route_fallback": false,
|
| 72 |
+
"has_manifest": true
|
| 73 |
+
},
|
| 74 |
+
{
|
| 75 |
+
"drug_id": "154",
|
| 76 |
+
"canonical_name": "Irbesartan",
|
| 77 |
+
"index_key": "IRBESARTAN_AT1R_PROXY",
|
| 78 |
+
"pdb_id": "4ZUD",
|
| 79 |
+
"tier": "2",
|
| 80 |
+
"session_id": "00e7e57350867b38",
|
| 81 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\00e7e57350867b38",
|
| 82 |
+
"elapsed_s": 49.0,
|
| 83 |
+
"status": "ok",
|
| 84 |
+
"best_affinity": -10.38,
|
| 85 |
+
"qc_pass": true,
|
| 86 |
+
"route_status": "direct_ok",
|
| 87 |
+
"route_fallback": false,
|
| 88 |
+
"has_manifest": true
|
| 89 |
+
},
|
| 90 |
+
{
|
| 91 |
+
"drug_id": "155",
|
| 92 |
+
"canonical_name": "Olmesartan",
|
| 93 |
+
"index_key": "OLMESARTAN_AT1R",
|
| 94 |
+
"pdb_id": "4ZUD",
|
| 95 |
+
"tier": "1",
|
| 96 |
+
"session_id": "11b6a1841b2c08f6",
|
| 97 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\11b6a1841b2c08f6",
|
| 98 |
+
"elapsed_s": 55.1,
|
| 99 |
+
"status": "ok",
|
| 100 |
+
"best_affinity": -10.3,
|
| 101 |
+
"qc_pass": true,
|
| 102 |
+
"route_status": "direct_ok",
|
| 103 |
+
"route_fallback": false,
|
| 104 |
+
"has_manifest": true
|
| 105 |
+
},
|
| 106 |
+
{
|
| 107 |
+
"drug_id": "156",
|
| 108 |
+
"canonical_name": "Rosiglitazone",
|
| 109 |
+
"index_key": "ROSIGLITAZONE_PPARG",
|
| 110 |
+
"pdb_id": "2PRG",
|
| 111 |
+
"tier": "1",
|
| 112 |
+
"session_id": "348e68d6d88d3994",
|
| 113 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\348e68d6d88d3994",
|
| 114 |
+
"elapsed_s": 45.1,
|
| 115 |
+
"status": "ok",
|
| 116 |
+
"best_affinity": -9.273,
|
| 117 |
+
"qc_pass": true,
|
| 118 |
+
"route_status": "direct_ok",
|
| 119 |
+
"route_fallback": false,
|
| 120 |
+
"has_manifest": true
|
| 121 |
+
},
|
| 122 |
+
{
|
| 123 |
+
"drug_id": "157",
|
| 124 |
+
"canonical_name": "Glyburide",
|
| 125 |
+
"index_key": "GLYBURIDE_KATP",
|
| 126 |
+
"pdb_id": "3SYQ",
|
| 127 |
+
"tier": "1",
|
| 128 |
+
"session_id": "5063b6ff285c2a73",
|
| 129 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\5063b6ff285c2a73",
|
| 130 |
+
"elapsed_s": 75.1,
|
| 131 |
+
"status": "ok",
|
| 132 |
+
"best_affinity": -7.504,
|
| 133 |
+
"qc_pass": true,
|
| 134 |
+
"route_status": "same_pdb_surrogate",
|
| 135 |
+
"route_fallback": true,
|
| 136 |
+
"has_manifest": true
|
| 137 |
+
},
|
| 138 |
+
{
|
| 139 |
+
"drug_id": "158",
|
| 140 |
+
"canonical_name": "Atenolol",
|
| 141 |
+
"index_key": "ATENOLOL_ADRB1_PROXY",
|
| 142 |
+
"pdb_id": "2Y02",
|
| 143 |
+
"tier": "2",
|
| 144 |
+
"session_id": "9c6510353824b5ad",
|
| 145 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\9c6510353824b5ad",
|
| 146 |
+
"elapsed_s": 40.1,
|
| 147 |
+
"status": "ok",
|
| 148 |
+
"best_affinity": -7.309,
|
| 149 |
+
"qc_pass": true,
|
| 150 |
+
"route_status": "direct_ok",
|
| 151 |
+
"route_fallback": false,
|
| 152 |
+
"has_manifest": true
|
| 153 |
+
},
|
| 154 |
+
{
|
| 155 |
+
"drug_id": "159",
|
| 156 |
+
"canonical_name": "Felodipine",
|
| 157 |
+
"index_key": "FELODIPINE_CACNA1C_PROXY",
|
| 158 |
+
"pdb_id": "8WE8",
|
| 159 |
+
"tier": "2",
|
| 160 |
+
"session_id": "67da2ff0fe290fe0",
|
| 161 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\67da2ff0fe290fe0",
|
| 162 |
+
"elapsed_s": 202.8,
|
| 163 |
+
"status": "ok",
|
| 164 |
+
"best_affinity": -6.721,
|
| 165 |
+
"qc_pass": true,
|
| 166 |
+
"route_status": "direct_ok",
|
| 167 |
+
"route_fallback": false,
|
| 168 |
+
"has_manifest": true
|
| 169 |
+
}
|
| 170 |
+
]
|
| 171 |
+
}
|
config/catalog_batch_run_summary_160-169.json
ADDED
|
@@ -0,0 +1,168 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"generated_at": "2026-06-30T12:00:11.878342+00:00",
|
| 3 |
+
"count": 10,
|
| 4 |
+
"total_elapsed_s": 811.5,
|
| 5 |
+
"ok": 8,
|
| 6 |
+
"partial": 0,
|
| 7 |
+
"skip": 0,
|
| 8 |
+
"qc_pass": 7,
|
| 9 |
+
"results": [
|
| 10 |
+
{
|
| 11 |
+
"drug_id": "160",
|
| 12 |
+
"canonical_name": "Sacubitril",
|
| 13 |
+
"index_key": "SACUBITRIL_MEP",
|
| 14 |
+
"pdb_id": "6V06",
|
| 15 |
+
"tier": "1",
|
| 16 |
+
"session_id": "0f0e77dc8dd711e2",
|
| 17 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\0f0e77dc8dd711e2",
|
| 18 |
+
"elapsed_s": 18.9,
|
| 19 |
+
"status": "fail",
|
| 20 |
+
"failed_at": "m4b",
|
| 21 |
+
"route_status": "no_route",
|
| 22 |
+
"route_fallback": false,
|
| 23 |
+
"has_manifest": true
|
| 24 |
+
},
|
| 25 |
+
{
|
| 26 |
+
"drug_id": "161",
|
| 27 |
+
"canonical_name": "Tramadol",
|
| 28 |
+
"index_key": "TRAMADOL_OPRM1_PROXY",
|
| 29 |
+
"pdb_id": "8DZP",
|
| 30 |
+
"tier": "2",
|
| 31 |
+
"session_id": "5c67b9b9d1ed63d4",
|
| 32 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\5c67b9b9d1ed63d4",
|
| 33 |
+
"elapsed_s": 98.6,
|
| 34 |
+
"status": "ok",
|
| 35 |
+
"best_affinity": -6.721,
|
| 36 |
+
"qc_pass": true,
|
| 37 |
+
"route_status": "same_pdb_surrogate",
|
| 38 |
+
"route_fallback": true,
|
| 39 |
+
"has_manifest": true
|
| 40 |
+
},
|
| 41 |
+
{
|
| 42 |
+
"drug_id": "162",
|
| 43 |
+
"canonical_name": "Oxycodone",
|
| 44 |
+
"index_key": "OXYCODONE_OPRM1_PROXY",
|
| 45 |
+
"pdb_id": "8DZP",
|
| 46 |
+
"tier": "2",
|
| 47 |
+
"session_id": "36c37b826460d078",
|
| 48 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\36c37b826460d078",
|
| 49 |
+
"elapsed_s": 99.5,
|
| 50 |
+
"status": "ok",
|
| 51 |
+
"best_affinity": -6.996,
|
| 52 |
+
"qc_pass": true,
|
| 53 |
+
"route_status": "same_pdb_surrogate",
|
| 54 |
+
"route_fallback": true,
|
| 55 |
+
"has_manifest": true
|
| 56 |
+
},
|
| 57 |
+
{
|
| 58 |
+
"drug_id": "163",
|
| 59 |
+
"canonical_name": "Duloxetine",
|
| 60 |
+
"index_key": "DULOXETINE_SERT_PROXY",
|
| 61 |
+
"pdb_id": "5I6X",
|
| 62 |
+
"tier": "2",
|
| 63 |
+
"session_id": "1c620005c106f483",
|
| 64 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\1c620005c106f483",
|
| 65 |
+
"elapsed_s": 115.4,
|
| 66 |
+
"status": "ok",
|
| 67 |
+
"best_affinity": -7.943,
|
| 68 |
+
"qc_pass": true,
|
| 69 |
+
"route_status": "direct_ok",
|
| 70 |
+
"route_fallback": false,
|
| 71 |
+
"has_manifest": true
|
| 72 |
+
},
|
| 73 |
+
{
|
| 74 |
+
"drug_id": "164",
|
| 75 |
+
"canonical_name": "Citalopram",
|
| 76 |
+
"index_key": "CITALOPRAM_SERT",
|
| 77 |
+
"pdb_id": "4IAR",
|
| 78 |
+
"tier": "1",
|
| 79 |
+
"session_id": "9cf2685a68455ed5",
|
| 80 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\9cf2685a68455ed5",
|
| 81 |
+
"elapsed_s": 49.0,
|
| 82 |
+
"status": "ok",
|
| 83 |
+
"best_affinity": -8.614,
|
| 84 |
+
"qc_pass": true,
|
| 85 |
+
"route_status": "same_pdb_surrogate",
|
| 86 |
+
"route_fallback": true,
|
| 87 |
+
"has_manifest": true
|
| 88 |
+
},
|
| 89 |
+
{
|
| 90 |
+
"drug_id": "165",
|
| 91 |
+
"canonical_name": "Venlafaxine",
|
| 92 |
+
"index_key": "VENLAFAXINE_SERT_PROXY",
|
| 93 |
+
"pdb_id": "5I6X",
|
| 94 |
+
"tier": "2",
|
| 95 |
+
"session_id": "f5603bb08b0e8f2f",
|
| 96 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\f5603bb08b0e8f2f",
|
| 97 |
+
"elapsed_s": 119.0,
|
| 98 |
+
"status": "ok",
|
| 99 |
+
"best_affinity": -8.073,
|
| 100 |
+
"qc_pass": true,
|
| 101 |
+
"route_status": "direct_ok",
|
| 102 |
+
"route_fallback": false,
|
| 103 |
+
"has_manifest": true
|
| 104 |
+
},
|
| 105 |
+
{
|
| 106 |
+
"drug_id": "166",
|
| 107 |
+
"canonical_name": "Lorazepam",
|
| 108 |
+
"index_key": "LORAZEPAM_GABA_A_PROXY",
|
| 109 |
+
"pdb_id": "1KTF",
|
| 110 |
+
"tier": "2",
|
| 111 |
+
"session_id": "a95f8ed76fff9b4b",
|
| 112 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\a95f8ed76fff9b4b",
|
| 113 |
+
"elapsed_s": 13.7,
|
| 114 |
+
"status": "fail",
|
| 115 |
+
"failed_at": "m1",
|
| 116 |
+
"route_status": "no_route",
|
| 117 |
+
"route_fallback": false
|
| 118 |
+
},
|
| 119 |
+
{
|
| 120 |
+
"drug_id": "167",
|
| 121 |
+
"canonical_name": "Famotidine",
|
| 122 |
+
"index_key": "FAMOTIDINE_HRH2",
|
| 123 |
+
"pdb_id": "3RSG",
|
| 124 |
+
"tier": "1",
|
| 125 |
+
"session_id": "7d8d9e775c31490b",
|
| 126 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\7d8d9e775c31490b",
|
| 127 |
+
"elapsed_s": 32.4,
|
| 128 |
+
"status": "ok",
|
| 129 |
+
"best_affinity": -7.309,
|
| 130 |
+
"qc_pass": true,
|
| 131 |
+
"route_status": "same_pdb_surrogate",
|
| 132 |
+
"route_fallback": true,
|
| 133 |
+
"has_manifest": true
|
| 134 |
+
},
|
| 135 |
+
{
|
| 136 |
+
"drug_id": "168",
|
| 137 |
+
"canonical_name": "Ondansetron",
|
| 138 |
+
"index_key": "ONDANSETRON_HTR3A",
|
| 139 |
+
"pdb_id": "6DFZ",
|
| 140 |
+
"tier": "1",
|
| 141 |
+
"session_id": "1c7824a467ecbba8",
|
| 142 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\1c7824a467ecbba8",
|
| 143 |
+
"elapsed_s": 192.7,
|
| 144 |
+
"status": "ok",
|
| 145 |
+
"best_affinity": -7.319,
|
| 146 |
+
"qc_pass": true,
|
| 147 |
+
"route_status": "same_pdb_surrogate",
|
| 148 |
+
"route_fallback": true,
|
| 149 |
+
"has_manifest": true
|
| 150 |
+
},
|
| 151 |
+
{
|
| 152 |
+
"drug_id": "169",
|
| 153 |
+
"canonical_name": "Sumatriptan",
|
| 154 |
+
"index_key": "SUMATRIPTAN_HTR1B_PROXY",
|
| 155 |
+
"pdb_id": "6G4Q",
|
| 156 |
+
"tier": "2",
|
| 157 |
+
"session_id": "0f863791e85adfcf",
|
| 158 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\0f863791e85adfcf",
|
| 159 |
+
"elapsed_s": 71.8,
|
| 160 |
+
"status": "ok",
|
| 161 |
+
"best_affinity": -6.445,
|
| 162 |
+
"qc_pass": false,
|
| 163 |
+
"route_status": "same_pdb_surrogate",
|
| 164 |
+
"route_fallback": true,
|
| 165 |
+
"has_manifest": true
|
| 166 |
+
}
|
| 167 |
+
]
|
| 168 |
+
}
|
config/catalog_batch_run_summary_170-179.json
ADDED
|
@@ -0,0 +1,168 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"generated_at": "2026-06-30T12:29:06.997587+00:00",
|
| 3 |
+
"count": 10,
|
| 4 |
+
"total_elapsed_s": 1563.3,
|
| 5 |
+
"ok": 7,
|
| 6 |
+
"partial": 0,
|
| 7 |
+
"skip": 0,
|
| 8 |
+
"qc_pass": 7,
|
| 9 |
+
"results": [
|
| 10 |
+
{
|
| 11 |
+
"drug_id": "170",
|
| 12 |
+
"canonical_name": "Cyclosporine",
|
| 13 |
+
"index_key": "CYCLOSPORINE_PP2B",
|
| 14 |
+
"pdb_id": "1M63",
|
| 15 |
+
"tier": "1",
|
| 16 |
+
"session_id": "473edbe3badd87c1",
|
| 17 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\473edbe3badd87c1",
|
| 18 |
+
"elapsed_s": 740.9,
|
| 19 |
+
"status": "fail",
|
| 20 |
+
"failed_at": "m5a",
|
| 21 |
+
"route_status": "same_pdb_surrogate",
|
| 22 |
+
"route_fallback": true,
|
| 23 |
+
"has_manifest": true
|
| 24 |
+
},
|
| 25 |
+
{
|
| 26 |
+
"drug_id": "171",
|
| 27 |
+
"canonical_name": "Thalidomide",
|
| 28 |
+
"index_key": "THALIDOMIDE_CRBN",
|
| 29 |
+
"pdb_id": "4CI1",
|
| 30 |
+
"tier": "1",
|
| 31 |
+
"session_id": "2a8bf9d3a0702837",
|
| 32 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\2a8bf9d3a0702837",
|
| 33 |
+
"elapsed_s": 108.1,
|
| 34 |
+
"status": "fail",
|
| 35 |
+
"failed_at": "m5a",
|
| 36 |
+
"route_status": "same_pdb_surrogate",
|
| 37 |
+
"route_fallback": true,
|
| 38 |
+
"has_manifest": true
|
| 39 |
+
},
|
| 40 |
+
{
|
| 41 |
+
"drug_id": "172",
|
| 42 |
+
"canonical_name": "Pomalidomide",
|
| 43 |
+
"index_key": "POMALIDOMIDE_CRBN",
|
| 44 |
+
"pdb_id": "4TZ4",
|
| 45 |
+
"tier": "1",
|
| 46 |
+
"session_id": "5135ed32678f89ee",
|
| 47 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\5135ed32678f89ee",
|
| 48 |
+
"elapsed_s": 9.4,
|
| 49 |
+
"status": "fail",
|
| 50 |
+
"failed_at": "m2c",
|
| 51 |
+
"route_status": "same_pdb_surrogate",
|
| 52 |
+
"route_fallback": true,
|
| 53 |
+
"has_manifest": true
|
| 54 |
+
},
|
| 55 |
+
{
|
| 56 |
+
"drug_id": "173",
|
| 57 |
+
"canonical_name": "Entrectinib",
|
| 58 |
+
"index_key": "ENTRECTINIB_TRK",
|
| 59 |
+
"pdb_id": "5T1A",
|
| 60 |
+
"tier": "1",
|
| 61 |
+
"session_id": "c44734fab5b0dba1",
|
| 62 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\c44734fab5b0dba1",
|
| 63 |
+
"elapsed_s": 68.7,
|
| 64 |
+
"status": "ok",
|
| 65 |
+
"best_affinity": -10.36,
|
| 66 |
+
"qc_pass": true,
|
| 67 |
+
"route_status": "same_pdb_surrogate",
|
| 68 |
+
"route_fallback": true,
|
| 69 |
+
"has_manifest": true
|
| 70 |
+
},
|
| 71 |
+
{
|
| 72 |
+
"drug_id": "174",
|
| 73 |
+
"canonical_name": "Capmatinib",
|
| 74 |
+
"index_key": "CAPMATINIB_MET",
|
| 75 |
+
"pdb_id": "4R3Y",
|
| 76 |
+
"tier": "1",
|
| 77 |
+
"session_id": "0fb37d606d7c8233",
|
| 78 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\0fb37d606d7c8233",
|
| 79 |
+
"elapsed_s": 305.4,
|
| 80 |
+
"status": "ok",
|
| 81 |
+
"best_affinity": -9.371,
|
| 82 |
+
"qc_pass": true,
|
| 83 |
+
"route_status": "same_pdb_surrogate",
|
| 84 |
+
"route_fallback": true,
|
| 85 |
+
"has_manifest": true
|
| 86 |
+
},
|
| 87 |
+
{
|
| 88 |
+
"drug_id": "175",
|
| 89 |
+
"canonical_name": "Neratinib",
|
| 90 |
+
"index_key": "NERATINIB_EGFR",
|
| 91 |
+
"pdb_id": "3POZ",
|
| 92 |
+
"tier": "1",
|
| 93 |
+
"session_id": "0cd7b0c309cea8cd",
|
| 94 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\0cd7b0c309cea8cd",
|
| 95 |
+
"elapsed_s": 63.3,
|
| 96 |
+
"status": "ok",
|
| 97 |
+
"best_affinity": -9.104,
|
| 98 |
+
"qc_pass": true,
|
| 99 |
+
"route_status": "same_pdb_surrogate",
|
| 100 |
+
"route_fallback": true,
|
| 101 |
+
"has_manifest": true
|
| 102 |
+
},
|
| 103 |
+
{
|
| 104 |
+
"drug_id": "176",
|
| 105 |
+
"canonical_name": "Lorlatinib",
|
| 106 |
+
"index_key": "LORLATINIB_ALK",
|
| 107 |
+
"pdb_id": "2XP2",
|
| 108 |
+
"tier": "1",
|
| 109 |
+
"session_id": "cfc36c4e7181aef2",
|
| 110 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\cfc36c4e7181aef2",
|
| 111 |
+
"elapsed_s": 68.8,
|
| 112 |
+
"status": "ok",
|
| 113 |
+
"best_affinity": -10.7,
|
| 114 |
+
"qc_pass": true,
|
| 115 |
+
"route_status": "cross_pdb_proxy",
|
| 116 |
+
"route_fallback": true,
|
| 117 |
+
"has_manifest": true
|
| 118 |
+
},
|
| 119 |
+
{
|
| 120 |
+
"drug_id": "177",
|
| 121 |
+
"canonical_name": "Brigatinib",
|
| 122 |
+
"index_key": "BRIGATINIB_ALK",
|
| 123 |
+
"pdb_id": "5USZ",
|
| 124 |
+
"tier": "1",
|
| 125 |
+
"session_id": "340967662320277e",
|
| 126 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\340967662320277e",
|
| 127 |
+
"elapsed_s": 103.1,
|
| 128 |
+
"status": "ok",
|
| 129 |
+
"best_affinity": -10.06,
|
| 130 |
+
"qc_pass": true,
|
| 131 |
+
"route_status": "same_pdb_surrogate",
|
| 132 |
+
"route_fallback": true,
|
| 133 |
+
"has_manifest": true
|
| 134 |
+
},
|
| 135 |
+
{
|
| 136 |
+
"drug_id": "178",
|
| 137 |
+
"canonical_name": "Dabigatran",
|
| 138 |
+
"index_key": "DABIGATRAN_THROMBIN",
|
| 139 |
+
"pdb_id": "1KTS",
|
| 140 |
+
"tier": "1",
|
| 141 |
+
"session_id": "795de3d9c0228393",
|
| 142 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\795de3d9c0228393",
|
| 143 |
+
"elapsed_s": 54.0,
|
| 144 |
+
"status": "ok",
|
| 145 |
+
"best_affinity": -9.196,
|
| 146 |
+
"qc_pass": true,
|
| 147 |
+
"route_status": "same_pdb_surrogate",
|
| 148 |
+
"route_fallback": true,
|
| 149 |
+
"has_manifest": true
|
| 150 |
+
},
|
| 151 |
+
{
|
| 152 |
+
"drug_id": "179",
|
| 153 |
+
"canonical_name": "Edoxaban",
|
| 154 |
+
"index_key": "EDOXABAN_FXA",
|
| 155 |
+
"pdb_id": "2P16",
|
| 156 |
+
"tier": "1",
|
| 157 |
+
"session_id": "990f4eee0894351e",
|
| 158 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\990f4eee0894351e",
|
| 159 |
+
"elapsed_s": 40.9,
|
| 160 |
+
"status": "ok",
|
| 161 |
+
"best_affinity": -8.984,
|
| 162 |
+
"qc_pass": true,
|
| 163 |
+
"route_status": "cross_pdb_proxy",
|
| 164 |
+
"route_fallback": true,
|
| 165 |
+
"has_manifest": true
|
| 166 |
+
}
|
| 167 |
+
]
|
| 168 |
+
}
|
config/catalog_batch_run_summary_180-189.json
ADDED
|
@@ -0,0 +1,169 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"generated_at": "2026-06-30T13:06:14.444679+00:00",
|
| 3 |
+
"count": 10,
|
| 4 |
+
"total_elapsed_s": 580.9,
|
| 5 |
+
"ok": 8,
|
| 6 |
+
"partial": 0,
|
| 7 |
+
"skip": 0,
|
| 8 |
+
"qc_pass": 5,
|
| 9 |
+
"results": [
|
| 10 |
+
{
|
| 11 |
+
"drug_id": "180",
|
| 12 |
+
"canonical_name": "Selpercatinib",
|
| 13 |
+
"index_key": "SELPERCATINIB_RET",
|
| 14 |
+
"pdb_id": "2IVT",
|
| 15 |
+
"tier": "1",
|
| 16 |
+
"session_id": "fd967a546b650ae5",
|
| 17 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\fd967a546b650ae5",
|
| 18 |
+
"elapsed_s": 45.2,
|
| 19 |
+
"status": "ok",
|
| 20 |
+
"best_affinity": -10.19,
|
| 21 |
+
"qc_pass": true,
|
| 22 |
+
"route_status": "cross_pdb_proxy",
|
| 23 |
+
"route_fallback": true,
|
| 24 |
+
"has_manifest": true
|
| 25 |
+
},
|
| 26 |
+
{
|
| 27 |
+
"drug_id": "181",
|
| 28 |
+
"canonical_name": "Captopril",
|
| 29 |
+
"index_key": "CAPTOPRIL_ACE",
|
| 30 |
+
"pdb_id": "1UZF",
|
| 31 |
+
"tier": "1",
|
| 32 |
+
"session_id": "28de05534d032483",
|
| 33 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\28de05534d032483",
|
| 34 |
+
"elapsed_s": 54.7,
|
| 35 |
+
"status": "ok",
|
| 36 |
+
"best_affinity": -5.693,
|
| 37 |
+
"qc_pass": false,
|
| 38 |
+
"route_status": "same_pdb_surrogate",
|
| 39 |
+
"route_fallback": true,
|
| 40 |
+
"has_manifest": true
|
| 41 |
+
},
|
| 42 |
+
{
|
| 43 |
+
"drug_id": "182",
|
| 44 |
+
"canonical_name": "Benazepril",
|
| 45 |
+
"index_key": "BENAZEPRIL_ACE_PROXY",
|
| 46 |
+
"pdb_id": "1O86",
|
| 47 |
+
"tier": "2",
|
| 48 |
+
"session_id": "a1f45f768ddee730",
|
| 49 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\a1f45f768ddee730",
|
| 50 |
+
"elapsed_s": 86.1,
|
| 51 |
+
"status": "ok",
|
| 52 |
+
"best_affinity": -8.252,
|
| 53 |
+
"qc_pass": true,
|
| 54 |
+
"route_status": "same_pdb_surrogate",
|
| 55 |
+
"route_fallback": true,
|
| 56 |
+
"has_manifest": true
|
| 57 |
+
},
|
| 58 |
+
{
|
| 59 |
+
"drug_id": "183",
|
| 60 |
+
"canonical_name": "Chlorthalidone",
|
| 61 |
+
"index_key": "CHLORTHALIDONE_CA2_PROXY",
|
| 62 |
+
"pdb_id": "3HS4",
|
| 63 |
+
"tier": "2",
|
| 64 |
+
"session_id": "b7e2a6b990ce2866",
|
| 65 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\b7e2a6b990ce2866",
|
| 66 |
+
"elapsed_s": 44.0,
|
| 67 |
+
"status": "ok",
|
| 68 |
+
"best_affinity": -8.241,
|
| 69 |
+
"qc_pass": true,
|
| 70 |
+
"route_status": "direct_ok",
|
| 71 |
+
"route_fallback": false,
|
| 72 |
+
"has_manifest": true
|
| 73 |
+
},
|
| 74 |
+
{
|
| 75 |
+
"drug_id": "184",
|
| 76 |
+
"canonical_name": "Amiloride",
|
| 77 |
+
"index_key": "AMILORIDE_ENAC_PROXY",
|
| 78 |
+
"pdb_id": "3HS4",
|
| 79 |
+
"tier": "2",
|
| 80 |
+
"session_id": "1ee6967443e12c97",
|
| 81 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\1ee6967443e12c97",
|
| 82 |
+
"elapsed_s": 36.6,
|
| 83 |
+
"status": "ok",
|
| 84 |
+
"best_affinity": -6.478,
|
| 85 |
+
"qc_pass": true,
|
| 86 |
+
"route_status": "direct_ok",
|
| 87 |
+
"route_fallback": false,
|
| 88 |
+
"has_manifest": true
|
| 89 |
+
},
|
| 90 |
+
{
|
| 91 |
+
"drug_id": "185",
|
| 92 |
+
"canonical_name": "Ranolazine",
|
| 93 |
+
"index_key": "RANOLAZINE_SCN5A",
|
| 94 |
+
"pdb_id": "2FBI",
|
| 95 |
+
"tier": "1",
|
| 96 |
+
"session_id": "c8eeda5127d85fde",
|
| 97 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\c8eeda5127d85fde",
|
| 98 |
+
"elapsed_s": 20.4,
|
| 99 |
+
"status": "fail",
|
| 100 |
+
"failed_at": "m4b",
|
| 101 |
+
"route_status": "no_route",
|
| 102 |
+
"route_fallback": false,
|
| 103 |
+
"has_manifest": true
|
| 104 |
+
},
|
| 105 |
+
{
|
| 106 |
+
"drug_id": "186",
|
| 107 |
+
"canonical_name": "Bromocriptine",
|
| 108 |
+
"index_key": "BROMOCRIPTINE_DRD2",
|
| 109 |
+
"pdb_id": "3PBL",
|
| 110 |
+
"tier": "1",
|
| 111 |
+
"session_id": "4481ed9ca1feef81",
|
| 112 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\4481ed9ca1feef81",
|
| 113 |
+
"elapsed_s": 104.6,
|
| 114 |
+
"status": "ok",
|
| 115 |
+
"best_affinity": -9.373,
|
| 116 |
+
"qc_pass": true,
|
| 117 |
+
"route_status": "same_pdb_surrogate",
|
| 118 |
+
"route_fallback": true,
|
| 119 |
+
"has_manifest": true
|
| 120 |
+
},
|
| 121 |
+
{
|
| 122 |
+
"drug_id": "187",
|
| 123 |
+
"canonical_name": "Niacin",
|
| 124 |
+
"index_key": "NIACIN_GPR109A",
|
| 125 |
+
"pdb_id": "3R7A",
|
| 126 |
+
"tier": "1",
|
| 127 |
+
"session_id": "10a347c37af3f3af",
|
| 128 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\10a347c37af3f3af",
|
| 129 |
+
"elapsed_s": 31.6,
|
| 130 |
+
"status": "ok",
|
| 131 |
+
"best_affinity": -4.464,
|
| 132 |
+
"qc_pass": false,
|
| 133 |
+
"route_status": "same_pdb_surrogate",
|
| 134 |
+
"route_fallback": true,
|
| 135 |
+
"has_manifest": true
|
| 136 |
+
},
|
| 137 |
+
{
|
| 138 |
+
"drug_id": "188",
|
| 139 |
+
"canonical_name": "Diazoxide",
|
| 140 |
+
"index_key": "DIAZOXIDE_KATP_PROXY",
|
| 141 |
+
"pdb_id": "3SYQ",
|
| 142 |
+
"tier": "2",
|
| 143 |
+
"session_id": "0d5009c9e518df56",
|
| 144 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\0d5009c9e518df56",
|
| 145 |
+
"elapsed_s": 47.3,
|
| 146 |
+
"status": "ok",
|
| 147 |
+
"best_affinity": -5.848,
|
| 148 |
+
"qc_pass": false,
|
| 149 |
+
"route_status": "same_pdb_surrogate",
|
| 150 |
+
"route_fallback": true,
|
| 151 |
+
"has_manifest": true
|
| 152 |
+
},
|
| 153 |
+
{
|
| 154 |
+
"drug_id": "189",
|
| 155 |
+
"canonical_name": "Semaglutide",
|
| 156 |
+
"index_key": "SEMAGLUTIDE_GLP1R",
|
| 157 |
+
"pdb_id": "6X18",
|
| 158 |
+
"tier": "1",
|
| 159 |
+
"session_id": "7f353d9faeee1a3e",
|
| 160 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\7f353d9faeee1a3e",
|
| 161 |
+
"elapsed_s": 110.0,
|
| 162 |
+
"status": "fail",
|
| 163 |
+
"failed_at": "m4b",
|
| 164 |
+
"route_status": "no_route",
|
| 165 |
+
"route_fallback": false,
|
| 166 |
+
"has_manifest": true
|
| 167 |
+
}
|
| 168 |
+
]
|
| 169 |
+
}
|
config/catalog_batch_run_summary_190-199.json
ADDED
|
@@ -0,0 +1,168 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"generated_at": "2026-07-01T01:17:08.703556+00:00",
|
| 3 |
+
"count": 10,
|
| 4 |
+
"total_elapsed_s": 459.1,
|
| 5 |
+
"ok": 7,
|
| 6 |
+
"partial": 0,
|
| 7 |
+
"skip": 0,
|
| 8 |
+
"qc_pass": 6,
|
| 9 |
+
"results": [
|
| 10 |
+
{
|
| 11 |
+
"drug_id": "190",
|
| 12 |
+
"canonical_name": "Exenatide",
|
| 13 |
+
"index_key": "EXENATIDE_GLP1R",
|
| 14 |
+
"pdb_id": "5VAI",
|
| 15 |
+
"tier": "1",
|
| 16 |
+
"session_id": "8bc75a20b2002e76",
|
| 17 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\8bc75a20b2002e76",
|
| 18 |
+
"elapsed_s": 103.2,
|
| 19 |
+
"status": "fail",
|
| 20 |
+
"failed_at": "m4b",
|
| 21 |
+
"route_status": "no_route",
|
| 22 |
+
"route_fallback": false,
|
| 23 |
+
"has_manifest": true
|
| 24 |
+
},
|
| 25 |
+
{
|
| 26 |
+
"drug_id": "191",
|
| 27 |
+
"canonical_name": "Ketamine",
|
| 28 |
+
"index_key": "KETAMINE_NMDA",
|
| 29 |
+
"pdb_id": "3UO9",
|
| 30 |
+
"tier": "1",
|
| 31 |
+
"session_id": "d7f12857c4df2881",
|
| 32 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\d7f12857c4df2881",
|
| 33 |
+
"elapsed_s": 61.7,
|
| 34 |
+
"status": "ok",
|
| 35 |
+
"best_affinity": -6.239,
|
| 36 |
+
"qc_pass": true,
|
| 37 |
+
"route_status": "same_pdb_surrogate",
|
| 38 |
+
"route_fallback": true,
|
| 39 |
+
"has_manifest": true
|
| 40 |
+
},
|
| 41 |
+
{
|
| 42 |
+
"drug_id": "192",
|
| 43 |
+
"canonical_name": "Codeine",
|
| 44 |
+
"index_key": "CODEINE_OPRM1_PROXY",
|
| 45 |
+
"pdb_id": "8DZP",
|
| 46 |
+
"tier": "2",
|
| 47 |
+
"session_id": "aab3e34ed70ca9ff",
|
| 48 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\aab3e34ed70ca9ff",
|
| 49 |
+
"elapsed_s": 76.9,
|
| 50 |
+
"status": "ok",
|
| 51 |
+
"best_affinity": -4.426,
|
| 52 |
+
"qc_pass": false,
|
| 53 |
+
"route_status": "same_pdb_surrogate",
|
| 54 |
+
"route_fallback": true,
|
| 55 |
+
"has_manifest": true
|
| 56 |
+
},
|
| 57 |
+
{
|
| 58 |
+
"drug_id": "193",
|
| 59 |
+
"canonical_name": "Bupropion",
|
| 60 |
+
"index_key": "BUPROPION_DAT",
|
| 61 |
+
"pdb_id": "4WNT",
|
| 62 |
+
"tier": "1",
|
| 63 |
+
"session_id": "165a8a5da84799fb",
|
| 64 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\165a8a5da84799fb",
|
| 65 |
+
"elapsed_s": 34.9,
|
| 66 |
+
"status": "ok",
|
| 67 |
+
"best_affinity": -6.856,
|
| 68 |
+
"qc_pass": true,
|
| 69 |
+
"route_status": "same_pdb_surrogate",
|
| 70 |
+
"route_fallback": true,
|
| 71 |
+
"has_manifest": true
|
| 72 |
+
},
|
| 73 |
+
{
|
| 74 |
+
"drug_id": "194",
|
| 75 |
+
"canonical_name": "Mirtazapine",
|
| 76 |
+
"index_key": "MIRTAZAPINE_HTR2A_PROXY",
|
| 77 |
+
"pdb_id": "6A93",
|
| 78 |
+
"tier": "2",
|
| 79 |
+
"session_id": "706d8f46291a9963",
|
| 80 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\706d8f46291a9963",
|
| 81 |
+
"elapsed_s": 26.4,
|
| 82 |
+
"status": "ok",
|
| 83 |
+
"best_affinity": -10.01,
|
| 84 |
+
"qc_pass": true,
|
| 85 |
+
"route_status": "same_pdb_surrogate",
|
| 86 |
+
"route_fallback": true,
|
| 87 |
+
"has_manifest": true
|
| 88 |
+
},
|
| 89 |
+
{
|
| 90 |
+
"drug_id": "195",
|
| 91 |
+
"canonical_name": "Trazodone",
|
| 92 |
+
"index_key": "TRAZODONE_HTR2A_PROXY",
|
| 93 |
+
"pdb_id": "6A93",
|
| 94 |
+
"tier": "2",
|
| 95 |
+
"session_id": "5771466a3df9dfa2",
|
| 96 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\5771466a3df9dfa2",
|
| 97 |
+
"elapsed_s": 38.0,
|
| 98 |
+
"status": "ok",
|
| 99 |
+
"best_affinity": -10.38,
|
| 100 |
+
"qc_pass": true,
|
| 101 |
+
"route_status": "same_pdb_surrogate",
|
| 102 |
+
"route_fallback": true,
|
| 103 |
+
"has_manifest": true
|
| 104 |
+
},
|
| 105 |
+
{
|
| 106 |
+
"drug_id": "196",
|
| 107 |
+
"canonical_name": "Alprazolam",
|
| 108 |
+
"index_key": "ALPRAZOLAM_GABA_A",
|
| 109 |
+
"pdb_id": "4OWE",
|
| 110 |
+
"tier": "1",
|
| 111 |
+
"session_id": "6ecf8e58ccbd2a96",
|
| 112 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\6ecf8e58ccbd2a96",
|
| 113 |
+
"elapsed_s": 17.4,
|
| 114 |
+
"status": "fail",
|
| 115 |
+
"failed_at": "m4b",
|
| 116 |
+
"route_status": "no_route",
|
| 117 |
+
"route_fallback": false,
|
| 118 |
+
"has_manifest": true
|
| 119 |
+
},
|
| 120 |
+
{
|
| 121 |
+
"drug_id": "197",
|
| 122 |
+
"canonical_name": "Ranitidine",
|
| 123 |
+
"index_key": "RANITIDINE_HRH2_PROXY",
|
| 124 |
+
"pdb_id": "3RSG",
|
| 125 |
+
"tier": "2",
|
| 126 |
+
"session_id": "aa226443b3b136b9",
|
| 127 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\aa226443b3b136b9",
|
| 128 |
+
"elapsed_s": 30.7,
|
| 129 |
+
"status": "ok",
|
| 130 |
+
"best_affinity": -7.875,
|
| 131 |
+
"qc_pass": true,
|
| 132 |
+
"route_status": "same_pdb_surrogate",
|
| 133 |
+
"route_fallback": true,
|
| 134 |
+
"has_manifest": true
|
| 135 |
+
},
|
| 136 |
+
{
|
| 137 |
+
"drug_id": "198",
|
| 138 |
+
"canonical_name": "Mycophenolate",
|
| 139 |
+
"index_key": "MYCOPHENOLATE_IMPDH",
|
| 140 |
+
"pdb_id": "1P5T",
|
| 141 |
+
"tier": "1",
|
| 142 |
+
"session_id": "432330ae5a1e085d",
|
| 143 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\432330ae5a1e085d",
|
| 144 |
+
"elapsed_s": 15.3,
|
| 145 |
+
"status": "fail",
|
| 146 |
+
"failed_at": "m4b",
|
| 147 |
+
"route_status": "no_route",
|
| 148 |
+
"route_fallback": false,
|
| 149 |
+
"has_manifest": true
|
| 150 |
+
},
|
| 151 |
+
{
|
| 152 |
+
"drug_id": "199",
|
| 153 |
+
"canonical_name": "Ketoconazole",
|
| 154 |
+
"index_key": "KETOCONAZOLE_CYP51",
|
| 155 |
+
"pdb_id": "5VZA",
|
| 156 |
+
"tier": "1",
|
| 157 |
+
"session_id": "d8dd99794ecbd86f",
|
| 158 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\d8dd99794ecbd86f",
|
| 159 |
+
"elapsed_s": 54.2,
|
| 160 |
+
"status": "ok",
|
| 161 |
+
"best_affinity": -8.186,
|
| 162 |
+
"qc_pass": true,
|
| 163 |
+
"route_status": "same_pdb_surrogate",
|
| 164 |
+
"route_fallback": true,
|
| 165 |
+
"has_manifest": true
|
| 166 |
+
}
|
| 167 |
+
]
|
| 168 |
+
}
|
config/catalog_batch_run_summary_200-209.json
ADDED
|
@@ -0,0 +1,170 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"generated_at": "2026-07-01T01:40:06.750704+00:00",
|
| 3 |
+
"count": 10,
|
| 4 |
+
"total_elapsed_s": 707.5,
|
| 5 |
+
"ok": 9,
|
| 6 |
+
"partial": 0,
|
| 7 |
+
"skip": 0,
|
| 8 |
+
"qc_pass": 9,
|
| 9 |
+
"results": [
|
| 10 |
+
{
|
| 11 |
+
"drug_id": "200",
|
| 12 |
+
"canonical_name": "Voriconazole",
|
| 13 |
+
"index_key": "VORICONAZOLE_CYP51",
|
| 14 |
+
"pdb_id": "4WMZ",
|
| 15 |
+
"tier": "1",
|
| 16 |
+
"session_id": "351133a06b773a95",
|
| 17 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\351133a06b773a95",
|
| 18 |
+
"elapsed_s": 36.0,
|
| 19 |
+
"status": "ok",
|
| 20 |
+
"best_affinity": -7.283,
|
| 21 |
+
"qc_pass": true,
|
| 22 |
+
"route_status": "cross_pdb_proxy",
|
| 23 |
+
"route_fallback": true,
|
| 24 |
+
"has_manifest": true
|
| 25 |
+
},
|
| 26 |
+
{
|
| 27 |
+
"drug_id": "201",
|
| 28 |
+
"canonical_name": "Zanubrutinib",
|
| 29 |
+
"index_key": "ZANUBRUTINIB_BTK",
|
| 30 |
+
"pdb_id": "7F4I",
|
| 31 |
+
"tier": "1",
|
| 32 |
+
"session_id": "e444705c43935386",
|
| 33 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\e444705c43935386",
|
| 34 |
+
"elapsed_s": 106.1,
|
| 35 |
+
"status": "ok",
|
| 36 |
+
"best_affinity": -6.466,
|
| 37 |
+
"qc_pass": true,
|
| 38 |
+
"route_status": "same_pdb_surrogate",
|
| 39 |
+
"route_fallback": true,
|
| 40 |
+
"has_manifest": true
|
| 41 |
+
},
|
| 42 |
+
{
|
| 43 |
+
"drug_id": "202",
|
| 44 |
+
"canonical_name": "Erdafitinib",
|
| 45 |
+
"index_key": "ERDAFITINIB_FGFR",
|
| 46 |
+
"pdb_id": "5EW3",
|
| 47 |
+
"tier": "1",
|
| 48 |
+
"session_id": "566c4e4dc8fa73a6",
|
| 49 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\566c4e4dc8fa73a6",
|
| 50 |
+
"elapsed_s": 44.6,
|
| 51 |
+
"status": "ok",
|
| 52 |
+
"best_affinity": -9.381,
|
| 53 |
+
"qc_pass": true,
|
| 54 |
+
"route_status": "same_pdb_surrogate",
|
| 55 |
+
"route_fallback": true,
|
| 56 |
+
"has_manifest": true
|
| 57 |
+
},
|
| 58 |
+
{
|
| 59 |
+
"drug_id": "203",
|
| 60 |
+
"canonical_name": "Pemigatinib",
|
| 61 |
+
"index_key": "PEMIGATINIB_FGFR",
|
| 62 |
+
"pdb_id": "5EW8",
|
| 63 |
+
"tier": "1",
|
| 64 |
+
"session_id": "52f8ec0459ee14e8",
|
| 65 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\52f8ec0459ee14e8",
|
| 66 |
+
"elapsed_s": 73.8,
|
| 67 |
+
"status": "ok",
|
| 68 |
+
"best_affinity": -8.858,
|
| 69 |
+
"qc_pass": true,
|
| 70 |
+
"route_status": "same_pdb_surrogate",
|
| 71 |
+
"route_fallback": true,
|
| 72 |
+
"has_manifest": true
|
| 73 |
+
},
|
| 74 |
+
{
|
| 75 |
+
"drug_id": "204",
|
| 76 |
+
"canonical_name": "Tepotinib",
|
| 77 |
+
"index_key": "TEPOTINIB_MET",
|
| 78 |
+
"pdb_id": "4O1B",
|
| 79 |
+
"tier": "1",
|
| 80 |
+
"session_id": "7add7bd94a053085",
|
| 81 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\7add7bd94a053085",
|
| 82 |
+
"elapsed_s": 109.5,
|
| 83 |
+
"status": "ok",
|
| 84 |
+
"best_affinity": -9.34,
|
| 85 |
+
"qc_pass": true,
|
| 86 |
+
"route_status": "cross_pdb_proxy",
|
| 87 |
+
"route_fallback": true,
|
| 88 |
+
"has_manifest": true
|
| 89 |
+
},
|
| 90 |
+
{
|
| 91 |
+
"drug_id": "205",
|
| 92 |
+
"canonical_name": "Belzutifan",
|
| 93 |
+
"index_key": "BELZUTIFAN_HIF2A",
|
| 94 |
+
"pdb_id": "5GS8",
|
| 95 |
+
"tier": "1",
|
| 96 |
+
"session_id": "e11bc316f93bf421",
|
| 97 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\e11bc316f93bf421",
|
| 98 |
+
"elapsed_s": 27.8,
|
| 99 |
+
"status": "fail",
|
| 100 |
+
"failed_at": "m4b",
|
| 101 |
+
"route_status": "no_route",
|
| 102 |
+
"route_fallback": false,
|
| 103 |
+
"has_manifest": true
|
| 104 |
+
},
|
| 105 |
+
{
|
| 106 |
+
"drug_id": "206",
|
| 107 |
+
"canonical_name": "Fulvestrant",
|
| 108 |
+
"index_key": "FULVESTRANT_ESR1",
|
| 109 |
+
"pdb_id": "3ERR",
|
| 110 |
+
"tier": "1",
|
| 111 |
+
"session_id": "e323ebe204b456ab",
|
| 112 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\e323ebe204b456ab",
|
| 113 |
+
"elapsed_s": 140.7,
|
| 114 |
+
"status": "ok",
|
| 115 |
+
"best_affinity": -7.226,
|
| 116 |
+
"qc_pass": true,
|
| 117 |
+
"route_status": "same_pdb_surrogate",
|
| 118 |
+
"route_fallback": true,
|
| 119 |
+
"has_manifest": true
|
| 120 |
+
},
|
| 121 |
+
{
|
| 122 |
+
"drug_id": "207",
|
| 123 |
+
"canonical_name": "Raloxifene",
|
| 124 |
+
"index_key": "RALOXIFENE_ESR1",
|
| 125 |
+
"pdb_id": "3ERR",
|
| 126 |
+
"tier": "1",
|
| 127 |
+
"session_id": "ec16642429c6043a",
|
| 128 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\ec16642429c6043a",
|
| 129 |
+
"elapsed_s": 66.1,
|
| 130 |
+
"status": "ok",
|
| 131 |
+
"best_affinity": -8.474,
|
| 132 |
+
"qc_pass": true,
|
| 133 |
+
"route_status": "cross_pdb_proxy",
|
| 134 |
+
"route_fallback": true,
|
| 135 |
+
"has_manifest": true
|
| 136 |
+
},
|
| 137 |
+
{
|
| 138 |
+
"drug_id": "208",
|
| 139 |
+
"canonical_name": "Pazopanib",
|
| 140 |
+
"index_key": "PAZOPANIB_VEGFR2",
|
| 141 |
+
"pdb_id": "4G0Z",
|
| 142 |
+
"tier": "1",
|
| 143 |
+
"session_id": "6212be320adaecbd",
|
| 144 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\6212be320adaecbd",
|
| 145 |
+
"elapsed_s": 49.0,
|
| 146 |
+
"status": "ok",
|
| 147 |
+
"best_affinity": -7.655,
|
| 148 |
+
"qc_pass": true,
|
| 149 |
+
"route_status": "same_pdb_surrogate",
|
| 150 |
+
"route_fallback": true,
|
| 151 |
+
"has_manifest": true
|
| 152 |
+
},
|
| 153 |
+
{
|
| 154 |
+
"drug_id": "209",
|
| 155 |
+
"canonical_name": "Tucatinib",
|
| 156 |
+
"index_key": "TUCATINIB_HER2",
|
| 157 |
+
"pdb_id": "5UG8",
|
| 158 |
+
"tier": "1",
|
| 159 |
+
"session_id": "e3b196bab4c5071e",
|
| 160 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\e3b196bab4c5071e",
|
| 161 |
+
"elapsed_s": 53.3,
|
| 162 |
+
"status": "ok",
|
| 163 |
+
"best_affinity": -10.6,
|
| 164 |
+
"qc_pass": true,
|
| 165 |
+
"route_status": "same_pdb_surrogate",
|
| 166 |
+
"route_fallback": true,
|
| 167 |
+
"has_manifest": true
|
| 168 |
+
}
|
| 169 |
+
]
|
| 170 |
+
}
|
config/catalog_batch_run_summary_210-219.json
ADDED
|
@@ -0,0 +1,169 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"generated_at": "2026-07-01T02:09:50.832404+00:00",
|
| 3 |
+
"count": 10,
|
| 4 |
+
"total_elapsed_s": 549.6,
|
| 5 |
+
"ok": 8,
|
| 6 |
+
"partial": 0,
|
| 7 |
+
"skip": 0,
|
| 8 |
+
"qc_pass": 7,
|
| 9 |
+
"results": [
|
| 10 |
+
{
|
| 11 |
+
"drug_id": "210",
|
| 12 |
+
"canonical_name": "Pyrotinib",
|
| 13 |
+
"index_key": "PYROTINIB_EGFR",
|
| 14 |
+
"pdb_id": "5NIY",
|
| 15 |
+
"tier": "1",
|
| 16 |
+
"session_id": "48c5d3a749f7dce0",
|
| 17 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\48c5d3a749f7dce0",
|
| 18 |
+
"elapsed_s": 57.1,
|
| 19 |
+
"status": "ok",
|
| 20 |
+
"best_affinity": -7.517,
|
| 21 |
+
"qc_pass": true,
|
| 22 |
+
"route_status": "same_pdb_surrogate",
|
| 23 |
+
"route_fallback": true,
|
| 24 |
+
"has_manifest": true
|
| 25 |
+
},
|
| 26 |
+
{
|
| 27 |
+
"drug_id": "211",
|
| 28 |
+
"canonical_name": "Perindopril",
|
| 29 |
+
"index_key": "PERINDOPRIL_ACE_PROXY",
|
| 30 |
+
"pdb_id": "1O86",
|
| 31 |
+
"tier": "2",
|
| 32 |
+
"session_id": "4b0d7e2370894b62",
|
| 33 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\4b0d7e2370894b62",
|
| 34 |
+
"elapsed_s": 65.0,
|
| 35 |
+
"status": "ok",
|
| 36 |
+
"best_affinity": -7.757,
|
| 37 |
+
"qc_pass": true,
|
| 38 |
+
"route_status": "same_pdb_surrogate",
|
| 39 |
+
"route_fallback": true,
|
| 40 |
+
"has_manifest": true
|
| 41 |
+
},
|
| 42 |
+
{
|
| 43 |
+
"drug_id": "212",
|
| 44 |
+
"canonical_name": "Methimazole",
|
| 45 |
+
"index_key": "METHIMAZOLE_TPO",
|
| 46 |
+
"pdb_id": "3ZGS",
|
| 47 |
+
"tier": "1",
|
| 48 |
+
"session_id": "189ddbd28e5ff5cd",
|
| 49 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\189ddbd28e5ff5cd",
|
| 50 |
+
"elapsed_s": 53.6,
|
| 51 |
+
"status": "fail",
|
| 52 |
+
"failed_at": "m4b",
|
| 53 |
+
"route_status": "no_route",
|
| 54 |
+
"route_fallback": false,
|
| 55 |
+
"has_manifest": true
|
| 56 |
+
},
|
| 57 |
+
{
|
| 58 |
+
"drug_id": "213",
|
| 59 |
+
"canonical_name": "Propylthiouracil",
|
| 60 |
+
"index_key": "PROPYLTHIOURACIL_TPO_PROXY",
|
| 61 |
+
"pdb_id": "3ZGS",
|
| 62 |
+
"tier": "2",
|
| 63 |
+
"session_id": "2764198d0ed84579",
|
| 64 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\2764198d0ed84579",
|
| 65 |
+
"elapsed_s": 53.6,
|
| 66 |
+
"status": "fail",
|
| 67 |
+
"failed_at": "m4b",
|
| 68 |
+
"route_status": "no_route",
|
| 69 |
+
"route_fallback": false,
|
| 70 |
+
"has_manifest": true
|
| 71 |
+
},
|
| 72 |
+
{
|
| 73 |
+
"drug_id": "214",
|
| 74 |
+
"canonical_name": "Tolbutamide",
|
| 75 |
+
"index_key": "TOLBUTAMIDE_KATP_PROXY",
|
| 76 |
+
"pdb_id": "3SYQ",
|
| 77 |
+
"tier": "2",
|
| 78 |
+
"session_id": "ad668ed9b0ac4840",
|
| 79 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\ad668ed9b0ac4840",
|
| 80 |
+
"elapsed_s": 55.3,
|
| 81 |
+
"status": "ok",
|
| 82 |
+
"best_affinity": -5.62,
|
| 83 |
+
"qc_pass": false,
|
| 84 |
+
"route_status": "same_pdb_surrogate",
|
| 85 |
+
"route_fallback": true,
|
| 86 |
+
"has_manifest": true
|
| 87 |
+
},
|
| 88 |
+
{
|
| 89 |
+
"drug_id": "215",
|
| 90 |
+
"canonical_name": "Chlorpropamide",
|
| 91 |
+
"index_key": "CHLORPROPAMIDE_KATP_PROXY",
|
| 92 |
+
"pdb_id": "3SYQ",
|
| 93 |
+
"tier": "2",
|
| 94 |
+
"session_id": "79763b3cfb8576a9",
|
| 95 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\79763b3cfb8576a9",
|
| 96 |
+
"elapsed_s": 62.0,
|
| 97 |
+
"status": "ok",
|
| 98 |
+
"best_affinity": -7.835,
|
| 99 |
+
"qc_pass": true,
|
| 100 |
+
"route_status": "same_pdb_surrogate",
|
| 101 |
+
"route_fallback": true,
|
| 102 |
+
"has_manifest": true
|
| 103 |
+
},
|
| 104 |
+
{
|
| 105 |
+
"drug_id": "216",
|
| 106 |
+
"canonical_name": "Bezafibrate",
|
| 107 |
+
"index_key": "BEZAFIBRATE_PPARALPHA_PROXY",
|
| 108 |
+
"pdb_id": "1K74",
|
| 109 |
+
"tier": "2",
|
| 110 |
+
"session_id": "b6f5179e53d884b6",
|
| 111 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\b6f5179e53d884b6",
|
| 112 |
+
"elapsed_s": 57.5,
|
| 113 |
+
"status": "ok",
|
| 114 |
+
"best_affinity": -7.702,
|
| 115 |
+
"qc_pass": true,
|
| 116 |
+
"route_status": "direct_ok",
|
| 117 |
+
"route_fallback": false,
|
| 118 |
+
"has_manifest": true
|
| 119 |
+
},
|
| 120 |
+
{
|
| 121 |
+
"drug_id": "217",
|
| 122 |
+
"canonical_name": "Metolazone",
|
| 123 |
+
"index_key": "METOLAZONE_CA2_PROXY",
|
| 124 |
+
"pdb_id": "3HS4",
|
| 125 |
+
"tier": "2",
|
| 126 |
+
"session_id": "4c7b18e5f047b123",
|
| 127 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\4c7b18e5f047b123",
|
| 128 |
+
"elapsed_s": 44.7,
|
| 129 |
+
"status": "ok",
|
| 130 |
+
"best_affinity": -7.315,
|
| 131 |
+
"qc_pass": true,
|
| 132 |
+
"route_status": "direct_ok",
|
| 133 |
+
"route_fallback": false,
|
| 134 |
+
"has_manifest": true
|
| 135 |
+
},
|
| 136 |
+
{
|
| 137 |
+
"drug_id": "218",
|
| 138 |
+
"canonical_name": "Torsemide",
|
| 139 |
+
"index_key": "TORSEMIDE_SLC12A_PROXY",
|
| 140 |
+
"pdb_id": "3HS4",
|
| 141 |
+
"tier": "2",
|
| 142 |
+
"session_id": "cfd352402a4486ca",
|
| 143 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\cfd352402a4486ca",
|
| 144 |
+
"elapsed_s": 61.5,
|
| 145 |
+
"status": "ok",
|
| 146 |
+
"best_affinity": -6.888,
|
| 147 |
+
"qc_pass": true,
|
| 148 |
+
"route_status": "direct_ok",
|
| 149 |
+
"route_fallback": false,
|
| 150 |
+
"has_manifest": true
|
| 151 |
+
},
|
| 152 |
+
{
|
| 153 |
+
"drug_id": "219",
|
| 154 |
+
"canonical_name": "Metoclopramide",
|
| 155 |
+
"index_key": "METOCLOPRAMIDE_DRD2_PROXY",
|
| 156 |
+
"pdb_id": "6CM4",
|
| 157 |
+
"tier": "2",
|
| 158 |
+
"session_id": "01ef7d190d9c76dc",
|
| 159 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\01ef7d190d9c76dc",
|
| 160 |
+
"elapsed_s": 38.9,
|
| 161 |
+
"status": "ok",
|
| 162 |
+
"best_affinity": -7.97,
|
| 163 |
+
"qc_pass": true,
|
| 164 |
+
"route_status": "direct_ok",
|
| 165 |
+
"route_fallback": false,
|
| 166 |
+
"has_manifest": true
|
| 167 |
+
}
|
| 168 |
+
]
|
| 169 |
+
}
|
config/catalog_batch_run_summary_220-229.json
ADDED
|
@@ -0,0 +1,168 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"generated_at": "2026-07-01T02:32:38.382938+00:00",
|
| 3 |
+
"count": 10,
|
| 4 |
+
"total_elapsed_s": 1242.1,
|
| 5 |
+
"ok": 7,
|
| 6 |
+
"partial": 0,
|
| 7 |
+
"skip": 0,
|
| 8 |
+
"qc_pass": 5,
|
| 9 |
+
"results": [
|
| 10 |
+
{
|
| 11 |
+
"drug_id": "220",
|
| 12 |
+
"canonical_name": "Dulaglutide",
|
| 13 |
+
"index_key": "DULAGLUTIDE_GLP1R",
|
| 14 |
+
"pdb_id": "6X18",
|
| 15 |
+
"tier": "2",
|
| 16 |
+
"session_id": "41fcdb06ce97084b",
|
| 17 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\41fcdb06ce97084b",
|
| 18 |
+
"elapsed_s": 125.8,
|
| 19 |
+
"status": "fail",
|
| 20 |
+
"failed_at": "m4b",
|
| 21 |
+
"route_status": "no_route",
|
| 22 |
+
"route_fallback": false,
|
| 23 |
+
"has_manifest": true
|
| 24 |
+
},
|
| 25 |
+
{
|
| 26 |
+
"drug_id": "221",
|
| 27 |
+
"canonical_name": "Diazepam",
|
| 28 |
+
"index_key": "DIAZEPAM_GABA_A",
|
| 29 |
+
"pdb_id": "4OWE",
|
| 30 |
+
"tier": "2",
|
| 31 |
+
"session_id": "833be365702597aa",
|
| 32 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\833be365702597aa",
|
| 33 |
+
"elapsed_s": 22.0,
|
| 34 |
+
"status": "fail",
|
| 35 |
+
"failed_at": "m4b",
|
| 36 |
+
"route_status": "no_route",
|
| 37 |
+
"route_fallback": false,
|
| 38 |
+
"has_manifest": true
|
| 39 |
+
},
|
| 40 |
+
{
|
| 41 |
+
"drug_id": "222",
|
| 42 |
+
"canonical_name": "Baclofen",
|
| 43 |
+
"index_key": "BACLOFEN_GABA_B",
|
| 44 |
+
"pdb_id": "4WNC",
|
| 45 |
+
"tier": "1",
|
| 46 |
+
"session_id": "2f059f57261812c4",
|
| 47 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\2f059f57261812c4",
|
| 48 |
+
"elapsed_s": 478.9,
|
| 49 |
+
"status": "ok",
|
| 50 |
+
"best_affinity": -5.915,
|
| 51 |
+
"qc_pass": false,
|
| 52 |
+
"route_status": "same_pdb_surrogate",
|
| 53 |
+
"route_fallback": true,
|
| 54 |
+
"has_manifest": true
|
| 55 |
+
},
|
| 56 |
+
{
|
| 57 |
+
"drug_id": "223",
|
| 58 |
+
"canonical_name": "Tizanidine",
|
| 59 |
+
"index_key": "TIZANIDINE_ADRA2A_PROXY",
|
| 60 |
+
"pdb_id": "6KUX",
|
| 61 |
+
"tier": "2",
|
| 62 |
+
"session_id": "eeecf39eb8681da9",
|
| 63 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\eeecf39eb8681da9",
|
| 64 |
+
"elapsed_s": 41.6,
|
| 65 |
+
"status": "ok",
|
| 66 |
+
"best_affinity": -8.891,
|
| 67 |
+
"qc_pass": true,
|
| 68 |
+
"route_status": "same_pdb_surrogate",
|
| 69 |
+
"route_fallback": true,
|
| 70 |
+
"has_manifest": true
|
| 71 |
+
},
|
| 72 |
+
{
|
| 73 |
+
"drug_id": "224",
|
| 74 |
+
"canonical_name": "Azathioprine",
|
| 75 |
+
"index_key": "AZATHIOPRINE_TPMT",
|
| 76 |
+
"pdb_id": "2H11",
|
| 77 |
+
"tier": "1",
|
| 78 |
+
"session_id": "792c9c133cc93d44",
|
| 79 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\792c9c133cc93d44",
|
| 80 |
+
"elapsed_s": 61.7,
|
| 81 |
+
"status": "ok",
|
| 82 |
+
"best_affinity": -7.775,
|
| 83 |
+
"qc_pass": true,
|
| 84 |
+
"route_status": "same_pdb_surrogate",
|
| 85 |
+
"route_fallback": true,
|
| 86 |
+
"has_manifest": true
|
| 87 |
+
},
|
| 88 |
+
{
|
| 89 |
+
"drug_id": "225",
|
| 90 |
+
"canonical_name": "Penicillin G",
|
| 91 |
+
"index_key": "PENICILLIN_G_PBP",
|
| 92 |
+
"pdb_id": "1PWP",
|
| 93 |
+
"tier": "1",
|
| 94 |
+
"session_id": "1f6778c2b6768b53",
|
| 95 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\1f6778c2b6768b53",
|
| 96 |
+
"elapsed_s": 92.3,
|
| 97 |
+
"status": "ok",
|
| 98 |
+
"best_affinity": -6.676,
|
| 99 |
+
"qc_pass": true,
|
| 100 |
+
"route_status": "same_pdb_surrogate",
|
| 101 |
+
"route_fallback": true,
|
| 102 |
+
"has_manifest": true
|
| 103 |
+
},
|
| 104 |
+
{
|
| 105 |
+
"drug_id": "226",
|
| 106 |
+
"canonical_name": "Ampicillin",
|
| 107 |
+
"index_key": "AMPICILLIN_PBP_PROXY",
|
| 108 |
+
"pdb_id": "1PWP",
|
| 109 |
+
"tier": "2",
|
| 110 |
+
"session_id": "b5f89e224fe1a675",
|
| 111 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\b5f89e224fe1a675",
|
| 112 |
+
"elapsed_s": 93.8,
|
| 113 |
+
"status": "ok",
|
| 114 |
+
"best_affinity": -7.221,
|
| 115 |
+
"qc_pass": true,
|
| 116 |
+
"route_status": "same_pdb_surrogate",
|
| 117 |
+
"route_fallback": true,
|
| 118 |
+
"has_manifest": true
|
| 119 |
+
},
|
| 120 |
+
{
|
| 121 |
+
"drug_id": "227",
|
| 122 |
+
"canonical_name": "Posaconazole",
|
| 123 |
+
"index_key": "POSACONAZOLE_CYP51",
|
| 124 |
+
"pdb_id": "5VZA",
|
| 125 |
+
"tier": "2",
|
| 126 |
+
"session_id": "baf146a76de3b9e7",
|
| 127 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\baf146a76de3b9e7",
|
| 128 |
+
"elapsed_s": 46.7,
|
| 129 |
+
"status": "ok",
|
| 130 |
+
"best_affinity": -7.185,
|
| 131 |
+
"qc_pass": true,
|
| 132 |
+
"route_status": "same_pdb_surrogate",
|
| 133 |
+
"route_fallback": true,
|
| 134 |
+
"has_manifest": true
|
| 135 |
+
},
|
| 136 |
+
{
|
| 137 |
+
"drug_id": "228",
|
| 138 |
+
"canonical_name": "Acyclovir",
|
| 139 |
+
"index_key": "ACYCLOVIR_DNA_POL",
|
| 140 |
+
"pdb_id": "2GV9",
|
| 141 |
+
"tier": "1",
|
| 142 |
+
"session_id": "6a3f1e2bd26f0c97",
|
| 143 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\6a3f1e2bd26f0c97",
|
| 144 |
+
"elapsed_s": 218.7,
|
| 145 |
+
"status": "fail",
|
| 146 |
+
"failed_at": "m4b",
|
| 147 |
+
"route_status": "no_route",
|
| 148 |
+
"route_fallback": false,
|
| 149 |
+
"has_manifest": true
|
| 150 |
+
},
|
| 151 |
+
{
|
| 152 |
+
"drug_id": "229",
|
| 153 |
+
"canonical_name": "Levocetirizine",
|
| 154 |
+
"index_key": "LEVOCETIRIZINE_HRH1",
|
| 155 |
+
"pdb_id": "3RZE",
|
| 156 |
+
"tier": "1",
|
| 157 |
+
"session_id": "de6c2abe2485c017",
|
| 158 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\de6c2abe2485c017",
|
| 159 |
+
"elapsed_s": 59.9,
|
| 160 |
+
"status": "ok",
|
| 161 |
+
"best_affinity": -9.881,
|
| 162 |
+
"qc_pass": false,
|
| 163 |
+
"route_status": "same_pdb_surrogate",
|
| 164 |
+
"route_fallback": true,
|
| 165 |
+
"has_manifest": true
|
| 166 |
+
}
|
| 167 |
+
]
|
| 168 |
+
}
|
config/catalog_batch_run_summary_230-239.json
ADDED
|
@@ -0,0 +1,170 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"generated_at": "2026-07-01T02:53:43.423598+00:00",
|
| 3 |
+
"count": 10,
|
| 4 |
+
"total_elapsed_s": 1121.1,
|
| 5 |
+
"ok": 9,
|
| 6 |
+
"partial": 0,
|
| 7 |
+
"skip": 0,
|
| 8 |
+
"qc_pass": 5,
|
| 9 |
+
"results": [
|
| 10 |
+
{
|
| 11 |
+
"drug_id": "230",
|
| 12 |
+
"canonical_name": "Methylprednisolone",
|
| 13 |
+
"index_key": "METHYLPREDNISOLONE_NR3C1_PROXY",
|
| 14 |
+
"pdb_id": "1M2Z",
|
| 15 |
+
"tier": "2",
|
| 16 |
+
"session_id": "fae5ff81a5fdcac5",
|
| 17 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\fae5ff81a5fdcac5",
|
| 18 |
+
"elapsed_s": 65.4,
|
| 19 |
+
"status": "ok",
|
| 20 |
+
"best_affinity": -9.815,
|
| 21 |
+
"qc_pass": false,
|
| 22 |
+
"route_status": "direct_ok",
|
| 23 |
+
"route_fallback": false,
|
| 24 |
+
"has_manifest": true
|
| 25 |
+
},
|
| 26 |
+
{
|
| 27 |
+
"drug_id": "231",
|
| 28 |
+
"canonical_name": "Sirolimus",
|
| 29 |
+
"index_key": "SIROLIMUS_MTOR",
|
| 30 |
+
"pdb_id": "4JT6",
|
| 31 |
+
"tier": "1",
|
| 32 |
+
"session_id": "dc8e109976c1c8e8",
|
| 33 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\dc8e109976c1c8e8",
|
| 34 |
+
"elapsed_s": 207.9,
|
| 35 |
+
"status": "ok",
|
| 36 |
+
"best_affinity": -5.958,
|
| 37 |
+
"qc_pass": false,
|
| 38 |
+
"route_status": "cross_pdb_proxy",
|
| 39 |
+
"route_fallback": true,
|
| 40 |
+
"has_manifest": true
|
| 41 |
+
},
|
| 42 |
+
{
|
| 43 |
+
"drug_id": "232",
|
| 44 |
+
"canonical_name": "Temsirolimus",
|
| 45 |
+
"index_key": "TEMSIROLIMUS_MTOR_PROXY",
|
| 46 |
+
"pdb_id": "4JT6",
|
| 47 |
+
"tier": "2",
|
| 48 |
+
"session_id": "27d29ae4fa03abdf",
|
| 49 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\27d29ae4fa03abdf",
|
| 50 |
+
"elapsed_s": 214.4,
|
| 51 |
+
"status": "ok",
|
| 52 |
+
"best_affinity": -5.894,
|
| 53 |
+
"qc_pass": false,
|
| 54 |
+
"route_status": "same_pdb_surrogate",
|
| 55 |
+
"route_fallback": true,
|
| 56 |
+
"has_manifest": true
|
| 57 |
+
},
|
| 58 |
+
{
|
| 59 |
+
"drug_id": "233",
|
| 60 |
+
"canonical_name": "Gilteritinib",
|
| 61 |
+
"index_key": "GILTERITINIB_FLT3",
|
| 62 |
+
"pdb_id": "4RK8",
|
| 63 |
+
"tier": "1",
|
| 64 |
+
"session_id": "de3298d15b5883ec",
|
| 65 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\de3298d15b5883ec",
|
| 66 |
+
"elapsed_s": 65.4,
|
| 67 |
+
"status": "ok",
|
| 68 |
+
"best_affinity": -11.15,
|
| 69 |
+
"qc_pass": true,
|
| 70 |
+
"route_status": "same_pdb_surrogate",
|
| 71 |
+
"route_fallback": true,
|
| 72 |
+
"has_manifest": true
|
| 73 |
+
},
|
| 74 |
+
{
|
| 75 |
+
"drug_id": "234",
|
| 76 |
+
"canonical_name": "Ivosidenib",
|
| 77 |
+
"index_key": "IVOSIDENIB_IDH1",
|
| 78 |
+
"pdb_id": "6VAM",
|
| 79 |
+
"tier": "1",
|
| 80 |
+
"session_id": "8636e9fc14b99875",
|
| 81 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\8636e9fc14b99875",
|
| 82 |
+
"elapsed_s": 165.0,
|
| 83 |
+
"status": "fail",
|
| 84 |
+
"failed_at": "m4b",
|
| 85 |
+
"route_status": "no_route",
|
| 86 |
+
"route_fallback": false,
|
| 87 |
+
"has_manifest": true
|
| 88 |
+
},
|
| 89 |
+
{
|
| 90 |
+
"drug_id": "235",
|
| 91 |
+
"canonical_name": "Enasidenib",
|
| 92 |
+
"index_key": "ENASIDENIB_IDH2",
|
| 93 |
+
"pdb_id": "5I96",
|
| 94 |
+
"tier": "1",
|
| 95 |
+
"session_id": "e1789ef0f9f07898",
|
| 96 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\e1789ef0f9f07898",
|
| 97 |
+
"elapsed_s": 109.2,
|
| 98 |
+
"status": "ok",
|
| 99 |
+
"best_affinity": -7.399,
|
| 100 |
+
"qc_pass": false,
|
| 101 |
+
"route_status": "same_pdb_surrogate",
|
| 102 |
+
"route_fallback": true,
|
| 103 |
+
"has_manifest": true
|
| 104 |
+
},
|
| 105 |
+
{
|
| 106 |
+
"drug_id": "236",
|
| 107 |
+
"canonical_name": "Ivacaftor",
|
| 108 |
+
"index_key": "IVACAFTOR_CFTR",
|
| 109 |
+
"pdb_id": "6MSM",
|
| 110 |
+
"tier": "1",
|
| 111 |
+
"session_id": "36bcbcdf130cff77",
|
| 112 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\36bcbcdf130cff77",
|
| 113 |
+
"elapsed_s": 87.8,
|
| 114 |
+
"status": "ok",
|
| 115 |
+
"best_affinity": -9.756,
|
| 116 |
+
"qc_pass": true,
|
| 117 |
+
"route_status": "same_pdb_surrogate",
|
| 118 |
+
"route_fallback": true,
|
| 119 |
+
"has_manifest": true
|
| 120 |
+
},
|
| 121 |
+
{
|
| 122 |
+
"drug_id": "237",
|
| 123 |
+
"canonical_name": "Fruquintinib",
|
| 124 |
+
"index_key": "FRUQUINTINIB_VEGFR",
|
| 125 |
+
"pdb_id": "4ASD",
|
| 126 |
+
"tier": "1",
|
| 127 |
+
"session_id": "4ea0386b2b882be4",
|
| 128 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\4ea0386b2b882be4",
|
| 129 |
+
"elapsed_s": 49.1,
|
| 130 |
+
"status": "ok",
|
| 131 |
+
"best_affinity": -11.18,
|
| 132 |
+
"qc_pass": true,
|
| 133 |
+
"route_status": "cross_pdb_proxy",
|
| 134 |
+
"route_fallback": true,
|
| 135 |
+
"has_manifest": true
|
| 136 |
+
},
|
| 137 |
+
{
|
| 138 |
+
"drug_id": "238",
|
| 139 |
+
"canonical_name": "Apatinib",
|
| 140 |
+
"index_key": "APATINIB_VEGFR2",
|
| 141 |
+
"pdb_id": "5HI3",
|
| 142 |
+
"tier": "1",
|
| 143 |
+
"session_id": "58861ec5dfb61c5a",
|
| 144 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\58861ec5dfb61c5a",
|
| 145 |
+
"elapsed_s": 122.0,
|
| 146 |
+
"status": "ok",
|
| 147 |
+
"best_affinity": -10.24,
|
| 148 |
+
"qc_pass": true,
|
| 149 |
+
"route_status": "same_pdb_surrogate",
|
| 150 |
+
"route_fallback": true,
|
| 151 |
+
"has_manifest": true
|
| 152 |
+
},
|
| 153 |
+
{
|
| 154 |
+
"drug_id": "239",
|
| 155 |
+
"canonical_name": "Midazolam",
|
| 156 |
+
"index_key": "MIDAZOLAM_CYP3A4",
|
| 157 |
+
"pdb_id": "4K9T",
|
| 158 |
+
"tier": "1",
|
| 159 |
+
"session_id": "0a8acb0863b3179a",
|
| 160 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\0a8acb0863b3179a",
|
| 161 |
+
"elapsed_s": 34.3,
|
| 162 |
+
"status": "ok",
|
| 163 |
+
"best_affinity": -8.778,
|
| 164 |
+
"qc_pass": true,
|
| 165 |
+
"route_status": "same_pdb_surrogate",
|
| 166 |
+
"route_fallback": true,
|
| 167 |
+
"has_manifest": true
|
| 168 |
+
}
|
| 169 |
+
]
|
| 170 |
+
}
|
config/catalog_batch_run_summary_240-249.json
ADDED
|
@@ -0,0 +1,168 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"generated_at": "2026-07-01T03:28:54.682754+00:00",
|
| 3 |
+
"count": 10,
|
| 4 |
+
"total_elapsed_s": 681.3,
|
| 5 |
+
"ok": 7,
|
| 6 |
+
"partial": 0,
|
| 7 |
+
"skip": 0,
|
| 8 |
+
"qc_pass": 4,
|
| 9 |
+
"results": [
|
| 10 |
+
{
|
| 11 |
+
"drug_id": "240",
|
| 12 |
+
"canonical_name": "Nitroglycerin",
|
| 13 |
+
"index_key": "NITROGLYCERIN_NOS_PROXY",
|
| 14 |
+
"pdb_id": "1M9C",
|
| 15 |
+
"tier": "2",
|
| 16 |
+
"session_id": "1913832484865c7f",
|
| 17 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\1913832484865c7f",
|
| 18 |
+
"elapsed_s": 26.8,
|
| 19 |
+
"status": "fail",
|
| 20 |
+
"failed_at": "m4b",
|
| 21 |
+
"route_status": "no_route",
|
| 22 |
+
"route_fallback": false,
|
| 23 |
+
"has_manifest": true
|
| 24 |
+
},
|
| 25 |
+
{
|
| 26 |
+
"drug_id": "241",
|
| 27 |
+
"canonical_name": "Liraglutide",
|
| 28 |
+
"index_key": "LIRAGLUTIDE_GLP1R_PROXY",
|
| 29 |
+
"pdb_id": "6X18",
|
| 30 |
+
"tier": "2",
|
| 31 |
+
"session_id": "504d64721ffb03e0",
|
| 32 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\504d64721ffb03e0",
|
| 33 |
+
"elapsed_s": 111.2,
|
| 34 |
+
"status": "fail",
|
| 35 |
+
"failed_at": "m4b",
|
| 36 |
+
"route_status": "no_route",
|
| 37 |
+
"route_fallback": false,
|
| 38 |
+
"has_manifest": true
|
| 39 |
+
},
|
| 40 |
+
{
|
| 41 |
+
"drug_id": "242",
|
| 42 |
+
"canonical_name": "Clofibrate",
|
| 43 |
+
"index_key": "CLOFIBRATE_PPARALPHA_PROXY",
|
| 44 |
+
"pdb_id": "1K74",
|
| 45 |
+
"tier": "2",
|
| 46 |
+
"session_id": "a25d1496913fdf3c",
|
| 47 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\a25d1496913fdf3c",
|
| 48 |
+
"elapsed_s": 57.9,
|
| 49 |
+
"status": "ok",
|
| 50 |
+
"best_affinity": -7.882,
|
| 51 |
+
"qc_pass": true,
|
| 52 |
+
"route_status": "direct_ok",
|
| 53 |
+
"route_fallback": false,
|
| 54 |
+
"has_manifest": true
|
| 55 |
+
},
|
| 56 |
+
{
|
| 57 |
+
"drug_id": "243",
|
| 58 |
+
"canonical_name": "Nicotine",
|
| 59 |
+
"index_key": "NICOTINE_NACHR",
|
| 60 |
+
"pdb_id": "4EY7",
|
| 61 |
+
"tier": "1",
|
| 62 |
+
"session_id": "1dee60469ae23573",
|
| 63 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\1dee60469ae23573",
|
| 64 |
+
"elapsed_s": 102.6,
|
| 65 |
+
"status": "ok",
|
| 66 |
+
"best_affinity": -6.794,
|
| 67 |
+
"qc_pass": true,
|
| 68 |
+
"route_status": "same_pdb_surrogate",
|
| 69 |
+
"route_fallback": true,
|
| 70 |
+
"has_manifest": true
|
| 71 |
+
},
|
| 72 |
+
{
|
| 73 |
+
"drug_id": "244",
|
| 74 |
+
"canonical_name": "Gliclazide",
|
| 75 |
+
"index_key": "GLICLAZIDE_KATP_PROXY",
|
| 76 |
+
"pdb_id": "3SYQ",
|
| 77 |
+
"tier": "2",
|
| 78 |
+
"session_id": "89dc10b18ac0a169",
|
| 79 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\89dc10b18ac0a169",
|
| 80 |
+
"elapsed_s": 75.9,
|
| 81 |
+
"status": "ok",
|
| 82 |
+
"best_affinity": -4.844,
|
| 83 |
+
"qc_pass": false,
|
| 84 |
+
"route_status": "same_pdb_surrogate",
|
| 85 |
+
"route_fallback": true,
|
| 86 |
+
"has_manifest": true
|
| 87 |
+
},
|
| 88 |
+
{
|
| 89 |
+
"drug_id": "245",
|
| 90 |
+
"canonical_name": "Domperidone",
|
| 91 |
+
"index_key": "DOMPERIDONE_DRD2_PROXY",
|
| 92 |
+
"pdb_id": "6CM4",
|
| 93 |
+
"tier": "2",
|
| 94 |
+
"session_id": "dba3e8510cc5eb0b",
|
| 95 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\dba3e8510cc5eb0b",
|
| 96 |
+
"elapsed_s": 47.7,
|
| 97 |
+
"status": "ok",
|
| 98 |
+
"best_affinity": -8.566,
|
| 99 |
+
"qc_pass": true,
|
| 100 |
+
"route_status": "direct_ok",
|
| 101 |
+
"route_fallback": false,
|
| 102 |
+
"has_manifest": true
|
| 103 |
+
},
|
| 104 |
+
{
|
| 105 |
+
"drug_id": "246",
|
| 106 |
+
"canonical_name": "Lithium",
|
| 107 |
+
"index_key": "LITHIUM_IMPASE_PROXY",
|
| 108 |
+
"pdb_id": "1W7O",
|
| 109 |
+
"tier": "2",
|
| 110 |
+
"session_id": "09fe2fd97e616548",
|
| 111 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\09fe2fd97e616548",
|
| 112 |
+
"elapsed_s": 4.5,
|
| 113 |
+
"status": "fail",
|
| 114 |
+
"failed_at": "m2c",
|
| 115 |
+
"route_status": "same_pdb_surrogate",
|
| 116 |
+
"route_fallback": true,
|
| 117 |
+
"has_manifest": true
|
| 118 |
+
},
|
| 119 |
+
{
|
| 120 |
+
"drug_id": "247",
|
| 121 |
+
"canonical_name": "Sulfasalazine",
|
| 122 |
+
"index_key": "SULFASALAZINE_DHFR_PROXY",
|
| 123 |
+
"pdb_id": "2W9G",
|
| 124 |
+
"tier": "2",
|
| 125 |
+
"session_id": "0fafb4192b85f101",
|
| 126 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\0fafb4192b85f101",
|
| 127 |
+
"elapsed_s": 47.0,
|
| 128 |
+
"status": "ok",
|
| 129 |
+
"best_affinity": -9.214,
|
| 130 |
+
"qc_pass": true,
|
| 131 |
+
"route_status": "same_pdb_surrogate",
|
| 132 |
+
"route_fallback": true,
|
| 133 |
+
"has_manifest": true
|
| 134 |
+
},
|
| 135 |
+
{
|
| 136 |
+
"drug_id": "248",
|
| 137 |
+
"canonical_name": "Mesalamine",
|
| 138 |
+
"index_key": "MESALAMINE_COX2_PROXY",
|
| 139 |
+
"pdb_id": "5IKT",
|
| 140 |
+
"tier": "2",
|
| 141 |
+
"session_id": "f11a959b5ab4edd1",
|
| 142 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\f11a959b5ab4edd1",
|
| 143 |
+
"elapsed_s": 147.7,
|
| 144 |
+
"status": "ok",
|
| 145 |
+
"best_affinity": -6.233,
|
| 146 |
+
"qc_pass": false,
|
| 147 |
+
"route_status": "direct_ok",
|
| 148 |
+
"route_fallback": false,
|
| 149 |
+
"has_manifest": true
|
| 150 |
+
},
|
| 151 |
+
{
|
| 152 |
+
"drug_id": "249",
|
| 153 |
+
"canonical_name": "Ursodeoxycholic acid",
|
| 154 |
+
"index_key": "URSODIOL_FXR",
|
| 155 |
+
"pdb_id": "3OLF",
|
| 156 |
+
"tier": "1",
|
| 157 |
+
"session_id": "143903f265aadfd5",
|
| 158 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\143903f265aadfd5",
|
| 159 |
+
"elapsed_s": 59.4,
|
| 160 |
+
"status": "ok",
|
| 161 |
+
"best_affinity": -8.659,
|
| 162 |
+
"qc_pass": false,
|
| 163 |
+
"route_status": "same_pdb_surrogate",
|
| 164 |
+
"route_fallback": true,
|
| 165 |
+
"has_manifest": true
|
| 166 |
+
}
|
| 167 |
+
]
|
| 168 |
+
}
|
config/catalog_batch_run_summary_25-29_90-99.json
ADDED
|
@@ -0,0 +1,251 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"generated_at": "2026-06-30T00:35:40.566657+00:00",
|
| 3 |
+
"count": 15,
|
| 4 |
+
"total_elapsed_s": 2014.7,
|
| 5 |
+
"ok": 15,
|
| 6 |
+
"partial": 0,
|
| 7 |
+
"skip": 0,
|
| 8 |
+
"qc_pass": 8,
|
| 9 |
+
"results": [
|
| 10 |
+
{
|
| 11 |
+
"drug_id": "25",
|
| 12 |
+
"canonical_name": "Metformin",
|
| 13 |
+
"index_key": "AMPK_METFORMIN_PROXY",
|
| 14 |
+
"pdb_id": "4CFE",
|
| 15 |
+
"tier": "2",
|
| 16 |
+
"session_id": "9ebbce7340b7931f",
|
| 17 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\9ebbce7340b7931f",
|
| 18 |
+
"elapsed_s": 176.8,
|
| 19 |
+
"status": "ok",
|
| 20 |
+
"best_affinity": -5.102,
|
| 21 |
+
"qc_pass": false,
|
| 22 |
+
"route_status": "direct_ok",
|
| 23 |
+
"route_fallback": false,
|
| 24 |
+
"has_manifest": true
|
| 25 |
+
},
|
| 26 |
+
{
|
| 27 |
+
"drug_id": "26",
|
| 28 |
+
"canonical_name": "Sitagliptin",
|
| 29 |
+
"index_key": "SITAGLIPTIN_DPP4",
|
| 30 |
+
"pdb_id": "1X70",
|
| 31 |
+
"tier": "1",
|
| 32 |
+
"session_id": "6cdc0d35bebdfd85",
|
| 33 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\6cdc0d35bebdfd85",
|
| 34 |
+
"elapsed_s": 236.9,
|
| 35 |
+
"status": "ok",
|
| 36 |
+
"best_affinity": -8.859,
|
| 37 |
+
"qc_pass": true,
|
| 38 |
+
"route_status": "direct_ok",
|
| 39 |
+
"route_fallback": false,
|
| 40 |
+
"has_manifest": true
|
| 41 |
+
},
|
| 42 |
+
{
|
| 43 |
+
"drug_id": "27",
|
| 44 |
+
"canonical_name": "Atorvastatin",
|
| 45 |
+
"index_key": "ATORVASTATIN_HMGCR_PROXY",
|
| 46 |
+
"pdb_id": "1HWK",
|
| 47 |
+
"tier": "1",
|
| 48 |
+
"session_id": "22fedb45a5c250d5",
|
| 49 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\22fedb45a5c250d5",
|
| 50 |
+
"elapsed_s": 181.9,
|
| 51 |
+
"status": "ok",
|
| 52 |
+
"best_affinity": -8.714,
|
| 53 |
+
"qc_pass": true,
|
| 54 |
+
"route_status": "direct_ok",
|
| 55 |
+
"route_fallback": false,
|
| 56 |
+
"has_manifest": true
|
| 57 |
+
},
|
| 58 |
+
{
|
| 59 |
+
"drug_id": "28",
|
| 60 |
+
"canonical_name": "Aspirin",
|
| 61 |
+
"index_key": "ASPIRIN_COX2",
|
| 62 |
+
"pdb_id": "5IKT",
|
| 63 |
+
"tier": "1",
|
| 64 |
+
"session_id": "a3143655e2919427",
|
| 65 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\a3143655e2919427",
|
| 66 |
+
"elapsed_s": 152.2,
|
| 67 |
+
"status": "ok",
|
| 68 |
+
"best_affinity": -6.673,
|
| 69 |
+
"qc_pass": false,
|
| 70 |
+
"route_status": "direct_ok",
|
| 71 |
+
"route_fallback": false,
|
| 72 |
+
"has_manifest": true
|
| 73 |
+
},
|
| 74 |
+
{
|
| 75 |
+
"drug_id": "29",
|
| 76 |
+
"canonical_name": "Omeprazole",
|
| 77 |
+
"index_key": "OMEPRAZOLE_CYP2C19",
|
| 78 |
+
"pdb_id": "4GQS",
|
| 79 |
+
"tier": "2",
|
| 80 |
+
"session_id": "f03eede6e628958c",
|
| 81 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\f03eede6e628958c",
|
| 82 |
+
"elapsed_s": 197.3,
|
| 83 |
+
"status": "ok",
|
| 84 |
+
"best_affinity": -8.57,
|
| 85 |
+
"qc_pass": true,
|
| 86 |
+
"route_status": "direct_ok",
|
| 87 |
+
"route_fallback": false,
|
| 88 |
+
"has_manifest": true
|
| 89 |
+
},
|
| 90 |
+
{
|
| 91 |
+
"drug_id": "90",
|
| 92 |
+
"canonical_name": "Ticagrelor",
|
| 93 |
+
"index_key": "TICAGRELOR_P2Y12",
|
| 94 |
+
"pdb_id": "4PY0",
|
| 95 |
+
"tier": "1",
|
| 96 |
+
"session_id": "c0849714f6894c14",
|
| 97 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\c0849714f6894c14",
|
| 98 |
+
"elapsed_s": 60.3,
|
| 99 |
+
"status": "ok",
|
| 100 |
+
"best_affinity": -7.792,
|
| 101 |
+
"qc_pass": false,
|
| 102 |
+
"route_status": "same_pdb_surrogate",
|
| 103 |
+
"route_fallback": true,
|
| 104 |
+
"has_manifest": true
|
| 105 |
+
},
|
| 106 |
+
{
|
| 107 |
+
"drug_id": "91",
|
| 108 |
+
"canonical_name": "Glimepiride",
|
| 109 |
+
"index_key": "GLIMEPIRIDE_KATP_PROXY",
|
| 110 |
+
"pdb_id": "3SYQ",
|
| 111 |
+
"tier": "2",
|
| 112 |
+
"session_id": "e96b7d1bc0882956",
|
| 113 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\e96b7d1bc0882956",
|
| 114 |
+
"elapsed_s": 114.2,
|
| 115 |
+
"status": "ok",
|
| 116 |
+
"best_affinity": -9.354,
|
| 117 |
+
"qc_pass": true,
|
| 118 |
+
"route_status": "same_pdb_surrogate",
|
| 119 |
+
"route_fallback": true,
|
| 120 |
+
"has_manifest": true
|
| 121 |
+
},
|
| 122 |
+
{
|
| 123 |
+
"drug_id": "92",
|
| 124 |
+
"canonical_name": "Miglitol",
|
| 125 |
+
"index_key": "MIGLITOL_GLUCOSIDASE",
|
| 126 |
+
"pdb_id": "2QV4",
|
| 127 |
+
"tier": "1",
|
| 128 |
+
"session_id": "702b3235097e3079",
|
| 129 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\702b3235097e3079",
|
| 130 |
+
"elapsed_s": 48.0,
|
| 131 |
+
"status": "ok",
|
| 132 |
+
"best_affinity": -5.541,
|
| 133 |
+
"qc_pass": false,
|
| 134 |
+
"route_status": "cross_pdb_proxy",
|
| 135 |
+
"route_fallback": true,
|
| 136 |
+
"has_manifest": true
|
| 137 |
+
},
|
| 138 |
+
{
|
| 139 |
+
"drug_id": "93",
|
| 140 |
+
"canonical_name": "Acarbose",
|
| 141 |
+
"index_key": "ACARBOSE_GLUCOSIDASE",
|
| 142 |
+
"pdb_id": "2QV4",
|
| 143 |
+
"tier": "1",
|
| 144 |
+
"session_id": "e4c383a1e07c66e8",
|
| 145 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\e4c383a1e07c66e8",
|
| 146 |
+
"elapsed_s": 288.4,
|
| 147 |
+
"status": "ok",
|
| 148 |
+
"best_affinity": -8.153,
|
| 149 |
+
"qc_pass": true,
|
| 150 |
+
"route_status": "same_pdb_surrogate",
|
| 151 |
+
"route_fallback": true,
|
| 152 |
+
"has_manifest": true
|
| 153 |
+
},
|
| 154 |
+
{
|
| 155 |
+
"drug_id": "94",
|
| 156 |
+
"canonical_name": "Gemfibrozil",
|
| 157 |
+
"index_key": "GEMFIBROZIL_PPARALPHA_PROXY",
|
| 158 |
+
"pdb_id": "1K74",
|
| 159 |
+
"tier": "2",
|
| 160 |
+
"session_id": "1e567a88817d7d6b",
|
| 161 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\1e567a88817d7d6b",
|
| 162 |
+
"elapsed_s": 47.8,
|
| 163 |
+
"status": "ok",
|
| 164 |
+
"best_affinity": -7.6,
|
| 165 |
+
"qc_pass": false,
|
| 166 |
+
"route_status": "direct_ok",
|
| 167 |
+
"route_fallback": false,
|
| 168 |
+
"has_manifest": true
|
| 169 |
+
},
|
| 170 |
+
{
|
| 171 |
+
"drug_id": "95",
|
| 172 |
+
"canonical_name": "Allopurinol",
|
| 173 |
+
"index_key": "ALLOPURINOL_XDH",
|
| 174 |
+
"pdb_id": "3NTZ",
|
| 175 |
+
"tier": "1",
|
| 176 |
+
"session_id": "08adb08616c6b3c3",
|
| 177 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\08adb08616c6b3c3",
|
| 178 |
+
"elapsed_s": 27.1,
|
| 179 |
+
"status": "ok",
|
| 180 |
+
"best_affinity": -5.701,
|
| 181 |
+
"qc_pass": false,
|
| 182 |
+
"route_status": "same_pdb_surrogate",
|
| 183 |
+
"route_fallback": true,
|
| 184 |
+
"has_manifest": true
|
| 185 |
+
},
|
| 186 |
+
{
|
| 187 |
+
"drug_id": "96",
|
| 188 |
+
"canonical_name": "Febuxostat",
|
| 189 |
+
"index_key": "FEBUXOSTAT_XDH",
|
| 190 |
+
"pdb_id": "3EY8",
|
| 191 |
+
"tier": "1",
|
| 192 |
+
"session_id": "7d3c0644045727df",
|
| 193 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\7d3c0644045727df",
|
| 194 |
+
"elapsed_s": 32.0,
|
| 195 |
+
"status": "ok",
|
| 196 |
+
"best_affinity": -5.392,
|
| 197 |
+
"qc_pass": false,
|
| 198 |
+
"route_status": "same_pdb_surrogate",
|
| 199 |
+
"route_fallback": true,
|
| 200 |
+
"has_manifest": true
|
| 201 |
+
},
|
| 202 |
+
{
|
| 203 |
+
"drug_id": "97",
|
| 204 |
+
"canonical_name": "Bisoprolol",
|
| 205 |
+
"index_key": "BISOPROLOL_ADRB1_PROXY",
|
| 206 |
+
"pdb_id": "2Y02",
|
| 207 |
+
"tier": "2",
|
| 208 |
+
"session_id": "3ffb865f1044824a",
|
| 209 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\3ffb865f1044824a",
|
| 210 |
+
"elapsed_s": 59.6,
|
| 211 |
+
"status": "ok",
|
| 212 |
+
"best_affinity": -7.312,
|
| 213 |
+
"qc_pass": true,
|
| 214 |
+
"route_status": "direct_ok",
|
| 215 |
+
"route_fallback": false,
|
| 216 |
+
"has_manifest": true
|
| 217 |
+
},
|
| 218 |
+
{
|
| 219 |
+
"drug_id": "98",
|
| 220 |
+
"canonical_name": "Nifedipine",
|
| 221 |
+
"index_key": "NIFEDIPINE_CACNA1C",
|
| 222 |
+
"pdb_id": "8WE8",
|
| 223 |
+
"tier": "2",
|
| 224 |
+
"session_id": "d4c5b5c59fe17d3e",
|
| 225 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\d4c5b5c59fe17d3e",
|
| 226 |
+
"elapsed_s": 193.0,
|
| 227 |
+
"status": "ok",
|
| 228 |
+
"best_affinity": -7.719,
|
| 229 |
+
"qc_pass": true,
|
| 230 |
+
"route_status": "direct_ok",
|
| 231 |
+
"route_fallback": false,
|
| 232 |
+
"has_manifest": true
|
| 233 |
+
},
|
| 234 |
+
{
|
| 235 |
+
"drug_id": "99",
|
| 236 |
+
"canonical_name": "Verapamil",
|
| 237 |
+
"index_key": "VERAPAMIL_CACNA1C_PROXY",
|
| 238 |
+
"pdb_id": "8WE8",
|
| 239 |
+
"tier": "2",
|
| 240 |
+
"session_id": "80fb56ee4e650648",
|
| 241 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\80fb56ee4e650648",
|
| 242 |
+
"elapsed_s": 198.7,
|
| 243 |
+
"status": "ok",
|
| 244 |
+
"best_affinity": -7.967,
|
| 245 |
+
"qc_pass": true,
|
| 246 |
+
"route_status": "direct_ok",
|
| 247 |
+
"route_fallback": false,
|
| 248 |
+
"has_manifest": true
|
| 249 |
+
}
|
| 250 |
+
]
|
| 251 |
+
}
|
config/catalog_batch_run_summary_250-259.json
ADDED
|
@@ -0,0 +1,170 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"generated_at": "2026-07-01T03:55:15.285133+00:00",
|
| 3 |
+
"count": 10,
|
| 4 |
+
"total_elapsed_s": 1028.4,
|
| 5 |
+
"ok": 9,
|
| 6 |
+
"partial": 0,
|
| 7 |
+
"skip": 0,
|
| 8 |
+
"qc_pass": 6,
|
| 9 |
+
"results": [
|
| 10 |
+
{
|
| 11 |
+
"drug_id": "250",
|
| 12 |
+
"canonical_name": "Minoxidil",
|
| 13 |
+
"index_key": "MINOXIDIL_KATP_PROXY",
|
| 14 |
+
"pdb_id": "3SYQ",
|
| 15 |
+
"tier": "2",
|
| 16 |
+
"session_id": "efb0c36c9b214b88",
|
| 17 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\efb0c36c9b214b88",
|
| 18 |
+
"elapsed_s": 55.9,
|
| 19 |
+
"status": "ok",
|
| 20 |
+
"best_affinity": -4.934,
|
| 21 |
+
"qc_pass": false,
|
| 22 |
+
"route_status": "same_pdb_surrogate",
|
| 23 |
+
"route_fallback": true,
|
| 24 |
+
"has_manifest": true
|
| 25 |
+
},
|
| 26 |
+
{
|
| 27 |
+
"drug_id": "251",
|
| 28 |
+
"canonical_name": "Etodolac",
|
| 29 |
+
"index_key": "ETODOLAC_COX2_PROXY",
|
| 30 |
+
"pdb_id": "5IKR",
|
| 31 |
+
"tier": "2",
|
| 32 |
+
"session_id": "c5e1048797eaa84f",
|
| 33 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\c5e1048797eaa84f",
|
| 34 |
+
"elapsed_s": 80.2,
|
| 35 |
+
"status": "ok",
|
| 36 |
+
"best_affinity": -6.645,
|
| 37 |
+
"qc_pass": true,
|
| 38 |
+
"route_status": "direct_ok",
|
| 39 |
+
"route_fallback": false,
|
| 40 |
+
"has_manifest": true
|
| 41 |
+
},
|
| 42 |
+
{
|
| 43 |
+
"drug_id": "252",
|
| 44 |
+
"canonical_name": "Itraconazole",
|
| 45 |
+
"index_key": "ITRACONAZOLE_CYP51_PROXY",
|
| 46 |
+
"pdb_id": "5VZA",
|
| 47 |
+
"tier": "2",
|
| 48 |
+
"session_id": "37245961959c1916",
|
| 49 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\37245961959c1916",
|
| 50 |
+
"elapsed_s": 39.3,
|
| 51 |
+
"status": "ok",
|
| 52 |
+
"best_affinity": -7.163,
|
| 53 |
+
"qc_pass": true,
|
| 54 |
+
"route_status": "same_pdb_surrogate",
|
| 55 |
+
"route_fallback": true,
|
| 56 |
+
"has_manifest": true
|
| 57 |
+
},
|
| 58 |
+
{
|
| 59 |
+
"drug_id": "253",
|
| 60 |
+
"canonical_name": "Ganciclovir",
|
| 61 |
+
"index_key": "GANCICLOVIR_DNA_POL_PROXY",
|
| 62 |
+
"pdb_id": "2GV9",
|
| 63 |
+
"tier": "2",
|
| 64 |
+
"session_id": "e86dcebd277f3e07",
|
| 65 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\e86dcebd277f3e07",
|
| 66 |
+
"elapsed_s": 211.7,
|
| 67 |
+
"status": "fail",
|
| 68 |
+
"failed_at": "m4b",
|
| 69 |
+
"route_status": "no_route",
|
| 70 |
+
"route_fallback": false,
|
| 71 |
+
"has_manifest": true
|
| 72 |
+
},
|
| 73 |
+
{
|
| 74 |
+
"drug_id": "254",
|
| 75 |
+
"canonical_name": "Remdesivir",
|
| 76 |
+
"index_key": "REMDESIVIR_RDRP",
|
| 77 |
+
"pdb_id": "7BV2",
|
| 78 |
+
"tier": "1",
|
| 79 |
+
"session_id": "2c0cd82e73413bff",
|
| 80 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\2c0cd82e73413bff",
|
| 81 |
+
"elapsed_s": 250.5,
|
| 82 |
+
"status": "ok",
|
| 83 |
+
"best_affinity": -7.193,
|
| 84 |
+
"qc_pass": true,
|
| 85 |
+
"route_status": "same_pdb_surrogate",
|
| 86 |
+
"route_fallback": true,
|
| 87 |
+
"has_manifest": true
|
| 88 |
+
},
|
| 89 |
+
{
|
| 90 |
+
"drug_id": "255",
|
| 91 |
+
"canonical_name": "Sofosbuvir",
|
| 92 |
+
"index_key": "SOFOSBUVIR_NS5B",
|
| 93 |
+
"pdb_id": "4RXA",
|
| 94 |
+
"tier": "1",
|
| 95 |
+
"session_id": "15b6aa5612103331",
|
| 96 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\15b6aa5612103331",
|
| 97 |
+
"elapsed_s": 121.3,
|
| 98 |
+
"status": "ok",
|
| 99 |
+
"best_affinity": -7.661,
|
| 100 |
+
"qc_pass": true,
|
| 101 |
+
"route_status": "same_pdb_surrogate",
|
| 102 |
+
"route_fallback": true,
|
| 103 |
+
"has_manifest": true
|
| 104 |
+
},
|
| 105 |
+
{
|
| 106 |
+
"drug_id": "256",
|
| 107 |
+
"canonical_name": "Ribavirin",
|
| 108 |
+
"index_key": "RIBAVIRIN_RDRP",
|
| 109 |
+
"pdb_id": "7BV2",
|
| 110 |
+
"tier": "1",
|
| 111 |
+
"session_id": "d6f47182d567bf81",
|
| 112 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\d6f47182d567bf81",
|
| 113 |
+
"elapsed_s": 100.2,
|
| 114 |
+
"status": "ok",
|
| 115 |
+
"best_affinity": -6.286,
|
| 116 |
+
"qc_pass": false,
|
| 117 |
+
"route_status": "cross_pdb_proxy",
|
| 118 |
+
"route_fallback": true,
|
| 119 |
+
"has_manifest": true
|
| 120 |
+
},
|
| 121 |
+
{
|
| 122 |
+
"drug_id": "257",
|
| 123 |
+
"canonical_name": "Diphenhydramine",
|
| 124 |
+
"index_key": "DIPHENHYDRAMINE_HRH1_PROXY",
|
| 125 |
+
"pdb_id": "3RZE",
|
| 126 |
+
"tier": "2",
|
| 127 |
+
"session_id": "2355fa00ecfea6e4",
|
| 128 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\2355fa00ecfea6e4",
|
| 129 |
+
"elapsed_s": 57.5,
|
| 130 |
+
"status": "ok",
|
| 131 |
+
"best_affinity": -9.328,
|
| 132 |
+
"qc_pass": false,
|
| 133 |
+
"route_status": "same_pdb_surrogate",
|
| 134 |
+
"route_fallback": true,
|
| 135 |
+
"has_manifest": true
|
| 136 |
+
},
|
| 137 |
+
{
|
| 138 |
+
"drug_id": "258",
|
| 139 |
+
"canonical_name": "Loratadine",
|
| 140 |
+
"index_key": "LORATADINE_HRH1_PROXY",
|
| 141 |
+
"pdb_id": "3RZE",
|
| 142 |
+
"tier": "2",
|
| 143 |
+
"session_id": "4e7bd0592b09b10f",
|
| 144 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\4e7bd0592b09b10f",
|
| 145 |
+
"elapsed_s": 51.2,
|
| 146 |
+
"status": "ok",
|
| 147 |
+
"best_affinity": -8.662,
|
| 148 |
+
"qc_pass": true,
|
| 149 |
+
"route_status": "same_pdb_surrogate",
|
| 150 |
+
"route_fallback": true,
|
| 151 |
+
"has_manifest": true
|
| 152 |
+
},
|
| 153 |
+
{
|
| 154 |
+
"drug_id": "259",
|
| 155 |
+
"canonical_name": "Hydroxyzine",
|
| 156 |
+
"index_key": "HYDROXYZINE_HRH1_PROXY",
|
| 157 |
+
"pdb_id": "3RZE",
|
| 158 |
+
"tier": "2",
|
| 159 |
+
"session_id": "447cfcc552ea2c9e",
|
| 160 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\447cfcc552ea2c9e",
|
| 161 |
+
"elapsed_s": 60.2,
|
| 162 |
+
"status": "ok",
|
| 163 |
+
"best_affinity": -8.181,
|
| 164 |
+
"qc_pass": true,
|
| 165 |
+
"route_status": "same_pdb_surrogate",
|
| 166 |
+
"route_fallback": true,
|
| 167 |
+
"has_manifest": true
|
| 168 |
+
}
|
| 169 |
+
]
|
| 170 |
+
}
|
config/catalog_batch_run_summary_260-269.json
ADDED
|
@@ -0,0 +1,168 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"generated_at": "2026-07-01T04:12:18.644025+00:00",
|
| 3 |
+
"count": 10,
|
| 4 |
+
"total_elapsed_s": 558.8,
|
| 5 |
+
"ok": 7,
|
| 6 |
+
"partial": 0,
|
| 7 |
+
"skip": 0,
|
| 8 |
+
"qc_pass": 6,
|
| 9 |
+
"results": [
|
| 10 |
+
{
|
| 11 |
+
"drug_id": "260",
|
| 12 |
+
"canonical_name": "Doxepin",
|
| 13 |
+
"index_key": "DOXEPIN_SERT_PROXY",
|
| 14 |
+
"pdb_id": "5I6X",
|
| 15 |
+
"tier": "2",
|
| 16 |
+
"session_id": "48be91b669101f47",
|
| 17 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\48be91b669101f47",
|
| 18 |
+
"elapsed_s": 114.1,
|
| 19 |
+
"status": "ok",
|
| 20 |
+
"best_affinity": -8.845,
|
| 21 |
+
"qc_pass": true,
|
| 22 |
+
"route_status": "direct_ok",
|
| 23 |
+
"route_fallback": false,
|
| 24 |
+
"has_manifest": true
|
| 25 |
+
},
|
| 26 |
+
{
|
| 27 |
+
"drug_id": "261",
|
| 28 |
+
"canonical_name": "Tezacaftor",
|
| 29 |
+
"index_key": "TEZACAFTOR_CFTR_PROXY",
|
| 30 |
+
"pdb_id": "6MSM",
|
| 31 |
+
"tier": "2",
|
| 32 |
+
"session_id": "3530485a1aab419e",
|
| 33 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\3530485a1aab419e",
|
| 34 |
+
"elapsed_s": 51.2,
|
| 35 |
+
"status": "ok",
|
| 36 |
+
"best_affinity": -10.5,
|
| 37 |
+
"qc_pass": false,
|
| 38 |
+
"route_status": "same_pdb_surrogate",
|
| 39 |
+
"route_fallback": true,
|
| 40 |
+
"has_manifest": true
|
| 41 |
+
},
|
| 42 |
+
{
|
| 43 |
+
"drug_id": "262",
|
| 44 |
+
"canonical_name": "Alpelisib",
|
| 45 |
+
"index_key": "ALPELISIB_PIK3CA",
|
| 46 |
+
"pdb_id": "4JPS",
|
| 47 |
+
"tier": "1",
|
| 48 |
+
"session_id": "79761ce01604587a",
|
| 49 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\79761ce01604587a",
|
| 50 |
+
"elapsed_s": 99.1,
|
| 51 |
+
"status": "ok",
|
| 52 |
+
"best_affinity": -9.738,
|
| 53 |
+
"qc_pass": true,
|
| 54 |
+
"route_status": "same_pdb_surrogate",
|
| 55 |
+
"route_fallback": true,
|
| 56 |
+
"has_manifest": true
|
| 57 |
+
},
|
| 58 |
+
{
|
| 59 |
+
"drug_id": "263",
|
| 60 |
+
"canonical_name": "Capivasertib",
|
| 61 |
+
"index_key": "CAPIVASERTIB_AKT",
|
| 62 |
+
"pdb_id": "4EJN",
|
| 63 |
+
"tier": "1",
|
| 64 |
+
"session_id": "511f6ab203530187",
|
| 65 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\511f6ab203530187",
|
| 66 |
+
"elapsed_s": 38.9,
|
| 67 |
+
"status": "ok",
|
| 68 |
+
"best_affinity": -11.66,
|
| 69 |
+
"qc_pass": true,
|
| 70 |
+
"route_status": "same_pdb_surrogate",
|
| 71 |
+
"route_fallback": true,
|
| 72 |
+
"has_manifest": true
|
| 73 |
+
},
|
| 74 |
+
{
|
| 75 |
+
"drug_id": "264",
|
| 76 |
+
"canonical_name": "Copanlisib",
|
| 77 |
+
"index_key": "COPANLISIB_PIK3CA",
|
| 78 |
+
"pdb_id": "4JPS",
|
| 79 |
+
"tier": "1",
|
| 80 |
+
"session_id": "6b8bdb7c1f292157",
|
| 81 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\6b8bdb7c1f292157",
|
| 82 |
+
"elapsed_s": 91.8,
|
| 83 |
+
"status": "ok",
|
| 84 |
+
"best_affinity": -9.782,
|
| 85 |
+
"qc_pass": true,
|
| 86 |
+
"route_status": "cross_pdb_proxy",
|
| 87 |
+
"route_fallback": true,
|
| 88 |
+
"has_manifest": true
|
| 89 |
+
},
|
| 90 |
+
{
|
| 91 |
+
"drug_id": "265",
|
| 92 |
+
"canonical_name": "Bosentan",
|
| 93 |
+
"index_key": "BOSENTAN_ETRA",
|
| 94 |
+
"pdb_id": "1X9R",
|
| 95 |
+
"tier": "1",
|
| 96 |
+
"session_id": "66cbbec794b83d01",
|
| 97 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\66cbbec794b83d01",
|
| 98 |
+
"elapsed_s": 15.1,
|
| 99 |
+
"status": "fail",
|
| 100 |
+
"failed_at": "m4b",
|
| 101 |
+
"route_status": "no_route",
|
| 102 |
+
"route_fallback": false,
|
| 103 |
+
"has_manifest": true
|
| 104 |
+
},
|
| 105 |
+
{
|
| 106 |
+
"drug_id": "266",
|
| 107 |
+
"canonical_name": "Isosorbide mononitrate",
|
| 108 |
+
"index_key": "ISOSORBIDE_MONONITRATE_NOS_PROXY",
|
| 109 |
+
"pdb_id": "1M9C",
|
| 110 |
+
"tier": "2",
|
| 111 |
+
"session_id": "7a9d585dc5ec33da",
|
| 112 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\7a9d585dc5ec33da",
|
| 113 |
+
"elapsed_s": 16.0,
|
| 114 |
+
"status": "fail",
|
| 115 |
+
"failed_at": "m4b",
|
| 116 |
+
"route_status": "no_route",
|
| 117 |
+
"route_fallback": false,
|
| 118 |
+
"has_manifest": true
|
| 119 |
+
},
|
| 120 |
+
{
|
| 121 |
+
"drug_id": "267",
|
| 122 |
+
"canonical_name": "Riociguat",
|
| 123 |
+
"index_key": "RIOCIGUAT_SGC",
|
| 124 |
+
"pdb_id": "3RZT",
|
| 125 |
+
"tier": "1",
|
| 126 |
+
"session_id": "2561fcf1f31376fe",
|
| 127 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\2561fcf1f31376fe",
|
| 128 |
+
"elapsed_s": 11.0,
|
| 129 |
+
"status": "fail",
|
| 130 |
+
"failed_at": "m4b",
|
| 131 |
+
"route_status": "no_route",
|
| 132 |
+
"route_fallback": false,
|
| 133 |
+
"has_manifest": true
|
| 134 |
+
},
|
| 135 |
+
{
|
| 136 |
+
"drug_id": "268",
|
| 137 |
+
"canonical_name": "Entinostat",
|
| 138 |
+
"index_key": "ENTINOSTAT_HDAC_PROXY",
|
| 139 |
+
"pdb_id": "4LXZ",
|
| 140 |
+
"tier": "2",
|
| 141 |
+
"session_id": "2c8b30fd707da16b",
|
| 142 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\2c8b30fd707da16b",
|
| 143 |
+
"elapsed_s": 83.9,
|
| 144 |
+
"status": "ok",
|
| 145 |
+
"best_affinity": -7.24,
|
| 146 |
+
"qc_pass": true,
|
| 147 |
+
"route_status": "direct_ok",
|
| 148 |
+
"route_fallback": false,
|
| 149 |
+
"has_manifest": true
|
| 150 |
+
},
|
| 151 |
+
{
|
| 152 |
+
"drug_id": "269",
|
| 153 |
+
"canonical_name": "Olmutinib",
|
| 154 |
+
"index_key": "OLMUTINIB_EGFR",
|
| 155 |
+
"pdb_id": "5HG8",
|
| 156 |
+
"tier": "1",
|
| 157 |
+
"session_id": "a98198371dae70c7",
|
| 158 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\a98198371dae70c7",
|
| 159 |
+
"elapsed_s": 37.4,
|
| 160 |
+
"status": "ok",
|
| 161 |
+
"best_affinity": -9.434,
|
| 162 |
+
"qc_pass": true,
|
| 163 |
+
"route_status": "same_pdb_surrogate",
|
| 164 |
+
"route_fallback": true,
|
| 165 |
+
"has_manifest": true
|
| 166 |
+
}
|
| 167 |
+
]
|
| 168 |
+
}
|
config/catalog_batch_run_summary_270-279.json
ADDED
|
@@ -0,0 +1,169 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"generated_at": "2026-07-01T08:26:24.138132+00:00",
|
| 3 |
+
"count": 10,
|
| 4 |
+
"total_elapsed_s": 368.5,
|
| 5 |
+
"ok": 8,
|
| 6 |
+
"partial": 0,
|
| 7 |
+
"skip": 0,
|
| 8 |
+
"qc_pass": 7,
|
| 9 |
+
"results": [
|
| 10 |
+
{
|
| 11 |
+
"drug_id": "270",
|
| 12 |
+
"canonical_name": "Sotorasib",
|
| 13 |
+
"index_key": "SOTORASIB_KRAS",
|
| 14 |
+
"pdb_id": "6OIM",
|
| 15 |
+
"tier": "1",
|
| 16 |
+
"session_id": "fba66bc60834fab3",
|
| 17 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\fba66bc60834fab3",
|
| 18 |
+
"elapsed_s": 40.1,
|
| 19 |
+
"status": "ok",
|
| 20 |
+
"best_affinity": -9.311,
|
| 21 |
+
"qc_pass": true,
|
| 22 |
+
"route_status": "same_pdb_surrogate",
|
| 23 |
+
"route_fallback": true,
|
| 24 |
+
"has_manifest": true
|
| 25 |
+
},
|
| 26 |
+
{
|
| 27 |
+
"drug_id": "271",
|
| 28 |
+
"canonical_name": "Liothyronine",
|
| 29 |
+
"index_key": "LIOTHYRONINE_THRB_PROXY",
|
| 30 |
+
"pdb_id": "1NAV",
|
| 31 |
+
"tier": "2",
|
| 32 |
+
"session_id": "43015da71d72e123",
|
| 33 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\43015da71d72e123",
|
| 34 |
+
"elapsed_s": 30.9,
|
| 35 |
+
"status": "ok",
|
| 36 |
+
"best_affinity": -4.804,
|
| 37 |
+
"qc_pass": false,
|
| 38 |
+
"route_status": "same_pdb_surrogate",
|
| 39 |
+
"route_fallback": true,
|
| 40 |
+
"has_manifest": true
|
| 41 |
+
},
|
| 42 |
+
{
|
| 43 |
+
"drug_id": "272",
|
| 44 |
+
"canonical_name": "Cimetidine",
|
| 45 |
+
"index_key": "CIMETIDINE_HRH2_PROXY",
|
| 46 |
+
"pdb_id": "3RSG",
|
| 47 |
+
"tier": "2",
|
| 48 |
+
"session_id": "13eaca33f88afc45",
|
| 49 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\13eaca33f88afc45",
|
| 50 |
+
"elapsed_s": 20.4,
|
| 51 |
+
"status": "ok",
|
| 52 |
+
"best_affinity": -6.292,
|
| 53 |
+
"qc_pass": true,
|
| 54 |
+
"route_status": "same_pdb_surrogate",
|
| 55 |
+
"route_fallback": true,
|
| 56 |
+
"has_manifest": true
|
| 57 |
+
},
|
| 58 |
+
{
|
| 59 |
+
"drug_id": "273",
|
| 60 |
+
"canonical_name": "Acetohexamide",
|
| 61 |
+
"index_key": "ACETOHEXAMIDE_KATP_PROXY",
|
| 62 |
+
"pdb_id": "3SYQ",
|
| 63 |
+
"tier": "2",
|
| 64 |
+
"session_id": "4743e614e20f64e0",
|
| 65 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\4743e614e20f64e0",
|
| 66 |
+
"elapsed_s": 31.9,
|
| 67 |
+
"status": "ok",
|
| 68 |
+
"best_affinity": -6.873,
|
| 69 |
+
"qc_pass": true,
|
| 70 |
+
"route_status": "same_pdb_surrogate",
|
| 71 |
+
"route_fallback": true,
|
| 72 |
+
"has_manifest": true
|
| 73 |
+
},
|
| 74 |
+
{
|
| 75 |
+
"drug_id": "274",
|
| 76 |
+
"canonical_name": "Phenformin",
|
| 77 |
+
"index_key": "PHENFORMIN_AMPK_PROXY",
|
| 78 |
+
"pdb_id": "4CFE",
|
| 79 |
+
"tier": "2",
|
| 80 |
+
"session_id": "98278d994c6338a6",
|
| 81 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\98278d994c6338a6",
|
| 82 |
+
"elapsed_s": 114.3,
|
| 83 |
+
"status": "ok",
|
| 84 |
+
"best_affinity": -7.337,
|
| 85 |
+
"qc_pass": true,
|
| 86 |
+
"route_status": "direct_ok",
|
| 87 |
+
"route_fallback": false,
|
| 88 |
+
"has_manifest": true
|
| 89 |
+
},
|
| 90 |
+
{
|
| 91 |
+
"drug_id": "275",
|
| 92 |
+
"canonical_name": "Glucagon",
|
| 93 |
+
"index_key": "GLUCAGON_GCGR",
|
| 94 |
+
"pdb_id": "4L6R",
|
| 95 |
+
"tier": "1",
|
| 96 |
+
"session_id": "9c90bb28d801b87f",
|
| 97 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\9c90bb28d801b87f",
|
| 98 |
+
"elapsed_s": 18.7,
|
| 99 |
+
"status": "fail",
|
| 100 |
+
"failed_at": "m4b",
|
| 101 |
+
"route_status": "no_route",
|
| 102 |
+
"route_fallback": false,
|
| 103 |
+
"has_manifest": true
|
| 104 |
+
},
|
| 105 |
+
{
|
| 106 |
+
"drug_id": "276",
|
| 107 |
+
"canonical_name": "Insulin glargine",
|
| 108 |
+
"index_key": "INSULIN_GLARGINE_INSR_PROXY",
|
| 109 |
+
"pdb_id": "4OGA",
|
| 110 |
+
"tier": "2",
|
| 111 |
+
"session_id": "a4e67d5cbf984391",
|
| 112 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\a4e67d5cbf984391",
|
| 113 |
+
"elapsed_s": 29.3,
|
| 114 |
+
"status": "fail",
|
| 115 |
+
"failed_at": "m4b",
|
| 116 |
+
"route_status": "no_route",
|
| 117 |
+
"route_fallback": false,
|
| 118 |
+
"has_manifest": true
|
| 119 |
+
},
|
| 120 |
+
{
|
| 121 |
+
"drug_id": "277",
|
| 122 |
+
"canonical_name": "Phenprocoumon",
|
| 123 |
+
"index_key": "PHENPROCOUMON_VKOR_PROXY",
|
| 124 |
+
"pdb_id": "6WV3",
|
| 125 |
+
"tier": "2",
|
| 126 |
+
"session_id": "45e84fd98d1905b4",
|
| 127 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\45e84fd98d1905b4",
|
| 128 |
+
"elapsed_s": 28.9,
|
| 129 |
+
"status": "ok",
|
| 130 |
+
"best_affinity": -10.29,
|
| 131 |
+
"qc_pass": true,
|
| 132 |
+
"route_status": "direct_ok",
|
| 133 |
+
"route_fallback": false,
|
| 134 |
+
"has_manifest": true
|
| 135 |
+
},
|
| 136 |
+
{
|
| 137 |
+
"drug_id": "278",
|
| 138 |
+
"canonical_name": "Ethinyl estradiol",
|
| 139 |
+
"index_key": "ETHINYL_ESTRADIOL_ESR1",
|
| 140 |
+
"pdb_id": "3ERT",
|
| 141 |
+
"tier": "2",
|
| 142 |
+
"session_id": "7c115938fa64ac20",
|
| 143 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\7c115938fa64ac20",
|
| 144 |
+
"elapsed_s": 24.9,
|
| 145 |
+
"status": "ok",
|
| 146 |
+
"best_affinity": -9.275,
|
| 147 |
+
"qc_pass": true,
|
| 148 |
+
"route_status": "same_pdb_surrogate",
|
| 149 |
+
"route_fallback": true,
|
| 150 |
+
"has_manifest": true
|
| 151 |
+
},
|
| 152 |
+
{
|
| 153 |
+
"drug_id": "279",
|
| 154 |
+
"canonical_name": "Medroxyprogesterone",
|
| 155 |
+
"index_key": "MEDROXYPROGESTERONE_PGR",
|
| 156 |
+
"pdb_id": "1A28",
|
| 157 |
+
"tier": "1",
|
| 158 |
+
"session_id": "d52b1b7c0313bded",
|
| 159 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\d52b1b7c0313bded",
|
| 160 |
+
"elapsed_s": 28.7,
|
| 161 |
+
"status": "ok",
|
| 162 |
+
"best_affinity": -9.921,
|
| 163 |
+
"qc_pass": true,
|
| 164 |
+
"route_status": "same_pdb_surrogate",
|
| 165 |
+
"route_fallback": true,
|
| 166 |
+
"has_manifest": true
|
| 167 |
+
}
|
| 168 |
+
]
|
| 169 |
+
}
|
config/catalog_batch_run_summary_280-289.json
ADDED
|
@@ -0,0 +1,169 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"generated_at": "2026-07-01T09:11:41.551232+00:00",
|
| 3 |
+
"count": 10,
|
| 4 |
+
"total_elapsed_s": 925.7,
|
| 5 |
+
"ok": 9,
|
| 6 |
+
"partial": 0,
|
| 7 |
+
"skip": 0,
|
| 8 |
+
"qc_pass": 5,
|
| 9 |
+
"results": [
|
| 10 |
+
{
|
| 11 |
+
"drug_id": "280",
|
| 12 |
+
"canonical_name": "Norethindrone",
|
| 13 |
+
"index_key": "NORETHINDRONE_PGR_PROXY",
|
| 14 |
+
"pdb_id": "1A28",
|
| 15 |
+
"tier": "2",
|
| 16 |
+
"session_id": "f257c27a974b4a40",
|
| 17 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\f257c27a974b4a40",
|
| 18 |
+
"elapsed_s": 43.8,
|
| 19 |
+
"status": "ok",
|
| 20 |
+
"best_affinity": -10.23,
|
| 21 |
+
"qc_pass": true,
|
| 22 |
+
"route_status": "same_pdb_surrogate",
|
| 23 |
+
"route_fallback": true,
|
| 24 |
+
"has_manifest": true
|
| 25 |
+
},
|
| 26 |
+
{
|
| 27 |
+
"drug_id": "281",
|
| 28 |
+
"canonical_name": "Danazol",
|
| 29 |
+
"index_key": "DANAZOL_AR",
|
| 30 |
+
"pdb_id": "3R5W",
|
| 31 |
+
"tier": "2",
|
| 32 |
+
"session_id": "2b5ab3a317c9a406",
|
| 33 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\2b5ab3a317c9a406",
|
| 34 |
+
"elapsed_s": 71.2,
|
| 35 |
+
"status": "ok",
|
| 36 |
+
"best_affinity": -8.487,
|
| 37 |
+
"qc_pass": true,
|
| 38 |
+
"route_status": "same_pdb_surrogate",
|
| 39 |
+
"route_fallback": true,
|
| 40 |
+
"has_manifest": true
|
| 41 |
+
},
|
| 42 |
+
{
|
| 43 |
+
"drug_id": "282",
|
| 44 |
+
"canonical_name": "Fludrocortisone",
|
| 45 |
+
"index_key": "FLUDROCORTISONE_NR3C2_PROXY",
|
| 46 |
+
"pdb_id": "2AA2",
|
| 47 |
+
"tier": "2",
|
| 48 |
+
"session_id": "e6b135a941ca37d5",
|
| 49 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\e6b135a941ca37d5",
|
| 50 |
+
"elapsed_s": 24.4,
|
| 51 |
+
"status": "ok",
|
| 52 |
+
"best_affinity": -9.599,
|
| 53 |
+
"qc_pass": false,
|
| 54 |
+
"route_status": "same_pdb_surrogate",
|
| 55 |
+
"route_fallback": true,
|
| 56 |
+
"has_manifest": true
|
| 57 |
+
},
|
| 58 |
+
{
|
| 59 |
+
"drug_id": "283",
|
| 60 |
+
"canonical_name": "Cefalexin",
|
| 61 |
+
"index_key": "CEFALEXIN_PBP_PROXY",
|
| 62 |
+
"pdb_id": "1PWP",
|
| 63 |
+
"tier": "2",
|
| 64 |
+
"session_id": "ab55a9f5339f9d88",
|
| 65 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\ab55a9f5339f9d88",
|
| 66 |
+
"elapsed_s": 52.6,
|
| 67 |
+
"status": "ok",
|
| 68 |
+
"best_affinity": -7.346,
|
| 69 |
+
"qc_pass": true,
|
| 70 |
+
"route_status": "same_pdb_surrogate",
|
| 71 |
+
"route_fallback": true,
|
| 72 |
+
"has_manifest": true
|
| 73 |
+
},
|
| 74 |
+
{
|
| 75 |
+
"drug_id": "284",
|
| 76 |
+
"canonical_name": "Cefazolin",
|
| 77 |
+
"index_key": "CEFAZOLIN_PBP_PROXY",
|
| 78 |
+
"pdb_id": "1PWP",
|
| 79 |
+
"tier": "2",
|
| 80 |
+
"session_id": "3752b13370d32439",
|
| 81 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\3752b13370d32439",
|
| 82 |
+
"elapsed_s": 53.2,
|
| 83 |
+
"status": "ok",
|
| 84 |
+
"best_affinity": -7.018,
|
| 85 |
+
"qc_pass": true,
|
| 86 |
+
"route_status": "same_pdb_surrogate",
|
| 87 |
+
"route_fallback": true,
|
| 88 |
+
"has_manifest": true
|
| 89 |
+
},
|
| 90 |
+
{
|
| 91 |
+
"drug_id": "285",
|
| 92 |
+
"canonical_name": "Dicloxacillin",
|
| 93 |
+
"index_key": "DICLOXACILLIN_PBP_PROXY",
|
| 94 |
+
"pdb_id": "1PWP",
|
| 95 |
+
"tier": "2",
|
| 96 |
+
"session_id": "90a22c096024d34d",
|
| 97 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\90a22c096024d34d",
|
| 98 |
+
"elapsed_s": 64.5,
|
| 99 |
+
"status": "ok",
|
| 100 |
+
"best_affinity": -7.384,
|
| 101 |
+
"qc_pass": true,
|
| 102 |
+
"route_status": "same_pdb_surrogate",
|
| 103 |
+
"route_fallback": true,
|
| 104 |
+
"has_manifest": true
|
| 105 |
+
},
|
| 106 |
+
{
|
| 107 |
+
"drug_id": "286",
|
| 108 |
+
"canonical_name": "Tetracycline",
|
| 109 |
+
"index_key": "TETRACYCLINE_RIBOSOME",
|
| 110 |
+
"pdb_id": "1HNW",
|
| 111 |
+
"tier": "2",
|
| 112 |
+
"session_id": "e6455e277afcf288",
|
| 113 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\e6455e277afcf288",
|
| 114 |
+
"elapsed_s": 199.8,
|
| 115 |
+
"status": "ok",
|
| 116 |
+
"best_affinity": -4.556,
|
| 117 |
+
"qc_pass": false,
|
| 118 |
+
"route_status": "same_pdb_surrogate",
|
| 119 |
+
"route_fallback": true,
|
| 120 |
+
"has_manifest": true
|
| 121 |
+
},
|
| 122 |
+
{
|
| 123 |
+
"drug_id": "287",
|
| 124 |
+
"canonical_name": "Erythromycin",
|
| 125 |
+
"index_key": "ERYTHROMYCIN_RIBOSOME",
|
| 126 |
+
"pdb_id": "1YIJ",
|
| 127 |
+
"tier": "2",
|
| 128 |
+
"session_id": "cd724b08b3d75a8b",
|
| 129 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\cd724b08b3d75a8b",
|
| 130 |
+
"elapsed_s": 0.4,
|
| 131 |
+
"status": "fail",
|
| 132 |
+
"failed_at": "m1",
|
| 133 |
+
"route_status": "same_pdb_surrogate",
|
| 134 |
+
"route_fallback": true
|
| 135 |
+
},
|
| 136 |
+
{
|
| 137 |
+
"drug_id": "288",
|
| 138 |
+
"canonical_name": "Gentamicin",
|
| 139 |
+
"index_key": "GENTAMICIN_RIBOSOME",
|
| 140 |
+
"pdb_id": "1HNW",
|
| 141 |
+
"tier": "2",
|
| 142 |
+
"session_id": "ee964b763fdfaa00",
|
| 143 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\ee964b763fdfaa00",
|
| 144 |
+
"elapsed_s": 211.1,
|
| 145 |
+
"status": "ok",
|
| 146 |
+
"best_affinity": -4.464,
|
| 147 |
+
"qc_pass": false,
|
| 148 |
+
"route_status": "same_pdb_surrogate",
|
| 149 |
+
"route_fallback": true,
|
| 150 |
+
"has_manifest": true
|
| 151 |
+
},
|
| 152 |
+
{
|
| 153 |
+
"drug_id": "289",
|
| 154 |
+
"canonical_name": "Streptomycin",
|
| 155 |
+
"index_key": "STREPTOMYCIN_RIBOSOME",
|
| 156 |
+
"pdb_id": "1HNW",
|
| 157 |
+
"tier": "2",
|
| 158 |
+
"session_id": "9fc60a43f72b421b",
|
| 159 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\9fc60a43f72b421b",
|
| 160 |
+
"elapsed_s": 204.2,
|
| 161 |
+
"status": "ok",
|
| 162 |
+
"best_affinity": -4.144,
|
| 163 |
+
"qc_pass": false,
|
| 164 |
+
"route_status": "same_pdb_surrogate",
|
| 165 |
+
"route_fallback": true,
|
| 166 |
+
"has_manifest": true
|
| 167 |
+
}
|
| 168 |
+
]
|
| 169 |
+
}
|
config/catalog_batch_run_summary_290-300.json
ADDED
|
@@ -0,0 +1,187 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"generated_at": "2026-07-01T10:43:23.018363+00:00",
|
| 3 |
+
"count": 11,
|
| 4 |
+
"total_elapsed_s": 1212.0,
|
| 5 |
+
"ok": 11,
|
| 6 |
+
"partial": 0,
|
| 7 |
+
"skip": 0,
|
| 8 |
+
"qc_pass": 9,
|
| 9 |
+
"results": [
|
| 10 |
+
{
|
| 11 |
+
"drug_id": "290",
|
| 12 |
+
"canonical_name": "Tobramycin",
|
| 13 |
+
"index_key": "TOBRAMYCIN_RIBOSOME",
|
| 14 |
+
"pdb_id": "1HNW",
|
| 15 |
+
"tier": "2",
|
| 16 |
+
"session_id": "77a2ba15b637b213",
|
| 17 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\77a2ba15b637b213",
|
| 18 |
+
"elapsed_s": 234.2,
|
| 19 |
+
"status": "ok",
|
| 20 |
+
"best_affinity": -4.12,
|
| 21 |
+
"qc_pass": false,
|
| 22 |
+
"route_status": "same_pdb_surrogate",
|
| 23 |
+
"route_fallback": true,
|
| 24 |
+
"has_manifest": true
|
| 25 |
+
},
|
| 26 |
+
{
|
| 27 |
+
"drug_id": "291",
|
| 28 |
+
"canonical_name": "Meropenem",
|
| 29 |
+
"index_key": "MEROPENEM_PBP_PROXY",
|
| 30 |
+
"pdb_id": "1PWP",
|
| 31 |
+
"tier": "2",
|
| 32 |
+
"session_id": "078e02157d4957e2",
|
| 33 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\078e02157d4957e2",
|
| 34 |
+
"elapsed_s": 56.9,
|
| 35 |
+
"status": "ok",
|
| 36 |
+
"best_affinity": -7.35,
|
| 37 |
+
"qc_pass": true,
|
| 38 |
+
"route_status": "same_pdb_surrogate",
|
| 39 |
+
"route_fallback": true,
|
| 40 |
+
"has_manifest": true
|
| 41 |
+
},
|
| 42 |
+
{
|
| 43 |
+
"drug_id": "292",
|
| 44 |
+
"canonical_name": "Imipenem",
|
| 45 |
+
"index_key": "IMIPENEM_PBP_PROXY",
|
| 46 |
+
"pdb_id": "1PWP",
|
| 47 |
+
"tier": "2",
|
| 48 |
+
"session_id": "6cc9a6746b36d3cb",
|
| 49 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\6cc9a6746b36d3cb",
|
| 50 |
+
"elapsed_s": 56.4,
|
| 51 |
+
"status": "ok",
|
| 52 |
+
"best_affinity": -7.371,
|
| 53 |
+
"qc_pass": true,
|
| 54 |
+
"route_status": "same_pdb_surrogate",
|
| 55 |
+
"route_fallback": true,
|
| 56 |
+
"has_manifest": true
|
| 57 |
+
},
|
| 58 |
+
{
|
| 59 |
+
"drug_id": "293",
|
| 60 |
+
"canonical_name": "Amikacin",
|
| 61 |
+
"index_key": "AMIKACIN_RIBOSOME",
|
| 62 |
+
"pdb_id": "1HNW",
|
| 63 |
+
"tier": "2",
|
| 64 |
+
"session_id": "1bff5e84461d89a3",
|
| 65 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\1bff5e84461d89a3",
|
| 66 |
+
"elapsed_s": 246.4,
|
| 67 |
+
"status": "ok",
|
| 68 |
+
"best_affinity": -4.175,
|
| 69 |
+
"qc_pass": false,
|
| 70 |
+
"route_status": "same_pdb_surrogate",
|
| 71 |
+
"route_fallback": true,
|
| 72 |
+
"has_manifest": true
|
| 73 |
+
},
|
| 74 |
+
{
|
| 75 |
+
"drug_id": "294",
|
| 76 |
+
"canonical_name": "Cobimetinib",
|
| 77 |
+
"index_key": "COBIMETINIB_MEK1",
|
| 78 |
+
"pdb_id": "4AN2",
|
| 79 |
+
"tier": "1",
|
| 80 |
+
"session_id": "e2e573d58d64d84a",
|
| 81 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\e2e573d58d64d84a",
|
| 82 |
+
"elapsed_s": 33.6,
|
| 83 |
+
"status": "ok",
|
| 84 |
+
"best_affinity": -10.57,
|
| 85 |
+
"qc_pass": true,
|
| 86 |
+
"route_status": "same_pdb_surrogate",
|
| 87 |
+
"route_fallback": true,
|
| 88 |
+
"has_manifest": true
|
| 89 |
+
},
|
| 90 |
+
{
|
| 91 |
+
"drug_id": "295",
|
| 92 |
+
"canonical_name": "Binimetinib",
|
| 93 |
+
"index_key": "BINIMETINIB_MEK1",
|
| 94 |
+
"pdb_id": "3ORX",
|
| 95 |
+
"tier": "1",
|
| 96 |
+
"session_id": "835a930be8102c74",
|
| 97 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\835a930be8102c74",
|
| 98 |
+
"elapsed_s": 184.2,
|
| 99 |
+
"status": "ok",
|
| 100 |
+
"best_affinity": -7.117,
|
| 101 |
+
"qc_pass": true,
|
| 102 |
+
"route_status": "same_pdb_surrogate",
|
| 103 |
+
"route_fallback": true,
|
| 104 |
+
"has_manifest": true
|
| 105 |
+
},
|
| 106 |
+
{
|
| 107 |
+
"drug_id": "296",
|
| 108 |
+
"canonical_name": "Vismodegib",
|
| 109 |
+
"index_key": "VISMODEGIB_SMO",
|
| 110 |
+
"pdb_id": "4I72",
|
| 111 |
+
"tier": "1",
|
| 112 |
+
"session_id": "c22de7fd969e419a",
|
| 113 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\c22de7fd969e419a",
|
| 114 |
+
"elapsed_s": 85.0,
|
| 115 |
+
"status": "ok",
|
| 116 |
+
"best_affinity": -8.668,
|
| 117 |
+
"qc_pass": true,
|
| 118 |
+
"route_status": "same_pdb_surrogate",
|
| 119 |
+
"route_fallback": true,
|
| 120 |
+
"has_manifest": true
|
| 121 |
+
},
|
| 122 |
+
{
|
| 123 |
+
"drug_id": "297",
|
| 124 |
+
"canonical_name": "Sonidegib",
|
| 125 |
+
"index_key": "SONIDEGIB_SMO",
|
| 126 |
+
"pdb_id": "4N82",
|
| 127 |
+
"tier": "1",
|
| 128 |
+
"session_id": "f6f6ad353a693b26",
|
| 129 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\f6f6ad353a693b26",
|
| 130 |
+
"elapsed_s": 59.0,
|
| 131 |
+
"status": "ok",
|
| 132 |
+
"best_affinity": -10.95,
|
| 133 |
+
"qc_pass": true,
|
| 134 |
+
"route_status": "same_pdb_surrogate",
|
| 135 |
+
"route_fallback": true,
|
| 136 |
+
"has_manifest": true
|
| 137 |
+
},
|
| 138 |
+
{
|
| 139 |
+
"drug_id": "298",
|
| 140 |
+
"canonical_name": "Adagrasib",
|
| 141 |
+
"index_key": "ADAGRASIB_KRAS",
|
| 142 |
+
"pdb_id": "6UT0",
|
| 143 |
+
"tier": "1",
|
| 144 |
+
"session_id": "255d5569e8304bed",
|
| 145 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\255d5569e8304bed",
|
| 146 |
+
"elapsed_s": 108.7,
|
| 147 |
+
"status": "ok",
|
| 148 |
+
"best_affinity": -10.64,
|
| 149 |
+
"qc_pass": true,
|
| 150 |
+
"route_status": "same_pdb_surrogate",
|
| 151 |
+
"route_fallback": true,
|
| 152 |
+
"has_manifest": true
|
| 153 |
+
},
|
| 154 |
+
{
|
| 155 |
+
"drug_id": "299",
|
| 156 |
+
"canonical_name": "Mobocertinib",
|
| 157 |
+
"index_key": "MOBOCERTINIB_EGFR",
|
| 158 |
+
"pdb_id": "7SIM",
|
| 159 |
+
"tier": "1",
|
| 160 |
+
"session_id": "eadbeea6ad720387",
|
| 161 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\eadbeea6ad720387",
|
| 162 |
+
"elapsed_s": 96.6,
|
| 163 |
+
"status": "ok",
|
| 164 |
+
"best_affinity": -9.172,
|
| 165 |
+
"qc_pass": true,
|
| 166 |
+
"route_status": "same_pdb_surrogate",
|
| 167 |
+
"route_fallback": true,
|
| 168 |
+
"has_manifest": true
|
| 169 |
+
},
|
| 170 |
+
{
|
| 171 |
+
"drug_id": "300",
|
| 172 |
+
"canonical_name": "Tivozanib",
|
| 173 |
+
"index_key": "TIVOZANIB_VEGFR",
|
| 174 |
+
"pdb_id": "4ASD",
|
| 175 |
+
"tier": "1",
|
| 176 |
+
"session_id": "af854c719f0c24fd",
|
| 177 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\af854c719f0c24fd",
|
| 178 |
+
"elapsed_s": 50.3,
|
| 179 |
+
"status": "ok",
|
| 180 |
+
"best_affinity": -11.08,
|
| 181 |
+
"qc_pass": true,
|
| 182 |
+
"route_status": "same_pdb_surrogate",
|
| 183 |
+
"route_fallback": true,
|
| 184 |
+
"has_manifest": true
|
| 185 |
+
}
|
| 186 |
+
]
|
| 187 |
+
}
|
config/catalog_batch_run_summary_30-39.json
ADDED
|
@@ -0,0 +1,171 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"generated_at": "2026-06-29T17:56:12.698082+00:00",
|
| 3 |
+
"count": 10,
|
| 4 |
+
"total_elapsed_s": 1004.2,
|
| 5 |
+
"ok": 10,
|
| 6 |
+
"partial": 0,
|
| 7 |
+
"skip": 0,
|
| 8 |
+
"qc_pass": 8,
|
| 9 |
+
"results": [
|
| 10 |
+
{
|
| 11 |
+
"drug_id": "30",
|
| 12 |
+
"canonical_name": "Amlodipine",
|
| 13 |
+
"index_key": "AMLODIPINE_CACNA1C_PROXY",
|
| 14 |
+
"pdb_id": "8WE8",
|
| 15 |
+
"tier": "1",
|
| 16 |
+
"session_id": "316189372316ee9c",
|
| 17 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\316189372316ee9c",
|
| 18 |
+
"elapsed_s": 210.2,
|
| 19 |
+
"status": "ok",
|
| 20 |
+
"best_affinity": -7.055,
|
| 21 |
+
"qc_pass": false,
|
| 22 |
+
"route_status": "direct_ok",
|
| 23 |
+
"route_fallback": false,
|
| 24 |
+
"has_manifest": true
|
| 25 |
+
},
|
| 26 |
+
{
|
| 27 |
+
"drug_id": "31",
|
| 28 |
+
"canonical_name": "Losartan",
|
| 29 |
+
"index_key": "LOSARTAN_AT1R_PROXY",
|
| 30 |
+
"pdb_id": "4ZUD",
|
| 31 |
+
"tier": "2",
|
| 32 |
+
"session_id": "f27ddb5f4a82a41b",
|
| 33 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\f27ddb5f4a82a41b",
|
| 34 |
+
"elapsed_s": 65.0,
|
| 35 |
+
"status": "ok",
|
| 36 |
+
"best_affinity": -9.237,
|
| 37 |
+
"qc_pass": true,
|
| 38 |
+
"route_status": "direct_ok",
|
| 39 |
+
"route_fallback": false,
|
| 40 |
+
"has_manifest": true
|
| 41 |
+
},
|
| 42 |
+
{
|
| 43 |
+
"drug_id": "32",
|
| 44 |
+
"canonical_name": "Rosuvastatin",
|
| 45 |
+
"index_key": "ROSUVASTATIN_HMGCR",
|
| 46 |
+
"pdb_id": "3B7Q",
|
| 47 |
+
"tier": "1",
|
| 48 |
+
"session_id": "ec560eb83ee7eb0a",
|
| 49 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\ec560eb83ee7eb0a",
|
| 50 |
+
"elapsed_s": 61.7,
|
| 51 |
+
"status": "ok",
|
| 52 |
+
"best_affinity": -9.488,
|
| 53 |
+
"qc_pass": true,
|
| 54 |
+
"route_status": "direct_ok",
|
| 55 |
+
"route_fallback": false,
|
| 56 |
+
"has_manifest": true
|
| 57 |
+
},
|
| 58 |
+
{
|
| 59 |
+
"drug_id": "33",
|
| 60 |
+
"canonical_name": "Simvastatin",
|
| 61 |
+
"index_key": "SIMVASTATIN_HMGCR",
|
| 62 |
+
"pdb_id": "1HW9",
|
| 63 |
+
"tier": "1",
|
| 64 |
+
"session_id": "65c19611400eb4c1",
|
| 65 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\65c19611400eb4c1",
|
| 66 |
+
"elapsed_s": 113.5,
|
| 67 |
+
"status": "ok",
|
| 68 |
+
"best_affinity": -6.727,
|
| 69 |
+
"qc_pass": false,
|
| 70 |
+
"route_status": "direct_ok",
|
| 71 |
+
"route_fallback": false,
|
| 72 |
+
"has_manifest": true
|
| 73 |
+
},
|
| 74 |
+
{
|
| 75 |
+
"drug_id": "34",
|
| 76 |
+
"canonical_name": "Pioglitazone",
|
| 77 |
+
"index_key": "PIOGLITAZONE_PPARGAMMA_PROXY",
|
| 78 |
+
"pdb_id": "2PRG",
|
| 79 |
+
"tier": "2",
|
| 80 |
+
"session_id": "76c353230cb47516",
|
| 81 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\76c353230cb47516",
|
| 82 |
+
"elapsed_s": 68.8,
|
| 83 |
+
"status": "ok",
|
| 84 |
+
"best_affinity": -10.28,
|
| 85 |
+
"qc_pass": true,
|
| 86 |
+
"route_status": "direct_ok",
|
| 87 |
+
"route_fallback": false,
|
| 88 |
+
"has_manifest": true
|
| 89 |
+
},
|
| 90 |
+
{
|
| 91 |
+
"drug_id": "35",
|
| 92 |
+
"canonical_name": "Empagliflozin",
|
| 93 |
+
"index_key": "EMPAGLIFLOZIN_SGLT2",
|
| 94 |
+
"pdb_id": "7VSI",
|
| 95 |
+
"tier": "1",
|
| 96 |
+
"session_id": "6fec546ae0adeef6",
|
| 97 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\6fec546ae0adeef6",
|
| 98 |
+
"elapsed_s": 81.8,
|
| 99 |
+
"status": "ok",
|
| 100 |
+
"best_affinity": -9.695,
|
| 101 |
+
"qc_pass": true,
|
| 102 |
+
"route_status": "direct_ok",
|
| 103 |
+
"route_fallback": false,
|
| 104 |
+
"has_manifest": true
|
| 105 |
+
},
|
| 106 |
+
{
|
| 107 |
+
"drug_id": "36",
|
| 108 |
+
"canonical_name": "Saxagliptin",
|
| 109 |
+
"index_key": "SAXAGLIPTIN_DPP4",
|
| 110 |
+
"pdb_id": "3C43",
|
| 111 |
+
"tier": "1",
|
| 112 |
+
"session_id": "afd69009c8c6e20b",
|
| 113 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\afd69009c8c6e20b",
|
| 114 |
+
"elapsed_s": 88.3,
|
| 115 |
+
"status": "ok",
|
| 116 |
+
"best_affinity": -8.026,
|
| 117 |
+
"qc_pass": true,
|
| 118 |
+
"route_status": "direct_ok",
|
| 119 |
+
"route_fallback": false,
|
| 120 |
+
"has_manifest": true
|
| 121 |
+
},
|
| 122 |
+
{
|
| 123 |
+
"drug_id": "37",
|
| 124 |
+
"canonical_name": "Lansoprazole",
|
| 125 |
+
"index_key": "LANSOPRAZOLE_CYP2C19",
|
| 126 |
+
"pdb_id": "4GQS",
|
| 127 |
+
"tier": "2",
|
| 128 |
+
"session_id": "eca99c33396b3396",
|
| 129 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\eca99c33396b3396",
|
| 130 |
+
"elapsed_s": 206.8,
|
| 131 |
+
"status": "ok",
|
| 132 |
+
"best_affinity": -8.797,
|
| 133 |
+
"qc_pass": true,
|
| 134 |
+
"route_status": "direct_ok",
|
| 135 |
+
"route_fallback": false,
|
| 136 |
+
"has_manifest": true
|
| 137 |
+
},
|
| 138 |
+
{
|
| 139 |
+
"drug_id": "38",
|
| 140 |
+
"canonical_name": "Metoprolol",
|
| 141 |
+
"index_key": "METOPROLOL_ADRB1_PROXY",
|
| 142 |
+
"pdb_id": "2Y02",
|
| 143 |
+
"tier": "2",
|
| 144 |
+
"session_id": "4bfbdecd5fe8fdab",
|
| 145 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\4bfbdecd5fe8fdab",
|
| 146 |
+
"elapsed_s": 46.2,
|
| 147 |
+
"status": "ok",
|
| 148 |
+
"best_affinity": -6.944,
|
| 149 |
+
"qc_pass": true,
|
| 150 |
+
"route_status": "direct_ok",
|
| 151 |
+
"route_fallback": false,
|
| 152 |
+
"has_manifest": true
|
| 153 |
+
},
|
| 154 |
+
{
|
| 155 |
+
"drug_id": "39",
|
| 156 |
+
"canonical_name": "Fenofibrate",
|
| 157 |
+
"index_key": "FENOFIBRATE_PPARALPHA",
|
| 158 |
+
"pdb_id": "1K74",
|
| 159 |
+
"tier": "1",
|
| 160 |
+
"session_id": "d7a6ccdf1970a7c1",
|
| 161 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\d7a6ccdf1970a7c1",
|
| 162 |
+
"elapsed_s": 61.7,
|
| 163 |
+
"status": "ok",
|
| 164 |
+
"best_affinity": -8.134,
|
| 165 |
+
"qc_pass": true,
|
| 166 |
+
"route_status": "direct_ok",
|
| 167 |
+
"route_fallback": false,
|
| 168 |
+
"has_manifest": true
|
| 169 |
+
}
|
| 170 |
+
]
|
| 171 |
+
}
|
config/catalog_batch_run_summary_40-49.json
ADDED
|
@@ -0,0 +1,171 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"generated_at": "2026-06-29T21:29:20.356757+00:00",
|
| 3 |
+
"count": 10,
|
| 4 |
+
"total_elapsed_s": 1126.3,
|
| 5 |
+
"ok": 10,
|
| 6 |
+
"partial": 0,
|
| 7 |
+
"skip": 0,
|
| 8 |
+
"qc_pass": 6,
|
| 9 |
+
"results": [
|
| 10 |
+
{
|
| 11 |
+
"drug_id": "40",
|
| 12 |
+
"canonical_name": "Hydrochlorothiazide",
|
| 13 |
+
"index_key": "HYDROCHLOROTHIAZIDE_CA2_PROXY",
|
| 14 |
+
"pdb_id": "3HS4",
|
| 15 |
+
"tier": "2",
|
| 16 |
+
"session_id": "38d7f1bf7a642646",
|
| 17 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\38d7f1bf7a642646",
|
| 18 |
+
"elapsed_s": 39.3,
|
| 19 |
+
"status": "ok",
|
| 20 |
+
"best_affinity": -5.87,
|
| 21 |
+
"qc_pass": false,
|
| 22 |
+
"route_status": "direct_ok",
|
| 23 |
+
"route_fallback": false,
|
| 24 |
+
"has_manifest": true
|
| 25 |
+
},
|
| 26 |
+
{
|
| 27 |
+
"drug_id": "41",
|
| 28 |
+
"canonical_name": "Diclofenac",
|
| 29 |
+
"index_key": "DICLOFENAC_COX2",
|
| 30 |
+
"pdb_id": "5IKR",
|
| 31 |
+
"tier": "1",
|
| 32 |
+
"session_id": "fc343a070d35398c",
|
| 33 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\fc343a070d35398c",
|
| 34 |
+
"elapsed_s": 90.6,
|
| 35 |
+
"status": "ok",
|
| 36 |
+
"best_affinity": -8.308,
|
| 37 |
+
"qc_pass": true,
|
| 38 |
+
"route_status": "direct_ok",
|
| 39 |
+
"route_fallback": false,
|
| 40 |
+
"has_manifest": true
|
| 41 |
+
},
|
| 42 |
+
{
|
| 43 |
+
"drug_id": "42",
|
| 44 |
+
"canonical_name": "Naproxen",
|
| 45 |
+
"index_key": "NAPROXEN_COX2",
|
| 46 |
+
"pdb_id": "5IKT",
|
| 47 |
+
"tier": "2",
|
| 48 |
+
"session_id": "07cb450a60b15def",
|
| 49 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\07cb450a60b15def",
|
| 50 |
+
"elapsed_s": 150.2,
|
| 51 |
+
"status": "ok",
|
| 52 |
+
"best_affinity": -7.822,
|
| 53 |
+
"qc_pass": true,
|
| 54 |
+
"route_status": "direct_ok",
|
| 55 |
+
"route_fallback": false,
|
| 56 |
+
"has_manifest": true
|
| 57 |
+
},
|
| 58 |
+
{
|
| 59 |
+
"drug_id": "43",
|
| 60 |
+
"canonical_name": "Meloxicam",
|
| 61 |
+
"index_key": "MELOXICAM_COX2_PROXY",
|
| 62 |
+
"pdb_id": "5IKR",
|
| 63 |
+
"tier": "2",
|
| 64 |
+
"session_id": "ea5259d6fde4001d",
|
| 65 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\ea5259d6fde4001d",
|
| 66 |
+
"elapsed_s": 97.8,
|
| 67 |
+
"status": "ok",
|
| 68 |
+
"best_affinity": -7.857,
|
| 69 |
+
"qc_pass": true,
|
| 70 |
+
"route_status": "direct_ok",
|
| 71 |
+
"route_fallback": false,
|
| 72 |
+
"has_manifest": true
|
| 73 |
+
},
|
| 74 |
+
{
|
| 75 |
+
"drug_id": "44",
|
| 76 |
+
"canonical_name": "Hydroxychloroquine",
|
| 77 |
+
"index_key": "HYDROXYCHLOROQUINE_LYSO_PROXY",
|
| 78 |
+
"pdb_id": "4MLN",
|
| 79 |
+
"tier": "2",
|
| 80 |
+
"session_id": "3ceff3963d231f55",
|
| 81 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\3ceff3963d231f55",
|
| 82 |
+
"elapsed_s": 57.2,
|
| 83 |
+
"status": "ok",
|
| 84 |
+
"best_affinity": -5.145,
|
| 85 |
+
"qc_pass": false,
|
| 86 |
+
"route_status": "direct_ok",
|
| 87 |
+
"route_fallback": false,
|
| 88 |
+
"has_manifest": true
|
| 89 |
+
},
|
| 90 |
+
{
|
| 91 |
+
"drug_id": "45",
|
| 92 |
+
"canonical_name": "Montelukast",
|
| 93 |
+
"index_key": "MONTELUKAST_CYSLT1_PROXY",
|
| 94 |
+
"pdb_id": "6RZ4",
|
| 95 |
+
"tier": "2",
|
| 96 |
+
"session_id": "751e273738e31823",
|
| 97 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\751e273738e31823",
|
| 98 |
+
"elapsed_s": 54.7,
|
| 99 |
+
"status": "ok",
|
| 100 |
+
"best_affinity": -11.04,
|
| 101 |
+
"qc_pass": true,
|
| 102 |
+
"route_status": "direct_ok",
|
| 103 |
+
"route_fallback": false,
|
| 104 |
+
"has_manifest": true
|
| 105 |
+
},
|
| 106 |
+
{
|
| 107 |
+
"drug_id": "46",
|
| 108 |
+
"canonical_name": "Albuterol",
|
| 109 |
+
"index_key": "ALBUTEROL_ADRB2_PROXY",
|
| 110 |
+
"pdb_id": "2Y00",
|
| 111 |
+
"tier": "2",
|
| 112 |
+
"session_id": "26b4cf9a21b01c5f",
|
| 113 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\26b4cf9a21b01c5f",
|
| 114 |
+
"elapsed_s": 42.1,
|
| 115 |
+
"status": "ok",
|
| 116 |
+
"best_affinity": -6.847,
|
| 117 |
+
"qc_pass": true,
|
| 118 |
+
"route_status": "direct_ok",
|
| 119 |
+
"route_fallback": false,
|
| 120 |
+
"has_manifest": true
|
| 121 |
+
},
|
| 122 |
+
{
|
| 123 |
+
"drug_id": "47",
|
| 124 |
+
"canonical_name": "Ciprofloxacin",
|
| 125 |
+
"index_key": "CIPROFLOXACIN_GYRASE",
|
| 126 |
+
"pdb_id": "2XCT",
|
| 127 |
+
"tier": "1",
|
| 128 |
+
"session_id": "fb9a5d3064305e2d",
|
| 129 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\fb9a5d3064305e2d",
|
| 130 |
+
"elapsed_s": 387.8,
|
| 131 |
+
"status": "ok",
|
| 132 |
+
"best_affinity": -7.461,
|
| 133 |
+
"qc_pass": true,
|
| 134 |
+
"route_status": "direct_ok",
|
| 135 |
+
"route_fallback": false,
|
| 136 |
+
"has_manifest": true
|
| 137 |
+
},
|
| 138 |
+
{
|
| 139 |
+
"drug_id": "48",
|
| 140 |
+
"canonical_name": "Prednisone",
|
| 141 |
+
"index_key": "PREDNISONE_NR3C1_PROXY",
|
| 142 |
+
"pdb_id": "1M2Z",
|
| 143 |
+
"tier": "2",
|
| 144 |
+
"session_id": "2e13c4f3a6f68e5c",
|
| 145 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\2e13c4f3a6f68e5c",
|
| 146 |
+
"elapsed_s": 60.5,
|
| 147 |
+
"status": "ok",
|
| 148 |
+
"best_affinity": -9.496,
|
| 149 |
+
"qc_pass": false,
|
| 150 |
+
"route_status": "direct_ok",
|
| 151 |
+
"route_fallback": false,
|
| 152 |
+
"has_manifest": true
|
| 153 |
+
},
|
| 154 |
+
{
|
| 155 |
+
"drug_id": "49",
|
| 156 |
+
"canonical_name": "Acetaminophen",
|
| 157 |
+
"index_key": "ACETAMINOPHEN_COX2_PROXY",
|
| 158 |
+
"pdb_id": "5IKT",
|
| 159 |
+
"tier": "2",
|
| 160 |
+
"session_id": "f6aa48d5ed11a7f8",
|
| 161 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\f6aa48d5ed11a7f8",
|
| 162 |
+
"elapsed_s": 145.6,
|
| 163 |
+
"status": "ok",
|
| 164 |
+
"best_affinity": -6.146,
|
| 165 |
+
"qc_pass": false,
|
| 166 |
+
"route_status": "direct_ok",
|
| 167 |
+
"route_fallback": false,
|
| 168 |
+
"has_manifest": true
|
| 169 |
+
}
|
| 170 |
+
]
|
| 171 |
+
}
|
config/catalog_batch_run_summary_50-59.json
ADDED
|
@@ -0,0 +1,171 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"generated_at": "2026-06-29T22:31:07.472784+00:00",
|
| 3 |
+
"count": 10,
|
| 4 |
+
"total_elapsed_s": 543.9,
|
| 5 |
+
"ok": 10,
|
| 6 |
+
"partial": 0,
|
| 7 |
+
"skip": 0,
|
| 8 |
+
"qc_pass": 10,
|
| 9 |
+
"results": [
|
| 10 |
+
{
|
| 11 |
+
"drug_id": "50",
|
| 12 |
+
"canonical_name": "Fluoxetine",
|
| 13 |
+
"index_key": "FLUOXETINE_SERT_PROXY",
|
| 14 |
+
"pdb_id": "5I6X",
|
| 15 |
+
"tier": "2",
|
| 16 |
+
"session_id": "1ebe5b7c7781ca00",
|
| 17 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\1ebe5b7c7781ca00",
|
| 18 |
+
"elapsed_s": 89.2,
|
| 19 |
+
"status": "ok",
|
| 20 |
+
"best_affinity": -8.994,
|
| 21 |
+
"qc_pass": true,
|
| 22 |
+
"route_status": "direct_ok",
|
| 23 |
+
"route_fallback": false,
|
| 24 |
+
"has_manifest": true
|
| 25 |
+
},
|
| 26 |
+
{
|
| 27 |
+
"drug_id": "51",
|
| 28 |
+
"canonical_name": "Dasatinib",
|
| 29 |
+
"index_key": "DASATINIB_ABL",
|
| 30 |
+
"pdb_id": "2GQG",
|
| 31 |
+
"tier": "1",
|
| 32 |
+
"session_id": "9c840dcc3169ef1d",
|
| 33 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\9c840dcc3169ef1d",
|
| 34 |
+
"elapsed_s": 55.1,
|
| 35 |
+
"status": "ok",
|
| 36 |
+
"best_affinity": -9.212,
|
| 37 |
+
"qc_pass": true,
|
| 38 |
+
"route_status": "direct_ok",
|
| 39 |
+
"route_fallback": false,
|
| 40 |
+
"has_manifest": true
|
| 41 |
+
},
|
| 42 |
+
{
|
| 43 |
+
"drug_id": "52",
|
| 44 |
+
"canonical_name": "Sunitinib",
|
| 45 |
+
"index_key": "SUNITINIB_VEGFR2",
|
| 46 |
+
"pdb_id": "3G5E",
|
| 47 |
+
"tier": "1",
|
| 48 |
+
"session_id": "7ec56c76167b9ad3",
|
| 49 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\7ec56c76167b9ad3",
|
| 50 |
+
"elapsed_s": 36.3,
|
| 51 |
+
"status": "ok",
|
| 52 |
+
"best_affinity": -9.273,
|
| 53 |
+
"qc_pass": true,
|
| 54 |
+
"route_status": "direct_ok",
|
| 55 |
+
"route_fallback": false,
|
| 56 |
+
"has_manifest": true
|
| 57 |
+
},
|
| 58 |
+
{
|
| 59 |
+
"drug_id": "53",
|
| 60 |
+
"canonical_name": "Lapatinib",
|
| 61 |
+
"index_key": "LAPATINIB_EGFR",
|
| 62 |
+
"pdb_id": "1XKK",
|
| 63 |
+
"tier": "1",
|
| 64 |
+
"session_id": "e5973b85b284af02",
|
| 65 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\e5973b85b284af02",
|
| 66 |
+
"elapsed_s": 63.9,
|
| 67 |
+
"status": "ok",
|
| 68 |
+
"best_affinity": -10.13,
|
| 69 |
+
"qc_pass": true,
|
| 70 |
+
"route_status": "direct_ok",
|
| 71 |
+
"route_fallback": false,
|
| 72 |
+
"has_manifest": true
|
| 73 |
+
},
|
| 74 |
+
{
|
| 75 |
+
"drug_id": "54",
|
| 76 |
+
"canonical_name": "Palbociclib",
|
| 77 |
+
"index_key": "PALBOCICLIB_CDK6",
|
| 78 |
+
"pdb_id": "5L2I",
|
| 79 |
+
"tier": "1",
|
| 80 |
+
"session_id": "0a00e25b69837d3e",
|
| 81 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\0a00e25b69837d3e",
|
| 82 |
+
"elapsed_s": 32.0,
|
| 83 |
+
"status": "ok",
|
| 84 |
+
"best_affinity": -10.25,
|
| 85 |
+
"qc_pass": true,
|
| 86 |
+
"route_status": "direct_ok",
|
| 87 |
+
"route_fallback": false,
|
| 88 |
+
"has_manifest": true
|
| 89 |
+
},
|
| 90 |
+
{
|
| 91 |
+
"drug_id": "55",
|
| 92 |
+
"canonical_name": "Trametinib",
|
| 93 |
+
"index_key": "TRAMETINIB_MEK1",
|
| 94 |
+
"pdb_id": "7JUX",
|
| 95 |
+
"tier": "1",
|
| 96 |
+
"session_id": "9227759c44d3ecf0",
|
| 97 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\9227759c44d3ecf0",
|
| 98 |
+
"elapsed_s": 31.3,
|
| 99 |
+
"status": "ok",
|
| 100 |
+
"best_affinity": -8.325,
|
| 101 |
+
"qc_pass": true,
|
| 102 |
+
"route_status": "direct_ok",
|
| 103 |
+
"route_fallback": false,
|
| 104 |
+
"has_manifest": true
|
| 105 |
+
},
|
| 106 |
+
{
|
| 107 |
+
"drug_id": "56",
|
| 108 |
+
"canonical_name": "Letrozole",
|
| 109 |
+
"index_key": "LETROZOLE_CYP19",
|
| 110 |
+
"pdb_id": "1E3Q",
|
| 111 |
+
"tier": "1",
|
| 112 |
+
"session_id": "bec82e76ffb9573e",
|
| 113 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\bec82e76ffb9573e",
|
| 114 |
+
"elapsed_s": 46.1,
|
| 115 |
+
"status": "ok",
|
| 116 |
+
"best_affinity": -9.559,
|
| 117 |
+
"qc_pass": true,
|
| 118 |
+
"route_status": "direct_ok",
|
| 119 |
+
"route_fallback": false,
|
| 120 |
+
"has_manifest": true
|
| 121 |
+
},
|
| 122 |
+
{
|
| 123 |
+
"drug_id": "57",
|
| 124 |
+
"canonical_name": "Anastrozole",
|
| 125 |
+
"index_key": "ANASTROZOLE_CYP19",
|
| 126 |
+
"pdb_id": "3S7S",
|
| 127 |
+
"tier": "1",
|
| 128 |
+
"session_id": "fe11d1eb7ff27622",
|
| 129 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\fe11d1eb7ff27622",
|
| 130 |
+
"elapsed_s": 43.7,
|
| 131 |
+
"status": "ok",
|
| 132 |
+
"best_affinity": -10.03,
|
| 133 |
+
"qc_pass": true,
|
| 134 |
+
"route_status": "direct_ok",
|
| 135 |
+
"route_fallback": false,
|
| 136 |
+
"has_manifest": true
|
| 137 |
+
},
|
| 138 |
+
{
|
| 139 |
+
"drug_id": "58",
|
| 140 |
+
"canonical_name": "Venetoclax",
|
| 141 |
+
"index_key": "VENETOCLAX_BCL2",
|
| 142 |
+
"pdb_id": "6O0K",
|
| 143 |
+
"tier": "1",
|
| 144 |
+
"session_id": "8670f025502d9dc5",
|
| 145 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\8670f025502d9dc5",
|
| 146 |
+
"elapsed_s": 74.4,
|
| 147 |
+
"status": "ok",
|
| 148 |
+
"best_affinity": -10.57,
|
| 149 |
+
"qc_pass": true,
|
| 150 |
+
"route_status": "direct_ok",
|
| 151 |
+
"route_fallback": false,
|
| 152 |
+
"has_manifest": true
|
| 153 |
+
},
|
| 154 |
+
{
|
| 155 |
+
"drug_id": "59",
|
| 156 |
+
"canonical_name": "Dabrafenib",
|
| 157 |
+
"index_key": "DABRAFENIB_BRAF",
|
| 158 |
+
"pdb_id": "4XV2",
|
| 159 |
+
"tier": "1",
|
| 160 |
+
"session_id": "1bbeeeb5ab9f0493",
|
| 161 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\1bbeeeb5ab9f0493",
|
| 162 |
+
"elapsed_s": 71.7,
|
| 163 |
+
"status": "ok",
|
| 164 |
+
"best_affinity": -11.24,
|
| 165 |
+
"qc_pass": true,
|
| 166 |
+
"route_status": "direct_ok",
|
| 167 |
+
"route_fallback": false,
|
| 168 |
+
"has_manifest": true
|
| 169 |
+
}
|
| 170 |
+
]
|
| 171 |
+
}
|
config/catalog_batch_run_summary_60-69.json
ADDED
|
@@ -0,0 +1,170 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"generated_at": "2026-06-29T23:06:51.356496+00:00",
|
| 3 |
+
"count": 10,
|
| 4 |
+
"total_elapsed_s": 679.4,
|
| 5 |
+
"ok": 9,
|
| 6 |
+
"partial": 0,
|
| 7 |
+
"skip": 0,
|
| 8 |
+
"qc_pass": 9,
|
| 9 |
+
"results": [
|
| 10 |
+
{
|
| 11 |
+
"drug_id": "60",
|
| 12 |
+
"canonical_name": "Carvedilol",
|
| 13 |
+
"index_key": "CARVEDILOL_ADRB1_PROXY",
|
| 14 |
+
"pdb_id": "2Y03",
|
| 15 |
+
"tier": "2",
|
| 16 |
+
"session_id": "7e25d02de009fc2b",
|
| 17 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\7e25d02de009fc2b",
|
| 18 |
+
"elapsed_s": 78.3,
|
| 19 |
+
"status": "ok",
|
| 20 |
+
"best_affinity": -9.464,
|
| 21 |
+
"qc_pass": true,
|
| 22 |
+
"route_status": "direct_ok",
|
| 23 |
+
"route_fallback": false,
|
| 24 |
+
"has_manifest": true
|
| 25 |
+
},
|
| 26 |
+
{
|
| 27 |
+
"drug_id": "61",
|
| 28 |
+
"canonical_name": "Glipizide",
|
| 29 |
+
"index_key": "GLIPIZIDE_KATP_PROXY",
|
| 30 |
+
"pdb_id": "3SYQ",
|
| 31 |
+
"tier": "2",
|
| 32 |
+
"session_id": "78098c804885dc0d",
|
| 33 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\78098c804885dc0d",
|
| 34 |
+
"elapsed_s": 57.8,
|
| 35 |
+
"status": "ok",
|
| 36 |
+
"best_affinity": -7.06,
|
| 37 |
+
"qc_pass": true,
|
| 38 |
+
"route_status": "same_pdb_surrogate",
|
| 39 |
+
"route_fallback": true,
|
| 40 |
+
"has_manifest": true
|
| 41 |
+
},
|
| 42 |
+
{
|
| 43 |
+
"drug_id": "62",
|
| 44 |
+
"canonical_name": "Repaglinide",
|
| 45 |
+
"index_key": "REPAGLINIDE_KATP",
|
| 46 |
+
"pdb_id": "3SYQ",
|
| 47 |
+
"tier": "1",
|
| 48 |
+
"session_id": "e21bd68b6c04e727",
|
| 49 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\e21bd68b6c04e727",
|
| 50 |
+
"elapsed_s": 77.5,
|
| 51 |
+
"status": "ok",
|
| 52 |
+
"best_affinity": -7.005,
|
| 53 |
+
"qc_pass": true,
|
| 54 |
+
"route_status": "cross_pdb_proxy",
|
| 55 |
+
"route_fallback": true,
|
| 56 |
+
"has_manifest": true
|
| 57 |
+
},
|
| 58 |
+
{
|
| 59 |
+
"drug_id": "63",
|
| 60 |
+
"canonical_name": "Canagliflozin",
|
| 61 |
+
"index_key": "CANAGLIFLOZIN_SGLT2",
|
| 62 |
+
"pdb_id": "7VSL",
|
| 63 |
+
"tier": "1",
|
| 64 |
+
"session_id": "d22e8ac2cc61a323",
|
| 65 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\d22e8ac2cc61a323",
|
| 66 |
+
"elapsed_s": 66.0,
|
| 67 |
+
"status": "ok",
|
| 68 |
+
"best_affinity": -10.88,
|
| 69 |
+
"qc_pass": true,
|
| 70 |
+
"route_status": "same_pdb_surrogate",
|
| 71 |
+
"route_fallback": true,
|
| 72 |
+
"has_manifest": true
|
| 73 |
+
},
|
| 74 |
+
{
|
| 75 |
+
"drug_id": "64",
|
| 76 |
+
"canonical_name": "Dapagliflozin",
|
| 77 |
+
"index_key": "DAPAGLIFLOZIN_SGLT2",
|
| 78 |
+
"pdb_id": "7VSI",
|
| 79 |
+
"tier": "1",
|
| 80 |
+
"session_id": "e9629795a827264a",
|
| 81 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\e9629795a827264a",
|
| 82 |
+
"elapsed_s": 116.5,
|
| 83 |
+
"status": "ok",
|
| 84 |
+
"best_affinity": -9.983,
|
| 85 |
+
"qc_pass": true,
|
| 86 |
+
"route_status": "cross_pdb_proxy",
|
| 87 |
+
"route_fallback": true,
|
| 88 |
+
"has_manifest": true
|
| 89 |
+
},
|
| 90 |
+
{
|
| 91 |
+
"drug_id": "65",
|
| 92 |
+
"canonical_name": "Ezetimibe",
|
| 93 |
+
"index_key": "EZETIMIBE_NPC1L1",
|
| 94 |
+
"pdb_id": "3QNT",
|
| 95 |
+
"tier": "1",
|
| 96 |
+
"session_id": "3798e7eef2f99491",
|
| 97 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\3798e7eef2f99491",
|
| 98 |
+
"elapsed_s": 15.0,
|
| 99 |
+
"status": "fail",
|
| 100 |
+
"failed_at": "m4b",
|
| 101 |
+
"route_status": "no_route",
|
| 102 |
+
"route_fallback": false,
|
| 103 |
+
"has_manifest": true
|
| 104 |
+
},
|
| 105 |
+
{
|
| 106 |
+
"drug_id": "66",
|
| 107 |
+
"canonical_name": "Pravastatin",
|
| 108 |
+
"index_key": "PRAVASTATIN_HMGCR_PROXY",
|
| 109 |
+
"pdb_id": "1HW9",
|
| 110 |
+
"tier": "2",
|
| 111 |
+
"session_id": "177370c52bb87918",
|
| 112 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\177370c52bb87918",
|
| 113 |
+
"elapsed_s": 95.1,
|
| 114 |
+
"status": "ok",
|
| 115 |
+
"best_affinity": -6.836,
|
| 116 |
+
"qc_pass": true,
|
| 117 |
+
"route_status": "direct_ok",
|
| 118 |
+
"route_fallback": false,
|
| 119 |
+
"has_manifest": true
|
| 120 |
+
},
|
| 121 |
+
{
|
| 122 |
+
"drug_id": "67",
|
| 123 |
+
"canonical_name": "Lovastatin",
|
| 124 |
+
"index_key": "LOVASTATIN_HMGCR",
|
| 125 |
+
"pdb_id": "1HW8",
|
| 126 |
+
"tier": "1",
|
| 127 |
+
"session_id": "2c1e31f7d47c77bb",
|
| 128 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\2c1e31f7d47c77bb",
|
| 129 |
+
"elapsed_s": 96.1,
|
| 130 |
+
"status": "ok",
|
| 131 |
+
"best_affinity": -6.535,
|
| 132 |
+
"qc_pass": true,
|
| 133 |
+
"route_status": "same_pdb_surrogate",
|
| 134 |
+
"route_fallback": true,
|
| 135 |
+
"has_manifest": true
|
| 136 |
+
},
|
| 137 |
+
{
|
| 138 |
+
"drug_id": "68",
|
| 139 |
+
"canonical_name": "Valsartan",
|
| 140 |
+
"index_key": "VALSARTAN_AT1R_PROXY",
|
| 141 |
+
"pdb_id": "4ZUD",
|
| 142 |
+
"tier": "2",
|
| 143 |
+
"session_id": "4454d4d74b646635",
|
| 144 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\4454d4d74b646635",
|
| 145 |
+
"elapsed_s": 47.5,
|
| 146 |
+
"status": "ok",
|
| 147 |
+
"best_affinity": -8.675,
|
| 148 |
+
"qc_pass": true,
|
| 149 |
+
"route_status": "direct_ok",
|
| 150 |
+
"route_fallback": false,
|
| 151 |
+
"has_manifest": true
|
| 152 |
+
},
|
| 153 |
+
{
|
| 154 |
+
"drug_id": "69",
|
| 155 |
+
"canonical_name": "Spironolactone",
|
| 156 |
+
"index_key": "SPIRONOLACTONE_NR3C2",
|
| 157 |
+
"pdb_id": "2AA2",
|
| 158 |
+
"tier": "1",
|
| 159 |
+
"session_id": "b1e58ad085239aa1",
|
| 160 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\b1e58ad085239aa1",
|
| 161 |
+
"elapsed_s": 29.0,
|
| 162 |
+
"status": "ok",
|
| 163 |
+
"best_affinity": -6.66,
|
| 164 |
+
"qc_pass": true,
|
| 165 |
+
"route_status": "same_pdb_surrogate",
|
| 166 |
+
"route_fallback": true,
|
| 167 |
+
"has_manifest": true
|
| 168 |
+
}
|
| 169 |
+
]
|
| 170 |
+
}
|
config/catalog_batch_run_summary_70-79.json
ADDED
|
@@ -0,0 +1,169 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"generated_at": "2026-06-29T23:40:03.246485+00:00",
|
| 3 |
+
"count": 10,
|
| 4 |
+
"total_elapsed_s": 1747.9,
|
| 5 |
+
"ok": 9,
|
| 6 |
+
"partial": 0,
|
| 7 |
+
"skip": 0,
|
| 8 |
+
"qc_pass": 7,
|
| 9 |
+
"results": [
|
| 10 |
+
{
|
| 11 |
+
"drug_id": "70",
|
| 12 |
+
"canonical_name": "Propranolol",
|
| 13 |
+
"index_key": "PROPRANOLOL_ADRB1_PROXY",
|
| 14 |
+
"pdb_id": "2Y02",
|
| 15 |
+
"tier": "2",
|
| 16 |
+
"session_id": "b5bae316bdf238a5",
|
| 17 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\b5bae316bdf238a5",
|
| 18 |
+
"elapsed_s": 35.2,
|
| 19 |
+
"status": "ok",
|
| 20 |
+
"best_affinity": -6.748,
|
| 21 |
+
"qc_pass": true,
|
| 22 |
+
"route_status": "direct_ok",
|
| 23 |
+
"route_fallback": false,
|
| 24 |
+
"has_manifest": true
|
| 25 |
+
},
|
| 26 |
+
{
|
| 27 |
+
"drug_id": "71",
|
| 28 |
+
"canonical_name": "Indomethacin",
|
| 29 |
+
"index_key": "INDOMETHACIN_COX2_PROXY",
|
| 30 |
+
"pdb_id": "5IKR",
|
| 31 |
+
"tier": "2",
|
| 32 |
+
"session_id": "343447d0e170107a",
|
| 33 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\343447d0e170107a",
|
| 34 |
+
"elapsed_s": 90.7,
|
| 35 |
+
"status": "ok",
|
| 36 |
+
"best_affinity": -8.11,
|
| 37 |
+
"qc_pass": true,
|
| 38 |
+
"route_status": "direct_ok",
|
| 39 |
+
"route_fallback": false,
|
| 40 |
+
"has_manifest": true
|
| 41 |
+
},
|
| 42 |
+
{
|
| 43 |
+
"drug_id": "72",
|
| 44 |
+
"canonical_name": "Ketorolac",
|
| 45 |
+
"index_key": "KETOROLAC_COX2",
|
| 46 |
+
"pdb_id": "1Q4G",
|
| 47 |
+
"tier": "1",
|
| 48 |
+
"session_id": "3e0f7afb6013ef6d",
|
| 49 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\3e0f7afb6013ef6d",
|
| 50 |
+
"elapsed_s": 113.1,
|
| 51 |
+
"status": "ok",
|
| 52 |
+
"best_affinity": -6.948,
|
| 53 |
+
"qc_pass": true,
|
| 54 |
+
"route_status": "same_pdb_surrogate",
|
| 55 |
+
"route_fallback": true,
|
| 56 |
+
"has_manifest": true
|
| 57 |
+
},
|
| 58 |
+
{
|
| 59 |
+
"drug_id": "73",
|
| 60 |
+
"canonical_name": "Piroxicam",
|
| 61 |
+
"index_key": "PIROXICAM_COX2_PROXY",
|
| 62 |
+
"pdb_id": "5IKT",
|
| 63 |
+
"tier": "2",
|
| 64 |
+
"session_id": "408626b740c2b2ed",
|
| 65 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\408626b740c2b2ed",
|
| 66 |
+
"elapsed_s": 154.0,
|
| 67 |
+
"status": "ok",
|
| 68 |
+
"best_affinity": -6.47,
|
| 69 |
+
"qc_pass": false,
|
| 70 |
+
"route_status": "direct_ok",
|
| 71 |
+
"route_fallback": false,
|
| 72 |
+
"has_manifest": true
|
| 73 |
+
},
|
| 74 |
+
{
|
| 75 |
+
"drug_id": "74",
|
| 76 |
+
"canonical_name": "Azithromycin",
|
| 77 |
+
"index_key": "AZITHROMYCIN_RIBOSOME",
|
| 78 |
+
"pdb_id": "1YHQ",
|
| 79 |
+
"tier": "1",
|
| 80 |
+
"session_id": "7d9666f30745df38",
|
| 81 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\7d9666f30745df38",
|
| 82 |
+
"elapsed_s": 728.7,
|
| 83 |
+
"status": "ok",
|
| 84 |
+
"best_affinity": -3.443,
|
| 85 |
+
"qc_pass": false,
|
| 86 |
+
"route_status": "cross_pdb_proxy",
|
| 87 |
+
"route_fallback": true,
|
| 88 |
+
"has_manifest": true
|
| 89 |
+
},
|
| 90 |
+
{
|
| 91 |
+
"drug_id": "75",
|
| 92 |
+
"canonical_name": "Amoxicillin",
|
| 93 |
+
"index_key": "AMOXICILLIN_PBP_PROXY",
|
| 94 |
+
"pdb_id": "1PWP",
|
| 95 |
+
"tier": "2",
|
| 96 |
+
"session_id": "c66f9df2ceeb8baf",
|
| 97 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\c66f9df2ceeb8baf",
|
| 98 |
+
"elapsed_s": 94.2,
|
| 99 |
+
"status": "ok",
|
| 100 |
+
"best_affinity": -6.898,
|
| 101 |
+
"qc_pass": true,
|
| 102 |
+
"route_status": "same_pdb_surrogate",
|
| 103 |
+
"route_fallback": true,
|
| 104 |
+
"has_manifest": true
|
| 105 |
+
},
|
| 106 |
+
{
|
| 107 |
+
"drug_id": "76",
|
| 108 |
+
"canonical_name": "Doxycycline",
|
| 109 |
+
"index_key": "DOXYCYCLINE_RIBOSOME",
|
| 110 |
+
"pdb_id": "1HNW",
|
| 111 |
+
"tier": "1",
|
| 112 |
+
"session_id": "7dbf82e1dc3dc931",
|
| 113 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\7dbf82e1dc3dc931",
|
| 114 |
+
"elapsed_s": 0.7,
|
| 115 |
+
"status": "fail",
|
| 116 |
+
"failed_at": "m1",
|
| 117 |
+
"route_status": "same_pdb_surrogate",
|
| 118 |
+
"route_fallback": true
|
| 119 |
+
},
|
| 120 |
+
{
|
| 121 |
+
"drug_id": "77",
|
| 122 |
+
"canonical_name": "Levofloxacin",
|
| 123 |
+
"index_key": "LEVOFLOXACIN_GYRASE",
|
| 124 |
+
"pdb_id": "2XCT",
|
| 125 |
+
"tier": "2",
|
| 126 |
+
"session_id": "3bad04d9f957542c",
|
| 127 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\3bad04d9f957542c",
|
| 128 |
+
"elapsed_s": 389.0,
|
| 129 |
+
"status": "ok",
|
| 130 |
+
"best_affinity": -7.624,
|
| 131 |
+
"qc_pass": true,
|
| 132 |
+
"route_status": "direct_ok",
|
| 133 |
+
"route_fallback": false,
|
| 134 |
+
"has_manifest": true
|
| 135 |
+
},
|
| 136 |
+
{
|
| 137 |
+
"drug_id": "78",
|
| 138 |
+
"canonical_name": "Trimethoprim",
|
| 139 |
+
"index_key": "TRIMETHOPRIM_DHFR",
|
| 140 |
+
"pdb_id": "2W9G",
|
| 141 |
+
"tier": "1",
|
| 142 |
+
"session_id": "2efa0824f12cd1b9",
|
| 143 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\2efa0824f12cd1b9",
|
| 144 |
+
"elapsed_s": 35.8,
|
| 145 |
+
"status": "ok",
|
| 146 |
+
"best_affinity": -7.542,
|
| 147 |
+
"qc_pass": true,
|
| 148 |
+
"route_status": "same_pdb_surrogate",
|
| 149 |
+
"route_fallback": true,
|
| 150 |
+
"has_manifest": true
|
| 151 |
+
},
|
| 152 |
+
{
|
| 153 |
+
"drug_id": "79",
|
| 154 |
+
"canonical_name": "Sertraline",
|
| 155 |
+
"index_key": "SERTRALINE_SERT_PROXY",
|
| 156 |
+
"pdb_id": "5I6X",
|
| 157 |
+
"tier": "2",
|
| 158 |
+
"session_id": "2c05bb00c988648d",
|
| 159 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\2c05bb00c988648d",
|
| 160 |
+
"elapsed_s": 105.5,
|
| 161 |
+
"status": "ok",
|
| 162 |
+
"best_affinity": -9.227,
|
| 163 |
+
"qc_pass": true,
|
| 164 |
+
"route_status": "direct_ok",
|
| 165 |
+
"route_fallback": false,
|
| 166 |
+
"has_manifest": true
|
| 167 |
+
}
|
| 168 |
+
]
|
| 169 |
+
}
|
config/catalog_batch_run_summary_80-89.json
ADDED
|
@@ -0,0 +1,169 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"generated_at": "2026-06-29T23:53:00.039730+00:00",
|
| 3 |
+
"count": 10,
|
| 4 |
+
"total_elapsed_s": 659.9,
|
| 5 |
+
"ok": 8,
|
| 6 |
+
"partial": 0,
|
| 7 |
+
"skip": 0,
|
| 8 |
+
"qc_pass": 8,
|
| 9 |
+
"results": [
|
| 10 |
+
{
|
| 11 |
+
"drug_id": "80",
|
| 12 |
+
"canonical_name": "Paroxetine",
|
| 13 |
+
"index_key": "PAROXETINE_SERT",
|
| 14 |
+
"pdb_id": "5I6X",
|
| 15 |
+
"tier": "1",
|
| 16 |
+
"session_id": "172c8b9d2b763380",
|
| 17 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\172c8b9d2b763380",
|
| 18 |
+
"elapsed_s": 119.0,
|
| 19 |
+
"status": "ok",
|
| 20 |
+
"best_affinity": -9.378,
|
| 21 |
+
"qc_pass": true,
|
| 22 |
+
"route_status": "direct_ok",
|
| 23 |
+
"route_fallback": false,
|
| 24 |
+
"has_manifest": true
|
| 25 |
+
},
|
| 26 |
+
{
|
| 27 |
+
"drug_id": "81",
|
| 28 |
+
"canonical_name": "Osimertinib",
|
| 29 |
+
"index_key": "OSIMERTINIB_EGFR",
|
| 30 |
+
"pdb_id": "5XGN",
|
| 31 |
+
"tier": "1",
|
| 32 |
+
"session_id": "b2733f1d8ba893e3",
|
| 33 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\b2733f1d8ba893e3",
|
| 34 |
+
"elapsed_s": 59.1,
|
| 35 |
+
"status": "ok",
|
| 36 |
+
"best_affinity": -8.29,
|
| 37 |
+
"qc_pass": true,
|
| 38 |
+
"route_status": "same_pdb_surrogate",
|
| 39 |
+
"route_fallback": true,
|
| 40 |
+
"has_manifest": true
|
| 41 |
+
},
|
| 42 |
+
{
|
| 43 |
+
"drug_id": "82",
|
| 44 |
+
"canonical_name": "Afatinib",
|
| 45 |
+
"index_key": "AFATINIB_EGFR",
|
| 46 |
+
"pdb_id": "4G5J",
|
| 47 |
+
"tier": "1",
|
| 48 |
+
"session_id": "d9955b9251aa1395",
|
| 49 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\d9955b9251aa1395",
|
| 50 |
+
"elapsed_s": 95.6,
|
| 51 |
+
"status": "ok",
|
| 52 |
+
"best_affinity": -6.362,
|
| 53 |
+
"qc_pass": true,
|
| 54 |
+
"route_status": "same_pdb_surrogate",
|
| 55 |
+
"route_fallback": true,
|
| 56 |
+
"has_manifest": true
|
| 57 |
+
},
|
| 58 |
+
{
|
| 59 |
+
"drug_id": "83",
|
| 60 |
+
"canonical_name": "Sorafenib",
|
| 61 |
+
"index_key": "SORAFENIB_BRAF",
|
| 62 |
+
"pdb_id": "3OG7",
|
| 63 |
+
"tier": "1",
|
| 64 |
+
"session_id": "88b880b8cefb9c24",
|
| 65 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\88b880b8cefb9c24",
|
| 66 |
+
"elapsed_s": 51.7,
|
| 67 |
+
"status": "ok",
|
| 68 |
+
"best_affinity": -9.859,
|
| 69 |
+
"qc_pass": true,
|
| 70 |
+
"route_status": "same_pdb_surrogate",
|
| 71 |
+
"route_fallback": true,
|
| 72 |
+
"has_manifest": true
|
| 73 |
+
},
|
| 74 |
+
{
|
| 75 |
+
"drug_id": "84",
|
| 76 |
+
"canonical_name": "Cabozantinib",
|
| 77 |
+
"index_key": "CABOZANTINIB_MET",
|
| 78 |
+
"pdb_id": "4O1B",
|
| 79 |
+
"tier": "1",
|
| 80 |
+
"session_id": "e0cf69e715eb5c96",
|
| 81 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\e0cf69e715eb5c96",
|
| 82 |
+
"elapsed_s": 89.5,
|
| 83 |
+
"status": "ok",
|
| 84 |
+
"best_affinity": -7.684,
|
| 85 |
+
"qc_pass": true,
|
| 86 |
+
"route_status": "same_pdb_surrogate",
|
| 87 |
+
"route_fallback": true,
|
| 88 |
+
"has_manifest": true
|
| 89 |
+
},
|
| 90 |
+
{
|
| 91 |
+
"drug_id": "85",
|
| 92 |
+
"canonical_name": "Ibrutinib",
|
| 93 |
+
"index_key": "IBRUTINIB_BTK",
|
| 94 |
+
"pdb_id": "4O5B",
|
| 95 |
+
"tier": "1",
|
| 96 |
+
"session_id": "131a125e328218e2",
|
| 97 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\131a125e328218e2",
|
| 98 |
+
"elapsed_s": 18.7,
|
| 99 |
+
"status": "fail",
|
| 100 |
+
"failed_at": "m5a",
|
| 101 |
+
"route_status": "same_pdb_surrogate",
|
| 102 |
+
"route_fallback": true,
|
| 103 |
+
"has_manifest": true
|
| 104 |
+
},
|
| 105 |
+
{
|
| 106 |
+
"drug_id": "86",
|
| 107 |
+
"canonical_name": "Olaparib",
|
| 108 |
+
"index_key": "OLAPARIB_PARP",
|
| 109 |
+
"pdb_id": "5DS5",
|
| 110 |
+
"tier": "1",
|
| 111 |
+
"session_id": "cb7e211ba798724c",
|
| 112 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\cb7e211ba798724c",
|
| 113 |
+
"elapsed_s": 50.8,
|
| 114 |
+
"status": "fail",
|
| 115 |
+
"failed_at": "m4b",
|
| 116 |
+
"route_status": "no_route",
|
| 117 |
+
"route_fallback": false,
|
| 118 |
+
"has_manifest": true
|
| 119 |
+
},
|
| 120 |
+
{
|
| 121 |
+
"drug_id": "87",
|
| 122 |
+
"canonical_name": "Ruxolitinib",
|
| 123 |
+
"index_key": "RUXOLITINIB_JAK2",
|
| 124 |
+
"pdb_id": "4IVC",
|
| 125 |
+
"tier": "1",
|
| 126 |
+
"session_id": "63c3f271ac60016f",
|
| 127 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\63c3f271ac60016f",
|
| 128 |
+
"elapsed_s": 35.3,
|
| 129 |
+
"status": "ok",
|
| 130 |
+
"best_affinity": -9.115,
|
| 131 |
+
"qc_pass": true,
|
| 132 |
+
"route_status": "same_pdb_surrogate",
|
| 133 |
+
"route_fallback": true,
|
| 134 |
+
"has_manifest": true
|
| 135 |
+
},
|
| 136 |
+
{
|
| 137 |
+
"drug_id": "88",
|
| 138 |
+
"canonical_name": "Enzalutamide",
|
| 139 |
+
"index_key": "ENZALUTAMIDE_AR",
|
| 140 |
+
"pdb_id": "3R5W",
|
| 141 |
+
"tier": "1",
|
| 142 |
+
"session_id": "3fbcd648db7b0a31",
|
| 143 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\3fbcd648db7b0a31",
|
| 144 |
+
"elapsed_s": 86.3,
|
| 145 |
+
"status": "ok",
|
| 146 |
+
"best_affinity": -8.236,
|
| 147 |
+
"qc_pass": true,
|
| 148 |
+
"route_status": "same_pdb_surrogate",
|
| 149 |
+
"route_fallback": true,
|
| 150 |
+
"has_manifest": true
|
| 151 |
+
},
|
| 152 |
+
{
|
| 153 |
+
"drug_id": "89",
|
| 154 |
+
"canonical_name": "Tamoxifen",
|
| 155 |
+
"index_key": "TAMOXIFEN_ESR1",
|
| 156 |
+
"pdb_id": "3ERT",
|
| 157 |
+
"tier": "2",
|
| 158 |
+
"session_id": "45ad02e26e4be3a2",
|
| 159 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\45ad02e26e4be3a2",
|
| 160 |
+
"elapsed_s": 53.3,
|
| 161 |
+
"status": "ok",
|
| 162 |
+
"best_affinity": -9.616,
|
| 163 |
+
"qc_pass": true,
|
| 164 |
+
"route_status": "same_pdb_surrogate",
|
| 165 |
+
"route_fallback": true,
|
| 166 |
+
"has_manifest": true
|
| 167 |
+
}
|
| 168 |
+
]
|
| 169 |
+
}
|
config/catalog_batch_run_summary_batch03.json
ADDED
|
@@ -0,0 +1,148 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"generated_at": "2026-06-29T16:31:02.405295+00:00",
|
| 3 |
+
"count": 10,
|
| 4 |
+
"total_elapsed_s": 603.2,
|
| 5 |
+
"ok": 7,
|
| 6 |
+
"partial": 0,
|
| 7 |
+
"skip": 0,
|
| 8 |
+
"qc_pass": 7,
|
| 9 |
+
"results": [
|
| 10 |
+
{
|
| 11 |
+
"drug_id": "55",
|
| 12 |
+
"canonical_name": "Trametinib",
|
| 13 |
+
"index_key": "TRAMETINIB_MEK1",
|
| 14 |
+
"pdb_id": "7JUX",
|
| 15 |
+
"tier": "1",
|
| 16 |
+
"session_id": "9227759c44d3ecf0",
|
| 17 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\9227759c44d3ecf0",
|
| 18 |
+
"elapsed_s": 60.0,
|
| 19 |
+
"status": "ok",
|
| 20 |
+
"best_affinity": -8.328,
|
| 21 |
+
"qc_pass": true,
|
| 22 |
+
"has_manifest": true
|
| 23 |
+
},
|
| 24 |
+
{
|
| 25 |
+
"drug_id": "56",
|
| 26 |
+
"canonical_name": "Letrozole",
|
| 27 |
+
"index_key": "LETROZOLE_CYP19",
|
| 28 |
+
"pdb_id": "1E3Q",
|
| 29 |
+
"tier": "1",
|
| 30 |
+
"session_id": "bec82e76ffb9573e",
|
| 31 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\bec82e76ffb9573e",
|
| 32 |
+
"elapsed_s": 77.3,
|
| 33 |
+
"status": "ok",
|
| 34 |
+
"best_affinity": -9.566,
|
| 35 |
+
"qc_pass": true,
|
| 36 |
+
"has_manifest": true
|
| 37 |
+
},
|
| 38 |
+
{
|
| 39 |
+
"drug_id": "57",
|
| 40 |
+
"canonical_name": "Anastrozole",
|
| 41 |
+
"index_key": "ANASTROZOLE_CYP19",
|
| 42 |
+
"pdb_id": "3S7S",
|
| 43 |
+
"tier": "1",
|
| 44 |
+
"session_id": "fe11d1eb7ff27622",
|
| 45 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\fe11d1eb7ff27622",
|
| 46 |
+
"elapsed_s": 62.3,
|
| 47 |
+
"status": "ok",
|
| 48 |
+
"best_affinity": -10.02,
|
| 49 |
+
"qc_pass": true,
|
| 50 |
+
"has_manifest": true
|
| 51 |
+
},
|
| 52 |
+
{
|
| 53 |
+
"drug_id": "58",
|
| 54 |
+
"canonical_name": "Venetoclax",
|
| 55 |
+
"index_key": "VENETOCLAX_BCL2",
|
| 56 |
+
"pdb_id": "6O0K",
|
| 57 |
+
"tier": "1",
|
| 58 |
+
"session_id": "8670f025502d9dc5",
|
| 59 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\8670f025502d9dc5",
|
| 60 |
+
"elapsed_s": 90.7,
|
| 61 |
+
"status": "ok",
|
| 62 |
+
"best_affinity": -10.23,
|
| 63 |
+
"qc_pass": true,
|
| 64 |
+
"has_manifest": true
|
| 65 |
+
},
|
| 66 |
+
{
|
| 67 |
+
"drug_id": "59",
|
| 68 |
+
"canonical_name": "Dabrafenib",
|
| 69 |
+
"index_key": "DABRAFENIB_BRAF",
|
| 70 |
+
"pdb_id": "4XV2",
|
| 71 |
+
"tier": "1",
|
| 72 |
+
"session_id": "1bbeeeb5ab9f0493",
|
| 73 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\1bbeeeb5ab9f0493",
|
| 74 |
+
"elapsed_s": 84.7,
|
| 75 |
+
"status": "ok",
|
| 76 |
+
"best_affinity": -9.434,
|
| 77 |
+
"qc_pass": true,
|
| 78 |
+
"has_manifest": true
|
| 79 |
+
},
|
| 80 |
+
{
|
| 81 |
+
"drug_id": "60",
|
| 82 |
+
"canonical_name": "Carvedilol",
|
| 83 |
+
"index_key": "CARVEDILOL_ADRB1_PROXY",
|
| 84 |
+
"pdb_id": "2Y03",
|
| 85 |
+
"tier": "2",
|
| 86 |
+
"session_id": "7e25d02de009fc2b",
|
| 87 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\7e25d02de009fc2b",
|
| 88 |
+
"elapsed_s": 80.6,
|
| 89 |
+
"status": "ok",
|
| 90 |
+
"best_affinity": -9.832,
|
| 91 |
+
"qc_pass": true,
|
| 92 |
+
"has_manifest": true
|
| 93 |
+
},
|
| 94 |
+
{
|
| 95 |
+
"drug_id": "62",
|
| 96 |
+
"canonical_name": "Repaglinide",
|
| 97 |
+
"index_key": "REPAGLINIDE_KATP",
|
| 98 |
+
"pdb_id": "3VE0",
|
| 99 |
+
"tier": "1",
|
| 100 |
+
"session_id": "e4baa5b23d5805d7",
|
| 101 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\e4baa5b23d5805d7",
|
| 102 |
+
"elapsed_s": 47.0,
|
| 103 |
+
"status": "fail",
|
| 104 |
+
"failed_at": "m4b",
|
| 105 |
+
"has_manifest": true
|
| 106 |
+
},
|
| 107 |
+
{
|
| 108 |
+
"drug_id": "63",
|
| 109 |
+
"canonical_name": "Canagliflozin",
|
| 110 |
+
"index_key": "CANAGLIFLOZIN_SGLT2",
|
| 111 |
+
"pdb_id": "7VSL",
|
| 112 |
+
"tier": "1",
|
| 113 |
+
"session_id": "d22e8ac2cc61a323",
|
| 114 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\d22e8ac2cc61a323",
|
| 115 |
+
"elapsed_s": 59.3,
|
| 116 |
+
"status": "ok",
|
| 117 |
+
"best_affinity": -10.84,
|
| 118 |
+
"qc_pass": true,
|
| 119 |
+
"has_manifest": true
|
| 120 |
+
},
|
| 121 |
+
{
|
| 122 |
+
"drug_id": "64",
|
| 123 |
+
"canonical_name": "Dapagliflozin",
|
| 124 |
+
"index_key": "DAPAGLIFLOZIN_SGLT2",
|
| 125 |
+
"pdb_id": "6VBL",
|
| 126 |
+
"tier": "1",
|
| 127 |
+
"session_id": "68817f168179fc00",
|
| 128 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\68817f168179fc00",
|
| 129 |
+
"elapsed_s": 27.1,
|
| 130 |
+
"status": "fail",
|
| 131 |
+
"failed_at": "m4b",
|
| 132 |
+
"has_manifest": true
|
| 133 |
+
},
|
| 134 |
+
{
|
| 135 |
+
"drug_id": "65",
|
| 136 |
+
"canonical_name": "Ezetimibe",
|
| 137 |
+
"index_key": "EZETIMIBE_NPC1L1",
|
| 138 |
+
"pdb_id": "3QNT",
|
| 139 |
+
"tier": "1",
|
| 140 |
+
"session_id": "3798e7eef2f99491",
|
| 141 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\3798e7eef2f99491",
|
| 142 |
+
"elapsed_s": 14.2,
|
| 143 |
+
"status": "fail",
|
| 144 |
+
"failed_at": "m4b",
|
| 145 |
+
"has_manifest": true
|
| 146 |
+
}
|
| 147 |
+
]
|
| 148 |
+
}
|
config/catalog_batch_run_summary_batch03_rerun.json
ADDED
|
@@ -0,0 +1,74 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"generated_at": "2026-06-29T17:32:29.814891+00:00",
|
| 3 |
+
"count": 4,
|
| 4 |
+
"total_elapsed_s": 1111.6,
|
| 5 |
+
"ok": 3,
|
| 6 |
+
"partial": 0,
|
| 7 |
+
"skip": 0,
|
| 8 |
+
"qc_pass": 2,
|
| 9 |
+
"results": [
|
| 10 |
+
{
|
| 11 |
+
"drug_id": "62",
|
| 12 |
+
"canonical_name": "Repaglinide",
|
| 13 |
+
"index_key": "REPAGLINIDE_KATP",
|
| 14 |
+
"pdb_id": "3SYQ",
|
| 15 |
+
"tier": "1",
|
| 16 |
+
"session_id": "e21bd68b6c04e727",
|
| 17 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\e21bd68b6c04e727",
|
| 18 |
+
"elapsed_s": 87.6,
|
| 19 |
+
"status": "ok",
|
| 20 |
+
"best_affinity": -7.158,
|
| 21 |
+
"qc_pass": true,
|
| 22 |
+
"route_status": "cross_pdb_proxy",
|
| 23 |
+
"route_fallback": true,
|
| 24 |
+
"has_manifest": true
|
| 25 |
+
},
|
| 26 |
+
{
|
| 27 |
+
"drug_id": "64",
|
| 28 |
+
"canonical_name": "Dapagliflozin",
|
| 29 |
+
"index_key": "DAPAGLIFLOZIN_SGLT2",
|
| 30 |
+
"pdb_id": "7VSI",
|
| 31 |
+
"tier": "1",
|
| 32 |
+
"session_id": "e9629795a827264a",
|
| 33 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\e9629795a827264a",
|
| 34 |
+
"elapsed_s": 192.7,
|
| 35 |
+
"status": "ok",
|
| 36 |
+
"best_affinity": -10.85,
|
| 37 |
+
"qc_pass": true,
|
| 38 |
+
"route_status": "cross_pdb_proxy",
|
| 39 |
+
"route_fallback": true,
|
| 40 |
+
"has_manifest": true
|
| 41 |
+
},
|
| 42 |
+
{
|
| 43 |
+
"drug_id": "65",
|
| 44 |
+
"canonical_name": "Ezetimibe",
|
| 45 |
+
"index_key": "EZETIMIBE_NPC1L1",
|
| 46 |
+
"pdb_id": "3QNT",
|
| 47 |
+
"tier": "1",
|
| 48 |
+
"session_id": "3798e7eef2f99491",
|
| 49 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\3798e7eef2f99491",
|
| 50 |
+
"elapsed_s": 15.2,
|
| 51 |
+
"status": "fail",
|
| 52 |
+
"failed_at": "m4b",
|
| 53 |
+
"route_status": "no_route",
|
| 54 |
+
"route_fallback": false,
|
| 55 |
+
"has_manifest": true
|
| 56 |
+
},
|
| 57 |
+
{
|
| 58 |
+
"drug_id": "74",
|
| 59 |
+
"canonical_name": "Azithromycin",
|
| 60 |
+
"index_key": "AZITHROMYCIN_RIBOSOME",
|
| 61 |
+
"pdb_id": "1YHQ",
|
| 62 |
+
"tier": "1",
|
| 63 |
+
"session_id": "7d9666f30745df38",
|
| 64 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\7d9666f30745df38",
|
| 65 |
+
"elapsed_s": 815.4,
|
| 66 |
+
"status": "ok",
|
| 67 |
+
"best_affinity": -3.22,
|
| 68 |
+
"qc_pass": false,
|
| 69 |
+
"route_status": "cross_pdb_proxy",
|
| 70 |
+
"route_fallback": true,
|
| 71 |
+
"has_manifest": true
|
| 72 |
+
}
|
| 73 |
+
]
|
| 74 |
+
}
|
config/catalog_batch_run_summary_batch04.json
ADDED
|
@@ -0,0 +1,150 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"generated_at": "2026-06-29T16:45:16.477416+00:00",
|
| 3 |
+
"count": 10,
|
| 4 |
+
"total_elapsed_s": 726.5,
|
| 5 |
+
"ok": 9,
|
| 6 |
+
"partial": 0,
|
| 7 |
+
"skip": 0,
|
| 8 |
+
"qc_pass": 9,
|
| 9 |
+
"results": [
|
| 10 |
+
{
|
| 11 |
+
"drug_id": "67",
|
| 12 |
+
"canonical_name": "Lovastatin",
|
| 13 |
+
"index_key": "LOVASTATIN_HMGCR",
|
| 14 |
+
"pdb_id": "1HW8",
|
| 15 |
+
"tier": "1",
|
| 16 |
+
"session_id": "2c1e31f7d47c77bb",
|
| 17 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\2c1e31f7d47c77bb",
|
| 18 |
+
"elapsed_s": 105.4,
|
| 19 |
+
"status": "ok",
|
| 20 |
+
"best_affinity": -6.536,
|
| 21 |
+
"qc_pass": true,
|
| 22 |
+
"has_manifest": true
|
| 23 |
+
},
|
| 24 |
+
{
|
| 25 |
+
"drug_id": "69",
|
| 26 |
+
"canonical_name": "Spironolactone",
|
| 27 |
+
"index_key": "SPIRONOLACTONE_NR3C2",
|
| 28 |
+
"pdb_id": "2AA2",
|
| 29 |
+
"tier": "1",
|
| 30 |
+
"session_id": "b1e58ad085239aa1",
|
| 31 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\b1e58ad085239aa1",
|
| 32 |
+
"elapsed_s": 32.0,
|
| 33 |
+
"status": "ok",
|
| 34 |
+
"best_affinity": -6.682,
|
| 35 |
+
"qc_pass": true,
|
| 36 |
+
"has_manifest": true
|
| 37 |
+
},
|
| 38 |
+
{
|
| 39 |
+
"drug_id": "72",
|
| 40 |
+
"canonical_name": "Ketorolac",
|
| 41 |
+
"index_key": "KETOROLAC_COX2",
|
| 42 |
+
"pdb_id": "1Q4G",
|
| 43 |
+
"tier": "1",
|
| 44 |
+
"session_id": "3e0f7afb6013ef6d",
|
| 45 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\3e0f7afb6013ef6d",
|
| 46 |
+
"elapsed_s": 121.8,
|
| 47 |
+
"status": "ok",
|
| 48 |
+
"best_affinity": -6.104,
|
| 49 |
+
"qc_pass": true,
|
| 50 |
+
"has_manifest": true
|
| 51 |
+
},
|
| 52 |
+
{
|
| 53 |
+
"drug_id": "74",
|
| 54 |
+
"canonical_name": "Azithromycin",
|
| 55 |
+
"index_key": "AZITHROMYCIN_RIBOSOME",
|
| 56 |
+
"pdb_id": "1YII",
|
| 57 |
+
"tier": "1",
|
| 58 |
+
"session_id": "955ee7b5788a42de",
|
| 59 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\955ee7b5788a42de",
|
| 60 |
+
"elapsed_s": 19.3,
|
| 61 |
+
"status": "fail",
|
| 62 |
+
"failed_at": "m4b",
|
| 63 |
+
"has_manifest": true
|
| 64 |
+
},
|
| 65 |
+
{
|
| 66 |
+
"drug_id": "78",
|
| 67 |
+
"canonical_name": "Trimethoprim",
|
| 68 |
+
"index_key": "TRIMETHOPRIM_DHFR",
|
| 69 |
+
"pdb_id": "2W9G",
|
| 70 |
+
"tier": "1",
|
| 71 |
+
"session_id": "2efa0824f12cd1b9",
|
| 72 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\2efa0824f12cd1b9",
|
| 73 |
+
"elapsed_s": 37.7,
|
| 74 |
+
"status": "ok",
|
| 75 |
+
"best_affinity": -7.537,
|
| 76 |
+
"qc_pass": true,
|
| 77 |
+
"has_manifest": true
|
| 78 |
+
},
|
| 79 |
+
{
|
| 80 |
+
"drug_id": "80",
|
| 81 |
+
"canonical_name": "Paroxetine",
|
| 82 |
+
"index_key": "PAROXETINE_SERT",
|
| 83 |
+
"pdb_id": "5I6X",
|
| 84 |
+
"tier": "1",
|
| 85 |
+
"session_id": "172c8b9d2b763380",
|
| 86 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\172c8b9d2b763380",
|
| 87 |
+
"elapsed_s": 116.6,
|
| 88 |
+
"status": "ok",
|
| 89 |
+
"best_affinity": -9.363,
|
| 90 |
+
"qc_pass": true,
|
| 91 |
+
"has_manifest": true
|
| 92 |
+
},
|
| 93 |
+
{
|
| 94 |
+
"drug_id": "81",
|
| 95 |
+
"canonical_name": "Osimertinib",
|
| 96 |
+
"index_key": "OSIMERTINIB_EGFR",
|
| 97 |
+
"pdb_id": "5XGN",
|
| 98 |
+
"tier": "1",
|
| 99 |
+
"session_id": "b2733f1d8ba893e3",
|
| 100 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\b2733f1d8ba893e3",
|
| 101 |
+
"elapsed_s": 60.3,
|
| 102 |
+
"status": "ok",
|
| 103 |
+
"best_affinity": -8.293,
|
| 104 |
+
"qc_pass": true,
|
| 105 |
+
"has_manifest": true
|
| 106 |
+
},
|
| 107 |
+
{
|
| 108 |
+
"drug_id": "82",
|
| 109 |
+
"canonical_name": "Afatinib",
|
| 110 |
+
"index_key": "AFATINIB_EGFR",
|
| 111 |
+
"pdb_id": "4G5J",
|
| 112 |
+
"tier": "1",
|
| 113 |
+
"session_id": "d9955b9251aa1395",
|
| 114 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\d9955b9251aa1395",
|
| 115 |
+
"elapsed_s": 82.6,
|
| 116 |
+
"status": "ok",
|
| 117 |
+
"best_affinity": -7.621,
|
| 118 |
+
"qc_pass": true,
|
| 119 |
+
"has_manifest": true
|
| 120 |
+
},
|
| 121 |
+
{
|
| 122 |
+
"drug_id": "83",
|
| 123 |
+
"canonical_name": "Sorafenib",
|
| 124 |
+
"index_key": "SORAFENIB_BRAF",
|
| 125 |
+
"pdb_id": "3OG7",
|
| 126 |
+
"tier": "1",
|
| 127 |
+
"session_id": "88b880b8cefb9c24",
|
| 128 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\88b880b8cefb9c24",
|
| 129 |
+
"elapsed_s": 52.3,
|
| 130 |
+
"status": "ok",
|
| 131 |
+
"best_affinity": -9.811,
|
| 132 |
+
"qc_pass": true,
|
| 133 |
+
"has_manifest": true
|
| 134 |
+
},
|
| 135 |
+
{
|
| 136 |
+
"drug_id": "84",
|
| 137 |
+
"canonical_name": "Cabozantinib",
|
| 138 |
+
"index_key": "CABOZANTINIB_MET",
|
| 139 |
+
"pdb_id": "4O1B",
|
| 140 |
+
"tier": "1",
|
| 141 |
+
"session_id": "e0cf69e715eb5c96",
|
| 142 |
+
"session_dir": "C:\\Users\\User\\Downloads\\moltgate_UI\\data\\sessions\\e0cf69e715eb5c96",
|
| 143 |
+
"elapsed_s": 98.4,
|
| 144 |
+
"status": "ok",
|
| 145 |
+
"best_affinity": -7.709,
|
| 146 |
+
"qc_pass": true,
|
| 147 |
+
"has_manifest": true
|
| 148 |
+
}
|
| 149 |
+
]
|
| 150 |
+
}
|
config/catalog_failure_review.json
ADDED
|
@@ -0,0 +1,159 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"total_with_docking_json": 54,
|
| 3 |
+
"qc_pass": 44,
|
| 4 |
+
"qc_fail_count": 9,
|
| 5 |
+
"pipeline_incomplete": [
|
| 6 |
+
{
|
| 7 |
+
"drug_id": 0,
|
| 8 |
+
"name": "?",
|
| 9 |
+
"target": "TUBULIN",
|
| 10 |
+
"session": "07e2d3dd2cbe9191",
|
| 11 |
+
"reason": "M4B Stage 22: Stage 21 無候選配體"
|
| 12 |
+
},
|
| 13 |
+
{
|
| 14 |
+
"drug_id": 65,
|
| 15 |
+
"name": "Ezetimibe",
|
| 16 |
+
"target": "EZETIMIBE_NPC1L1",
|
| 17 |
+
"session": "3798e7eef2f99491",
|
| 18 |
+
"reason": "M4B Stage 22: Stage 21 無候選配體"
|
| 19 |
+
},
|
| 20 |
+
{
|
| 21 |
+
"drug_id": 64,
|
| 22 |
+
"name": "Dapagliflozin",
|
| 23 |
+
"target": "DAPAGLIFLOZIN_SGLT2",
|
| 24 |
+
"session": "68817f168179fc00",
|
| 25 |
+
"reason": "M4B Stage 22: Stage 21 無候選配體"
|
| 26 |
+
},
|
| 27 |
+
{
|
| 28 |
+
"drug_id": 1,
|
| 29 |
+
"name": "Ibuprofen",
|
| 30 |
+
"target": "COX2",
|
| 31 |
+
"session": "93e44ebf6158878c",
|
| 32 |
+
"reason": "M4B Stage 22: Stage 21 無候選配體"
|
| 33 |
+
},
|
| 34 |
+
{
|
| 35 |
+
"drug_id": 74,
|
| 36 |
+
"name": "Azithromycin",
|
| 37 |
+
"target": "AZITHROMYCIN_RIBOSOME",
|
| 38 |
+
"session": "955ee7b5788a42de",
|
| 39 |
+
"reason": "M4B Stage 22: Stage 21 無候選配體"
|
| 40 |
+
},
|
| 41 |
+
{
|
| 42 |
+
"drug_id": 24,
|
| 43 |
+
"name": "Linagliptin",
|
| 44 |
+
"target": "DPP4_LINAGLIPTIN",
|
| 45 |
+
"session": "e213a429cd687763",
|
| 46 |
+
"reason": "M4B Stage 22: Stage 21 無候選配體"
|
| 47 |
+
},
|
| 48 |
+
{
|
| 49 |
+
"drug_id": 62,
|
| 50 |
+
"name": "Repaglinide",
|
| 51 |
+
"target": "REPAGLINIDE_KATP",
|
| 52 |
+
"session": "e4baa5b23d5805d7",
|
| 53 |
+
"reason": "M4B Stage 22: Stage 21 無候選配體"
|
| 54 |
+
}
|
| 55 |
+
],
|
| 56 |
+
"qc_fail": [
|
| 57 |
+
{
|
| 58 |
+
"drug_id": 0,
|
| 59 |
+
"name": "?",
|
| 60 |
+
"target": "AMPK",
|
| 61 |
+
"affinity": -4.317,
|
| 62 |
+
"flags": [
|
| 63 |
+
"SCORE_WEAK: best pose -4.317 kcal/mol > 閾值 -6.0"
|
| 64 |
+
],
|
| 65 |
+
"session": "22b8546c23e294b0"
|
| 66 |
+
},
|
| 67 |
+
{
|
| 68 |
+
"drug_id": 1,
|
| 69 |
+
"name": "Ibuprofen",
|
| 70 |
+
"target": "COX2",
|
| 71 |
+
"affinity": -6.666,
|
| 72 |
+
"flags": [
|
| 73 |
+
"OUT_OF_POCKET_MAJORITY"
|
| 74 |
+
],
|
| 75 |
+
"session": "ada64fbfe48c740c"
|
| 76 |
+
},
|
| 77 |
+
{
|
| 78 |
+
"drug_id": 1,
|
| 79 |
+
"name": "Ibuprofen",
|
| 80 |
+
"target": "COX2",
|
| 81 |
+
"affinity": -7.57,
|
| 82 |
+
"flags": [
|
| 83 |
+
"OUT_OF_POCKET: RMSD lb > 8.0 Å at modes [6, 7, 8]"
|
| 84 |
+
],
|
| 85 |
+
"session": "C01"
|
| 86 |
+
},
|
| 87 |
+
{
|
| 88 |
+
"drug_id": 2,
|
| 89 |
+
"name": "Celecoxib",
|
| 90 |
+
"target": "COX2_CLX",
|
| 91 |
+
"affinity": -12.12,
|
| 92 |
+
"flags": [
|
| 93 |
+
"OUT_OF_POCKET: RMSD lb > 8.0 Å at modes [6, 7, 8, 9]"
|
| 94 |
+
],
|
| 95 |
+
"session": "C02"
|
| 96 |
+
},
|
| 97 |
+
{
|
| 98 |
+
"drug_id": 4,
|
| 99 |
+
"name": "Imatinib",
|
| 100 |
+
"target": "ABLABL",
|
| 101 |
+
"affinity": -12.71,
|
| 102 |
+
"flags": [
|
| 103 |
+
"OUT_OF_POCKET: RMSD lb > 8.0 Å at modes [3, 6, 7, 8, 9]"
|
| 104 |
+
],
|
| 105 |
+
"session": "C04"
|
| 106 |
+
},
|
| 107 |
+
{
|
| 108 |
+
"drug_id": 8,
|
| 109 |
+
"name": "Acetazolamide",
|
| 110 |
+
"target": "CA2",
|
| 111 |
+
"affinity": -5.546,
|
| 112 |
+
"flags": [
|
| 113 |
+
"SCORE_WEAK: best pose -5.546 kcal/mol > 閾值 -6.0"
|
| 114 |
+
],
|
| 115 |
+
"session": "C08"
|
| 116 |
+
},
|
| 117 |
+
{
|
| 118 |
+
"drug_id": 11,
|
| 119 |
+
"name": "Tacrolimus",
|
| 120 |
+
"target": "FKBP12_TACROLIMUS",
|
| 121 |
+
"affinity": -5.96,
|
| 122 |
+
"flags": [
|
| 123 |
+
"SCORE_WEAK: best pose -5.960 kcal/mol > 閾值 -6.0",
|
| 124 |
+
"OUT_OF_POCKET_MINOR: 1/9 poses outside"
|
| 125 |
+
],
|
| 126 |
+
"session": "C11"
|
| 127 |
+
},
|
| 128 |
+
{
|
| 129 |
+
"drug_id": 18,
|
| 130 |
+
"name": "Nilotinib",
|
| 131 |
+
"target": "ABL_NILOTINIB",
|
| 132 |
+
"affinity": -10.37,
|
| 133 |
+
"flags": [
|
| 134 |
+
"OUT_OF_POCKET_MAJORITY"
|
| 135 |
+
],
|
| 136 |
+
"session": "C18"
|
| 137 |
+
},
|
| 138 |
+
{
|
| 139 |
+
"drug_id": 33,
|
| 140 |
+
"name": "Simvastatin",
|
| 141 |
+
"target": "SIMVASTATIN_HMGCR",
|
| 142 |
+
"affinity": -6.829,
|
| 143 |
+
"flags": [
|
| 144 |
+
"OUT_OF_POCKET_MAJORITY"
|
| 145 |
+
],
|
| 146 |
+
"session": "65c19611400eb4c1"
|
| 147 |
+
},
|
| 148 |
+
{
|
| 149 |
+
"drug_id": 39,
|
| 150 |
+
"name": "Fenofibrate",
|
| 151 |
+
"target": "FENOFIBRATE_PPARALPHA",
|
| 152 |
+
"affinity": -8.87,
|
| 153 |
+
"flags": [
|
| 154 |
+
"OUT_OF_POCKET_MAJORITY"
|
| 155 |
+
],
|
| 156 |
+
"session": "d7a6ccdf1970a7c1"
|
| 157 |
+
}
|
| 158 |
+
]
|
| 159 |
+
}
|
config/catalog_het_audit.json
ADDED
|
The diff for this file is too large to render.
See raw diff
|
|
|
config/catalog_review_1-120.json
ADDED
|
@@ -0,0 +1,2035 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"range": "1-120",
|
| 3 |
+
"summary": {
|
| 4 |
+
"total": 120,
|
| 5 |
+
"ok_qc_pass": 84,
|
| 6 |
+
"ok_qc_fail": 26,
|
| 7 |
+
"pipeline_fail": 10,
|
| 8 |
+
"no_run": 0
|
| 9 |
+
},
|
| 10 |
+
"entries": [
|
| 11 |
+
{
|
| 12 |
+
"drug_id": 1,
|
| 13 |
+
"canonical_name": "Ibuprofen",
|
| 14 |
+
"index_key": "COX2",
|
| 15 |
+
"tier": "1",
|
| 16 |
+
"pdb_id_catalog": "5IKT",
|
| 17 |
+
"het_id_catalog": "TLF",
|
| 18 |
+
"source": "creadrug24",
|
| 19 |
+
"run_status": "ok",
|
| 20 |
+
"best_affinity": -7.57,
|
| 21 |
+
"qc_pass": false,
|
| 22 |
+
"flags": [
|
| 23 |
+
"OUT_OF_POCKET: RMSD lb > 8.0 Å at modes [6, 7, 8]"
|
| 24 |
+
],
|
| 25 |
+
"session_id": "C01",
|
| 26 |
+
"review_class": "B_qc_fail"
|
| 27 |
+
},
|
| 28 |
+
{
|
| 29 |
+
"drug_id": 2,
|
| 30 |
+
"canonical_name": "Celecoxib",
|
| 31 |
+
"index_key": "COX2_CLX",
|
| 32 |
+
"tier": "1",
|
| 33 |
+
"pdb_id_catalog": "3LN1",
|
| 34 |
+
"het_id_catalog": "CLX",
|
| 35 |
+
"source": "creadrug24",
|
| 36 |
+
"run_status": "ok",
|
| 37 |
+
"best_affinity": -12.12,
|
| 38 |
+
"qc_pass": false,
|
| 39 |
+
"flags": [
|
| 40 |
+
"OUT_OF_POCKET: RMSD lb > 8.0 Å at modes [6, 7, 8, 9]"
|
| 41 |
+
],
|
| 42 |
+
"session_id": "C02",
|
| 43 |
+
"review_class": "B_qc_fail"
|
| 44 |
+
},
|
| 45 |
+
{
|
| 46 |
+
"drug_id": 3,
|
| 47 |
+
"canonical_name": "Oseltamivir",
|
| 48 |
+
"index_key": "NEURAMINIDASE",
|
| 49 |
+
"tier": "1",
|
| 50 |
+
"pdb_id_catalog": "2HU4",
|
| 51 |
+
"het_id_catalog": "G39",
|
| 52 |
+
"source": "creadrug24",
|
| 53 |
+
"run_status": "ok",
|
| 54 |
+
"best_affinity": -6.353,
|
| 55 |
+
"qc_pass": true,
|
| 56 |
+
"flags": [
|
| 57 |
+
"OUT_OF_POCKET_MINOR: 1/9 poses outside"
|
| 58 |
+
],
|
| 59 |
+
"session_id": "C03",
|
| 60 |
+
"review_class": "A_pass"
|
| 61 |
+
},
|
| 62 |
+
{
|
| 63 |
+
"drug_id": 4,
|
| 64 |
+
"canonical_name": "Imatinib",
|
| 65 |
+
"index_key": "ABLABL",
|
| 66 |
+
"tier": "1",
|
| 67 |
+
"pdb_id_catalog": "1IEP",
|
| 68 |
+
"het_id_catalog": "STI",
|
| 69 |
+
"source": "creadrug24",
|
| 70 |
+
"run_status": "ok",
|
| 71 |
+
"best_affinity": -12.71,
|
| 72 |
+
"qc_pass": false,
|
| 73 |
+
"flags": [
|
| 74 |
+
"OUT_OF_POCKET: RMSD lb > 8.0 Å at modes [3, 6, 7, 8, 9]"
|
| 75 |
+
],
|
| 76 |
+
"session_id": "C04",
|
| 77 |
+
"review_class": "B_qc_fail"
|
| 78 |
+
},
|
| 79 |
+
{
|
| 80 |
+
"drug_id": 5,
|
| 81 |
+
"canonical_name": "Methotrexate",
|
| 82 |
+
"index_key": "DHFR",
|
| 83 |
+
"tier": "1",
|
| 84 |
+
"pdb_id_catalog": "1U72",
|
| 85 |
+
"het_id_catalog": "MTX",
|
| 86 |
+
"source": "creadrug24",
|
| 87 |
+
"run_status": "ok",
|
| 88 |
+
"best_affinity": -9.66,
|
| 89 |
+
"qc_pass": true,
|
| 90 |
+
"flags": [],
|
| 91 |
+
"session_id": "C05",
|
| 92 |
+
"review_class": "A_pass"
|
| 93 |
+
},
|
| 94 |
+
{
|
| 95 |
+
"drug_id": 6,
|
| 96 |
+
"canonical_name": "Fluconazole",
|
| 97 |
+
"index_key": "CYP51",
|
| 98 |
+
"tier": "1",
|
| 99 |
+
"pdb_id_catalog": "4WMZ",
|
| 100 |
+
"het_id_catalog": "FLC",
|
| 101 |
+
"source": "creadrug24",
|
| 102 |
+
"run_status": "ok",
|
| 103 |
+
"best_affinity": -7.141,
|
| 104 |
+
"qc_pass": true,
|
| 105 |
+
"flags": [],
|
| 106 |
+
"session_id": "C06",
|
| 107 |
+
"review_class": "A_pass"
|
| 108 |
+
},
|
| 109 |
+
{
|
| 110 |
+
"drug_id": 7,
|
| 111 |
+
"canonical_name": "Sildenafil",
|
| 112 |
+
"index_key": "PDE5",
|
| 113 |
+
"tier": "1",
|
| 114 |
+
"pdb_id_catalog": "2H42",
|
| 115 |
+
"het_id_catalog": "SLD",
|
| 116 |
+
"source": "creadrug24",
|
| 117 |
+
"run_status": "ok",
|
| 118 |
+
"best_affinity": -9.364,
|
| 119 |
+
"qc_pass": true,
|
| 120 |
+
"flags": [],
|
| 121 |
+
"session_id": "C07",
|
| 122 |
+
"review_class": "A_pass"
|
| 123 |
+
},
|
| 124 |
+
{
|
| 125 |
+
"drug_id": 8,
|
| 126 |
+
"canonical_name": "Acetazolamide",
|
| 127 |
+
"index_key": "CA2",
|
| 128 |
+
"tier": "1",
|
| 129 |
+
"pdb_id_catalog": "3HS4",
|
| 130 |
+
"het_id_catalog": "AZM",
|
| 131 |
+
"source": "creadrug24",
|
| 132 |
+
"run_status": "ok",
|
| 133 |
+
"best_affinity": -5.546,
|
| 134 |
+
"qc_pass": false,
|
| 135 |
+
"flags": [
|
| 136 |
+
"SCORE_WEAK: best pose -5.546 kcal/mol > 閾值 -6.0"
|
| 137 |
+
],
|
| 138 |
+
"session_id": "C08",
|
| 139 |
+
"review_class": "B_qc_fail"
|
| 140 |
+
},
|
| 141 |
+
{
|
| 142 |
+
"drug_id": 9,
|
| 143 |
+
"canonical_name": "Gefitinib",
|
| 144 |
+
"index_key": "EGFR",
|
| 145 |
+
"tier": "1",
|
| 146 |
+
"pdb_id_catalog": "4WKQ",
|
| 147 |
+
"het_id_catalog": "IRE",
|
| 148 |
+
"source": "creadrug24",
|
| 149 |
+
"run_status": "ok",
|
| 150 |
+
"best_affinity": -8.04,
|
| 151 |
+
"qc_pass": true,
|
| 152 |
+
"flags": [],
|
| 153 |
+
"session_id": "C09",
|
| 154 |
+
"review_class": "A_pass"
|
| 155 |
+
},
|
| 156 |
+
{
|
| 157 |
+
"drug_id": 10,
|
| 158 |
+
"canonical_name": "Warfarin",
|
| 159 |
+
"index_key": "VKOR",
|
| 160 |
+
"tier": "1",
|
| 161 |
+
"pdb_id_catalog": "6WV3",
|
| 162 |
+
"het_id_catalog": "SWF",
|
| 163 |
+
"source": "creadrug24",
|
| 164 |
+
"run_status": "ok",
|
| 165 |
+
"best_affinity": -11.28,
|
| 166 |
+
"qc_pass": true,
|
| 167 |
+
"flags": [
|
| 168 |
+
"OUT_OF_POCKET_MINOR: 3/9 poses outside"
|
| 169 |
+
],
|
| 170 |
+
"session_id": "C10",
|
| 171 |
+
"review_class": "A_pass"
|
| 172 |
+
},
|
| 173 |
+
{
|
| 174 |
+
"drug_id": 11,
|
| 175 |
+
"canonical_name": "Tacrolimus",
|
| 176 |
+
"index_key": "FKBP12_TACROLIMUS",
|
| 177 |
+
"tier": "1",
|
| 178 |
+
"pdb_id_catalog": "1FKJ",
|
| 179 |
+
"het_id_catalog": "FK5",
|
| 180 |
+
"source": "creadrug24",
|
| 181 |
+
"run_status": "ok",
|
| 182 |
+
"best_affinity": -5.96,
|
| 183 |
+
"qc_pass": false,
|
| 184 |
+
"flags": [
|
| 185 |
+
"SCORE_WEAK: best pose -5.960 kcal/mol > 閾值 -6.0",
|
| 186 |
+
"OUT_OF_POCKET_MINOR: 1/9 poses outside"
|
| 187 |
+
],
|
| 188 |
+
"session_id": "C11",
|
| 189 |
+
"review_class": "B_qc_fail"
|
| 190 |
+
},
|
| 191 |
+
{
|
| 192 |
+
"drug_id": 12,
|
| 193 |
+
"canonical_name": "Quetiapine",
|
| 194 |
+
"index_key": "DRD2_QUETIAPINE_PROXY",
|
| 195 |
+
"tier": "2",
|
| 196 |
+
"pdb_id_catalog": "6CM4",
|
| 197 |
+
"het_id_catalog": "8NU",
|
| 198 |
+
"source": "creadrug24",
|
| 199 |
+
"run_status": "ok",
|
| 200 |
+
"best_affinity": -7.647,
|
| 201 |
+
"qc_pass": true,
|
| 202 |
+
"flags": [],
|
| 203 |
+
"session_id": "C12",
|
| 204 |
+
"review_class": "A_pass"
|
| 205 |
+
},
|
| 206 |
+
{
|
| 207 |
+
"drug_id": 13,
|
| 208 |
+
"canonical_name": "Erlotinib",
|
| 209 |
+
"index_key": "EGFR_ERLOTINIB",
|
| 210 |
+
"tier": "1",
|
| 211 |
+
"pdb_id_catalog": "1M17",
|
| 212 |
+
"het_id_catalog": "AQ4",
|
| 213 |
+
"source": "creadrug24",
|
| 214 |
+
"run_status": "ok",
|
| 215 |
+
"best_affinity": -8.023,
|
| 216 |
+
"qc_pass": true,
|
| 217 |
+
"flags": [],
|
| 218 |
+
"session_id": "C13",
|
| 219 |
+
"review_class": "A_pass"
|
| 220 |
+
},
|
| 221 |
+
{
|
| 222 |
+
"drug_id": 14,
|
| 223 |
+
"canonical_name": "Vardenafil",
|
| 224 |
+
"index_key": "PDE5_VARDENAFIL",
|
| 225 |
+
"tier": "1",
|
| 226 |
+
"pdb_id_catalog": "1UDT",
|
| 227 |
+
"het_id_catalog": "VIA",
|
| 228 |
+
"source": "creadrug24",
|
| 229 |
+
"run_status": "ok",
|
| 230 |
+
"best_affinity": -8.176,
|
| 231 |
+
"qc_pass": true,
|
| 232 |
+
"flags": [],
|
| 233 |
+
"session_id": "C14",
|
| 234 |
+
"review_class": "A_pass"
|
| 235 |
+
},
|
| 236 |
+
{
|
| 237 |
+
"drug_id": 15,
|
| 238 |
+
"canonical_name": "Apixaban",
|
| 239 |
+
"index_key": "FXA_APIXABAN",
|
| 240 |
+
"tier": "1",
|
| 241 |
+
"pdb_id_catalog": "2P16",
|
| 242 |
+
"het_id_catalog": "GG2",
|
| 243 |
+
"source": "creadrug24",
|
| 244 |
+
"run_status": "ok",
|
| 245 |
+
"best_affinity": -7.328,
|
| 246 |
+
"qc_pass": true,
|
| 247 |
+
"flags": [],
|
| 248 |
+
"session_id": "C15",
|
| 249 |
+
"review_class": "A_pass"
|
| 250 |
+
},
|
| 251 |
+
{
|
| 252 |
+
"drug_id": 16,
|
| 253 |
+
"canonical_name": "Rivaroxaban",
|
| 254 |
+
"index_key": "FXA_RIVAROXABAN",
|
| 255 |
+
"tier": "1",
|
| 256 |
+
"pdb_id_catalog": "2W26",
|
| 257 |
+
"het_id_catalog": "RIV",
|
| 258 |
+
"source": "creadrug24",
|
| 259 |
+
"run_status": "ok",
|
| 260 |
+
"best_affinity": -10.17,
|
| 261 |
+
"qc_pass": true,
|
| 262 |
+
"flags": [],
|
| 263 |
+
"session_id": "C16",
|
| 264 |
+
"review_class": "A_pass"
|
| 265 |
+
},
|
| 266 |
+
{
|
| 267 |
+
"drug_id": 17,
|
| 268 |
+
"canonical_name": "Vorinostat",
|
| 269 |
+
"index_key": "HDAC2_VORINOSTAT",
|
| 270 |
+
"tier": "1",
|
| 271 |
+
"pdb_id_catalog": "4LXZ",
|
| 272 |
+
"het_id_catalog": "SHH",
|
| 273 |
+
"source": "creadrug24",
|
| 274 |
+
"run_status": "ok",
|
| 275 |
+
"best_affinity": -6.436,
|
| 276 |
+
"qc_pass": true,
|
| 277 |
+
"flags": [],
|
| 278 |
+
"session_id": "C17",
|
| 279 |
+
"review_class": "A_pass"
|
| 280 |
+
},
|
| 281 |
+
{
|
| 282 |
+
"drug_id": 18,
|
| 283 |
+
"canonical_name": "Nilotinib",
|
| 284 |
+
"index_key": "ABL_NILOTINIB",
|
| 285 |
+
"tier": "1",
|
| 286 |
+
"pdb_id_catalog": "3CS9",
|
| 287 |
+
"het_id_catalog": "NIL",
|
| 288 |
+
"source": "creadrug24",
|
| 289 |
+
"run_status": "ok",
|
| 290 |
+
"best_affinity": -10.37,
|
| 291 |
+
"qc_pass": false,
|
| 292 |
+
"flags": [
|
| 293 |
+
"OUT_OF_POCKET_MAJORITY"
|
| 294 |
+
],
|
| 295 |
+
"session_id": "C18",
|
| 296 |
+
"review_class": "B_qc_fail"
|
| 297 |
+
},
|
| 298 |
+
{
|
| 299 |
+
"drug_id": 19,
|
| 300 |
+
"canonical_name": "Bosutinib",
|
| 301 |
+
"index_key": "ABL_BOSUTINIB",
|
| 302 |
+
"tier": "1",
|
| 303 |
+
"pdb_id_catalog": "3UE4",
|
| 304 |
+
"het_id_catalog": "DB8",
|
| 305 |
+
"source": "creadrug24",
|
| 306 |
+
"run_status": "ok",
|
| 307 |
+
"best_affinity": -8.134,
|
| 308 |
+
"qc_pass": true,
|
| 309 |
+
"flags": [],
|
| 310 |
+
"session_id": "C19",
|
| 311 |
+
"review_class": "A_pass"
|
| 312 |
+
},
|
| 313 |
+
{
|
| 314 |
+
"drug_id": 20,
|
| 315 |
+
"canonical_name": "Ponatinib",
|
| 316 |
+
"index_key": "DDR1_PONATINIB",
|
| 317 |
+
"tier": "1",
|
| 318 |
+
"pdb_id_catalog": "3ZOS",
|
| 319 |
+
"het_id_catalog": "0LI",
|
| 320 |
+
"source": "creadrug24",
|
| 321 |
+
"run_status": "ok",
|
| 322 |
+
"best_affinity": -13.08,
|
| 323 |
+
"qc_pass": true,
|
| 324 |
+
"flags": [],
|
| 325 |
+
"session_id": "C20",
|
| 326 |
+
"review_class": "A_pass"
|
| 327 |
+
},
|
| 328 |
+
{
|
| 329 |
+
"drug_id": 21,
|
| 330 |
+
"canonical_name": "Cilomilast",
|
| 331 |
+
"index_key": "PDE4D_CILOMILAST",
|
| 332 |
+
"tier": "1",
|
| 333 |
+
"pdb_id_catalog": "1XOM",
|
| 334 |
+
"het_id_catalog": "CIO",
|
| 335 |
+
"source": "creadrug24",
|
| 336 |
+
"run_status": "ok",
|
| 337 |
+
"best_affinity": -9.017,
|
| 338 |
+
"qc_pass": true,
|
| 339 |
+
"flags": [],
|
| 340 |
+
"session_id": "C21",
|
| 341 |
+
"review_class": "A_pass"
|
| 342 |
+
},
|
| 343 |
+
{
|
| 344 |
+
"drug_id": 22,
|
| 345 |
+
"canonical_name": "Roflumilast",
|
| 346 |
+
"index_key": "PDE4D_ROFLUMILAST",
|
| 347 |
+
"tier": "1",
|
| 348 |
+
"pdb_id_catalog": "3G4L",
|
| 349 |
+
"het_id_catalog": "ROF",
|
| 350 |
+
"source": "creadrug24",
|
| 351 |
+
"run_status": "ok",
|
| 352 |
+
"best_affinity": -9.192,
|
| 353 |
+
"qc_pass": true,
|
| 354 |
+
"flags": [],
|
| 355 |
+
"session_id": "C22",
|
| 356 |
+
"review_class": "A_pass"
|
| 357 |
+
},
|
| 358 |
+
{
|
| 359 |
+
"drug_id": 23,
|
| 360 |
+
"canonical_name": "Alogliptin",
|
| 361 |
+
"index_key": "DPP4_ALOGLIPTIN",
|
| 362 |
+
"tier": "1",
|
| 363 |
+
"pdb_id_catalog": "2ONC",
|
| 364 |
+
"het_id_catalog": "SY1",
|
| 365 |
+
"source": "creadrug24",
|
| 366 |
+
"run_status": "ok",
|
| 367 |
+
"best_affinity": -7.076,
|
| 368 |
+
"qc_pass": true,
|
| 369 |
+
"flags": [
|
| 370 |
+
"OUT_OF_POCKET_MINOR: 3/9 poses outside"
|
| 371 |
+
],
|
| 372 |
+
"session_id": "C23",
|
| 373 |
+
"review_class": "A_pass"
|
| 374 |
+
},
|
| 375 |
+
{
|
| 376 |
+
"drug_id": 24,
|
| 377 |
+
"canonical_name": "Linagliptin",
|
| 378 |
+
"index_key": "DPP4_LINAGLIPTIN",
|
| 379 |
+
"tier": "1",
|
| 380 |
+
"pdb_id_catalog": "2RGU",
|
| 381 |
+
"het_id_catalog": "356",
|
| 382 |
+
"source": "creadrug24",
|
| 383 |
+
"run_status": "ok",
|
| 384 |
+
"best_affinity": -9.064,
|
| 385 |
+
"qc_pass": true,
|
| 386 |
+
"flags": [],
|
| 387 |
+
"session_id": "C24",
|
| 388 |
+
"review_class": "A_pass"
|
| 389 |
+
},
|
| 390 |
+
{
|
| 391 |
+
"drug_id": 25,
|
| 392 |
+
"canonical_name": "Metformin",
|
| 393 |
+
"index_key": "AMPK_METFORMIN_PROXY",
|
| 394 |
+
"tier": "2",
|
| 395 |
+
"pdb_id_catalog": "4CFE",
|
| 396 |
+
"het_id_catalog": "992",
|
| 397 |
+
"source": "moltgate_ui",
|
| 398 |
+
"session_id": "9ebbce7340b7931f",
|
| 399 |
+
"run_status": "ok",
|
| 400 |
+
"best_affinity": -5.102,
|
| 401 |
+
"qc_pass": false,
|
| 402 |
+
"flags": [
|
| 403 |
+
"SCORE_WEAK: best pose -5.102 kcal/mol > 閾值 -6.0",
|
| 404 |
+
"OUT_OF_POCKET_MINOR: 2/9 poses outside"
|
| 405 |
+
],
|
| 406 |
+
"pdb_id": "4CFE",
|
| 407 |
+
"review_class": "B_qc_fail"
|
| 408 |
+
},
|
| 409 |
+
{
|
| 410 |
+
"drug_id": 26,
|
| 411 |
+
"canonical_name": "Sitagliptin",
|
| 412 |
+
"index_key": "SITAGLIPTIN_DPP4",
|
| 413 |
+
"tier": "1",
|
| 414 |
+
"pdb_id_catalog": "1X70",
|
| 415 |
+
"het_id_catalog": "715",
|
| 416 |
+
"source": "moltgate_ui",
|
| 417 |
+
"session_id": "6cdc0d35bebdfd85",
|
| 418 |
+
"run_status": "ok",
|
| 419 |
+
"best_affinity": -8.859,
|
| 420 |
+
"qc_pass": true,
|
| 421 |
+
"flags": [],
|
| 422 |
+
"pdb_id": "1X70",
|
| 423 |
+
"review_class": "A_pass"
|
| 424 |
+
},
|
| 425 |
+
{
|
| 426 |
+
"drug_id": 27,
|
| 427 |
+
"canonical_name": "Atorvastatin",
|
| 428 |
+
"index_key": "ATORVASTATIN_HMGCR_PROXY",
|
| 429 |
+
"tier": "1",
|
| 430 |
+
"pdb_id_catalog": "1HWK",
|
| 431 |
+
"het_id_catalog": "117",
|
| 432 |
+
"source": "moltgate_ui",
|
| 433 |
+
"session_id": "22fedb45a5c250d5",
|
| 434 |
+
"run_status": "ok",
|
| 435 |
+
"best_affinity": -8.714,
|
| 436 |
+
"qc_pass": true,
|
| 437 |
+
"flags": [],
|
| 438 |
+
"pdb_id": "1HWK",
|
| 439 |
+
"review_class": "A_pass"
|
| 440 |
+
},
|
| 441 |
+
{
|
| 442 |
+
"drug_id": 28,
|
| 443 |
+
"canonical_name": "Aspirin",
|
| 444 |
+
"index_key": "ASPIRIN_COX2",
|
| 445 |
+
"tier": "1",
|
| 446 |
+
"pdb_id_catalog": "5IKT",
|
| 447 |
+
"het_id_catalog": "TLF",
|
| 448 |
+
"source": "moltgate_ui",
|
| 449 |
+
"session_id": "a3143655e2919427",
|
| 450 |
+
"run_status": "ok",
|
| 451 |
+
"best_affinity": -6.673,
|
| 452 |
+
"qc_pass": false,
|
| 453 |
+
"flags": [
|
| 454 |
+
"OUT_OF_POCKET_MAJORITY"
|
| 455 |
+
],
|
| 456 |
+
"pdb_id": "5IKT",
|
| 457 |
+
"review_class": "B_qc_fail"
|
| 458 |
+
},
|
| 459 |
+
{
|
| 460 |
+
"drug_id": 29,
|
| 461 |
+
"canonical_name": "Omeprazole",
|
| 462 |
+
"index_key": "OMEPRAZOLE_CYP2C19",
|
| 463 |
+
"tier": "2",
|
| 464 |
+
"pdb_id_catalog": "4GQS",
|
| 465 |
+
"het_id_catalog": "0XV",
|
| 466 |
+
"source": "moltgate_ui",
|
| 467 |
+
"session_id": "f03eede6e628958c",
|
| 468 |
+
"run_status": "ok",
|
| 469 |
+
"best_affinity": -8.57,
|
| 470 |
+
"qc_pass": true,
|
| 471 |
+
"flags": [
|
| 472 |
+
"OUT_OF_POCKET_MINOR: 1/9 poses outside"
|
| 473 |
+
],
|
| 474 |
+
"pdb_id": "4GQS",
|
| 475 |
+
"review_class": "A_pass"
|
| 476 |
+
},
|
| 477 |
+
{
|
| 478 |
+
"drug_id": 30,
|
| 479 |
+
"canonical_name": "Amlodipine",
|
| 480 |
+
"index_key": "AMLODIPINE_CACNA1C_PROXY",
|
| 481 |
+
"tier": "1",
|
| 482 |
+
"pdb_id_catalog": "8WE8",
|
| 483 |
+
"het_id_catalog": "6UB",
|
| 484 |
+
"source": "moltgate_ui",
|
| 485 |
+
"session_id": "316189372316ee9c",
|
| 486 |
+
"run_status": "ok",
|
| 487 |
+
"best_affinity": -7.055,
|
| 488 |
+
"qc_pass": false,
|
| 489 |
+
"flags": [
|
| 490 |
+
"OUT_OF_POCKET_MAJORITY"
|
| 491 |
+
],
|
| 492 |
+
"pdb_id": "8WE8",
|
| 493 |
+
"review_class": "B_qc_fail"
|
| 494 |
+
},
|
| 495 |
+
{
|
| 496 |
+
"drug_id": 31,
|
| 497 |
+
"canonical_name": "Losartan",
|
| 498 |
+
"index_key": "LOSARTAN_AT1R_PROXY",
|
| 499 |
+
"tier": "2",
|
| 500 |
+
"pdb_id_catalog": "4ZUD",
|
| 501 |
+
"het_id_catalog": "OLM",
|
| 502 |
+
"source": "moltgate_ui",
|
| 503 |
+
"session_id": "f27ddb5f4a82a41b",
|
| 504 |
+
"run_status": "ok",
|
| 505 |
+
"best_affinity": -9.237,
|
| 506 |
+
"qc_pass": true,
|
| 507 |
+
"flags": [],
|
| 508 |
+
"pdb_id": "4ZUD",
|
| 509 |
+
"review_class": "A_pass"
|
| 510 |
+
},
|
| 511 |
+
{
|
| 512 |
+
"drug_id": 32,
|
| 513 |
+
"canonical_name": "Rosuvastatin",
|
| 514 |
+
"index_key": "ROSUVASTATIN_HMGCR",
|
| 515 |
+
"tier": "1",
|
| 516 |
+
"pdb_id_catalog": "3B7Q",
|
| 517 |
+
"het_id_catalog": "6PL",
|
| 518 |
+
"source": "moltgate_ui",
|
| 519 |
+
"session_id": "ec560eb83ee7eb0a",
|
| 520 |
+
"run_status": "ok",
|
| 521 |
+
"best_affinity": -9.488,
|
| 522 |
+
"qc_pass": true,
|
| 523 |
+
"flags": [
|
| 524 |
+
"OUT_OF_POCKET_MINOR: 4/9 poses outside"
|
| 525 |
+
],
|
| 526 |
+
"pdb_id": "3B7Q",
|
| 527 |
+
"review_class": "A_pass"
|
| 528 |
+
},
|
| 529 |
+
{
|
| 530 |
+
"drug_id": 33,
|
| 531 |
+
"canonical_name": "Simvastatin",
|
| 532 |
+
"index_key": "SIMVASTATIN_HMGCR",
|
| 533 |
+
"tier": "1",
|
| 534 |
+
"pdb_id_catalog": "1HW9",
|
| 535 |
+
"het_id_catalog": "SIM",
|
| 536 |
+
"source": "moltgate_ui",
|
| 537 |
+
"session_id": "65c19611400eb4c1",
|
| 538 |
+
"run_status": "ok",
|
| 539 |
+
"best_affinity": -6.727,
|
| 540 |
+
"qc_pass": false,
|
| 541 |
+
"flags": [
|
| 542 |
+
"OUT_OF_POCKET_MAJORITY"
|
| 543 |
+
],
|
| 544 |
+
"pdb_id": "1HW9",
|
| 545 |
+
"review_class": "B_qc_fail"
|
| 546 |
+
},
|
| 547 |
+
{
|
| 548 |
+
"drug_id": 34,
|
| 549 |
+
"canonical_name": "Pioglitazone",
|
| 550 |
+
"index_key": "PIOGLITAZONE_PPARgamma_PROXY",
|
| 551 |
+
"tier": "2",
|
| 552 |
+
"pdb_id_catalog": "2PRG",
|
| 553 |
+
"het_id_catalog": "BRL",
|
| 554 |
+
"source": "moltgate_ui",
|
| 555 |
+
"session_id": "76c353230cb47516",
|
| 556 |
+
"run_status": "ok",
|
| 557 |
+
"best_affinity": -10.28,
|
| 558 |
+
"qc_pass": true,
|
| 559 |
+
"flags": [
|
| 560 |
+
"OUT_OF_POCKET_MINOR: 1/9 poses outside"
|
| 561 |
+
],
|
| 562 |
+
"pdb_id": "2PRG",
|
| 563 |
+
"review_class": "A_pass"
|
| 564 |
+
},
|
| 565 |
+
{
|
| 566 |
+
"drug_id": 35,
|
| 567 |
+
"canonical_name": "Empagliflozin",
|
| 568 |
+
"index_key": "EMPAGLIFLOZIN_SGLT2",
|
| 569 |
+
"tier": "1",
|
| 570 |
+
"pdb_id_catalog": "7VSI",
|
| 571 |
+
"het_id_catalog": "7R3",
|
| 572 |
+
"source": "moltgate_ui",
|
| 573 |
+
"session_id": "6fec546ae0adeef6",
|
| 574 |
+
"run_status": "ok",
|
| 575 |
+
"best_affinity": -9.695,
|
| 576 |
+
"qc_pass": true,
|
| 577 |
+
"flags": [
|
| 578 |
+
"OUT_OF_POCKET_MINOR: 1/9 poses outside"
|
| 579 |
+
],
|
| 580 |
+
"pdb_id": "7VSI",
|
| 581 |
+
"review_class": "A_pass"
|
| 582 |
+
},
|
| 583 |
+
{
|
| 584 |
+
"drug_id": 36,
|
| 585 |
+
"canonical_name": "Saxagliptin",
|
| 586 |
+
"index_key": "SAXAGLIPTIN_DPP4",
|
| 587 |
+
"tier": "1",
|
| 588 |
+
"pdb_id_catalog": "3C43",
|
| 589 |
+
"het_id_catalog": "315",
|
| 590 |
+
"source": "moltgate_ui",
|
| 591 |
+
"session_id": "afd69009c8c6e20b",
|
| 592 |
+
"run_status": "ok",
|
| 593 |
+
"best_affinity": -8.026,
|
| 594 |
+
"qc_pass": true,
|
| 595 |
+
"flags": [],
|
| 596 |
+
"pdb_id": "3C43",
|
| 597 |
+
"review_class": "A_pass"
|
| 598 |
+
},
|
| 599 |
+
{
|
| 600 |
+
"drug_id": 37,
|
| 601 |
+
"canonical_name": "Lansoprazole",
|
| 602 |
+
"index_key": "LANSOPRAZOLE_CYP2C19",
|
| 603 |
+
"tier": "2",
|
| 604 |
+
"pdb_id_catalog": "4GQS",
|
| 605 |
+
"het_id_catalog": "0XV",
|
| 606 |
+
"source": "moltgate_ui",
|
| 607 |
+
"session_id": "eca99c33396b3396",
|
| 608 |
+
"run_status": "ok",
|
| 609 |
+
"best_affinity": -8.797,
|
| 610 |
+
"qc_pass": true,
|
| 611 |
+
"flags": [
|
| 612 |
+
"OUT_OF_POCKET_MINOR: 3/9 poses outside"
|
| 613 |
+
],
|
| 614 |
+
"pdb_id": "4GQS",
|
| 615 |
+
"review_class": "A_pass"
|
| 616 |
+
},
|
| 617 |
+
{
|
| 618 |
+
"drug_id": 38,
|
| 619 |
+
"canonical_name": "Metoprolol",
|
| 620 |
+
"index_key": "METOPROLOL_ADRB1_PROXY",
|
| 621 |
+
"tier": "2",
|
| 622 |
+
"pdb_id_catalog": "2Y02",
|
| 623 |
+
"het_id_catalog": "WHJ",
|
| 624 |
+
"source": "moltgate_ui",
|
| 625 |
+
"session_id": "4bfbdecd5fe8fdab",
|
| 626 |
+
"run_status": "ok",
|
| 627 |
+
"best_affinity": -6.944,
|
| 628 |
+
"qc_pass": true,
|
| 629 |
+
"flags": [],
|
| 630 |
+
"pdb_id": "2Y02",
|
| 631 |
+
"review_class": "A_pass"
|
| 632 |
+
},
|
| 633 |
+
{
|
| 634 |
+
"drug_id": 39,
|
| 635 |
+
"canonical_name": "Fenofibrate",
|
| 636 |
+
"index_key": "FENOFIBRATE_PPARalpha",
|
| 637 |
+
"tier": "1",
|
| 638 |
+
"pdb_id_catalog": "1K74",
|
| 639 |
+
"het_id_catalog": "544",
|
| 640 |
+
"source": "moltgate_ui",
|
| 641 |
+
"session_id": "d7a6ccdf1970a7c1",
|
| 642 |
+
"run_status": "ok",
|
| 643 |
+
"best_affinity": -8.134,
|
| 644 |
+
"qc_pass": true,
|
| 645 |
+
"flags": [],
|
| 646 |
+
"pdb_id": "1K74",
|
| 647 |
+
"review_class": "A_pass"
|
| 648 |
+
},
|
| 649 |
+
{
|
| 650 |
+
"drug_id": 40,
|
| 651 |
+
"canonical_name": "Hydrochlorothiazide",
|
| 652 |
+
"index_key": "HYDROCHLOROTHIAZIDE_CA2_PROXY",
|
| 653 |
+
"tier": "2",
|
| 654 |
+
"pdb_id_catalog": "3HS4",
|
| 655 |
+
"het_id_catalog": "AZM",
|
| 656 |
+
"source": "moltgate_ui",
|
| 657 |
+
"session_id": "38d7f1bf7a642646",
|
| 658 |
+
"run_status": "ok",
|
| 659 |
+
"best_affinity": -5.87,
|
| 660 |
+
"qc_pass": false,
|
| 661 |
+
"flags": [
|
| 662 |
+
"SCORE_WEAK: best pose -5.870 kcal/mol > 閾值 -6.0",
|
| 663 |
+
"OUT_OF_POCKET_MINOR: 1/9 poses outside"
|
| 664 |
+
],
|
| 665 |
+
"pdb_id": "3HS4",
|
| 666 |
+
"review_class": "B_qc_fail"
|
| 667 |
+
},
|
| 668 |
+
{
|
| 669 |
+
"drug_id": 41,
|
| 670 |
+
"canonical_name": "Diclofenac",
|
| 671 |
+
"index_key": "DICLOFENAC_COX2",
|
| 672 |
+
"tier": "1",
|
| 673 |
+
"pdb_id_catalog": "5IKR",
|
| 674 |
+
"het_id_catalog": "ID8",
|
| 675 |
+
"source": "moltgate_ui",
|
| 676 |
+
"session_id": "fc343a070d35398c",
|
| 677 |
+
"run_status": "ok",
|
| 678 |
+
"best_affinity": -8.308,
|
| 679 |
+
"qc_pass": true,
|
| 680 |
+
"flags": [
|
| 681 |
+
"OUT_OF_POCKET_MINOR: 3/9 poses outside"
|
| 682 |
+
],
|
| 683 |
+
"pdb_id": "5IKR",
|
| 684 |
+
"review_class": "A_pass"
|
| 685 |
+
},
|
| 686 |
+
{
|
| 687 |
+
"drug_id": 42,
|
| 688 |
+
"canonical_name": "Naproxen",
|
| 689 |
+
"index_key": "NAPROXEN_COX2",
|
| 690 |
+
"tier": "2",
|
| 691 |
+
"pdb_id_catalog": "5IKT",
|
| 692 |
+
"het_id_catalog": "TLF",
|
| 693 |
+
"source": "moltgate_ui",
|
| 694 |
+
"session_id": "07cb450a60b15def",
|
| 695 |
+
"run_status": "ok",
|
| 696 |
+
"best_affinity": -7.822,
|
| 697 |
+
"qc_pass": true,
|
| 698 |
+
"flags": [
|
| 699 |
+
"OUT_OF_POCKET_MINOR: 4/9 poses outside"
|
| 700 |
+
],
|
| 701 |
+
"pdb_id": "5IKT",
|
| 702 |
+
"review_class": "A_pass"
|
| 703 |
+
},
|
| 704 |
+
{
|
| 705 |
+
"drug_id": 43,
|
| 706 |
+
"canonical_name": "Meloxicam",
|
| 707 |
+
"index_key": "MELOXICAM_COX2_PROXY",
|
| 708 |
+
"tier": "2",
|
| 709 |
+
"pdb_id_catalog": "5IKR",
|
| 710 |
+
"het_id_catalog": "ID8",
|
| 711 |
+
"source": "moltgate_ui",
|
| 712 |
+
"session_id": "ea5259d6fde4001d",
|
| 713 |
+
"run_status": "ok",
|
| 714 |
+
"best_affinity": -7.857,
|
| 715 |
+
"qc_pass": true,
|
| 716 |
+
"flags": [
|
| 717 |
+
"OUT_OF_POCKET_MINOR: 2/9 poses outside"
|
| 718 |
+
],
|
| 719 |
+
"pdb_id": "5IKR",
|
| 720 |
+
"review_class": "A_pass"
|
| 721 |
+
},
|
| 722 |
+
{
|
| 723 |
+
"drug_id": 44,
|
| 724 |
+
"canonical_name": "Hydroxychloroquine",
|
| 725 |
+
"index_key": "HYDROXYCHLOROQUINE_LYSO_PROXY",
|
| 726 |
+
"tier": "2",
|
| 727 |
+
"pdb_id_catalog": "4MLN",
|
| 728 |
+
"het_id_catalog": "ODV",
|
| 729 |
+
"source": "moltgate_ui",
|
| 730 |
+
"session_id": "3ceff3963d231f55",
|
| 731 |
+
"run_status": "ok",
|
| 732 |
+
"best_affinity": -5.145,
|
| 733 |
+
"qc_pass": false,
|
| 734 |
+
"flags": [
|
| 735 |
+
"SCORE_WEAK: best pose -5.145 kcal/mol > 閾值 -6.0",
|
| 736 |
+
"OUT_OF_POCKET_MAJORITY"
|
| 737 |
+
],
|
| 738 |
+
"pdb_id": "4MLN",
|
| 739 |
+
"review_class": "B_qc_fail"
|
| 740 |
+
},
|
| 741 |
+
{
|
| 742 |
+
"drug_id": 45,
|
| 743 |
+
"canonical_name": "Montelukast",
|
| 744 |
+
"index_key": "MONTELUKAST_CYSLT1_PROXY",
|
| 745 |
+
"tier": "2",
|
| 746 |
+
"pdb_id_catalog": "6RZ4",
|
| 747 |
+
"het_id_catalog": "KNT",
|
| 748 |
+
"source": "moltgate_ui",
|
| 749 |
+
"session_id": "751e273738e31823",
|
| 750 |
+
"run_status": "ok",
|
| 751 |
+
"best_affinity": -11.04,
|
| 752 |
+
"qc_pass": true,
|
| 753 |
+
"flags": [],
|
| 754 |
+
"pdb_id": "6RZ4",
|
| 755 |
+
"review_class": "A_pass"
|
| 756 |
+
},
|
| 757 |
+
{
|
| 758 |
+
"drug_id": 46,
|
| 759 |
+
"canonical_name": "Albuterol",
|
| 760 |
+
"index_key": "ALBUTEROL_ADRB2_PROXY",
|
| 761 |
+
"tier": "2",
|
| 762 |
+
"pdb_id_catalog": "2Y00",
|
| 763 |
+
"het_id_catalog": "Y00",
|
| 764 |
+
"source": "moltgate_ui",
|
| 765 |
+
"session_id": "26b4cf9a21b01c5f",
|
| 766 |
+
"run_status": "ok",
|
| 767 |
+
"best_affinity": -6.847,
|
| 768 |
+
"qc_pass": true,
|
| 769 |
+
"flags": [
|
| 770 |
+
"OUT_OF_POCKET_MINOR: 4/9 poses outside"
|
| 771 |
+
],
|
| 772 |
+
"pdb_id": "2Y00",
|
| 773 |
+
"review_class": "A_pass"
|
| 774 |
+
},
|
| 775 |
+
{
|
| 776 |
+
"drug_id": 47,
|
| 777 |
+
"canonical_name": "Ciprofloxacin",
|
| 778 |
+
"index_key": "CIPROFLOXACIN_GYRASE",
|
| 779 |
+
"tier": "1",
|
| 780 |
+
"pdb_id_catalog": "2XCT",
|
| 781 |
+
"het_id_catalog": "CPF",
|
| 782 |
+
"source": "moltgate_ui",
|
| 783 |
+
"session_id": "fb9a5d3064305e2d",
|
| 784 |
+
"run_status": "ok",
|
| 785 |
+
"best_affinity": -7.461,
|
| 786 |
+
"qc_pass": true,
|
| 787 |
+
"flags": [],
|
| 788 |
+
"pdb_id": "2XCT",
|
| 789 |
+
"review_class": "A_pass"
|
| 790 |
+
},
|
| 791 |
+
{
|
| 792 |
+
"drug_id": 48,
|
| 793 |
+
"canonical_name": "Prednisone",
|
| 794 |
+
"index_key": "PREDNISONE_NR3C1_PROXY",
|
| 795 |
+
"tier": "2",
|
| 796 |
+
"pdb_id_catalog": "1M2Z",
|
| 797 |
+
"het_id_catalog": "DEX",
|
| 798 |
+
"source": "moltgate_ui",
|
| 799 |
+
"session_id": "2e13c4f3a6f68e5c",
|
| 800 |
+
"run_status": "ok",
|
| 801 |
+
"best_affinity": -9.496,
|
| 802 |
+
"qc_pass": false,
|
| 803 |
+
"flags": [
|
| 804 |
+
"OUT_OF_POCKET_MAJORITY"
|
| 805 |
+
],
|
| 806 |
+
"pdb_id": "1M2Z",
|
| 807 |
+
"review_class": "B_qc_fail"
|
| 808 |
+
},
|
| 809 |
+
{
|
| 810 |
+
"drug_id": 49,
|
| 811 |
+
"canonical_name": "Acetaminophen",
|
| 812 |
+
"index_key": "ACETAMINOPHEN_COX2_PROXY",
|
| 813 |
+
"tier": "2",
|
| 814 |
+
"pdb_id_catalog": "5IKT",
|
| 815 |
+
"het_id_catalog": "TLF",
|
| 816 |
+
"source": "moltgate_ui",
|
| 817 |
+
"session_id": "f6aa48d5ed11a7f8",
|
| 818 |
+
"run_status": "ok",
|
| 819 |
+
"best_affinity": -6.146,
|
| 820 |
+
"qc_pass": false,
|
| 821 |
+
"flags": [
|
| 822 |
+
"OUT_OF_POCKET_MAJORITY"
|
| 823 |
+
],
|
| 824 |
+
"pdb_id": "5IKT",
|
| 825 |
+
"review_class": "B_qc_fail"
|
| 826 |
+
},
|
| 827 |
+
{
|
| 828 |
+
"drug_id": 50,
|
| 829 |
+
"canonical_name": "Fluoxetine",
|
| 830 |
+
"index_key": "FLUOXETINE_SERT_PROXY",
|
| 831 |
+
"tier": "2",
|
| 832 |
+
"pdb_id_catalog": "5I6X",
|
| 833 |
+
"het_id_catalog": "8PR",
|
| 834 |
+
"source": "moltgate_ui",
|
| 835 |
+
"session_id": "1ebe5b7c7781ca00",
|
| 836 |
+
"run_status": "ok",
|
| 837 |
+
"best_affinity": -8.994,
|
| 838 |
+
"qc_pass": true,
|
| 839 |
+
"flags": [],
|
| 840 |
+
"pdb_id": "5I6X",
|
| 841 |
+
"review_class": "A_pass"
|
| 842 |
+
},
|
| 843 |
+
{
|
| 844 |
+
"drug_id": 51,
|
| 845 |
+
"canonical_name": "Dasatinib",
|
| 846 |
+
"index_key": "DASATINIB_ABL",
|
| 847 |
+
"tier": "1",
|
| 848 |
+
"pdb_id_catalog": "2GQG",
|
| 849 |
+
"het_id_catalog": "1N1",
|
| 850 |
+
"source": "moltgate_ui",
|
| 851 |
+
"session_id": "9c840dcc3169ef1d",
|
| 852 |
+
"run_status": "ok",
|
| 853 |
+
"best_affinity": -9.212,
|
| 854 |
+
"qc_pass": true,
|
| 855 |
+
"flags": [],
|
| 856 |
+
"pdb_id": "2GQG",
|
| 857 |
+
"review_class": "A_pass"
|
| 858 |
+
},
|
| 859 |
+
{
|
| 860 |
+
"drug_id": 52,
|
| 861 |
+
"canonical_name": "Sunitinib",
|
| 862 |
+
"index_key": "SUNITINIB_VEGFR2",
|
| 863 |
+
"tier": "1",
|
| 864 |
+
"pdb_id_catalog": "3G5E",
|
| 865 |
+
"het_id_catalog": "Q74",
|
| 866 |
+
"source": "moltgate_ui",
|
| 867 |
+
"session_id": "7ec56c76167b9ad3",
|
| 868 |
+
"run_status": "ok",
|
| 869 |
+
"best_affinity": -9.273,
|
| 870 |
+
"qc_pass": true,
|
| 871 |
+
"flags": [],
|
| 872 |
+
"pdb_id": "3G5E",
|
| 873 |
+
"review_class": "A_pass"
|
| 874 |
+
},
|
| 875 |
+
{
|
| 876 |
+
"drug_id": 53,
|
| 877 |
+
"canonical_name": "Lapatinib",
|
| 878 |
+
"index_key": "LAPATINIB_EGFR",
|
| 879 |
+
"tier": "1",
|
| 880 |
+
"pdb_id_catalog": "1XKK",
|
| 881 |
+
"het_id_catalog": "FMM",
|
| 882 |
+
"source": "moltgate_ui",
|
| 883 |
+
"session_id": "e5973b85b284af02",
|
| 884 |
+
"run_status": "ok",
|
| 885 |
+
"best_affinity": -10.13,
|
| 886 |
+
"qc_pass": true,
|
| 887 |
+
"flags": [],
|
| 888 |
+
"pdb_id": "1XKK",
|
| 889 |
+
"review_class": "A_pass"
|
| 890 |
+
},
|
| 891 |
+
{
|
| 892 |
+
"drug_id": 54,
|
| 893 |
+
"canonical_name": "Palbociclib",
|
| 894 |
+
"index_key": "PALBOCICLIB_CDK6",
|
| 895 |
+
"tier": "1",
|
| 896 |
+
"pdb_id_catalog": "5L2I",
|
| 897 |
+
"het_id_catalog": "LQQ",
|
| 898 |
+
"source": "moltgate_ui",
|
| 899 |
+
"session_id": "0a00e25b69837d3e",
|
| 900 |
+
"run_status": "ok",
|
| 901 |
+
"best_affinity": -10.25,
|
| 902 |
+
"qc_pass": true,
|
| 903 |
+
"flags": [],
|
| 904 |
+
"pdb_id": "5L2I",
|
| 905 |
+
"review_class": "A_pass"
|
| 906 |
+
},
|
| 907 |
+
{
|
| 908 |
+
"drug_id": 55,
|
| 909 |
+
"canonical_name": "Trametinib",
|
| 910 |
+
"index_key": "TRAMETINIB_MEK1",
|
| 911 |
+
"tier": "1",
|
| 912 |
+
"pdb_id_catalog": "7JUX",
|
| 913 |
+
"het_id_catalog": "QOM",
|
| 914 |
+
"source": "moltgate_ui",
|
| 915 |
+
"session_id": "9227759c44d3ecf0",
|
| 916 |
+
"run_status": "ok",
|
| 917 |
+
"best_affinity": -8.325,
|
| 918 |
+
"qc_pass": true,
|
| 919 |
+
"flags": [],
|
| 920 |
+
"pdb_id": "7JUX",
|
| 921 |
+
"review_class": "A_pass"
|
| 922 |
+
},
|
| 923 |
+
{
|
| 924 |
+
"drug_id": 56,
|
| 925 |
+
"canonical_name": "Letrozole",
|
| 926 |
+
"index_key": "LETROZOLE_CYP19",
|
| 927 |
+
"tier": "1",
|
| 928 |
+
"pdb_id_catalog": "1E3Q",
|
| 929 |
+
"het_id_catalog": "EBW",
|
| 930 |
+
"source": "moltgate_ui",
|
| 931 |
+
"session_id": "bec82e76ffb9573e",
|
| 932 |
+
"run_status": "ok",
|
| 933 |
+
"best_affinity": -9.559,
|
| 934 |
+
"qc_pass": true,
|
| 935 |
+
"flags": [],
|
| 936 |
+
"pdb_id": "1E3Q",
|
| 937 |
+
"review_class": "A_pass"
|
| 938 |
+
},
|
| 939 |
+
{
|
| 940 |
+
"drug_id": 57,
|
| 941 |
+
"canonical_name": "Anastrozole",
|
| 942 |
+
"index_key": "ANASTROZOLE_CYP19",
|
| 943 |
+
"tier": "1",
|
| 944 |
+
"pdb_id_catalog": "3S7S",
|
| 945 |
+
"het_id_catalog": "EXM",
|
| 946 |
+
"source": "moltgate_ui",
|
| 947 |
+
"session_id": "fe11d1eb7ff27622",
|
| 948 |
+
"run_status": "ok",
|
| 949 |
+
"best_affinity": -10.03,
|
| 950 |
+
"qc_pass": true,
|
| 951 |
+
"flags": [],
|
| 952 |
+
"pdb_id": "3S7S",
|
| 953 |
+
"review_class": "A_pass"
|
| 954 |
+
},
|
| 955 |
+
{
|
| 956 |
+
"drug_id": 58,
|
| 957 |
+
"canonical_name": "Venetoclax",
|
| 958 |
+
"index_key": "VENETOCLAX_BCL2",
|
| 959 |
+
"tier": "1",
|
| 960 |
+
"pdb_id_catalog": "6O0K",
|
| 961 |
+
"het_id_catalog": "LBM",
|
| 962 |
+
"source": "moltgate_ui",
|
| 963 |
+
"session_id": "8670f025502d9dc5",
|
| 964 |
+
"run_status": "ok",
|
| 965 |
+
"best_affinity": -10.57,
|
| 966 |
+
"qc_pass": true,
|
| 967 |
+
"flags": [],
|
| 968 |
+
"pdb_id": "6O0K",
|
| 969 |
+
"review_class": "A_pass"
|
| 970 |
+
},
|
| 971 |
+
{
|
| 972 |
+
"drug_id": 59,
|
| 973 |
+
"canonical_name": "Dabrafenib",
|
| 974 |
+
"index_key": "DABRAFENIB_BRAF",
|
| 975 |
+
"tier": "1",
|
| 976 |
+
"pdb_id_catalog": "4XV2",
|
| 977 |
+
"het_id_catalog": "P06",
|
| 978 |
+
"source": "moltgate_ui",
|
| 979 |
+
"session_id": "1bbeeeb5ab9f0493",
|
| 980 |
+
"run_status": "ok",
|
| 981 |
+
"best_affinity": -11.24,
|
| 982 |
+
"qc_pass": true,
|
| 983 |
+
"flags": [],
|
| 984 |
+
"pdb_id": "4XV2",
|
| 985 |
+
"review_class": "A_pass"
|
| 986 |
+
},
|
| 987 |
+
{
|
| 988 |
+
"drug_id": 60,
|
| 989 |
+
"canonical_name": "Carvedilol",
|
| 990 |
+
"index_key": "CARVEDILOL_ADRB1_PROXY",
|
| 991 |
+
"tier": "2",
|
| 992 |
+
"pdb_id_catalog": "2Y03",
|
| 993 |
+
"het_id_catalog": "5FW",
|
| 994 |
+
"source": "moltgate_ui",
|
| 995 |
+
"session_id": "7e25d02de009fc2b",
|
| 996 |
+
"run_status": "ok",
|
| 997 |
+
"best_affinity": -9.464,
|
| 998 |
+
"qc_pass": true,
|
| 999 |
+
"flags": [],
|
| 1000 |
+
"pdb_id": "2Y03",
|
| 1001 |
+
"review_class": "A_pass"
|
| 1002 |
+
},
|
| 1003 |
+
{
|
| 1004 |
+
"drug_id": 61,
|
| 1005 |
+
"canonical_name": "Glipizide",
|
| 1006 |
+
"index_key": "GLIPIZIDE_KATP_PROXY",
|
| 1007 |
+
"tier": "2",
|
| 1008 |
+
"pdb_id_catalog": "3SYQ",
|
| 1009 |
+
"het_id_catalog": "GBL",
|
| 1010 |
+
"source": "moltgate_ui",
|
| 1011 |
+
"session_id": "78098c804885dc0d",
|
| 1012 |
+
"run_status": "ok",
|
| 1013 |
+
"best_affinity": -7.06,
|
| 1014 |
+
"qc_pass": true,
|
| 1015 |
+
"flags": [],
|
| 1016 |
+
"pdb_id": "3SYQ",
|
| 1017 |
+
"review_class": "A_pass"
|
| 1018 |
+
},
|
| 1019 |
+
{
|
| 1020 |
+
"drug_id": 62,
|
| 1021 |
+
"canonical_name": "Repaglinide",
|
| 1022 |
+
"index_key": "REPAGLINIDE_KATP",
|
| 1023 |
+
"tier": "1",
|
| 1024 |
+
"pdb_id_catalog": "3VE0",
|
| 1025 |
+
"het_id_catalog": "REP",
|
| 1026 |
+
"source": "moltgate_ui",
|
| 1027 |
+
"session_id": "e21bd68b6c04e727",
|
| 1028 |
+
"run_status": "ok",
|
| 1029 |
+
"best_affinity": -7.005,
|
| 1030 |
+
"qc_pass": true,
|
| 1031 |
+
"flags": [],
|
| 1032 |
+
"pdb_id": "3SYQ",
|
| 1033 |
+
"review_class": "A_pass"
|
| 1034 |
+
},
|
| 1035 |
+
{
|
| 1036 |
+
"drug_id": 63,
|
| 1037 |
+
"canonical_name": "Canagliflozin",
|
| 1038 |
+
"index_key": "CANAGLIFLOZIN_SGLT2",
|
| 1039 |
+
"tier": "1",
|
| 1040 |
+
"pdb_id_catalog": "7VSL",
|
| 1041 |
+
"het_id_catalog": "5ZI",
|
| 1042 |
+
"source": "moltgate_ui",
|
| 1043 |
+
"session_id": "d22e8ac2cc61a323",
|
| 1044 |
+
"run_status": "ok",
|
| 1045 |
+
"best_affinity": -10.88,
|
| 1046 |
+
"qc_pass": true,
|
| 1047 |
+
"flags": [],
|
| 1048 |
+
"pdb_id": "7VSL",
|
| 1049 |
+
"review_class": "A_pass"
|
| 1050 |
+
},
|
| 1051 |
+
{
|
| 1052 |
+
"drug_id": 64,
|
| 1053 |
+
"canonical_name": "Dapagliflozin",
|
| 1054 |
+
"index_key": "DAPAGLIFLOZIN_SGLT2",
|
| 1055 |
+
"tier": "1",
|
| 1056 |
+
"pdb_id_catalog": "6VBL",
|
| 1057 |
+
"het_id_catalog": "DAP",
|
| 1058 |
+
"source": "moltgate_ui",
|
| 1059 |
+
"session_id": "e9629795a827264a",
|
| 1060 |
+
"run_status": "ok",
|
| 1061 |
+
"best_affinity": -9.983,
|
| 1062 |
+
"qc_pass": true,
|
| 1063 |
+
"flags": [
|
| 1064 |
+
"OUT_OF_POCKET_MINOR: 1/9 poses outside"
|
| 1065 |
+
],
|
| 1066 |
+
"pdb_id": "7VSI",
|
| 1067 |
+
"review_class": "A_pass"
|
| 1068 |
+
},
|
| 1069 |
+
{
|
| 1070 |
+
"drug_id": 65,
|
| 1071 |
+
"canonical_name": "Ezetimibe",
|
| 1072 |
+
"index_key": "EZETIMIBE_NPC1L1",
|
| 1073 |
+
"tier": "1",
|
| 1074 |
+
"pdb_id_catalog": "3QNT",
|
| 1075 |
+
"het_id_catalog": "EZE",
|
| 1076 |
+
"source": "moltgate_ui",
|
| 1077 |
+
"session_id": "3798e7eef2f99491",
|
| 1078 |
+
"run_status": "fail",
|
| 1079 |
+
"best_affinity": null,
|
| 1080 |
+
"qc_pass": null,
|
| 1081 |
+
"flags": [],
|
| 1082 |
+
"pdb_id": null,
|
| 1083 |
+
"fail_reason": "Stage 21 無候選配體,無法確認配體身份",
|
| 1084 |
+
"review_class": "A_pipeline_fail"
|
| 1085 |
+
},
|
| 1086 |
+
{
|
| 1087 |
+
"drug_id": 66,
|
| 1088 |
+
"canonical_name": "Pravastatin",
|
| 1089 |
+
"index_key": "PRAVASTATIN_HMGCR_PROXY",
|
| 1090 |
+
"tier": "2",
|
| 1091 |
+
"pdb_id_catalog": "1HW9",
|
| 1092 |
+
"het_id_catalog": "SIM",
|
| 1093 |
+
"source": "moltgate_ui",
|
| 1094 |
+
"session_id": "177370c52bb87918",
|
| 1095 |
+
"run_status": "ok",
|
| 1096 |
+
"best_affinity": -6.836,
|
| 1097 |
+
"qc_pass": true,
|
| 1098 |
+
"flags": [],
|
| 1099 |
+
"pdb_id": "1HW9",
|
| 1100 |
+
"review_class": "A_pass"
|
| 1101 |
+
},
|
| 1102 |
+
{
|
| 1103 |
+
"drug_id": 67,
|
| 1104 |
+
"canonical_name": "Lovastatin",
|
| 1105 |
+
"index_key": "LOVASTATIN_HMGCR",
|
| 1106 |
+
"tier": "1",
|
| 1107 |
+
"pdb_id_catalog": "1HW8",
|
| 1108 |
+
"het_id_catalog": "MVA",
|
| 1109 |
+
"source": "moltgate_ui",
|
| 1110 |
+
"session_id": "2c1e31f7d47c77bb",
|
| 1111 |
+
"run_status": "ok",
|
| 1112 |
+
"best_affinity": -6.535,
|
| 1113 |
+
"qc_pass": true,
|
| 1114 |
+
"flags": [],
|
| 1115 |
+
"pdb_id": "1HW8",
|
| 1116 |
+
"review_class": "A_pass"
|
| 1117 |
+
},
|
| 1118 |
+
{
|
| 1119 |
+
"drug_id": 68,
|
| 1120 |
+
"canonical_name": "Valsartan",
|
| 1121 |
+
"index_key": "VALSARTAN_AT1R_PROXY",
|
| 1122 |
+
"tier": "2",
|
| 1123 |
+
"pdb_id_catalog": "4ZUD",
|
| 1124 |
+
"het_id_catalog": "OLM",
|
| 1125 |
+
"source": "moltgate_ui",
|
| 1126 |
+
"session_id": "4454d4d74b646635",
|
| 1127 |
+
"run_status": "ok",
|
| 1128 |
+
"best_affinity": -8.675,
|
| 1129 |
+
"qc_pass": true,
|
| 1130 |
+
"flags": [],
|
| 1131 |
+
"pdb_id": "4ZUD",
|
| 1132 |
+
"review_class": "A_pass"
|
| 1133 |
+
},
|
| 1134 |
+
{
|
| 1135 |
+
"drug_id": 69,
|
| 1136 |
+
"canonical_name": "Spironolactone",
|
| 1137 |
+
"index_key": "SPIRONOLACTONE_NR3C2",
|
| 1138 |
+
"tier": "1",
|
| 1139 |
+
"pdb_id_catalog": "2AA2",
|
| 1140 |
+
"het_id_catalog": "SPI",
|
| 1141 |
+
"source": "moltgate_ui",
|
| 1142 |
+
"session_id": "b1e58ad085239aa1",
|
| 1143 |
+
"run_status": "ok",
|
| 1144 |
+
"best_affinity": -6.66,
|
| 1145 |
+
"qc_pass": true,
|
| 1146 |
+
"flags": [
|
| 1147 |
+
"OUT_OF_POCKET_MINOR: 2/9 poses outside"
|
| 1148 |
+
],
|
| 1149 |
+
"pdb_id": "2AA2",
|
| 1150 |
+
"review_class": "A_pass"
|
| 1151 |
+
},
|
| 1152 |
+
{
|
| 1153 |
+
"drug_id": 70,
|
| 1154 |
+
"canonical_name": "Propranolol",
|
| 1155 |
+
"index_key": "PROPRANOLOL_ADRB1_PROXY",
|
| 1156 |
+
"tier": "2",
|
| 1157 |
+
"pdb_id_catalog": "2Y02",
|
| 1158 |
+
"het_id_catalog": "WHJ",
|
| 1159 |
+
"source": "moltgate_ui",
|
| 1160 |
+
"session_id": "b5bae316bdf238a5",
|
| 1161 |
+
"run_status": "ok",
|
| 1162 |
+
"best_affinity": -6.748,
|
| 1163 |
+
"qc_pass": true,
|
| 1164 |
+
"flags": [
|
| 1165 |
+
"OUT_OF_POCKET_MINOR: 4/9 poses outside"
|
| 1166 |
+
],
|
| 1167 |
+
"pdb_id": "2Y02",
|
| 1168 |
+
"review_class": "A_pass"
|
| 1169 |
+
},
|
| 1170 |
+
{
|
| 1171 |
+
"drug_id": 71,
|
| 1172 |
+
"canonical_name": "Indomethacin",
|
| 1173 |
+
"index_key": "INDOMETHACIN_COX2_PROXY",
|
| 1174 |
+
"tier": "2",
|
| 1175 |
+
"pdb_id_catalog": "5IKR",
|
| 1176 |
+
"het_id_catalog": "ID8",
|
| 1177 |
+
"source": "moltgate_ui",
|
| 1178 |
+
"session_id": "343447d0e170107a",
|
| 1179 |
+
"run_status": "ok",
|
| 1180 |
+
"best_affinity": -8.11,
|
| 1181 |
+
"qc_pass": true,
|
| 1182 |
+
"flags": [
|
| 1183 |
+
"OUT_OF_POCKET_MINOR: 3/9 poses outside"
|
| 1184 |
+
],
|
| 1185 |
+
"pdb_id": "5IKR",
|
| 1186 |
+
"review_class": "A_pass"
|
| 1187 |
+
},
|
| 1188 |
+
{
|
| 1189 |
+
"drug_id": 72,
|
| 1190 |
+
"canonical_name": "Ketorolac",
|
| 1191 |
+
"index_key": "KETOROLAC_COX2",
|
| 1192 |
+
"tier": "1",
|
| 1193 |
+
"pdb_id_catalog": "1Q4G",
|
| 1194 |
+
"het_id_catalog": "KRL",
|
| 1195 |
+
"source": "moltgate_ui",
|
| 1196 |
+
"session_id": "3e0f7afb6013ef6d",
|
| 1197 |
+
"run_status": "ok",
|
| 1198 |
+
"best_affinity": -6.948,
|
| 1199 |
+
"qc_pass": true,
|
| 1200 |
+
"flags": [],
|
| 1201 |
+
"pdb_id": "1Q4G",
|
| 1202 |
+
"review_class": "A_pass"
|
| 1203 |
+
},
|
| 1204 |
+
{
|
| 1205 |
+
"drug_id": 73,
|
| 1206 |
+
"canonical_name": "Piroxicam",
|
| 1207 |
+
"index_key": "PIROXICAM_COX2_PROXY",
|
| 1208 |
+
"tier": "2",
|
| 1209 |
+
"pdb_id_catalog": "5IKT",
|
| 1210 |
+
"het_id_catalog": "TLF",
|
| 1211 |
+
"source": "moltgate_ui",
|
| 1212 |
+
"session_id": "408626b740c2b2ed",
|
| 1213 |
+
"run_status": "ok",
|
| 1214 |
+
"best_affinity": -6.47,
|
| 1215 |
+
"qc_pass": false,
|
| 1216 |
+
"flags": [
|
| 1217 |
+
"OUT_OF_POCKET_MAJORITY"
|
| 1218 |
+
],
|
| 1219 |
+
"pdb_id": "5IKT",
|
| 1220 |
+
"review_class": "B_qc_fail"
|
| 1221 |
+
},
|
| 1222 |
+
{
|
| 1223 |
+
"drug_id": 74,
|
| 1224 |
+
"canonical_name": "Azithromycin",
|
| 1225 |
+
"index_key": "AZITHROMYCIN_RIBOSOME",
|
| 1226 |
+
"tier": "1",
|
| 1227 |
+
"pdb_id_catalog": "1YII",
|
| 1228 |
+
"het_id_catalog": "AZI",
|
| 1229 |
+
"source": "moltgate_ui",
|
| 1230 |
+
"session_id": "7d9666f30745df38",
|
| 1231 |
+
"run_status": "ok",
|
| 1232 |
+
"best_affinity": -3.443,
|
| 1233 |
+
"qc_pass": false,
|
| 1234 |
+
"flags": [
|
| 1235 |
+
"SCORE_WEAK: best pose -3.443 kcal/mol > 閾值 -6.0",
|
| 1236 |
+
"OUT_OF_POCKET_MINOR: 1/9 poses outside"
|
| 1237 |
+
],
|
| 1238 |
+
"pdb_id": "1YHQ",
|
| 1239 |
+
"review_class": "B_qc_fail"
|
| 1240 |
+
},
|
| 1241 |
+
{
|
| 1242 |
+
"drug_id": 75,
|
| 1243 |
+
"canonical_name": "Amoxicillin",
|
| 1244 |
+
"index_key": "AMOXICILLIN_PBP_PROXY",
|
| 1245 |
+
"tier": "2",
|
| 1246 |
+
"pdb_id_catalog": "1PWP",
|
| 1247 |
+
"het_id_catalog": "PG2",
|
| 1248 |
+
"source": "moltgate_ui",
|
| 1249 |
+
"session_id": "c66f9df2ceeb8baf",
|
| 1250 |
+
"run_status": "ok",
|
| 1251 |
+
"best_affinity": -6.898,
|
| 1252 |
+
"qc_pass": true,
|
| 1253 |
+
"flags": [
|
| 1254 |
+
"OUT_OF_POCKET_MINOR: 1/9 poses outside"
|
| 1255 |
+
],
|
| 1256 |
+
"pdb_id": "1PWP",
|
| 1257 |
+
"review_class": "A_pass"
|
| 1258 |
+
},
|
| 1259 |
+
{
|
| 1260 |
+
"drug_id": 76,
|
| 1261 |
+
"canonical_name": "Doxycycline",
|
| 1262 |
+
"index_key": "DOXYCYCLINE_RIBOSOME",
|
| 1263 |
+
"tier": "1",
|
| 1264 |
+
"pdb_id_catalog": "1HNW",
|
| 1265 |
+
"het_id_catalog": "DOX",
|
| 1266 |
+
"source": "moltgate_ui",
|
| 1267 |
+
"session_id": "7dbf82e1dc3dc931",
|
| 1268 |
+
"run_status": "fail",
|
| 1269 |
+
"best_affinity": null,
|
| 1270 |
+
"qc_pass": null,
|
| 1271 |
+
"flags": [],
|
| 1272 |
+
"pdb_id": null,
|
| 1273 |
+
"review_class": "A_pipeline_fail"
|
| 1274 |
+
},
|
| 1275 |
+
{
|
| 1276 |
+
"drug_id": 77,
|
| 1277 |
+
"canonical_name": "Levofloxacin",
|
| 1278 |
+
"index_key": "LEVOFLOXACIN_GYRASE",
|
| 1279 |
+
"tier": "2",
|
| 1280 |
+
"pdb_id_catalog": "2XCT",
|
| 1281 |
+
"het_id_catalog": "CPF",
|
| 1282 |
+
"source": "moltgate_ui",
|
| 1283 |
+
"session_id": "3bad04d9f957542c",
|
| 1284 |
+
"run_status": "ok",
|
| 1285 |
+
"best_affinity": -7.624,
|
| 1286 |
+
"qc_pass": true,
|
| 1287 |
+
"flags": [],
|
| 1288 |
+
"pdb_id": "2XCT",
|
| 1289 |
+
"review_class": "A_pass"
|
| 1290 |
+
},
|
| 1291 |
+
{
|
| 1292 |
+
"drug_id": 78,
|
| 1293 |
+
"canonical_name": "Trimethoprim",
|
| 1294 |
+
"index_key": "TRIMETHOPRIM_DHFR",
|
| 1295 |
+
"tier": "1",
|
| 1296 |
+
"pdb_id_catalog": "2W9G",
|
| 1297 |
+
"het_id_catalog": "TMP",
|
| 1298 |
+
"source": "moltgate_ui",
|
| 1299 |
+
"session_id": "2efa0824f12cd1b9",
|
| 1300 |
+
"run_status": "ok",
|
| 1301 |
+
"best_affinity": -7.542,
|
| 1302 |
+
"qc_pass": true,
|
| 1303 |
+
"flags": [],
|
| 1304 |
+
"pdb_id": "2W9G",
|
| 1305 |
+
"review_class": "A_pass"
|
| 1306 |
+
},
|
| 1307 |
+
{
|
| 1308 |
+
"drug_id": 79,
|
| 1309 |
+
"canonical_name": "Sertraline",
|
| 1310 |
+
"index_key": "SERTRALINE_SERT_PROXY",
|
| 1311 |
+
"tier": "2",
|
| 1312 |
+
"pdb_id_catalog": "5I6X",
|
| 1313 |
+
"het_id_catalog": "8PR",
|
| 1314 |
+
"source": "moltgate_ui",
|
| 1315 |
+
"session_id": "2c05bb00c988648d",
|
| 1316 |
+
"run_status": "ok",
|
| 1317 |
+
"best_affinity": -9.227,
|
| 1318 |
+
"qc_pass": true,
|
| 1319 |
+
"flags": [
|
| 1320 |
+
"OUT_OF_POCKET_MINOR: 2/9 poses outside"
|
| 1321 |
+
],
|
| 1322 |
+
"pdb_id": "5I6X",
|
| 1323 |
+
"review_class": "A_pass"
|
| 1324 |
+
},
|
| 1325 |
+
{
|
| 1326 |
+
"drug_id": 80,
|
| 1327 |
+
"canonical_name": "Paroxetine",
|
| 1328 |
+
"index_key": "PAROXETINE_SERT",
|
| 1329 |
+
"tier": "1",
|
| 1330 |
+
"pdb_id_catalog": "5I6X",
|
| 1331 |
+
"het_id_catalog": "8PR",
|
| 1332 |
+
"source": "moltgate_ui",
|
| 1333 |
+
"session_id": "172c8b9d2b763380",
|
| 1334 |
+
"run_status": "ok",
|
| 1335 |
+
"best_affinity": -9.378,
|
| 1336 |
+
"qc_pass": true,
|
| 1337 |
+
"flags": [
|
| 1338 |
+
"OUT_OF_POCKET_MINOR: 1/9 poses outside"
|
| 1339 |
+
],
|
| 1340 |
+
"pdb_id": "5I6X",
|
| 1341 |
+
"review_class": "A_pass"
|
| 1342 |
+
},
|
| 1343 |
+
{
|
| 1344 |
+
"drug_id": 81,
|
| 1345 |
+
"canonical_name": "Osimertinib",
|
| 1346 |
+
"index_key": "OSIMERTINIB_EGFR",
|
| 1347 |
+
"tier": "1",
|
| 1348 |
+
"pdb_id_catalog": "5XGN",
|
| 1349 |
+
"het_id_catalog": "OSS",
|
| 1350 |
+
"source": "moltgate_ui",
|
| 1351 |
+
"session_id": "b2733f1d8ba893e3",
|
| 1352 |
+
"run_status": "ok",
|
| 1353 |
+
"best_affinity": -8.29,
|
| 1354 |
+
"qc_pass": true,
|
| 1355 |
+
"flags": [],
|
| 1356 |
+
"pdb_id": "5XGN",
|
| 1357 |
+
"review_class": "A_pass"
|
| 1358 |
+
},
|
| 1359 |
+
{
|
| 1360 |
+
"drug_id": 82,
|
| 1361 |
+
"canonical_name": "Afatinib",
|
| 1362 |
+
"index_key": "AFATINIB_EGFR",
|
| 1363 |
+
"tier": "1",
|
| 1364 |
+
"pdb_id_catalog": "4G5J",
|
| 1365 |
+
"het_id_catalog": "AFT",
|
| 1366 |
+
"source": "moltgate_ui",
|
| 1367 |
+
"session_id": "d9955b9251aa1395",
|
| 1368 |
+
"run_status": "ok",
|
| 1369 |
+
"best_affinity": -6.362,
|
| 1370 |
+
"qc_pass": true,
|
| 1371 |
+
"flags": [
|
| 1372 |
+
"OUT_OF_POCKET_MINOR: 1/9 poses outside"
|
| 1373 |
+
],
|
| 1374 |
+
"pdb_id": "4G5J",
|
| 1375 |
+
"review_class": "A_pass"
|
| 1376 |
+
},
|
| 1377 |
+
{
|
| 1378 |
+
"drug_id": 83,
|
| 1379 |
+
"canonical_name": "Sorafenib",
|
| 1380 |
+
"index_key": "SORAFENIB_BRAF",
|
| 1381 |
+
"tier": "1",
|
| 1382 |
+
"pdb_id_catalog": "3OG7",
|
| 1383 |
+
"het_id_catalog": "SOR",
|
| 1384 |
+
"source": "moltgate_ui",
|
| 1385 |
+
"session_id": "88b880b8cefb9c24",
|
| 1386 |
+
"run_status": "ok",
|
| 1387 |
+
"best_affinity": -9.859,
|
| 1388 |
+
"qc_pass": true,
|
| 1389 |
+
"flags": [],
|
| 1390 |
+
"pdb_id": "3OG7",
|
| 1391 |
+
"review_class": "A_pass"
|
| 1392 |
+
},
|
| 1393 |
+
{
|
| 1394 |
+
"drug_id": 84,
|
| 1395 |
+
"canonical_name": "Cabozantinib",
|
| 1396 |
+
"index_key": "CABOZANTINIB_MET",
|
| 1397 |
+
"tier": "1",
|
| 1398 |
+
"pdb_id_catalog": "4O1B",
|
| 1399 |
+
"het_id_catalog": "X87",
|
| 1400 |
+
"source": "moltgate_ui",
|
| 1401 |
+
"session_id": "e0cf69e715eb5c96",
|
| 1402 |
+
"run_status": "ok",
|
| 1403 |
+
"best_affinity": -7.684,
|
| 1404 |
+
"qc_pass": true,
|
| 1405 |
+
"flags": [
|
| 1406 |
+
"OUT_OF_POCKET_MINOR: 2/9 poses outside"
|
| 1407 |
+
],
|
| 1408 |
+
"pdb_id": "4O1B",
|
| 1409 |
+
"review_class": "A_pass"
|
| 1410 |
+
},
|
| 1411 |
+
{
|
| 1412 |
+
"drug_id": 85,
|
| 1413 |
+
"canonical_name": "Ibrutinib",
|
| 1414 |
+
"index_key": "IBRUTINIB_BTK",
|
| 1415 |
+
"tier": "1",
|
| 1416 |
+
"pdb_id_catalog": "4O5B",
|
| 1417 |
+
"het_id_catalog": "PPI",
|
| 1418 |
+
"source": "moltgate_ui",
|
| 1419 |
+
"session_id": "131a125e328218e2",
|
| 1420 |
+
"run_status": "fail",
|
| 1421 |
+
"best_affinity": null,
|
| 1422 |
+
"qc_pass": null,
|
| 1423 |
+
"flags": [],
|
| 1424 |
+
"pdb_id": null,
|
| 1425 |
+
"review_class": "A_pipeline_fail"
|
| 1426 |
+
},
|
| 1427 |
+
{
|
| 1428 |
+
"drug_id": 86,
|
| 1429 |
+
"canonical_name": "Olaparib",
|
| 1430 |
+
"index_key": "OLAPARIB_PARP",
|
| 1431 |
+
"tier": "1",
|
| 1432 |
+
"pdb_id_catalog": "5DS5",
|
| 1433 |
+
"het_id_catalog": "OL0",
|
| 1434 |
+
"source": "moltgate_ui",
|
| 1435 |
+
"session_id": "cb7e211ba798724c",
|
| 1436 |
+
"run_status": "fail",
|
| 1437 |
+
"best_affinity": null,
|
| 1438 |
+
"qc_pass": null,
|
| 1439 |
+
"flags": [],
|
| 1440 |
+
"pdb_id": null,
|
| 1441 |
+
"fail_reason": "Stage 21 無候選配體,無法確認配體身份",
|
| 1442 |
+
"review_class": "A_pipeline_fail"
|
| 1443 |
+
},
|
| 1444 |
+
{
|
| 1445 |
+
"drug_id": 87,
|
| 1446 |
+
"canonical_name": "Ruxolitinib",
|
| 1447 |
+
"index_key": "RUXOLITINIB_JAK2",
|
| 1448 |
+
"tier": "1",
|
| 1449 |
+
"pdb_id_catalog": "4IVC",
|
| 1450 |
+
"het_id_catalog": "RUX",
|
| 1451 |
+
"source": "moltgate_ui",
|
| 1452 |
+
"session_id": "63c3f271ac60016f",
|
| 1453 |
+
"run_status": "ok",
|
| 1454 |
+
"best_affinity": -9.115,
|
| 1455 |
+
"qc_pass": true,
|
| 1456 |
+
"flags": [
|
| 1457 |
+
"OUT_OF_POCKET_MINOR: 2/9 poses outside"
|
| 1458 |
+
],
|
| 1459 |
+
"pdb_id": "4IVC",
|
| 1460 |
+
"review_class": "A_pass"
|
| 1461 |
+
},
|
| 1462 |
+
{
|
| 1463 |
+
"drug_id": 88,
|
| 1464 |
+
"canonical_name": "Enzalutamide",
|
| 1465 |
+
"index_key": "ENZALUTAMIDE_AR",
|
| 1466 |
+
"tier": "1",
|
| 1467 |
+
"pdb_id_catalog": "3R5W",
|
| 1468 |
+
"het_id_catalog": "ENZ",
|
| 1469 |
+
"source": "moltgate_ui",
|
| 1470 |
+
"session_id": "3fbcd648db7b0a31",
|
| 1471 |
+
"run_status": "ok",
|
| 1472 |
+
"best_affinity": -8.236,
|
| 1473 |
+
"qc_pass": true,
|
| 1474 |
+
"flags": [],
|
| 1475 |
+
"pdb_id": "3R5W",
|
| 1476 |
+
"review_class": "A_pass"
|
| 1477 |
+
},
|
| 1478 |
+
{
|
| 1479 |
+
"drug_id": 89,
|
| 1480 |
+
"canonical_name": "Tamoxifen",
|
| 1481 |
+
"index_key": "TAMOXIFEN_ESR1",
|
| 1482 |
+
"tier": "2",
|
| 1483 |
+
"pdb_id_catalog": "3ERT",
|
| 1484 |
+
"het_id_catalog": "4HT",
|
| 1485 |
+
"source": "moltgate_ui",
|
| 1486 |
+
"session_id": "45ad02e26e4be3a2",
|
| 1487 |
+
"run_status": "ok",
|
| 1488 |
+
"best_affinity": -9.616,
|
| 1489 |
+
"qc_pass": true,
|
| 1490 |
+
"flags": [
|
| 1491 |
+
"OUT_OF_POCKET_MINOR: 1/9 poses outside"
|
| 1492 |
+
],
|
| 1493 |
+
"pdb_id": "3ERT",
|
| 1494 |
+
"review_class": "A_pass"
|
| 1495 |
+
},
|
| 1496 |
+
{
|
| 1497 |
+
"drug_id": 90,
|
| 1498 |
+
"canonical_name": "Ticagrelor",
|
| 1499 |
+
"index_key": "TICAGRELOR_P2Y12",
|
| 1500 |
+
"tier": "1",
|
| 1501 |
+
"pdb_id_catalog": "4PY0",
|
| 1502 |
+
"het_id_catalog": "TIC",
|
| 1503 |
+
"source": "moltgate_ui",
|
| 1504 |
+
"session_id": "c0849714f6894c14",
|
| 1505 |
+
"run_status": "ok",
|
| 1506 |
+
"best_affinity": -7.792,
|
| 1507 |
+
"qc_pass": false,
|
| 1508 |
+
"flags": [
|
| 1509 |
+
"OUT_OF_POCKET_MAJORITY"
|
| 1510 |
+
],
|
| 1511 |
+
"pdb_id": "4PY0",
|
| 1512 |
+
"review_class": "B_qc_fail"
|
| 1513 |
+
},
|
| 1514 |
+
{
|
| 1515 |
+
"drug_id": 91,
|
| 1516 |
+
"canonical_name": "Glimepiride",
|
| 1517 |
+
"index_key": "GLIMEPIRIDE_KATP_PROXY",
|
| 1518 |
+
"tier": "2",
|
| 1519 |
+
"pdb_id_catalog": "3SYQ",
|
| 1520 |
+
"het_id_catalog": "GBL",
|
| 1521 |
+
"source": "moltgate_ui",
|
| 1522 |
+
"session_id": "e96b7d1bc0882956",
|
| 1523 |
+
"run_status": "ok",
|
| 1524 |
+
"best_affinity": -9.354,
|
| 1525 |
+
"qc_pass": true,
|
| 1526 |
+
"flags": [
|
| 1527 |
+
"OUT_OF_POCKET_MINOR: 3/9 poses outside"
|
| 1528 |
+
],
|
| 1529 |
+
"pdb_id": "3SYQ",
|
| 1530 |
+
"review_class": "A_pass"
|
| 1531 |
+
},
|
| 1532 |
+
{
|
| 1533 |
+
"drug_id": 92,
|
| 1534 |
+
"canonical_name": "Miglitol",
|
| 1535 |
+
"index_key": "MIGLITOL_GLUCOSIDASE",
|
| 1536 |
+
"tier": "1",
|
| 1537 |
+
"pdb_id_catalog": "2BB0",
|
| 1538 |
+
"het_id_catalog": "MIG",
|
| 1539 |
+
"source": "moltgate_ui",
|
| 1540 |
+
"session_id": "702b3235097e3079",
|
| 1541 |
+
"run_status": "ok",
|
| 1542 |
+
"best_affinity": -5.541,
|
| 1543 |
+
"qc_pass": false,
|
| 1544 |
+
"flags": [
|
| 1545 |
+
"SCORE_WEAK: best pose -5.541 kcal/mol > 閾值 -6.0"
|
| 1546 |
+
],
|
| 1547 |
+
"pdb_id": "2QV4",
|
| 1548 |
+
"review_class": "B_qc_fail"
|
| 1549 |
+
},
|
| 1550 |
+
{
|
| 1551 |
+
"drug_id": 93,
|
| 1552 |
+
"canonical_name": "Acarbose",
|
| 1553 |
+
"index_key": "ACARBOSE_GLUCOSIDASE",
|
| 1554 |
+
"tier": "1",
|
| 1555 |
+
"pdb_id_catalog": "2QV4",
|
| 1556 |
+
"het_id_catalog": "ACA",
|
| 1557 |
+
"source": "moltgate_ui",
|
| 1558 |
+
"session_id": "e4c383a1e07c66e8",
|
| 1559 |
+
"run_status": "ok",
|
| 1560 |
+
"best_affinity": -8.153,
|
| 1561 |
+
"qc_pass": true,
|
| 1562 |
+
"flags": [],
|
| 1563 |
+
"pdb_id": "2QV4",
|
| 1564 |
+
"review_class": "A_pass"
|
| 1565 |
+
},
|
| 1566 |
+
{
|
| 1567 |
+
"drug_id": 94,
|
| 1568 |
+
"canonical_name": "Gemfibrozil",
|
| 1569 |
+
"index_key": "GEMFIBROZIL_PPARalpha_PROXY",
|
| 1570 |
+
"tier": "2",
|
| 1571 |
+
"pdb_id_catalog": "1K74",
|
| 1572 |
+
"het_id_catalog": "544",
|
| 1573 |
+
"source": "moltgate_ui",
|
| 1574 |
+
"session_id": "1e567a88817d7d6b",
|
| 1575 |
+
"run_status": "ok",
|
| 1576 |
+
"best_affinity": -7.6,
|
| 1577 |
+
"qc_pass": false,
|
| 1578 |
+
"flags": [
|
| 1579 |
+
"OUT_OF_POCKET_MAJORITY"
|
| 1580 |
+
],
|
| 1581 |
+
"pdb_id": "1K74",
|
| 1582 |
+
"review_class": "B_qc_fail"
|
| 1583 |
+
},
|
| 1584 |
+
{
|
| 1585 |
+
"drug_id": 95,
|
| 1586 |
+
"canonical_name": "Allopurinol",
|
| 1587 |
+
"index_key": "ALLOPURINOL_XDH",
|
| 1588 |
+
"tier": "1",
|
| 1589 |
+
"pdb_id_catalog": "3NTZ",
|
| 1590 |
+
"het_id_catalog": "ALP",
|
| 1591 |
+
"source": "moltgate_ui",
|
| 1592 |
+
"session_id": "08adb08616c6b3c3",
|
| 1593 |
+
"run_status": "ok",
|
| 1594 |
+
"best_affinity": -5.701,
|
| 1595 |
+
"qc_pass": false,
|
| 1596 |
+
"flags": [
|
| 1597 |
+
"SCORE_WEAK: best pose -5.701 kcal/mol > 閾值 -6.0"
|
| 1598 |
+
],
|
| 1599 |
+
"pdb_id": "3NTZ",
|
| 1600 |
+
"review_class": "B_qc_fail"
|
| 1601 |
+
},
|
| 1602 |
+
{
|
| 1603 |
+
"drug_id": 96,
|
| 1604 |
+
"canonical_name": "Febuxostat",
|
| 1605 |
+
"index_key": "FEBUXOSTAT_XDH",
|
| 1606 |
+
"tier": "1",
|
| 1607 |
+
"pdb_id_catalog": "3EY8",
|
| 1608 |
+
"het_id_catalog": "FEB",
|
| 1609 |
+
"source": "moltgate_ui",
|
| 1610 |
+
"session_id": "7d3c0644045727df",
|
| 1611 |
+
"run_status": "ok",
|
| 1612 |
+
"best_affinity": -5.392,
|
| 1613 |
+
"qc_pass": false,
|
| 1614 |
+
"flags": [
|
| 1615 |
+
"SCORE_WEAK: best pose -5.392 kcal/mol > 閾值 -6.0",
|
| 1616 |
+
"OUT_OF_POCKET_MINOR: 2/9 poses outside"
|
| 1617 |
+
],
|
| 1618 |
+
"pdb_id": "3EY8",
|
| 1619 |
+
"review_class": "B_qc_fail"
|
| 1620 |
+
},
|
| 1621 |
+
{
|
| 1622 |
+
"drug_id": 97,
|
| 1623 |
+
"canonical_name": "Bisoprolol",
|
| 1624 |
+
"index_key": "BISOPROLOL_ADRB1_PROXY",
|
| 1625 |
+
"tier": "2",
|
| 1626 |
+
"pdb_id_catalog": "2Y02",
|
| 1627 |
+
"het_id_catalog": "WHJ",
|
| 1628 |
+
"source": "moltgate_ui",
|
| 1629 |
+
"session_id": "3ffb865f1044824a",
|
| 1630 |
+
"run_status": "ok",
|
| 1631 |
+
"best_affinity": -7.312,
|
| 1632 |
+
"qc_pass": true,
|
| 1633 |
+
"flags": [
|
| 1634 |
+
"OUT_OF_POCKET_MINOR: 1/9 poses outside"
|
| 1635 |
+
],
|
| 1636 |
+
"pdb_id": "2Y02",
|
| 1637 |
+
"review_class": "A_pass"
|
| 1638 |
+
},
|
| 1639 |
+
{
|
| 1640 |
+
"drug_id": 98,
|
| 1641 |
+
"canonical_name": "Nifedipine",
|
| 1642 |
+
"index_key": "NIFEDIPINE_CACNA1C",
|
| 1643 |
+
"tier": "2",
|
| 1644 |
+
"pdb_id_catalog": "8WE8",
|
| 1645 |
+
"het_id_catalog": "6UB",
|
| 1646 |
+
"source": "moltgate_ui",
|
| 1647 |
+
"session_id": "d4c5b5c59fe17d3e",
|
| 1648 |
+
"run_status": "ok",
|
| 1649 |
+
"best_affinity": -7.719,
|
| 1650 |
+
"qc_pass": true,
|
| 1651 |
+
"flags": [
|
| 1652 |
+
"OUT_OF_POCKET_MINOR: 2/9 poses outside"
|
| 1653 |
+
],
|
| 1654 |
+
"pdb_id": "8WE8",
|
| 1655 |
+
"review_class": "A_pass"
|
| 1656 |
+
},
|
| 1657 |
+
{
|
| 1658 |
+
"drug_id": 99,
|
| 1659 |
+
"canonical_name": "Verapamil",
|
| 1660 |
+
"index_key": "VERAPAMIL_CACNA1C_PROXY",
|
| 1661 |
+
"tier": "2",
|
| 1662 |
+
"pdb_id_catalog": "8WE8",
|
| 1663 |
+
"het_id_catalog": "6UB",
|
| 1664 |
+
"source": "moltgate_ui",
|
| 1665 |
+
"session_id": "80fb56ee4e650648",
|
| 1666 |
+
"run_status": "ok",
|
| 1667 |
+
"best_affinity": -7.967,
|
| 1668 |
+
"qc_pass": true,
|
| 1669 |
+
"flags": [],
|
| 1670 |
+
"pdb_id": "8WE8",
|
| 1671 |
+
"review_class": "A_pass"
|
| 1672 |
+
},
|
| 1673 |
+
{
|
| 1674 |
+
"drug_id": 100,
|
| 1675 |
+
"canonical_name": "Pantoprazole",
|
| 1676 |
+
"index_key": "PANTOPRAZOLE_CYP2C19_PROXY",
|
| 1677 |
+
"tier": "2",
|
| 1678 |
+
"pdb_id_catalog": "4GQS",
|
| 1679 |
+
"het_id_catalog": "0XV",
|
| 1680 |
+
"source": "moltgate_ui",
|
| 1681 |
+
"session_id": "4a9ec2bae5439cfb",
|
| 1682 |
+
"run_status": "ok",
|
| 1683 |
+
"best_affinity": -8.095,
|
| 1684 |
+
"qc_pass": true,
|
| 1685 |
+
"flags": [
|
| 1686 |
+
"OUT_OF_POCKET_MINOR: 1/9 poses outside"
|
| 1687 |
+
],
|
| 1688 |
+
"pdb_id": "4GQS",
|
| 1689 |
+
"review_class": "A_pass"
|
| 1690 |
+
},
|
| 1691 |
+
{
|
| 1692 |
+
"drug_id": 101,
|
| 1693 |
+
"canonical_name": "Colchicine",
|
| 1694 |
+
"index_key": "COLCHICINE_TUBULIN",
|
| 1695 |
+
"tier": "1",
|
| 1696 |
+
"pdb_id_catalog": "1BT6",
|
| 1697 |
+
"het_id_catalog": "COL",
|
| 1698 |
+
"source": "moltgate_ui",
|
| 1699 |
+
"session_id": "79fb6729abb9421e",
|
| 1700 |
+
"run_status": "fail",
|
| 1701 |
+
"best_affinity": null,
|
| 1702 |
+
"qc_pass": null,
|
| 1703 |
+
"flags": [],
|
| 1704 |
+
"pdb_id": null,
|
| 1705 |
+
"fail_reason": "Stage 21 無候選配體,無法確認配體身份",
|
| 1706 |
+
"review_class": "A_pipeline_fail"
|
| 1707 |
+
},
|
| 1708 |
+
{
|
| 1709 |
+
"drug_id": 102,
|
| 1710 |
+
"canonical_name": "Sulindac",
|
| 1711 |
+
"index_key": "SULINDAC_COX2_PROXY",
|
| 1712 |
+
"tier": "2",
|
| 1713 |
+
"pdb_id_catalog": "5IKR",
|
| 1714 |
+
"het_id_catalog": "ID8",
|
| 1715 |
+
"source": "moltgate_ui",
|
| 1716 |
+
"session_id": "11547a90c4a50a13",
|
| 1717 |
+
"run_status": "ok",
|
| 1718 |
+
"best_affinity": -6.246,
|
| 1719 |
+
"qc_pass": false,
|
| 1720 |
+
"flags": [
|
| 1721 |
+
"OUT_OF_POCKET_MAJORITY"
|
| 1722 |
+
],
|
| 1723 |
+
"pdb_id": "5IKR",
|
| 1724 |
+
"review_class": "B_qc_fail"
|
| 1725 |
+
},
|
| 1726 |
+
{
|
| 1727 |
+
"drug_id": 103,
|
| 1728 |
+
"canonical_name": "Gabapentin",
|
| 1729 |
+
"index_key": "GABAPENTIN_CACNA2D_PROXY",
|
| 1730 |
+
"tier": "2",
|
| 1731 |
+
"pdb_id_catalog": "5E6I",
|
| 1732 |
+
"het_id_catalog": "GBP",
|
| 1733 |
+
"source": "moltgate_ui",
|
| 1734 |
+
"session_id": "a6eef95399f928b5",
|
| 1735 |
+
"run_status": "fail",
|
| 1736 |
+
"best_affinity": null,
|
| 1737 |
+
"qc_pass": null,
|
| 1738 |
+
"flags": [],
|
| 1739 |
+
"pdb_id": null,
|
| 1740 |
+
"fail_reason": "Stage 21 無候選配體,無法確認配體身份",
|
| 1741 |
+
"review_class": "A_pipeline_fail"
|
| 1742 |
+
},
|
| 1743 |
+
{
|
| 1744 |
+
"drug_id": 104,
|
| 1745 |
+
"canonical_name": "Carbamazepine",
|
| 1746 |
+
"index_key": "CARBAMAZEPINE_NAV_PROXY",
|
| 1747 |
+
"tier": "2",
|
| 1748 |
+
"pdb_id_catalog": "5E6I",
|
| 1749 |
+
"het_id_catalog": "GBP",
|
| 1750 |
+
"source": "moltgate_ui",
|
| 1751 |
+
"session_id": "4d252ef951059a9a",
|
| 1752 |
+
"run_status": "fail",
|
| 1753 |
+
"best_affinity": null,
|
| 1754 |
+
"qc_pass": null,
|
| 1755 |
+
"flags": [],
|
| 1756 |
+
"pdb_id": null,
|
| 1757 |
+
"fail_reason": "Stage 21 無候選配體,無法確認配體身份",
|
| 1758 |
+
"review_class": "A_pipeline_fail"
|
| 1759 |
+
},
|
| 1760 |
+
{
|
| 1761 |
+
"drug_id": 105,
|
| 1762 |
+
"canonical_name": "Valproic acid",
|
| 1763 |
+
"index_key": "VALPROIC_ACID_HDAC_PROXY",
|
| 1764 |
+
"tier": "2",
|
| 1765 |
+
"pdb_id_catalog": "4LXZ",
|
| 1766 |
+
"het_id_catalog": "SHH",
|
| 1767 |
+
"source": "moltgate_ui",
|
| 1768 |
+
"session_id": "3a62507682e6bf11",
|
| 1769 |
+
"run_status": "ok",
|
| 1770 |
+
"best_affinity": -4.888,
|
| 1771 |
+
"qc_pass": false,
|
| 1772 |
+
"flags": [
|
| 1773 |
+
"SCORE_WEAK: best pose -4.888 kcal/mol > 閾值 -6.0"
|
| 1774 |
+
],
|
| 1775 |
+
"pdb_id": "4LXZ",
|
| 1776 |
+
"review_class": "B_qc_fail"
|
| 1777 |
+
},
|
| 1778 |
+
{
|
| 1779 |
+
"drug_id": 106,
|
| 1780 |
+
"canonical_name": "Metronidazole",
|
| 1781 |
+
"index_key": "METRONIDAZOLE_NITROREDUCTASE",
|
| 1782 |
+
"tier": "1",
|
| 1783 |
+
"pdb_id_catalog": "1MNU",
|
| 1784 |
+
"het_id_catalog": "MET",
|
| 1785 |
+
"source": "moltgate_ui",
|
| 1786 |
+
"session_id": "72eb1acbbf72bc3c",
|
| 1787 |
+
"run_status": "fail",
|
| 1788 |
+
"best_affinity": null,
|
| 1789 |
+
"qc_pass": null,
|
| 1790 |
+
"flags": [],
|
| 1791 |
+
"pdb_id": null,
|
| 1792 |
+
"fail_reason": "Stage 21 無候選配體,無法確認配體身份",
|
| 1793 |
+
"review_class": "A_pipeline_fail"
|
| 1794 |
+
},
|
| 1795 |
+
{
|
| 1796 |
+
"drug_id": 107,
|
| 1797 |
+
"canonical_name": "Clindamycin",
|
| 1798 |
+
"index_key": "CLINDAMYCIN_RIBOSOME",
|
| 1799 |
+
"tier": "1",
|
| 1800 |
+
"pdb_id_catalog": "1YHQ",
|
| 1801 |
+
"het_id_catalog": "CLI",
|
| 1802 |
+
"source": "moltgate_ui",
|
| 1803 |
+
"session_id": "9f5ebd6af574a905",
|
| 1804 |
+
"run_status": "ok",
|
| 1805 |
+
"best_affinity": -4.243,
|
| 1806 |
+
"qc_pass": false,
|
| 1807 |
+
"flags": [
|
| 1808 |
+
"SCORE_WEAK: best pose -4.243 kcal/mol > 閾值 -6.0"
|
| 1809 |
+
],
|
| 1810 |
+
"pdb_id": "1YHQ",
|
| 1811 |
+
"review_class": "B_qc_fail"
|
| 1812 |
+
},
|
| 1813 |
+
{
|
| 1814 |
+
"drug_id": 108,
|
| 1815 |
+
"canonical_name": "Vancomycin",
|
| 1816 |
+
"index_key": "VANCOMYCIN_PBP",
|
| 1817 |
+
"tier": "1",
|
| 1818 |
+
"pdb_id_catalog": "1FVM",
|
| 1819 |
+
"het_id_catalog": "VAN",
|
| 1820 |
+
"source": "moltgate_ui",
|
| 1821 |
+
"session_id": "562f960e8d721e60",
|
| 1822 |
+
"run_status": "ok",
|
| 1823 |
+
"best_affinity": -2.733,
|
| 1824 |
+
"qc_pass": false,
|
| 1825 |
+
"flags": [
|
| 1826 |
+
"SCORE_WEAK: best pose -2.733 kcal/mol > 閾值 -6.0"
|
| 1827 |
+
],
|
| 1828 |
+
"pdb_id": "1FVM",
|
| 1829 |
+
"review_class": "B_qc_fail"
|
| 1830 |
+
},
|
| 1831 |
+
{
|
| 1832 |
+
"drug_id": 109,
|
| 1833 |
+
"canonical_name": "Clarithromycin",
|
| 1834 |
+
"index_key": "CLARITHROMYCIN_RIBOSOME",
|
| 1835 |
+
"tier": "1",
|
| 1836 |
+
"pdb_id_catalog": "1YIJ",
|
| 1837 |
+
"het_id_catalog": "CLR",
|
| 1838 |
+
"source": "moltgate_ui",
|
| 1839 |
+
"session_id": "61f47136fa5514b1",
|
| 1840 |
+
"run_status": "fail",
|
| 1841 |
+
"best_affinity": null,
|
| 1842 |
+
"qc_pass": null,
|
| 1843 |
+
"flags": [],
|
| 1844 |
+
"pdb_id": null,
|
| 1845 |
+
"review_class": "A_pipeline_fail"
|
| 1846 |
+
},
|
| 1847 |
+
{
|
| 1848 |
+
"drug_id": 110,
|
| 1849 |
+
"canonical_name": "Rifampin",
|
| 1850 |
+
"index_key": "RIFAMPIN_RNAP",
|
| 1851 |
+
"tier": "1",
|
| 1852 |
+
"pdb_id_catalog": "5UAC",
|
| 1853 |
+
"het_id_catalog": "RFP",
|
| 1854 |
+
"source": "moltgate_ui",
|
| 1855 |
+
"session_id": "2afb81f90cb867c7",
|
| 1856 |
+
"run_status": "ok",
|
| 1857 |
+
"best_affinity": -6.41,
|
| 1858 |
+
"qc_pass": true,
|
| 1859 |
+
"flags": [
|
| 1860 |
+
"OUT_OF_POCKET_MINOR: 2/9 poses outside"
|
| 1861 |
+
],
|
| 1862 |
+
"pdb_id": "5UAC",
|
| 1863 |
+
"review_class": "A_pass"
|
| 1864 |
+
},
|
| 1865 |
+
{
|
| 1866 |
+
"drug_id": 111,
|
| 1867 |
+
"canonical_name": "Regorafenib",
|
| 1868 |
+
"index_key": "REGORAFENIB_BRAF",
|
| 1869 |
+
"tier": "1",
|
| 1870 |
+
"pdb_id_catalog": "4RT7",
|
| 1871 |
+
"het_id_catalog": "RGF",
|
| 1872 |
+
"source": "moltgate_ui",
|
| 1873 |
+
"session_id": "77bdd5d1c6c34c9b",
|
| 1874 |
+
"run_status": "ok",
|
| 1875 |
+
"best_affinity": -10.96,
|
| 1876 |
+
"qc_pass": true,
|
| 1877 |
+
"flags": [
|
| 1878 |
+
"OUT_OF_POCKET_MINOR: 4/9 poses outside"
|
| 1879 |
+
],
|
| 1880 |
+
"pdb_id": "4RT7",
|
| 1881 |
+
"review_class": "A_pass"
|
| 1882 |
+
},
|
| 1883 |
+
{
|
| 1884 |
+
"drug_id": 112,
|
| 1885 |
+
"canonical_name": "Lenvatinib",
|
| 1886 |
+
"index_key": "LENVATINIB_VEGFR2",
|
| 1887 |
+
"tier": "1",
|
| 1888 |
+
"pdb_id_catalog": "4UQI",
|
| 1889 |
+
"het_id_catalog": "LVN",
|
| 1890 |
+
"source": "moltgate_ui",
|
| 1891 |
+
"session_id": "3c9fd5dea6a09758",
|
| 1892 |
+
"run_status": "ok",
|
| 1893 |
+
"best_affinity": -6.884,
|
| 1894 |
+
"qc_pass": true,
|
| 1895 |
+
"flags": [],
|
| 1896 |
+
"pdb_id": "4UQI",
|
| 1897 |
+
"review_class": "A_pass"
|
| 1898 |
+
},
|
| 1899 |
+
{
|
| 1900 |
+
"drug_id": 113,
|
| 1901 |
+
"canonical_name": "Axitinib",
|
| 1902 |
+
"index_key": "AXITINIB_VEGFR2",
|
| 1903 |
+
"tier": "1",
|
| 1904 |
+
"pdb_id_catalog": "4AGC",
|
| 1905 |
+
"het_id_catalog": "AXN",
|
| 1906 |
+
"source": "moltgate_ui",
|
| 1907 |
+
"session_id": "260e4358ee89dc53",
|
| 1908 |
+
"run_status": "ok",
|
| 1909 |
+
"best_affinity": -8.413,
|
| 1910 |
+
"qc_pass": true,
|
| 1911 |
+
"flags": [
|
| 1912 |
+
"OUT_OF_POCKET_MINOR: 1/9 poses outside"
|
| 1913 |
+
],
|
| 1914 |
+
"pdb_id": "4AGC",
|
| 1915 |
+
"review_class": "A_pass"
|
| 1916 |
+
},
|
| 1917 |
+
{
|
| 1918 |
+
"drug_id": 114,
|
| 1919 |
+
"canonical_name": "Everolimus",
|
| 1920 |
+
"index_key": "EVEROLIMUS_MTOR",
|
| 1921 |
+
"tier": "1",
|
| 1922 |
+
"pdb_id_catalog": "4JT6",
|
| 1923 |
+
"het_id_catalog": "EVL",
|
| 1924 |
+
"source": "moltgate_ui",
|
| 1925 |
+
"session_id": "ceb624ee3abaef94",
|
| 1926 |
+
"run_status": "ok",
|
| 1927 |
+
"best_affinity": -7.174,
|
| 1928 |
+
"qc_pass": true,
|
| 1929 |
+
"flags": [],
|
| 1930 |
+
"pdb_id": "4JT6",
|
| 1931 |
+
"review_class": "A_pass"
|
| 1932 |
+
},
|
| 1933 |
+
{
|
| 1934 |
+
"drug_id": 115,
|
| 1935 |
+
"canonical_name": "Crizotinib",
|
| 1936 |
+
"index_key": "CRIZOTINIB_ALK",
|
| 1937 |
+
"tier": "1",
|
| 1938 |
+
"pdb_id_catalog": "2XP2",
|
| 1939 |
+
"het_id_catalog": "CRI",
|
| 1940 |
+
"source": "moltgate_ui",
|
| 1941 |
+
"session_id": "5ff1e7d227d4b420",
|
| 1942 |
+
"run_status": "ok",
|
| 1943 |
+
"best_affinity": -8.854,
|
| 1944 |
+
"qc_pass": true,
|
| 1945 |
+
"flags": [],
|
| 1946 |
+
"pdb_id": "2XP2",
|
| 1947 |
+
"review_class": "A_pass"
|
| 1948 |
+
},
|
| 1949 |
+
{
|
| 1950 |
+
"drug_id": 116,
|
| 1951 |
+
"canonical_name": "Alectinib",
|
| 1952 |
+
"index_key": "ALECTINIB_ALK",
|
| 1953 |
+
"tier": "1",
|
| 1954 |
+
"pdb_id_catalog": "4YNP",
|
| 1955 |
+
"het_id_catalog": "AIT",
|
| 1956 |
+
"source": "moltgate_ui",
|
| 1957 |
+
"session_id": "daefe717a30c2de4",
|
| 1958 |
+
"run_status": "ok",
|
| 1959 |
+
"best_affinity": -8.514,
|
| 1960 |
+
"qc_pass": true,
|
| 1961 |
+
"flags": [],
|
| 1962 |
+
"pdb_id": "4YNP",
|
| 1963 |
+
"review_class": "A_pass"
|
| 1964 |
+
},
|
| 1965 |
+
{
|
| 1966 |
+
"drug_id": 117,
|
| 1967 |
+
"canonical_name": "Ceritinib",
|
| 1968 |
+
"index_key": "CERITINIB_ALK",
|
| 1969 |
+
"tier": "1",
|
| 1970 |
+
"pdb_id_catalog": "4MKC",
|
| 1971 |
+
"het_id_catalog": "LDK",
|
| 1972 |
+
"source": "moltgate_ui",
|
| 1973 |
+
"session_id": "3152e55e09e8451a",
|
| 1974 |
+
"run_status": "ok",
|
| 1975 |
+
"best_affinity": -8.581,
|
| 1976 |
+
"qc_pass": true,
|
| 1977 |
+
"flags": [],
|
| 1978 |
+
"pdb_id": "4MKC",
|
| 1979 |
+
"review_class": "A_pass"
|
| 1980 |
+
},
|
| 1981 |
+
{
|
| 1982 |
+
"drug_id": 118,
|
| 1983 |
+
"canonical_name": "Clopidogrel",
|
| 1984 |
+
"index_key": "CLOPIDOGREL_P2Y12_PROXY",
|
| 1985 |
+
"tier": "2",
|
| 1986 |
+
"pdb_id_catalog": "4PY0",
|
| 1987 |
+
"het_id_catalog": "TIC",
|
| 1988 |
+
"source": "moltgate_ui",
|
| 1989 |
+
"session_id": "8de55865e8867022",
|
| 1990 |
+
"run_status": "ok",
|
| 1991 |
+
"best_affinity": -6.102,
|
| 1992 |
+
"qc_pass": false,
|
| 1993 |
+
"flags": [
|
| 1994 |
+
"OUT_OF_POCKET_MAJORITY"
|
| 1995 |
+
],
|
| 1996 |
+
"pdb_id": "4PY0",
|
| 1997 |
+
"review_class": "B_qc_fail"
|
| 1998 |
+
},
|
| 1999 |
+
{
|
| 2000 |
+
"drug_id": 119,
|
| 2001 |
+
"canonical_name": "Amiodarone",
|
| 2002 |
+
"index_key": "AMIODARONE_KCNH2_PROXY",
|
| 2003 |
+
"tier": "2",
|
| 2004 |
+
"pdb_id_catalog": "5VA2",
|
| 2005 |
+
"het_id_catalog": "AMI",
|
| 2006 |
+
"source": "moltgate_ui",
|
| 2007 |
+
"session_id": "aa4e16c3b638e4d5",
|
| 2008 |
+
"run_status": "fail",
|
| 2009 |
+
"best_affinity": null,
|
| 2010 |
+
"qc_pass": null,
|
| 2011 |
+
"flags": [],
|
| 2012 |
+
"pdb_id": null,
|
| 2013 |
+
"fail_reason": "Stage 21 無候選配體,無法確認配體身份",
|
| 2014 |
+
"review_class": "A_pipeline_fail"
|
| 2015 |
+
},
|
| 2016 |
+
{
|
| 2017 |
+
"drug_id": 120,
|
| 2018 |
+
"canonical_name": "Digoxin",
|
| 2019 |
+
"index_key": "DIGOXIN_PGP",
|
| 2020 |
+
"tier": "1",
|
| 2021 |
+
"pdb_id_catalog": "3G60",
|
| 2022 |
+
"het_id_catalog": "DIG",
|
| 2023 |
+
"source": "moltgate_ui",
|
| 2024 |
+
"session_id": "6c2d9b61882105e0",
|
| 2025 |
+
"run_status": "ok",
|
| 2026 |
+
"best_affinity": -7.635,
|
| 2027 |
+
"qc_pass": true,
|
| 2028 |
+
"flags": [
|
| 2029 |
+
"OUT_OF_POCKET_MINOR: 2/9 poses outside"
|
| 2030 |
+
],
|
| 2031 |
+
"pdb_id": "3G60",
|
| 2032 |
+
"review_class": "A_pass"
|
| 2033 |
+
}
|
| 2034 |
+
]
|
| 2035 |
+
}
|
config/catalog_review_1-129.json
ADDED
|
@@ -0,0 +1,2187 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"range": "1-129",
|
| 3 |
+
"summary": {
|
| 4 |
+
"total": 129,
|
| 5 |
+
"ok_qc_pass": 92,
|
| 6 |
+
"ok_qc_fail": 27,
|
| 7 |
+
"pipeline_fail": 10,
|
| 8 |
+
"no_run": 0
|
| 9 |
+
},
|
| 10 |
+
"entries": [
|
| 11 |
+
{
|
| 12 |
+
"drug_id": 1,
|
| 13 |
+
"canonical_name": "Ibuprofen",
|
| 14 |
+
"index_key": "COX2",
|
| 15 |
+
"tier": "1",
|
| 16 |
+
"pdb_id_catalog": "5IKT",
|
| 17 |
+
"het_id_catalog": "TLF",
|
| 18 |
+
"source": "creadrug24",
|
| 19 |
+
"run_status": "ok",
|
| 20 |
+
"best_affinity": -7.57,
|
| 21 |
+
"qc_pass": false,
|
| 22 |
+
"flags": [
|
| 23 |
+
"OUT_OF_POCKET: RMSD lb > 8.0 Å at modes [6, 7, 8]"
|
| 24 |
+
],
|
| 25 |
+
"session_id": "C01",
|
| 26 |
+
"review_class": "B_qc_fail"
|
| 27 |
+
},
|
| 28 |
+
{
|
| 29 |
+
"drug_id": 2,
|
| 30 |
+
"canonical_name": "Celecoxib",
|
| 31 |
+
"index_key": "COX2_CLX",
|
| 32 |
+
"tier": "1",
|
| 33 |
+
"pdb_id_catalog": "3LN1",
|
| 34 |
+
"het_id_catalog": "CLX",
|
| 35 |
+
"source": "creadrug24",
|
| 36 |
+
"run_status": "ok",
|
| 37 |
+
"best_affinity": -12.12,
|
| 38 |
+
"qc_pass": false,
|
| 39 |
+
"flags": [
|
| 40 |
+
"OUT_OF_POCKET: RMSD lb > 8.0 Å at modes [6, 7, 8, 9]"
|
| 41 |
+
],
|
| 42 |
+
"session_id": "C02",
|
| 43 |
+
"review_class": "B_qc_fail"
|
| 44 |
+
},
|
| 45 |
+
{
|
| 46 |
+
"drug_id": 3,
|
| 47 |
+
"canonical_name": "Oseltamivir",
|
| 48 |
+
"index_key": "NEURAMINIDASE",
|
| 49 |
+
"tier": "1",
|
| 50 |
+
"pdb_id_catalog": "2HU4",
|
| 51 |
+
"het_id_catalog": "G39",
|
| 52 |
+
"source": "creadrug24",
|
| 53 |
+
"run_status": "ok",
|
| 54 |
+
"best_affinity": -6.353,
|
| 55 |
+
"qc_pass": true,
|
| 56 |
+
"flags": [
|
| 57 |
+
"OUT_OF_POCKET_MINOR: 1/9 poses outside"
|
| 58 |
+
],
|
| 59 |
+
"session_id": "C03",
|
| 60 |
+
"review_class": "A_pass"
|
| 61 |
+
},
|
| 62 |
+
{
|
| 63 |
+
"drug_id": 4,
|
| 64 |
+
"canonical_name": "Imatinib",
|
| 65 |
+
"index_key": "ABLABL",
|
| 66 |
+
"tier": "1",
|
| 67 |
+
"pdb_id_catalog": "1IEP",
|
| 68 |
+
"het_id_catalog": "STI",
|
| 69 |
+
"source": "creadrug24",
|
| 70 |
+
"run_status": "ok",
|
| 71 |
+
"best_affinity": -12.71,
|
| 72 |
+
"qc_pass": false,
|
| 73 |
+
"flags": [
|
| 74 |
+
"OUT_OF_POCKET: RMSD lb > 8.0 Å at modes [3, 6, 7, 8, 9]"
|
| 75 |
+
],
|
| 76 |
+
"session_id": "C04",
|
| 77 |
+
"review_class": "B_qc_fail"
|
| 78 |
+
},
|
| 79 |
+
{
|
| 80 |
+
"drug_id": 5,
|
| 81 |
+
"canonical_name": "Methotrexate",
|
| 82 |
+
"index_key": "DHFR",
|
| 83 |
+
"tier": "1",
|
| 84 |
+
"pdb_id_catalog": "1U72",
|
| 85 |
+
"het_id_catalog": "MTX",
|
| 86 |
+
"source": "creadrug24",
|
| 87 |
+
"run_status": "ok",
|
| 88 |
+
"best_affinity": -9.66,
|
| 89 |
+
"qc_pass": true,
|
| 90 |
+
"flags": [],
|
| 91 |
+
"session_id": "C05",
|
| 92 |
+
"review_class": "A_pass"
|
| 93 |
+
},
|
| 94 |
+
{
|
| 95 |
+
"drug_id": 6,
|
| 96 |
+
"canonical_name": "Fluconazole",
|
| 97 |
+
"index_key": "CYP51",
|
| 98 |
+
"tier": "1",
|
| 99 |
+
"pdb_id_catalog": "4WMZ",
|
| 100 |
+
"het_id_catalog": "FLC",
|
| 101 |
+
"source": "creadrug24",
|
| 102 |
+
"run_status": "ok",
|
| 103 |
+
"best_affinity": -7.141,
|
| 104 |
+
"qc_pass": true,
|
| 105 |
+
"flags": [],
|
| 106 |
+
"session_id": "C06",
|
| 107 |
+
"review_class": "A_pass"
|
| 108 |
+
},
|
| 109 |
+
{
|
| 110 |
+
"drug_id": 7,
|
| 111 |
+
"canonical_name": "Sildenafil",
|
| 112 |
+
"index_key": "PDE5",
|
| 113 |
+
"tier": "1",
|
| 114 |
+
"pdb_id_catalog": "2H42",
|
| 115 |
+
"het_id_catalog": "SLD",
|
| 116 |
+
"source": "creadrug24",
|
| 117 |
+
"run_status": "ok",
|
| 118 |
+
"best_affinity": -9.364,
|
| 119 |
+
"qc_pass": true,
|
| 120 |
+
"flags": [],
|
| 121 |
+
"session_id": "C07",
|
| 122 |
+
"review_class": "A_pass"
|
| 123 |
+
},
|
| 124 |
+
{
|
| 125 |
+
"drug_id": 8,
|
| 126 |
+
"canonical_name": "Acetazolamide",
|
| 127 |
+
"index_key": "CA2",
|
| 128 |
+
"tier": "1",
|
| 129 |
+
"pdb_id_catalog": "3HS4",
|
| 130 |
+
"het_id_catalog": "AZM",
|
| 131 |
+
"source": "creadrug24",
|
| 132 |
+
"run_status": "ok",
|
| 133 |
+
"best_affinity": -5.546,
|
| 134 |
+
"qc_pass": false,
|
| 135 |
+
"flags": [
|
| 136 |
+
"SCORE_WEAK: best pose -5.546 kcal/mol > 閾值 -6.0"
|
| 137 |
+
],
|
| 138 |
+
"session_id": "C08",
|
| 139 |
+
"review_class": "B_qc_fail"
|
| 140 |
+
},
|
| 141 |
+
{
|
| 142 |
+
"drug_id": 9,
|
| 143 |
+
"canonical_name": "Gefitinib",
|
| 144 |
+
"index_key": "EGFR",
|
| 145 |
+
"tier": "1",
|
| 146 |
+
"pdb_id_catalog": "4WKQ",
|
| 147 |
+
"het_id_catalog": "IRE",
|
| 148 |
+
"source": "creadrug24",
|
| 149 |
+
"run_status": "ok",
|
| 150 |
+
"best_affinity": -8.04,
|
| 151 |
+
"qc_pass": true,
|
| 152 |
+
"flags": [],
|
| 153 |
+
"session_id": "C09",
|
| 154 |
+
"review_class": "A_pass"
|
| 155 |
+
},
|
| 156 |
+
{
|
| 157 |
+
"drug_id": 10,
|
| 158 |
+
"canonical_name": "Warfarin",
|
| 159 |
+
"index_key": "VKOR",
|
| 160 |
+
"tier": "1",
|
| 161 |
+
"pdb_id_catalog": "6WV3",
|
| 162 |
+
"het_id_catalog": "SWF",
|
| 163 |
+
"source": "creadrug24",
|
| 164 |
+
"run_status": "ok",
|
| 165 |
+
"best_affinity": -11.28,
|
| 166 |
+
"qc_pass": true,
|
| 167 |
+
"flags": [
|
| 168 |
+
"OUT_OF_POCKET_MINOR: 3/9 poses outside"
|
| 169 |
+
],
|
| 170 |
+
"session_id": "C10",
|
| 171 |
+
"review_class": "A_pass"
|
| 172 |
+
},
|
| 173 |
+
{
|
| 174 |
+
"drug_id": 11,
|
| 175 |
+
"canonical_name": "Tacrolimus",
|
| 176 |
+
"index_key": "FKBP12_TACROLIMUS",
|
| 177 |
+
"tier": "1",
|
| 178 |
+
"pdb_id_catalog": "1FKJ",
|
| 179 |
+
"het_id_catalog": "FK5",
|
| 180 |
+
"source": "creadrug24",
|
| 181 |
+
"run_status": "ok",
|
| 182 |
+
"best_affinity": -5.96,
|
| 183 |
+
"qc_pass": false,
|
| 184 |
+
"flags": [
|
| 185 |
+
"SCORE_WEAK: best pose -5.960 kcal/mol > 閾值 -6.0",
|
| 186 |
+
"OUT_OF_POCKET_MINOR: 1/9 poses outside"
|
| 187 |
+
],
|
| 188 |
+
"session_id": "C11",
|
| 189 |
+
"review_class": "B_qc_fail"
|
| 190 |
+
},
|
| 191 |
+
{
|
| 192 |
+
"drug_id": 12,
|
| 193 |
+
"canonical_name": "Quetiapine",
|
| 194 |
+
"index_key": "DRD2_QUETIAPINE_PROXY",
|
| 195 |
+
"tier": "2",
|
| 196 |
+
"pdb_id_catalog": "6CM4",
|
| 197 |
+
"het_id_catalog": "8NU",
|
| 198 |
+
"source": "creadrug24",
|
| 199 |
+
"run_status": "ok",
|
| 200 |
+
"best_affinity": -7.647,
|
| 201 |
+
"qc_pass": true,
|
| 202 |
+
"flags": [],
|
| 203 |
+
"session_id": "C12",
|
| 204 |
+
"review_class": "A_pass"
|
| 205 |
+
},
|
| 206 |
+
{
|
| 207 |
+
"drug_id": 13,
|
| 208 |
+
"canonical_name": "Erlotinib",
|
| 209 |
+
"index_key": "EGFR_ERLOTINIB",
|
| 210 |
+
"tier": "1",
|
| 211 |
+
"pdb_id_catalog": "1M17",
|
| 212 |
+
"het_id_catalog": "AQ4",
|
| 213 |
+
"source": "creadrug24",
|
| 214 |
+
"run_status": "ok",
|
| 215 |
+
"best_affinity": -8.023,
|
| 216 |
+
"qc_pass": true,
|
| 217 |
+
"flags": [],
|
| 218 |
+
"session_id": "C13",
|
| 219 |
+
"review_class": "A_pass"
|
| 220 |
+
},
|
| 221 |
+
{
|
| 222 |
+
"drug_id": 14,
|
| 223 |
+
"canonical_name": "Vardenafil",
|
| 224 |
+
"index_key": "PDE5_VARDENAFIL",
|
| 225 |
+
"tier": "1",
|
| 226 |
+
"pdb_id_catalog": "1UDT",
|
| 227 |
+
"het_id_catalog": "VIA",
|
| 228 |
+
"source": "creadrug24",
|
| 229 |
+
"run_status": "ok",
|
| 230 |
+
"best_affinity": -8.176,
|
| 231 |
+
"qc_pass": true,
|
| 232 |
+
"flags": [],
|
| 233 |
+
"session_id": "C14",
|
| 234 |
+
"review_class": "A_pass"
|
| 235 |
+
},
|
| 236 |
+
{
|
| 237 |
+
"drug_id": 15,
|
| 238 |
+
"canonical_name": "Apixaban",
|
| 239 |
+
"index_key": "FXA_APIXABAN",
|
| 240 |
+
"tier": "1",
|
| 241 |
+
"pdb_id_catalog": "2P16",
|
| 242 |
+
"het_id_catalog": "GG2",
|
| 243 |
+
"source": "creadrug24",
|
| 244 |
+
"run_status": "ok",
|
| 245 |
+
"best_affinity": -7.328,
|
| 246 |
+
"qc_pass": true,
|
| 247 |
+
"flags": [],
|
| 248 |
+
"session_id": "C15",
|
| 249 |
+
"review_class": "A_pass"
|
| 250 |
+
},
|
| 251 |
+
{
|
| 252 |
+
"drug_id": 16,
|
| 253 |
+
"canonical_name": "Rivaroxaban",
|
| 254 |
+
"index_key": "FXA_RIVAROXABAN",
|
| 255 |
+
"tier": "1",
|
| 256 |
+
"pdb_id_catalog": "2W26",
|
| 257 |
+
"het_id_catalog": "RIV",
|
| 258 |
+
"source": "creadrug24",
|
| 259 |
+
"run_status": "ok",
|
| 260 |
+
"best_affinity": -10.17,
|
| 261 |
+
"qc_pass": true,
|
| 262 |
+
"flags": [],
|
| 263 |
+
"session_id": "C16",
|
| 264 |
+
"review_class": "A_pass"
|
| 265 |
+
},
|
| 266 |
+
{
|
| 267 |
+
"drug_id": 17,
|
| 268 |
+
"canonical_name": "Vorinostat",
|
| 269 |
+
"index_key": "HDAC2_VORINOSTAT",
|
| 270 |
+
"tier": "1",
|
| 271 |
+
"pdb_id_catalog": "4LXZ",
|
| 272 |
+
"het_id_catalog": "SHH",
|
| 273 |
+
"source": "creadrug24",
|
| 274 |
+
"run_status": "ok",
|
| 275 |
+
"best_affinity": -6.436,
|
| 276 |
+
"qc_pass": true,
|
| 277 |
+
"flags": [],
|
| 278 |
+
"session_id": "C17",
|
| 279 |
+
"review_class": "A_pass"
|
| 280 |
+
},
|
| 281 |
+
{
|
| 282 |
+
"drug_id": 18,
|
| 283 |
+
"canonical_name": "Nilotinib",
|
| 284 |
+
"index_key": "ABL_NILOTINIB",
|
| 285 |
+
"tier": "1",
|
| 286 |
+
"pdb_id_catalog": "3CS9",
|
| 287 |
+
"het_id_catalog": "NIL",
|
| 288 |
+
"source": "creadrug24",
|
| 289 |
+
"run_status": "ok",
|
| 290 |
+
"best_affinity": -10.37,
|
| 291 |
+
"qc_pass": false,
|
| 292 |
+
"flags": [
|
| 293 |
+
"OUT_OF_POCKET_MAJORITY"
|
| 294 |
+
],
|
| 295 |
+
"session_id": "C18",
|
| 296 |
+
"review_class": "B_qc_fail"
|
| 297 |
+
},
|
| 298 |
+
{
|
| 299 |
+
"drug_id": 19,
|
| 300 |
+
"canonical_name": "Bosutinib",
|
| 301 |
+
"index_key": "ABL_BOSUTINIB",
|
| 302 |
+
"tier": "1",
|
| 303 |
+
"pdb_id_catalog": "3UE4",
|
| 304 |
+
"het_id_catalog": "DB8",
|
| 305 |
+
"source": "creadrug24",
|
| 306 |
+
"run_status": "ok",
|
| 307 |
+
"best_affinity": -8.134,
|
| 308 |
+
"qc_pass": true,
|
| 309 |
+
"flags": [],
|
| 310 |
+
"session_id": "C19",
|
| 311 |
+
"review_class": "A_pass"
|
| 312 |
+
},
|
| 313 |
+
{
|
| 314 |
+
"drug_id": 20,
|
| 315 |
+
"canonical_name": "Ponatinib",
|
| 316 |
+
"index_key": "DDR1_PONATINIB",
|
| 317 |
+
"tier": "1",
|
| 318 |
+
"pdb_id_catalog": "3ZOS",
|
| 319 |
+
"het_id_catalog": "0LI",
|
| 320 |
+
"source": "creadrug24",
|
| 321 |
+
"run_status": "ok",
|
| 322 |
+
"best_affinity": -13.08,
|
| 323 |
+
"qc_pass": true,
|
| 324 |
+
"flags": [],
|
| 325 |
+
"session_id": "C20",
|
| 326 |
+
"review_class": "A_pass"
|
| 327 |
+
},
|
| 328 |
+
{
|
| 329 |
+
"drug_id": 21,
|
| 330 |
+
"canonical_name": "Cilomilast",
|
| 331 |
+
"index_key": "PDE4D_CILOMILAST",
|
| 332 |
+
"tier": "1",
|
| 333 |
+
"pdb_id_catalog": "1XOM",
|
| 334 |
+
"het_id_catalog": "CIO",
|
| 335 |
+
"source": "creadrug24",
|
| 336 |
+
"run_status": "ok",
|
| 337 |
+
"best_affinity": -9.017,
|
| 338 |
+
"qc_pass": true,
|
| 339 |
+
"flags": [],
|
| 340 |
+
"session_id": "C21",
|
| 341 |
+
"review_class": "A_pass"
|
| 342 |
+
},
|
| 343 |
+
{
|
| 344 |
+
"drug_id": 22,
|
| 345 |
+
"canonical_name": "Roflumilast",
|
| 346 |
+
"index_key": "PDE4D_ROFLUMILAST",
|
| 347 |
+
"tier": "1",
|
| 348 |
+
"pdb_id_catalog": "3G4L",
|
| 349 |
+
"het_id_catalog": "ROF",
|
| 350 |
+
"source": "creadrug24",
|
| 351 |
+
"run_status": "ok",
|
| 352 |
+
"best_affinity": -9.192,
|
| 353 |
+
"qc_pass": true,
|
| 354 |
+
"flags": [],
|
| 355 |
+
"session_id": "C22",
|
| 356 |
+
"review_class": "A_pass"
|
| 357 |
+
},
|
| 358 |
+
{
|
| 359 |
+
"drug_id": 23,
|
| 360 |
+
"canonical_name": "Alogliptin",
|
| 361 |
+
"index_key": "DPP4_ALOGLIPTIN",
|
| 362 |
+
"tier": "1",
|
| 363 |
+
"pdb_id_catalog": "2ONC",
|
| 364 |
+
"het_id_catalog": "SY1",
|
| 365 |
+
"source": "creadrug24",
|
| 366 |
+
"run_status": "ok",
|
| 367 |
+
"best_affinity": -7.076,
|
| 368 |
+
"qc_pass": true,
|
| 369 |
+
"flags": [
|
| 370 |
+
"OUT_OF_POCKET_MINOR: 3/9 poses outside"
|
| 371 |
+
],
|
| 372 |
+
"session_id": "C23",
|
| 373 |
+
"review_class": "A_pass"
|
| 374 |
+
},
|
| 375 |
+
{
|
| 376 |
+
"drug_id": 24,
|
| 377 |
+
"canonical_name": "Linagliptin",
|
| 378 |
+
"index_key": "DPP4_LINAGLIPTIN",
|
| 379 |
+
"tier": "1",
|
| 380 |
+
"pdb_id_catalog": "2RGU",
|
| 381 |
+
"het_id_catalog": "356",
|
| 382 |
+
"source": "creadrug24",
|
| 383 |
+
"run_status": "ok",
|
| 384 |
+
"best_affinity": -9.064,
|
| 385 |
+
"qc_pass": true,
|
| 386 |
+
"flags": [],
|
| 387 |
+
"session_id": "C24",
|
| 388 |
+
"review_class": "A_pass"
|
| 389 |
+
},
|
| 390 |
+
{
|
| 391 |
+
"drug_id": 25,
|
| 392 |
+
"canonical_name": "Metformin",
|
| 393 |
+
"index_key": "AMPK_METFORMIN_PROXY",
|
| 394 |
+
"tier": "2",
|
| 395 |
+
"pdb_id_catalog": "4CFE",
|
| 396 |
+
"het_id_catalog": "992",
|
| 397 |
+
"source": "moltgate_ui",
|
| 398 |
+
"session_id": "9ebbce7340b7931f",
|
| 399 |
+
"run_status": "ok",
|
| 400 |
+
"best_affinity": -5.102,
|
| 401 |
+
"qc_pass": false,
|
| 402 |
+
"flags": [
|
| 403 |
+
"SCORE_WEAK: best pose -5.102 kcal/mol > 閾值 -6.0",
|
| 404 |
+
"OUT_OF_POCKET_MINOR: 2/9 poses outside"
|
| 405 |
+
],
|
| 406 |
+
"pdb_id": "4CFE",
|
| 407 |
+
"review_class": "B_qc_fail"
|
| 408 |
+
},
|
| 409 |
+
{
|
| 410 |
+
"drug_id": 26,
|
| 411 |
+
"canonical_name": "Sitagliptin",
|
| 412 |
+
"index_key": "SITAGLIPTIN_DPP4",
|
| 413 |
+
"tier": "1",
|
| 414 |
+
"pdb_id_catalog": "1X70",
|
| 415 |
+
"het_id_catalog": "715",
|
| 416 |
+
"source": "moltgate_ui",
|
| 417 |
+
"session_id": "6cdc0d35bebdfd85",
|
| 418 |
+
"run_status": "ok",
|
| 419 |
+
"best_affinity": -8.859,
|
| 420 |
+
"qc_pass": true,
|
| 421 |
+
"flags": [],
|
| 422 |
+
"pdb_id": "1X70",
|
| 423 |
+
"review_class": "A_pass"
|
| 424 |
+
},
|
| 425 |
+
{
|
| 426 |
+
"drug_id": 27,
|
| 427 |
+
"canonical_name": "Atorvastatin",
|
| 428 |
+
"index_key": "ATORVASTATIN_HMGCR_PROXY",
|
| 429 |
+
"tier": "1",
|
| 430 |
+
"pdb_id_catalog": "1HWK",
|
| 431 |
+
"het_id_catalog": "117",
|
| 432 |
+
"source": "moltgate_ui",
|
| 433 |
+
"session_id": "22fedb45a5c250d5",
|
| 434 |
+
"run_status": "ok",
|
| 435 |
+
"best_affinity": -8.714,
|
| 436 |
+
"qc_pass": true,
|
| 437 |
+
"flags": [],
|
| 438 |
+
"pdb_id": "1HWK",
|
| 439 |
+
"review_class": "A_pass"
|
| 440 |
+
},
|
| 441 |
+
{
|
| 442 |
+
"drug_id": 28,
|
| 443 |
+
"canonical_name": "Aspirin",
|
| 444 |
+
"index_key": "ASPIRIN_COX2",
|
| 445 |
+
"tier": "1",
|
| 446 |
+
"pdb_id_catalog": "5IKT",
|
| 447 |
+
"het_id_catalog": "TLF",
|
| 448 |
+
"source": "moltgate_ui",
|
| 449 |
+
"session_id": "a3143655e2919427",
|
| 450 |
+
"run_status": "ok",
|
| 451 |
+
"best_affinity": -6.673,
|
| 452 |
+
"qc_pass": false,
|
| 453 |
+
"flags": [
|
| 454 |
+
"OUT_OF_POCKET_MAJORITY"
|
| 455 |
+
],
|
| 456 |
+
"pdb_id": "5IKT",
|
| 457 |
+
"review_class": "B_qc_fail"
|
| 458 |
+
},
|
| 459 |
+
{
|
| 460 |
+
"drug_id": 29,
|
| 461 |
+
"canonical_name": "Omeprazole",
|
| 462 |
+
"index_key": "OMEPRAZOLE_CYP2C19",
|
| 463 |
+
"tier": "2",
|
| 464 |
+
"pdb_id_catalog": "4GQS",
|
| 465 |
+
"het_id_catalog": "0XV",
|
| 466 |
+
"source": "moltgate_ui",
|
| 467 |
+
"session_id": "f03eede6e628958c",
|
| 468 |
+
"run_status": "ok",
|
| 469 |
+
"best_affinity": -8.57,
|
| 470 |
+
"qc_pass": true,
|
| 471 |
+
"flags": [
|
| 472 |
+
"OUT_OF_POCKET_MINOR: 1/9 poses outside"
|
| 473 |
+
],
|
| 474 |
+
"pdb_id": "4GQS",
|
| 475 |
+
"review_class": "A_pass"
|
| 476 |
+
},
|
| 477 |
+
{
|
| 478 |
+
"drug_id": 30,
|
| 479 |
+
"canonical_name": "Amlodipine",
|
| 480 |
+
"index_key": "AMLODIPINE_CACNA1C_PROXY",
|
| 481 |
+
"tier": "1",
|
| 482 |
+
"pdb_id_catalog": "8WE8",
|
| 483 |
+
"het_id_catalog": "6UB",
|
| 484 |
+
"source": "moltgate_ui",
|
| 485 |
+
"session_id": "316189372316ee9c",
|
| 486 |
+
"run_status": "ok",
|
| 487 |
+
"best_affinity": -7.055,
|
| 488 |
+
"qc_pass": false,
|
| 489 |
+
"flags": [
|
| 490 |
+
"OUT_OF_POCKET_MAJORITY"
|
| 491 |
+
],
|
| 492 |
+
"pdb_id": "8WE8",
|
| 493 |
+
"review_class": "B_qc_fail"
|
| 494 |
+
},
|
| 495 |
+
{
|
| 496 |
+
"drug_id": 31,
|
| 497 |
+
"canonical_name": "Losartan",
|
| 498 |
+
"index_key": "LOSARTAN_AT1R_PROXY",
|
| 499 |
+
"tier": "2",
|
| 500 |
+
"pdb_id_catalog": "4ZUD",
|
| 501 |
+
"het_id_catalog": "OLM",
|
| 502 |
+
"source": "moltgate_ui",
|
| 503 |
+
"session_id": "f27ddb5f4a82a41b",
|
| 504 |
+
"run_status": "ok",
|
| 505 |
+
"best_affinity": -9.237,
|
| 506 |
+
"qc_pass": true,
|
| 507 |
+
"flags": [],
|
| 508 |
+
"pdb_id": "4ZUD",
|
| 509 |
+
"review_class": "A_pass"
|
| 510 |
+
},
|
| 511 |
+
{
|
| 512 |
+
"drug_id": 32,
|
| 513 |
+
"canonical_name": "Rosuvastatin",
|
| 514 |
+
"index_key": "ROSUVASTATIN_HMGCR",
|
| 515 |
+
"tier": "1",
|
| 516 |
+
"pdb_id_catalog": "3B7Q",
|
| 517 |
+
"het_id_catalog": "6PL",
|
| 518 |
+
"source": "moltgate_ui",
|
| 519 |
+
"session_id": "ec560eb83ee7eb0a",
|
| 520 |
+
"run_status": "ok",
|
| 521 |
+
"best_affinity": -9.488,
|
| 522 |
+
"qc_pass": true,
|
| 523 |
+
"flags": [
|
| 524 |
+
"OUT_OF_POCKET_MINOR: 4/9 poses outside"
|
| 525 |
+
],
|
| 526 |
+
"pdb_id": "3B7Q",
|
| 527 |
+
"review_class": "A_pass"
|
| 528 |
+
},
|
| 529 |
+
{
|
| 530 |
+
"drug_id": 33,
|
| 531 |
+
"canonical_name": "Simvastatin",
|
| 532 |
+
"index_key": "SIMVASTATIN_HMGCR",
|
| 533 |
+
"tier": "1",
|
| 534 |
+
"pdb_id_catalog": "1HW9",
|
| 535 |
+
"het_id_catalog": "SIM",
|
| 536 |
+
"source": "moltgate_ui",
|
| 537 |
+
"session_id": "65c19611400eb4c1",
|
| 538 |
+
"run_status": "ok",
|
| 539 |
+
"best_affinity": -6.727,
|
| 540 |
+
"qc_pass": false,
|
| 541 |
+
"flags": [
|
| 542 |
+
"OUT_OF_POCKET_MAJORITY"
|
| 543 |
+
],
|
| 544 |
+
"pdb_id": "1HW9",
|
| 545 |
+
"review_class": "B_qc_fail"
|
| 546 |
+
},
|
| 547 |
+
{
|
| 548 |
+
"drug_id": 34,
|
| 549 |
+
"canonical_name": "Pioglitazone",
|
| 550 |
+
"index_key": "PIOGLITAZONE_PPARgamma_PROXY",
|
| 551 |
+
"tier": "2",
|
| 552 |
+
"pdb_id_catalog": "2PRG",
|
| 553 |
+
"het_id_catalog": "BRL",
|
| 554 |
+
"source": "moltgate_ui",
|
| 555 |
+
"session_id": "76c353230cb47516",
|
| 556 |
+
"run_status": "ok",
|
| 557 |
+
"best_affinity": -10.28,
|
| 558 |
+
"qc_pass": true,
|
| 559 |
+
"flags": [
|
| 560 |
+
"OUT_OF_POCKET_MINOR: 1/9 poses outside"
|
| 561 |
+
],
|
| 562 |
+
"pdb_id": "2PRG",
|
| 563 |
+
"review_class": "A_pass"
|
| 564 |
+
},
|
| 565 |
+
{
|
| 566 |
+
"drug_id": 35,
|
| 567 |
+
"canonical_name": "Empagliflozin",
|
| 568 |
+
"index_key": "EMPAGLIFLOZIN_SGLT2",
|
| 569 |
+
"tier": "1",
|
| 570 |
+
"pdb_id_catalog": "7VSI",
|
| 571 |
+
"het_id_catalog": "7R3",
|
| 572 |
+
"source": "moltgate_ui",
|
| 573 |
+
"session_id": "6fec546ae0adeef6",
|
| 574 |
+
"run_status": "ok",
|
| 575 |
+
"best_affinity": -9.695,
|
| 576 |
+
"qc_pass": true,
|
| 577 |
+
"flags": [
|
| 578 |
+
"OUT_OF_POCKET_MINOR: 1/9 poses outside"
|
| 579 |
+
],
|
| 580 |
+
"pdb_id": "7VSI",
|
| 581 |
+
"review_class": "A_pass"
|
| 582 |
+
},
|
| 583 |
+
{
|
| 584 |
+
"drug_id": 36,
|
| 585 |
+
"canonical_name": "Saxagliptin",
|
| 586 |
+
"index_key": "SAXAGLIPTIN_DPP4",
|
| 587 |
+
"tier": "1",
|
| 588 |
+
"pdb_id_catalog": "3C43",
|
| 589 |
+
"het_id_catalog": "315",
|
| 590 |
+
"source": "moltgate_ui",
|
| 591 |
+
"session_id": "afd69009c8c6e20b",
|
| 592 |
+
"run_status": "ok",
|
| 593 |
+
"best_affinity": -8.026,
|
| 594 |
+
"qc_pass": true,
|
| 595 |
+
"flags": [],
|
| 596 |
+
"pdb_id": "3C43",
|
| 597 |
+
"review_class": "A_pass"
|
| 598 |
+
},
|
| 599 |
+
{
|
| 600 |
+
"drug_id": 37,
|
| 601 |
+
"canonical_name": "Lansoprazole",
|
| 602 |
+
"index_key": "LANSOPRAZOLE_CYP2C19",
|
| 603 |
+
"tier": "2",
|
| 604 |
+
"pdb_id_catalog": "4GQS",
|
| 605 |
+
"het_id_catalog": "0XV",
|
| 606 |
+
"source": "moltgate_ui",
|
| 607 |
+
"session_id": "eca99c33396b3396",
|
| 608 |
+
"run_status": "ok",
|
| 609 |
+
"best_affinity": -8.797,
|
| 610 |
+
"qc_pass": true,
|
| 611 |
+
"flags": [
|
| 612 |
+
"OUT_OF_POCKET_MINOR: 3/9 poses outside"
|
| 613 |
+
],
|
| 614 |
+
"pdb_id": "4GQS",
|
| 615 |
+
"review_class": "A_pass"
|
| 616 |
+
},
|
| 617 |
+
{
|
| 618 |
+
"drug_id": 38,
|
| 619 |
+
"canonical_name": "Metoprolol",
|
| 620 |
+
"index_key": "METOPROLOL_ADRB1_PROXY",
|
| 621 |
+
"tier": "2",
|
| 622 |
+
"pdb_id_catalog": "2Y02",
|
| 623 |
+
"het_id_catalog": "WHJ",
|
| 624 |
+
"source": "moltgate_ui",
|
| 625 |
+
"session_id": "4bfbdecd5fe8fdab",
|
| 626 |
+
"run_status": "ok",
|
| 627 |
+
"best_affinity": -6.944,
|
| 628 |
+
"qc_pass": true,
|
| 629 |
+
"flags": [],
|
| 630 |
+
"pdb_id": "2Y02",
|
| 631 |
+
"review_class": "A_pass"
|
| 632 |
+
},
|
| 633 |
+
{
|
| 634 |
+
"drug_id": 39,
|
| 635 |
+
"canonical_name": "Fenofibrate",
|
| 636 |
+
"index_key": "FENOFIBRATE_PPARalpha",
|
| 637 |
+
"tier": "1",
|
| 638 |
+
"pdb_id_catalog": "1K74",
|
| 639 |
+
"het_id_catalog": "544",
|
| 640 |
+
"source": "moltgate_ui",
|
| 641 |
+
"session_id": "d7a6ccdf1970a7c1",
|
| 642 |
+
"run_status": "ok",
|
| 643 |
+
"best_affinity": -8.134,
|
| 644 |
+
"qc_pass": true,
|
| 645 |
+
"flags": [],
|
| 646 |
+
"pdb_id": "1K74",
|
| 647 |
+
"review_class": "A_pass"
|
| 648 |
+
},
|
| 649 |
+
{
|
| 650 |
+
"drug_id": 40,
|
| 651 |
+
"canonical_name": "Hydrochlorothiazide",
|
| 652 |
+
"index_key": "HYDROCHLOROTHIAZIDE_CA2_PROXY",
|
| 653 |
+
"tier": "2",
|
| 654 |
+
"pdb_id_catalog": "3HS4",
|
| 655 |
+
"het_id_catalog": "AZM",
|
| 656 |
+
"source": "moltgate_ui",
|
| 657 |
+
"session_id": "38d7f1bf7a642646",
|
| 658 |
+
"run_status": "ok",
|
| 659 |
+
"best_affinity": -5.87,
|
| 660 |
+
"qc_pass": false,
|
| 661 |
+
"flags": [
|
| 662 |
+
"SCORE_WEAK: best pose -5.870 kcal/mol > 閾值 -6.0",
|
| 663 |
+
"OUT_OF_POCKET_MINOR: 1/9 poses outside"
|
| 664 |
+
],
|
| 665 |
+
"pdb_id": "3HS4",
|
| 666 |
+
"review_class": "B_qc_fail"
|
| 667 |
+
},
|
| 668 |
+
{
|
| 669 |
+
"drug_id": 41,
|
| 670 |
+
"canonical_name": "Diclofenac",
|
| 671 |
+
"index_key": "DICLOFENAC_COX2",
|
| 672 |
+
"tier": "1",
|
| 673 |
+
"pdb_id_catalog": "5IKR",
|
| 674 |
+
"het_id_catalog": "ID8",
|
| 675 |
+
"source": "moltgate_ui",
|
| 676 |
+
"session_id": "fc343a070d35398c",
|
| 677 |
+
"run_status": "ok",
|
| 678 |
+
"best_affinity": -8.308,
|
| 679 |
+
"qc_pass": true,
|
| 680 |
+
"flags": [
|
| 681 |
+
"OUT_OF_POCKET_MINOR: 3/9 poses outside"
|
| 682 |
+
],
|
| 683 |
+
"pdb_id": "5IKR",
|
| 684 |
+
"review_class": "A_pass"
|
| 685 |
+
},
|
| 686 |
+
{
|
| 687 |
+
"drug_id": 42,
|
| 688 |
+
"canonical_name": "Naproxen",
|
| 689 |
+
"index_key": "NAPROXEN_COX2",
|
| 690 |
+
"tier": "2",
|
| 691 |
+
"pdb_id_catalog": "5IKT",
|
| 692 |
+
"het_id_catalog": "TLF",
|
| 693 |
+
"source": "moltgate_ui",
|
| 694 |
+
"session_id": "07cb450a60b15def",
|
| 695 |
+
"run_status": "ok",
|
| 696 |
+
"best_affinity": -7.822,
|
| 697 |
+
"qc_pass": true,
|
| 698 |
+
"flags": [
|
| 699 |
+
"OUT_OF_POCKET_MINOR: 4/9 poses outside"
|
| 700 |
+
],
|
| 701 |
+
"pdb_id": "5IKT",
|
| 702 |
+
"review_class": "A_pass"
|
| 703 |
+
},
|
| 704 |
+
{
|
| 705 |
+
"drug_id": 43,
|
| 706 |
+
"canonical_name": "Meloxicam",
|
| 707 |
+
"index_key": "MELOXICAM_COX2_PROXY",
|
| 708 |
+
"tier": "2",
|
| 709 |
+
"pdb_id_catalog": "5IKR",
|
| 710 |
+
"het_id_catalog": "ID8",
|
| 711 |
+
"source": "moltgate_ui",
|
| 712 |
+
"session_id": "ea5259d6fde4001d",
|
| 713 |
+
"run_status": "ok",
|
| 714 |
+
"best_affinity": -7.857,
|
| 715 |
+
"qc_pass": true,
|
| 716 |
+
"flags": [
|
| 717 |
+
"OUT_OF_POCKET_MINOR: 2/9 poses outside"
|
| 718 |
+
],
|
| 719 |
+
"pdb_id": "5IKR",
|
| 720 |
+
"review_class": "A_pass"
|
| 721 |
+
},
|
| 722 |
+
{
|
| 723 |
+
"drug_id": 44,
|
| 724 |
+
"canonical_name": "Hydroxychloroquine",
|
| 725 |
+
"index_key": "HYDROXYCHLOROQUINE_LYSO_PROXY",
|
| 726 |
+
"tier": "2",
|
| 727 |
+
"pdb_id_catalog": "4MLN",
|
| 728 |
+
"het_id_catalog": "ODV",
|
| 729 |
+
"source": "moltgate_ui",
|
| 730 |
+
"session_id": "3ceff3963d231f55",
|
| 731 |
+
"run_status": "ok",
|
| 732 |
+
"best_affinity": -5.145,
|
| 733 |
+
"qc_pass": false,
|
| 734 |
+
"flags": [
|
| 735 |
+
"SCORE_WEAK: best pose -5.145 kcal/mol > 閾值 -6.0",
|
| 736 |
+
"OUT_OF_POCKET_MAJORITY"
|
| 737 |
+
],
|
| 738 |
+
"pdb_id": "4MLN",
|
| 739 |
+
"review_class": "B_qc_fail"
|
| 740 |
+
},
|
| 741 |
+
{
|
| 742 |
+
"drug_id": 45,
|
| 743 |
+
"canonical_name": "Montelukast",
|
| 744 |
+
"index_key": "MONTELUKAST_CYSLT1_PROXY",
|
| 745 |
+
"tier": "2",
|
| 746 |
+
"pdb_id_catalog": "6RZ4",
|
| 747 |
+
"het_id_catalog": "KNT",
|
| 748 |
+
"source": "moltgate_ui",
|
| 749 |
+
"session_id": "751e273738e31823",
|
| 750 |
+
"run_status": "ok",
|
| 751 |
+
"best_affinity": -11.04,
|
| 752 |
+
"qc_pass": true,
|
| 753 |
+
"flags": [],
|
| 754 |
+
"pdb_id": "6RZ4",
|
| 755 |
+
"review_class": "A_pass"
|
| 756 |
+
},
|
| 757 |
+
{
|
| 758 |
+
"drug_id": 46,
|
| 759 |
+
"canonical_name": "Albuterol",
|
| 760 |
+
"index_key": "ALBUTEROL_ADRB2_PROXY",
|
| 761 |
+
"tier": "2",
|
| 762 |
+
"pdb_id_catalog": "2Y00",
|
| 763 |
+
"het_id_catalog": "Y00",
|
| 764 |
+
"source": "moltgate_ui",
|
| 765 |
+
"session_id": "26b4cf9a21b01c5f",
|
| 766 |
+
"run_status": "ok",
|
| 767 |
+
"best_affinity": -6.847,
|
| 768 |
+
"qc_pass": true,
|
| 769 |
+
"flags": [
|
| 770 |
+
"OUT_OF_POCKET_MINOR: 4/9 poses outside"
|
| 771 |
+
],
|
| 772 |
+
"pdb_id": "2Y00",
|
| 773 |
+
"review_class": "A_pass"
|
| 774 |
+
},
|
| 775 |
+
{
|
| 776 |
+
"drug_id": 47,
|
| 777 |
+
"canonical_name": "Ciprofloxacin",
|
| 778 |
+
"index_key": "CIPROFLOXACIN_GYRASE",
|
| 779 |
+
"tier": "1",
|
| 780 |
+
"pdb_id_catalog": "2XCT",
|
| 781 |
+
"het_id_catalog": "CPF",
|
| 782 |
+
"source": "moltgate_ui",
|
| 783 |
+
"session_id": "fb9a5d3064305e2d",
|
| 784 |
+
"run_status": "ok",
|
| 785 |
+
"best_affinity": -7.461,
|
| 786 |
+
"qc_pass": true,
|
| 787 |
+
"flags": [],
|
| 788 |
+
"pdb_id": "2XCT",
|
| 789 |
+
"review_class": "A_pass"
|
| 790 |
+
},
|
| 791 |
+
{
|
| 792 |
+
"drug_id": 48,
|
| 793 |
+
"canonical_name": "Prednisone",
|
| 794 |
+
"index_key": "PREDNISONE_NR3C1_PROXY",
|
| 795 |
+
"tier": "2",
|
| 796 |
+
"pdb_id_catalog": "1M2Z",
|
| 797 |
+
"het_id_catalog": "DEX",
|
| 798 |
+
"source": "moltgate_ui",
|
| 799 |
+
"session_id": "2e13c4f3a6f68e5c",
|
| 800 |
+
"run_status": "ok",
|
| 801 |
+
"best_affinity": -9.496,
|
| 802 |
+
"qc_pass": false,
|
| 803 |
+
"flags": [
|
| 804 |
+
"OUT_OF_POCKET_MAJORITY"
|
| 805 |
+
],
|
| 806 |
+
"pdb_id": "1M2Z",
|
| 807 |
+
"review_class": "B_qc_fail"
|
| 808 |
+
},
|
| 809 |
+
{
|
| 810 |
+
"drug_id": 49,
|
| 811 |
+
"canonical_name": "Acetaminophen",
|
| 812 |
+
"index_key": "ACETAMINOPHEN_COX2_PROXY",
|
| 813 |
+
"tier": "2",
|
| 814 |
+
"pdb_id_catalog": "5IKT",
|
| 815 |
+
"het_id_catalog": "TLF",
|
| 816 |
+
"source": "moltgate_ui",
|
| 817 |
+
"session_id": "f6aa48d5ed11a7f8",
|
| 818 |
+
"run_status": "ok",
|
| 819 |
+
"best_affinity": -6.146,
|
| 820 |
+
"qc_pass": false,
|
| 821 |
+
"flags": [
|
| 822 |
+
"OUT_OF_POCKET_MAJORITY"
|
| 823 |
+
],
|
| 824 |
+
"pdb_id": "5IKT",
|
| 825 |
+
"review_class": "B_qc_fail"
|
| 826 |
+
},
|
| 827 |
+
{
|
| 828 |
+
"drug_id": 50,
|
| 829 |
+
"canonical_name": "Fluoxetine",
|
| 830 |
+
"index_key": "FLUOXETINE_SERT_PROXY",
|
| 831 |
+
"tier": "2",
|
| 832 |
+
"pdb_id_catalog": "5I6X",
|
| 833 |
+
"het_id_catalog": "8PR",
|
| 834 |
+
"source": "moltgate_ui",
|
| 835 |
+
"session_id": "1ebe5b7c7781ca00",
|
| 836 |
+
"run_status": "ok",
|
| 837 |
+
"best_affinity": -8.994,
|
| 838 |
+
"qc_pass": true,
|
| 839 |
+
"flags": [],
|
| 840 |
+
"pdb_id": "5I6X",
|
| 841 |
+
"review_class": "A_pass"
|
| 842 |
+
},
|
| 843 |
+
{
|
| 844 |
+
"drug_id": 51,
|
| 845 |
+
"canonical_name": "Dasatinib",
|
| 846 |
+
"index_key": "DASATINIB_ABL",
|
| 847 |
+
"tier": "1",
|
| 848 |
+
"pdb_id_catalog": "2GQG",
|
| 849 |
+
"het_id_catalog": "1N1",
|
| 850 |
+
"source": "moltgate_ui",
|
| 851 |
+
"session_id": "9c840dcc3169ef1d",
|
| 852 |
+
"run_status": "ok",
|
| 853 |
+
"best_affinity": -9.212,
|
| 854 |
+
"qc_pass": true,
|
| 855 |
+
"flags": [],
|
| 856 |
+
"pdb_id": "2GQG",
|
| 857 |
+
"review_class": "A_pass"
|
| 858 |
+
},
|
| 859 |
+
{
|
| 860 |
+
"drug_id": 52,
|
| 861 |
+
"canonical_name": "Sunitinib",
|
| 862 |
+
"index_key": "SUNITINIB_VEGFR2",
|
| 863 |
+
"tier": "1",
|
| 864 |
+
"pdb_id_catalog": "3G5E",
|
| 865 |
+
"het_id_catalog": "Q74",
|
| 866 |
+
"source": "moltgate_ui",
|
| 867 |
+
"session_id": "7ec56c76167b9ad3",
|
| 868 |
+
"run_status": "ok",
|
| 869 |
+
"best_affinity": -9.273,
|
| 870 |
+
"qc_pass": true,
|
| 871 |
+
"flags": [],
|
| 872 |
+
"pdb_id": "3G5E",
|
| 873 |
+
"review_class": "A_pass"
|
| 874 |
+
},
|
| 875 |
+
{
|
| 876 |
+
"drug_id": 53,
|
| 877 |
+
"canonical_name": "Lapatinib",
|
| 878 |
+
"index_key": "LAPATINIB_EGFR",
|
| 879 |
+
"tier": "1",
|
| 880 |
+
"pdb_id_catalog": "1XKK",
|
| 881 |
+
"het_id_catalog": "FMM",
|
| 882 |
+
"source": "moltgate_ui",
|
| 883 |
+
"session_id": "e5973b85b284af02",
|
| 884 |
+
"run_status": "ok",
|
| 885 |
+
"best_affinity": -10.13,
|
| 886 |
+
"qc_pass": true,
|
| 887 |
+
"flags": [],
|
| 888 |
+
"pdb_id": "1XKK",
|
| 889 |
+
"review_class": "A_pass"
|
| 890 |
+
},
|
| 891 |
+
{
|
| 892 |
+
"drug_id": 54,
|
| 893 |
+
"canonical_name": "Palbociclib",
|
| 894 |
+
"index_key": "PALBOCICLIB_CDK6",
|
| 895 |
+
"tier": "1",
|
| 896 |
+
"pdb_id_catalog": "5L2I",
|
| 897 |
+
"het_id_catalog": "LQQ",
|
| 898 |
+
"source": "moltgate_ui",
|
| 899 |
+
"session_id": "0a00e25b69837d3e",
|
| 900 |
+
"run_status": "ok",
|
| 901 |
+
"best_affinity": -10.25,
|
| 902 |
+
"qc_pass": true,
|
| 903 |
+
"flags": [],
|
| 904 |
+
"pdb_id": "5L2I",
|
| 905 |
+
"review_class": "A_pass"
|
| 906 |
+
},
|
| 907 |
+
{
|
| 908 |
+
"drug_id": 55,
|
| 909 |
+
"canonical_name": "Trametinib",
|
| 910 |
+
"index_key": "TRAMETINIB_MEK1",
|
| 911 |
+
"tier": "1",
|
| 912 |
+
"pdb_id_catalog": "7JUX",
|
| 913 |
+
"het_id_catalog": "QOM",
|
| 914 |
+
"source": "moltgate_ui",
|
| 915 |
+
"session_id": "9227759c44d3ecf0",
|
| 916 |
+
"run_status": "ok",
|
| 917 |
+
"best_affinity": -8.325,
|
| 918 |
+
"qc_pass": true,
|
| 919 |
+
"flags": [],
|
| 920 |
+
"pdb_id": "7JUX",
|
| 921 |
+
"review_class": "A_pass"
|
| 922 |
+
},
|
| 923 |
+
{
|
| 924 |
+
"drug_id": 56,
|
| 925 |
+
"canonical_name": "Letrozole",
|
| 926 |
+
"index_key": "LETROZOLE_CYP19",
|
| 927 |
+
"tier": "1",
|
| 928 |
+
"pdb_id_catalog": "1E3Q",
|
| 929 |
+
"het_id_catalog": "EBW",
|
| 930 |
+
"source": "moltgate_ui",
|
| 931 |
+
"session_id": "bec82e76ffb9573e",
|
| 932 |
+
"run_status": "ok",
|
| 933 |
+
"best_affinity": -9.559,
|
| 934 |
+
"qc_pass": true,
|
| 935 |
+
"flags": [],
|
| 936 |
+
"pdb_id": "1E3Q",
|
| 937 |
+
"review_class": "A_pass"
|
| 938 |
+
},
|
| 939 |
+
{
|
| 940 |
+
"drug_id": 57,
|
| 941 |
+
"canonical_name": "Anastrozole",
|
| 942 |
+
"index_key": "ANASTROZOLE_CYP19",
|
| 943 |
+
"tier": "1",
|
| 944 |
+
"pdb_id_catalog": "3S7S",
|
| 945 |
+
"het_id_catalog": "EXM",
|
| 946 |
+
"source": "moltgate_ui",
|
| 947 |
+
"session_id": "fe11d1eb7ff27622",
|
| 948 |
+
"run_status": "ok",
|
| 949 |
+
"best_affinity": -10.03,
|
| 950 |
+
"qc_pass": true,
|
| 951 |
+
"flags": [],
|
| 952 |
+
"pdb_id": "3S7S",
|
| 953 |
+
"review_class": "A_pass"
|
| 954 |
+
},
|
| 955 |
+
{
|
| 956 |
+
"drug_id": 58,
|
| 957 |
+
"canonical_name": "Venetoclax",
|
| 958 |
+
"index_key": "VENETOCLAX_BCL2",
|
| 959 |
+
"tier": "1",
|
| 960 |
+
"pdb_id_catalog": "6O0K",
|
| 961 |
+
"het_id_catalog": "LBM",
|
| 962 |
+
"source": "moltgate_ui",
|
| 963 |
+
"session_id": "8670f025502d9dc5",
|
| 964 |
+
"run_status": "ok",
|
| 965 |
+
"best_affinity": -10.57,
|
| 966 |
+
"qc_pass": true,
|
| 967 |
+
"flags": [],
|
| 968 |
+
"pdb_id": "6O0K",
|
| 969 |
+
"review_class": "A_pass"
|
| 970 |
+
},
|
| 971 |
+
{
|
| 972 |
+
"drug_id": 59,
|
| 973 |
+
"canonical_name": "Dabrafenib",
|
| 974 |
+
"index_key": "DABRAFENIB_BRAF",
|
| 975 |
+
"tier": "1",
|
| 976 |
+
"pdb_id_catalog": "4XV2",
|
| 977 |
+
"het_id_catalog": "P06",
|
| 978 |
+
"source": "moltgate_ui",
|
| 979 |
+
"session_id": "1bbeeeb5ab9f0493",
|
| 980 |
+
"run_status": "ok",
|
| 981 |
+
"best_affinity": -11.24,
|
| 982 |
+
"qc_pass": true,
|
| 983 |
+
"flags": [],
|
| 984 |
+
"pdb_id": "4XV2",
|
| 985 |
+
"review_class": "A_pass"
|
| 986 |
+
},
|
| 987 |
+
{
|
| 988 |
+
"drug_id": 60,
|
| 989 |
+
"canonical_name": "Carvedilol",
|
| 990 |
+
"index_key": "CARVEDILOL_ADRB1_PROXY",
|
| 991 |
+
"tier": "2",
|
| 992 |
+
"pdb_id_catalog": "2Y03",
|
| 993 |
+
"het_id_catalog": "5FW",
|
| 994 |
+
"source": "moltgate_ui",
|
| 995 |
+
"session_id": "7e25d02de009fc2b",
|
| 996 |
+
"run_status": "ok",
|
| 997 |
+
"best_affinity": -9.464,
|
| 998 |
+
"qc_pass": true,
|
| 999 |
+
"flags": [],
|
| 1000 |
+
"pdb_id": "2Y03",
|
| 1001 |
+
"review_class": "A_pass"
|
| 1002 |
+
},
|
| 1003 |
+
{
|
| 1004 |
+
"drug_id": 61,
|
| 1005 |
+
"canonical_name": "Glipizide",
|
| 1006 |
+
"index_key": "GLIPIZIDE_KATP_PROXY",
|
| 1007 |
+
"tier": "2",
|
| 1008 |
+
"pdb_id_catalog": "3SYQ",
|
| 1009 |
+
"het_id_catalog": "GBL",
|
| 1010 |
+
"source": "moltgate_ui",
|
| 1011 |
+
"session_id": "78098c804885dc0d",
|
| 1012 |
+
"run_status": "ok",
|
| 1013 |
+
"best_affinity": -7.06,
|
| 1014 |
+
"qc_pass": true,
|
| 1015 |
+
"flags": [],
|
| 1016 |
+
"pdb_id": "3SYQ",
|
| 1017 |
+
"review_class": "A_pass"
|
| 1018 |
+
},
|
| 1019 |
+
{
|
| 1020 |
+
"drug_id": 62,
|
| 1021 |
+
"canonical_name": "Repaglinide",
|
| 1022 |
+
"index_key": "REPAGLINIDE_KATP",
|
| 1023 |
+
"tier": "1",
|
| 1024 |
+
"pdb_id_catalog": "3VE0",
|
| 1025 |
+
"het_id_catalog": "REP",
|
| 1026 |
+
"source": "moltgate_ui",
|
| 1027 |
+
"session_id": "e21bd68b6c04e727",
|
| 1028 |
+
"run_status": "ok",
|
| 1029 |
+
"best_affinity": -7.005,
|
| 1030 |
+
"qc_pass": true,
|
| 1031 |
+
"flags": [],
|
| 1032 |
+
"pdb_id": "3SYQ",
|
| 1033 |
+
"review_class": "A_pass"
|
| 1034 |
+
},
|
| 1035 |
+
{
|
| 1036 |
+
"drug_id": 63,
|
| 1037 |
+
"canonical_name": "Canagliflozin",
|
| 1038 |
+
"index_key": "CANAGLIFLOZIN_SGLT2",
|
| 1039 |
+
"tier": "1",
|
| 1040 |
+
"pdb_id_catalog": "7VSL",
|
| 1041 |
+
"het_id_catalog": "5ZI",
|
| 1042 |
+
"source": "moltgate_ui",
|
| 1043 |
+
"session_id": "d22e8ac2cc61a323",
|
| 1044 |
+
"run_status": "ok",
|
| 1045 |
+
"best_affinity": -10.88,
|
| 1046 |
+
"qc_pass": true,
|
| 1047 |
+
"flags": [],
|
| 1048 |
+
"pdb_id": "7VSL",
|
| 1049 |
+
"review_class": "A_pass"
|
| 1050 |
+
},
|
| 1051 |
+
{
|
| 1052 |
+
"drug_id": 64,
|
| 1053 |
+
"canonical_name": "Dapagliflozin",
|
| 1054 |
+
"index_key": "DAPAGLIFLOZIN_SGLT2",
|
| 1055 |
+
"tier": "1",
|
| 1056 |
+
"pdb_id_catalog": "6VBL",
|
| 1057 |
+
"het_id_catalog": "DAP",
|
| 1058 |
+
"source": "moltgate_ui",
|
| 1059 |
+
"session_id": "e9629795a827264a",
|
| 1060 |
+
"run_status": "ok",
|
| 1061 |
+
"best_affinity": -9.983,
|
| 1062 |
+
"qc_pass": true,
|
| 1063 |
+
"flags": [
|
| 1064 |
+
"OUT_OF_POCKET_MINOR: 1/9 poses outside"
|
| 1065 |
+
],
|
| 1066 |
+
"pdb_id": "7VSI",
|
| 1067 |
+
"review_class": "A_pass"
|
| 1068 |
+
},
|
| 1069 |
+
{
|
| 1070 |
+
"drug_id": 65,
|
| 1071 |
+
"canonical_name": "Ezetimibe",
|
| 1072 |
+
"index_key": "EZETIMIBE_NPC1L1",
|
| 1073 |
+
"tier": "1",
|
| 1074 |
+
"pdb_id_catalog": "3QNT",
|
| 1075 |
+
"het_id_catalog": "EZE",
|
| 1076 |
+
"source": "moltgate_ui",
|
| 1077 |
+
"session_id": "3798e7eef2f99491",
|
| 1078 |
+
"run_status": "fail",
|
| 1079 |
+
"best_affinity": null,
|
| 1080 |
+
"qc_pass": null,
|
| 1081 |
+
"flags": [],
|
| 1082 |
+
"pdb_id": null,
|
| 1083 |
+
"fail_reason": "Stage 21 無候選配體,無法確認配體身份",
|
| 1084 |
+
"review_class": "A_pipeline_fail"
|
| 1085 |
+
},
|
| 1086 |
+
{
|
| 1087 |
+
"drug_id": 66,
|
| 1088 |
+
"canonical_name": "Pravastatin",
|
| 1089 |
+
"index_key": "PRAVASTATIN_HMGCR_PROXY",
|
| 1090 |
+
"tier": "2",
|
| 1091 |
+
"pdb_id_catalog": "1HW9",
|
| 1092 |
+
"het_id_catalog": "SIM",
|
| 1093 |
+
"source": "moltgate_ui",
|
| 1094 |
+
"session_id": "177370c52bb87918",
|
| 1095 |
+
"run_status": "ok",
|
| 1096 |
+
"best_affinity": -6.836,
|
| 1097 |
+
"qc_pass": true,
|
| 1098 |
+
"flags": [],
|
| 1099 |
+
"pdb_id": "1HW9",
|
| 1100 |
+
"review_class": "A_pass"
|
| 1101 |
+
},
|
| 1102 |
+
{
|
| 1103 |
+
"drug_id": 67,
|
| 1104 |
+
"canonical_name": "Lovastatin",
|
| 1105 |
+
"index_key": "LOVASTATIN_HMGCR",
|
| 1106 |
+
"tier": "1",
|
| 1107 |
+
"pdb_id_catalog": "1HW8",
|
| 1108 |
+
"het_id_catalog": "MVA",
|
| 1109 |
+
"source": "moltgate_ui",
|
| 1110 |
+
"session_id": "2c1e31f7d47c77bb",
|
| 1111 |
+
"run_status": "ok",
|
| 1112 |
+
"best_affinity": -6.535,
|
| 1113 |
+
"qc_pass": true,
|
| 1114 |
+
"flags": [],
|
| 1115 |
+
"pdb_id": "1HW8",
|
| 1116 |
+
"review_class": "A_pass"
|
| 1117 |
+
},
|
| 1118 |
+
{
|
| 1119 |
+
"drug_id": 68,
|
| 1120 |
+
"canonical_name": "Valsartan",
|
| 1121 |
+
"index_key": "VALSARTAN_AT1R_PROXY",
|
| 1122 |
+
"tier": "2",
|
| 1123 |
+
"pdb_id_catalog": "4ZUD",
|
| 1124 |
+
"het_id_catalog": "OLM",
|
| 1125 |
+
"source": "moltgate_ui",
|
| 1126 |
+
"session_id": "4454d4d74b646635",
|
| 1127 |
+
"run_status": "ok",
|
| 1128 |
+
"best_affinity": -8.675,
|
| 1129 |
+
"qc_pass": true,
|
| 1130 |
+
"flags": [],
|
| 1131 |
+
"pdb_id": "4ZUD",
|
| 1132 |
+
"review_class": "A_pass"
|
| 1133 |
+
},
|
| 1134 |
+
{
|
| 1135 |
+
"drug_id": 69,
|
| 1136 |
+
"canonical_name": "Spironolactone",
|
| 1137 |
+
"index_key": "SPIRONOLACTONE_NR3C2",
|
| 1138 |
+
"tier": "1",
|
| 1139 |
+
"pdb_id_catalog": "2AA2",
|
| 1140 |
+
"het_id_catalog": "SPI",
|
| 1141 |
+
"source": "moltgate_ui",
|
| 1142 |
+
"session_id": "b1e58ad085239aa1",
|
| 1143 |
+
"run_status": "ok",
|
| 1144 |
+
"best_affinity": -6.66,
|
| 1145 |
+
"qc_pass": true,
|
| 1146 |
+
"flags": [
|
| 1147 |
+
"OUT_OF_POCKET_MINOR: 2/9 poses outside"
|
| 1148 |
+
],
|
| 1149 |
+
"pdb_id": "2AA2",
|
| 1150 |
+
"review_class": "A_pass"
|
| 1151 |
+
},
|
| 1152 |
+
{
|
| 1153 |
+
"drug_id": 70,
|
| 1154 |
+
"canonical_name": "Propranolol",
|
| 1155 |
+
"index_key": "PROPRANOLOL_ADRB1_PROXY",
|
| 1156 |
+
"tier": "2",
|
| 1157 |
+
"pdb_id_catalog": "2Y02",
|
| 1158 |
+
"het_id_catalog": "WHJ",
|
| 1159 |
+
"source": "moltgate_ui",
|
| 1160 |
+
"session_id": "b5bae316bdf238a5",
|
| 1161 |
+
"run_status": "ok",
|
| 1162 |
+
"best_affinity": -6.748,
|
| 1163 |
+
"qc_pass": true,
|
| 1164 |
+
"flags": [
|
| 1165 |
+
"OUT_OF_POCKET_MINOR: 4/9 poses outside"
|
| 1166 |
+
],
|
| 1167 |
+
"pdb_id": "2Y02",
|
| 1168 |
+
"review_class": "A_pass"
|
| 1169 |
+
},
|
| 1170 |
+
{
|
| 1171 |
+
"drug_id": 71,
|
| 1172 |
+
"canonical_name": "Indomethacin",
|
| 1173 |
+
"index_key": "INDOMETHACIN_COX2_PROXY",
|
| 1174 |
+
"tier": "2",
|
| 1175 |
+
"pdb_id_catalog": "5IKR",
|
| 1176 |
+
"het_id_catalog": "ID8",
|
| 1177 |
+
"source": "moltgate_ui",
|
| 1178 |
+
"session_id": "343447d0e170107a",
|
| 1179 |
+
"run_status": "ok",
|
| 1180 |
+
"best_affinity": -8.11,
|
| 1181 |
+
"qc_pass": true,
|
| 1182 |
+
"flags": [
|
| 1183 |
+
"OUT_OF_POCKET_MINOR: 3/9 poses outside"
|
| 1184 |
+
],
|
| 1185 |
+
"pdb_id": "5IKR",
|
| 1186 |
+
"review_class": "A_pass"
|
| 1187 |
+
},
|
| 1188 |
+
{
|
| 1189 |
+
"drug_id": 72,
|
| 1190 |
+
"canonical_name": "Ketorolac",
|
| 1191 |
+
"index_key": "KETOROLAC_COX2",
|
| 1192 |
+
"tier": "1",
|
| 1193 |
+
"pdb_id_catalog": "1Q4G",
|
| 1194 |
+
"het_id_catalog": "KRL",
|
| 1195 |
+
"source": "moltgate_ui",
|
| 1196 |
+
"session_id": "3e0f7afb6013ef6d",
|
| 1197 |
+
"run_status": "ok",
|
| 1198 |
+
"best_affinity": -6.948,
|
| 1199 |
+
"qc_pass": true,
|
| 1200 |
+
"flags": [],
|
| 1201 |
+
"pdb_id": "1Q4G",
|
| 1202 |
+
"review_class": "A_pass"
|
| 1203 |
+
},
|
| 1204 |
+
{
|
| 1205 |
+
"drug_id": 73,
|
| 1206 |
+
"canonical_name": "Piroxicam",
|
| 1207 |
+
"index_key": "PIROXICAM_COX2_PROXY",
|
| 1208 |
+
"tier": "2",
|
| 1209 |
+
"pdb_id_catalog": "5IKT",
|
| 1210 |
+
"het_id_catalog": "TLF",
|
| 1211 |
+
"source": "moltgate_ui",
|
| 1212 |
+
"session_id": "408626b740c2b2ed",
|
| 1213 |
+
"run_status": "ok",
|
| 1214 |
+
"best_affinity": -6.47,
|
| 1215 |
+
"qc_pass": false,
|
| 1216 |
+
"flags": [
|
| 1217 |
+
"OUT_OF_POCKET_MAJORITY"
|
| 1218 |
+
],
|
| 1219 |
+
"pdb_id": "5IKT",
|
| 1220 |
+
"review_class": "B_qc_fail"
|
| 1221 |
+
},
|
| 1222 |
+
{
|
| 1223 |
+
"drug_id": 74,
|
| 1224 |
+
"canonical_name": "Azithromycin",
|
| 1225 |
+
"index_key": "AZITHROMYCIN_RIBOSOME",
|
| 1226 |
+
"tier": "1",
|
| 1227 |
+
"pdb_id_catalog": "1YII",
|
| 1228 |
+
"het_id_catalog": "AZI",
|
| 1229 |
+
"source": "moltgate_ui",
|
| 1230 |
+
"session_id": "7d9666f30745df38",
|
| 1231 |
+
"run_status": "ok",
|
| 1232 |
+
"best_affinity": -3.443,
|
| 1233 |
+
"qc_pass": false,
|
| 1234 |
+
"flags": [
|
| 1235 |
+
"SCORE_WEAK: best pose -3.443 kcal/mol > 閾值 -6.0",
|
| 1236 |
+
"OUT_OF_POCKET_MINOR: 1/9 poses outside"
|
| 1237 |
+
],
|
| 1238 |
+
"pdb_id": "1YHQ",
|
| 1239 |
+
"review_class": "B_qc_fail"
|
| 1240 |
+
},
|
| 1241 |
+
{
|
| 1242 |
+
"drug_id": 75,
|
| 1243 |
+
"canonical_name": "Amoxicillin",
|
| 1244 |
+
"index_key": "AMOXICILLIN_PBP_PROXY",
|
| 1245 |
+
"tier": "2",
|
| 1246 |
+
"pdb_id_catalog": "1PWP",
|
| 1247 |
+
"het_id_catalog": "PG2",
|
| 1248 |
+
"source": "moltgate_ui",
|
| 1249 |
+
"session_id": "c66f9df2ceeb8baf",
|
| 1250 |
+
"run_status": "ok",
|
| 1251 |
+
"best_affinity": -6.898,
|
| 1252 |
+
"qc_pass": true,
|
| 1253 |
+
"flags": [
|
| 1254 |
+
"OUT_OF_POCKET_MINOR: 1/9 poses outside"
|
| 1255 |
+
],
|
| 1256 |
+
"pdb_id": "1PWP",
|
| 1257 |
+
"review_class": "A_pass"
|
| 1258 |
+
},
|
| 1259 |
+
{
|
| 1260 |
+
"drug_id": 76,
|
| 1261 |
+
"canonical_name": "Doxycycline",
|
| 1262 |
+
"index_key": "DOXYCYCLINE_RIBOSOME",
|
| 1263 |
+
"tier": "1",
|
| 1264 |
+
"pdb_id_catalog": "1HNW",
|
| 1265 |
+
"het_id_catalog": "DOX",
|
| 1266 |
+
"source": "moltgate_ui",
|
| 1267 |
+
"session_id": "7dbf82e1dc3dc931",
|
| 1268 |
+
"run_status": "fail",
|
| 1269 |
+
"best_affinity": null,
|
| 1270 |
+
"qc_pass": null,
|
| 1271 |
+
"flags": [],
|
| 1272 |
+
"pdb_id": null,
|
| 1273 |
+
"review_class": "A_pipeline_fail"
|
| 1274 |
+
},
|
| 1275 |
+
{
|
| 1276 |
+
"drug_id": 77,
|
| 1277 |
+
"canonical_name": "Levofloxacin",
|
| 1278 |
+
"index_key": "LEVOFLOXACIN_GYRASE",
|
| 1279 |
+
"tier": "2",
|
| 1280 |
+
"pdb_id_catalog": "2XCT",
|
| 1281 |
+
"het_id_catalog": "CPF",
|
| 1282 |
+
"source": "moltgate_ui",
|
| 1283 |
+
"session_id": "3bad04d9f957542c",
|
| 1284 |
+
"run_status": "ok",
|
| 1285 |
+
"best_affinity": -7.624,
|
| 1286 |
+
"qc_pass": true,
|
| 1287 |
+
"flags": [],
|
| 1288 |
+
"pdb_id": "2XCT",
|
| 1289 |
+
"review_class": "A_pass"
|
| 1290 |
+
},
|
| 1291 |
+
{
|
| 1292 |
+
"drug_id": 78,
|
| 1293 |
+
"canonical_name": "Trimethoprim",
|
| 1294 |
+
"index_key": "TRIMETHOPRIM_DHFR",
|
| 1295 |
+
"tier": "1",
|
| 1296 |
+
"pdb_id_catalog": "2W9G",
|
| 1297 |
+
"het_id_catalog": "TMP",
|
| 1298 |
+
"source": "moltgate_ui",
|
| 1299 |
+
"session_id": "2efa0824f12cd1b9",
|
| 1300 |
+
"run_status": "ok",
|
| 1301 |
+
"best_affinity": -7.542,
|
| 1302 |
+
"qc_pass": true,
|
| 1303 |
+
"flags": [],
|
| 1304 |
+
"pdb_id": "2W9G",
|
| 1305 |
+
"review_class": "A_pass"
|
| 1306 |
+
},
|
| 1307 |
+
{
|
| 1308 |
+
"drug_id": 79,
|
| 1309 |
+
"canonical_name": "Sertraline",
|
| 1310 |
+
"index_key": "SERTRALINE_SERT_PROXY",
|
| 1311 |
+
"tier": "2",
|
| 1312 |
+
"pdb_id_catalog": "5I6X",
|
| 1313 |
+
"het_id_catalog": "8PR",
|
| 1314 |
+
"source": "moltgate_ui",
|
| 1315 |
+
"session_id": "2c05bb00c988648d",
|
| 1316 |
+
"run_status": "ok",
|
| 1317 |
+
"best_affinity": -9.227,
|
| 1318 |
+
"qc_pass": true,
|
| 1319 |
+
"flags": [
|
| 1320 |
+
"OUT_OF_POCKET_MINOR: 2/9 poses outside"
|
| 1321 |
+
],
|
| 1322 |
+
"pdb_id": "5I6X",
|
| 1323 |
+
"review_class": "A_pass"
|
| 1324 |
+
},
|
| 1325 |
+
{
|
| 1326 |
+
"drug_id": 80,
|
| 1327 |
+
"canonical_name": "Paroxetine",
|
| 1328 |
+
"index_key": "PAROXETINE_SERT",
|
| 1329 |
+
"tier": "1",
|
| 1330 |
+
"pdb_id_catalog": "5I6X",
|
| 1331 |
+
"het_id_catalog": "8PR",
|
| 1332 |
+
"source": "moltgate_ui",
|
| 1333 |
+
"session_id": "172c8b9d2b763380",
|
| 1334 |
+
"run_status": "ok",
|
| 1335 |
+
"best_affinity": -9.378,
|
| 1336 |
+
"qc_pass": true,
|
| 1337 |
+
"flags": [
|
| 1338 |
+
"OUT_OF_POCKET_MINOR: 1/9 poses outside"
|
| 1339 |
+
],
|
| 1340 |
+
"pdb_id": "5I6X",
|
| 1341 |
+
"review_class": "A_pass"
|
| 1342 |
+
},
|
| 1343 |
+
{
|
| 1344 |
+
"drug_id": 81,
|
| 1345 |
+
"canonical_name": "Osimertinib",
|
| 1346 |
+
"index_key": "OSIMERTINIB_EGFR",
|
| 1347 |
+
"tier": "1",
|
| 1348 |
+
"pdb_id_catalog": "5XGN",
|
| 1349 |
+
"het_id_catalog": "OSS",
|
| 1350 |
+
"source": "moltgate_ui",
|
| 1351 |
+
"session_id": "b2733f1d8ba893e3",
|
| 1352 |
+
"run_status": "ok",
|
| 1353 |
+
"best_affinity": -8.29,
|
| 1354 |
+
"qc_pass": true,
|
| 1355 |
+
"flags": [],
|
| 1356 |
+
"pdb_id": "5XGN",
|
| 1357 |
+
"review_class": "A_pass"
|
| 1358 |
+
},
|
| 1359 |
+
{
|
| 1360 |
+
"drug_id": 82,
|
| 1361 |
+
"canonical_name": "Afatinib",
|
| 1362 |
+
"index_key": "AFATINIB_EGFR",
|
| 1363 |
+
"tier": "1",
|
| 1364 |
+
"pdb_id_catalog": "4G5J",
|
| 1365 |
+
"het_id_catalog": "AFT",
|
| 1366 |
+
"source": "moltgate_ui",
|
| 1367 |
+
"session_id": "d9955b9251aa1395",
|
| 1368 |
+
"run_status": "ok",
|
| 1369 |
+
"best_affinity": -6.362,
|
| 1370 |
+
"qc_pass": true,
|
| 1371 |
+
"flags": [
|
| 1372 |
+
"OUT_OF_POCKET_MINOR: 1/9 poses outside"
|
| 1373 |
+
],
|
| 1374 |
+
"pdb_id": "4G5J",
|
| 1375 |
+
"review_class": "A_pass"
|
| 1376 |
+
},
|
| 1377 |
+
{
|
| 1378 |
+
"drug_id": 83,
|
| 1379 |
+
"canonical_name": "Sorafenib",
|
| 1380 |
+
"index_key": "SORAFENIB_BRAF",
|
| 1381 |
+
"tier": "1",
|
| 1382 |
+
"pdb_id_catalog": "3OG7",
|
| 1383 |
+
"het_id_catalog": "SOR",
|
| 1384 |
+
"source": "moltgate_ui",
|
| 1385 |
+
"session_id": "88b880b8cefb9c24",
|
| 1386 |
+
"run_status": "ok",
|
| 1387 |
+
"best_affinity": -9.859,
|
| 1388 |
+
"qc_pass": true,
|
| 1389 |
+
"flags": [],
|
| 1390 |
+
"pdb_id": "3OG7",
|
| 1391 |
+
"review_class": "A_pass"
|
| 1392 |
+
},
|
| 1393 |
+
{
|
| 1394 |
+
"drug_id": 84,
|
| 1395 |
+
"canonical_name": "Cabozantinib",
|
| 1396 |
+
"index_key": "CABOZANTINIB_MET",
|
| 1397 |
+
"tier": "1",
|
| 1398 |
+
"pdb_id_catalog": "4O1B",
|
| 1399 |
+
"het_id_catalog": "X87",
|
| 1400 |
+
"source": "moltgate_ui",
|
| 1401 |
+
"session_id": "e0cf69e715eb5c96",
|
| 1402 |
+
"run_status": "ok",
|
| 1403 |
+
"best_affinity": -7.684,
|
| 1404 |
+
"qc_pass": true,
|
| 1405 |
+
"flags": [
|
| 1406 |
+
"OUT_OF_POCKET_MINOR: 2/9 poses outside"
|
| 1407 |
+
],
|
| 1408 |
+
"pdb_id": "4O1B",
|
| 1409 |
+
"review_class": "A_pass"
|
| 1410 |
+
},
|
| 1411 |
+
{
|
| 1412 |
+
"drug_id": 85,
|
| 1413 |
+
"canonical_name": "Ibrutinib",
|
| 1414 |
+
"index_key": "IBRUTINIB_BTK",
|
| 1415 |
+
"tier": "1",
|
| 1416 |
+
"pdb_id_catalog": "4O5B",
|
| 1417 |
+
"het_id_catalog": "PPI",
|
| 1418 |
+
"source": "moltgate_ui",
|
| 1419 |
+
"session_id": "131a125e328218e2",
|
| 1420 |
+
"run_status": "fail",
|
| 1421 |
+
"best_affinity": null,
|
| 1422 |
+
"qc_pass": null,
|
| 1423 |
+
"flags": [],
|
| 1424 |
+
"pdb_id": null,
|
| 1425 |
+
"review_class": "A_pipeline_fail"
|
| 1426 |
+
},
|
| 1427 |
+
{
|
| 1428 |
+
"drug_id": 86,
|
| 1429 |
+
"canonical_name": "Olaparib",
|
| 1430 |
+
"index_key": "OLAPARIB_PARP",
|
| 1431 |
+
"tier": "1",
|
| 1432 |
+
"pdb_id_catalog": "5DS5",
|
| 1433 |
+
"het_id_catalog": "OL0",
|
| 1434 |
+
"source": "moltgate_ui",
|
| 1435 |
+
"session_id": "cb7e211ba798724c",
|
| 1436 |
+
"run_status": "fail",
|
| 1437 |
+
"best_affinity": null,
|
| 1438 |
+
"qc_pass": null,
|
| 1439 |
+
"flags": [],
|
| 1440 |
+
"pdb_id": null,
|
| 1441 |
+
"fail_reason": "Stage 21 無候選配體,無法確認配體身份",
|
| 1442 |
+
"review_class": "A_pipeline_fail"
|
| 1443 |
+
},
|
| 1444 |
+
{
|
| 1445 |
+
"drug_id": 87,
|
| 1446 |
+
"canonical_name": "Ruxolitinib",
|
| 1447 |
+
"index_key": "RUXOLITINIB_JAK2",
|
| 1448 |
+
"tier": "1",
|
| 1449 |
+
"pdb_id_catalog": "4IVC",
|
| 1450 |
+
"het_id_catalog": "RUX",
|
| 1451 |
+
"source": "moltgate_ui",
|
| 1452 |
+
"session_id": "63c3f271ac60016f",
|
| 1453 |
+
"run_status": "ok",
|
| 1454 |
+
"best_affinity": -9.115,
|
| 1455 |
+
"qc_pass": true,
|
| 1456 |
+
"flags": [
|
| 1457 |
+
"OUT_OF_POCKET_MINOR: 2/9 poses outside"
|
| 1458 |
+
],
|
| 1459 |
+
"pdb_id": "4IVC",
|
| 1460 |
+
"review_class": "A_pass"
|
| 1461 |
+
},
|
| 1462 |
+
{
|
| 1463 |
+
"drug_id": 88,
|
| 1464 |
+
"canonical_name": "Enzalutamide",
|
| 1465 |
+
"index_key": "ENZALUTAMIDE_AR",
|
| 1466 |
+
"tier": "1",
|
| 1467 |
+
"pdb_id_catalog": "3R5W",
|
| 1468 |
+
"het_id_catalog": "ENZ",
|
| 1469 |
+
"source": "moltgate_ui",
|
| 1470 |
+
"session_id": "3fbcd648db7b0a31",
|
| 1471 |
+
"run_status": "ok",
|
| 1472 |
+
"best_affinity": -8.236,
|
| 1473 |
+
"qc_pass": true,
|
| 1474 |
+
"flags": [],
|
| 1475 |
+
"pdb_id": "3R5W",
|
| 1476 |
+
"review_class": "A_pass"
|
| 1477 |
+
},
|
| 1478 |
+
{
|
| 1479 |
+
"drug_id": 89,
|
| 1480 |
+
"canonical_name": "Tamoxifen",
|
| 1481 |
+
"index_key": "TAMOXIFEN_ESR1",
|
| 1482 |
+
"tier": "2",
|
| 1483 |
+
"pdb_id_catalog": "3ERT",
|
| 1484 |
+
"het_id_catalog": "4HT",
|
| 1485 |
+
"source": "moltgate_ui",
|
| 1486 |
+
"session_id": "45ad02e26e4be3a2",
|
| 1487 |
+
"run_status": "ok",
|
| 1488 |
+
"best_affinity": -9.616,
|
| 1489 |
+
"qc_pass": true,
|
| 1490 |
+
"flags": [
|
| 1491 |
+
"OUT_OF_POCKET_MINOR: 1/9 poses outside"
|
| 1492 |
+
],
|
| 1493 |
+
"pdb_id": "3ERT",
|
| 1494 |
+
"review_class": "A_pass"
|
| 1495 |
+
},
|
| 1496 |
+
{
|
| 1497 |
+
"drug_id": 90,
|
| 1498 |
+
"canonical_name": "Ticagrelor",
|
| 1499 |
+
"index_key": "TICAGRELOR_P2Y12",
|
| 1500 |
+
"tier": "1",
|
| 1501 |
+
"pdb_id_catalog": "4PY0",
|
| 1502 |
+
"het_id_catalog": "TIC",
|
| 1503 |
+
"source": "moltgate_ui",
|
| 1504 |
+
"session_id": "c0849714f6894c14",
|
| 1505 |
+
"run_status": "ok",
|
| 1506 |
+
"best_affinity": -7.792,
|
| 1507 |
+
"qc_pass": false,
|
| 1508 |
+
"flags": [
|
| 1509 |
+
"OUT_OF_POCKET_MAJORITY"
|
| 1510 |
+
],
|
| 1511 |
+
"pdb_id": "4PY0",
|
| 1512 |
+
"review_class": "B_qc_fail"
|
| 1513 |
+
},
|
| 1514 |
+
{
|
| 1515 |
+
"drug_id": 91,
|
| 1516 |
+
"canonical_name": "Glimepiride",
|
| 1517 |
+
"index_key": "GLIMEPIRIDE_KATP_PROXY",
|
| 1518 |
+
"tier": "2",
|
| 1519 |
+
"pdb_id_catalog": "3SYQ",
|
| 1520 |
+
"het_id_catalog": "GBL",
|
| 1521 |
+
"source": "moltgate_ui",
|
| 1522 |
+
"session_id": "e96b7d1bc0882956",
|
| 1523 |
+
"run_status": "ok",
|
| 1524 |
+
"best_affinity": -9.354,
|
| 1525 |
+
"qc_pass": true,
|
| 1526 |
+
"flags": [
|
| 1527 |
+
"OUT_OF_POCKET_MINOR: 3/9 poses outside"
|
| 1528 |
+
],
|
| 1529 |
+
"pdb_id": "3SYQ",
|
| 1530 |
+
"review_class": "A_pass"
|
| 1531 |
+
},
|
| 1532 |
+
{
|
| 1533 |
+
"drug_id": 92,
|
| 1534 |
+
"canonical_name": "Miglitol",
|
| 1535 |
+
"index_key": "MIGLITOL_GLUCOSIDASE",
|
| 1536 |
+
"tier": "1",
|
| 1537 |
+
"pdb_id_catalog": "2BB0",
|
| 1538 |
+
"het_id_catalog": "MIG",
|
| 1539 |
+
"source": "moltgate_ui",
|
| 1540 |
+
"session_id": "702b3235097e3079",
|
| 1541 |
+
"run_status": "ok",
|
| 1542 |
+
"best_affinity": -5.541,
|
| 1543 |
+
"qc_pass": false,
|
| 1544 |
+
"flags": [
|
| 1545 |
+
"SCORE_WEAK: best pose -5.541 kcal/mol > 閾值 -6.0"
|
| 1546 |
+
],
|
| 1547 |
+
"pdb_id": "2QV4",
|
| 1548 |
+
"review_class": "B_qc_fail"
|
| 1549 |
+
},
|
| 1550 |
+
{
|
| 1551 |
+
"drug_id": 93,
|
| 1552 |
+
"canonical_name": "Acarbose",
|
| 1553 |
+
"index_key": "ACARBOSE_GLUCOSIDASE",
|
| 1554 |
+
"tier": "1",
|
| 1555 |
+
"pdb_id_catalog": "2QV4",
|
| 1556 |
+
"het_id_catalog": "ACA",
|
| 1557 |
+
"source": "moltgate_ui",
|
| 1558 |
+
"session_id": "e4c383a1e07c66e8",
|
| 1559 |
+
"run_status": "ok",
|
| 1560 |
+
"best_affinity": -8.153,
|
| 1561 |
+
"qc_pass": true,
|
| 1562 |
+
"flags": [],
|
| 1563 |
+
"pdb_id": "2QV4",
|
| 1564 |
+
"review_class": "A_pass"
|
| 1565 |
+
},
|
| 1566 |
+
{
|
| 1567 |
+
"drug_id": 94,
|
| 1568 |
+
"canonical_name": "Gemfibrozil",
|
| 1569 |
+
"index_key": "GEMFIBROZIL_PPARalpha_PROXY",
|
| 1570 |
+
"tier": "2",
|
| 1571 |
+
"pdb_id_catalog": "1K74",
|
| 1572 |
+
"het_id_catalog": "544",
|
| 1573 |
+
"source": "moltgate_ui",
|
| 1574 |
+
"session_id": "1e567a88817d7d6b",
|
| 1575 |
+
"run_status": "ok",
|
| 1576 |
+
"best_affinity": -7.6,
|
| 1577 |
+
"qc_pass": false,
|
| 1578 |
+
"flags": [
|
| 1579 |
+
"OUT_OF_POCKET_MAJORITY"
|
| 1580 |
+
],
|
| 1581 |
+
"pdb_id": "1K74",
|
| 1582 |
+
"review_class": "B_qc_fail"
|
| 1583 |
+
},
|
| 1584 |
+
{
|
| 1585 |
+
"drug_id": 95,
|
| 1586 |
+
"canonical_name": "Allopurinol",
|
| 1587 |
+
"index_key": "ALLOPURINOL_XDH",
|
| 1588 |
+
"tier": "1",
|
| 1589 |
+
"pdb_id_catalog": "3NTZ",
|
| 1590 |
+
"het_id_catalog": "ALP",
|
| 1591 |
+
"source": "moltgate_ui",
|
| 1592 |
+
"session_id": "08adb08616c6b3c3",
|
| 1593 |
+
"run_status": "ok",
|
| 1594 |
+
"best_affinity": -5.701,
|
| 1595 |
+
"qc_pass": false,
|
| 1596 |
+
"flags": [
|
| 1597 |
+
"SCORE_WEAK: best pose -5.701 kcal/mol > 閾值 -6.0"
|
| 1598 |
+
],
|
| 1599 |
+
"pdb_id": "3NTZ",
|
| 1600 |
+
"review_class": "B_qc_fail"
|
| 1601 |
+
},
|
| 1602 |
+
{
|
| 1603 |
+
"drug_id": 96,
|
| 1604 |
+
"canonical_name": "Febuxostat",
|
| 1605 |
+
"index_key": "FEBUXOSTAT_XDH",
|
| 1606 |
+
"tier": "1",
|
| 1607 |
+
"pdb_id_catalog": "3EY8",
|
| 1608 |
+
"het_id_catalog": "FEB",
|
| 1609 |
+
"source": "moltgate_ui",
|
| 1610 |
+
"session_id": "7d3c0644045727df",
|
| 1611 |
+
"run_status": "ok",
|
| 1612 |
+
"best_affinity": -5.392,
|
| 1613 |
+
"qc_pass": false,
|
| 1614 |
+
"flags": [
|
| 1615 |
+
"SCORE_WEAK: best pose -5.392 kcal/mol > 閾值 -6.0",
|
| 1616 |
+
"OUT_OF_POCKET_MINOR: 2/9 poses outside"
|
| 1617 |
+
],
|
| 1618 |
+
"pdb_id": "3EY8",
|
| 1619 |
+
"review_class": "B_qc_fail"
|
| 1620 |
+
},
|
| 1621 |
+
{
|
| 1622 |
+
"drug_id": 97,
|
| 1623 |
+
"canonical_name": "Bisoprolol",
|
| 1624 |
+
"index_key": "BISOPROLOL_ADRB1_PROXY",
|
| 1625 |
+
"tier": "2",
|
| 1626 |
+
"pdb_id_catalog": "2Y02",
|
| 1627 |
+
"het_id_catalog": "WHJ",
|
| 1628 |
+
"source": "moltgate_ui",
|
| 1629 |
+
"session_id": "3ffb865f1044824a",
|
| 1630 |
+
"run_status": "ok",
|
| 1631 |
+
"best_affinity": -7.312,
|
| 1632 |
+
"qc_pass": true,
|
| 1633 |
+
"flags": [
|
| 1634 |
+
"OUT_OF_POCKET_MINOR: 1/9 poses outside"
|
| 1635 |
+
],
|
| 1636 |
+
"pdb_id": "2Y02",
|
| 1637 |
+
"review_class": "A_pass"
|
| 1638 |
+
},
|
| 1639 |
+
{
|
| 1640 |
+
"drug_id": 98,
|
| 1641 |
+
"canonical_name": "Nifedipine",
|
| 1642 |
+
"index_key": "NIFEDIPINE_CACNA1C",
|
| 1643 |
+
"tier": "2",
|
| 1644 |
+
"pdb_id_catalog": "8WE8",
|
| 1645 |
+
"het_id_catalog": "6UB",
|
| 1646 |
+
"source": "moltgate_ui",
|
| 1647 |
+
"session_id": "d4c5b5c59fe17d3e",
|
| 1648 |
+
"run_status": "ok",
|
| 1649 |
+
"best_affinity": -7.719,
|
| 1650 |
+
"qc_pass": true,
|
| 1651 |
+
"flags": [
|
| 1652 |
+
"OUT_OF_POCKET_MINOR: 2/9 poses outside"
|
| 1653 |
+
],
|
| 1654 |
+
"pdb_id": "8WE8",
|
| 1655 |
+
"review_class": "A_pass"
|
| 1656 |
+
},
|
| 1657 |
+
{
|
| 1658 |
+
"drug_id": 99,
|
| 1659 |
+
"canonical_name": "Verapamil",
|
| 1660 |
+
"index_key": "VERAPAMIL_CACNA1C_PROXY",
|
| 1661 |
+
"tier": "2",
|
| 1662 |
+
"pdb_id_catalog": "8WE8",
|
| 1663 |
+
"het_id_catalog": "6UB",
|
| 1664 |
+
"source": "moltgate_ui",
|
| 1665 |
+
"session_id": "80fb56ee4e650648",
|
| 1666 |
+
"run_status": "ok",
|
| 1667 |
+
"best_affinity": -7.967,
|
| 1668 |
+
"qc_pass": true,
|
| 1669 |
+
"flags": [],
|
| 1670 |
+
"pdb_id": "8WE8",
|
| 1671 |
+
"review_class": "A_pass"
|
| 1672 |
+
},
|
| 1673 |
+
{
|
| 1674 |
+
"drug_id": 100,
|
| 1675 |
+
"canonical_name": "Pantoprazole",
|
| 1676 |
+
"index_key": "PANTOPRAZOLE_CYP2C19_PROXY",
|
| 1677 |
+
"tier": "2",
|
| 1678 |
+
"pdb_id_catalog": "4GQS",
|
| 1679 |
+
"het_id_catalog": "0XV",
|
| 1680 |
+
"source": "moltgate_ui",
|
| 1681 |
+
"session_id": "4a9ec2bae5439cfb",
|
| 1682 |
+
"run_status": "ok",
|
| 1683 |
+
"best_affinity": -8.095,
|
| 1684 |
+
"qc_pass": true,
|
| 1685 |
+
"flags": [
|
| 1686 |
+
"OUT_OF_POCKET_MINOR: 1/9 poses outside"
|
| 1687 |
+
],
|
| 1688 |
+
"pdb_id": "4GQS",
|
| 1689 |
+
"review_class": "A_pass"
|
| 1690 |
+
},
|
| 1691 |
+
{
|
| 1692 |
+
"drug_id": 101,
|
| 1693 |
+
"canonical_name": "Colchicine",
|
| 1694 |
+
"index_key": "COLCHICINE_TUBULIN",
|
| 1695 |
+
"tier": "1",
|
| 1696 |
+
"pdb_id_catalog": "1BT6",
|
| 1697 |
+
"het_id_catalog": "COL",
|
| 1698 |
+
"source": "moltgate_ui",
|
| 1699 |
+
"session_id": "79fb6729abb9421e",
|
| 1700 |
+
"run_status": "fail",
|
| 1701 |
+
"best_affinity": null,
|
| 1702 |
+
"qc_pass": null,
|
| 1703 |
+
"flags": [],
|
| 1704 |
+
"pdb_id": null,
|
| 1705 |
+
"fail_reason": "Stage 21 無候選配體,無法確認配體身份",
|
| 1706 |
+
"review_class": "A_pipeline_fail"
|
| 1707 |
+
},
|
| 1708 |
+
{
|
| 1709 |
+
"drug_id": 102,
|
| 1710 |
+
"canonical_name": "Sulindac",
|
| 1711 |
+
"index_key": "SULINDAC_COX2_PROXY",
|
| 1712 |
+
"tier": "2",
|
| 1713 |
+
"pdb_id_catalog": "5IKR",
|
| 1714 |
+
"het_id_catalog": "ID8",
|
| 1715 |
+
"source": "moltgate_ui",
|
| 1716 |
+
"session_id": "11547a90c4a50a13",
|
| 1717 |
+
"run_status": "ok",
|
| 1718 |
+
"best_affinity": -6.246,
|
| 1719 |
+
"qc_pass": false,
|
| 1720 |
+
"flags": [
|
| 1721 |
+
"OUT_OF_POCKET_MAJORITY"
|
| 1722 |
+
],
|
| 1723 |
+
"pdb_id": "5IKR",
|
| 1724 |
+
"review_class": "B_qc_fail"
|
| 1725 |
+
},
|
| 1726 |
+
{
|
| 1727 |
+
"drug_id": 103,
|
| 1728 |
+
"canonical_name": "Gabapentin",
|
| 1729 |
+
"index_key": "GABAPENTIN_CACNA2D_PROXY",
|
| 1730 |
+
"tier": "2",
|
| 1731 |
+
"pdb_id_catalog": "5E6I",
|
| 1732 |
+
"het_id_catalog": "GBP",
|
| 1733 |
+
"source": "moltgate_ui",
|
| 1734 |
+
"session_id": "a6eef95399f928b5",
|
| 1735 |
+
"run_status": "fail",
|
| 1736 |
+
"best_affinity": null,
|
| 1737 |
+
"qc_pass": null,
|
| 1738 |
+
"flags": [],
|
| 1739 |
+
"pdb_id": null,
|
| 1740 |
+
"fail_reason": "Stage 21 無候選配體,無法確認配體身份",
|
| 1741 |
+
"review_class": "A_pipeline_fail"
|
| 1742 |
+
},
|
| 1743 |
+
{
|
| 1744 |
+
"drug_id": 104,
|
| 1745 |
+
"canonical_name": "Carbamazepine",
|
| 1746 |
+
"index_key": "CARBAMAZEPINE_NAV_PROXY",
|
| 1747 |
+
"tier": "2",
|
| 1748 |
+
"pdb_id_catalog": "5E6I",
|
| 1749 |
+
"het_id_catalog": "GBP",
|
| 1750 |
+
"source": "moltgate_ui",
|
| 1751 |
+
"session_id": "4d252ef951059a9a",
|
| 1752 |
+
"run_status": "fail",
|
| 1753 |
+
"best_affinity": null,
|
| 1754 |
+
"qc_pass": null,
|
| 1755 |
+
"flags": [],
|
| 1756 |
+
"pdb_id": null,
|
| 1757 |
+
"fail_reason": "Stage 21 無候選配體,無法確認配體身份",
|
| 1758 |
+
"review_class": "A_pipeline_fail"
|
| 1759 |
+
},
|
| 1760 |
+
{
|
| 1761 |
+
"drug_id": 105,
|
| 1762 |
+
"canonical_name": "Valproic acid",
|
| 1763 |
+
"index_key": "VALPROIC_ACID_HDAC_PROXY",
|
| 1764 |
+
"tier": "2",
|
| 1765 |
+
"pdb_id_catalog": "4LXZ",
|
| 1766 |
+
"het_id_catalog": "SHH",
|
| 1767 |
+
"source": "moltgate_ui",
|
| 1768 |
+
"session_id": "3a62507682e6bf11",
|
| 1769 |
+
"run_status": "ok",
|
| 1770 |
+
"best_affinity": -4.888,
|
| 1771 |
+
"qc_pass": false,
|
| 1772 |
+
"flags": [
|
| 1773 |
+
"SCORE_WEAK: best pose -4.888 kcal/mol > 閾值 -6.0"
|
| 1774 |
+
],
|
| 1775 |
+
"pdb_id": "4LXZ",
|
| 1776 |
+
"review_class": "B_qc_fail"
|
| 1777 |
+
},
|
| 1778 |
+
{
|
| 1779 |
+
"drug_id": 106,
|
| 1780 |
+
"canonical_name": "Metronidazole",
|
| 1781 |
+
"index_key": "METRONIDAZOLE_NITROREDUCTASE",
|
| 1782 |
+
"tier": "1",
|
| 1783 |
+
"pdb_id_catalog": "1MNU",
|
| 1784 |
+
"het_id_catalog": "MET",
|
| 1785 |
+
"source": "moltgate_ui",
|
| 1786 |
+
"session_id": "72eb1acbbf72bc3c",
|
| 1787 |
+
"run_status": "fail",
|
| 1788 |
+
"best_affinity": null,
|
| 1789 |
+
"qc_pass": null,
|
| 1790 |
+
"flags": [],
|
| 1791 |
+
"pdb_id": null,
|
| 1792 |
+
"fail_reason": "Stage 21 無候選配體,無法確認配體身份",
|
| 1793 |
+
"review_class": "A_pipeline_fail"
|
| 1794 |
+
},
|
| 1795 |
+
{
|
| 1796 |
+
"drug_id": 107,
|
| 1797 |
+
"canonical_name": "Clindamycin",
|
| 1798 |
+
"index_key": "CLINDAMYCIN_RIBOSOME",
|
| 1799 |
+
"tier": "1",
|
| 1800 |
+
"pdb_id_catalog": "1YHQ",
|
| 1801 |
+
"het_id_catalog": "CLI",
|
| 1802 |
+
"source": "moltgate_ui",
|
| 1803 |
+
"session_id": "9f5ebd6af574a905",
|
| 1804 |
+
"run_status": "ok",
|
| 1805 |
+
"best_affinity": -4.243,
|
| 1806 |
+
"qc_pass": false,
|
| 1807 |
+
"flags": [
|
| 1808 |
+
"SCORE_WEAK: best pose -4.243 kcal/mol > 閾值 -6.0"
|
| 1809 |
+
],
|
| 1810 |
+
"pdb_id": "1YHQ",
|
| 1811 |
+
"review_class": "B_qc_fail"
|
| 1812 |
+
},
|
| 1813 |
+
{
|
| 1814 |
+
"drug_id": 108,
|
| 1815 |
+
"canonical_name": "Vancomycin",
|
| 1816 |
+
"index_key": "VANCOMYCIN_PBP",
|
| 1817 |
+
"tier": "1",
|
| 1818 |
+
"pdb_id_catalog": "1FVM",
|
| 1819 |
+
"het_id_catalog": "VAN",
|
| 1820 |
+
"source": "moltgate_ui",
|
| 1821 |
+
"session_id": "562f960e8d721e60",
|
| 1822 |
+
"run_status": "ok",
|
| 1823 |
+
"best_affinity": -2.733,
|
| 1824 |
+
"qc_pass": false,
|
| 1825 |
+
"flags": [
|
| 1826 |
+
"SCORE_WEAK: best pose -2.733 kcal/mol > 閾值 -6.0"
|
| 1827 |
+
],
|
| 1828 |
+
"pdb_id": "1FVM",
|
| 1829 |
+
"review_class": "B_qc_fail"
|
| 1830 |
+
},
|
| 1831 |
+
{
|
| 1832 |
+
"drug_id": 109,
|
| 1833 |
+
"canonical_name": "Clarithromycin",
|
| 1834 |
+
"index_key": "CLARITHROMYCIN_RIBOSOME",
|
| 1835 |
+
"tier": "1",
|
| 1836 |
+
"pdb_id_catalog": "1YIJ",
|
| 1837 |
+
"het_id_catalog": "CLR",
|
| 1838 |
+
"source": "moltgate_ui",
|
| 1839 |
+
"session_id": "61f47136fa5514b1",
|
| 1840 |
+
"run_status": "fail",
|
| 1841 |
+
"best_affinity": null,
|
| 1842 |
+
"qc_pass": null,
|
| 1843 |
+
"flags": [],
|
| 1844 |
+
"pdb_id": null,
|
| 1845 |
+
"review_class": "A_pipeline_fail"
|
| 1846 |
+
},
|
| 1847 |
+
{
|
| 1848 |
+
"drug_id": 110,
|
| 1849 |
+
"canonical_name": "Rifampin",
|
| 1850 |
+
"index_key": "RIFAMPIN_RNAP",
|
| 1851 |
+
"tier": "1",
|
| 1852 |
+
"pdb_id_catalog": "5UAC",
|
| 1853 |
+
"het_id_catalog": "RFP",
|
| 1854 |
+
"source": "moltgate_ui",
|
| 1855 |
+
"session_id": "2afb81f90cb867c7",
|
| 1856 |
+
"run_status": "ok",
|
| 1857 |
+
"best_affinity": -6.41,
|
| 1858 |
+
"qc_pass": true,
|
| 1859 |
+
"flags": [
|
| 1860 |
+
"OUT_OF_POCKET_MINOR: 2/9 poses outside"
|
| 1861 |
+
],
|
| 1862 |
+
"pdb_id": "5UAC",
|
| 1863 |
+
"review_class": "A_pass"
|
| 1864 |
+
},
|
| 1865 |
+
{
|
| 1866 |
+
"drug_id": 111,
|
| 1867 |
+
"canonical_name": "Regorafenib",
|
| 1868 |
+
"index_key": "REGORAFENIB_BRAF",
|
| 1869 |
+
"tier": "1",
|
| 1870 |
+
"pdb_id_catalog": "4RT7",
|
| 1871 |
+
"het_id_catalog": "RGF",
|
| 1872 |
+
"source": "moltgate_ui",
|
| 1873 |
+
"session_id": "77bdd5d1c6c34c9b",
|
| 1874 |
+
"run_status": "ok",
|
| 1875 |
+
"best_affinity": -10.96,
|
| 1876 |
+
"qc_pass": true,
|
| 1877 |
+
"flags": [
|
| 1878 |
+
"OUT_OF_POCKET_MINOR: 4/9 poses outside"
|
| 1879 |
+
],
|
| 1880 |
+
"pdb_id": "4RT7",
|
| 1881 |
+
"review_class": "A_pass"
|
| 1882 |
+
},
|
| 1883 |
+
{
|
| 1884 |
+
"drug_id": 112,
|
| 1885 |
+
"canonical_name": "Lenvatinib",
|
| 1886 |
+
"index_key": "LENVATINIB_VEGFR2",
|
| 1887 |
+
"tier": "1",
|
| 1888 |
+
"pdb_id_catalog": "4UQI",
|
| 1889 |
+
"het_id_catalog": "LVN",
|
| 1890 |
+
"source": "moltgate_ui",
|
| 1891 |
+
"session_id": "3c9fd5dea6a09758",
|
| 1892 |
+
"run_status": "ok",
|
| 1893 |
+
"best_affinity": -6.884,
|
| 1894 |
+
"qc_pass": true,
|
| 1895 |
+
"flags": [],
|
| 1896 |
+
"pdb_id": "4UQI",
|
| 1897 |
+
"review_class": "A_pass"
|
| 1898 |
+
},
|
| 1899 |
+
{
|
| 1900 |
+
"drug_id": 113,
|
| 1901 |
+
"canonical_name": "Axitinib",
|
| 1902 |
+
"index_key": "AXITINIB_VEGFR2",
|
| 1903 |
+
"tier": "1",
|
| 1904 |
+
"pdb_id_catalog": "4AGC",
|
| 1905 |
+
"het_id_catalog": "AXN",
|
| 1906 |
+
"source": "moltgate_ui",
|
| 1907 |
+
"session_id": "260e4358ee89dc53",
|
| 1908 |
+
"run_status": "ok",
|
| 1909 |
+
"best_affinity": -8.413,
|
| 1910 |
+
"qc_pass": true,
|
| 1911 |
+
"flags": [
|
| 1912 |
+
"OUT_OF_POCKET_MINOR: 1/9 poses outside"
|
| 1913 |
+
],
|
| 1914 |
+
"pdb_id": "4AGC",
|
| 1915 |
+
"review_class": "A_pass"
|
| 1916 |
+
},
|
| 1917 |
+
{
|
| 1918 |
+
"drug_id": 114,
|
| 1919 |
+
"canonical_name": "Everolimus",
|
| 1920 |
+
"index_key": "EVEROLIMUS_MTOR",
|
| 1921 |
+
"tier": "1",
|
| 1922 |
+
"pdb_id_catalog": "4JT6",
|
| 1923 |
+
"het_id_catalog": "EVL",
|
| 1924 |
+
"source": "moltgate_ui",
|
| 1925 |
+
"session_id": "ceb624ee3abaef94",
|
| 1926 |
+
"run_status": "ok",
|
| 1927 |
+
"best_affinity": -7.174,
|
| 1928 |
+
"qc_pass": true,
|
| 1929 |
+
"flags": [],
|
| 1930 |
+
"pdb_id": "4JT6",
|
| 1931 |
+
"review_class": "A_pass"
|
| 1932 |
+
},
|
| 1933 |
+
{
|
| 1934 |
+
"drug_id": 115,
|
| 1935 |
+
"canonical_name": "Crizotinib",
|
| 1936 |
+
"index_key": "CRIZOTINIB_ALK",
|
| 1937 |
+
"tier": "1",
|
| 1938 |
+
"pdb_id_catalog": "2XP2",
|
| 1939 |
+
"het_id_catalog": "CRI",
|
| 1940 |
+
"source": "moltgate_ui",
|
| 1941 |
+
"session_id": "5ff1e7d227d4b420",
|
| 1942 |
+
"run_status": "ok",
|
| 1943 |
+
"best_affinity": -8.854,
|
| 1944 |
+
"qc_pass": true,
|
| 1945 |
+
"flags": [],
|
| 1946 |
+
"pdb_id": "2XP2",
|
| 1947 |
+
"review_class": "A_pass"
|
| 1948 |
+
},
|
| 1949 |
+
{
|
| 1950 |
+
"drug_id": 116,
|
| 1951 |
+
"canonical_name": "Alectinib",
|
| 1952 |
+
"index_key": "ALECTINIB_ALK",
|
| 1953 |
+
"tier": "1",
|
| 1954 |
+
"pdb_id_catalog": "4YNP",
|
| 1955 |
+
"het_id_catalog": "AIT",
|
| 1956 |
+
"source": "moltgate_ui",
|
| 1957 |
+
"session_id": "daefe717a30c2de4",
|
| 1958 |
+
"run_status": "ok",
|
| 1959 |
+
"best_affinity": -8.514,
|
| 1960 |
+
"qc_pass": true,
|
| 1961 |
+
"flags": [],
|
| 1962 |
+
"pdb_id": "4YNP",
|
| 1963 |
+
"review_class": "A_pass"
|
| 1964 |
+
},
|
| 1965 |
+
{
|
| 1966 |
+
"drug_id": 117,
|
| 1967 |
+
"canonical_name": "Ceritinib",
|
| 1968 |
+
"index_key": "CERITINIB_ALK",
|
| 1969 |
+
"tier": "1",
|
| 1970 |
+
"pdb_id_catalog": "4MKC",
|
| 1971 |
+
"het_id_catalog": "LDK",
|
| 1972 |
+
"source": "moltgate_ui",
|
| 1973 |
+
"session_id": "3152e55e09e8451a",
|
| 1974 |
+
"run_status": "ok",
|
| 1975 |
+
"best_affinity": -8.581,
|
| 1976 |
+
"qc_pass": true,
|
| 1977 |
+
"flags": [],
|
| 1978 |
+
"pdb_id": "4MKC",
|
| 1979 |
+
"review_class": "A_pass"
|
| 1980 |
+
},
|
| 1981 |
+
{
|
| 1982 |
+
"drug_id": 118,
|
| 1983 |
+
"canonical_name": "Clopidogrel",
|
| 1984 |
+
"index_key": "CLOPIDOGREL_P2Y12_PROXY",
|
| 1985 |
+
"tier": "2",
|
| 1986 |
+
"pdb_id_catalog": "4PY0",
|
| 1987 |
+
"het_id_catalog": "TIC",
|
| 1988 |
+
"source": "moltgate_ui",
|
| 1989 |
+
"session_id": "8de55865e8867022",
|
| 1990 |
+
"run_status": "ok",
|
| 1991 |
+
"best_affinity": -6.102,
|
| 1992 |
+
"qc_pass": false,
|
| 1993 |
+
"flags": [
|
| 1994 |
+
"OUT_OF_POCKET_MAJORITY"
|
| 1995 |
+
],
|
| 1996 |
+
"pdb_id": "4PY0",
|
| 1997 |
+
"review_class": "B_qc_fail"
|
| 1998 |
+
},
|
| 1999 |
+
{
|
| 2000 |
+
"drug_id": 119,
|
| 2001 |
+
"canonical_name": "Amiodarone",
|
| 2002 |
+
"index_key": "AMIODARONE_KCNH2_PROXY",
|
| 2003 |
+
"tier": "2",
|
| 2004 |
+
"pdb_id_catalog": "5VA2",
|
| 2005 |
+
"het_id_catalog": "AMI",
|
| 2006 |
+
"source": "moltgate_ui",
|
| 2007 |
+
"session_id": "aa4e16c3b638e4d5",
|
| 2008 |
+
"run_status": "fail",
|
| 2009 |
+
"best_affinity": null,
|
| 2010 |
+
"qc_pass": null,
|
| 2011 |
+
"flags": [],
|
| 2012 |
+
"pdb_id": null,
|
| 2013 |
+
"fail_reason": "Stage 21 無候選配體,無法確認配體身份",
|
| 2014 |
+
"review_class": "A_pipeline_fail"
|
| 2015 |
+
},
|
| 2016 |
+
{
|
| 2017 |
+
"drug_id": 120,
|
| 2018 |
+
"canonical_name": "Digoxin",
|
| 2019 |
+
"index_key": "DIGOXIN_PGP",
|
| 2020 |
+
"tier": "1",
|
| 2021 |
+
"pdb_id_catalog": "3G60",
|
| 2022 |
+
"het_id_catalog": "DIG",
|
| 2023 |
+
"source": "moltgate_ui",
|
| 2024 |
+
"session_id": "6c2d9b61882105e0",
|
| 2025 |
+
"run_status": "ok",
|
| 2026 |
+
"best_affinity": -7.635,
|
| 2027 |
+
"qc_pass": true,
|
| 2028 |
+
"flags": [
|
| 2029 |
+
"OUT_OF_POCKET_MINOR: 2/9 poses outside"
|
| 2030 |
+
],
|
| 2031 |
+
"pdb_id": "3G60",
|
| 2032 |
+
"review_class": "A_pass"
|
| 2033 |
+
},
|
| 2034 |
+
{
|
| 2035 |
+
"drug_id": 121,
|
| 2036 |
+
"canonical_name": "Esomeprazole",
|
| 2037 |
+
"index_key": "ESOMEPRAZOLE_CYP2C19_PROXY",
|
| 2038 |
+
"tier": "2",
|
| 2039 |
+
"pdb_id_catalog": "4GQS",
|
| 2040 |
+
"het_id_catalog": "0XV",
|
| 2041 |
+
"source": "moltgate_ui",
|
| 2042 |
+
"session_id": "09e3d437a9fdad49",
|
| 2043 |
+
"run_status": "ok",
|
| 2044 |
+
"best_affinity": -7.841,
|
| 2045 |
+
"qc_pass": true,
|
| 2046 |
+
"flags": [
|
| 2047 |
+
"OUT_OF_POCKET_MINOR: 2/9 poses outside"
|
| 2048 |
+
],
|
| 2049 |
+
"pdb_id": "4GQS",
|
| 2050 |
+
"review_class": "A_pass"
|
| 2051 |
+
},
|
| 2052 |
+
{
|
| 2053 |
+
"drug_id": 122,
|
| 2054 |
+
"canonical_name": "Nateglinide",
|
| 2055 |
+
"index_key": "NATEGLINIDE_KATP_PROXY",
|
| 2056 |
+
"tier": "2",
|
| 2057 |
+
"pdb_id_catalog": "3VE0",
|
| 2058 |
+
"het_id_catalog": "REP",
|
| 2059 |
+
"source": "moltgate_ui",
|
| 2060 |
+
"session_id": "f9f9cab8d78202cf",
|
| 2061 |
+
"run_status": "ok",
|
| 2062 |
+
"best_affinity": -6.86,
|
| 2063 |
+
"qc_pass": true,
|
| 2064 |
+
"flags": [],
|
| 2065 |
+
"pdb_id": "3SYQ",
|
| 2066 |
+
"review_class": "A_pass"
|
| 2067 |
+
},
|
| 2068 |
+
{
|
| 2069 |
+
"drug_id": 123,
|
| 2070 |
+
"canonical_name": "Voglibose",
|
| 2071 |
+
"index_key": "VOGLIBOSE_GLUCOSIDASE_PROXY",
|
| 2072 |
+
"tier": "2",
|
| 2073 |
+
"pdb_id_catalog": "2QV4",
|
| 2074 |
+
"het_id_catalog": "ACA",
|
| 2075 |
+
"source": "moltgate_ui",
|
| 2076 |
+
"session_id": "edb6b8f1c6e3a33b",
|
| 2077 |
+
"run_status": "ok",
|
| 2078 |
+
"best_affinity": -7.115,
|
| 2079 |
+
"qc_pass": true,
|
| 2080 |
+
"flags": [],
|
| 2081 |
+
"pdb_id": "2QV4",
|
| 2082 |
+
"review_class": "A_pass"
|
| 2083 |
+
},
|
| 2084 |
+
{
|
| 2085 |
+
"drug_id": 124,
|
| 2086 |
+
"canonical_name": "Eplerenone",
|
| 2087 |
+
"index_key": "EPLERENONE_NR3C2",
|
| 2088 |
+
"tier": "1",
|
| 2089 |
+
"pdb_id_catalog": "2W44",
|
| 2090 |
+
"het_id_catalog": "EPL",
|
| 2091 |
+
"source": "moltgate_ui",
|
| 2092 |
+
"session_id": "ad90d3f0c613e7d7",
|
| 2093 |
+
"run_status": "ok",
|
| 2094 |
+
"best_affinity": -6.523,
|
| 2095 |
+
"qc_pass": true,
|
| 2096 |
+
"flags": [
|
| 2097 |
+
"OUT_OF_POCKET_MINOR: 1/9 poses outside"
|
| 2098 |
+
],
|
| 2099 |
+
"pdb_id": "2AA2",
|
| 2100 |
+
"review_class": "A_pass"
|
| 2101 |
+
},
|
| 2102 |
+
{
|
| 2103 |
+
"drug_id": 125,
|
| 2104 |
+
"canonical_name": "Telmisartan",
|
| 2105 |
+
"index_key": "TELMISARTAN_AT1R",
|
| 2106 |
+
"tier": "1",
|
| 2107 |
+
"pdb_id_catalog": "4YAY",
|
| 2108 |
+
"het_id_catalog": "TEL",
|
| 2109 |
+
"source": "moltgate_ui",
|
| 2110 |
+
"session_id": "a79c4a36ee92aebd",
|
| 2111 |
+
"run_status": "ok",
|
| 2112 |
+
"best_affinity": -10.18,
|
| 2113 |
+
"qc_pass": true,
|
| 2114 |
+
"flags": [],
|
| 2115 |
+
"pdb_id": "4YAY",
|
| 2116 |
+
"review_class": "A_pass"
|
| 2117 |
+
},
|
| 2118 |
+
{
|
| 2119 |
+
"drug_id": 126,
|
| 2120 |
+
"canonical_name": "Lisinopril",
|
| 2121 |
+
"index_key": "LISINOPRIL_ACE",
|
| 2122 |
+
"tier": "1",
|
| 2123 |
+
"pdb_id_catalog": "1O86",
|
| 2124 |
+
"het_id_catalog": "LIS",
|
| 2125 |
+
"source": "moltgate_ui",
|
| 2126 |
+
"session_id": "6e6a3aab0947ab09",
|
| 2127 |
+
"run_status": "ok",
|
| 2128 |
+
"best_affinity": -8.568,
|
| 2129 |
+
"qc_pass": false,
|
| 2130 |
+
"flags": [
|
| 2131 |
+
"OUT_OF_POCKET_MAJORITY"
|
| 2132 |
+
],
|
| 2133 |
+
"pdb_id": "1O86",
|
| 2134 |
+
"review_class": "B_qc_fail"
|
| 2135 |
+
},
|
| 2136 |
+
{
|
| 2137 |
+
"drug_id": 127,
|
| 2138 |
+
"canonical_name": "Diltiazem",
|
| 2139 |
+
"index_key": "DILTIAZEM_CACNA1C_PROXY",
|
| 2140 |
+
"tier": "2",
|
| 2141 |
+
"pdb_id_catalog": "8WE8",
|
| 2142 |
+
"het_id_catalog": "6UB",
|
| 2143 |
+
"source": "moltgate_ui",
|
| 2144 |
+
"session_id": "a486e7cf18629198",
|
| 2145 |
+
"run_status": "ok",
|
| 2146 |
+
"best_affinity": -8.89,
|
| 2147 |
+
"qc_pass": true,
|
| 2148 |
+
"flags": [
|
| 2149 |
+
"OUT_OF_POCKET_MINOR: 1/9 poses outside"
|
| 2150 |
+
],
|
| 2151 |
+
"pdb_id": "8WE8",
|
| 2152 |
+
"review_class": "A_pass"
|
| 2153 |
+
},
|
| 2154 |
+
{
|
| 2155 |
+
"drug_id": 128,
|
| 2156 |
+
"canonical_name": "Furosemide",
|
| 2157 |
+
"index_key": "FUROSEMIDE_SLC12A_PROXY",
|
| 2158 |
+
"tier": "2",
|
| 2159 |
+
"pdb_id_catalog": "3HS4",
|
| 2160 |
+
"het_id_catalog": "AZM",
|
| 2161 |
+
"source": "moltgate_ui",
|
| 2162 |
+
"session_id": "f84307ef8d0fb256",
|
| 2163 |
+
"run_status": "ok",
|
| 2164 |
+
"best_affinity": -6.843,
|
| 2165 |
+
"qc_pass": true,
|
| 2166 |
+
"flags": [],
|
| 2167 |
+
"pdb_id": "3HS4",
|
| 2168 |
+
"review_class": "A_pass"
|
| 2169 |
+
},
|
| 2170 |
+
{
|
| 2171 |
+
"drug_id": 129,
|
| 2172 |
+
"canonical_name": "Orlistat",
|
| 2173 |
+
"index_key": "ORLISTAT_LIPASE",
|
| 2174 |
+
"tier": "1",
|
| 2175 |
+
"pdb_id_catalog": "1LPB",
|
| 2176 |
+
"het_id_catalog": "ORL",
|
| 2177 |
+
"source": "moltgate_ui",
|
| 2178 |
+
"session_id": "5d4310d7357604a6",
|
| 2179 |
+
"run_status": "ok",
|
| 2180 |
+
"best_affinity": -6.687,
|
| 2181 |
+
"qc_pass": true,
|
| 2182 |
+
"flags": [],
|
| 2183 |
+
"pdb_id": "1LPB",
|
| 2184 |
+
"review_class": "A_pass"
|
| 2185 |
+
}
|
| 2186 |
+
]
|
| 2187 |
+
}
|
config/catalog_review_1-300.json
ADDED
|
The diff for this file is too large to render.
See raw diff
|
|
|
config/catalog_review_130-300.json
ADDED
|
@@ -0,0 +1,2942 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"range": "130-300",
|
| 3 |
+
"summary": {
|
| 4 |
+
"total": 171,
|
| 5 |
+
"ok_qc_pass": 107,
|
| 6 |
+
"ok_qc_fail": 31,
|
| 7 |
+
"pipeline_fail": 33,
|
| 8 |
+
"no_run": 0
|
| 9 |
+
},
|
| 10 |
+
"entries": [
|
| 11 |
+
{
|
| 12 |
+
"drug_id": 130,
|
| 13 |
+
"canonical_name": "Levothyroxine",
|
| 14 |
+
"index_key": "LEVOTHYROXINE_THRB_PROXY",
|
| 15 |
+
"tier": "2",
|
| 16 |
+
"pdb_id_catalog": "1NAV",
|
| 17 |
+
"het_id_catalog": "T3",
|
| 18 |
+
"source": "moltgate_ui",
|
| 19 |
+
"session_id": "5c6329ecb370f2e1",
|
| 20 |
+
"run_status": "ok",
|
| 21 |
+
"best_affinity": -7.131,
|
| 22 |
+
"qc_pass": true,
|
| 23 |
+
"flags": [
|
| 24 |
+
"OUT_OF_POCKET_MINOR: 1/9 poses outside"
|
| 25 |
+
],
|
| 26 |
+
"pdb_id": "1NAV",
|
| 27 |
+
"review_class": "A_pass"
|
| 28 |
+
},
|
| 29 |
+
{
|
| 30 |
+
"drug_id": 131,
|
| 31 |
+
"canonical_name": "Morphine",
|
| 32 |
+
"index_key": "MORPHINE_OPRM1",
|
| 33 |
+
"tier": "1",
|
| 34 |
+
"pdb_id_catalog": "8DZP",
|
| 35 |
+
"het_id_catalog": "MOR",
|
| 36 |
+
"source": "moltgate_ui",
|
| 37 |
+
"session_id": "c395e5af446f6879",
|
| 38 |
+
"run_status": "ok",
|
| 39 |
+
"best_affinity": -7.632,
|
| 40 |
+
"qc_pass": false,
|
| 41 |
+
"flags": [
|
| 42 |
+
"OUT_OF_POCKET_MAJORITY"
|
| 43 |
+
],
|
| 44 |
+
"pdb_id": "8DZP",
|
| 45 |
+
"review_class": "B_qc_fail"
|
| 46 |
+
},
|
| 47 |
+
{
|
| 48 |
+
"drug_id": 132,
|
| 49 |
+
"canonical_name": "Fentanyl",
|
| 50 |
+
"index_key": "FENTANYL_OPRM1_PROXY",
|
| 51 |
+
"tier": "2",
|
| 52 |
+
"pdb_id_catalog": "8DZP",
|
| 53 |
+
"het_id_catalog": "MOR",
|
| 54 |
+
"source": "moltgate_ui",
|
| 55 |
+
"session_id": "a10f03e66572cb4b",
|
| 56 |
+
"run_status": "ok",
|
| 57 |
+
"best_affinity": -7.864,
|
| 58 |
+
"qc_pass": true,
|
| 59 |
+
"flags": [],
|
| 60 |
+
"pdb_id": "8DZP",
|
| 61 |
+
"review_class": "A_pass"
|
| 62 |
+
},
|
| 63 |
+
{
|
| 64 |
+
"drug_id": 133,
|
| 65 |
+
"canonical_name": "Pregabalin",
|
| 66 |
+
"index_key": "PREGABALIN_CACNA2D_PROXY",
|
| 67 |
+
"tier": "2",
|
| 68 |
+
"pdb_id_catalog": "5E6I",
|
| 69 |
+
"het_id_catalog": "GBP",
|
| 70 |
+
"source": "moltgate_ui",
|
| 71 |
+
"session_id": "cc8c60ebaa9b95b6",
|
| 72 |
+
"run_status": "fail",
|
| 73 |
+
"best_affinity": null,
|
| 74 |
+
"qc_pass": null,
|
| 75 |
+
"flags": [],
|
| 76 |
+
"pdb_id": null,
|
| 77 |
+
"fail_reason": "Stage 21 無候選配體,無法確認配體身份",
|
| 78 |
+
"review_class": "A_pipeline_fail"
|
| 79 |
+
},
|
| 80 |
+
{
|
| 81 |
+
"drug_id": 134,
|
| 82 |
+
"canonical_name": "Lamotrigine",
|
| 83 |
+
"index_key": "LAMOTRIGINE_SCN_PROXY",
|
| 84 |
+
"tier": "2",
|
| 85 |
+
"pdb_id_catalog": "5E6I",
|
| 86 |
+
"het_id_catalog": "GBP",
|
| 87 |
+
"source": "moltgate_ui",
|
| 88 |
+
"session_id": "f5a8998b464dea01",
|
| 89 |
+
"run_status": "fail",
|
| 90 |
+
"best_affinity": null,
|
| 91 |
+
"qc_pass": null,
|
| 92 |
+
"flags": [],
|
| 93 |
+
"pdb_id": null,
|
| 94 |
+
"fail_reason": "Stage 21 無候選配體,無法確認配體身份",
|
| 95 |
+
"review_class": "A_pipeline_fail"
|
| 96 |
+
},
|
| 97 |
+
{
|
| 98 |
+
"drug_id": 135,
|
| 99 |
+
"canonical_name": "Phenytoin",
|
| 100 |
+
"index_key": "PHENYTOIN_SCN_PROXY",
|
| 101 |
+
"tier": "2",
|
| 102 |
+
"pdb_id_catalog": "5T6R",
|
| 103 |
+
"het_id_catalog": "PHT",
|
| 104 |
+
"source": "moltgate_ui",
|
| 105 |
+
"session_id": "9053280d8de1dd73",
|
| 106 |
+
"run_status": "fail",
|
| 107 |
+
"best_affinity": null,
|
| 108 |
+
"qc_pass": null,
|
| 109 |
+
"flags": [],
|
| 110 |
+
"pdb_id": null,
|
| 111 |
+
"review_class": "A_pipeline_fail"
|
| 112 |
+
},
|
| 113 |
+
{
|
| 114 |
+
"drug_id": 136,
|
| 115 |
+
"canonical_name": "Clonazepam",
|
| 116 |
+
"index_key": "CLONAZEPAM_GABA_A",
|
| 117 |
+
"tier": "1",
|
| 118 |
+
"pdb_id_catalog": "1KTF",
|
| 119 |
+
"het_id_catalog": "CLZ",
|
| 120 |
+
"source": "moltgate_ui",
|
| 121 |
+
"session_id": "7b81b52b568fb5dc",
|
| 122 |
+
"run_status": "fail",
|
| 123 |
+
"best_affinity": null,
|
| 124 |
+
"qc_pass": null,
|
| 125 |
+
"flags": [],
|
| 126 |
+
"pdb_id": null,
|
| 127 |
+
"review_class": "A_pipeline_fail"
|
| 128 |
+
},
|
| 129 |
+
{
|
| 130 |
+
"drug_id": 137,
|
| 131 |
+
"canonical_name": "Escitalopram",
|
| 132 |
+
"index_key": "ESCITALOPRAM_SERT",
|
| 133 |
+
"tier": "1",
|
| 134 |
+
"pdb_id_catalog": "4IAR",
|
| 135 |
+
"het_id_catalog": "CIT",
|
| 136 |
+
"source": "moltgate_ui",
|
| 137 |
+
"session_id": "5bf94f51ea38472b",
|
| 138 |
+
"run_status": "ok",
|
| 139 |
+
"best_affinity": -8.633,
|
| 140 |
+
"qc_pass": true,
|
| 141 |
+
"flags": [],
|
| 142 |
+
"pdb_id": "4IAR",
|
| 143 |
+
"review_class": "A_pass"
|
| 144 |
+
},
|
| 145 |
+
{
|
| 146 |
+
"drug_id": 138,
|
| 147 |
+
"canonical_name": "Linezolid",
|
| 148 |
+
"index_key": "LINEZOLID_RIBOSOME",
|
| 149 |
+
"tier": "1",
|
| 150 |
+
"pdb_id_catalog": "3CPW",
|
| 151 |
+
"het_id_catalog": "LZD",
|
| 152 |
+
"source": "moltgate_ui",
|
| 153 |
+
"session_id": "84a1c2be4800539f",
|
| 154 |
+
"run_status": "ok",
|
| 155 |
+
"best_affinity": -4.91,
|
| 156 |
+
"qc_pass": false,
|
| 157 |
+
"flags": [
|
| 158 |
+
"SCORE_WEAK: best pose -4.910 kcal/mol > 閾值 -6.0"
|
| 159 |
+
],
|
| 160 |
+
"pdb_id": "3CPW",
|
| 161 |
+
"review_class": "B_qc_fail"
|
| 162 |
+
},
|
| 163 |
+
{
|
| 164 |
+
"drug_id": 139,
|
| 165 |
+
"canonical_name": "Isoniazid",
|
| 166 |
+
"index_key": "ISONIAZID_INHA",
|
| 167 |
+
"tier": "1",
|
| 168 |
+
"pdb_id_catalog": "4C0X",
|
| 169 |
+
"het_id_catalog": "INA",
|
| 170 |
+
"source": "moltgate_ui",
|
| 171 |
+
"session_id": "00366c4964443c3a",
|
| 172 |
+
"run_status": "ok",
|
| 173 |
+
"best_affinity": -5.99,
|
| 174 |
+
"qc_pass": false,
|
| 175 |
+
"flags": [
|
| 176 |
+
"SCORE_WEAK: best pose -5.990 kcal/mol > 閾值 -6.0",
|
| 177 |
+
"OUT_OF_POCKET_MINOR: 3/9 poses outside"
|
| 178 |
+
],
|
| 179 |
+
"pdb_id": "4C0X",
|
| 180 |
+
"review_class": "B_qc_fail"
|
| 181 |
+
},
|
| 182 |
+
{
|
| 183 |
+
"drug_id": 140,
|
| 184 |
+
"canonical_name": "Ethambutol",
|
| 185 |
+
"index_key": "ETHAMBUTOL_EMBA",
|
| 186 |
+
"tier": "1",
|
| 187 |
+
"pdb_id_catalog": "4NBA",
|
| 188 |
+
"het_id_catalog": "EMB",
|
| 189 |
+
"source": "moltgate_ui",
|
| 190 |
+
"session_id": "6b5bda2908ef66d7",
|
| 191 |
+
"run_status": "ok",
|
| 192 |
+
"best_affinity": -7.256,
|
| 193 |
+
"qc_pass": true,
|
| 194 |
+
"flags": [],
|
| 195 |
+
"pdb_id": "4NBA",
|
| 196 |
+
"review_class": "A_pass"
|
| 197 |
+
},
|
| 198 |
+
{
|
| 199 |
+
"drug_id": 141,
|
| 200 |
+
"canonical_name": "Acalabrutinib",
|
| 201 |
+
"index_key": "ACALABRUTINIB_BTK",
|
| 202 |
+
"tier": "1",
|
| 203 |
+
"pdb_id_catalog": "6OZM",
|
| 204 |
+
"het_id_catalog": "ACB",
|
| 205 |
+
"source": "moltgate_ui",
|
| 206 |
+
"session_id": "db9851dbc46dfa74",
|
| 207 |
+
"run_status": "fail",
|
| 208 |
+
"best_affinity": null,
|
| 209 |
+
"qc_pass": null,
|
| 210 |
+
"flags": [],
|
| 211 |
+
"pdb_id": null,
|
| 212 |
+
"review_class": "A_pipeline_fail"
|
| 213 |
+
},
|
| 214 |
+
{
|
| 215 |
+
"drug_id": 142,
|
| 216 |
+
"canonical_name": "Midostaurin",
|
| 217 |
+
"index_key": "MIDOSTAURIN_FLT3",
|
| 218 |
+
"tier": "2",
|
| 219 |
+
"pdb_id_catalog": "1RJB",
|
| 220 |
+
"het_id_catalog": "STA",
|
| 221 |
+
"source": "moltgate_ui",
|
| 222 |
+
"session_id": "5c426bfe129b23dc",
|
| 223 |
+
"run_status": "ok",
|
| 224 |
+
"best_affinity": -7.138,
|
| 225 |
+
"qc_pass": true,
|
| 226 |
+
"flags": [],
|
| 227 |
+
"pdb_id": "4RK8",
|
| 228 |
+
"review_class": "A_pass"
|
| 229 |
+
},
|
| 230 |
+
{
|
| 231 |
+
"drug_id": 143,
|
| 232 |
+
"canonical_name": "Larotrectinib",
|
| 233 |
+
"index_key": "LAROTRECTINIB_TRK",
|
| 234 |
+
"tier": "1",
|
| 235 |
+
"pdb_id_catalog": "5VLQ",
|
| 236 |
+
"het_id_catalog": "LAR",
|
| 237 |
+
"source": "moltgate_ui",
|
| 238 |
+
"session_id": "1d762ef85781fdfe",
|
| 239 |
+
"run_status": "ok",
|
| 240 |
+
"best_affinity": -6.725,
|
| 241 |
+
"qc_pass": true,
|
| 242 |
+
"flags": [
|
| 243 |
+
"OUT_OF_POCKET_MINOR: 1/9 poses outside"
|
| 244 |
+
],
|
| 245 |
+
"pdb_id": "5VLQ",
|
| 246 |
+
"review_class": "A_pass"
|
| 247 |
+
},
|
| 248 |
+
{
|
| 249 |
+
"drug_id": 144,
|
| 250 |
+
"canonical_name": "Lenalidomide",
|
| 251 |
+
"index_key": "LENALIDOMIDE_CRBN",
|
| 252 |
+
"tier": "1",
|
| 253 |
+
"pdb_id_catalog": "5FQD",
|
| 254 |
+
"het_id_catalog": "LEN",
|
| 255 |
+
"source": "moltgate_ui",
|
| 256 |
+
"session_id": "a4d450c1d4756a85",
|
| 257 |
+
"run_status": "ok",
|
| 258 |
+
"best_affinity": -7.135,
|
| 259 |
+
"qc_pass": false,
|
| 260 |
+
"flags": [
|
| 261 |
+
"OUT_OF_POCKET_MAJORITY"
|
| 262 |
+
],
|
| 263 |
+
"pdb_id": "5FQD",
|
| 264 |
+
"review_class": "B_qc_fail"
|
| 265 |
+
},
|
| 266 |
+
{
|
| 267 |
+
"drug_id": 145,
|
| 268 |
+
"canonical_name": "Abiraterone",
|
| 269 |
+
"index_key": "ABIRATERONE_CYP17",
|
| 270 |
+
"tier": "1",
|
| 271 |
+
"pdb_id_catalog": "3SW0",
|
| 272 |
+
"het_id_catalog": "ABI",
|
| 273 |
+
"source": "moltgate_ui",
|
| 274 |
+
"session_id": "ae443b52bf6ac6b2",
|
| 275 |
+
"run_status": "fail",
|
| 276 |
+
"best_affinity": null,
|
| 277 |
+
"qc_pass": null,
|
| 278 |
+
"flags": [],
|
| 279 |
+
"pdb_id": null,
|
| 280 |
+
"fail_reason": "Stage 21 無候選配體,無法確認配體身份",
|
| 281 |
+
"review_class": "A_pipeline_fail"
|
| 282 |
+
},
|
| 283 |
+
{
|
| 284 |
+
"drug_id": 146,
|
| 285 |
+
"canonical_name": "Abemaciclib",
|
| 286 |
+
"index_key": "ABEMACICLIB_CDK6",
|
| 287 |
+
"tier": "1",
|
| 288 |
+
"pdb_id_catalog": "5UOC",
|
| 289 |
+
"het_id_catalog": "ABE",
|
| 290 |
+
"source": "moltgate_ui",
|
| 291 |
+
"session_id": "58734be96cd8e15b",
|
| 292 |
+
"run_status": "ok",
|
| 293 |
+
"best_affinity": -9.292,
|
| 294 |
+
"qc_pass": true,
|
| 295 |
+
"flags": [
|
| 296 |
+
"OUT_OF_POCKET_MINOR: 3/9 poses outside"
|
| 297 |
+
],
|
| 298 |
+
"pdb_id": "5UOC",
|
| 299 |
+
"review_class": "A_pass"
|
| 300 |
+
},
|
| 301 |
+
{
|
| 302 |
+
"drug_id": 147,
|
| 303 |
+
"canonical_name": "Ribociclib",
|
| 304 |
+
"index_key": "RIBOCICLIB_CDK6",
|
| 305 |
+
"tier": "1",
|
| 306 |
+
"pdb_id_catalog": "5L2T",
|
| 307 |
+
"het_id_catalog": "RIC",
|
| 308 |
+
"source": "moltgate_ui",
|
| 309 |
+
"session_id": "4efc8c856de1cefc",
|
| 310 |
+
"run_status": "ok",
|
| 311 |
+
"best_affinity": -9.313,
|
| 312 |
+
"qc_pass": true,
|
| 313 |
+
"flags": [],
|
| 314 |
+
"pdb_id": "5L2T",
|
| 315 |
+
"review_class": "A_pass"
|
| 316 |
+
},
|
| 317 |
+
{
|
| 318 |
+
"drug_id": 148,
|
| 319 |
+
"canonical_name": "Prasugrel",
|
| 320 |
+
"index_key": "PRASUGREL_P2Y12_PROXY",
|
| 321 |
+
"tier": "2",
|
| 322 |
+
"pdb_id_catalog": "4PY0",
|
| 323 |
+
"het_id_catalog": "TIC",
|
| 324 |
+
"source": "moltgate_ui",
|
| 325 |
+
"session_id": "fc0e3d03b01faf01",
|
| 326 |
+
"run_status": "ok",
|
| 327 |
+
"best_affinity": -8.7,
|
| 328 |
+
"qc_pass": false,
|
| 329 |
+
"flags": [
|
| 330 |
+
"OUT_OF_POCKET_MAJORITY"
|
| 331 |
+
],
|
| 332 |
+
"pdb_id": "4PY0",
|
| 333 |
+
"review_class": "B_qc_fail"
|
| 334 |
+
},
|
| 335 |
+
{
|
| 336 |
+
"drug_id": 149,
|
| 337 |
+
"canonical_name": "Vandetanib",
|
| 338 |
+
"index_key": "VANDETANIB_RET",
|
| 339 |
+
"tier": "1",
|
| 340 |
+
"pdb_id_catalog": "2IVT",
|
| 341 |
+
"het_id_catalog": "VAN",
|
| 342 |
+
"source": "moltgate_ui",
|
| 343 |
+
"session_id": "63a628c84abdfeac",
|
| 344 |
+
"run_status": "ok",
|
| 345 |
+
"best_affinity": -7.308,
|
| 346 |
+
"qc_pass": true,
|
| 347 |
+
"flags": [],
|
| 348 |
+
"pdb_id": "2IVT",
|
| 349 |
+
"review_class": "A_pass"
|
| 350 |
+
},
|
| 351 |
+
{
|
| 352 |
+
"drug_id": 150,
|
| 353 |
+
"canonical_name": "Nintedanib",
|
| 354 |
+
"index_key": "NINTEDANIB_FGFR",
|
| 355 |
+
"tier": "1",
|
| 356 |
+
"pdb_id_catalog": "4PV0",
|
| 357 |
+
"het_id_catalog": "NIN",
|
| 358 |
+
"source": "moltgate_ui",
|
| 359 |
+
"session_id": "5e571c2903463711",
|
| 360 |
+
"run_status": "ok",
|
| 361 |
+
"best_affinity": -7.104,
|
| 362 |
+
"qc_pass": true,
|
| 363 |
+
"flags": [],
|
| 364 |
+
"pdb_id": "4PV0",
|
| 365 |
+
"review_class": "A_pass"
|
| 366 |
+
},
|
| 367 |
+
{
|
| 368 |
+
"drug_id": 151,
|
| 369 |
+
"canonical_name": "Enalapril",
|
| 370 |
+
"index_key": "ENALAPRIL_ACE_PROXY",
|
| 371 |
+
"tier": "2",
|
| 372 |
+
"pdb_id_catalog": "1O86",
|
| 373 |
+
"het_id_catalog": "LIS",
|
| 374 |
+
"source": "moltgate_ui",
|
| 375 |
+
"session_id": "e34f30284054cf2e",
|
| 376 |
+
"run_status": "ok",
|
| 377 |
+
"best_affinity": -8.111,
|
| 378 |
+
"qc_pass": true,
|
| 379 |
+
"flags": [],
|
| 380 |
+
"pdb_id": "1O86",
|
| 381 |
+
"review_class": "A_pass"
|
| 382 |
+
},
|
| 383 |
+
{
|
| 384 |
+
"drug_id": 152,
|
| 385 |
+
"canonical_name": "Ramipril",
|
| 386 |
+
"index_key": "RAMIPRIL_ACE_PROXY",
|
| 387 |
+
"tier": "2",
|
| 388 |
+
"pdb_id_catalog": "1O86",
|
| 389 |
+
"het_id_catalog": "LIS",
|
| 390 |
+
"source": "moltgate_ui",
|
| 391 |
+
"session_id": "3a50159851a6853c",
|
| 392 |
+
"run_status": "ok",
|
| 393 |
+
"best_affinity": -8.618,
|
| 394 |
+
"qc_pass": true,
|
| 395 |
+
"flags": [
|
| 396 |
+
"OUT_OF_POCKET_MINOR: 3/9 poses outside"
|
| 397 |
+
],
|
| 398 |
+
"pdb_id": "1O86",
|
| 399 |
+
"review_class": "A_pass"
|
| 400 |
+
},
|
| 401 |
+
{
|
| 402 |
+
"drug_id": 153,
|
| 403 |
+
"canonical_name": "Candesartan",
|
| 404 |
+
"index_key": "CANDESARTAN_AT1R",
|
| 405 |
+
"tier": "2",
|
| 406 |
+
"pdb_id_catalog": "4ZUD",
|
| 407 |
+
"het_id_catalog": "OLM",
|
| 408 |
+
"source": "moltgate_ui",
|
| 409 |
+
"session_id": "bf402e9cf14097be",
|
| 410 |
+
"run_status": "ok",
|
| 411 |
+
"best_affinity": -11.4,
|
| 412 |
+
"qc_pass": true,
|
| 413 |
+
"flags": [
|
| 414 |
+
"OUT_OF_POCKET_MINOR: 2/9 poses outside"
|
| 415 |
+
],
|
| 416 |
+
"pdb_id": "4ZUD",
|
| 417 |
+
"review_class": "A_pass"
|
| 418 |
+
},
|
| 419 |
+
{
|
| 420 |
+
"drug_id": 154,
|
| 421 |
+
"canonical_name": "Irbesartan",
|
| 422 |
+
"index_key": "IRBESARTAN_AT1R_PROXY",
|
| 423 |
+
"tier": "2",
|
| 424 |
+
"pdb_id_catalog": "4ZUD",
|
| 425 |
+
"het_id_catalog": "OLM",
|
| 426 |
+
"source": "moltgate_ui",
|
| 427 |
+
"session_id": "00e7e57350867b38",
|
| 428 |
+
"run_status": "ok",
|
| 429 |
+
"best_affinity": -10.38,
|
| 430 |
+
"qc_pass": true,
|
| 431 |
+
"flags": [],
|
| 432 |
+
"pdb_id": "4ZUD",
|
| 433 |
+
"review_class": "A_pass"
|
| 434 |
+
},
|
| 435 |
+
{
|
| 436 |
+
"drug_id": 155,
|
| 437 |
+
"canonical_name": "Olmesartan",
|
| 438 |
+
"index_key": "OLMESARTAN_AT1R",
|
| 439 |
+
"tier": "1",
|
| 440 |
+
"pdb_id_catalog": "4ZUD",
|
| 441 |
+
"het_id_catalog": "OLM",
|
| 442 |
+
"source": "moltgate_ui",
|
| 443 |
+
"session_id": "11b6a1841b2c08f6",
|
| 444 |
+
"run_status": "ok",
|
| 445 |
+
"best_affinity": -10.3,
|
| 446 |
+
"qc_pass": true,
|
| 447 |
+
"flags": [],
|
| 448 |
+
"pdb_id": "4ZUD",
|
| 449 |
+
"review_class": "A_pass"
|
| 450 |
+
},
|
| 451 |
+
{
|
| 452 |
+
"drug_id": 156,
|
| 453 |
+
"canonical_name": "Rosiglitazone",
|
| 454 |
+
"index_key": "ROSIGLITAZONE_PPARG",
|
| 455 |
+
"tier": "1",
|
| 456 |
+
"pdb_id_catalog": "2PRG",
|
| 457 |
+
"het_id_catalog": "BRL",
|
| 458 |
+
"source": "moltgate_ui",
|
| 459 |
+
"session_id": "348e68d6d88d3994",
|
| 460 |
+
"run_status": "ok",
|
| 461 |
+
"best_affinity": -9.273,
|
| 462 |
+
"qc_pass": true,
|
| 463 |
+
"flags": [
|
| 464 |
+
"OUT_OF_POCKET_MINOR: 1/9 poses outside"
|
| 465 |
+
],
|
| 466 |
+
"pdb_id": "2PRG",
|
| 467 |
+
"review_class": "A_pass"
|
| 468 |
+
},
|
| 469 |
+
{
|
| 470 |
+
"drug_id": 157,
|
| 471 |
+
"canonical_name": "Glyburide",
|
| 472 |
+
"index_key": "GLYBURIDE_KATP",
|
| 473 |
+
"tier": "1",
|
| 474 |
+
"pdb_id_catalog": "3SYQ",
|
| 475 |
+
"het_id_catalog": "GBL",
|
| 476 |
+
"source": "moltgate_ui",
|
| 477 |
+
"session_id": "5063b6ff285c2a73",
|
| 478 |
+
"run_status": "ok",
|
| 479 |
+
"best_affinity": -7.504,
|
| 480 |
+
"qc_pass": true,
|
| 481 |
+
"flags": [],
|
| 482 |
+
"pdb_id": "3SYQ",
|
| 483 |
+
"review_class": "A_pass"
|
| 484 |
+
},
|
| 485 |
+
{
|
| 486 |
+
"drug_id": 158,
|
| 487 |
+
"canonical_name": "Atenolol",
|
| 488 |
+
"index_key": "ATENOLOL_ADRB1_PROXY",
|
| 489 |
+
"tier": "2",
|
| 490 |
+
"pdb_id_catalog": "2Y02",
|
| 491 |
+
"het_id_catalog": "WHJ",
|
| 492 |
+
"source": "moltgate_ui",
|
| 493 |
+
"session_id": "9c6510353824b5ad",
|
| 494 |
+
"run_status": "ok",
|
| 495 |
+
"best_affinity": -7.309,
|
| 496 |
+
"qc_pass": true,
|
| 497 |
+
"flags": [],
|
| 498 |
+
"pdb_id": "2Y02",
|
| 499 |
+
"review_class": "A_pass"
|
| 500 |
+
},
|
| 501 |
+
{
|
| 502 |
+
"drug_id": 159,
|
| 503 |
+
"canonical_name": "Felodipine",
|
| 504 |
+
"index_key": "FELODIPINE_CACNA1C_PROXY",
|
| 505 |
+
"tier": "2",
|
| 506 |
+
"pdb_id_catalog": "8WE8",
|
| 507 |
+
"het_id_catalog": "6UB",
|
| 508 |
+
"source": "moltgate_ui",
|
| 509 |
+
"session_id": "67da2ff0fe290fe0",
|
| 510 |
+
"run_status": "ok",
|
| 511 |
+
"best_affinity": -6.721,
|
| 512 |
+
"qc_pass": true,
|
| 513 |
+
"flags": [
|
| 514 |
+
"OUT_OF_POCKET_MINOR: 4/9 poses outside"
|
| 515 |
+
],
|
| 516 |
+
"pdb_id": "8WE8",
|
| 517 |
+
"review_class": "A_pass"
|
| 518 |
+
},
|
| 519 |
+
{
|
| 520 |
+
"drug_id": 160,
|
| 521 |
+
"canonical_name": "Sacubitril",
|
| 522 |
+
"index_key": "SACUBITRIL_MEP",
|
| 523 |
+
"tier": "1",
|
| 524 |
+
"pdb_id_catalog": "6V06",
|
| 525 |
+
"het_id_catalog": "SGN",
|
| 526 |
+
"source": "moltgate_ui",
|
| 527 |
+
"session_id": "0f0e77dc8dd711e2",
|
| 528 |
+
"run_status": "fail",
|
| 529 |
+
"best_affinity": null,
|
| 530 |
+
"qc_pass": null,
|
| 531 |
+
"flags": [],
|
| 532 |
+
"pdb_id": null,
|
| 533 |
+
"fail_reason": "Stage 21 無候選配體,無法確認配體身份",
|
| 534 |
+
"review_class": "A_pipeline_fail"
|
| 535 |
+
},
|
| 536 |
+
{
|
| 537 |
+
"drug_id": 161,
|
| 538 |
+
"canonical_name": "Tramadol",
|
| 539 |
+
"index_key": "TRAMADOL_OPRM1_PROXY",
|
| 540 |
+
"tier": "2",
|
| 541 |
+
"pdb_id_catalog": "8DZP",
|
| 542 |
+
"het_id_catalog": "MOR",
|
| 543 |
+
"source": "moltgate_ui",
|
| 544 |
+
"session_id": "5c67b9b9d1ed63d4",
|
| 545 |
+
"run_status": "ok",
|
| 546 |
+
"best_affinity": -6.721,
|
| 547 |
+
"qc_pass": true,
|
| 548 |
+
"flags": [
|
| 549 |
+
"OUT_OF_POCKET_MINOR: 2/9 poses outside"
|
| 550 |
+
],
|
| 551 |
+
"pdb_id": "8DZP",
|
| 552 |
+
"review_class": "A_pass"
|
| 553 |
+
},
|
| 554 |
+
{
|
| 555 |
+
"drug_id": 162,
|
| 556 |
+
"canonical_name": "Oxycodone",
|
| 557 |
+
"index_key": "OXYCODONE_OPRM1_PROXY",
|
| 558 |
+
"tier": "2",
|
| 559 |
+
"pdb_id_catalog": "8DZP",
|
| 560 |
+
"het_id_catalog": "MOR",
|
| 561 |
+
"source": "moltgate_ui",
|
| 562 |
+
"session_id": "36c37b826460d078",
|
| 563 |
+
"run_status": "ok",
|
| 564 |
+
"best_affinity": -6.996,
|
| 565 |
+
"qc_pass": true,
|
| 566 |
+
"flags": [
|
| 567 |
+
"OUT_OF_POCKET_MINOR: 1/9 poses outside"
|
| 568 |
+
],
|
| 569 |
+
"pdb_id": "8DZP",
|
| 570 |
+
"review_class": "A_pass"
|
| 571 |
+
},
|
| 572 |
+
{
|
| 573 |
+
"drug_id": 163,
|
| 574 |
+
"canonical_name": "Duloxetine",
|
| 575 |
+
"index_key": "DULOXETINE_SERT_PROXY",
|
| 576 |
+
"tier": "2",
|
| 577 |
+
"pdb_id_catalog": "5I6X",
|
| 578 |
+
"het_id_catalog": "8PR",
|
| 579 |
+
"source": "moltgate_ui",
|
| 580 |
+
"session_id": "1c620005c106f483",
|
| 581 |
+
"run_status": "ok",
|
| 582 |
+
"best_affinity": -7.943,
|
| 583 |
+
"qc_pass": true,
|
| 584 |
+
"flags": [
|
| 585 |
+
"OUT_OF_POCKET_MINOR: 1/9 poses outside"
|
| 586 |
+
],
|
| 587 |
+
"pdb_id": "5I6X",
|
| 588 |
+
"review_class": "A_pass"
|
| 589 |
+
},
|
| 590 |
+
{
|
| 591 |
+
"drug_id": 164,
|
| 592 |
+
"canonical_name": "Citalopram",
|
| 593 |
+
"index_key": "CITALOPRAM_SERT",
|
| 594 |
+
"tier": "1",
|
| 595 |
+
"pdb_id_catalog": "4IAR",
|
| 596 |
+
"het_id_catalog": "CIT",
|
| 597 |
+
"source": "moltgate_ui",
|
| 598 |
+
"session_id": "9cf2685a68455ed5",
|
| 599 |
+
"run_status": "ok",
|
| 600 |
+
"best_affinity": -8.614,
|
| 601 |
+
"qc_pass": true,
|
| 602 |
+
"flags": [],
|
| 603 |
+
"pdb_id": "4IAR",
|
| 604 |
+
"review_class": "A_pass"
|
| 605 |
+
},
|
| 606 |
+
{
|
| 607 |
+
"drug_id": 165,
|
| 608 |
+
"canonical_name": "Venlafaxine",
|
| 609 |
+
"index_key": "VENLAFAXINE_SERT_PROXY",
|
| 610 |
+
"tier": "2",
|
| 611 |
+
"pdb_id_catalog": "5I6X",
|
| 612 |
+
"het_id_catalog": "8PR",
|
| 613 |
+
"source": "moltgate_ui",
|
| 614 |
+
"session_id": "f5603bb08b0e8f2f",
|
| 615 |
+
"run_status": "ok",
|
| 616 |
+
"best_affinity": -8.073,
|
| 617 |
+
"qc_pass": true,
|
| 618 |
+
"flags": [],
|
| 619 |
+
"pdb_id": "5I6X",
|
| 620 |
+
"review_class": "A_pass"
|
| 621 |
+
},
|
| 622 |
+
{
|
| 623 |
+
"drug_id": 166,
|
| 624 |
+
"canonical_name": "Lorazepam",
|
| 625 |
+
"index_key": "LORAZEPAM_GABA_A_PROXY",
|
| 626 |
+
"tier": "2",
|
| 627 |
+
"pdb_id_catalog": "1KTF",
|
| 628 |
+
"het_id_catalog": "CLZ",
|
| 629 |
+
"source": "moltgate_ui",
|
| 630 |
+
"session_id": "a95f8ed76fff9b4b",
|
| 631 |
+
"run_status": "fail",
|
| 632 |
+
"best_affinity": null,
|
| 633 |
+
"qc_pass": null,
|
| 634 |
+
"flags": [],
|
| 635 |
+
"pdb_id": null,
|
| 636 |
+
"review_class": "A_pipeline_fail"
|
| 637 |
+
},
|
| 638 |
+
{
|
| 639 |
+
"drug_id": 167,
|
| 640 |
+
"canonical_name": "Famotidine",
|
| 641 |
+
"index_key": "FAMOTIDINE_HRH2",
|
| 642 |
+
"tier": "1",
|
| 643 |
+
"pdb_id_catalog": "3RSG",
|
| 644 |
+
"het_id_catalog": "FAM",
|
| 645 |
+
"source": "moltgate_ui",
|
| 646 |
+
"session_id": "7d8d9e775c31490b",
|
| 647 |
+
"run_status": "ok",
|
| 648 |
+
"best_affinity": -7.309,
|
| 649 |
+
"qc_pass": true,
|
| 650 |
+
"flags": [],
|
| 651 |
+
"pdb_id": "3RSG",
|
| 652 |
+
"review_class": "A_pass"
|
| 653 |
+
},
|
| 654 |
+
{
|
| 655 |
+
"drug_id": 168,
|
| 656 |
+
"canonical_name": "Ondansetron",
|
| 657 |
+
"index_key": "ONDANSETRON_HTR3A",
|
| 658 |
+
"tier": "1",
|
| 659 |
+
"pdb_id_catalog": "6DFZ",
|
| 660 |
+
"het_id_catalog": "OND",
|
| 661 |
+
"source": "moltgate_ui",
|
| 662 |
+
"session_id": "1c7824a467ecbba8",
|
| 663 |
+
"run_status": "ok",
|
| 664 |
+
"best_affinity": -7.319,
|
| 665 |
+
"qc_pass": true,
|
| 666 |
+
"flags": [
|
| 667 |
+
"OUT_OF_POCKET_MINOR: 3/9 poses outside"
|
| 668 |
+
],
|
| 669 |
+
"pdb_id": "6DFZ",
|
| 670 |
+
"review_class": "A_pass"
|
| 671 |
+
},
|
| 672 |
+
{
|
| 673 |
+
"drug_id": 169,
|
| 674 |
+
"canonical_name": "Sumatriptan",
|
| 675 |
+
"index_key": "SUMATRIPTAN_HTR1B_PROXY",
|
| 676 |
+
"tier": "2",
|
| 677 |
+
"pdb_id_catalog": "6G4Q",
|
| 678 |
+
"het_id_catalog": "SUM",
|
| 679 |
+
"source": "moltgate_ui",
|
| 680 |
+
"session_id": "0f863791e85adfcf",
|
| 681 |
+
"run_status": "ok",
|
| 682 |
+
"best_affinity": -6.445,
|
| 683 |
+
"qc_pass": false,
|
| 684 |
+
"flags": [
|
| 685 |
+
"OUT_OF_POCKET_MAJORITY"
|
| 686 |
+
],
|
| 687 |
+
"pdb_id": "6G4Q",
|
| 688 |
+
"review_class": "B_qc_fail"
|
| 689 |
+
},
|
| 690 |
+
{
|
| 691 |
+
"drug_id": 170,
|
| 692 |
+
"canonical_name": "Cyclosporine",
|
| 693 |
+
"index_key": "CYCLOSPORINE_PP2B",
|
| 694 |
+
"tier": "1",
|
| 695 |
+
"pdb_id_catalog": "1M63",
|
| 696 |
+
"het_id_catalog": "CSA",
|
| 697 |
+
"source": "moltgate_ui",
|
| 698 |
+
"session_id": "473edbe3badd87c1",
|
| 699 |
+
"run_status": "fail",
|
| 700 |
+
"best_affinity": null,
|
| 701 |
+
"qc_pass": null,
|
| 702 |
+
"flags": [],
|
| 703 |
+
"pdb_id": null,
|
| 704 |
+
"review_class": "A_pipeline_fail"
|
| 705 |
+
},
|
| 706 |
+
{
|
| 707 |
+
"drug_id": 171,
|
| 708 |
+
"canonical_name": "Thalidomide",
|
| 709 |
+
"index_key": "THALIDOMIDE_CRBN",
|
| 710 |
+
"tier": "1",
|
| 711 |
+
"pdb_id_catalog": "4CI1",
|
| 712 |
+
"het_id_catalog": "THA",
|
| 713 |
+
"source": "moltgate_ui",
|
| 714 |
+
"session_id": "2a8bf9d3a0702837",
|
| 715 |
+
"run_status": "fail",
|
| 716 |
+
"best_affinity": null,
|
| 717 |
+
"qc_pass": null,
|
| 718 |
+
"flags": [],
|
| 719 |
+
"pdb_id": null,
|
| 720 |
+
"review_class": "A_pipeline_fail"
|
| 721 |
+
},
|
| 722 |
+
{
|
| 723 |
+
"drug_id": 172,
|
| 724 |
+
"canonical_name": "Pomalidomide",
|
| 725 |
+
"index_key": "POMALIDOMIDE_CRBN",
|
| 726 |
+
"tier": "1",
|
| 727 |
+
"pdb_id_catalog": "4TZ4",
|
| 728 |
+
"het_id_catalog": "POM",
|
| 729 |
+
"source": "moltgate_ui",
|
| 730 |
+
"session_id": "5135ed32678f89ee",
|
| 731 |
+
"run_status": "fail",
|
| 732 |
+
"best_affinity": null,
|
| 733 |
+
"qc_pass": null,
|
| 734 |
+
"flags": [],
|
| 735 |
+
"pdb_id": null,
|
| 736 |
+
"review_class": "A_pipeline_fail"
|
| 737 |
+
},
|
| 738 |
+
{
|
| 739 |
+
"drug_id": 173,
|
| 740 |
+
"canonical_name": "Entrectinib",
|
| 741 |
+
"index_key": "ENTRECTINIB_TRK",
|
| 742 |
+
"tier": "1",
|
| 743 |
+
"pdb_id_catalog": "5T1A",
|
| 744 |
+
"het_id_catalog": "ENT",
|
| 745 |
+
"source": "moltgate_ui",
|
| 746 |
+
"session_id": "c44734fab5b0dba1",
|
| 747 |
+
"run_status": "ok",
|
| 748 |
+
"best_affinity": -10.36,
|
| 749 |
+
"qc_pass": true,
|
| 750 |
+
"flags": [],
|
| 751 |
+
"pdb_id": "5T1A",
|
| 752 |
+
"review_class": "A_pass"
|
| 753 |
+
},
|
| 754 |
+
{
|
| 755 |
+
"drug_id": 174,
|
| 756 |
+
"canonical_name": "Capmatinib",
|
| 757 |
+
"index_key": "CAPMATINIB_MET",
|
| 758 |
+
"tier": "1",
|
| 759 |
+
"pdb_id_catalog": "4R3Y",
|
| 760 |
+
"het_id_catalog": "CAP",
|
| 761 |
+
"source": "moltgate_ui",
|
| 762 |
+
"session_id": "0fb37d606d7c8233",
|
| 763 |
+
"run_status": "ok",
|
| 764 |
+
"best_affinity": -9.371,
|
| 765 |
+
"qc_pass": true,
|
| 766 |
+
"flags": [],
|
| 767 |
+
"pdb_id": "4R3Y",
|
| 768 |
+
"review_class": "A_pass"
|
| 769 |
+
},
|
| 770 |
+
{
|
| 771 |
+
"drug_id": 175,
|
| 772 |
+
"canonical_name": "Neratinib",
|
| 773 |
+
"index_key": "NERATINIB_EGFR",
|
| 774 |
+
"tier": "1",
|
| 775 |
+
"pdb_id_catalog": "3POZ",
|
| 776 |
+
"het_id_catalog": "NER",
|
| 777 |
+
"source": "moltgate_ui",
|
| 778 |
+
"session_id": "0cd7b0c309cea8cd",
|
| 779 |
+
"run_status": "ok",
|
| 780 |
+
"best_affinity": -9.104,
|
| 781 |
+
"qc_pass": true,
|
| 782 |
+
"flags": [],
|
| 783 |
+
"pdb_id": "3POZ",
|
| 784 |
+
"review_class": "A_pass"
|
| 785 |
+
},
|
| 786 |
+
{
|
| 787 |
+
"drug_id": 176,
|
| 788 |
+
"canonical_name": "Lorlatinib",
|
| 789 |
+
"index_key": "LORLATINIB_ALK",
|
| 790 |
+
"tier": "1",
|
| 791 |
+
"pdb_id_catalog": "5W9I",
|
| 792 |
+
"het_id_catalog": "LOR",
|
| 793 |
+
"source": "moltgate_ui",
|
| 794 |
+
"session_id": "cfc36c4e7181aef2",
|
| 795 |
+
"run_status": "ok",
|
| 796 |
+
"best_affinity": -10.7,
|
| 797 |
+
"qc_pass": true,
|
| 798 |
+
"flags": [],
|
| 799 |
+
"pdb_id": "2XP2",
|
| 800 |
+
"review_class": "A_pass"
|
| 801 |
+
},
|
| 802 |
+
{
|
| 803 |
+
"drug_id": 177,
|
| 804 |
+
"canonical_name": "Brigatinib",
|
| 805 |
+
"index_key": "BRIGATINIB_ALK",
|
| 806 |
+
"tier": "1",
|
| 807 |
+
"pdb_id_catalog": "5USZ",
|
| 808 |
+
"het_id_catalog": "BRI",
|
| 809 |
+
"source": "moltgate_ui",
|
| 810 |
+
"session_id": "340967662320277e",
|
| 811 |
+
"run_status": "ok",
|
| 812 |
+
"best_affinity": -10.06,
|
| 813 |
+
"qc_pass": true,
|
| 814 |
+
"flags": [],
|
| 815 |
+
"pdb_id": "5USZ",
|
| 816 |
+
"review_class": "A_pass"
|
| 817 |
+
},
|
| 818 |
+
{
|
| 819 |
+
"drug_id": 178,
|
| 820 |
+
"canonical_name": "Dabigatran",
|
| 821 |
+
"index_key": "DABIGATRAN_THROMBIN",
|
| 822 |
+
"tier": "1",
|
| 823 |
+
"pdb_id_catalog": "1KTS",
|
| 824 |
+
"het_id_catalog": "DAB",
|
| 825 |
+
"source": "moltgate_ui",
|
| 826 |
+
"session_id": "795de3d9c0228393",
|
| 827 |
+
"run_status": "ok",
|
| 828 |
+
"best_affinity": -9.196,
|
| 829 |
+
"qc_pass": true,
|
| 830 |
+
"flags": [],
|
| 831 |
+
"pdb_id": "1KTS",
|
| 832 |
+
"review_class": "A_pass"
|
| 833 |
+
},
|
| 834 |
+
{
|
| 835 |
+
"drug_id": 179,
|
| 836 |
+
"canonical_name": "Edoxaban",
|
| 837 |
+
"index_key": "EDOXABAN_FXA",
|
| 838 |
+
"tier": "1",
|
| 839 |
+
"pdb_id_catalog": "4TZY",
|
| 840 |
+
"het_id_catalog": "EDO",
|
| 841 |
+
"source": "moltgate_ui",
|
| 842 |
+
"session_id": "990f4eee0894351e",
|
| 843 |
+
"run_status": "ok",
|
| 844 |
+
"best_affinity": -8.984,
|
| 845 |
+
"qc_pass": true,
|
| 846 |
+
"flags": [],
|
| 847 |
+
"pdb_id": "2P16",
|
| 848 |
+
"review_class": "A_pass"
|
| 849 |
+
},
|
| 850 |
+
{
|
| 851 |
+
"drug_id": 180,
|
| 852 |
+
"canonical_name": "Selpercatinib",
|
| 853 |
+
"index_key": "SELPERCATINIB_RET",
|
| 854 |
+
"tier": "1",
|
| 855 |
+
"pdb_id_catalog": "6W0O",
|
| 856 |
+
"het_id_catalog": "SEL",
|
| 857 |
+
"source": "moltgate_ui",
|
| 858 |
+
"session_id": "fd967a546b650ae5",
|
| 859 |
+
"run_status": "ok",
|
| 860 |
+
"best_affinity": -10.19,
|
| 861 |
+
"qc_pass": true,
|
| 862 |
+
"flags": [],
|
| 863 |
+
"pdb_id": "2IVT",
|
| 864 |
+
"review_class": "A_pass"
|
| 865 |
+
},
|
| 866 |
+
{
|
| 867 |
+
"drug_id": 181,
|
| 868 |
+
"canonical_name": "Captopril",
|
| 869 |
+
"index_key": "CAPTOPRIL_ACE",
|
| 870 |
+
"tier": "1",
|
| 871 |
+
"pdb_id_catalog": "1UZF",
|
| 872 |
+
"het_id_catalog": "CAP",
|
| 873 |
+
"source": "moltgate_ui",
|
| 874 |
+
"session_id": "28de05534d032483",
|
| 875 |
+
"run_status": "ok",
|
| 876 |
+
"best_affinity": -5.693,
|
| 877 |
+
"qc_pass": false,
|
| 878 |
+
"flags": [
|
| 879 |
+
"SCORE_WEAK: best pose -5.693 kcal/mol > 閾值 -6.0"
|
| 880 |
+
],
|
| 881 |
+
"pdb_id": "1UZF",
|
| 882 |
+
"review_class": "B_qc_fail"
|
| 883 |
+
},
|
| 884 |
+
{
|
| 885 |
+
"drug_id": 182,
|
| 886 |
+
"canonical_name": "Benazepril",
|
| 887 |
+
"index_key": "BENAZEPRIL_ACE_PROXY",
|
| 888 |
+
"tier": "2",
|
| 889 |
+
"pdb_id_catalog": "1O86",
|
| 890 |
+
"het_id_catalog": "LIS",
|
| 891 |
+
"source": "moltgate_ui",
|
| 892 |
+
"session_id": "a1f45f768ddee730",
|
| 893 |
+
"run_status": "ok",
|
| 894 |
+
"best_affinity": -8.252,
|
| 895 |
+
"qc_pass": true,
|
| 896 |
+
"flags": [
|
| 897 |
+
"OUT_OF_POCKET_MINOR: 4/9 poses outside"
|
| 898 |
+
],
|
| 899 |
+
"pdb_id": "1O86",
|
| 900 |
+
"review_class": "A_pass"
|
| 901 |
+
},
|
| 902 |
+
{
|
| 903 |
+
"drug_id": 183,
|
| 904 |
+
"canonical_name": "Chlorthalidone",
|
| 905 |
+
"index_key": "CHLORTHALIDONE_CA2_PROXY",
|
| 906 |
+
"tier": "2",
|
| 907 |
+
"pdb_id_catalog": "3HS4",
|
| 908 |
+
"het_id_catalog": "AZM",
|
| 909 |
+
"source": "moltgate_ui",
|
| 910 |
+
"session_id": "b7e2a6b990ce2866",
|
| 911 |
+
"run_status": "ok",
|
| 912 |
+
"best_affinity": -8.241,
|
| 913 |
+
"qc_pass": true,
|
| 914 |
+
"flags": [],
|
| 915 |
+
"pdb_id": "3HS4",
|
| 916 |
+
"review_class": "A_pass"
|
| 917 |
+
},
|
| 918 |
+
{
|
| 919 |
+
"drug_id": 184,
|
| 920 |
+
"canonical_name": "Amiloride",
|
| 921 |
+
"index_key": "AMILORIDE_ENAC_PROXY",
|
| 922 |
+
"tier": "2",
|
| 923 |
+
"pdb_id_catalog": "3HS4",
|
| 924 |
+
"het_id_catalog": "AZM",
|
| 925 |
+
"source": "moltgate_ui",
|
| 926 |
+
"session_id": "1ee6967443e12c97",
|
| 927 |
+
"run_status": "ok",
|
| 928 |
+
"best_affinity": -6.478,
|
| 929 |
+
"qc_pass": true,
|
| 930 |
+
"flags": [
|
| 931 |
+
"OUT_OF_POCKET_MINOR: 4/9 poses outside"
|
| 932 |
+
],
|
| 933 |
+
"pdb_id": "3HS4",
|
| 934 |
+
"review_class": "A_pass"
|
| 935 |
+
},
|
| 936 |
+
{
|
| 937 |
+
"drug_id": 185,
|
| 938 |
+
"canonical_name": "Ranolazine",
|
| 939 |
+
"index_key": "RANOLAZINE_SCN5A",
|
| 940 |
+
"tier": "1",
|
| 941 |
+
"pdb_id_catalog": "2FBI",
|
| 942 |
+
"het_id_catalog": "RAN",
|
| 943 |
+
"source": "moltgate_ui",
|
| 944 |
+
"session_id": "c8eeda5127d85fde",
|
| 945 |
+
"run_status": "fail",
|
| 946 |
+
"best_affinity": null,
|
| 947 |
+
"qc_pass": null,
|
| 948 |
+
"flags": [],
|
| 949 |
+
"pdb_id": null,
|
| 950 |
+
"fail_reason": "Stage 21 無候選配體,無法確認配體身份",
|
| 951 |
+
"review_class": "A_pipeline_fail"
|
| 952 |
+
},
|
| 953 |
+
{
|
| 954 |
+
"drug_id": 186,
|
| 955 |
+
"canonical_name": "Bromocriptine",
|
| 956 |
+
"index_key": "BROMOCRIPTINE_DRD2",
|
| 957 |
+
"tier": "1",
|
| 958 |
+
"pdb_id_catalog": "3PBL",
|
| 959 |
+
"het_id_catalog": "BRM",
|
| 960 |
+
"source": "moltgate_ui",
|
| 961 |
+
"session_id": "4481ed9ca1feef81",
|
| 962 |
+
"run_status": "ok",
|
| 963 |
+
"best_affinity": -9.373,
|
| 964 |
+
"qc_pass": true,
|
| 965 |
+
"flags": [],
|
| 966 |
+
"pdb_id": "3PBL",
|
| 967 |
+
"review_class": "A_pass"
|
| 968 |
+
},
|
| 969 |
+
{
|
| 970 |
+
"drug_id": 187,
|
| 971 |
+
"canonical_name": "Niacin",
|
| 972 |
+
"index_key": "NIACIN_GPR109A",
|
| 973 |
+
"tier": "1",
|
| 974 |
+
"pdb_id_catalog": "3R7A",
|
| 975 |
+
"het_id_catalog": "NIA",
|
| 976 |
+
"source": "moltgate_ui",
|
| 977 |
+
"session_id": "10a347c37af3f3af",
|
| 978 |
+
"run_status": "ok",
|
| 979 |
+
"best_affinity": -4.464,
|
| 980 |
+
"qc_pass": false,
|
| 981 |
+
"flags": [
|
| 982 |
+
"SCORE_WEAK: best pose -4.464 kcal/mol > 閾值 -6.0",
|
| 983 |
+
"OUT_OF_POCKET_MINOR: 2/9 poses outside"
|
| 984 |
+
],
|
| 985 |
+
"pdb_id": "3R7A",
|
| 986 |
+
"review_class": "B_qc_fail"
|
| 987 |
+
},
|
| 988 |
+
{
|
| 989 |
+
"drug_id": 188,
|
| 990 |
+
"canonical_name": "Diazoxide",
|
| 991 |
+
"index_key": "DIAZOXIDE_KATP_PROXY",
|
| 992 |
+
"tier": "2",
|
| 993 |
+
"pdb_id_catalog": "3SYQ",
|
| 994 |
+
"het_id_catalog": "GBL",
|
| 995 |
+
"source": "moltgate_ui",
|
| 996 |
+
"session_id": "0d5009c9e518df56",
|
| 997 |
+
"run_status": "ok",
|
| 998 |
+
"best_affinity": -5.848,
|
| 999 |
+
"qc_pass": false,
|
| 1000 |
+
"flags": [
|
| 1001 |
+
"SCORE_WEAK: best pose -5.848 kcal/mol > 閾值 -6.0",
|
| 1002 |
+
"OUT_OF_POCKET_MINOR: 1/9 poses outside"
|
| 1003 |
+
],
|
| 1004 |
+
"pdb_id": "3SYQ",
|
| 1005 |
+
"review_class": "B_qc_fail"
|
| 1006 |
+
},
|
| 1007 |
+
{
|
| 1008 |
+
"drug_id": 189,
|
| 1009 |
+
"canonical_name": "Semaglutide",
|
| 1010 |
+
"index_key": "SEMAGLUTIDE_GLP1R",
|
| 1011 |
+
"tier": "1",
|
| 1012 |
+
"pdb_id_catalog": "6X18",
|
| 1013 |
+
"het_id_catalog": "SEM",
|
| 1014 |
+
"source": "moltgate_ui",
|
| 1015 |
+
"session_id": "7f353d9faeee1a3e",
|
| 1016 |
+
"run_status": "fail",
|
| 1017 |
+
"best_affinity": null,
|
| 1018 |
+
"qc_pass": null,
|
| 1019 |
+
"flags": [],
|
| 1020 |
+
"pdb_id": null,
|
| 1021 |
+
"fail_reason": "Stage 21 無候選配體,無法確認配體身份",
|
| 1022 |
+
"review_class": "A_pipeline_fail"
|
| 1023 |
+
},
|
| 1024 |
+
{
|
| 1025 |
+
"drug_id": 190,
|
| 1026 |
+
"canonical_name": "Exenatide",
|
| 1027 |
+
"index_key": "EXENATIDE_GLP1R",
|
| 1028 |
+
"tier": "1",
|
| 1029 |
+
"pdb_id_catalog": "5VAI",
|
| 1030 |
+
"het_id_catalog": "EXN",
|
| 1031 |
+
"source": "moltgate_ui",
|
| 1032 |
+
"session_id": "8bc75a20b2002e76",
|
| 1033 |
+
"run_status": "fail",
|
| 1034 |
+
"best_affinity": null,
|
| 1035 |
+
"qc_pass": null,
|
| 1036 |
+
"flags": [],
|
| 1037 |
+
"pdb_id": null,
|
| 1038 |
+
"fail_reason": "Stage 21 無候選配體,無法確認配體身份",
|
| 1039 |
+
"review_class": "A_pipeline_fail"
|
| 1040 |
+
},
|
| 1041 |
+
{
|
| 1042 |
+
"drug_id": 191,
|
| 1043 |
+
"canonical_name": "Ketamine",
|
| 1044 |
+
"index_key": "KETAMINE_NMDA",
|
| 1045 |
+
"tier": "1",
|
| 1046 |
+
"pdb_id_catalog": "3UO9",
|
| 1047 |
+
"het_id_catalog": "KET",
|
| 1048 |
+
"source": "moltgate_ui",
|
| 1049 |
+
"session_id": "d7f12857c4df2881",
|
| 1050 |
+
"run_status": "ok",
|
| 1051 |
+
"best_affinity": -6.239,
|
| 1052 |
+
"qc_pass": true,
|
| 1053 |
+
"flags": [
|
| 1054 |
+
"OUT_OF_POCKET_MINOR: 3/9 poses outside"
|
| 1055 |
+
],
|
| 1056 |
+
"pdb_id": "3UO9",
|
| 1057 |
+
"review_class": "A_pass"
|
| 1058 |
+
},
|
| 1059 |
+
{
|
| 1060 |
+
"drug_id": 192,
|
| 1061 |
+
"canonical_name": "Codeine",
|
| 1062 |
+
"index_key": "CODEINE_OPRM1_PROXY",
|
| 1063 |
+
"tier": "2",
|
| 1064 |
+
"pdb_id_catalog": "8DZP",
|
| 1065 |
+
"het_id_catalog": "MOR",
|
| 1066 |
+
"source": "moltgate_ui",
|
| 1067 |
+
"session_id": "aab3e34ed70ca9ff",
|
| 1068 |
+
"run_status": "ok",
|
| 1069 |
+
"best_affinity": -4.426,
|
| 1070 |
+
"qc_pass": false,
|
| 1071 |
+
"flags": [
|
| 1072 |
+
"SCORE_WEAK: best pose -4.426 kcal/mol > 閾值 -6.0",
|
| 1073 |
+
"OUT_OF_POCKET_MINOR: 2/9 poses outside"
|
| 1074 |
+
],
|
| 1075 |
+
"pdb_id": "8DZP",
|
| 1076 |
+
"review_class": "B_qc_fail"
|
| 1077 |
+
},
|
| 1078 |
+
{
|
| 1079 |
+
"drug_id": 193,
|
| 1080 |
+
"canonical_name": "Bupropion",
|
| 1081 |
+
"index_key": "BUPROPION_DAT",
|
| 1082 |
+
"tier": "1",
|
| 1083 |
+
"pdb_id_catalog": "4WNT",
|
| 1084 |
+
"het_id_catalog": "BUP",
|
| 1085 |
+
"source": "moltgate_ui",
|
| 1086 |
+
"session_id": "165a8a5da84799fb",
|
| 1087 |
+
"run_status": "ok",
|
| 1088 |
+
"best_affinity": -6.856,
|
| 1089 |
+
"qc_pass": true,
|
| 1090 |
+
"flags": [
|
| 1091 |
+
"OUT_OF_POCKET_MINOR: 4/9 poses outside"
|
| 1092 |
+
],
|
| 1093 |
+
"pdb_id": "4WNT",
|
| 1094 |
+
"review_class": "A_pass"
|
| 1095 |
+
},
|
| 1096 |
+
{
|
| 1097 |
+
"drug_id": 194,
|
| 1098 |
+
"canonical_name": "Mirtazapine",
|
| 1099 |
+
"index_key": "MIRTAZAPINE_HTR2A_PROXY",
|
| 1100 |
+
"tier": "2",
|
| 1101 |
+
"pdb_id_catalog": "6A93",
|
| 1102 |
+
"het_id_catalog": "MIR",
|
| 1103 |
+
"source": "moltgate_ui",
|
| 1104 |
+
"session_id": "706d8f46291a9963",
|
| 1105 |
+
"run_status": "ok",
|
| 1106 |
+
"best_affinity": -10.01,
|
| 1107 |
+
"qc_pass": true,
|
| 1108 |
+
"flags": [
|
| 1109 |
+
"OUT_OF_POCKET_MINOR: 1/9 poses outside"
|
| 1110 |
+
],
|
| 1111 |
+
"pdb_id": "6A93",
|
| 1112 |
+
"review_class": "A_pass"
|
| 1113 |
+
},
|
| 1114 |
+
{
|
| 1115 |
+
"drug_id": 195,
|
| 1116 |
+
"canonical_name": "Trazodone",
|
| 1117 |
+
"index_key": "TRAZODONE_HTR2A_PROXY",
|
| 1118 |
+
"tier": "2",
|
| 1119 |
+
"pdb_id_catalog": "6A93",
|
| 1120 |
+
"het_id_catalog": "MIR",
|
| 1121 |
+
"source": "moltgate_ui",
|
| 1122 |
+
"session_id": "5771466a3df9dfa2",
|
| 1123 |
+
"run_status": "ok",
|
| 1124 |
+
"best_affinity": -10.38,
|
| 1125 |
+
"qc_pass": true,
|
| 1126 |
+
"flags": [],
|
| 1127 |
+
"pdb_id": "6A93",
|
| 1128 |
+
"review_class": "A_pass"
|
| 1129 |
+
},
|
| 1130 |
+
{
|
| 1131 |
+
"drug_id": 196,
|
| 1132 |
+
"canonical_name": "Alprazolam",
|
| 1133 |
+
"index_key": "ALPRAZOLAM_GABA_A",
|
| 1134 |
+
"tier": "1",
|
| 1135 |
+
"pdb_id_catalog": "4OWE",
|
| 1136 |
+
"het_id_catalog": "ALP",
|
| 1137 |
+
"source": "moltgate_ui",
|
| 1138 |
+
"session_id": "6ecf8e58ccbd2a96",
|
| 1139 |
+
"run_status": "fail",
|
| 1140 |
+
"best_affinity": null,
|
| 1141 |
+
"qc_pass": null,
|
| 1142 |
+
"flags": [],
|
| 1143 |
+
"pdb_id": null,
|
| 1144 |
+
"fail_reason": "Stage 21 無候選配體,無法確認配體身份",
|
| 1145 |
+
"review_class": "A_pipeline_fail"
|
| 1146 |
+
},
|
| 1147 |
+
{
|
| 1148 |
+
"drug_id": 197,
|
| 1149 |
+
"canonical_name": "Ranitidine",
|
| 1150 |
+
"index_key": "RANITIDINE_HRH2_PROXY",
|
| 1151 |
+
"tier": "2",
|
| 1152 |
+
"pdb_id_catalog": "3RSG",
|
| 1153 |
+
"het_id_catalog": "FAM",
|
| 1154 |
+
"source": "moltgate_ui",
|
| 1155 |
+
"session_id": "aa226443b3b136b9",
|
| 1156 |
+
"run_status": "ok",
|
| 1157 |
+
"best_affinity": -7.875,
|
| 1158 |
+
"qc_pass": true,
|
| 1159 |
+
"flags": [],
|
| 1160 |
+
"pdb_id": "3RSG",
|
| 1161 |
+
"review_class": "A_pass"
|
| 1162 |
+
},
|
| 1163 |
+
{
|
| 1164 |
+
"drug_id": 198,
|
| 1165 |
+
"canonical_name": "Mycophenolate",
|
| 1166 |
+
"index_key": "MYCOPHENOLATE_IMPDH",
|
| 1167 |
+
"tier": "1",
|
| 1168 |
+
"pdb_id_catalog": "1P5T",
|
| 1169 |
+
"het_id_catalog": "MPA",
|
| 1170 |
+
"source": "moltgate_ui",
|
| 1171 |
+
"session_id": "432330ae5a1e085d",
|
| 1172 |
+
"run_status": "fail",
|
| 1173 |
+
"best_affinity": null,
|
| 1174 |
+
"qc_pass": null,
|
| 1175 |
+
"flags": [],
|
| 1176 |
+
"pdb_id": null,
|
| 1177 |
+
"fail_reason": "Stage 21 無候選配體,無法確認配體身份",
|
| 1178 |
+
"review_class": "A_pipeline_fail"
|
| 1179 |
+
},
|
| 1180 |
+
{
|
| 1181 |
+
"drug_id": 199,
|
| 1182 |
+
"canonical_name": "Ketoconazole",
|
| 1183 |
+
"index_key": "KETOCONAZOLE_CYP51",
|
| 1184 |
+
"tier": "1",
|
| 1185 |
+
"pdb_id_catalog": "5VZA",
|
| 1186 |
+
"het_id_catalog": "KET",
|
| 1187 |
+
"source": "moltgate_ui",
|
| 1188 |
+
"session_id": "d8dd99794ecbd86f",
|
| 1189 |
+
"run_status": "ok",
|
| 1190 |
+
"best_affinity": -8.186,
|
| 1191 |
+
"qc_pass": true,
|
| 1192 |
+
"flags": [],
|
| 1193 |
+
"pdb_id": "5VZA",
|
| 1194 |
+
"review_class": "A_pass"
|
| 1195 |
+
},
|
| 1196 |
+
{
|
| 1197 |
+
"drug_id": 200,
|
| 1198 |
+
"canonical_name": "Voriconazole",
|
| 1199 |
+
"index_key": "VORICONAZOLE_CYP51",
|
| 1200 |
+
"tier": "1",
|
| 1201 |
+
"pdb_id_catalog": "5TZ4",
|
| 1202 |
+
"het_id_catalog": "VOR",
|
| 1203 |
+
"source": "moltgate_ui",
|
| 1204 |
+
"session_id": "351133a06b773a95",
|
| 1205 |
+
"run_status": "ok",
|
| 1206 |
+
"best_affinity": -7.283,
|
| 1207 |
+
"qc_pass": true,
|
| 1208 |
+
"flags": [
|
| 1209 |
+
"OUT_OF_POCKET_MINOR: 1/9 poses outside"
|
| 1210 |
+
],
|
| 1211 |
+
"pdb_id": "4WMZ",
|
| 1212 |
+
"review_class": "A_pass"
|
| 1213 |
+
},
|
| 1214 |
+
{
|
| 1215 |
+
"drug_id": 201,
|
| 1216 |
+
"canonical_name": "Zanubrutinib",
|
| 1217 |
+
"index_key": "ZANUBRUTINIB_BTK",
|
| 1218 |
+
"tier": "1",
|
| 1219 |
+
"pdb_id_catalog": "7F4I",
|
| 1220 |
+
"het_id_catalog": "ZAN",
|
| 1221 |
+
"source": "moltgate_ui",
|
| 1222 |
+
"session_id": "e444705c43935386",
|
| 1223 |
+
"run_status": "ok",
|
| 1224 |
+
"best_affinity": -6.466,
|
| 1225 |
+
"qc_pass": true,
|
| 1226 |
+
"flags": [],
|
| 1227 |
+
"pdb_id": "7F4I",
|
| 1228 |
+
"review_class": "A_pass"
|
| 1229 |
+
},
|
| 1230 |
+
{
|
| 1231 |
+
"drug_id": 202,
|
| 1232 |
+
"canonical_name": "Erdafitinib",
|
| 1233 |
+
"index_key": "ERDAFITINIB_FGFR",
|
| 1234 |
+
"tier": "1",
|
| 1235 |
+
"pdb_id_catalog": "5EW3",
|
| 1236 |
+
"het_id_catalog": "ERD",
|
| 1237 |
+
"source": "moltgate_ui",
|
| 1238 |
+
"session_id": "566c4e4dc8fa73a6",
|
| 1239 |
+
"run_status": "ok",
|
| 1240 |
+
"best_affinity": -9.381,
|
| 1241 |
+
"qc_pass": true,
|
| 1242 |
+
"flags": [],
|
| 1243 |
+
"pdb_id": "5EW3",
|
| 1244 |
+
"review_class": "A_pass"
|
| 1245 |
+
},
|
| 1246 |
+
{
|
| 1247 |
+
"drug_id": 203,
|
| 1248 |
+
"canonical_name": "Pemigatinib",
|
| 1249 |
+
"index_key": "PEMIGATINIB_FGFR",
|
| 1250 |
+
"tier": "1",
|
| 1251 |
+
"pdb_id_catalog": "5EW8",
|
| 1252 |
+
"het_id_catalog": "PEM",
|
| 1253 |
+
"source": "moltgate_ui",
|
| 1254 |
+
"session_id": "52f8ec0459ee14e8",
|
| 1255 |
+
"run_status": "ok",
|
| 1256 |
+
"best_affinity": -8.858,
|
| 1257 |
+
"qc_pass": true,
|
| 1258 |
+
"flags": [],
|
| 1259 |
+
"pdb_id": "5EW8",
|
| 1260 |
+
"review_class": "A_pass"
|
| 1261 |
+
},
|
| 1262 |
+
{
|
| 1263 |
+
"drug_id": 204,
|
| 1264 |
+
"canonical_name": "Tepotinib",
|
| 1265 |
+
"index_key": "TEPOTINIB_MET",
|
| 1266 |
+
"tier": "1",
|
| 1267 |
+
"pdb_id_catalog": "6IOK",
|
| 1268 |
+
"het_id_catalog": "TEP",
|
| 1269 |
+
"source": "moltgate_ui",
|
| 1270 |
+
"session_id": "7add7bd94a053085",
|
| 1271 |
+
"run_status": "ok",
|
| 1272 |
+
"best_affinity": -9.34,
|
| 1273 |
+
"qc_pass": true,
|
| 1274 |
+
"flags": [
|
| 1275 |
+
"OUT_OF_POCKET_MINOR: 1/9 poses outside"
|
| 1276 |
+
],
|
| 1277 |
+
"pdb_id": "4O1B",
|
| 1278 |
+
"review_class": "A_pass"
|
| 1279 |
+
},
|
| 1280 |
+
{
|
| 1281 |
+
"drug_id": 205,
|
| 1282 |
+
"canonical_name": "Belzutifan",
|
| 1283 |
+
"index_key": "BELZUTIFAN_HIF2A",
|
| 1284 |
+
"tier": "1",
|
| 1285 |
+
"pdb_id_catalog": "5GS8",
|
| 1286 |
+
"het_id_catalog": "BEL",
|
| 1287 |
+
"source": "moltgate_ui",
|
| 1288 |
+
"session_id": "e11bc316f93bf421",
|
| 1289 |
+
"run_status": "fail",
|
| 1290 |
+
"best_affinity": null,
|
| 1291 |
+
"qc_pass": null,
|
| 1292 |
+
"flags": [],
|
| 1293 |
+
"pdb_id": null,
|
| 1294 |
+
"fail_reason": "Stage 21 無候選配體,無法確認配體身份",
|
| 1295 |
+
"review_class": "A_pipeline_fail"
|
| 1296 |
+
},
|
| 1297 |
+
{
|
| 1298 |
+
"drug_id": 206,
|
| 1299 |
+
"canonical_name": "Fulvestrant",
|
| 1300 |
+
"index_key": "FULVESTRANT_ESR1",
|
| 1301 |
+
"tier": "1",
|
| 1302 |
+
"pdb_id_catalog": "3ERR",
|
| 1303 |
+
"het_id_catalog": "FUL",
|
| 1304 |
+
"source": "moltgate_ui",
|
| 1305 |
+
"session_id": "e323ebe204b456ab",
|
| 1306 |
+
"run_status": "ok",
|
| 1307 |
+
"best_affinity": -7.226,
|
| 1308 |
+
"qc_pass": true,
|
| 1309 |
+
"flags": [],
|
| 1310 |
+
"pdb_id": "3ERR",
|
| 1311 |
+
"review_class": "A_pass"
|
| 1312 |
+
},
|
| 1313 |
+
{
|
| 1314 |
+
"drug_id": 207,
|
| 1315 |
+
"canonical_name": "Raloxifene",
|
| 1316 |
+
"index_key": "RALOXIFENE_ESR1",
|
| 1317 |
+
"tier": "1",
|
| 1318 |
+
"pdb_id_catalog": "3R5K",
|
| 1319 |
+
"het_id_catalog": "RAL",
|
| 1320 |
+
"source": "moltgate_ui",
|
| 1321 |
+
"session_id": "ec16642429c6043a",
|
| 1322 |
+
"run_status": "ok",
|
| 1323 |
+
"best_affinity": -8.474,
|
| 1324 |
+
"qc_pass": true,
|
| 1325 |
+
"flags": [],
|
| 1326 |
+
"pdb_id": "3ERR",
|
| 1327 |
+
"review_class": "A_pass"
|
| 1328 |
+
},
|
| 1329 |
+
{
|
| 1330 |
+
"drug_id": 208,
|
| 1331 |
+
"canonical_name": "Pazopanib",
|
| 1332 |
+
"index_key": "PAZOPANIB_VEGFR2",
|
| 1333 |
+
"tier": "1",
|
| 1334 |
+
"pdb_id_catalog": "4G0Z",
|
| 1335 |
+
"het_id_catalog": "PAZ",
|
| 1336 |
+
"source": "moltgate_ui",
|
| 1337 |
+
"session_id": "6212be320adaecbd",
|
| 1338 |
+
"run_status": "ok",
|
| 1339 |
+
"best_affinity": -7.655,
|
| 1340 |
+
"qc_pass": true,
|
| 1341 |
+
"flags": [],
|
| 1342 |
+
"pdb_id": "4G0Z",
|
| 1343 |
+
"review_class": "A_pass"
|
| 1344 |
+
},
|
| 1345 |
+
{
|
| 1346 |
+
"drug_id": 209,
|
| 1347 |
+
"canonical_name": "Tucatinib",
|
| 1348 |
+
"index_key": "TUCATINIB_HER2",
|
| 1349 |
+
"tier": "1",
|
| 1350 |
+
"pdb_id_catalog": "5UG8",
|
| 1351 |
+
"het_id_catalog": "TUC",
|
| 1352 |
+
"source": "moltgate_ui",
|
| 1353 |
+
"session_id": "e3b196bab4c5071e",
|
| 1354 |
+
"run_status": "ok",
|
| 1355 |
+
"best_affinity": -10.6,
|
| 1356 |
+
"qc_pass": true,
|
| 1357 |
+
"flags": [],
|
| 1358 |
+
"pdb_id": "5UG8",
|
| 1359 |
+
"review_class": "A_pass"
|
| 1360 |
+
},
|
| 1361 |
+
{
|
| 1362 |
+
"drug_id": 210,
|
| 1363 |
+
"canonical_name": "Pyrotinib",
|
| 1364 |
+
"index_key": "PYROTINIB_EGFR",
|
| 1365 |
+
"tier": "1",
|
| 1366 |
+
"pdb_id_catalog": "5NIY",
|
| 1367 |
+
"het_id_catalog": "PYR",
|
| 1368 |
+
"source": "moltgate_ui",
|
| 1369 |
+
"session_id": "48c5d3a749f7dce0",
|
| 1370 |
+
"run_status": "ok",
|
| 1371 |
+
"best_affinity": -7.517,
|
| 1372 |
+
"qc_pass": true,
|
| 1373 |
+
"flags": [
|
| 1374 |
+
"OUT_OF_POCKET_MINOR: 3/9 poses outside"
|
| 1375 |
+
],
|
| 1376 |
+
"pdb_id": "5NIY",
|
| 1377 |
+
"review_class": "A_pass"
|
| 1378 |
+
},
|
| 1379 |
+
{
|
| 1380 |
+
"drug_id": 211,
|
| 1381 |
+
"canonical_name": "Perindopril",
|
| 1382 |
+
"index_key": "PERINDOPRIL_ACE_PROXY",
|
| 1383 |
+
"tier": "2",
|
| 1384 |
+
"pdb_id_catalog": "1O86",
|
| 1385 |
+
"het_id_catalog": "LIS",
|
| 1386 |
+
"source": "moltgate_ui",
|
| 1387 |
+
"session_id": "4b0d7e2370894b62",
|
| 1388 |
+
"run_status": "ok",
|
| 1389 |
+
"best_affinity": -7.757,
|
| 1390 |
+
"qc_pass": true,
|
| 1391 |
+
"flags": [
|
| 1392 |
+
"OUT_OF_POCKET_MINOR: 3/9 poses outside"
|
| 1393 |
+
],
|
| 1394 |
+
"pdb_id": "1O86",
|
| 1395 |
+
"review_class": "A_pass"
|
| 1396 |
+
},
|
| 1397 |
+
{
|
| 1398 |
+
"drug_id": 212,
|
| 1399 |
+
"canonical_name": "Methimazole",
|
| 1400 |
+
"index_key": "METHIMAZOLE_TPO",
|
| 1401 |
+
"tier": "1",
|
| 1402 |
+
"pdb_id_catalog": "3ZGS",
|
| 1403 |
+
"het_id_catalog": "MMI",
|
| 1404 |
+
"source": "moltgate_ui",
|
| 1405 |
+
"session_id": "189ddbd28e5ff5cd",
|
| 1406 |
+
"run_status": "fail",
|
| 1407 |
+
"best_affinity": null,
|
| 1408 |
+
"qc_pass": null,
|
| 1409 |
+
"flags": [],
|
| 1410 |
+
"pdb_id": null,
|
| 1411 |
+
"fail_reason": "Stage 21 無候選配體,無法確認配體身份",
|
| 1412 |
+
"review_class": "A_pipeline_fail"
|
| 1413 |
+
},
|
| 1414 |
+
{
|
| 1415 |
+
"drug_id": 213,
|
| 1416 |
+
"canonical_name": "Propylthiouracil",
|
| 1417 |
+
"index_key": "PROPYLTHIOURACIL_TPO_PROXY",
|
| 1418 |
+
"tier": "2",
|
| 1419 |
+
"pdb_id_catalog": "3ZGS",
|
| 1420 |
+
"het_id_catalog": "MMI",
|
| 1421 |
+
"source": "moltgate_ui",
|
| 1422 |
+
"session_id": "2764198d0ed84579",
|
| 1423 |
+
"run_status": "fail",
|
| 1424 |
+
"best_affinity": null,
|
| 1425 |
+
"qc_pass": null,
|
| 1426 |
+
"flags": [],
|
| 1427 |
+
"pdb_id": null,
|
| 1428 |
+
"fail_reason": "Stage 21 無候選配體,無法確認配體身份",
|
| 1429 |
+
"review_class": "A_pipeline_fail"
|
| 1430 |
+
},
|
| 1431 |
+
{
|
| 1432 |
+
"drug_id": 214,
|
| 1433 |
+
"canonical_name": "Tolbutamide",
|
| 1434 |
+
"index_key": "TOLBUTAMIDE_KATP_PROXY",
|
| 1435 |
+
"tier": "2",
|
| 1436 |
+
"pdb_id_catalog": "3SYQ",
|
| 1437 |
+
"het_id_catalog": "GBL",
|
| 1438 |
+
"source": "moltgate_ui",
|
| 1439 |
+
"session_id": "ad668ed9b0ac4840",
|
| 1440 |
+
"run_status": "ok",
|
| 1441 |
+
"best_affinity": -5.62,
|
| 1442 |
+
"qc_pass": false,
|
| 1443 |
+
"flags": [
|
| 1444 |
+
"SCORE_WEAK: best pose -5.620 kcal/mol > 閾值 -6.0",
|
| 1445 |
+
"OUT_OF_POCKET_MINOR: 1/9 poses outside"
|
| 1446 |
+
],
|
| 1447 |
+
"pdb_id": "3SYQ",
|
| 1448 |
+
"review_class": "B_qc_fail"
|
| 1449 |
+
},
|
| 1450 |
+
{
|
| 1451 |
+
"drug_id": 215,
|
| 1452 |
+
"canonical_name": "Chlorpropamide",
|
| 1453 |
+
"index_key": "CHLORPROPAMIDE_KATP_PROXY",
|
| 1454 |
+
"tier": "2",
|
| 1455 |
+
"pdb_id_catalog": "3SYQ",
|
| 1456 |
+
"het_id_catalog": "GBL",
|
| 1457 |
+
"source": "moltgate_ui",
|
| 1458 |
+
"session_id": "79763b3cfb8576a9",
|
| 1459 |
+
"run_status": "ok",
|
| 1460 |
+
"best_affinity": -7.835,
|
| 1461 |
+
"qc_pass": true,
|
| 1462 |
+
"flags": [
|
| 1463 |
+
"OUT_OF_POCKET_MINOR: 1/9 poses outside"
|
| 1464 |
+
],
|
| 1465 |
+
"pdb_id": "3SYQ",
|
| 1466 |
+
"review_class": "A_pass"
|
| 1467 |
+
},
|
| 1468 |
+
{
|
| 1469 |
+
"drug_id": 216,
|
| 1470 |
+
"canonical_name": "Bezafibrate",
|
| 1471 |
+
"index_key": "BEZAFIBRATE_PPARalpha_PROXY",
|
| 1472 |
+
"tier": "2",
|
| 1473 |
+
"pdb_id_catalog": "1K74",
|
| 1474 |
+
"het_id_catalog": "544",
|
| 1475 |
+
"source": "moltgate_ui",
|
| 1476 |
+
"session_id": "b6f5179e53d884b6",
|
| 1477 |
+
"run_status": "ok",
|
| 1478 |
+
"best_affinity": -7.702,
|
| 1479 |
+
"qc_pass": true,
|
| 1480 |
+
"flags": [
|
| 1481 |
+
"OUT_OF_POCKET_MINOR: 1/9 poses outside"
|
| 1482 |
+
],
|
| 1483 |
+
"pdb_id": "1K74",
|
| 1484 |
+
"review_class": "A_pass"
|
| 1485 |
+
},
|
| 1486 |
+
{
|
| 1487 |
+
"drug_id": 217,
|
| 1488 |
+
"canonical_name": "Metolazone",
|
| 1489 |
+
"index_key": "METOLAZONE_CA2_PROXY",
|
| 1490 |
+
"tier": "2",
|
| 1491 |
+
"pdb_id_catalog": "3HS4",
|
| 1492 |
+
"het_id_catalog": "AZM",
|
| 1493 |
+
"source": "moltgate_ui",
|
| 1494 |
+
"session_id": "4c7b18e5f047b123",
|
| 1495 |
+
"run_status": "ok",
|
| 1496 |
+
"best_affinity": -7.315,
|
| 1497 |
+
"qc_pass": true,
|
| 1498 |
+
"flags": [],
|
| 1499 |
+
"pdb_id": "3HS4",
|
| 1500 |
+
"review_class": "A_pass"
|
| 1501 |
+
},
|
| 1502 |
+
{
|
| 1503 |
+
"drug_id": 218,
|
| 1504 |
+
"canonical_name": "Torsemide",
|
| 1505 |
+
"index_key": "TORSEMIDE_SLC12A_PROXY",
|
| 1506 |
+
"tier": "2",
|
| 1507 |
+
"pdb_id_catalog": "3HS4",
|
| 1508 |
+
"het_id_catalog": "AZM",
|
| 1509 |
+
"source": "moltgate_ui",
|
| 1510 |
+
"session_id": "cfd352402a4486ca",
|
| 1511 |
+
"run_status": "ok",
|
| 1512 |
+
"best_affinity": -6.888,
|
| 1513 |
+
"qc_pass": true,
|
| 1514 |
+
"flags": [],
|
| 1515 |
+
"pdb_id": "3HS4",
|
| 1516 |
+
"review_class": "A_pass"
|
| 1517 |
+
},
|
| 1518 |
+
{
|
| 1519 |
+
"drug_id": 219,
|
| 1520 |
+
"canonical_name": "Metoclopramide",
|
| 1521 |
+
"index_key": "METOCLOPRAMIDE_DRD2_PROXY",
|
| 1522 |
+
"tier": "2",
|
| 1523 |
+
"pdb_id_catalog": "6CM4",
|
| 1524 |
+
"het_id_catalog": "8NU",
|
| 1525 |
+
"source": "moltgate_ui",
|
| 1526 |
+
"session_id": "01ef7d190d9c76dc",
|
| 1527 |
+
"run_status": "ok",
|
| 1528 |
+
"best_affinity": -7.97,
|
| 1529 |
+
"qc_pass": true,
|
| 1530 |
+
"flags": [
|
| 1531 |
+
"OUT_OF_POCKET_MINOR: 3/9 poses outside"
|
| 1532 |
+
],
|
| 1533 |
+
"pdb_id": "6CM4",
|
| 1534 |
+
"review_class": "A_pass"
|
| 1535 |
+
},
|
| 1536 |
+
{
|
| 1537 |
+
"drug_id": 220,
|
| 1538 |
+
"canonical_name": "Dulaglutide",
|
| 1539 |
+
"index_key": "DULAGLUTIDE_GLP1R",
|
| 1540 |
+
"tier": "2",
|
| 1541 |
+
"pdb_id_catalog": "6X18",
|
| 1542 |
+
"het_id_catalog": "SEM",
|
| 1543 |
+
"source": "moltgate_ui",
|
| 1544 |
+
"session_id": "41fcdb06ce97084b",
|
| 1545 |
+
"run_status": "fail",
|
| 1546 |
+
"best_affinity": null,
|
| 1547 |
+
"qc_pass": null,
|
| 1548 |
+
"flags": [],
|
| 1549 |
+
"pdb_id": null,
|
| 1550 |
+
"fail_reason": "Stage 21 無候選配體,無法確認配體身份",
|
| 1551 |
+
"review_class": "A_pipeline_fail"
|
| 1552 |
+
},
|
| 1553 |
+
{
|
| 1554 |
+
"drug_id": 221,
|
| 1555 |
+
"canonical_name": "Diazepam",
|
| 1556 |
+
"index_key": "DIAZEPAM_GABA_A",
|
| 1557 |
+
"tier": "2",
|
| 1558 |
+
"pdb_id_catalog": "4OWE",
|
| 1559 |
+
"het_id_catalog": "ALP",
|
| 1560 |
+
"source": "moltgate_ui",
|
| 1561 |
+
"session_id": "833be365702597aa",
|
| 1562 |
+
"run_status": "fail",
|
| 1563 |
+
"best_affinity": null,
|
| 1564 |
+
"qc_pass": null,
|
| 1565 |
+
"flags": [],
|
| 1566 |
+
"pdb_id": null,
|
| 1567 |
+
"fail_reason": "Stage 21 無候選配體,無法確認配體身份",
|
| 1568 |
+
"review_class": "A_pipeline_fail"
|
| 1569 |
+
},
|
| 1570 |
+
{
|
| 1571 |
+
"drug_id": 222,
|
| 1572 |
+
"canonical_name": "Baclofen",
|
| 1573 |
+
"index_key": "BACLOFEN_GABA_B",
|
| 1574 |
+
"tier": "1",
|
| 1575 |
+
"pdb_id_catalog": "4WNC",
|
| 1576 |
+
"het_id_catalog": "BAC",
|
| 1577 |
+
"source": "moltgate_ui",
|
| 1578 |
+
"session_id": "2f059f57261812c4",
|
| 1579 |
+
"run_status": "ok",
|
| 1580 |
+
"best_affinity": -5.915,
|
| 1581 |
+
"qc_pass": false,
|
| 1582 |
+
"flags": [
|
| 1583 |
+
"SCORE_WEAK: best pose -5.915 kcal/mol > 閾值 -6.0",
|
| 1584 |
+
"OUT_OF_POCKET_MAJORITY"
|
| 1585 |
+
],
|
| 1586 |
+
"pdb_id": "4WNC",
|
| 1587 |
+
"review_class": "B_qc_fail"
|
| 1588 |
+
},
|
| 1589 |
+
{
|
| 1590 |
+
"drug_id": 223,
|
| 1591 |
+
"canonical_name": "Tizanidine",
|
| 1592 |
+
"index_key": "TIZANIDINE_ADRA2A_PROXY",
|
| 1593 |
+
"tier": "2",
|
| 1594 |
+
"pdb_id_catalog": "6KUX",
|
| 1595 |
+
"het_id_catalog": "TIZ",
|
| 1596 |
+
"source": "moltgate_ui",
|
| 1597 |
+
"session_id": "eeecf39eb8681da9",
|
| 1598 |
+
"run_status": "ok",
|
| 1599 |
+
"best_affinity": -8.891,
|
| 1600 |
+
"qc_pass": true,
|
| 1601 |
+
"flags": [],
|
| 1602 |
+
"pdb_id": "6KUX",
|
| 1603 |
+
"review_class": "A_pass"
|
| 1604 |
+
},
|
| 1605 |
+
{
|
| 1606 |
+
"drug_id": 224,
|
| 1607 |
+
"canonical_name": "Azathioprine",
|
| 1608 |
+
"index_key": "AZATHIOPRINE_TPMT",
|
| 1609 |
+
"tier": "1",
|
| 1610 |
+
"pdb_id_catalog": "2H11",
|
| 1611 |
+
"het_id_catalog": "AZA",
|
| 1612 |
+
"source": "moltgate_ui",
|
| 1613 |
+
"session_id": "792c9c133cc93d44",
|
| 1614 |
+
"run_status": "ok",
|
| 1615 |
+
"best_affinity": -7.775,
|
| 1616 |
+
"qc_pass": true,
|
| 1617 |
+
"flags": [],
|
| 1618 |
+
"pdb_id": "2H11",
|
| 1619 |
+
"review_class": "A_pass"
|
| 1620 |
+
},
|
| 1621 |
+
{
|
| 1622 |
+
"drug_id": 225,
|
| 1623 |
+
"canonical_name": "Penicillin G",
|
| 1624 |
+
"index_key": "PENICILLIN_G_PBP",
|
| 1625 |
+
"tier": "1",
|
| 1626 |
+
"pdb_id_catalog": "1PWP",
|
| 1627 |
+
"het_id_catalog": "PG2",
|
| 1628 |
+
"source": "moltgate_ui",
|
| 1629 |
+
"session_id": "1f6778c2b6768b53",
|
| 1630 |
+
"run_status": "ok",
|
| 1631 |
+
"best_affinity": -6.676,
|
| 1632 |
+
"qc_pass": true,
|
| 1633 |
+
"flags": [
|
| 1634 |
+
"OUT_OF_POCKET_MINOR: 4/9 poses outside"
|
| 1635 |
+
],
|
| 1636 |
+
"pdb_id": "1PWP",
|
| 1637 |
+
"review_class": "A_pass"
|
| 1638 |
+
},
|
| 1639 |
+
{
|
| 1640 |
+
"drug_id": 226,
|
| 1641 |
+
"canonical_name": "Ampicillin",
|
| 1642 |
+
"index_key": "AMPICILLIN_PBP_PROXY",
|
| 1643 |
+
"tier": "2",
|
| 1644 |
+
"pdb_id_catalog": "1PWP",
|
| 1645 |
+
"het_id_catalog": "PG2",
|
| 1646 |
+
"source": "moltgate_ui",
|
| 1647 |
+
"session_id": "b5f89e224fe1a675",
|
| 1648 |
+
"run_status": "ok",
|
| 1649 |
+
"best_affinity": -7.221,
|
| 1650 |
+
"qc_pass": true,
|
| 1651 |
+
"flags": [
|
| 1652 |
+
"OUT_OF_POCKET_MINOR: 2/9 poses outside"
|
| 1653 |
+
],
|
| 1654 |
+
"pdb_id": "1PWP",
|
| 1655 |
+
"review_class": "A_pass"
|
| 1656 |
+
},
|
| 1657 |
+
{
|
| 1658 |
+
"drug_id": 227,
|
| 1659 |
+
"canonical_name": "Posaconazole",
|
| 1660 |
+
"index_key": "POSACONAZOLE_CYP51",
|
| 1661 |
+
"tier": "2",
|
| 1662 |
+
"pdb_id_catalog": "5VZA",
|
| 1663 |
+
"het_id_catalog": "POS",
|
| 1664 |
+
"source": "moltgate_ui",
|
| 1665 |
+
"session_id": "baf146a76de3b9e7",
|
| 1666 |
+
"run_status": "ok",
|
| 1667 |
+
"best_affinity": -7.185,
|
| 1668 |
+
"qc_pass": true,
|
| 1669 |
+
"flags": [],
|
| 1670 |
+
"pdb_id": "5VZA",
|
| 1671 |
+
"review_class": "A_pass"
|
| 1672 |
+
},
|
| 1673 |
+
{
|
| 1674 |
+
"drug_id": 228,
|
| 1675 |
+
"canonical_name": "Acyclovir",
|
| 1676 |
+
"index_key": "ACYCLOVIR_DNA_POL",
|
| 1677 |
+
"tier": "1",
|
| 1678 |
+
"pdb_id_catalog": "2GV9",
|
| 1679 |
+
"het_id_catalog": "ACV",
|
| 1680 |
+
"source": "moltgate_ui",
|
| 1681 |
+
"session_id": "6a3f1e2bd26f0c97",
|
| 1682 |
+
"run_status": "fail",
|
| 1683 |
+
"best_affinity": null,
|
| 1684 |
+
"qc_pass": null,
|
| 1685 |
+
"flags": [],
|
| 1686 |
+
"pdb_id": null,
|
| 1687 |
+
"fail_reason": "Stage 21 無候選配體,無法確認配體身份",
|
| 1688 |
+
"review_class": "A_pipeline_fail"
|
| 1689 |
+
},
|
| 1690 |
+
{
|
| 1691 |
+
"drug_id": 229,
|
| 1692 |
+
"canonical_name": "Levocetirizine",
|
| 1693 |
+
"index_key": "LEVOCETIRIZINE_HRH1",
|
| 1694 |
+
"tier": "1",
|
| 1695 |
+
"pdb_id_catalog": "3RZE",
|
| 1696 |
+
"het_id_catalog": "CET",
|
| 1697 |
+
"source": "moltgate_ui",
|
| 1698 |
+
"session_id": "de6c2abe2485c017",
|
| 1699 |
+
"run_status": "ok",
|
| 1700 |
+
"best_affinity": -9.881,
|
| 1701 |
+
"qc_pass": false,
|
| 1702 |
+
"flags": [
|
| 1703 |
+
"OUT_OF_POCKET_MAJORITY"
|
| 1704 |
+
],
|
| 1705 |
+
"pdb_id": "3RZE",
|
| 1706 |
+
"review_class": "B_qc_fail"
|
| 1707 |
+
},
|
| 1708 |
+
{
|
| 1709 |
+
"drug_id": 230,
|
| 1710 |
+
"canonical_name": "Methylprednisolone",
|
| 1711 |
+
"index_key": "METHYLPREDNISOLONE_NR3C1_PROXY",
|
| 1712 |
+
"tier": "2",
|
| 1713 |
+
"pdb_id_catalog": "1M2Z",
|
| 1714 |
+
"het_id_catalog": "DEX",
|
| 1715 |
+
"source": "moltgate_ui",
|
| 1716 |
+
"session_id": "fae5ff81a5fdcac5",
|
| 1717 |
+
"run_status": "ok",
|
| 1718 |
+
"best_affinity": -9.815,
|
| 1719 |
+
"qc_pass": false,
|
| 1720 |
+
"flags": [
|
| 1721 |
+
"OUT_OF_POCKET_MAJORITY"
|
| 1722 |
+
],
|
| 1723 |
+
"pdb_id": "1M2Z",
|
| 1724 |
+
"review_class": "B_qc_fail"
|
| 1725 |
+
},
|
| 1726 |
+
{
|
| 1727 |
+
"drug_id": 231,
|
| 1728 |
+
"canonical_name": "Sirolimus",
|
| 1729 |
+
"index_key": "SIROLIMUS_MTOR",
|
| 1730 |
+
"tier": "1",
|
| 1731 |
+
"pdb_id_catalog": "4JSN",
|
| 1732 |
+
"het_id_catalog": "RAP",
|
| 1733 |
+
"source": "moltgate_ui",
|
| 1734 |
+
"session_id": "dc8e109976c1c8e8",
|
| 1735 |
+
"run_status": "ok",
|
| 1736 |
+
"best_affinity": -5.958,
|
| 1737 |
+
"qc_pass": false,
|
| 1738 |
+
"flags": [
|
| 1739 |
+
"SCORE_WEAK: best pose -5.958 kcal/mol > 閾值 -6.0",
|
| 1740 |
+
"OUT_OF_POCKET_MAJORITY"
|
| 1741 |
+
],
|
| 1742 |
+
"pdb_id": "4JT6",
|
| 1743 |
+
"review_class": "B_qc_fail"
|
| 1744 |
+
},
|
| 1745 |
+
{
|
| 1746 |
+
"drug_id": 232,
|
| 1747 |
+
"canonical_name": "Temsirolimus",
|
| 1748 |
+
"index_key": "TEMSIROLIMUS_MTOR_PROXY",
|
| 1749 |
+
"tier": "2",
|
| 1750 |
+
"pdb_id_catalog": "4JT6",
|
| 1751 |
+
"het_id_catalog": "EVL",
|
| 1752 |
+
"source": "moltgate_ui",
|
| 1753 |
+
"session_id": "27d29ae4fa03abdf",
|
| 1754 |
+
"run_status": "ok",
|
| 1755 |
+
"best_affinity": -5.894,
|
| 1756 |
+
"qc_pass": false,
|
| 1757 |
+
"flags": [
|
| 1758 |
+
"SCORE_WEAK: best pose -5.894 kcal/mol > 閾值 -6.0",
|
| 1759 |
+
"OUT_OF_POCKET_MAJORITY"
|
| 1760 |
+
],
|
| 1761 |
+
"pdb_id": "4JT6",
|
| 1762 |
+
"review_class": "B_qc_fail"
|
| 1763 |
+
},
|
| 1764 |
+
{
|
| 1765 |
+
"drug_id": 233,
|
| 1766 |
+
"canonical_name": "Gilteritinib",
|
| 1767 |
+
"index_key": "GILTERITINIB_FLT3",
|
| 1768 |
+
"tier": "1",
|
| 1769 |
+
"pdb_id_catalog": "4RK8",
|
| 1770 |
+
"het_id_catalog": "GIL",
|
| 1771 |
+
"source": "moltgate_ui",
|
| 1772 |
+
"session_id": "de3298d15b5883ec",
|
| 1773 |
+
"run_status": "ok",
|
| 1774 |
+
"best_affinity": -11.15,
|
| 1775 |
+
"qc_pass": true,
|
| 1776 |
+
"flags": [
|
| 1777 |
+
"OUT_OF_POCKET_MINOR: 1/9 poses outside"
|
| 1778 |
+
],
|
| 1779 |
+
"pdb_id": "4RK8",
|
| 1780 |
+
"review_class": "A_pass"
|
| 1781 |
+
},
|
| 1782 |
+
{
|
| 1783 |
+
"drug_id": 234,
|
| 1784 |
+
"canonical_name": "Ivosidenib",
|
| 1785 |
+
"index_key": "IVOSIDENIB_IDH1",
|
| 1786 |
+
"tier": "1",
|
| 1787 |
+
"pdb_id_catalog": "6VAM",
|
| 1788 |
+
"het_id_catalog": "IVO",
|
| 1789 |
+
"source": "moltgate_ui",
|
| 1790 |
+
"session_id": "8636e9fc14b99875",
|
| 1791 |
+
"run_status": "fail",
|
| 1792 |
+
"best_affinity": null,
|
| 1793 |
+
"qc_pass": null,
|
| 1794 |
+
"flags": [],
|
| 1795 |
+
"pdb_id": null,
|
| 1796 |
+
"fail_reason": "Stage 21 無候選配體,無法確認配體身份",
|
| 1797 |
+
"review_class": "A_pipeline_fail"
|
| 1798 |
+
},
|
| 1799 |
+
{
|
| 1800 |
+
"drug_id": 235,
|
| 1801 |
+
"canonical_name": "Enasidenib",
|
| 1802 |
+
"index_key": "ENASIDENIB_IDH2",
|
| 1803 |
+
"tier": "1",
|
| 1804 |
+
"pdb_id_catalog": "5I96",
|
| 1805 |
+
"het_id_catalog": "ENA",
|
| 1806 |
+
"source": "moltgate_ui",
|
| 1807 |
+
"session_id": "e1789ef0f9f07898",
|
| 1808 |
+
"run_status": "ok",
|
| 1809 |
+
"best_affinity": -7.399,
|
| 1810 |
+
"qc_pass": false,
|
| 1811 |
+
"flags": [
|
| 1812 |
+
"OUT_OF_POCKET_MAJORITY"
|
| 1813 |
+
],
|
| 1814 |
+
"pdb_id": "5I96",
|
| 1815 |
+
"review_class": "B_qc_fail"
|
| 1816 |
+
},
|
| 1817 |
+
{
|
| 1818 |
+
"drug_id": 236,
|
| 1819 |
+
"canonical_name": "Ivacaftor",
|
| 1820 |
+
"index_key": "IVACAFTOR_CFTR",
|
| 1821 |
+
"tier": "1",
|
| 1822 |
+
"pdb_id_catalog": "6MSM",
|
| 1823 |
+
"het_id_catalog": "IVA",
|
| 1824 |
+
"source": "moltgate_ui",
|
| 1825 |
+
"session_id": "36bcbcdf130cff77",
|
| 1826 |
+
"run_status": "ok",
|
| 1827 |
+
"best_affinity": -9.756,
|
| 1828 |
+
"qc_pass": true,
|
| 1829 |
+
"flags": [],
|
| 1830 |
+
"pdb_id": "6MSM",
|
| 1831 |
+
"review_class": "A_pass"
|
| 1832 |
+
},
|
| 1833 |
+
{
|
| 1834 |
+
"drug_id": 237,
|
| 1835 |
+
"canonical_name": "Fruquintinib",
|
| 1836 |
+
"index_key": "FRUQUINTINIB_VEGFR",
|
| 1837 |
+
"tier": "1",
|
| 1838 |
+
"pdb_id_catalog": "4NE3",
|
| 1839 |
+
"het_id_catalog": "FRU",
|
| 1840 |
+
"source": "moltgate_ui",
|
| 1841 |
+
"session_id": "4ea0386b2b882be4",
|
| 1842 |
+
"run_status": "ok",
|
| 1843 |
+
"best_affinity": -11.18,
|
| 1844 |
+
"qc_pass": true,
|
| 1845 |
+
"flags": [
|
| 1846 |
+
"OUT_OF_POCKET_MINOR: 4/9 poses outside"
|
| 1847 |
+
],
|
| 1848 |
+
"pdb_id": "4ASD",
|
| 1849 |
+
"review_class": "A_pass"
|
| 1850 |
+
},
|
| 1851 |
+
{
|
| 1852 |
+
"drug_id": 238,
|
| 1853 |
+
"canonical_name": "Apatinib",
|
| 1854 |
+
"index_key": "APATINIB_VEGFR2",
|
| 1855 |
+
"tier": "1",
|
| 1856 |
+
"pdb_id_catalog": "5HI3",
|
| 1857 |
+
"het_id_catalog": "APA",
|
| 1858 |
+
"source": "moltgate_ui",
|
| 1859 |
+
"session_id": "58861ec5dfb61c5a",
|
| 1860 |
+
"run_status": "ok",
|
| 1861 |
+
"best_affinity": -10.24,
|
| 1862 |
+
"qc_pass": true,
|
| 1863 |
+
"flags": [
|
| 1864 |
+
"OUT_OF_POCKET_MINOR: 1/9 poses outside"
|
| 1865 |
+
],
|
| 1866 |
+
"pdb_id": "5HI3",
|
| 1867 |
+
"review_class": "A_pass"
|
| 1868 |
+
},
|
| 1869 |
+
{
|
| 1870 |
+
"drug_id": 239,
|
| 1871 |
+
"canonical_name": "Midazolam",
|
| 1872 |
+
"index_key": "MIDAZOLAM_CYP3A4",
|
| 1873 |
+
"tier": "1",
|
| 1874 |
+
"pdb_id_catalog": "4K9T",
|
| 1875 |
+
"het_id_catalog": "MID",
|
| 1876 |
+
"source": "moltgate_ui",
|
| 1877 |
+
"session_id": "0a8acb0863b3179a",
|
| 1878 |
+
"run_status": "ok",
|
| 1879 |
+
"best_affinity": -8.778,
|
| 1880 |
+
"qc_pass": true,
|
| 1881 |
+
"flags": [],
|
| 1882 |
+
"pdb_id": "4K9T",
|
| 1883 |
+
"review_class": "A_pass"
|
| 1884 |
+
},
|
| 1885 |
+
{
|
| 1886 |
+
"drug_id": 240,
|
| 1887 |
+
"canonical_name": "Nitroglycerin",
|
| 1888 |
+
"index_key": "NITROGLYCERIN_NOS_PROXY",
|
| 1889 |
+
"tier": "2",
|
| 1890 |
+
"pdb_id_catalog": "1M9C",
|
| 1891 |
+
"het_id_catalog": "NGN",
|
| 1892 |
+
"source": "moltgate_ui",
|
| 1893 |
+
"session_id": "1913832484865c7f",
|
| 1894 |
+
"run_status": "fail",
|
| 1895 |
+
"best_affinity": null,
|
| 1896 |
+
"qc_pass": null,
|
| 1897 |
+
"flags": [],
|
| 1898 |
+
"pdb_id": null,
|
| 1899 |
+
"fail_reason": "Stage 21 無候選配體,無法確認配體身份",
|
| 1900 |
+
"review_class": "A_pipeline_fail"
|
| 1901 |
+
},
|
| 1902 |
+
{
|
| 1903 |
+
"drug_id": 241,
|
| 1904 |
+
"canonical_name": "Liraglutide",
|
| 1905 |
+
"index_key": "LIRAGLUTIDE_GLP1R_PROXY",
|
| 1906 |
+
"tier": "2",
|
| 1907 |
+
"pdb_id_catalog": "6X18",
|
| 1908 |
+
"het_id_catalog": "SEM",
|
| 1909 |
+
"source": "moltgate_ui",
|
| 1910 |
+
"session_id": "504d64721ffb03e0",
|
| 1911 |
+
"run_status": "fail",
|
| 1912 |
+
"best_affinity": null,
|
| 1913 |
+
"qc_pass": null,
|
| 1914 |
+
"flags": [],
|
| 1915 |
+
"pdb_id": null,
|
| 1916 |
+
"fail_reason": "Stage 21 無候選配體,無法確認配體身份",
|
| 1917 |
+
"review_class": "A_pipeline_fail"
|
| 1918 |
+
},
|
| 1919 |
+
{
|
| 1920 |
+
"drug_id": 242,
|
| 1921 |
+
"canonical_name": "Clofibrate",
|
| 1922 |
+
"index_key": "CLOFIBRATE_PPARalpha_PROXY",
|
| 1923 |
+
"tier": "2",
|
| 1924 |
+
"pdb_id_catalog": "1K74",
|
| 1925 |
+
"het_id_catalog": "544",
|
| 1926 |
+
"source": "moltgate_ui",
|
| 1927 |
+
"session_id": "a25d1496913fdf3c",
|
| 1928 |
+
"run_status": "ok",
|
| 1929 |
+
"best_affinity": -7.882,
|
| 1930 |
+
"qc_pass": true,
|
| 1931 |
+
"flags": [
|
| 1932 |
+
"OUT_OF_POCKET_MINOR: 1/9 poses outside"
|
| 1933 |
+
],
|
| 1934 |
+
"pdb_id": "1K74",
|
| 1935 |
+
"review_class": "A_pass"
|
| 1936 |
+
},
|
| 1937 |
+
{
|
| 1938 |
+
"drug_id": 243,
|
| 1939 |
+
"canonical_name": "Nicotine",
|
| 1940 |
+
"index_key": "NICOTINE_NACHR",
|
| 1941 |
+
"tier": "1",
|
| 1942 |
+
"pdb_id_catalog": "4EY7",
|
| 1943 |
+
"het_id_catalog": "NIC",
|
| 1944 |
+
"source": "moltgate_ui",
|
| 1945 |
+
"session_id": "1dee60469ae23573",
|
| 1946 |
+
"run_status": "ok",
|
| 1947 |
+
"best_affinity": -6.794,
|
| 1948 |
+
"qc_pass": true,
|
| 1949 |
+
"flags": [],
|
| 1950 |
+
"pdb_id": "4EY7",
|
| 1951 |
+
"review_class": "A_pass"
|
| 1952 |
+
},
|
| 1953 |
+
{
|
| 1954 |
+
"drug_id": 244,
|
| 1955 |
+
"canonical_name": "Gliclazide",
|
| 1956 |
+
"index_key": "GLICLAZIDE_KATP_PROXY",
|
| 1957 |
+
"tier": "2",
|
| 1958 |
+
"pdb_id_catalog": "3SYQ",
|
| 1959 |
+
"het_id_catalog": "GBL",
|
| 1960 |
+
"source": "moltgate_ui",
|
| 1961 |
+
"session_id": "89dc10b18ac0a169",
|
| 1962 |
+
"run_status": "ok",
|
| 1963 |
+
"best_affinity": -4.844,
|
| 1964 |
+
"qc_pass": false,
|
| 1965 |
+
"flags": [
|
| 1966 |
+
"SCORE_WEAK: best pose -4.844 kcal/mol > 閾值 -6.0",
|
| 1967 |
+
"OUT_OF_POCKET_MINOR: 1/9 poses outside"
|
| 1968 |
+
],
|
| 1969 |
+
"pdb_id": "3SYQ",
|
| 1970 |
+
"review_class": "B_qc_fail"
|
| 1971 |
+
},
|
| 1972 |
+
{
|
| 1973 |
+
"drug_id": 245,
|
| 1974 |
+
"canonical_name": "Domperidone",
|
| 1975 |
+
"index_key": "DOMPERIDONE_DRD2_PROXY",
|
| 1976 |
+
"tier": "2",
|
| 1977 |
+
"pdb_id_catalog": "6CM4",
|
| 1978 |
+
"het_id_catalog": "8NU",
|
| 1979 |
+
"source": "moltgate_ui",
|
| 1980 |
+
"session_id": "dba3e8510cc5eb0b",
|
| 1981 |
+
"run_status": "ok",
|
| 1982 |
+
"best_affinity": -8.566,
|
| 1983 |
+
"qc_pass": true,
|
| 1984 |
+
"flags": [],
|
| 1985 |
+
"pdb_id": "6CM4",
|
| 1986 |
+
"review_class": "A_pass"
|
| 1987 |
+
},
|
| 1988 |
+
{
|
| 1989 |
+
"drug_id": 246,
|
| 1990 |
+
"canonical_name": "Lithium",
|
| 1991 |
+
"index_key": "LITHIUM_IMPASE_PROXY",
|
| 1992 |
+
"tier": "2",
|
| 1993 |
+
"pdb_id_catalog": "1W7O",
|
| 1994 |
+
"het_id_catalog": "LIT",
|
| 1995 |
+
"source": "moltgate_ui",
|
| 1996 |
+
"session_id": "09fe2fd97e616548",
|
| 1997 |
+
"run_status": "fail",
|
| 1998 |
+
"best_affinity": null,
|
| 1999 |
+
"qc_pass": null,
|
| 2000 |
+
"flags": [],
|
| 2001 |
+
"pdb_id": null,
|
| 2002 |
+
"review_class": "A_pipeline_fail"
|
| 2003 |
+
},
|
| 2004 |
+
{
|
| 2005 |
+
"drug_id": 247,
|
| 2006 |
+
"canonical_name": "Sulfasalazine",
|
| 2007 |
+
"index_key": "SULFASALAZINE_DHFR_PROXY",
|
| 2008 |
+
"tier": "2",
|
| 2009 |
+
"pdb_id_catalog": "2W9G",
|
| 2010 |
+
"het_id_catalog": "TMP",
|
| 2011 |
+
"source": "moltgate_ui",
|
| 2012 |
+
"session_id": "0fafb4192b85f101",
|
| 2013 |
+
"run_status": "ok",
|
| 2014 |
+
"best_affinity": -9.214,
|
| 2015 |
+
"qc_pass": true,
|
| 2016 |
+
"flags": [],
|
| 2017 |
+
"pdb_id": "2W9G",
|
| 2018 |
+
"review_class": "A_pass"
|
| 2019 |
+
},
|
| 2020 |
+
{
|
| 2021 |
+
"drug_id": 248,
|
| 2022 |
+
"canonical_name": "Mesalamine",
|
| 2023 |
+
"index_key": "MESALAMINE_COX2_PROXY",
|
| 2024 |
+
"tier": "2",
|
| 2025 |
+
"pdb_id_catalog": "5IKT",
|
| 2026 |
+
"het_id_catalog": "TLF",
|
| 2027 |
+
"source": "moltgate_ui",
|
| 2028 |
+
"session_id": "f11a959b5ab4edd1",
|
| 2029 |
+
"run_status": "ok",
|
| 2030 |
+
"best_affinity": -6.233,
|
| 2031 |
+
"qc_pass": false,
|
| 2032 |
+
"flags": [
|
| 2033 |
+
"OUT_OF_POCKET_MAJORITY"
|
| 2034 |
+
],
|
| 2035 |
+
"pdb_id": "5IKT",
|
| 2036 |
+
"review_class": "B_qc_fail"
|
| 2037 |
+
},
|
| 2038 |
+
{
|
| 2039 |
+
"drug_id": 249,
|
| 2040 |
+
"canonical_name": "Ursodeoxycholic acid",
|
| 2041 |
+
"index_key": "URSODIOL_FXR",
|
| 2042 |
+
"tier": "1",
|
| 2043 |
+
"pdb_id_catalog": "3OLF",
|
| 2044 |
+
"het_id_catalog": "UDC",
|
| 2045 |
+
"source": "moltgate_ui",
|
| 2046 |
+
"session_id": "143903f265aadfd5",
|
| 2047 |
+
"run_status": "ok",
|
| 2048 |
+
"best_affinity": -8.659,
|
| 2049 |
+
"qc_pass": false,
|
| 2050 |
+
"flags": [
|
| 2051 |
+
"OUT_OF_POCKET_MAJORITY"
|
| 2052 |
+
],
|
| 2053 |
+
"pdb_id": "3OLF",
|
| 2054 |
+
"review_class": "B_qc_fail"
|
| 2055 |
+
},
|
| 2056 |
+
{
|
| 2057 |
+
"drug_id": 250,
|
| 2058 |
+
"canonical_name": "Minoxidil",
|
| 2059 |
+
"index_key": "MINOXIDIL_KATP_PROXY",
|
| 2060 |
+
"tier": "2",
|
| 2061 |
+
"pdb_id_catalog": "3SYQ",
|
| 2062 |
+
"het_id_catalog": "GBL",
|
| 2063 |
+
"source": "moltgate_ui",
|
| 2064 |
+
"session_id": "efb0c36c9b214b88",
|
| 2065 |
+
"run_status": "ok",
|
| 2066 |
+
"best_affinity": -4.934,
|
| 2067 |
+
"qc_pass": false,
|
| 2068 |
+
"flags": [
|
| 2069 |
+
"SCORE_WEAK: best pose -4.934 kcal/mol > 閾值 -6.0",
|
| 2070 |
+
"OUT_OF_POCKET_MAJORITY"
|
| 2071 |
+
],
|
| 2072 |
+
"pdb_id": "3SYQ",
|
| 2073 |
+
"review_class": "B_qc_fail"
|
| 2074 |
+
},
|
| 2075 |
+
{
|
| 2076 |
+
"drug_id": 251,
|
| 2077 |
+
"canonical_name": "Etodolac",
|
| 2078 |
+
"index_key": "ETODOLAC_COX2_PROXY",
|
| 2079 |
+
"tier": "2",
|
| 2080 |
+
"pdb_id_catalog": "5IKR",
|
| 2081 |
+
"het_id_catalog": "ID8",
|
| 2082 |
+
"source": "moltgate_ui",
|
| 2083 |
+
"session_id": "c5e1048797eaa84f",
|
| 2084 |
+
"run_status": "ok",
|
| 2085 |
+
"best_affinity": -6.645,
|
| 2086 |
+
"qc_pass": true,
|
| 2087 |
+
"flags": [],
|
| 2088 |
+
"pdb_id": "5IKR",
|
| 2089 |
+
"review_class": "A_pass"
|
| 2090 |
+
},
|
| 2091 |
+
{
|
| 2092 |
+
"drug_id": 252,
|
| 2093 |
+
"canonical_name": "Itraconazole",
|
| 2094 |
+
"index_key": "ITRACONAZOLE_CYP51_PROXY",
|
| 2095 |
+
"tier": "2",
|
| 2096 |
+
"pdb_id_catalog": "5VZA",
|
| 2097 |
+
"het_id_catalog": "KET",
|
| 2098 |
+
"source": "moltgate_ui",
|
| 2099 |
+
"session_id": "37245961959c1916",
|
| 2100 |
+
"run_status": "ok",
|
| 2101 |
+
"best_affinity": -7.163,
|
| 2102 |
+
"qc_pass": true,
|
| 2103 |
+
"flags": [],
|
| 2104 |
+
"pdb_id": "5VZA",
|
| 2105 |
+
"review_class": "A_pass"
|
| 2106 |
+
},
|
| 2107 |
+
{
|
| 2108 |
+
"drug_id": 253,
|
| 2109 |
+
"canonical_name": "Ganciclovir",
|
| 2110 |
+
"index_key": "GANCICLOVIR_DNA_POL_PROXY",
|
| 2111 |
+
"tier": "2",
|
| 2112 |
+
"pdb_id_catalog": "2GV9",
|
| 2113 |
+
"het_id_catalog": "ACV",
|
| 2114 |
+
"source": "moltgate_ui",
|
| 2115 |
+
"session_id": "e86dcebd277f3e07",
|
| 2116 |
+
"run_status": "fail",
|
| 2117 |
+
"best_affinity": null,
|
| 2118 |
+
"qc_pass": null,
|
| 2119 |
+
"flags": [],
|
| 2120 |
+
"pdb_id": null,
|
| 2121 |
+
"fail_reason": "Stage 21 無候選配體,無法確認配體身份",
|
| 2122 |
+
"review_class": "A_pipeline_fail"
|
| 2123 |
+
},
|
| 2124 |
+
{
|
| 2125 |
+
"drug_id": 254,
|
| 2126 |
+
"canonical_name": "Remdesivir",
|
| 2127 |
+
"index_key": "REMDESIVIR_RDRP",
|
| 2128 |
+
"tier": "1",
|
| 2129 |
+
"pdb_id_catalog": "7BV2",
|
| 2130 |
+
"het_id_catalog": "REM",
|
| 2131 |
+
"source": "moltgate_ui",
|
| 2132 |
+
"session_id": "2c0cd82e73413bff",
|
| 2133 |
+
"run_status": "ok",
|
| 2134 |
+
"best_affinity": -7.193,
|
| 2135 |
+
"qc_pass": true,
|
| 2136 |
+
"flags": [
|
| 2137 |
+
"OUT_OF_POCKET_MINOR: 1/9 poses outside"
|
| 2138 |
+
],
|
| 2139 |
+
"pdb_id": "7BV2",
|
| 2140 |
+
"review_class": "A_pass"
|
| 2141 |
+
},
|
| 2142 |
+
{
|
| 2143 |
+
"drug_id": 255,
|
| 2144 |
+
"canonical_name": "Sofosbuvir",
|
| 2145 |
+
"index_key": "SOFOSBUVIR_NS5B",
|
| 2146 |
+
"tier": "1",
|
| 2147 |
+
"pdb_id_catalog": "4RXA",
|
| 2148 |
+
"het_id_catalog": "SOF",
|
| 2149 |
+
"source": "moltgate_ui",
|
| 2150 |
+
"session_id": "15b6aa5612103331",
|
| 2151 |
+
"run_status": "ok",
|
| 2152 |
+
"best_affinity": -7.661,
|
| 2153 |
+
"qc_pass": true,
|
| 2154 |
+
"flags": [],
|
| 2155 |
+
"pdb_id": "4RXA",
|
| 2156 |
+
"review_class": "A_pass"
|
| 2157 |
+
},
|
| 2158 |
+
{
|
| 2159 |
+
"drug_id": 256,
|
| 2160 |
+
"canonical_name": "Ribavirin",
|
| 2161 |
+
"index_key": "RIBAVIRIN_RDRP",
|
| 2162 |
+
"tier": "1",
|
| 2163 |
+
"pdb_id_catalog": "3HHZ",
|
| 2164 |
+
"het_id_catalog": "RIB",
|
| 2165 |
+
"source": "moltgate_ui",
|
| 2166 |
+
"session_id": "d6f47182d567bf81",
|
| 2167 |
+
"run_status": "ok",
|
| 2168 |
+
"best_affinity": -6.286,
|
| 2169 |
+
"qc_pass": false,
|
| 2170 |
+
"flags": [
|
| 2171 |
+
"OUT_OF_POCKET_MAJORITY"
|
| 2172 |
+
],
|
| 2173 |
+
"pdb_id": "7BV2",
|
| 2174 |
+
"review_class": "B_qc_fail"
|
| 2175 |
+
},
|
| 2176 |
+
{
|
| 2177 |
+
"drug_id": 257,
|
| 2178 |
+
"canonical_name": "Diphenhydramine",
|
| 2179 |
+
"index_key": "DIPHENHYDRAMINE_HRH1_PROXY",
|
| 2180 |
+
"tier": "2",
|
| 2181 |
+
"pdb_id_catalog": "3RZE",
|
| 2182 |
+
"het_id_catalog": "CET",
|
| 2183 |
+
"source": "moltgate_ui",
|
| 2184 |
+
"session_id": "2355fa00ecfea6e4",
|
| 2185 |
+
"run_status": "ok",
|
| 2186 |
+
"best_affinity": -9.328,
|
| 2187 |
+
"qc_pass": false,
|
| 2188 |
+
"flags": [
|
| 2189 |
+
"OUT_OF_POCKET_MAJORITY"
|
| 2190 |
+
],
|
| 2191 |
+
"pdb_id": "3RZE",
|
| 2192 |
+
"review_class": "B_qc_fail"
|
| 2193 |
+
},
|
| 2194 |
+
{
|
| 2195 |
+
"drug_id": 258,
|
| 2196 |
+
"canonical_name": "Loratadine",
|
| 2197 |
+
"index_key": "LORATADINE_HRH1_PROXY",
|
| 2198 |
+
"tier": "2",
|
| 2199 |
+
"pdb_id_catalog": "3RZE",
|
| 2200 |
+
"het_id_catalog": "CET",
|
| 2201 |
+
"source": "moltgate_ui",
|
| 2202 |
+
"session_id": "4e7bd0592b09b10f",
|
| 2203 |
+
"run_status": "ok",
|
| 2204 |
+
"best_affinity": -8.662,
|
| 2205 |
+
"qc_pass": true,
|
| 2206 |
+
"flags": [
|
| 2207 |
+
"OUT_OF_POCKET_MINOR: 3/9 poses outside"
|
| 2208 |
+
],
|
| 2209 |
+
"pdb_id": "3RZE",
|
| 2210 |
+
"review_class": "A_pass"
|
| 2211 |
+
},
|
| 2212 |
+
{
|
| 2213 |
+
"drug_id": 259,
|
| 2214 |
+
"canonical_name": "Hydroxyzine",
|
| 2215 |
+
"index_key": "HYDROXYZINE_HRH1_PROXY",
|
| 2216 |
+
"tier": "2",
|
| 2217 |
+
"pdb_id_catalog": "3RZE",
|
| 2218 |
+
"het_id_catalog": "CET",
|
| 2219 |
+
"source": "moltgate_ui",
|
| 2220 |
+
"session_id": "447cfcc552ea2c9e",
|
| 2221 |
+
"run_status": "ok",
|
| 2222 |
+
"best_affinity": -8.181,
|
| 2223 |
+
"qc_pass": true,
|
| 2224 |
+
"flags": [
|
| 2225 |
+
"OUT_OF_POCKET_MINOR: 3/9 poses outside"
|
| 2226 |
+
],
|
| 2227 |
+
"pdb_id": "3RZE",
|
| 2228 |
+
"review_class": "A_pass"
|
| 2229 |
+
},
|
| 2230 |
+
{
|
| 2231 |
+
"drug_id": 260,
|
| 2232 |
+
"canonical_name": "Doxepin",
|
| 2233 |
+
"index_key": "DOXEPIN_SERT_PROXY",
|
| 2234 |
+
"tier": "2",
|
| 2235 |
+
"pdb_id_catalog": "5I6X",
|
| 2236 |
+
"het_id_catalog": "8PR",
|
| 2237 |
+
"source": "moltgate_ui",
|
| 2238 |
+
"session_id": "48be91b669101f47",
|
| 2239 |
+
"run_status": "ok",
|
| 2240 |
+
"best_affinity": -8.845,
|
| 2241 |
+
"qc_pass": true,
|
| 2242 |
+
"flags": [],
|
| 2243 |
+
"pdb_id": "5I6X",
|
| 2244 |
+
"review_class": "A_pass"
|
| 2245 |
+
},
|
| 2246 |
+
{
|
| 2247 |
+
"drug_id": 261,
|
| 2248 |
+
"canonical_name": "Tezacaftor",
|
| 2249 |
+
"index_key": "TEZACAFTOR_CFTR_PROXY",
|
| 2250 |
+
"tier": "2",
|
| 2251 |
+
"pdb_id_catalog": "6MSM",
|
| 2252 |
+
"het_id_catalog": "IVA",
|
| 2253 |
+
"source": "moltgate_ui",
|
| 2254 |
+
"session_id": "3530485a1aab419e",
|
| 2255 |
+
"run_status": "ok",
|
| 2256 |
+
"best_affinity": -10.5,
|
| 2257 |
+
"qc_pass": false,
|
| 2258 |
+
"flags": [
|
| 2259 |
+
"OUT_OF_POCKET_MAJORITY"
|
| 2260 |
+
],
|
| 2261 |
+
"pdb_id": "6MSM",
|
| 2262 |
+
"review_class": "B_qc_fail"
|
| 2263 |
+
},
|
| 2264 |
+
{
|
| 2265 |
+
"drug_id": 262,
|
| 2266 |
+
"canonical_name": "Alpelisib",
|
| 2267 |
+
"index_key": "ALPELISIB_PIK3CA",
|
| 2268 |
+
"tier": "1",
|
| 2269 |
+
"pdb_id_catalog": "4JPS",
|
| 2270 |
+
"het_id_catalog": "ALP",
|
| 2271 |
+
"source": "moltgate_ui",
|
| 2272 |
+
"session_id": "79761ce01604587a",
|
| 2273 |
+
"run_status": "ok",
|
| 2274 |
+
"best_affinity": -9.738,
|
| 2275 |
+
"qc_pass": true,
|
| 2276 |
+
"flags": [],
|
| 2277 |
+
"pdb_id": "4JPS",
|
| 2278 |
+
"review_class": "A_pass"
|
| 2279 |
+
},
|
| 2280 |
+
{
|
| 2281 |
+
"drug_id": 263,
|
| 2282 |
+
"canonical_name": "Capivasertib",
|
| 2283 |
+
"index_key": "CAPIVASERTIB_AKT",
|
| 2284 |
+
"tier": "1",
|
| 2285 |
+
"pdb_id_catalog": "4EJN",
|
| 2286 |
+
"het_id_catalog": "CPV",
|
| 2287 |
+
"source": "moltgate_ui",
|
| 2288 |
+
"session_id": "511f6ab203530187",
|
| 2289 |
+
"run_status": "ok",
|
| 2290 |
+
"best_affinity": -11.66,
|
| 2291 |
+
"qc_pass": true,
|
| 2292 |
+
"flags": [],
|
| 2293 |
+
"pdb_id": "4EJN",
|
| 2294 |
+
"review_class": "A_pass"
|
| 2295 |
+
},
|
| 2296 |
+
{
|
| 2297 |
+
"drug_id": 264,
|
| 2298 |
+
"canonical_name": "Copanlisib",
|
| 2299 |
+
"index_key": "COPANLISIB_PIK3CA",
|
| 2300 |
+
"tier": "1",
|
| 2301 |
+
"pdb_id_catalog": "5HX9",
|
| 2302 |
+
"het_id_catalog": "COP",
|
| 2303 |
+
"source": "moltgate_ui",
|
| 2304 |
+
"session_id": "6b8bdb7c1f292157",
|
| 2305 |
+
"run_status": "ok",
|
| 2306 |
+
"best_affinity": -9.782,
|
| 2307 |
+
"qc_pass": true,
|
| 2308 |
+
"flags": [],
|
| 2309 |
+
"pdb_id": "4JPS",
|
| 2310 |
+
"review_class": "A_pass"
|
| 2311 |
+
},
|
| 2312 |
+
{
|
| 2313 |
+
"drug_id": 265,
|
| 2314 |
+
"canonical_name": "Bosentan",
|
| 2315 |
+
"index_key": "BOSENTAN_ETRA",
|
| 2316 |
+
"tier": "1",
|
| 2317 |
+
"pdb_id_catalog": "1X9R",
|
| 2318 |
+
"het_id_catalog": "BOS",
|
| 2319 |
+
"source": "moltgate_ui",
|
| 2320 |
+
"session_id": "66cbbec794b83d01",
|
| 2321 |
+
"run_status": "fail",
|
| 2322 |
+
"best_affinity": null,
|
| 2323 |
+
"qc_pass": null,
|
| 2324 |
+
"flags": [],
|
| 2325 |
+
"pdb_id": null,
|
| 2326 |
+
"fail_reason": "Stage 21 無候選配體,無法確認配體身份",
|
| 2327 |
+
"review_class": "A_pipeline_fail"
|
| 2328 |
+
},
|
| 2329 |
+
{
|
| 2330 |
+
"drug_id": 266,
|
| 2331 |
+
"canonical_name": "Isosorbide mononitrate",
|
| 2332 |
+
"index_key": "ISOSORBIDE_MONONITRATE_NOS_PROXY",
|
| 2333 |
+
"tier": "2",
|
| 2334 |
+
"pdb_id_catalog": "1M9C",
|
| 2335 |
+
"het_id_catalog": "NGN",
|
| 2336 |
+
"source": "moltgate_ui",
|
| 2337 |
+
"session_id": "7a9d585dc5ec33da",
|
| 2338 |
+
"run_status": "fail",
|
| 2339 |
+
"best_affinity": null,
|
| 2340 |
+
"qc_pass": null,
|
| 2341 |
+
"flags": [],
|
| 2342 |
+
"pdb_id": null,
|
| 2343 |
+
"fail_reason": "Stage 21 無候選配體,無法確認配體身份",
|
| 2344 |
+
"review_class": "A_pipeline_fail"
|
| 2345 |
+
},
|
| 2346 |
+
{
|
| 2347 |
+
"drug_id": 267,
|
| 2348 |
+
"canonical_name": "Riociguat",
|
| 2349 |
+
"index_key": "RIOCIGUAT_SGC",
|
| 2350 |
+
"tier": "1",
|
| 2351 |
+
"pdb_id_catalog": "3RZT",
|
| 2352 |
+
"het_id_catalog": "RIO",
|
| 2353 |
+
"source": "moltgate_ui",
|
| 2354 |
+
"session_id": "2561fcf1f31376fe",
|
| 2355 |
+
"run_status": "fail",
|
| 2356 |
+
"best_affinity": null,
|
| 2357 |
+
"qc_pass": null,
|
| 2358 |
+
"flags": [],
|
| 2359 |
+
"pdb_id": null,
|
| 2360 |
+
"fail_reason": "Stage 21 無候選配體,無法確認配體身份",
|
| 2361 |
+
"review_class": "A_pipeline_fail"
|
| 2362 |
+
},
|
| 2363 |
+
{
|
| 2364 |
+
"drug_id": 268,
|
| 2365 |
+
"canonical_name": "Entinostat",
|
| 2366 |
+
"index_key": "ENTINOSTAT_HDAC_PROXY",
|
| 2367 |
+
"tier": "2",
|
| 2368 |
+
"pdb_id_catalog": "4LXZ",
|
| 2369 |
+
"het_id_catalog": "SHH",
|
| 2370 |
+
"source": "moltgate_ui",
|
| 2371 |
+
"session_id": "2c8b30fd707da16b",
|
| 2372 |
+
"run_status": "ok",
|
| 2373 |
+
"best_affinity": -7.24,
|
| 2374 |
+
"qc_pass": true,
|
| 2375 |
+
"flags": [],
|
| 2376 |
+
"pdb_id": "4LXZ",
|
| 2377 |
+
"review_class": "A_pass"
|
| 2378 |
+
},
|
| 2379 |
+
{
|
| 2380 |
+
"drug_id": 269,
|
| 2381 |
+
"canonical_name": "Olmutinib",
|
| 2382 |
+
"index_key": "OLMUTINIB_EGFR",
|
| 2383 |
+
"tier": "1",
|
| 2384 |
+
"pdb_id_catalog": "5HG8",
|
| 2385 |
+
"het_id_catalog": "OLM",
|
| 2386 |
+
"source": "moltgate_ui",
|
| 2387 |
+
"session_id": "a98198371dae70c7",
|
| 2388 |
+
"run_status": "ok",
|
| 2389 |
+
"best_affinity": -9.434,
|
| 2390 |
+
"qc_pass": true,
|
| 2391 |
+
"flags": [],
|
| 2392 |
+
"pdb_id": "5HG8",
|
| 2393 |
+
"review_class": "A_pass"
|
| 2394 |
+
},
|
| 2395 |
+
{
|
| 2396 |
+
"drug_id": 270,
|
| 2397 |
+
"canonical_name": "Sotorasib",
|
| 2398 |
+
"index_key": "SOTORASIB_KRAS",
|
| 2399 |
+
"tier": "1",
|
| 2400 |
+
"pdb_id_catalog": "6OIM",
|
| 2401 |
+
"het_id_catalog": "SOT",
|
| 2402 |
+
"source": "moltgate_ui",
|
| 2403 |
+
"session_id": "fba66bc60834fab3",
|
| 2404 |
+
"run_status": "ok",
|
| 2405 |
+
"best_affinity": -9.311,
|
| 2406 |
+
"qc_pass": true,
|
| 2407 |
+
"flags": [],
|
| 2408 |
+
"pdb_id": "6OIM",
|
| 2409 |
+
"review_class": "A_pass"
|
| 2410 |
+
},
|
| 2411 |
+
{
|
| 2412 |
+
"drug_id": 271,
|
| 2413 |
+
"canonical_name": "Liothyronine",
|
| 2414 |
+
"index_key": "LIOTHYRONINE_THRB_PROXY",
|
| 2415 |
+
"tier": "2",
|
| 2416 |
+
"pdb_id_catalog": "1NAV",
|
| 2417 |
+
"het_id_catalog": "T3",
|
| 2418 |
+
"source": "moltgate_ui",
|
| 2419 |
+
"session_id": "43015da71d72e123",
|
| 2420 |
+
"run_status": "ok",
|
| 2421 |
+
"best_affinity": -4.804,
|
| 2422 |
+
"qc_pass": false,
|
| 2423 |
+
"flags": [
|
| 2424 |
+
"SCORE_WEAK: best pose -4.804 kcal/mol > 閾值 -6.0",
|
| 2425 |
+
"OUT_OF_POCKET_MAJORITY"
|
| 2426 |
+
],
|
| 2427 |
+
"pdb_id": "1NAV",
|
| 2428 |
+
"review_class": "B_qc_fail"
|
| 2429 |
+
},
|
| 2430 |
+
{
|
| 2431 |
+
"drug_id": 272,
|
| 2432 |
+
"canonical_name": "Cimetidine",
|
| 2433 |
+
"index_key": "CIMETIDINE_HRH2_PROXY",
|
| 2434 |
+
"tier": "2",
|
| 2435 |
+
"pdb_id_catalog": "3RSG",
|
| 2436 |
+
"het_id_catalog": "FAM",
|
| 2437 |
+
"source": "moltgate_ui",
|
| 2438 |
+
"session_id": "13eaca33f88afc45",
|
| 2439 |
+
"run_status": "ok",
|
| 2440 |
+
"best_affinity": -6.292,
|
| 2441 |
+
"qc_pass": true,
|
| 2442 |
+
"flags": [],
|
| 2443 |
+
"pdb_id": "3RSG",
|
| 2444 |
+
"review_class": "A_pass"
|
| 2445 |
+
},
|
| 2446 |
+
{
|
| 2447 |
+
"drug_id": 273,
|
| 2448 |
+
"canonical_name": "Acetohexamide",
|
| 2449 |
+
"index_key": "ACETOHEXAMIDE_KATP_PROXY",
|
| 2450 |
+
"tier": "2",
|
| 2451 |
+
"pdb_id_catalog": "3SYQ",
|
| 2452 |
+
"het_id_catalog": "GBL",
|
| 2453 |
+
"source": "moltgate_ui",
|
| 2454 |
+
"session_id": "4743e614e20f64e0",
|
| 2455 |
+
"run_status": "ok",
|
| 2456 |
+
"best_affinity": -6.873,
|
| 2457 |
+
"qc_pass": true,
|
| 2458 |
+
"flags": [
|
| 2459 |
+
"OUT_OF_POCKET_MINOR: 1/9 poses outside"
|
| 2460 |
+
],
|
| 2461 |
+
"pdb_id": "3SYQ",
|
| 2462 |
+
"review_class": "A_pass"
|
| 2463 |
+
},
|
| 2464 |
+
{
|
| 2465 |
+
"drug_id": 274,
|
| 2466 |
+
"canonical_name": "Phenformin",
|
| 2467 |
+
"index_key": "PHENFORMIN_AMPK_PROXY",
|
| 2468 |
+
"tier": "2",
|
| 2469 |
+
"pdb_id_catalog": "4CFE",
|
| 2470 |
+
"het_id_catalog": "992",
|
| 2471 |
+
"source": "moltgate_ui",
|
| 2472 |
+
"session_id": "98278d994c6338a6",
|
| 2473 |
+
"run_status": "ok",
|
| 2474 |
+
"best_affinity": -7.337,
|
| 2475 |
+
"qc_pass": true,
|
| 2476 |
+
"flags": [
|
| 2477 |
+
"OUT_OF_POCKET_MINOR: 2/9 poses outside"
|
| 2478 |
+
],
|
| 2479 |
+
"pdb_id": "4CFE",
|
| 2480 |
+
"review_class": "A_pass"
|
| 2481 |
+
},
|
| 2482 |
+
{
|
| 2483 |
+
"drug_id": 275,
|
| 2484 |
+
"canonical_name": "Glucagon",
|
| 2485 |
+
"index_key": "GLUCAGON_GCGR",
|
| 2486 |
+
"tier": "1",
|
| 2487 |
+
"pdb_id_catalog": "4L6R",
|
| 2488 |
+
"het_id_catalog": "GLU",
|
| 2489 |
+
"source": "moltgate_ui",
|
| 2490 |
+
"session_id": "9c90bb28d801b87f",
|
| 2491 |
+
"run_status": "fail",
|
| 2492 |
+
"best_affinity": null,
|
| 2493 |
+
"qc_pass": null,
|
| 2494 |
+
"flags": [],
|
| 2495 |
+
"pdb_id": null,
|
| 2496 |
+
"fail_reason": "Stage 21 無候選配體,無法確認配體身份",
|
| 2497 |
+
"review_class": "A_pipeline_fail"
|
| 2498 |
+
},
|
| 2499 |
+
{
|
| 2500 |
+
"drug_id": 276,
|
| 2501 |
+
"canonical_name": "Insulin glargine",
|
| 2502 |
+
"index_key": "INSULIN_GLARGINE_INSR_PROXY",
|
| 2503 |
+
"tier": "2",
|
| 2504 |
+
"pdb_id_catalog": "4OGA",
|
| 2505 |
+
"het_id_catalog": "INS",
|
| 2506 |
+
"source": "moltgate_ui",
|
| 2507 |
+
"session_id": "a4e67d5cbf984391",
|
| 2508 |
+
"run_status": "fail",
|
| 2509 |
+
"best_affinity": null,
|
| 2510 |
+
"qc_pass": null,
|
| 2511 |
+
"flags": [],
|
| 2512 |
+
"pdb_id": null,
|
| 2513 |
+
"fail_reason": "Stage 21 無候選配體,無法確認配體身份",
|
| 2514 |
+
"review_class": "A_pipeline_fail"
|
| 2515 |
+
},
|
| 2516 |
+
{
|
| 2517 |
+
"drug_id": 277,
|
| 2518 |
+
"canonical_name": "Phenprocoumon",
|
| 2519 |
+
"index_key": "PHENPROCOUMON_VKOR_PROXY",
|
| 2520 |
+
"tier": "2",
|
| 2521 |
+
"pdb_id_catalog": "6WV3",
|
| 2522 |
+
"het_id_catalog": "SWF",
|
| 2523 |
+
"source": "moltgate_ui",
|
| 2524 |
+
"session_id": "45e84fd98d1905b4",
|
| 2525 |
+
"run_status": "ok",
|
| 2526 |
+
"best_affinity": -10.29,
|
| 2527 |
+
"qc_pass": true,
|
| 2528 |
+
"flags": [],
|
| 2529 |
+
"pdb_id": "6WV3",
|
| 2530 |
+
"review_class": "A_pass"
|
| 2531 |
+
},
|
| 2532 |
+
{
|
| 2533 |
+
"drug_id": 278,
|
| 2534 |
+
"canonical_name": "Ethinyl estradiol",
|
| 2535 |
+
"index_key": "ETHINYL_ESTRADIOL_ESR1",
|
| 2536 |
+
"tier": "2",
|
| 2537 |
+
"pdb_id_catalog": "3ERT",
|
| 2538 |
+
"het_id_catalog": "4HT",
|
| 2539 |
+
"source": "moltgate_ui",
|
| 2540 |
+
"session_id": "7c115938fa64ac20",
|
| 2541 |
+
"run_status": "ok",
|
| 2542 |
+
"best_affinity": -9.275,
|
| 2543 |
+
"qc_pass": true,
|
| 2544 |
+
"flags": [
|
| 2545 |
+
"OUT_OF_POCKET_MINOR: 4/9 poses outside"
|
| 2546 |
+
],
|
| 2547 |
+
"pdb_id": "3ERT",
|
| 2548 |
+
"review_class": "A_pass"
|
| 2549 |
+
},
|
| 2550 |
+
{
|
| 2551 |
+
"drug_id": 279,
|
| 2552 |
+
"canonical_name": "Medroxyprogesterone",
|
| 2553 |
+
"index_key": "MEDROXYPROGESTERONE_PGR",
|
| 2554 |
+
"tier": "1",
|
| 2555 |
+
"pdb_id_catalog": "1A28",
|
| 2556 |
+
"het_id_catalog": "PRG",
|
| 2557 |
+
"source": "moltgate_ui",
|
| 2558 |
+
"session_id": "d52b1b7c0313bded",
|
| 2559 |
+
"run_status": "ok",
|
| 2560 |
+
"best_affinity": -9.921,
|
| 2561 |
+
"qc_pass": true,
|
| 2562 |
+
"flags": [
|
| 2563 |
+
"OUT_OF_POCKET_MINOR: 3/9 poses outside"
|
| 2564 |
+
],
|
| 2565 |
+
"pdb_id": "1A28",
|
| 2566 |
+
"review_class": "A_pass"
|
| 2567 |
+
},
|
| 2568 |
+
{
|
| 2569 |
+
"drug_id": 280,
|
| 2570 |
+
"canonical_name": "Norethindrone",
|
| 2571 |
+
"index_key": "NORETHINDRONE_PGR_PROXY",
|
| 2572 |
+
"tier": "2",
|
| 2573 |
+
"pdb_id_catalog": "1A28",
|
| 2574 |
+
"het_id_catalog": "PRG",
|
| 2575 |
+
"source": "moltgate_ui",
|
| 2576 |
+
"session_id": "f257c27a974b4a40",
|
| 2577 |
+
"run_status": "ok",
|
| 2578 |
+
"best_affinity": -10.23,
|
| 2579 |
+
"qc_pass": true,
|
| 2580 |
+
"flags": [
|
| 2581 |
+
"OUT_OF_POCKET_MINOR: 1/9 poses outside"
|
| 2582 |
+
],
|
| 2583 |
+
"pdb_id": "1A28",
|
| 2584 |
+
"review_class": "A_pass"
|
| 2585 |
+
},
|
| 2586 |
+
{
|
| 2587 |
+
"drug_id": 281,
|
| 2588 |
+
"canonical_name": "Danazol",
|
| 2589 |
+
"index_key": "DANAZOL_AR",
|
| 2590 |
+
"tier": "2",
|
| 2591 |
+
"pdb_id_catalog": "3R5W",
|
| 2592 |
+
"het_id_catalog": "ENZ",
|
| 2593 |
+
"source": "moltgate_ui",
|
| 2594 |
+
"session_id": "2b5ab3a317c9a406",
|
| 2595 |
+
"run_status": "ok",
|
| 2596 |
+
"best_affinity": -8.487,
|
| 2597 |
+
"qc_pass": true,
|
| 2598 |
+
"flags": [
|
| 2599 |
+
"OUT_OF_POCKET_MINOR: 3/9 poses outside"
|
| 2600 |
+
],
|
| 2601 |
+
"pdb_id": "3R5W",
|
| 2602 |
+
"review_class": "A_pass"
|
| 2603 |
+
},
|
| 2604 |
+
{
|
| 2605 |
+
"drug_id": 282,
|
| 2606 |
+
"canonical_name": "Fludrocortisone",
|
| 2607 |
+
"index_key": "FLUDROCORTISONE_NR3C2_PROXY",
|
| 2608 |
+
"tier": "2",
|
| 2609 |
+
"pdb_id_catalog": "2AA2",
|
| 2610 |
+
"het_id_catalog": "SPI",
|
| 2611 |
+
"source": "moltgate_ui",
|
| 2612 |
+
"session_id": "e6b135a941ca37d5",
|
| 2613 |
+
"run_status": "ok",
|
| 2614 |
+
"best_affinity": -9.599,
|
| 2615 |
+
"qc_pass": false,
|
| 2616 |
+
"flags": [
|
| 2617 |
+
"OUT_OF_POCKET_MAJORITY"
|
| 2618 |
+
],
|
| 2619 |
+
"pdb_id": "2AA2",
|
| 2620 |
+
"review_class": "B_qc_fail"
|
| 2621 |
+
},
|
| 2622 |
+
{
|
| 2623 |
+
"drug_id": 283,
|
| 2624 |
+
"canonical_name": "Cefalexin",
|
| 2625 |
+
"index_key": "CEFALEXIN_PBP_PROXY",
|
| 2626 |
+
"tier": "2",
|
| 2627 |
+
"pdb_id_catalog": "1PWP",
|
| 2628 |
+
"het_id_catalog": "PG2",
|
| 2629 |
+
"source": "moltgate_ui",
|
| 2630 |
+
"session_id": "ab55a9f5339f9d88",
|
| 2631 |
+
"run_status": "ok",
|
| 2632 |
+
"best_affinity": -7.346,
|
| 2633 |
+
"qc_pass": true,
|
| 2634 |
+
"flags": [
|
| 2635 |
+
"OUT_OF_POCKET_MINOR: 4/9 poses outside"
|
| 2636 |
+
],
|
| 2637 |
+
"pdb_id": "1PWP",
|
| 2638 |
+
"review_class": "A_pass"
|
| 2639 |
+
},
|
| 2640 |
+
{
|
| 2641 |
+
"drug_id": 284,
|
| 2642 |
+
"canonical_name": "Cefazolin",
|
| 2643 |
+
"index_key": "CEFAZOLIN_PBP_PROXY",
|
| 2644 |
+
"tier": "2",
|
| 2645 |
+
"pdb_id_catalog": "1PWP",
|
| 2646 |
+
"het_id_catalog": "PG2",
|
| 2647 |
+
"source": "moltgate_ui",
|
| 2648 |
+
"session_id": "3752b13370d32439",
|
| 2649 |
+
"run_status": "ok",
|
| 2650 |
+
"best_affinity": -7.018,
|
| 2651 |
+
"qc_pass": true,
|
| 2652 |
+
"flags": [
|
| 2653 |
+
"OUT_OF_POCKET_MINOR: 3/9 poses outside"
|
| 2654 |
+
],
|
| 2655 |
+
"pdb_id": "1PWP",
|
| 2656 |
+
"review_class": "A_pass"
|
| 2657 |
+
},
|
| 2658 |
+
{
|
| 2659 |
+
"drug_id": 285,
|
| 2660 |
+
"canonical_name": "Dicloxacillin",
|
| 2661 |
+
"index_key": "DICLOXACILLIN_PBP_PROXY",
|
| 2662 |
+
"tier": "2",
|
| 2663 |
+
"pdb_id_catalog": "1PWP",
|
| 2664 |
+
"het_id_catalog": "PG2",
|
| 2665 |
+
"source": "moltgate_ui",
|
| 2666 |
+
"session_id": "90a22c096024d34d",
|
| 2667 |
+
"run_status": "ok",
|
| 2668 |
+
"best_affinity": -7.384,
|
| 2669 |
+
"qc_pass": true,
|
| 2670 |
+
"flags": [
|
| 2671 |
+
"OUT_OF_POCKET_MINOR: 3/9 poses outside"
|
| 2672 |
+
],
|
| 2673 |
+
"pdb_id": "1PWP",
|
| 2674 |
+
"review_class": "A_pass"
|
| 2675 |
+
},
|
| 2676 |
+
{
|
| 2677 |
+
"drug_id": 286,
|
| 2678 |
+
"canonical_name": "Tetracycline",
|
| 2679 |
+
"index_key": "TETRACYCLINE_RIBOSOME",
|
| 2680 |
+
"tier": "2",
|
| 2681 |
+
"pdb_id_catalog": "1HNW",
|
| 2682 |
+
"het_id_catalog": "DOX",
|
| 2683 |
+
"source": "moltgate_ui",
|
| 2684 |
+
"session_id": "e6455e277afcf288",
|
| 2685 |
+
"run_status": "ok",
|
| 2686 |
+
"best_affinity": -4.556,
|
| 2687 |
+
"qc_pass": false,
|
| 2688 |
+
"flags": [
|
| 2689 |
+
"SCORE_WEAK: best pose -4.556 kcal/mol > 閾值 -6.0",
|
| 2690 |
+
"OUT_OF_POCKET_MINOR: 4/9 poses outside"
|
| 2691 |
+
],
|
| 2692 |
+
"pdb_id": "1HNW",
|
| 2693 |
+
"review_class": "B_qc_fail"
|
| 2694 |
+
},
|
| 2695 |
+
{
|
| 2696 |
+
"drug_id": 287,
|
| 2697 |
+
"canonical_name": "Erythromycin",
|
| 2698 |
+
"index_key": "ERYTHROMYCIN_RIBOSOME",
|
| 2699 |
+
"tier": "2",
|
| 2700 |
+
"pdb_id_catalog": "1YIJ",
|
| 2701 |
+
"het_id_catalog": "CLR",
|
| 2702 |
+
"source": "moltgate_ui",
|
| 2703 |
+
"session_id": "cd724b08b3d75a8b",
|
| 2704 |
+
"run_status": "fail",
|
| 2705 |
+
"best_affinity": null,
|
| 2706 |
+
"qc_pass": null,
|
| 2707 |
+
"flags": [],
|
| 2708 |
+
"pdb_id": null,
|
| 2709 |
+
"review_class": "A_pipeline_fail"
|
| 2710 |
+
},
|
| 2711 |
+
{
|
| 2712 |
+
"drug_id": 288,
|
| 2713 |
+
"canonical_name": "Gentamicin",
|
| 2714 |
+
"index_key": "GENTAMICIN_RIBOSOME",
|
| 2715 |
+
"tier": "2",
|
| 2716 |
+
"pdb_id_catalog": "1HNW",
|
| 2717 |
+
"het_id_catalog": "DOX",
|
| 2718 |
+
"source": "moltgate_ui",
|
| 2719 |
+
"session_id": "ee964b763fdfaa00",
|
| 2720 |
+
"run_status": "ok",
|
| 2721 |
+
"best_affinity": -4.464,
|
| 2722 |
+
"qc_pass": false,
|
| 2723 |
+
"flags": [
|
| 2724 |
+
"SCORE_WEAK: best pose -4.464 kcal/mol > 閾值 -6.0"
|
| 2725 |
+
],
|
| 2726 |
+
"pdb_id": "1HNW",
|
| 2727 |
+
"review_class": "B_qc_fail"
|
| 2728 |
+
},
|
| 2729 |
+
{
|
| 2730 |
+
"drug_id": 289,
|
| 2731 |
+
"canonical_name": "Streptomycin",
|
| 2732 |
+
"index_key": "STREPTOMYCIN_RIBOSOME",
|
| 2733 |
+
"tier": "2",
|
| 2734 |
+
"pdb_id_catalog": "1HNW",
|
| 2735 |
+
"het_id_catalog": "DOX",
|
| 2736 |
+
"source": "moltgate_ui",
|
| 2737 |
+
"session_id": "9fc60a43f72b421b",
|
| 2738 |
+
"run_status": "ok",
|
| 2739 |
+
"best_affinity": -4.144,
|
| 2740 |
+
"qc_pass": false,
|
| 2741 |
+
"flags": [
|
| 2742 |
+
"SCORE_WEAK: best pose -4.144 kcal/mol > 閾值 -6.0"
|
| 2743 |
+
],
|
| 2744 |
+
"pdb_id": "1HNW",
|
| 2745 |
+
"review_class": "B_qc_fail"
|
| 2746 |
+
},
|
| 2747 |
+
{
|
| 2748 |
+
"drug_id": 290,
|
| 2749 |
+
"canonical_name": "Tobramycin",
|
| 2750 |
+
"index_key": "TOBRAMYCIN_RIBOSOME",
|
| 2751 |
+
"tier": "2",
|
| 2752 |
+
"pdb_id_catalog": "1HNW",
|
| 2753 |
+
"het_id_catalog": "DOX",
|
| 2754 |
+
"source": "moltgate_ui",
|
| 2755 |
+
"session_id": "77a2ba15b637b213",
|
| 2756 |
+
"run_status": "ok",
|
| 2757 |
+
"best_affinity": -4.12,
|
| 2758 |
+
"qc_pass": false,
|
| 2759 |
+
"flags": [
|
| 2760 |
+
"SCORE_WEAK: best pose -4.120 kcal/mol > 閾值 -6.0"
|
| 2761 |
+
],
|
| 2762 |
+
"pdb_id": "1HNW",
|
| 2763 |
+
"review_class": "B_qc_fail"
|
| 2764 |
+
},
|
| 2765 |
+
{
|
| 2766 |
+
"drug_id": 291,
|
| 2767 |
+
"canonical_name": "Meropenem",
|
| 2768 |
+
"index_key": "MEROPENEM_PBP_PROXY",
|
| 2769 |
+
"tier": "2",
|
| 2770 |
+
"pdb_id_catalog": "1PWP",
|
| 2771 |
+
"het_id_catalog": "PG2",
|
| 2772 |
+
"source": "moltgate_ui",
|
| 2773 |
+
"session_id": "078e02157d4957e2",
|
| 2774 |
+
"run_status": "ok",
|
| 2775 |
+
"best_affinity": -7.35,
|
| 2776 |
+
"qc_pass": true,
|
| 2777 |
+
"flags": [
|
| 2778 |
+
"OUT_OF_POCKET_MINOR: 3/9 poses outside"
|
| 2779 |
+
],
|
| 2780 |
+
"pdb_id": "1PWP",
|
| 2781 |
+
"review_class": "A_pass"
|
| 2782 |
+
},
|
| 2783 |
+
{
|
| 2784 |
+
"drug_id": 292,
|
| 2785 |
+
"canonical_name": "Imipenem",
|
| 2786 |
+
"index_key": "IMIPENEM_PBP_PROXY",
|
| 2787 |
+
"tier": "2",
|
| 2788 |
+
"pdb_id_catalog": "1PWP",
|
| 2789 |
+
"het_id_catalog": "PG2",
|
| 2790 |
+
"source": "moltgate_ui",
|
| 2791 |
+
"session_id": "6cc9a6746b36d3cb",
|
| 2792 |
+
"run_status": "ok",
|
| 2793 |
+
"best_affinity": -7.371,
|
| 2794 |
+
"qc_pass": true,
|
| 2795 |
+
"flags": [
|
| 2796 |
+
"OUT_OF_POCKET_MINOR: 3/9 poses outside"
|
| 2797 |
+
],
|
| 2798 |
+
"pdb_id": "1PWP",
|
| 2799 |
+
"review_class": "A_pass"
|
| 2800 |
+
},
|
| 2801 |
+
{
|
| 2802 |
+
"drug_id": 293,
|
| 2803 |
+
"canonical_name": "Amikacin",
|
| 2804 |
+
"index_key": "AMIKACIN_RIBOSOME",
|
| 2805 |
+
"tier": "2",
|
| 2806 |
+
"pdb_id_catalog": "1HNW",
|
| 2807 |
+
"het_id_catalog": "DOX",
|
| 2808 |
+
"source": "moltgate_ui",
|
| 2809 |
+
"session_id": "1bff5e84461d89a3",
|
| 2810 |
+
"run_status": "ok",
|
| 2811 |
+
"best_affinity": -4.175,
|
| 2812 |
+
"qc_pass": false,
|
| 2813 |
+
"flags": [
|
| 2814 |
+
"SCORE_WEAK: best pose -4.175 kcal/mol > 閾值 -6.0"
|
| 2815 |
+
],
|
| 2816 |
+
"pdb_id": "1HNW",
|
| 2817 |
+
"review_class": "B_qc_fail"
|
| 2818 |
+
},
|
| 2819 |
+
{
|
| 2820 |
+
"drug_id": 294,
|
| 2821 |
+
"canonical_name": "Cobimetinib",
|
| 2822 |
+
"index_key": "COBIMETINIB_MEK1",
|
| 2823 |
+
"tier": "1",
|
| 2824 |
+
"pdb_id_catalog": "4AN2",
|
| 2825 |
+
"het_id_catalog": "COB",
|
| 2826 |
+
"source": "moltgate_ui",
|
| 2827 |
+
"session_id": "e2e573d58d64d84a",
|
| 2828 |
+
"run_status": "ok",
|
| 2829 |
+
"best_affinity": -10.57,
|
| 2830 |
+
"qc_pass": true,
|
| 2831 |
+
"flags": [
|
| 2832 |
+
"OUT_OF_POCKET_MINOR: 1/9 poses outside"
|
| 2833 |
+
],
|
| 2834 |
+
"pdb_id": "4AN2",
|
| 2835 |
+
"review_class": "A_pass"
|
| 2836 |
+
},
|
| 2837 |
+
{
|
| 2838 |
+
"drug_id": 295,
|
| 2839 |
+
"canonical_name": "Binimetinib",
|
| 2840 |
+
"index_key": "BINIMETINIB_MEK1",
|
| 2841 |
+
"tier": "1",
|
| 2842 |
+
"pdb_id_catalog": "3ORX",
|
| 2843 |
+
"het_id_catalog": "BIN",
|
| 2844 |
+
"source": "moltgate_ui",
|
| 2845 |
+
"session_id": "835a930be8102c74",
|
| 2846 |
+
"run_status": "ok",
|
| 2847 |
+
"best_affinity": -7.117,
|
| 2848 |
+
"qc_pass": true,
|
| 2849 |
+
"flags": [
|
| 2850 |
+
"OUT_OF_POCKET_MINOR: 4/9 poses outside"
|
| 2851 |
+
],
|
| 2852 |
+
"pdb_id": "3ORX",
|
| 2853 |
+
"review_class": "A_pass"
|
| 2854 |
+
},
|
| 2855 |
+
{
|
| 2856 |
+
"drug_id": 296,
|
| 2857 |
+
"canonical_name": "Vismodegib",
|
| 2858 |
+
"index_key": "VISMODEGIB_SMO",
|
| 2859 |
+
"tier": "1",
|
| 2860 |
+
"pdb_id_catalog": "4I72",
|
| 2861 |
+
"het_id_catalog": "VIS",
|
| 2862 |
+
"source": "moltgate_ui",
|
| 2863 |
+
"session_id": "c22de7fd969e419a",
|
| 2864 |
+
"run_status": "ok",
|
| 2865 |
+
"best_affinity": -8.668,
|
| 2866 |
+
"qc_pass": true,
|
| 2867 |
+
"flags": [],
|
| 2868 |
+
"pdb_id": "4I72",
|
| 2869 |
+
"review_class": "A_pass"
|
| 2870 |
+
},
|
| 2871 |
+
{
|
| 2872 |
+
"drug_id": 297,
|
| 2873 |
+
"canonical_name": "Sonidegib",
|
| 2874 |
+
"index_key": "SONIDEGIB_SMO",
|
| 2875 |
+
"tier": "1",
|
| 2876 |
+
"pdb_id_catalog": "4N82",
|
| 2877 |
+
"het_id_catalog": "SON",
|
| 2878 |
+
"source": "moltgate_ui",
|
| 2879 |
+
"session_id": "f6f6ad353a693b26",
|
| 2880 |
+
"run_status": "ok",
|
| 2881 |
+
"best_affinity": -10.95,
|
| 2882 |
+
"qc_pass": true,
|
| 2883 |
+
"flags": [
|
| 2884 |
+
"OUT_OF_POCKET_MINOR: 2/9 poses outside"
|
| 2885 |
+
],
|
| 2886 |
+
"pdb_id": "4N82",
|
| 2887 |
+
"review_class": "A_pass"
|
| 2888 |
+
},
|
| 2889 |
+
{
|
| 2890 |
+
"drug_id": 298,
|
| 2891 |
+
"canonical_name": "Adagrasib",
|
| 2892 |
+
"index_key": "ADAGRASIB_KRAS",
|
| 2893 |
+
"tier": "1",
|
| 2894 |
+
"pdb_id_catalog": "6UT0",
|
| 2895 |
+
"het_id_catalog": "ADG",
|
| 2896 |
+
"source": "moltgate_ui",
|
| 2897 |
+
"session_id": "255d5569e8304bed",
|
| 2898 |
+
"run_status": "ok",
|
| 2899 |
+
"best_affinity": -10.64,
|
| 2900 |
+
"qc_pass": true,
|
| 2901 |
+
"flags": [
|
| 2902 |
+
"OUT_OF_POCKET_MINOR: 2/9 poses outside"
|
| 2903 |
+
],
|
| 2904 |
+
"pdb_id": "6UT0",
|
| 2905 |
+
"review_class": "A_pass"
|
| 2906 |
+
},
|
| 2907 |
+
{
|
| 2908 |
+
"drug_id": 299,
|
| 2909 |
+
"canonical_name": "Mobocertinib",
|
| 2910 |
+
"index_key": "MOBOCERTINIB_EGFR",
|
| 2911 |
+
"tier": "1",
|
| 2912 |
+
"pdb_id_catalog": "7SIM",
|
| 2913 |
+
"het_id_catalog": "MOB",
|
| 2914 |
+
"source": "moltgate_ui",
|
| 2915 |
+
"session_id": "eadbeea6ad720387",
|
| 2916 |
+
"run_status": "ok",
|
| 2917 |
+
"best_affinity": -9.172,
|
| 2918 |
+
"qc_pass": true,
|
| 2919 |
+
"flags": [],
|
| 2920 |
+
"pdb_id": "7SIM",
|
| 2921 |
+
"review_class": "A_pass"
|
| 2922 |
+
},
|
| 2923 |
+
{
|
| 2924 |
+
"drug_id": 300,
|
| 2925 |
+
"canonical_name": "Tivozanib",
|
| 2926 |
+
"index_key": "TIVOZANIB_VEGFR",
|
| 2927 |
+
"tier": "1",
|
| 2928 |
+
"pdb_id_catalog": "4ASD",
|
| 2929 |
+
"het_id_catalog": "TIV",
|
| 2930 |
+
"source": "moltgate_ui",
|
| 2931 |
+
"session_id": "af854c719f0c24fd",
|
| 2932 |
+
"run_status": "ok",
|
| 2933 |
+
"best_affinity": -11.08,
|
| 2934 |
+
"qc_pass": true,
|
| 2935 |
+
"flags": [
|
| 2936 |
+
"OUT_OF_POCKET_MINOR: 3/9 poses outside"
|
| 2937 |
+
],
|
| 2938 |
+
"pdb_id": "4ASD",
|
| 2939 |
+
"review_class": "A_pass"
|
| 2940 |
+
}
|
| 2941 |
+
]
|
| 2942 |
+
}
|
config/drug_catalog_300_plan.csv
ADDED
|
@@ -0,0 +1,301 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
symptom_group,group_slot,drug_id,index_key,canonical_name,catalog_status,index_in_master,batch,notes
|
| 2 |
+
METABOLIC,1,8,CA2,Acetazolamide,seed_ok,yes,01,CreaDrug24 seed
|
| 3 |
+
METABOLIC,2,23,DPP4_ALOGLIPTIN,Alogliptin,seed_ok,yes,01,CreaDrug24 seed
|
| 4 |
+
METABOLIC,3,24,DPP4_LINAGLIPTIN,Linagliptin,seed_ok,yes,01,CreaDrug24 seed
|
| 5 |
+
METABOLIC,4,25,AMPK_METFORMIN_PROXY,Metformin,seed_ok,yes,01,Proxy ADaM pocket; M4 must select 992 not STU
|
| 6 |
+
METABOLIC,5,26,SITAGLIPTIN_DPP4,Sitagliptin,seed_ok,yes,01,Direct DPP4-sitagliptin cocrystal (1X70)
|
| 7 |
+
METABOLIC,6,27,ATORVASTATIN_HMGCR_PROXY,Atorvastatin,seed_ok,yes,01,Direct HMGCR-atorvastatin cocrystal (1HWK); index_key retains _PROXY legacy name
|
| 8 |
+
METABOLIC,7,29,OMEPRAZOLE_CYP2C19,Omeprazole,seed_ok,yes,01,Human CYP2C19 (4GQS); co-crystal ligand 0XV is inhibitor not omeprazole (substrate)
|
| 9 |
+
METABOLIC,8,30,AMLODIPINE_CACNA1C_PROXY,Amlodipine,seed_ok,yes,01,Human Cav1.2 cryo-EM (8WE8) with amlodipine (6UB) in DHP blocker site
|
| 10 |
+
METABOLIC,9,31,LOSARTAN_AT1R_PROXY,Losartan,seed_ok,yes,02,"Human AT1R (4ZUD); co-crystal OLM is olmesartan, not losartan"
|
| 11 |
+
METABOLIC,10,32,ROSUVASTATIN_HMGCR,Rosuvastatin,seed_ok,yes,02,HMG-CoA reductase rosuvastatin analog (3B7Q/6PL)
|
| 12 |
+
METABOLIC,11,33,SIMVASTATIN_HMGCR,Simvastatin,seed_ok,yes,02,Direct HMGCR-simvastatin (1HW9/SIM)
|
| 13 |
+
METABOLIC,12,34,PIOGLITAZONE_PPARgamma_PROXY,Pioglitazone,seed_ok,yes,02,"PPARgamma TZD scaffold (2PRG/BRL), not pioglitazone co-crystal"
|
| 14 |
+
METABOLIC,13,35,EMPAGLIFLOZIN_SGLT2,Empagliflozin,seed_ok,yes,02,SGLT2 inhibitor bound state (7VSI/7R3)
|
| 15 |
+
METABOLIC,14,36,SAXAGLIPTIN_DPP4,Saxagliptin,seed_ok,yes,02,Direct DPP4-saxagliptin analog (3C43/315)
|
| 16 |
+
METABOLIC,15,37,LANSOPRAZOLE_CYP2C19,Lansoprazole,seed_ok,yes,02,Human CYP2C19 template; 0XV is inhibitor not lansoprazole
|
| 17 |
+
METABOLIC,16,38,METOPROLOL_ADRB1_PROXY,Metoprolol,seed_ok,yes,02,Beta-1 adrenergic receptor; WHJ is carmoterol surrogate
|
| 18 |
+
METABOLIC,17,39,FENOFIBRATE_PPARalpha,Fenofibrate,seed_ok,yes,02,PPARalpha fenofibric acid analog (1K74/544)
|
| 19 |
+
METABOLIC,18,40,HYDROCHLOROTHIAZIDE_CA2_PROXY,Hydrochlorothiazide,seed_ok,yes,02,CA2 pocket template via acetazolamide; thiazide mechanism differs
|
| 20 |
+
METABOLIC,19,61,GLIPIZIDE_KATP_PROXY,Glipizide,seed_ok,yes,03,KATP SUR1-Kir6.2; GBL is glibenclamide surrogate (3SYQ)
|
| 21 |
+
METABOLIC,20,62,REPAGLINIDE_KATP,Repaglinide,seed_ok,yes,03,Direct KATP-repaglinide co-crystal (3VE0/REP)
|
| 22 |
+
METABOLIC,21,63,CANAGLIFLOZIN_SGLT2,Canagliflozin,seed_ok,yes,03,SGLT2-canagliflozin bound state (7VSL/5ZI)
|
| 23 |
+
METABOLIC,22,64,DAPAGLIFLOZIN_SGLT2,Dapagliflozin,seed_ok,yes,03,SGLT2-dapagliflozin co-crystal (6VBL/DAP)
|
| 24 |
+
METABOLIC,23,65,EZETIMIBE_NPC1L1,Ezetimibe,seed_ok,yes,03,NPC1L1-ezetimibe co-crystal (3QNT/EZE)
|
| 25 |
+
METABOLIC,24,66,PRAVASTATIN_HMGCR_PROXY,Pravastatin,seed_ok,yes,03,HMGCR statin pocket via simvastatin site (1HW9/SIM); pravastatin not co-crystal ligand
|
| 26 |
+
METABOLIC,25,67,LOVASTATIN_HMGCR,Lovastatin,seed_ok,yes,03,HMGCR-mevastatin/lovastatin family co-crystal (1HW8/MVA)
|
| 27 |
+
METABOLIC,26,68,VALSARTAN_AT1R_PROXY,Valsartan,seed_ok,yes,03,"Human AT1R (4ZUD); OLM is olmesartan surrogate, not valsartan"
|
| 28 |
+
METABOLIC,27,69,SPIRONOLACTONE_NR3C2,Spironolactone,seed_ok,yes,03,Mineralocorticoid receptor-spironolactone (2AA2/SPI)
|
| 29 |
+
METABOLIC,28,70,PROPRANOLOL_ADRB1_PROXY,Propranolol,seed_ok,yes,03,Beta-1 adrenergic receptor; WHJ is carmoterol surrogate (2Y02)
|
| 30 |
+
METABOLIC,29,91,GLIMEPIRIDE_KATP_PROXY,Glimepiride,seed_ok,yes,04,KATP SUR1-Kir6.2; GBL is glibenclamide surrogate (3SYQ)
|
| 31 |
+
METABOLIC,30,92,MIGLITOL_GLUCOSIDASE,Miglitol,seed_ok,yes,04,Alpha-glucosidase-miglitol co-crystal (2BB0/MIG)
|
| 32 |
+
METABOLIC,31,93,ACARBOSE_GLUCOSIDASE,Acarbose,seed_ok,yes,04,Maltase-acarbose co-crystal (2QV4/ACA)
|
| 33 |
+
METABOLIC,32,94,GEMFIBROZIL_PPARalpha_PROXY,Gemfibrozil,seed_ok,yes,04,PPARalpha fibrate pocket via fenofibric acid analog (1K74/544)
|
| 34 |
+
METABOLIC,33,95,ALLOPURINOL_XDH,Allopurinol,seed_ok,yes,04,Xanthine oxidase-allopurinol analog (3NTZ/ALP)
|
| 35 |
+
METABOLIC,34,96,FEBUXOSTAT_XDH,Febuxostat,seed_ok,yes,04,Xanthine oxidase-febuxostat co-crystal (3EY8/FEB)
|
| 36 |
+
METABOLIC,35,97,BISOPROLOL_ADRB1_PROXY,Bisoprolol,seed_ok,yes,04,Beta-1 adrenergic receptor; WHJ is carmoterol surrogate (2Y02)
|
| 37 |
+
METABOLIC,36,98,NIFEDIPINE_CACNA1C,Nifedipine,seed_ok,yes,04,Cav1.2 DHP blocker site via amlodipine template (8WE8/6UB); nifedipine not co-crystal ligand
|
| 38 |
+
METABOLIC,37,99,VERAPAMIL_CACNA1C_PROXY,Verapamil,seed_ok,yes,04,Cav1.2 channel template; phenylalkylamine mechanism differs from DHP site
|
| 39 |
+
METABOLIC,38,100,PANTOPRAZOLE_CYP2C19_PROXY,Pantoprazole,seed_ok,yes,04,"Human CYP2C19 (4GQS); 0XV is inhibitor surrogate, not pantoprazole"
|
| 40 |
+
METABOLIC,39,121,ESOMEPRAZOLE_CYP2C19_PROXY,Esomeprazole,seed_ok,yes,05,"Human CYP2C19 (4GQS); 0XV is inhibitor surrogate, not esomeprazole"
|
| 41 |
+
METABOLIC,40,122,NATEGLINIDE_KATP_PROXY,Nateglinide,seed_ok,yes,05,KATP pocket via repaglinide site (3VE0/REP); nateglinide not co-crystal ligand
|
| 42 |
+
METABOLIC,41,123,VOGLIBOSE_GLUCOSIDASE_PROXY,Voglibose,seed_ok,yes,05,Alpha-glucosidase pocket via acarbose site (2QV4/ACA)
|
| 43 |
+
METABOLIC,42,124,EPLERENONE_NR3C2,Eplerenone,seed_ok,yes,05,Mineralocorticoid receptor-eplerenone (2W44/EPL)
|
| 44 |
+
METABOLIC,43,125,TELMISARTAN_AT1R,Telmisartan,seed_ok,yes,05,AT1R-telmisartan co-crystal (4YAY/TEL)
|
| 45 |
+
METABOLIC,44,126,LISINOPRIL_ACE,Lisinopril,seed_ok,yes,05,ACE-lisinopril co-crystal (1O86/LIS)
|
| 46 |
+
METABOLIC,45,127,DILTIAZEM_CACNA1C_PROXY,Diltiazem,seed_ok,yes,05,Cav1.2 channel template; benzothiazepine mechanism differs from DHP site
|
| 47 |
+
METABOLIC,46,128,FUROSEMIDE_SLC12A_PROXY,Furosemide,seed_ok,yes,05,Exploratory loop diuretic template via CA2 site (3HS4/AZM); mechanism is NKCC2
|
| 48 |
+
METABOLIC,47,129,ORLISTAT_LIPASE,Orlistat,seed_ok,yes,05,Pancreatic lipase-orlistat co-crystal (1LPB/ORL)
|
| 49 |
+
METABOLIC,48,130,LEVOTHYROXINE_THRB_PROXY,Levothyroxine,seed_ok,yes,05,Thyroid hormone receptor template via T3 site (1NAV/T3)
|
| 50 |
+
METABOLIC,49,151,ENALAPRIL_ACE_PROXY,Enalapril,seed_ok,yes,06,ACE pocket via lisinopril site (1O86/LIS); enalapril is prodrug
|
| 51 |
+
METABOLIC,50,152,RAMIPRIL_ACE_PROXY,Ramipril,seed_ok,yes,06,ACE pocket via lisinopril site (1O86/LIS); ramipril is prodrug
|
| 52 |
+
METABOLIC,51,153,CANDESARTAN_AT1R,Candesartan,seed_ok,yes,06,"Human AT1R (4ZUD); OLM olmesartan surrogate, not candesartan co-crystal"
|
| 53 |
+
METABOLIC,52,154,IRBESARTAN_AT1R_PROXY,Irbesartan,seed_ok,yes,06,Human AT1R (4ZUD); OLM is olmesartan surrogate
|
| 54 |
+
METABOLIC,53,155,OLMESARTAN_AT1R,Olmesartan,seed_ok,yes,06,AT1R-olmesartan co-crystal (4ZUD/OLM)
|
| 55 |
+
METABOLIC,54,156,ROSIGLITAZONE_PPARG,Rosiglitazone,seed_ok,yes,06,PPARgamma-rosiglitazone co-crystal (2PRG/BRL)
|
| 56 |
+
METABOLIC,55,157,GLYBURIDE_KATP,Glyburide,seed_ok,yes,06,KATP SUR1-Kir6.2 glibenclamide co-crystal (3SYQ/GBL)
|
| 57 |
+
METABOLIC,56,158,ATENOLOL_ADRB1_PROXY,Atenolol,seed_ok,yes,06,Beta-1 adrenergic receptor; WHJ is carmoterol surrogate (2Y02)
|
| 58 |
+
METABOLIC,57,159,FELODIPINE_CACNA1C_PROXY,Felodipine,seed_ok,yes,06,Cav1.2 DHP blocker site via amlodipine template (8WE8/6UB)
|
| 59 |
+
METABOLIC,58,160,SACUBITRIL_MEP,Sacubitril,seed_ok,yes,06,Neprilysin-sacubitril analog in LCZ696 complex (6V06/SGN)
|
| 60 |
+
METABOLIC,59,181,CAPTOPRIL_ACE,Captopril,seed_ok,yes,07,ACE-captopril co-crystal (1UZF/CAP)
|
| 61 |
+
METABOLIC,60,182,BENAZEPRIL_ACE_PROXY,Benazepril,seed_ok,yes,07,ACE pocket via lisinopril site (1O86/LIS); benazepril is prodrug
|
| 62 |
+
METABOLIC,61,183,CHLORTHALIDONE_CA2_PROXY,Chlorthalidone,seed_ok,yes,07,CA2 template via acetazolamide (3HS4/AZM); thiazide-like diuretic
|
| 63 |
+
METABOLIC,62,184,AMILORIDE_ENAC_PROXY,Amiloride,seed_ok,yes,07,Exploratory ENaC blocker template; mechanism differs from CA2 site
|
| 64 |
+
METABOLIC,63,185,RANOLAZINE_SCN5A,Ranolazine,seed_ok,yes,07,NaV1.5-ranolazine analog site (2FBI/RAN)
|
| 65 |
+
METABOLIC,64,186,BROMOCRIPTINE_DRD2,Bromocriptine,seed_ok,yes,07,D2 receptor-bromocriptine (3PBL/BRM)
|
| 66 |
+
METABOLIC,65,187,NIACIN_GPR109A,Niacin,seed_ok,yes,07,GPR109A-niacin co-crystal (3R7A/NIA)
|
| 67 |
+
METABOLIC,66,188,DIAZOXIDE_KATP_PROXY,Diazoxide,seed_ok,yes,07,KATP channel template via sulfonylurea site (3SYQ/GBL); diazoxide is channel opener
|
| 68 |
+
METABOLIC,67,189,SEMAGLUTIDE_GLP1R,Semaglutide,seed_ok,yes,07,GLP-1R-semaglutide cryo-EM (6X18/SEM); peptide SMILES is placeholder
|
| 69 |
+
METABOLIC,68,190,EXENATIDE_GLP1R,Exenatide,seed_ok,yes,07,GLP-1R-exenatide cryo-EM (5VAI/EXN); peptide SMILES is placeholder
|
| 70 |
+
METABOLIC,69,211,PERINDOPRIL_ACE_PROXY,Perindopril,seed_ok,yes,08,ACE pocket via lisinopril (1O86/LIS); prodrug
|
| 71 |
+
METABOLIC,70,212,METHIMAZOLE_TPO,Methimazole,seed_ok,yes,08,Thyroid peroxidase-methimazole (3ZGS/MMI)
|
| 72 |
+
METABOLIC,71,213,PROPYLTHIOURACIL_TPO_PROXY,Propylthiouracil,seed_ok,yes,08,TPO pocket via methimazole site (3ZGS/MMI)
|
| 73 |
+
METABOLIC,72,214,TOLBUTAMIDE_KATP_PROXY,Tolbutamide,seed_ok,yes,08,KATP via glibenclamide site (3SYQ/GBL)
|
| 74 |
+
METABOLIC,73,215,CHLORPROPAMIDE_KATP_PROXY,Chlorpropamide,seed_ok,yes,08,KATP sulfonylurea pocket template (3SYQ/GBL)
|
| 75 |
+
METABOLIC,74,216,BEZAFIBRATE_PPARalpha_PROXY,Bezafibrate,seed_ok,yes,08,PPARalpha via fenofibric acid (1K74/544)
|
| 76 |
+
METABOLIC,75,217,METOLAZONE_CA2_PROXY,Metolazone,seed_ok,yes,08,CA2 template via acetazolamide (3HS4/AZM)
|
| 77 |
+
METABOLIC,76,218,TORSEMIDE_SLC12A_PROXY,Torsemide,seed_ok,yes,08,Loop diuretic exploratory template
|
| 78 |
+
METABOLIC,77,219,METOCLOPRAMIDE_DRD2_PROXY,Metoclopramide,seed_ok,yes,08,D2 receptor template (6CM4/8NU)
|
| 79 |
+
METABOLIC,78,220,DULAGLUTIDE_GLP1R,Dulaglutide,seed_ok,yes,08,GLP-1R via semaglutide cryo-EM (6X18/SEM); peptide placeholder SMILES
|
| 80 |
+
METABOLIC,79,241,LIRAGLUTIDE_GLP1R_PROXY,Liraglutide,seed_ok,yes,09,GLP-1R via semaglutide cryo-EM (6X18/SEM); peptide placeholder
|
| 81 |
+
METABOLIC,80,242,CLOFIBRATE_PPARalpha_PROXY,Clofibrate,seed_ok,yes,09,PPARalpha via fenofibric acid (1K74/544)
|
| 82 |
+
METABOLIC,81,243,NICOTINE_NACHR,Nicotine,seed_ok,yes,09,nAChR-nicotine co-crystal (4EY7/NIC)
|
| 83 |
+
METABOLIC,82,244,GLICLAZIDE_KATP_PROXY,Gliclazide,seed_ok,yes,09,KATP via glibenclamide (3SYQ/GBL)
|
| 84 |
+
METABOLIC,83,245,DOMPERIDONE_DRD2_PROXY,Domperidone,seed_ok,yes,09,D2/3 receptor template (6CM4/8NU)
|
| 85 |
+
METABOLIC,84,246,LITHIUM_IMPASE_PROXY,Lithium,seed_ok,yes,09,Inositol monophosphatase exploratory template (1W7O/LIT)
|
| 86 |
+
METABOLIC,85,247,SULFASALAZINE_DHFR_PROXY,Sulfasalazine,seed_ok,yes,09,DHFR pocket via trimethoprim (2W9G/TMP); also anti-inflammatory prodrug
|
| 87 |
+
METABOLIC,86,248,MESALAMINE_COX2_PROXY,Mesalamine,seed_ok,yes,09,COX pocket template (5IKT/TLF); gut anti-inflammatory
|
| 88 |
+
METABOLIC,87,249,URSODIOL_FXR,Ursodeoxycholic acid,seed_ok,yes,09,FXR-ursodeoxycholic acid (3OLF/UDC)
|
| 89 |
+
METABOLIC,88,250,MINOXIDIL_KATP_PROXY,Minoxidil,seed_ok,yes,09,KATP channel opener; template via sulfonylurea site (3SYQ/GBL)
|
| 90 |
+
METABOLIC,89,271,LIOTHYRONINE_THRB_PROXY,Liothyronine,seed_ok,yes,10,Thyroid hormone receptor via T3 (1NAV/T3)
|
| 91 |
+
METABOLIC,90,272,CIMETIDINE_HRH2_PROXY,Cimetidine,seed_ok,yes,10,H2 receptor via famotidine site (3RSG/FAM)
|
| 92 |
+
METABOLIC,91,273,ACETOHEXAMIDE_KATP_PROXY,Acetohexamide,seed_ok,yes,10,KATP via glibenclamide (3SYQ/GBL)
|
| 93 |
+
METABOLIC,92,274,PHENFORMIN_AMPK_PROXY,Phenformin,seed_ok,yes,10,AMPK/biguanide pocket via metformin surrogate (4CFE/992)
|
| 94 |
+
METABOLIC,93,275,GLUCAGON_GCGR,Glucagon,seed_ok,yes,10,Glucagon receptor cryo-EM (4L6R/GLU); peptide placeholder SMILES
|
| 95 |
+
METABOLIC,94,276,INSULIN_GLARGINE_INSR_PROXY,Insulin glargine,seed_ok,yes,10,Insulin receptor template (4OGA/INS); peptide placeholder
|
| 96 |
+
METABOLIC,95,277,PHENPROCOUMON_VKOR_PROXY,Phenprocoumon,seed_ok,yes,10,VKOR via warfarin site (6WV3/SWF)
|
| 97 |
+
METABOLIC,96,278,ETHINYL_ESTRADIOL_ESR1,Ethinyl estradiol,seed_ok,yes,10,Estrogen receptor via 4-hydroxytamoxifen site (3ERT/4HT)
|
| 98 |
+
METABOLIC,97,279,MEDROXYPROGESTERONE_PGR,Medroxyprogesterone,seed_ok,yes,10,Progesterone receptor-progesterone (1A28/PRG)
|
| 99 |
+
METABOLIC,98,280,NORETHINDRONE_PGR_PROXY,Norethindrone,seed_ok,yes,10,Progesterone receptor template (1A28/PRG)
|
| 100 |
+
METABOLIC,99,281,DANAZOL_AR,Danazol,seed_ok,yes,10,Androgen receptor via enzalutamide (3R5W/ENZ)
|
| 101 |
+
METABOLIC,100,282,FLUDROCORTISONE_NR3C2_PROXY,Fludrocortisone,seed_ok,yes,10,Mineralocorticoid receptor via spironolactone (2AA2/SPI)
|
| 102 |
+
INFLAM,1,1,COX2,Ibuprofen,seed_ok,yes,01,CreaDrug24 seed
|
| 103 |
+
INFLAM,2,2,COX2_CLX,Celecoxib,seed_ok,yes,01,CreaDrug24 seed
|
| 104 |
+
INFLAM,3,3,NEURAMINIDASE,Oseltamivir,seed_ok,yes,01,CreaDrug24 seed
|
| 105 |
+
INFLAM,4,5,DHFR,Methotrexate,seed_ok,yes,01,CreaDrug24 seed
|
| 106 |
+
INFLAM,5,6,CYP51,Fluconazole,seed_ok,yes,01,CreaDrug24 seed
|
| 107 |
+
INFLAM,6,12,DRD2_QUETIAPINE_PROXY,Quetiapine,seed_ok,yes,01,CreaDrug24 seed
|
| 108 |
+
INFLAM,7,21,PDE4D_CILOMILAST,Cilomilast,seed_ok,yes,01,CreaDrug24 seed
|
| 109 |
+
INFLAM,8,22,PDE4D_ROFLUMILAST,Roflumilast,seed_ok,yes,01,CreaDrug24 seed
|
| 110 |
+
INFLAM,9,28,ASPIRIN_COX2,Aspirin,seed_ok,yes,01,COX-2 NSAID pocket via 5IKT flurbiprofen (TLF); paired with Ibuprofen entry
|
| 111 |
+
INFLAM,10,41,DICLOFENAC_COX2,Diclofenac,seed_ok,yes,02,COX-2 diclofenac analog co-crystal (5IKR/ID8)
|
| 112 |
+
INFLAM,11,42,NAPROXEN_COX2,Naproxen,seed_ok,yes,02,NSAID pocket via 5IKT/TLF template; naproxen is not co-crystal ligand
|
| 113 |
+
INFLAM,12,43,MELOXICAM_COX2_PROXY,Meloxicam,seed_ok,yes,02,COX-2 pocket via diclofenac analog site (5IKR/ID8)
|
| 114 |
+
INFLAM,13,44,HYDROXYCHLOROQUINE_LYSO_PROXY,Hydroxychloroquine,seed_ok,yes,02,Exploratory lysosomal/endosomal template; not direct HCQ co-crystal
|
| 115 |
+
INFLAM,14,45,MONTELUKAST_CYSLT1_PROXY,Montelukast,seed_ok,yes,02,CysLT receptor; KNT is pranlukast surrogate (6RZ4)
|
| 116 |
+
INFLAM,15,46,ALBUTEROL_ADRB2_PROXY,Albuterol,seed_ok,yes,02,Beta-2 receptor; Y00 is dobutamine surrogate (2Y00)
|
| 117 |
+
INFLAM,16,47,CIPROFLOXACIN_GYRASE,Ciprofloxacin,seed_ok,yes,02,DNA gyrase-ciprofloxacin (2XCT/CPF)
|
| 118 |
+
INFLAM,17,48,PREDNISONE_NR3C1_PROXY,Prednisone,seed_ok,yes,02,Glucocorticoid receptor; DEX is dexamethasone surrogate
|
| 119 |
+
INFLAM,18,49,ACETAMINOPHEN_COX2_PROXY,Acetaminophen,seed_ok,yes,02,COX pocket template via 5IKT/TLF; acetaminophen COX mechanism debated
|
| 120 |
+
INFLAM,19,50,FLUOXETINE_SERT_PROXY,Fluoxetine,seed_ok,yes,02,SERT template; 8PR is paroxetine surrogate (5I6X)
|
| 121 |
+
INFLAM,20,71,INDOMETHACIN_COX2_PROXY,Indomethacin,seed_ok,yes,03,COX-2 pocket via diclofenac analog site (5IKR/ID8)
|
| 122 |
+
INFLAM,21,72,KETOROLAC_COX2,Ketorolac,seed_ok,yes,03,COX-2-ketorolac co-crystal (1Q4G/KRL)
|
| 123 |
+
INFLAM,22,73,PIROXICAM_COX2_PROXY,Piroxicam,seed_ok,yes,03,COX pocket via flurbiprofen template (5IKT/TLF)
|
| 124 |
+
INFLAM,23,74,AZITHROMYCIN_RIBOSOME,Azithromycin,seed_ok,yes,03,50S ribosome-azithromycin (1YII/AZI)
|
| 125 |
+
INFLAM,24,75,AMOXICILLIN_PBP_PROXY,Amoxicillin,seed_ok,yes,03,Penicillin-binding protein template; PG2 is penicillin G surrogate (1PWP)
|
| 126 |
+
INFLAM,25,76,DOXYCYCLINE_RIBOSOME,Doxycycline,seed_ok,yes,03,30S ribosome-doxycycline (1HNW/DOX)
|
| 127 |
+
INFLAM,26,77,LEVOFLOXACIN_GYRASE,Levofloxacin,seed_ok,yes,03,DNA gyrase fluoroquinolone pocket via ciprofloxacin (2XCT/CPF)
|
| 128 |
+
INFLAM,27,78,TRIMETHOPRIM_DHFR,Trimethoprim,seed_ok,yes,03,DHFR-trimethoprim co-crystal (2W9G/TMP)
|
| 129 |
+
INFLAM,28,79,SERTRALINE_SERT_PROXY,Sertraline,seed_ok,yes,03,SERT template; 8PR is paroxetine surrogate (5I6X)
|
| 130 |
+
INFLAM,29,80,PAROXETINE_SERT,Paroxetine,seed_ok,yes,03,Direct SERT-paroxetine co-crystal (5I6X/8PR)
|
| 131 |
+
INFLAM,30,101,COLCHICINE_TUBULIN,Colchicine,seed_ok,yes,04,Tubulin-colchicine co-crystal (1BT6/COL)
|
| 132 |
+
INFLAM,31,102,SULINDAC_COX2_PROXY,Sulindac,seed_ok,yes,04,COX-2 pocket via diclofenac analog site (5IKR/ID8)
|
| 133 |
+
INFLAM,32,103,GABAPENTIN_CACNA2D_PROXY,Gabapentin,seed_ok,yes,04,Alpha2delta subunit exploratory template (5E6I); binding site debated
|
| 134 |
+
INFLAM,33,104,CARBAMAZEPINE_NAV_PROXY,Carbamazepine,seed_ok,yes,04,Exploratory voltage-gated channel template; carbamazepine mechanism is Na+ channel
|
| 135 |
+
INFLAM,34,105,VALPROIC_ACID_HDAC_PROXY,Valproic acid,seed_ok,yes,04,HDAC pocket template via vorinostat site (4LXZ/SHH); VPA also has GABAergic mechanism
|
| 136 |
+
INFLAM,35,106,METRONIDAZOLE_NITROREDUCTASE,Metronidazole,seed_ok,yes,04,Nitroreductase-metronidazole (1MNU/MET)
|
| 137 |
+
INFLAM,36,107,CLINDAMYCIN_RIBOSOME,Clindamycin,seed_ok,yes,04,50S ribosome-clindamycin (1YHQ/CLI)
|
| 138 |
+
INFLAM,37,108,VANCOMYCIN_PBP,Vancomycin,seed_ok,yes,04,Peptidoglycan-vancomycin complex (1FVM/VAN)
|
| 139 |
+
INFLAM,38,109,CLARITHROMYCIN_RIBOSOME,Clarithromycin,seed_ok,yes,04,50S ribosome-clarithromycin (1YIJ/CLR)
|
| 140 |
+
INFLAM,39,110,RIFAMPIN_RNAP,Rifampin,seed_ok,yes,04,RNA polymerase-rifampin (5UAC/RFP)
|
| 141 |
+
INFLAM,40,131,MORPHINE_OPRM1,Morphine,seed_ok,yes,05,Mu-opioid receptor-morphine analog (8DZP/MOR)
|
| 142 |
+
INFLAM,41,132,FENTANYL_OPRM1_PROXY,Fentanyl,seed_ok,yes,05,Mu-opioid receptor template via morphine site (8DZP/MOR)
|
| 143 |
+
INFLAM,42,133,PREGABALIN_CACNA2D_PROXY,Pregabalin,seed_ok,yes,05,Alpha2delta subunit exploratory template (5E6I); paired with gabapentin entry
|
| 144 |
+
INFLAM,43,134,LAMOTRIGINE_SCN_PROXY,Lamotrigine,seed_ok,yes,05,Exploratory voltage-gated channel template; lamotrigine targets Na+ channels
|
| 145 |
+
INFLAM,44,135,PHENYTOIN_SCN_PROXY,Phenytoin,seed_ok,yes,05,Na+ channel exploratory template (5T6R/PHT)
|
| 146 |
+
INFLAM,45,136,CLONAZEPAM_GABA_A,Clonazepam,seed_ok,yes,05,GABA-A receptor-clonazepam analog (1KTF/CLZ)
|
| 147 |
+
INFLAM,46,137,ESCITALOPRAM_SERT,Escitalopram,seed_ok,yes,05,SERT-citalopram/escitalopram family co-crystal (4IAR/CIT)
|
| 148 |
+
INFLAM,47,138,LINEZOLID_RIBOSOME,Linezolid,seed_ok,yes,05,50S ribosome-linezolid (3CPW/LZD)
|
| 149 |
+
INFLAM,48,139,ISONIAZID_INHA,Isoniazid,seed_ok,yes,05,InhA-isoniazid analog co-crystal (4C0X/INA)
|
| 150 |
+
INFLAM,49,140,ETHAMBUTOL_EMBA,Ethambutol,seed_ok,yes,05,EmbA-ethambutol co-crystal (4NBA/EMB)
|
| 151 |
+
INFLAM,50,161,TRAMADOL_OPRM1_PROXY,Tramadol,seed_ok,yes,06,Mu-opioid receptor template via morphine site (8DZP/MOR)
|
| 152 |
+
INFLAM,51,162,OXYCODONE_OPRM1_PROXY,Oxycodone,seed_ok,yes,06,Mu-opioid receptor template via morphine site (8DZP/MOR)
|
| 153 |
+
INFLAM,52,163,DULOXETINE_SERT_PROXY,Duloxetine,seed_ok,yes,06,SERT template; 8PR is paroxetine surrogate (5I6X); also NET activity
|
| 154 |
+
INFLAM,53,164,CITALOPRAM_SERT,Citalopram,seed_ok,yes,06,SERT-citalopram co-crystal (4IAR/CIT)
|
| 155 |
+
INFLAM,54,165,VENLAFAXINE_SERT_PROXY,Venlafaxine,seed_ok,yes,06,SERT/NET template via paroxetine site (5I6X/8PR)
|
| 156 |
+
INFLAM,55,166,LORAZEPAM_GABA_A_PROXY,Lorazepam,seed_ok,yes,06,GABA-A benzodiazepine site via clonazepam template (1KTF/CLZ)
|
| 157 |
+
INFLAM,56,167,FAMOTIDINE_HRH2,Famotidine,seed_ok,yes,06,Histamine H2 receptor-famotidine analog (3RSG/FAM)
|
| 158 |
+
INFLAM,57,168,ONDANSETRON_HTR3A,Ondansetron,seed_ok,yes,06,5-HT3 receptor-ondansetron analog (6DFZ/OND)
|
| 159 |
+
INFLAM,58,169,SUMATRIPTAN_HTR1B_PROXY,Sumatriptan,seed_ok,yes,06,5-HT1B receptor triptan template (6G4Q/SUM)
|
| 160 |
+
INFLAM,59,170,CYCLOSPORINE_PP2B,Cyclosporine,seed_ok,yes,06,Calcineurin-cyclosporine complex (1M63/CSA)
|
| 161 |
+
INFLAM,60,191,KETAMINE_NMDA,Ketamine,seed_ok,yes,07,NMDA receptor-ketamine site (3UO9/KET)
|
| 162 |
+
INFLAM,61,192,CODEINE_OPRM1_PROXY,Codeine,seed_ok,yes,07,Mu-opioid receptor template via morphine site (8DZP/MOR)
|
| 163 |
+
INFLAM,62,193,BUPROPION_DAT,Bupropion,seed_ok,yes,07,DAT-bupropion analog (4WNT/BUP)
|
| 164 |
+
INFLAM,63,194,MIRTAZAPINE_HTR2A_PROXY,Mirtazapine,seed_ok,yes,07,5-HT2A receptor template (6A93/MIR); also alpha2 antagonist
|
| 165 |
+
INFLAM,64,195,TRAZODONE_HTR2A_PROXY,Trazodone,seed_ok,yes,07,5-HT2A template via mirtazapine site (6A93/MIR)
|
| 166 |
+
INFLAM,65,196,ALPRAZOLAM_GABA_A,Alprazolam,seed_ok,yes,07,GABA-A receptor-alprazolam (4OWE/ALP)
|
| 167 |
+
INFLAM,66,197,RANITIDINE_HRH2_PROXY,Ranitidine,seed_ok,yes,07,H2 receptor template via famotidine site (3RSG/FAM)
|
| 168 |
+
INFLAM,67,198,MYCOPHENOLATE_IMPDH,Mycophenolate,seed_ok,yes,07,IMPDH-mycophenolic acid (1P5T/MPA)
|
| 169 |
+
INFLAM,68,199,KETOCONAZOLE_CYP51,Ketoconazole,seed_ok,yes,07,CYP51-ketoconazole (5VZA/KET)
|
| 170 |
+
INFLAM,69,200,VORICONAZOLE_CYP51,Voriconazole,seed_ok,yes,07,CYP51-voriconazole (5TZ4/VOR)
|
| 171 |
+
INFLAM,70,221,DIAZEPAM_GABA_A,Diazepam,seed_ok,yes,08,GABA-A via alprazolam site (4OWE/ALP)
|
| 172 |
+
INFLAM,71,222,BACLOFEN_GABA_B,Baclofen,seed_ok,yes,08,GABA-B receptor-baclofen (4WNC/BAC)
|
| 173 |
+
INFLAM,72,223,TIZANIDINE_ADRA2A_PROXY,Tizanidine,seed_ok,yes,08,Alpha-2 adrenergic template (6KUX/TIZ)
|
| 174 |
+
INFLAM,73,224,AZATHIOPRINE_TPMT,Azathioprine,seed_ok,yes,08,TPMT-azathioprine metabolite site (2H11/AZA)
|
| 175 |
+
INFLAM,74,225,PENICILLIN_G_PBP,Penicillin G,seed_ok,yes,08,PBP-penicillin G (1PWP/PG2)
|
| 176 |
+
INFLAM,75,226,AMPICILLIN_PBP_PROXY,Ampicillin,seed_ok,yes,08,PBP via penicillin G site (1PWP/PG2)
|
| 177 |
+
INFLAM,76,227,POSACONAZOLE_CYP51,Posaconazole,seed_ok,yes,08,CYP51 via ketoconazole site (5VZA/KET)
|
| 178 |
+
INFLAM,77,228,ACYCLOVIR_DNA_POL,Acyclovir,seed_ok,yes,08,Viral DNA polymerase-acyclovir analog (2GV9/ACV)
|
| 179 |
+
INFLAM,78,229,LEVOCETIRIZINE_HRH1,Levocetirizine,seed_ok,yes,08,H1 receptor-cetirizine family (3RZE/CET)
|
| 180 |
+
INFLAM,79,230,METHYLPREDNISOLONE_NR3C1_PROXY,Methylprednisolone,seed_ok,yes,08,Glucocorticoid receptor via dexamethasone (1M2Z/DEX)
|
| 181 |
+
INFLAM,80,251,ETODOLAC_COX2_PROXY,Etodolac,seed_ok,yes,09,COX-2 pocket via diclofenac analog (5IKR/ID8)
|
| 182 |
+
INFLAM,81,252,ITRACONAZOLE_CYP51_PROXY,Itraconazole,seed_ok,yes,09,CYP51 via ketoconazole site (5VZA/KET)
|
| 183 |
+
INFLAM,82,253,GANCICLOVIR_DNA_POL_PROXY,Ganciclovir,seed_ok,yes,09,Viral DNA polymerase via acyclovir site (2GV9/ACV)
|
| 184 |
+
INFLAM,83,254,REMDESIVIR_RDRP,Remdesivir,seed_ok,yes,09,RdRp-remdesivir complex (7BV2/REM)
|
| 185 |
+
INFLAM,84,255,SOFOSBUVIR_NS5B,Sofosbuvir,seed_ok,yes,09,HCV NS5B-sofosbuvir analog (4RXA/SOF)
|
| 186 |
+
INFLAM,85,256,RIBAVIRIN_RDRP,Ribavirin,seed_ok,yes,09,Viral polymerase-ribavirin analog (3HHZ/RIB)
|
| 187 |
+
INFLAM,86,257,DIPHENHYDRAMINE_HRH1_PROXY,Diphenhydramine,seed_ok,yes,09,H1 receptor via cetirizine site (3RZE/CET)
|
| 188 |
+
INFLAM,87,258,LORATADINE_HRH1_PROXY,Loratadine,seed_ok,yes,09,H1 receptor template (3RZE/CET)
|
| 189 |
+
INFLAM,88,259,HYDROXYZINE_HRH1_PROXY,Hydroxyzine,seed_ok,yes,09,H1 receptor template (3RZE/CET)
|
| 190 |
+
INFLAM,89,260,DOXEPIN_SERT_PROXY,Doxepin,seed_ok,yes,09,SERT template via paroxetine (5I6X/8PR)
|
| 191 |
+
INFLAM,90,283,CEFALEXIN_PBP_PROXY,Cefalexin,seed_ok,yes,10,PBP via penicillin G (1PWP/PG2)
|
| 192 |
+
INFLAM,91,284,CEFAZOLIN_PBP_PROXY,Cefazolin,seed_ok,yes,10,PBP cephalosporin template (1PWP/PG2)
|
| 193 |
+
INFLAM,92,285,DICLOXACILLIN_PBP_PROXY,Dicloxacillin,seed_ok,yes,10,PBP penicillinase-resistant template (1PWP/PG2)
|
| 194 |
+
INFLAM,93,286,TETRACYCLINE_RIBOSOME,Tetracycline,seed_ok,yes,10,30S ribosome via doxycycline (1HNW/DOX)
|
| 195 |
+
INFLAM,94,287,ERYTHROMYCIN_RIBOSOME,Erythromycin,seed_ok,yes,10,50S ribosome via clarithromycin (1YIJ/CLR)
|
| 196 |
+
INFLAM,95,288,GENTAMICIN_RIBOSOME,Gentamicin,seed_ok,yes,10,30S ribosome aminoglycoside template (1HNW/DOX)
|
| 197 |
+
INFLAM,96,289,STREPTOMYCIN_RIBOSOME,Streptomycin,seed_ok,yes,10,30S ribosome aminoglycoside template (1HNW/DOX)
|
| 198 |
+
INFLAM,97,290,TOBRAMYCIN_RIBOSOME,Tobramycin,seed_ok,yes,10,30S ribosome aminoglycoside template (1HNW/DOX)
|
| 199 |
+
INFLAM,98,291,MEROPENEM_PBP_PROXY,Meropenem,seed_ok,yes,10,PBP carbapenem template (1PWP/PG2)
|
| 200 |
+
INFLAM,99,292,IMIPENEM_PBP_PROXY,Imipenem,seed_ok,yes,10,PBP carbapenem template (1PWP/PG2)
|
| 201 |
+
INFLAM,100,293,AMIKACIN_RIBOSOME,Amikacin,seed_ok,yes,10,30S ribosome aminoglycoside template (1HNW/DOX)
|
| 202 |
+
ONCO_CV,1,4,ABLABL,Imatinib,seed_ok,yes,01,CreaDrug24 seed
|
| 203 |
+
ONCO_CV,2,7,PDE5,Sildenafil,seed_ok,yes,01,CreaDrug24 seed
|
| 204 |
+
ONCO_CV,3,9,EGFR,Gefitinib,seed_ok,yes,01,CreaDrug24 seed
|
| 205 |
+
ONCO_CV,4,10,VKOR,Warfarin,seed_ok,yes,01,CreaDrug24 seed
|
| 206 |
+
ONCO_CV,5,11,FKBP12_TACROLIMUS,Tacrolimus,seed_ok,yes,01,CreaDrug24 seed
|
| 207 |
+
ONCO_CV,6,13,EGFR_ERLOTINIB,Erlotinib,seed_ok,yes,01,CreaDrug24 seed
|
| 208 |
+
ONCO_CV,7,14,PDE5_VARDENAFIL,Vardenafil,seed_ok,yes,01,CreaDrug24 seed
|
| 209 |
+
ONCO_CV,8,15,FXA_APIXABAN,Apixaban,seed_ok,yes,01,CreaDrug24 seed
|
| 210 |
+
ONCO_CV,9,16,FXA_RIVAROXABAN,Rivaroxaban,seed_ok,yes,01,CreaDrug24 seed
|
| 211 |
+
ONCO_CV,10,17,HDAC2_VORINOSTAT,Vorinostat,seed_ok,yes,01,CreaDrug24 seed
|
| 212 |
+
ONCO_CV,11,18,ABL_NILOTINIB,Nilotinib,seed_ok,yes,01,CreaDrug24 seed
|
| 213 |
+
ONCO_CV,12,19,ABL_BOSUTINIB,Bosutinib,seed_ok,yes,01,CreaDrug24 seed
|
| 214 |
+
ONCO_CV,13,20,DDR1_PONATINIB,Ponatinib,seed_ok,yes,01,CreaDrug24 seed
|
| 215 |
+
ONCO_CV,14,51,DASATINIB_ABL,Dasatinib,seed_ok,yes,02,ABL-dasatinib co-crystal (2GQG/1N1)
|
| 216 |
+
ONCO_CV,15,52,SUNITINIB_VEGFR2,Sunitinib,seed_ok,yes,02,VEGFR2-sunitinib analog (3G5E/Q74)
|
| 217 |
+
ONCO_CV,16,53,LAPATINIB_EGFR,Lapatinib,seed_ok,yes,02,EGFR-lapatinib (1XKK/FMM)
|
| 218 |
+
ONCO_CV,17,54,PALBOCICLIB_CDK6,Palbociclib,seed_ok,yes,02,CDK6-palbociclib (5L2I/LQQ)
|
| 219 |
+
ONCO_CV,18,55,TRAMETINIB_MEK1,Trametinib,seed_ok,yes,02,MEK1-trametinib (7JUX/QOM)
|
| 220 |
+
ONCO_CV,19,56,LETROZOLE_CYP19,Letrozole,seed_ok,yes,02,Aromatase-letrozole analog (1E3Q/EBW)
|
| 221 |
+
ONCO_CV,20,57,ANASTROZOLE_CYP19,Anastrozole,seed_ok,yes,02,Aromatase-anastrozole (3S7S/EXM)
|
| 222 |
+
ONCO_CV,21,58,VENETOCLAX_BCL2,Venetoclax,seed_ok,yes,02,BCL2-venetoclax (6O0K/LBM)
|
| 223 |
+
ONCO_CV,22,59,DABRAFENIB_BRAF,Dabrafenib,seed_ok,yes,02,BRAF-dabrafenib (4XV2/P06)
|
| 224 |
+
ONCO_CV,23,60,CARVEDILOL_ADRB1_PROXY,Carvedilol,seed_ok,yes,02,Beta-1 receptor; 5FW is isoproterenol surrogate (2Y03)
|
| 225 |
+
ONCO_CV,24,81,OSIMERTINIB_EGFR,Osimertinib,seed_ok,yes,03,EGFR-osimertinib co-crystal (5XGN/OSS)
|
| 226 |
+
ONCO_CV,25,82,AFATINIB_EGFR,Afatinib,seed_ok,yes,03,EGFR-afatinib co-crystal (4G5J/AFT)
|
| 227 |
+
ONCO_CV,26,83,SORAFENIB_BRAF,Sorafenib,seed_ok,yes,03,BRAF-sorafenib co-crystal (3OG7/SOR)
|
| 228 |
+
ONCO_CV,27,84,CABOZANTINIB_MET,Cabozantinib,seed_ok,yes,03,MET kinase-cabozantinib analog (4O1B/X87)
|
| 229 |
+
ONCO_CV,28,85,IBRUTINIB_BTK,Ibrutinib,seed_ok,yes,03,BTK-ibrutinib co-crystal (4O5B/PPI)
|
| 230 |
+
ONCO_CV,29,86,OLAPARIB_PARP,Olaparib,seed_ok,yes,03,PARP1-olaparib co-crystal (5DS5/OL0)
|
| 231 |
+
ONCO_CV,30,87,RUXOLITINIB_JAK2,Ruxolitinib,seed_ok,yes,03,JAK2-ruxolitinib co-crystal (4IVC/RUX)
|
| 232 |
+
ONCO_CV,31,88,ENZALUTAMIDE_AR,Enzalutamide,seed_ok,yes,03,Androgen receptor-enzalutamide (3R5W/ENZ)
|
| 233 |
+
ONCO_CV,32,89,TAMOXIFEN_ESR1,Tamoxifen,seed_ok,yes,03,Estrogen receptor template; 4HT is 4-hydroxytamoxifen surrogate (3ERT)
|
| 234 |
+
ONCO_CV,33,90,TICAGRELOR_P2Y12,Ticagrelor,seed_ok,yes,03,P2Y12 receptor-ticagrelor co-crystal (4PY0/TIC)
|
| 235 |
+
ONCO_CV,34,111,REGORAFENIB_BRAF,Regorafenib,seed_ok,yes,04,BRAF-regorafenib co-crystal (4RT7/RGF)
|
| 236 |
+
ONCO_CV,35,112,LENVATINIB_VEGFR2,Lenvatinib,seed_ok,yes,04,VEGFR2-lenvatinib co-crystal (4UQI/LVN)
|
| 237 |
+
ONCO_CV,36,113,AXITINIB_VEGFR2,Axitinib,seed_ok,yes,04,VEGFR2-axitinib co-crystal (4AGC/AXN)
|
| 238 |
+
ONCO_CV,37,114,EVEROLIMUS_MTOR,Everolimus,seed_ok,yes,04,mTOR-everolimus co-crystal (4JT6/EVL)
|
| 239 |
+
ONCO_CV,38,115,CRIZOTINIB_ALK,Crizotinib,seed_ok,yes,04,ALK-crizotinib co-crystal (2XP2/CRI)
|
| 240 |
+
ONCO_CV,39,116,ALECTINIB_ALK,Alectinib,seed_ok,yes,04,ALK-alectinib co-crystal (4YNP/AIT)
|
| 241 |
+
ONCO_CV,40,117,CERITINIB_ALK,Ceritinib,seed_ok,yes,04,ALK-ceritinib co-crystal (4MKC/LDK)
|
| 242 |
+
ONCO_CV,41,118,CLOPIDOGREL_P2Y12_PROXY,Clopidogrel,seed_ok,yes,04,P2Y12 template via ticagrelor site (4PY0/TIC); clopidogrel is prodrug
|
| 243 |
+
ONCO_CV,42,119,AMIODARONE_KCNH2_PROXY,Amiodarone,seed_ok,yes,04,hERG channel template (5VA2/AMI); amiodarone has multi-target CV effects
|
| 244 |
+
ONCO_CV,43,120,DIGOXIN_PGP,Digoxin,seed_ok,yes,04,P-glycoprotein-digoxin binding model (3G60/DIG)
|
| 245 |
+
ONCO_CV,44,141,ACALABRUTINIB_BTK,Acalabrutinib,seed_ok,yes,05,BTK-acalabrutinib co-crystal (6OZM/ACB)
|
| 246 |
+
ONCO_CV,45,142,MIDOSTAURIN_FLT3,Midostaurin,seed_ok,yes,05,FLT3/PKC kinase pocket via staurosporine site (1RJB/STA); midostaurin is staurosporine analog
|
| 247 |
+
ONCO_CV,46,143,LAROTRECTINIB_TRK,Larotrectinib,seed_ok,yes,05,TRK-larotrectinib co-crystal (5VLQ/LAR)
|
| 248 |
+
ONCO_CV,47,144,LENALIDOMIDE_CRBN,Lenalidomide,seed_ok,yes,05,Cereblon-lenalidomide co-crystal (5FQD/LEN)
|
| 249 |
+
ONCO_CV,48,145,ABIRATERONE_CYP17,Abiraterone,seed_ok,yes,05,CYP17-abiraterone co-crystal (3SW0/ABI)
|
| 250 |
+
ONCO_CV,49,146,ABEMACICLIB_CDK6,Abemaciclib,seed_ok,yes,05,CDK6-abemaciclib co-crystal (5UOC/ABE)
|
| 251 |
+
ONCO_CV,50,147,RIBOCICLIB_CDK6,Ribociclib,seed_ok,yes,05,CDK6-ribociclib co-crystal (5L2T/RIC)
|
| 252 |
+
ONCO_CV,51,148,PRASUGREL_P2Y12_PROXY,Prasugrel,seed_ok,yes,05,P2Y12 template via ticagrelor site (4PY0/TIC); prasugrel is prodrug
|
| 253 |
+
ONCO_CV,52,149,VANDETANIB_RET,Vandetanib,seed_ok,yes,05,RET kinase-vandetanib co-crystal (2IVT/VAN)
|
| 254 |
+
ONCO_CV,53,150,NINTEDANIB_FGFR,Nintedanib,seed_ok,yes,05,FGFR1-nintedanib co-crystal (4PV0/NIN)
|
| 255 |
+
ONCO_CV,54,171,THALIDOMIDE_CRBN,Thalidomide,seed_ok,yes,06,Cereblon-thalidomide co-crystal (4CI1/THA)
|
| 256 |
+
ONCO_CV,55,172,POMALIDOMIDE_CRBN,Pomalidomide,seed_ok,yes,06,Cereblon-pomalidomide co-crystal (4TZ4/POM)
|
| 257 |
+
ONCO_CV,56,173,ENTRECTINIB_TRK,Entrectinib,seed_ok,yes,06,TRK-entrectinib co-crystal (5T1A/ENT)
|
| 258 |
+
ONCO_CV,57,174,CAPMATINIB_MET,Capmatinib,seed_ok,yes,06,MET kinase-capmatinib co-crystal (4R3Y/CAP)
|
| 259 |
+
ONCO_CV,58,175,NERATINIB_EGFR,Neratinib,seed_ok,yes,06,EGFR-neratinib co-crystal (3POZ/NER)
|
| 260 |
+
ONCO_CV,59,176,LORLATINIB_ALK,Lorlatinib,seed_ok,yes,06,ALK-lorlatinib co-crystal (5W9I/LOR)
|
| 261 |
+
ONCO_CV,60,177,BRIGATINIB_ALK,Brigatinib,seed_ok,yes,06,ALK-brigatinib co-crystal (5USZ/BRI)
|
| 262 |
+
ONCO_CV,61,178,DABIGATRAN_THROMBIN,Dabigatran,seed_ok,yes,06,Thrombin-dabigatran co-crystal (1KTS/DAB)
|
| 263 |
+
ONCO_CV,62,179,EDOXABAN_FXA,Edoxaban,seed_ok,yes,06,Factor Xa-edoxaban co-crystal (4TZY/EDO)
|
| 264 |
+
ONCO_CV,63,180,SELPERCATINIB_RET,Selpercatinib,seed_ok,yes,06,RET-selpercatinib co-crystal (6W0O/SEL)
|
| 265 |
+
ONCO_CV,64,201,ZANUBRUTINIB_BTK,Zanubrutinib,seed_ok,yes,07,BTK-zanubrutinib co-crystal (7F4I/ZAN)
|
| 266 |
+
ONCO_CV,65,202,ERDAFITINIB_FGFR,Erdafitinib,seed_ok,yes,07,FGFR1-erdafitinib co-crystal (5EW3/ERD)
|
| 267 |
+
ONCO_CV,66,203,PEMIGATINIB_FGFR,Pemigatinib,seed_ok,yes,07,FGFR1-pemigatinib co-crystal (5EW8/PEM)
|
| 268 |
+
ONCO_CV,67,204,TEPOTINIB_MET,Tepotinib,seed_ok,yes,07,MET-tepotinib co-crystal (6IOK/TEP)
|
| 269 |
+
ONCO_CV,68,205,BELZUTIFAN_HIF2A,Belzutifan,seed_ok,yes,07,HIF-2alpha-belzutifan (5GS8/BEL)
|
| 270 |
+
ONCO_CV,69,206,FULVESTRANT_ESR1,Fulvestrant,seed_ok,yes,07,ER-fulvestrant co-crystal (3ERR/FUL)
|
| 271 |
+
ONCO_CV,70,207,RALOXIFENE_ESR1,Raloxifene,seed_ok,yes,07,ER-raloxifene co-crystal (3R5K/RAL)
|
| 272 |
+
ONCO_CV,71,208,PAZOPANIB_VEGFR2,Pazopanib,seed_ok,yes,07,VEGFR2-pazopanib co-crystal (4G0Z/PAZ)
|
| 273 |
+
ONCO_CV,72,209,TUCATINIB_HER2,Tucatinib,seed_ok,yes,07,HER2-tucatinib co-crystal (5UG8/TUC)
|
| 274 |
+
ONCO_CV,73,210,PYROTINIB_EGFR,Pyrotinib,seed_ok,yes,07,EGFR-pyrotinib co-crystal (5NIY/PYR)
|
| 275 |
+
ONCO_CV,74,231,SIROLIMUS_MTOR,Sirolimus,seed_ok,yes,08,mTOR-rapamycin/sirolimus (4JSN/RAP)
|
| 276 |
+
ONCO_CV,75,232,TEMSIROLIMUS_MTOR_PROXY,Temsirolimus,seed_ok,yes,08,mTOR via everolimus site (4JT6/EVL); rapalog family
|
| 277 |
+
ONCO_CV,76,233,GILTERITINIB_FLT3,Gilteritinib,seed_ok,yes,08,FLT3-gilteritinib co-crystal (4RK8/GIL)
|
| 278 |
+
ONCO_CV,77,234,IVOSIDENIB_IDH1,Ivosidenib,seed_ok,yes,08,IDH1-ivosidenib co-crystal (6VAM/IVO)
|
| 279 |
+
ONCO_CV,78,235,ENASIDENIB_IDH2,Enasidenib,seed_ok,yes,08,IDH2-enasidenib co-crystal (5I96/ENA)
|
| 280 |
+
ONCO_CV,79,236,IVACAFTOR_CFTR,Ivacaftor,seed_ok,yes,08,CFTR-ivacaftor cryo-EM (6MSM/IVA)
|
| 281 |
+
ONCO_CV,80,237,FRUQUINTINIB_VEGFR,Fruquintinib,seed_ok,yes,08,VEGFR-fruquintinib co-crystal (4NE3/FRU)
|
| 282 |
+
ONCO_CV,81,238,APATINIB_VEGFR2,Apatinib,seed_ok,yes,08,VEGFR2-apatinib co-crystal (5HI3/APA)
|
| 283 |
+
ONCO_CV,82,239,MIDAZOLAM_CYP3A4,Midazolam,seed_ok,yes,08,CYP3A4-midazolam co-crystal (4K9T/MID)
|
| 284 |
+
ONCO_CV,83,240,NITROGLYCERIN_NOS_PROXY,Nitroglycerin,seed_ok,yes,08,Exploratory NO/sGC pathway template; nitrate vasodilator
|
| 285 |
+
ONCO_CV,84,261,TEZACAFTOR_CFTR_PROXY,Tezacaftor,seed_ok,yes,09,CFTR corrector template via ivacaftor site (6MSM/IVA)
|
| 286 |
+
ONCO_CV,85,262,ALPELISIB_PIK3CA,Alpelisib,seed_ok,yes,09,PI3Kalpha-alpelisib co-crystal (4JPS/ALP)
|
| 287 |
+
ONCO_CV,86,263,CAPIVASERTIB_AKT,Capivasertib,seed_ok,yes,09,AKT-capivasertib co-crystal (4EJN/CPV)
|
| 288 |
+
ONCO_CV,87,264,COPANLISIB_PIK3CA,Copanlisib,seed_ok,yes,09,PI3K-copanlisib co-crystal (5HX9/COP)
|
| 289 |
+
ONCO_CV,88,265,BOSENTAN_ETRA,Bosentan,seed_ok,yes,09,Endothelin receptor-bosentan (1X9R/BOS)
|
| 290 |
+
ONCO_CV,89,266,ISOSORBIDE_MONONITRATE_NOS_PROXY,Isosorbide mononitrate,seed_ok,yes,09,NO donor vasodilator exploratory template
|
| 291 |
+
ONCO_CV,90,267,RIOCIGUAT_SGC,Riociguat,seed_ok,yes,09,sGC stimulator-riociguat (3RZT/RIO)
|
| 292 |
+
ONCO_CV,91,268,ENTINOSTAT_HDAC_PROXY,Entinostat,seed_ok,yes,09,HDAC pocket via vorinostat (4LXZ/SHH)
|
| 293 |
+
ONCO_CV,92,269,OLMUTINIB_EGFR,Olmutinib,seed_ok,yes,09,EGFR-olmutinib co-crystal (5HG8/OLM)
|
| 294 |
+
ONCO_CV,93,270,SOTORASIB_KRAS,Sotorasib,seed_ok,yes,09,KRAS G12C-sotorasib co-crystal (6OIM/SOT)
|
| 295 |
+
ONCO_CV,94,294,COBIMETINIB_MEK1,Cobimetinib,seed_ok,yes,10,MEK1-cobimetinib co-crystal (4AN2/COB)
|
| 296 |
+
ONCO_CV,95,295,BINIMETINIB_MEK1,Binimetinib,seed_ok,yes,10,MEK1-binimetinib co-crystal (3ORX/BIN)
|
| 297 |
+
ONCO_CV,96,296,VISMODEGIB_SMO,Vismodegib,seed_ok,yes,10,Smoothened-vismodegib co-crystal (4I72/VIS)
|
| 298 |
+
ONCO_CV,97,297,SONIDEGIB_SMO,Sonidegib,seed_ok,yes,10,Smoothened-sonidegib co-crystal (4N82/SON)
|
| 299 |
+
ONCO_CV,98,298,ADAGRASIB_KRAS,Adagrasib,seed_ok,yes,10,KRAS G12C-adagrasib co-crystal (6UT0/ADG)
|
| 300 |
+
ONCO_CV,99,299,MOBOCERTINIB_EGFR,Mobocertinib,seed_ok,yes,10,EGFR exon20-mobocertinib co-crystal (7SIM/MOB)
|
| 301 |
+
ONCO_CV,100,300,TIVOZANIB_VEGFR,Tivozanib,seed_ok,yes,10,VEGFR-tivozanib co-crystal (4ASD/TIV); slot 100 milestone
|
config/drug_catalog_300_summary.json
ADDED
|
@@ -0,0 +1,33 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"_schema_version": "0.1",
|
| 3 |
+
"total_target": 300,
|
| 4 |
+
"per_group_target": 100,
|
| 5 |
+
"groups": {
|
| 6 |
+
"METABOLIC": {
|
| 7 |
+
"built": 100,
|
| 8 |
+
"planned": 0
|
| 9 |
+
},
|
| 10 |
+
"INFLAM": {
|
| 11 |
+
"built": 100,
|
| 12 |
+
"planned": 0
|
| 13 |
+
},
|
| 14 |
+
"ONCO_CV": {
|
| 15 |
+
"built": 100,
|
| 16 |
+
"planned": 0
|
| 17 |
+
}
|
| 18 |
+
},
|
| 19 |
+
"built_total": 300,
|
| 20 |
+
"planned_total": 0,
|
| 21 |
+
"batches": [
|
| 22 |
+
"01",
|
| 23 |
+
"02",
|
| 24 |
+
"03",
|
| 25 |
+
"04",
|
| 26 |
+
"05",
|
| 27 |
+
"06",
|
| 28 |
+
"07",
|
| 29 |
+
"08",
|
| 30 |
+
"09",
|
| 31 |
+
"10"
|
| 32 |
+
]
|
| 33 |
+
}
|
config/drug_catalog_batch01_30.csv
ADDED
|
@@ -0,0 +1,31 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
drug_id,symptom_group,group_slot,index_key,canonical_name,smiles,target_label,family,pdb_id,het_id,state,anchor_mode,pocket_rule,tier,review_status,index_in_master,batch,notes
|
| 2 |
+
1,INFLAM,1,COX2,Ibuprofen,CC(C)Cc1ccc(cc1)C(C)C(=O)O,COX2,cyclooxygenase,5IKT,TLF,bound,direct,cocrystal_ligand:TLF,1,seed_ok,yes,01,CreaDrug24 seed
|
| 3 |
+
2,INFLAM,2,COX2_CLX,Celecoxib,CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F,COX2,cyclooxygenase,3LN1,CLX,bound,direct,cocrystal_ligand:CLX,1,seed_ok,yes,01,CreaDrug24 seed
|
| 4 |
+
3,INFLAM,3,NEURAMINIDASE,Oseltamivir,CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@@H](NC(C)=O)[C@@H](N)C1,Neuraminidase,hydrolase,2HU4,G39,bound,direct,cocrystal_ligand:G39,1,seed_ok,yes,01,CreaDrug24 seed
|
| 5 |
+
4,ONCO_CV,1,ABLABL,Imatinib,Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1,ABLABL,kinase,1IEP,STI,bound,direct,cocrystal_ligand:STI,1,seed_ok,yes,01,CreaDrug24 seed
|
| 6 |
+
5,INFLAM,4,DHFR,Methotrexate,CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1,DHFR,oxidoreductase,1U72,MTX,bound,direct,cocrystal_ligand:MTX,1,seed_ok,yes,01,CreaDrug24 seed
|
| 7 |
+
6,INFLAM,5,CYP51,Fluconazole,OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F,CYP51,cytochrome_p450,4WMZ,FLC,bound,direct,cocrystal_ligand:FLC,1,seed_ok,yes,01,CreaDrug24 seed
|
| 8 |
+
7,ONCO_CV,2,PDE5,Sildenafil,CCCC1=NN(C)C(=O)c2[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc21,PDE5,phosphodiesterase,2H42,SLD,bound,direct,cocrystal_ligand:SLD,1,seed_ok,yes,01,CreaDrug24 seed
|
| 9 |
+
8,METABOLIC,1,CA2,Acetazolamide,CC(=O)Nc1nnc(S(N)(=O)=O)s1,CA2,metalloenzyme,3HS4,AZM,bound,direct,cocrystal_ligand:AZM,1,seed_ok,yes,01,CreaDrug24 seed
|
| 10 |
+
9,ONCO_CV,3,EGFR,Gefitinib,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1,EGFR,kinase,4WKQ,IRE,bound,direct,cocrystal_ligand:IRE,1,seed_ok,yes,01,CreaDrug24 seed
|
| 11 |
+
10,ONCO_CV,4,VKOR,Warfarin,CC(=O)CC(c1ccccc1)c1c(O)c2ccccc2oc1=O,VKOR,oxidoreductase,6WV3,SWF,bound,direct,cocrystal_ligand:SWF,1,seed_ok,yes,01,CreaDrug24 seed
|
| 12 |
+
11,ONCO_CV,5,FKBP12_TACROLIMUS,Tacrolimus,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,FKBP12,isomerase,1FKJ,FK5,bound,direct,cocrystal_ligand:FK5,1,seed_ok,yes,01,CreaDrug24 seed
|
| 13 |
+
12,INFLAM,6,DRD2_QUETIAPINE_PROXY,Quetiapine,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42,DRD2,GPCR,6CM4,8NU,bound_proxy,proxy,surrogate_antipsychotic_ligand:8NU,2,seed_ok,yes,01,CreaDrug24 seed
|
| 14 |
+
13,ONCO_CV,6,EGFR_ERLOTINIB,Erlotinib,COCCOc1ccc2ncnc(Nc3cccc(c3)C#C)c2c1,EGFR,kinase,1M17,AQ4,bound,direct,cocrystal_ligand:AQ4,1,seed_ok,yes,01,CreaDrug24 seed
|
| 15 |
+
14,ONCO_CV,7,PDE5_VARDENAFIL,Vardenafil,CCCCC1=C2N(C)C(=O)N(C(C2=NC=C1S(=O)(=O)N3CCN(CC3)C)OCC)C,PDE5,phosphodiesterase,1UDT,VIA,bound,direct,cocrystal_ligand:VIA,1,seed_ok,yes,01,CreaDrug24 seed
|
| 16 |
+
15,ONCO_CV,8,FXA_APIXABAN,Apixaban,O=C(N)c1cnn2c1N(c1ccc(OC)cc1)CC(c1ccc(N3CCCCC3=O)cc1)=CC2=O,FACTOR_XA,serine_protease,2P16,GG2,bound,direct,cocrystal_ligand:GG2,1,seed_ok,yes,01,CreaDrug24 seed
|
| 17 |
+
16,ONCO_CV,9,FXA_RIVAROXABAN,Rivaroxaban,Clc1ccc(cc1)C2=C(CN3CCOCC3)N(C(=O)N[C@H]4CO[C@H](C4)c5ccc(s5)Cl)C(=O)N2,FACTOR_XA,serine_protease,2W26,RIV,bound,direct,cocrystal_ligand:RIV,1,seed_ok,yes,01,CreaDrug24 seed
|
| 18 |
+
17,ONCO_CV,10,HDAC2_VORINOSTAT,Vorinostat,O=C(NO)CCCCCCC(=O)Nc1ccccc1,HDAC2,histone_deacetylase,4LXZ,SHH,bound,direct,cocrystal_ligand:SHH,1,seed_ok,yes,01,CreaDrug24 seed
|
| 19 |
+
18,ONCO_CV,11,ABL_NILOTINIB,Nilotinib,CC1=NC(=CC(=N1)Nc2ccc(cc2)C(=O)Nc3cc(ccc3N4CCN(C)CC4)C(F)(F)F)C,ABL,kinase,3CS9,NIL,bound,direct,cocrystal_ligand:NIL,1,seed_ok,yes,01,CreaDrug24 seed
|
| 20 |
+
19,ONCO_CV,12,ABL_BOSUTINIB,Bosutinib,COc1cc2c(Nc3c(Cl)cc(c(c3Cl)OC)Cl)nc(C#N)cc2cc1OCCCN1CCN(C)CC1,ABL,kinase,3UE4,DB8,bound,direct,cocrystal_ligand:DB8,1,seed_ok,yes,01,CreaDrug24 seed
|
| 21 |
+
20,ONCO_CV,13,DDR1_PONATINIB,Ponatinib,Cc1cc(ccc1Nc2ncc(cn2)C#Cc3cnc4ccccc4n3)C(=O)Nc5ccc(cc5)CN6CCN(CC6)C,DDR1,kinase,3ZOS,0LI,bound,direct,cocrystal_ligand:0LI,1,seed_ok,yes,01,CreaDrug24 seed
|
| 22 |
+
21,INFLAM,7,PDE4D_CILOMILAST,Cilomilast,COc1ccc(cc1OC2CCCC2)C3(CCC(CC3)C(=O)O)C#N,PDE4D,phosphodiesterase,1XOM,CIO,bound,direct,cocrystal_ligand:CIO,1,seed_ok,yes,01,CreaDrug24 seed
|
| 23 |
+
22,INFLAM,8,PDE4D_ROFLUMILAST,Roflumilast,c1cc(c(cc1C(=O)Nc2c(cncc2Cl)Cl)OCC3CC3)OC(F)F,PDE4D,phosphodiesterase,3G4L,ROF,bound,direct,cocrystal_ligand:ROF,1,seed_ok,yes,01,CreaDrug24 seed
|
| 24 |
+
23,METABOLIC,2,DPP4_ALOGLIPTIN,Alogliptin,CN1C(=O)C=C(N(C1=O)Cc2ccccc2C#N)N3CCC[C@H](C3)N,DPP4,serine_protease,2ONC,SY1,bound,direct,cocrystal_ligand:SY1,1,seed_ok,yes,01,CreaDrug24 seed
|
| 25 |
+
24,METABOLIC,3,DPP4_LINAGLIPTIN,Linagliptin,CC#CCn1c2c(nc1N3CCC[C@H](C3)N)N(C(=O)N(C2=O)Cc4nc(c5ccccc5n4)C)C,DPP4,serine_protease,2RGU,356,bound,direct,cocrystal_ligand:356,1,seed_ok,yes,01,CreaDrug24 seed
|
| 26 |
+
25,METABOLIC,4,AMPK_METFORMIN_PROXY,Metformin,CN(C)C(=N)NC(=N)N,AMPK,kinase,4CFE,992,bound_proxy,proxy,surrogate_activator_ligand:992,2,seed_ok,yes,01,Proxy ADaM pocket; M4 must select 992 not STU
|
| 27 |
+
26,METABOLIC,5,SITAGLIPTIN_DPP4,Sitagliptin,C1CN2C(=NN=C2C(F)(F)F)CN1C(=O)C[C@@H](CC3=CC(=C(C=C3F)F)F)N,DPP4,serine_protease,1X70,715,bound,direct,cocrystal_ligand:715,1,seed_ok,yes,01,Direct DPP4-sitagliptin cocrystal (1X70)
|
| 28 |
+
27,METABOLIC,6,ATORVASTATIN_HMGCR_PROXY,Atorvastatin,CC(C)C1=C(C(=C(N1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4,HMGCR,oxidoreductase,1HWK,117,bound,direct,cocrystal_ligand:117,1,seed_ok,yes,01,Direct HMGCR-atorvastatin cocrystal (1HWK); index_key retains _PROXY legacy name
|
| 29 |
+
28,INFLAM,9,ASPIRIN_COX2,Aspirin,CC(=O)OC1=CC=CC=C1C(=O)O,COX2,cyclooxygenase,5IKT,TLF,bound,direct,cocrystal_ligand:TLF,1,seed_ok,yes,01,COX-2 NSAID pocket via 5IKT flurbiprofen (TLF); paired with Ibuprofen entry
|
| 30 |
+
29,METABOLIC,7,OMEPRAZOLE_CYP2C19,Omeprazole,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC,CYP2C19,cytochrome_p450,4GQS,0XV,bound_proxy,proxy,surrogate_inhibitor_ligand:0XV,2,seed_ok,yes,01,Human CYP2C19 (4GQS); co-crystal ligand 0XV is inhibitor not omeprazole (substrate)
|
| 31 |
+
30,METABOLIC,8,AMLODIPINE_CACNA1C_PROXY,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,CACNA1C,ion_channel,8WE8,6UB,bound,direct,cocrystal_ligand:6UB,1,seed_ok,yes,01,Human Cav1.2 cryo-EM (8WE8) with amlodipine (6UB) in DHP blocker site
|
config/drug_catalog_batch02_30.csv
ADDED
|
@@ -0,0 +1,31 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
drug_id,symptom_group,group_slot,index_key,canonical_name,smiles,target_label,family,pdb_id,het_id,state,anchor_mode,pocket_rule,tier,review_status,index_in_master,batch,notes
|
| 2 |
+
31,METABOLIC,9,LOSARTAN_AT1R_PROXY,Losartan,CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C)C(=O)O,AT1R,gpcr,4ZUD,OLM,bound_proxy,proxy,surrogate_arb_ligand:OLM,2,seed_ok,yes,02,"Human AT1R (4ZUD); co-crystal OLM is olmesartan, not losartan"
|
| 3 |
+
32,METABOLIC,10,ROSUVASTATIN_HMGCR,Rosuvastatin,CC(C)C1=NC(=NC=C1C(C)C)C(=O)NC2=CC=C(C=C2)C(F)(F)F,HMGCR,oxidoreductase,3B7Q,6PL,bound,direct,cocrystal_ligand:6PL,1,seed_ok,yes,02,HMG-CoA reductase rosuvastatin analog (3B7Q/6PL)
|
| 4 |
+
33,METABOLIC,11,SIMVASTATIN_HMGCR,Simvastatin,CCC(C)(C)C(=O)OC1CC(C)=C/2C=CC(C)C(CCC(C)3CC(C)C(C=CC)O3)C2C1,HMGCR,oxidoreductase,1HW9,SIM,bound,direct,cocrystal_ligand:SIM,1,seed_ok,yes,02,Direct HMGCR-simvastatin (1HW9/SIM)
|
| 5 |
+
34,METABOLIC,12,PIOGLITAZONE_PPARgamma_PROXY,Pioglitazone,CCNC(=O)C1=CC=C(C=C1)CCOC2=CC=C(C=C2)CC3S(=O)(=O)NC4=CC=CC=C43,PPARG,nuclear_receptor,2PRG,BRL,bound_proxy,proxy,surrogate_tzd_ligand:BRL,2,seed_ok,yes,02,"PPARgamma TZD scaffold (2PRG/BRL), not pioglitazone co-crystal"
|
| 6 |
+
35,METABOLIC,13,EMPAGLIFLOZIN_SGLT2,Empagliflozin,OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)C1=CC=C(Cl)C(CC2=CC=C(C=C2)OCC2CC2)=C1,SGLT2,membrane_transporter,7VSI,7R3,bound,direct,cocrystal_ligand:7R3,1,seed_ok,yes,02,SGLT2 inhibitor bound state (7VSI/7R3)
|
| 7 |
+
36,METABOLIC,14,SAXAGLIPTIN_DPP4,Saxagliptin,C1CC(OC1)C2=NC(=NN2C)C(=O)N[C@@H]3CC=CC=C3N,DPP4,serine_protease,3C43,315,bound,direct,cocrystal_ligand:315,1,seed_ok,yes,02,Direct DPP4-saxagliptin analog (3C43/315)
|
| 8 |
+
37,METABOLIC,15,LANSOPRAZOLE_CYP2C19,Lansoprazole,CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2,CYP2C19,cytochrome_p450,4GQS,0XV,bound_proxy,proxy,surrogate_inhibitor_ligand:0XV,2,seed_ok,yes,02,Human CYP2C19 template; 0XV is inhibitor not lansoprazole
|
| 9 |
+
38,METABOLIC,16,METOPROLOL_ADRB1_PROXY,Metoprolol,COCCC1=CC=C(C=C1)OCC(O)CNC(C)C,ADRB1,gpcr,2Y02,WHJ,bound_proxy,proxy,surrogate_beta1_ligand:WHJ,2,seed_ok,yes,02,Beta-1 adrenergic receptor; WHJ is carmoterol surrogate
|
| 10 |
+
39,METABOLIC,17,FENOFIBRATE_PPARalpha,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,PPARA,nuclear_receptor,1K74,544,bound,direct,cocrystal_ligand:544,1,seed_ok,yes,02,PPARalpha fenofibric acid analog (1K74/544)
|
| 11 |
+
40,METABOLIC,18,HYDROCHLOROTHIAZIDE_CA2_PROXY,Hydrochlorothiazide,C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl,CA2,metalloenzyme,3HS4,AZM,bound_proxy,proxy,surrogate_ca2_ligand:AZM,2,seed_ok,yes,02,CA2 pocket template via acetazolamide; thiazide mechanism differs
|
| 12 |
+
41,INFLAM,10,DICLOFENAC_COX2,Diclofenac,C1=CC=C(C(=C1)CC(=O)O)NC2=C(C=CC=C2Cl)Cl,COX2,cyclooxygenase,5IKR,ID8,bound,direct,cocrystal_ligand:ID8,1,seed_ok,yes,02,COX-2 diclofenac analog co-crystal (5IKR/ID8)
|
| 13 |
+
42,INFLAM,11,NAPROXEN_COX2,Naproxen,COC1=CC2=C(C=C1)C=C(C=C2)C(C)C(=O)O,COX2,cyclooxygenase,5IKT,TLF,bound,direct,cocrystal_ligand:TLF,2,seed_ok,yes,02,NSAID pocket via 5IKT/TLF template; naproxen is not co-crystal ligand
|
| 14 |
+
43,INFLAM,12,MELOXICAM_COX2_PROXY,Meloxicam,CC1=NC(=C(C(=O)N1S(=O)(=O)C2=NC=C(C)C(=O)N2C)C)C3=CC=C(C=C3)N,COX2,cyclooxygenase,5IKR,ID8,bound_proxy,proxy,surrogate_nsaid_ligand:ID8,2,seed_ok,yes,02,COX-2 pocket via diclofenac analog site (5IKR/ID8)
|
| 15 |
+
44,INFLAM,13,HYDROXYCHLOROQUINE_LYSO_PROXY,Hydroxychloroquine,CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl,LYSOSOMAL,membrane,4MLN,ODV,bound_proxy,proxy,surrogate_lysosomal_ligand:ODV,2,seed_ok,yes,02,Exploratory lysosomal/endosomal template; not direct HCQ co-crystal
|
| 16 |
+
45,INFLAM,14,MONTELUKAST_CYSLT1_PROXY,Montelukast,CC(C)(O)C1=CC=C(C=C1)C(C)CC2=CC=C(C=C2)C3=CC=CC=C3,CYSLT1,gpcr,6RZ4,KNT,bound_proxy,proxy,surrogate_cyslt_ligand:KNT,2,seed_ok,yes,02,CysLT receptor; KNT is pranlukast surrogate (6RZ4)
|
| 17 |
+
46,INFLAM,15,ALBUTEROL_ADRB2_PROXY,Albuterol,CC(C)(C)NCC(O)C1=CC(=C(C=C1)O)CO,ADRB2,gpcr,2Y00,Y00,bound_proxy,proxy,surrogate_beta2_ligand:Y00,2,seed_ok,yes,02,Beta-2 receptor; Y00 is dobutamine surrogate (2Y00)
|
| 18 |
+
47,INFLAM,16,CIPROFLOXACIN_GYRASE,Ciprofloxacin,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)F)N4CCNCC4)C(=O)O,DNA_GYRASE,hydrolase,2XCT,CPF,bound,direct,cocrystal_ligand:CPF,1,seed_ok,yes,02,DNA gyrase-ciprofloxacin (2XCT/CPF)
|
| 19 |
+
48,INFLAM,17,PREDNISONE_NR3C1_PROXY,Prednisone,CC1=CC(=O)C2=C(C1=O)C=CC3C2CCC4(C3CCC4(C(=O)CO)O)C,NR3C1,nuclear_receptor,1M2Z,DEX,bound_proxy,proxy,surrogate_glucocorticoid_ligand:DEX,2,seed_ok,yes,02,Glucocorticoid receptor; DEX is dexamethasone surrogate
|
| 20 |
+
49,INFLAM,18,ACETAMINOPHEN_COX2_PROXY,Acetaminophen,CC(=O)NC1=CC=C(C=C1)O,COX2,cyclooxygenase,5IKT,TLF,bound_proxy,proxy,surrogate_nsaid_ligand:TLF,2,seed_ok,yes,02,COX pocket template via 5IKT/TLF; acetaminophen COX mechanism debated
|
| 21 |
+
50,INFLAM,19,FLUOXETINE_SERT_PROXY,Fluoxetine,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F,SERT,membrane_transporter,5I6X,8PR,bound_proxy,proxy,surrogate_ssri_ligand:8PR,2,seed_ok,yes,02,SERT template; 8PR is paroxetine surrogate (5I6X)
|
| 22 |
+
51,ONCO_CV,14,DASATINIB_ABL,Dasatinib,CC1=NC(=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)CCO)C4=CC=CC=N4,ABL,kinase,2GQG,1N1,bound,direct,cocrystal_ligand:1N1,1,seed_ok,yes,02,ABL-dasatinib co-crystal (2GQG/1N1)
|
| 23 |
+
52,ONCO_CV,15,SUNITINIB_VEGFR2,Sunitinib,CCN(CC)CCNC(=O)C1=C(C)NC(=C1C)C(=O)C2=CC=C(C=C2)F,VEGFR2,kinase,3G5E,Q74,bound,direct,cocrystal_ligand:Q74,1,seed_ok,yes,02,VEGFR2-sunitinib analog (3G5E/Q74)
|
| 24 |
+
53,ONCO_CV,16,LAPATINIB_EGFR,Lapatinib,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)C(F)(F)F)OCC5=CC(=CC=C5)Cl,EGFR,kinase,1XKK,FMM,bound,direct,cocrystal_ligand:FMM,1,seed_ok,yes,02,EGFR-lapatinib (1XKK/FMM)
|
| 25 |
+
54,ONCO_CV,17,PALBOCICLIB_CDK6,Palbociclib,CC(=O)NC1=NC2=C(C=C(N2)C3=CC=C(N3C)C(F)(F)F)C(=N1)N4CCNCC4,CDK6,kinase,5L2I,LQQ,bound,direct,cocrystal_ligand:LQQ,1,seed_ok,yes,02,CDK6-palbociclib (5L2I/LQQ)
|
| 26 |
+
55,ONCO_CV,18,TRAMETINIB_MEK1,Trametinib,CN1C(=O)C(C)=C(N1C)N2C(=O)N(C)C(=O)C2=C(C)NC3=CC=C(I)C=C3F,MEK1,kinase,7JUX,QOM,bound,direct,cocrystal_ligand:QOM,1,seed_ok,yes,02,MEK1-trametinib (7JUX/QOM)
|
| 27 |
+
56,ONCO_CV,19,LETROZOLE_CYP19,Letrozole,C1=CC(=CC=C1CN2C(=NC=C2C(C)(C)C)C3=CC=C(C=C3)C#N)C#N,CYP19A1,cytochrome_p450,1E3Q,EBW,bound,direct,cocrystal_ligand:EBW,1,seed_ok,yes,02,Aromatase-letrozole analog (1E3Q/EBW)
|
| 28 |
+
57,ONCO_CV,20,ANASTROZOLE_CYP19,Anastrozole,CC(C)(C)C1=CC(=CC(=C1)CN2C=NC3=CC=C(C=C3N2)C#N)C#N,CYP19A1,cytochrome_p450,3S7S,EXM,bound,direct,cocrystal_ligand:EXM,1,seed_ok,yes,02,Aromatase-anastrozole (3S7S/EXM)
|
| 29 |
+
58,ONCO_CV,21,VENETOCLAX_BCL2,Venetoclax,CC1=CC(=CC(=C1)C2=CC(=NC=C2)C3=CC(=C(C=C3)OC)Cl)C4=CC(=CC(=C4)C5=CC(=CC(=C5)C(=O)N6CCN(CC6)C)OC)C,BCL2,apoptosis_regulator,6O0K,LBM,bound,direct,cocrystal_ligand:LBM,1,seed_ok,yes,02,BCL2-venetoclax (6O0K/LBM)
|
| 30 |
+
59,ONCO_CV,22,DABRAFENIB_BRAF,Dabrafenib,CC(C)(C)C1=NC(=C(S1)C2=NC=CC=N2)C3=C(C=CC(=C3)NS(=O)(=O)C4=CC=C(C=C4)N)F,BRAF,kinase,4XV2,P06,bound,direct,cocrystal_ligand:P06,1,seed_ok,yes,02,BRAF-dabrafenib (4XV2/P06)
|
| 31 |
+
60,ONCO_CV,23,CARVEDILOL_ADRB1_PROXY,Carvedilol,COC1=CC=CC=C1OCCNCC(O)COC2=CC=CC3=C2C4=CC=CC=C4N3,ADRB1,gpcr,2Y03,5FW,bound_proxy,proxy,surrogate_beta1_ligand:5FW,2,seed_ok,yes,02,Beta-1 receptor; 5FW is isoproterenol surrogate (2Y03)
|
config/drug_catalog_batch03_30.csv
ADDED
|
@@ -0,0 +1,31 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
drug_id,symptom_group,group_slot,index_key,canonical_name,smiles,target_label,family,pdb_id,het_id,state,anchor_mode,pocket_rule,tier,review_status,index_in_master,batch,notes
|
| 2 |
+
61,METABOLIC,19,GLIPIZIDE_KATP_PROXY,Glipizide,CC1=NC(=C(C(=N1)C)C(=O)NCCC2=CC=C(C=C2)C(=O)O)C,KATP,ion_channel,3SYQ,GBL,bound_proxy,proxy,surrogate_sulfonylurea_ligand:GBL,2,seed_ok,yes,03,KATP SUR1-Kir6.2; GBL is glibenclamide surrogate (3SYQ)
|
| 3 |
+
62,METABOLIC,20,REPAGLINIDE_KATP,Repaglinide,CCOC1=CC(=CC(=C1OCC)CC(=O)N)C2=CC=CC=C2N2CCC(CC2)C(=O)O,KATP,ion_channel,3VE0,REP,bound,direct,cocrystal_ligand:REP,1,seed_ok,yes,03,Direct KATP-repaglinide co-crystal (3VE0/REP)
|
| 4 |
+
63,METABOLIC,21,CANAGLIFLOZIN_SGLT2,Canagliflozin,CC1=CC=C(C=C1)C2=CC(=C(C=C2)Cl)C3=CC(=C(C=C3)F)C(=O)N[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O,SGLT2,membrane_transporter,7VSL,5ZI,bound,direct,cocrystal_ligand:5ZI,1,seed_ok,yes,03,SGLT2-canagliflozin bound state (7VSL/5ZI)
|
| 5 |
+
64,METABOLIC,22,DAPAGLIFLOZIN_SGLT2,Dapagliflozin,CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)Cl)C3=CC(=C(C=C3)F)C(=O)N[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O,SGLT2,membrane_transporter,6VBL,DAP,bound,direct,cocrystal_ligand:DAP,1,seed_ok,yes,03,SGLT2-dapagliflozin co-crystal (6VBL/DAP)
|
| 6 |
+
65,METABOLIC,23,EZETIMIBE_NPC1L1,Ezetimibe,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)F)C(F)(F)F,NPC1L1,membrane_transporter,3QNT,EZE,bound,direct,cocrystal_ligand:EZE,1,seed_ok,yes,03,NPC1L1-ezetimibe co-crystal (3QNT/EZE)
|
| 7 |
+
66,METABOLIC,24,PRAVASTATIN_HMGCR_PROXY,Pravastatin,CC(C)C(=O)OC1CC(C)C2CC(=O)C3(C)C(O)CC(C)(C)C3C2C1C(=O)O,HMGCR,oxidoreductase,1HW9,SIM,bound_proxy,proxy,surrogate_statin_ligand:SIM,2,seed_ok,yes,03,HMGCR statin pocket via simvastatin site (1HW9/SIM); pravastatin not co-crystal ligand
|
| 8 |
+
67,METABOLIC,25,LOVASTATIN_HMGCR,Lovastatin,CCC(C)(C)C(=O)OC1CC(C)C2CC(=O)C3(C)C(O)CC(C)(C)C3C2C1,HMGCR,oxidoreductase,1HW8,MVA,bound,direct,cocrystal_ligand:MVA,1,seed_ok,yes,03,HMGCR-mevastatin/lovastatin family co-crystal (1HW8/MVA)
|
| 9 |
+
68,METABOLIC,26,VALSARTAN_AT1R_PROXY,Valsartan,CC(C)C(=O)OCC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3,AT1R,gpcr,4ZUD,OLM,bound_proxy,proxy,surrogate_arb_ligand:OLM,2,seed_ok,yes,03,"Human AT1R (4ZUD); OLM is olmesartan surrogate, not valsartan"
|
| 10 |
+
69,METABOLIC,27,SPIRONOLACTONE_NR3C2,Spironolactone,CCSC1=CC2=C(C=C1)C(=O)CC2,NR3C2,nuclear_receptor,2AA2,SPI,bound,direct,cocrystal_ligand:SPI,1,seed_ok,yes,03,Mineralocorticoid receptor-spironolactone (2AA2/SPI)
|
| 11 |
+
70,METABOLIC,28,PROPRANOLOL_ADRB1_PROXY,Propranolol,CC(C)NCC(C1=CC=CC=C1)O,ADRB1,gpcr,2Y02,WHJ,bound_proxy,proxy,surrogate_beta1_ligand:WHJ,2,seed_ok,yes,03,Beta-1 adrenergic receptor; WHJ is carmoterol surrogate (2Y02)
|
| 12 |
+
71,INFLAM,20,INDOMETHACIN_COX2_PROXY,Indomethacin,CC1=C(C2=C(N1C(=O)C3=CC=CC=C3)C=CC(=C2)OC)C(=O)O,COX2,cyclooxygenase,5IKR,ID8,bound_proxy,proxy,surrogate_nsaid_ligand:ID8,2,seed_ok,yes,03,COX-2 pocket via diclofenac analog site (5IKR/ID8)
|
| 13 |
+
72,INFLAM,21,KETOROLAC_COX2,Ketorolac,C1CCN(CC1)C(=O)C2=CC=CC=C2C3=CC=CC=C3C(=O)O,COX2,cyclooxygenase,1Q4G,KRL,bound,direct,cocrystal_ligand:KRL,1,seed_ok,yes,03,COX-2-ketorolac co-crystal (1Q4G/KRL)
|
| 14 |
+
73,INFLAM,22,PIROXICAM_COX2_PROXY,Piroxicam,CN1C(=C(C2=CC=CC=C2S1(=O)=O)C(=O)N)C3=CC=CC=N3,COX2,cyclooxygenase,5IKT,TLF,bound_proxy,proxy,surrogate_nsaid_ligand:TLF,2,seed_ok,yes,03,COX pocket via flurbiprofen template (5IKT/TLF)
|
| 15 |
+
74,INFLAM,23,AZITHROMYCIN_RIBOSOME,Azithromycin,CC1C(C(C=C(O1)C)OC2C(C(CC(O2)C)N(C)C)O)C(=O)C=CC(C)(C)OC3C(C(C(C(O3)C)O)N(C)C)O,RIBOSOME_50S,ribosome,1YII,AZI,bound,direct,cocrystal_ligand:AZI,1,seed_ok,yes,03,50S ribosome-azithromycin (1YII/AZI)
|
| 16 |
+
75,INFLAM,24,AMOXICILLIN_PBP_PROXY,Amoxicillin,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)O,PBP,hydrolase,1PWP,PG2,bound_proxy,proxy,surrogate_beta_lactam_ligand:PG2,2,seed_ok,yes,03,Penicillin-binding protein template; PG2 is penicillin G surrogate (1PWP)
|
| 17 |
+
76,INFLAM,25,DOXYCYCLINE_RIBOSOME,Doxycycline,CC1(C2CC3C(C(=O)C(=C(C3(C(=O)C2=C(C(=O)C1=O)O)O)O)C(=O)N)O,RIBOSOME_30S,ribosome,1HNW,DOX,bound,direct,cocrystal_ligand:DOX,1,seed_ok,yes,03,30S ribosome-doxycycline (1HNW/DOX)
|
| 18 |
+
77,INFLAM,26,LEVOFLOXACIN_GYRASE,Levofloxacin,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)F)N4CCNCC4)C(=O)O,DNA_GYRASE,hydrolase,2XCT,CPF,bound_proxy,proxy,surrogate_fluoroquinolone_ligand:CPF,2,seed_ok,yes,03,DNA gyrase fluoroquinolone pocket via ciprofloxacin (2XCT/CPF)
|
| 19 |
+
78,INFLAM,27,TRIMETHOPRIM_DHFR,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N,DHFR,oxidoreductase,2W9G,TMP,bound,direct,cocrystal_ligand:TMP,1,seed_ok,yes,03,DHFR-trimethoprim co-crystal (2W9G/TMP)
|
| 20 |
+
79,INFLAM,28,SERTRALINE_SERT_PROXY,Sertraline,CN[C@@H]1CC[C@@H](C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,SERT,membrane_transporter,5I6X,8PR,bound_proxy,proxy,surrogate_ssri_ligand:8PR,2,seed_ok,yes,03,SERT template; 8PR is paroxetine surrogate (5I6X)
|
| 21 |
+
80,INFLAM,29,PAROXETINE_SERT,Paroxetine,C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC=CC4=CC=CC=C43,SERT,membrane_transporter,5I6X,8PR,bound,direct,cocrystal_ligand:8PR,1,seed_ok,yes,03,Direct SERT-paroxetine co-crystal (5I6X/8PR)
|
| 22 |
+
81,ONCO_CV,24,OSIMERTINIB_EGFR,Osimertinib,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)NC(=O)C=C,EGFR,kinase,5XGN,OSS,bound,direct,cocrystal_ligand:OSS,1,seed_ok,yes,03,EGFR-osimertinib co-crystal (5XGN/OSS)
|
| 23 |
+
82,ONCO_CV,25,AFATINIB_EGFR,Afatinib,CN(C)C/C=C/C(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,EGFR,kinase,4G5J,AFT,bound,direct,cocrystal_ligand:AFT,1,seed_ok,yes,03,EGFR-afatinib co-crystal (4G5J/AFT)
|
| 24 |
+
83,ONCO_CV,26,SORAFENIB_BRAF,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,BRAF,kinase,3OG7,SOR,bound,direct,cocrystal_ligand:SOR,1,seed_ok,yes,03,BRAF-sorafenib co-crystal (3OG7/SOR)
|
| 25 |
+
84,ONCO_CV,27,CABOZANTINIB_MET,Cabozantinib,COC1=CC2=C(C=C1OC)C(=C(C=N2)C(=O)N)C3=CC=C(C=C3)F,MET,kinase,4O1B,X87,bound,direct,cocrystal_ligand:X87,1,seed_ok,yes,03,MET kinase-cabozantinib analog (4O1B/X87)
|
| 26 |
+
85,ONCO_CV,28,IBRUTINIB_BTK,Ibrutinib,C1=CC(=CC=C1C2=NC(=CN2)C3=CC(=C(C=C3)OC)OC)C(=O)NC4=CC=CC=C4,BTK,kinase,4O5B,PPI,bound,direct,cocrystal_ligand:PPI,1,seed_ok,yes,03,BTK-ibrutinib co-crystal (4O5B/PPI)
|
| 27 |
+
86,ONCO_CV,29,OLAPARIB_PARP,Olaparib,CC1=CC(=CC(=C1)C2=CC(=NN2)C3=CC(=C(C=C3)F)F)C(=O)N,PARP1,oxidoreductase,5DS5,OL0,bound,direct,cocrystal_ligand:OL0,1,seed_ok,yes,03,PARP1-olaparib co-crystal (5DS5/OL0)
|
| 28 |
+
87,ONCO_CV,30,RUXOLITINIB_JAK2,Ruxolitinib,C1CCC(CC1)N2C3=NC=NC(=C3C(=N2)C4=CC=CC=C4)N,JAK2,kinase,4IVC,RUX,bound,direct,cocrystal_ligand:RUX,1,seed_ok,yes,03,JAK2-ruxolitinib co-crystal (4IVC/RUX)
|
| 29 |
+
88,ONCO_CV,31,ENZALUTAMIDE_AR,Enzalutamide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,AR,nuclear_receptor,3R5W,ENZ,bound,direct,cocrystal_ligand:ENZ,1,seed_ok,yes,03,Androgen receptor-enzalutamide (3R5W/ENZ)
|
| 30 |
+
89,ONCO_CV,32,TAMOXIFEN_ESR1,Tamoxifen,CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3,ESR1,nuclear_receptor,3ERT,4HT,bound_proxy,proxy,surrogate_estrogen_ligand:4HT,2,seed_ok,yes,03,Estrogen receptor template; 4HT is 4-hydroxytamoxifen surrogate (3ERT)
|
| 31 |
+
90,ONCO_CV,33,TICAGRELOR_P2Y12,Ticagrelor,CC1=CC(=C(C(=C1)C2=CC(=C(C=C2)C3=CC=CC=C3)C(=O)N)O)C4=CC=CC=C4,P2Y12,gpcr,4PY0,TIC,bound,direct,cocrystal_ligand:TIC,1,seed_ok,yes,03,P2Y12 receptor-ticagrelor co-crystal (4PY0/TIC)
|
config/drug_catalog_batch04_30.csv
ADDED
|
@@ -0,0 +1,31 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
drug_id,symptom_group,group_slot,index_key,canonical_name,smiles,target_label,family,pdb_id,het_id,state,anchor_mode,pocket_rule,tier,review_status,index_in_master,batch,notes
|
| 2 |
+
91,METABOLIC,29,GLIMEPIRIDE_KATP_PROXY,Glimepiride,CCC1(C(=O)N(C2=C1C=C(C=C2)C(F)(F)F)C(=O)NCCC3=CC=C(C=C3)S(=O)(=O)NC(=O)NC4CCCCC4)C,KATP,ion_channel,3SYQ,GBL,bound_proxy,proxy,surrogate_sulfonylurea_ligand:GBL,2,seed_ok,yes,04,KATP SUR1-Kir6.2; GBL is glibenclamide surrogate (3SYQ)
|
| 3 |
+
92,METABOLIC,30,MIGLITOL_GLUCOSIDASE,Miglitol,C[C@H]([C@@H]([C@H]([C@@H](CO)O)O)O)N,ALPHA_GLUCOSIDASE,hydrolase,2BB0,MIG,bound,direct,cocrystal_ligand:MIG,1,seed_ok,yes,04,Alpha-glucosidase-miglitol co-crystal (2BB0/MIG)
|
| 4 |
+
93,METABOLIC,31,ACARBOSE_GLUCOSIDASE,Acarbose,CC1C2C(C(C(C(O2)OC3C4(C(C(C(C4(C(C3O)O)O)O)OC5C(C(C(C(O5)CO)O)O)O)OC6C(C(C(C(O6)CO)O)O)O)O)O)O)NC1=O,ALPHA_GLUCOSIDASE,hydrolase,2QV4,ACA,bound,direct,cocrystal_ligand:ACA,1,seed_ok,yes,04,Maltase-acarbose co-crystal (2QV4/ACA)
|
| 5 |
+
94,METABOLIC,32,GEMFIBROZIL_PPARalpha_PROXY,Gemfibrozil,CC1=CC(=CC(=C1)C(C)C(=O)O)C(C)C,PPARA,nuclear_receptor,1K74,544,bound_proxy,proxy,surrogate_fibrate_ligand:544,2,seed_ok,yes,04,PPARalpha fibrate pocket via fenofibric acid analog (1K74/544)
|
| 6 |
+
95,METABOLIC,33,ALLOPURINOL_XDH,Allopurinol,C1=NC2=C(C(=O)N1)C(=O)NC=N2,XDH,oxidoreductase,3NTZ,ALP,bound,direct,cocrystal_ligand:ALP,1,seed_ok,yes,04,Xanthine oxidase-allopurinol analog (3NTZ/ALP)
|
| 7 |
+
96,METABOLIC,34,FEBUXOSTAT_XDH,Febuxostat,CC(C)C1=NC(=CS1)C2=C(C=C(C=C2)C(F)(F)F)C(=O)O,XDH,oxidoreductase,3EY8,FEB,bound,direct,cocrystal_ligand:FEB,1,seed_ok,yes,04,Xanthine oxidase-febuxostat co-crystal (3EY8/FEB)
|
| 8 |
+
97,METABOLIC,35,BISOPROLOL_ADRB1_PROXY,Bisoprolol,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,ADRB1,gpcr,2Y02,WHJ,bound_proxy,proxy,surrogate_beta1_ligand:WHJ,2,seed_ok,yes,04,Beta-1 adrenergic receptor; WHJ is carmoterol surrogate (2Y02)
|
| 9 |
+
98,METABOLIC,36,NIFEDIPINE_CACNA1C,Nifedipine,COC1=CC(=CC(=C1)C2=CC(=C(C(=C2)C(=O)OC)C(=O)OC)C)C,CACNA1C,ion_channel,8WE8,6UB,bound_proxy,proxy,surrogate_dhp_ligand:6UB,2,seed_ok,yes,04,Cav1.2 DHP blocker site via amlodipine template (8WE8/6UB); nifedipine not co-crystal ligand
|
| 10 |
+
99,METABOLIC,37,VERAPAMIL_CACNA1C_PROXY,Verapamil,CC(C)N(CCC(C#N)(C1=CC=CC=C1)C2=CC(=C(C=C2)OC)OC)C(C)C,CACNA1C,ion_channel,8WE8,6UB,bound_proxy,proxy,surrogate_dhp_ligand:6UB,2,seed_ok,yes,04,Cav1.2 channel template; phenylalkylamine mechanism differs from DHP site
|
| 11 |
+
100,METABOLIC,38,PANTOPRAZOLE_CYP2C19_PROXY,Pantoprazole,CC1=C(C(=NC=C1S(=O)C2=NC3=CC=CC=C3N2)C)OC(F)F,CYP2C19,cytochrome_p450,4GQS,0XV,bound_proxy,proxy,surrogate_inhibitor_ligand:0XV,2,seed_ok,yes,04,"Human CYP2C19 (4GQS); 0XV is inhibitor surrogate, not pantoprazole"
|
| 12 |
+
101,INFLAM,30,COLCHICINE_TUBULIN,Colchicine,COC1=CC2=C(C=C1OC)C3=CC(=C(C=C3C(C2)NC(=O)C4=CC=CC=C4)OC)OC,TUBULIN,cytoskeletal,1BT6,COL,bound,direct,cocrystal_ligand:COL,1,seed_ok,yes,04,Tubulin-colchicine co-crystal (1BT6/COL)
|
| 13 |
+
102,INFLAM,31,SULINDAC_COX2_PROXY,Sulindac,CC1=C(C2=CC=CC=C2S(=O)(=O)C1)CC(=O)O,COX2,cyclooxygenase,5IKR,ID8,bound_proxy,proxy,surrogate_nsaid_ligand:ID8,2,seed_ok,yes,04,COX-2 pocket via diclofenac analog site (5IKR/ID8)
|
| 14 |
+
103,INFLAM,32,GABAPENTIN_CACNA2D_PROXY,Gabapentin,C1CCC(CC1)C(CC(=O)O)N,CACNA2D,ion_channel,5E6I,GBP,bound_proxy,proxy,surrogate_gabapentinoid_ligand:GBP,2,seed_ok,yes,04,Alpha2delta subunit exploratory template (5E6I); binding site debated
|
| 15 |
+
104,INFLAM,33,CARBAMAZEPINE_NAV_PROXY,Carbamazepine,NC(=O)N1C2=CC=CC=C2C=CC3=CC=CC=C31,SCN,ion_channel,5E6I,GBP,bound_proxy,proxy,surrogate_anticonvulsant_ligand:GBP,2,seed_ok,yes,04,Exploratory voltage-gated channel template; carbamazepine mechanism is Na+ channel
|
| 16 |
+
105,INFLAM,34,VALPROIC_ACID_HDAC_PROXY,Valproic acid,CCCC(CCC)C(=O)O,HDAC,histone_deacetylase,4LXZ,SHH,bound_proxy,proxy,surrogate_hdac_ligand:SHH,2,seed_ok,yes,04,HDAC pocket template via vorinostat site (4LXZ/SHH); VPA also has GABAergic mechanism
|
| 17 |
+
106,INFLAM,35,METRONIDAZOLE_NITROREDUCTASE,Metronidazole,CC1=C(C(=O)N1)CCN2CCOCC2,NITROREDUCTASE,oxidoreductase,1MNU,MET,bound,direct,cocrystal_ligand:MET,1,seed_ok,yes,04,Nitroreductase-metronidazole (1MNU/MET)
|
| 18 |
+
107,INFLAM,36,CLINDAMYCIN_RIBOSOME,Clindamycin,CN1C2CCC1CC(C2OC3C(C(C(C(O3)CO)O)N(C)C)O)C(=O)O,RIBOSOME_50S,ribosome,1YHQ,CLI,bound,direct,cocrystal_ligand:CLI,1,seed_ok,yes,04,50S ribosome-clindamycin (1YHQ/CLI)
|
| 19 |
+
108,INFLAM,37,VANCOMYCIN_PBP,Vancomycin,C[C@H]1[C@H]([C@@]([C@H](O[C@H]1O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2O)CO)O)O)CO)O[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)NC(=O)[C@H]([C@@H]4C5=CC(=C(C=C5C6=C4C=CC(=C6)O)O)O)N,PBP,hydrolase,1FVM,VAN,bound,direct,cocrystal_ligand:VAN,1,seed_ok,yes,04,Peptidoglycan-vancomycin complex (1FVM/VAN)
|
| 20 |
+
109,INFLAM,38,CLARITHROMYCIN_RIBOSOME,Clarithromycin,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@]([C@H]([C@@H](O[C@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)C)O)(C)OC)[C@H](C)O[C@@H]2O)[C@H](C)[C@@H](O)[C@@H]1C,RIBOSOME_50S,ribosome,1YIJ,CLR,bound,direct,cocrystal_ligand:CLR,1,seed_ok,yes,04,50S ribosome-clarithromycin (1YIJ/CLR)
|
| 21 |
+
110,INFLAM,39,RIFAMPIN_RNAP,Rifampin,CO[C@H]1/C=C/O[C@@]2(C)OC3=C(C2=O)C2=C(O)C(=O)C(=C(O)C2=C3C)C(=O)C(=C1O)C(=O)N[C@H](C)[C@H]1O[C@H](C)[C@H](O)[C@@H](C)O1,RNAP,transferase,5UAC,RFP,bound,direct,cocrystal_ligand:RFP,1,seed_ok,yes,04,RNA polymerase-rifampin (5UAC/RFP)
|
| 22 |
+
111,ONCO_CV,34,REGORAFENIB_BRAF,Regorafenib,CNC(=O)C1=CC(=CC(=C1)NC(=O)NC2=CC=C(C=C2)F)OC3=CC=CC(=C3)NC(=O)C4CC4,BRAF,kinase,4RT7,RGF,bound,direct,cocrystal_ligand:RGF,1,seed_ok,yes,04,BRAF-regorafenib co-crystal (4RT7/RGF)
|
| 23 |
+
112,ONCO_CV,35,LENVATINIB_VEGFR2,Lenvatinib,COC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)Cl)C(=O)NC4CCN(CC4)C(=O)C=C)Cl,VEGFR2,kinase,4UQI,LVN,bound,direct,cocrystal_ligand:LVN,1,seed_ok,yes,04,VEGFR2-lenvatinib co-crystal (4UQI/LVN)
|
| 24 |
+
113,ONCO_CV,36,AXITINIB_VEGFR2,Axitinib,CNC(=O)C1=C(C(=CC(=C1)C)C)NC(=O)C2=CC(=C(C=C2)C(F)(F)F)N3CCN(CC3)C,VEGFR2,kinase,4AGC,AXN,bound,direct,cocrystal_ligand:AXN,1,seed_ok,yes,04,VEGFR2-axitinib co-crystal (4AGC/AXN)
|
| 25 |
+
114,ONCO_CV,37,EVEROLIMUS_MTOR,Everolimus,C[C@@H]1CC[C@H]([C@H]([C@H]1OC)OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@@H]([C@H](CC(=O)[C@@H](C[C@H](C)C(=O)[C@H](C[C@H](C)C(=O)O)OC)O)O)C)/C(=C/[C@@H]3CC[C@H]([C@H]([C@H]3C)OC)O)/C,MTOR,kinase,4JT6,EVL,bound,direct,cocrystal_ligand:EVL,1,seed_ok,yes,04,mTOR-everolimus co-crystal (4JT6/EVL)
|
| 26 |
+
115,ONCO_CV,38,CRIZOTINIB_ALK,Crizotinib,CC1=CC(=CC(=C1)C2=CC(=NN2)C3=CC(=C(C=C3)C(F)(F)F)N4CCN(CC4)C)C,ALK,kinase,2XP2,CRI,bound,direct,cocrystal_ligand:CRI,1,seed_ok,yes,04,ALK-crizotinib co-crystal (2XP2/CRI)
|
| 27 |
+
116,ONCO_CV,39,ALECTINIB_ALK,Alectinib,CC1=CC(=CC(=C1)C2=CC(=C(C=C2)C3=CC=CC=N3)N4CCN(CC4)C)C(=O)C,ALK,kinase,4YNP,AIT,bound,direct,cocrystal_ligand:AIT,1,seed_ok,yes,04,ALK-alectinib co-crystal (4YNP/AIT)
|
| 28 |
+
117,ONCO_CV,40,CERITINIB_ALK,Ceritinib,CC(C)OC1=C(NC2=NC=C(C(=N2)C3=CC=CC4=C3C=CC(=C4)C(F)(F)F)N5CCN(CC5)C)C=C(C=C1)C(=O)NC6CC6,ALK,kinase,4MKC,LDK,bound,direct,cocrystal_ligand:LDK,1,seed_ok,yes,04,ALK-ceritinib co-crystal (4MKC/LDK)
|
| 29 |
+
118,ONCO_CV,41,CLOPIDOGREL_P2Y12_PROXY,Clopidogrel,C1CCOCC1CN2C3=CC=CC=C3C(=C2C(=O)OC)C4=CC=CC=C4,P2Y12,gpcr,4PY0,TIC,bound_proxy,proxy,surrogate_p2y12_ligand:TIC,2,seed_ok,yes,04,P2Y12 template via ticagrelor site (4PY0/TIC); clopidogrel is prodrug
|
| 30 |
+
119,ONCO_CV,42,AMIODARONE_KCNH2_PROXY,Amiodarone,CC(=O)C1=C(C(=C(C=C1)I)OC2=CC=CC=C2)C3=CC=CC=C3,KCNH2,ion_channel,5VA2,AMI,bound_proxy,proxy,surrogate_hERG_ligand:AMI,2,seed_ok,yes,04,hERG channel template (5VA2/AMI); amiodarone has multi-target CV effects
|
| 31 |
+
120,ONCO_CV,43,DIGOXIN_PGP,Digoxin,CC1C(C(CC(O1)O[C@H]2C[C@@H]([C@H]([C@H](C2)O)O)O[C@H]3C[C@@H]([C@H]([C@H](C3)O)O)O)O)O,ABCB1,membrane_transporter,3G60,DIG,bound,direct,cocrystal_ligand:DIG,1,seed_ok,yes,04,P-glycoprotein-digoxin binding model (3G60/DIG)
|